Citrus Sinensis ID: 016950
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | 2.2.26 [Sep-21-2011] | |||||||
| Q39011 | 380 | Shaggy-related protein ki | yes | no | 1.0 | 1.0 | 0.931 | 0.0 | |
| Q39010 | 412 | Shaggy-related protein ki | no | no | 0.992 | 0.915 | 0.893 | 0.0 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.973 | 0.909 | 0.902 | 0.0 | |
| Q8VZD5 | 410 | Shaggy-related protein ki | no | no | 0.971 | 0.9 | 0.821 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.971 | 0.902 | 0.791 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.978 | 0.918 | 0.792 | 0.0 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.978 | 0.909 | 0.779 | 1e-179 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.978 | 0.905 | 0.779 | 1e-178 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.973 | 0.900 | 0.782 | 1e-178 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.978 | 0.905 | 0.766 | 1e-177 |
| >sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/380 (93%), Positives = 368/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/377 (89%), Positives = 364/377 (96%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 334
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
RLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LI
Sbjct: 335 RLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLI 394
Query: 363 PDHVKRQLGLNFLHPAG 379
P+HV+RQ+ F AG
Sbjct: 395 PEHVRRQMNGGFPFQAG 411
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/370 (90%), Positives = 358/370 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 31 LDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 90
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE
Sbjct: 91 ETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 150
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQV
Sbjct: 151 TLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQV 210
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPL
Sbjct: 211 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPL 270
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 271 FPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 330
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+
Sbjct: 331 ASRLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINR 390
Query: 361 LIPDHVKRQL 370
LIP+HV+RQ+
Sbjct: 391 LIPEHVRRQM 400
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/370 (82%), Positives = 337/370 (91%), Gaps = 1/370 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCL
Sbjct: 35 IKDDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCL 94
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 154
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRV KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQV
Sbjct: 155 TVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQV 214
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPL 274
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL
Sbjct: 275 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDL 334
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++
Sbjct: 335 VSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLS 394
Query: 360 KLIPDHVKRQ 369
KLIPDH ++Q
Sbjct: 395 KLIPDHARKQ 404
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 293/370 (79%), Positives = 335/370 (90%), Gaps = 1/370 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCL
Sbjct: 34 IQDDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCL 93
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 153
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQV 213
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPL 273
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 274 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDL 333
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V
Sbjct: 334 VSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVA 393
Query: 360 KLIPDHVKRQ 369
KL+P+H ++Q
Sbjct: 394 KLVPEHARKQ 403
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 634 bits (1636), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 298/376 (79%), Positives = 336/376 (89%), Gaps = 4/376 (1%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCL
Sbjct: 30 IRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCL 89
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 90 ETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 149
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 150 TVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQV 209
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPL
Sbjct: 210 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPL 269
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 270 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDL 329
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V
Sbjct: 330 VSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVA 389
Query: 360 KLIPDHVKRQ---LGL 372
KL+P+H ++Q LGL
Sbjct: 390 KLVPEHARKQCPWLGL 405
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 629 bits (1621), Expect = e-179, Method: Compositional matrix adjust.
Identities = 293/376 (77%), Positives = 335/376 (89%), Gaps = 4/376 (1%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKE+ AA+VDG+ TGHII TTIGG++G+PKQTISYMAER+VG GSFG+VFQAKCL
Sbjct: 34 IRDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQTISYMAERIVGQGSFGVVFQAKCL 93
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+ LKHCFFSTT K+E++LNLV+EYVPE
Sbjct: 94 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPE 153
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHY+ NQRMPLI VKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 154 TVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQV 213
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPL
Sbjct: 214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPL 273
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE+ VDQLVEIIKVLGTPTREEI+CMNPNY +F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 274 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDL 333
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LRCTALEA H FFDELR+PN RLPNGR LPPLFNFK EL G S E +
Sbjct: 334 VSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLL 393
Query: 360 KLIPDHVKRQ---LGL 372
KL+P+H ++Q LGL
Sbjct: 394 KLVPEHARKQCPSLGL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 293/376 (77%), Positives = 332/376 (88%), Gaps = 4/376 (1%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DD+EM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCL
Sbjct: 36 IRDDREMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCL 95
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE
Sbjct: 96 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE 155
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV+KHYS NQRMP+IYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQV
Sbjct: 156 TVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQV 215
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WS GCVLAELLLGQPL
Sbjct: 216 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPL 275
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMP EA+DL
Sbjct: 276 FPGERGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDL 335
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LRC AL+ HPFFDELR+PNARLP GR LPPLFNFK EL G E +
Sbjct: 336 VSRLLQYSPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLM 395
Query: 360 KLIPDHVKRQ---LGL 372
KL+P+H ++Q LGL
Sbjct: 396 KLVPEHARKQCPFLGL 411
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 625 bits (1611), Expect = e-178, Method: Compositional matrix adjust.
Identities = 291/372 (78%), Positives = 331/372 (88%), Gaps = 2/372 (0%)
Query: 3 DDKEMSAA-VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLE 61
DDKEM AA +VDG+ TGHII TTIGGKNG+PKQTISYMAERVVG GSFG+VFQAKCLE
Sbjct: 36 DDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLE 95
Query: 62 TGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 121
TGETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE+
Sbjct: 96 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET 155
Query: 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181
+ RV++HY+ NQRMP+IYVKLY+YQI R LAYIH VCHRD+KPQNLLV+P THQ+K
Sbjct: 156 VSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLK 215
Query: 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
ICDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVL ELLLGQPLF
Sbjct: 216 ICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLF 275
Query: 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 301
PGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 276 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLV 335
Query: 302 SRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNK 360
SRLLQYSP+LR TALEA HPF+D++R+PN RLPNGR LPPLFNFK EL G E++ K
Sbjct: 336 SRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVK 395
Query: 361 LIPDHVKRQLGL 372
L+P H ++Q L
Sbjct: 396 LVPPHARKQCAL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1600), Expect = e-177, Method: Compositional matrix adjust.
Identities = 286/373 (76%), Positives = 327/373 (87%), Gaps = 1/373 (0%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDKEM A VVDG+ GH+I TTIGGKNG+PKQTISYMAER VG GSFG+VFQAKCL
Sbjct: 35 IKDDKEMEAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCL 94
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQ MR++DHPNV++LKHCFFSTT K+EL+LNLV+E+VPE
Sbjct: 95 ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPE 154
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+++RV++HYS NQRMPLIYVKLY+YQI R LAYIH V HRD+KPQNLLV+P THQ+
Sbjct: 155 TVHRVIRHYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQL 214
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT++IDIWSAGCVL ELLLGQPL
Sbjct: 215 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPL 274
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPG + VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL
Sbjct: 275 FPGASGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDL 334
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
SRLLQYSP+LR TALEA HPFFDELR+PN RLPNGR LPPLFNFK EL G E++
Sbjct: 335 VSRLLQYSPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLV 394
Query: 360 KLIPDHVKRQLGL 372
KL+P H ++Q L
Sbjct: 395 KLVPSHARKQCSL 407
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| 359483773 | 380 | PREDICTED: shaggy-related protein kinase | 1.0 | 1.0 | 0.939 | 0.0 | |
| 255562450 | 380 | Glycogen synthase kinase-3 beta, putativ | 1.0 | 1.0 | 0.939 | 0.0 | |
| 224116828 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 1.0 | 0.942 | 0.0 | |
| 297804284 | 380 | hypothetical protein ARALYDRAFT_914806 [ | 1.0 | 1.0 | 0.934 | 0.0 | |
| 1161512 | 380 | shaggy-like kinase etha [Arabidopsis tha | 1.0 | 1.0 | 0.926 | 0.0 | |
| 15233984 | 380 | Shaggy-related protein kinase eta [Arabi | 1.0 | 1.0 | 0.931 | 0.0 | |
| 312281491 | 380 | unnamed protein product [Thellungiella h | 1.0 | 1.0 | 0.931 | 0.0 | |
| 18700188 | 380 | AT4g18710/F28A21_120 [Arabidopsis thalia | 1.0 | 1.0 | 0.928 | 0.0 | |
| 224079065 | 380 | predicted protein [Populus trichocarpa] | 1.0 | 1.0 | 0.928 | 0.0 | |
| 356507479 | 380 | PREDICTED: shaggy-related protein kinase | 1.0 | 1.0 | 0.913 | 0.0 |
| >gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/380 (93%), Positives = 372/380 (97%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
M+DDKE+SA VVDG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MSDDKEISAPVVDGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRTMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
+MYRVLKHYS+A QRMPLIYVKLYTYQIFRGLAYIH+VP VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 TMYRVLKHYSNAKQRMPLIYVKLYTYQIFRGLAYIHSVPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPSYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIP+HV+RQ+GL+F HPAGT
Sbjct: 361 LIPEHVRRQIGLSFFHPAGT 380
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/380 (93%), Positives = 369/380 (97%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM+A VVD +D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMAARVVDSNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQD+RYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDKRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPL+YVKLY YQIFRGLAYIHTVP VCHRDLKPQN+LVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQTMPLVYVKLYMYQIFRGLAYIHTVPGVCHRDLKPQNILVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL+GASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELNGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQ+GLNFLH AGT
Sbjct: 361 LIPDHMKRQMGLNFLHLAGT 380
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/380 (94%), Positives = 367/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEM+A V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MAEDKEMNARVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTDNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQAMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
F GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 241 FSGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPALFNFKQELNGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDHVKRQ+GLN +H AGT
Sbjct: 361 LIPDHVKRQMGLNLMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1940), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/380 (93%), Positives = 368/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++GASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 751 bits (1938), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/380 (92%), Positives = 370/380 (97%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTT K+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTEKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YRVLKHYSSANQRMPL+YVKLY+YQIFRGLAYIH+ P VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 TLYRVLKHYSSANQRMPLVYVKLYSYQIFRGLAYIHSCPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GE NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEPNISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF+FPQIKAHPWHK+FHKRMPPEA+DL
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFKFPQIKAHPWHKIFHKRMPPEAVDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQE++G+SPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEVAGSSPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/380 (93%), Positives = 368/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312281491|dbj|BAJ33611.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/380 (93%), Positives = 367/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVRGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++ ASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAAASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18700188|gb|AAL77705.1| AT4g18710/F28A21_120 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/380 (92%), Positives = 367/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDE REPNARLPNGRP PPLFNFKQE++G+SPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDEHREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 746 bits (1925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/380 (92%), Positives = 366/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEM+ V DG+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFG+VFQAKCL
Sbjct: 1 MAEDKEMTTRVADGNDPVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGVVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT+ NELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTNNNELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+A Q MPLIYVKLY YQIFRGLAYIH VP VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SMYRVLKHYSNAKQTMPLIYVKLYMYQIFRGLAYIHAVPGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLV+IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL
Sbjct: 241 FPGENAVDQLVDIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP LFNFKQEL+GASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPSLFNFKQELNGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIP+HVKRQ+GLNF+H AGT
Sbjct: 361 LIPEHVKRQMGLNFMHLAGT 380
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507479|ref|XP_003522493.1| PREDICTED: shaggy-related protein kinase eta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/380 (91%), Positives = 367/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MA+DKEMS +V++G+D +TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MAEDKEMSTSVINGNDSLTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGE VAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS +ELFLNLVMEYVPE
Sbjct: 61 ETGEAVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSTDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
SMYRVLKHYS+ANQRMP+IYVKLY YQIFRGLAYIHTVP+VCHRDLKPQN+LVDPLTHQV
Sbjct: 121 SMYRVLKHYSNANQRMPIIYVKLYMYQIFRGLAYIHTVPKVCHRDLKPQNILVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
K+CDFGSAK L+ GEANISYICSRFYRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPL
Sbjct: 181 KLCDFGSAKVLVKGEANISYICSRFYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLV IIKVLGTPTREE+RCMNPNY DFRFPQIKAHPWHK+FHK+MPPEAIDL
Sbjct: 241 FPGENAVDQLVHIIKVLGTPTREEVRCMNPNYNDFRFPQIKAHPWHKIFHKKMPPEAIDL 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQELSGASPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQELSGASPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDHVKRQ+GL F+H G+
Sbjct: 361 LIPDHVKRQMGLQFMHLGGS 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 1.0 | 1.0 | 0.931 | 1.5e-195 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.992 | 0.915 | 0.893 | 2.3e-188 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.965 | 0.901 | 0.910 | 3.1e-186 | |
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.965 | 0.895 | 0.826 | 9.4e-169 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.965 | 0.897 | 0.796 | 5.4e-166 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.973 | 0.913 | 0.796 | 8.7e-166 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.955 | 0.769 | 0.763 | 6.8e-159 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.984 | 0.888 | 0.709 | 3.2e-152 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.968 | 0.840 | 0.693 | 2.8e-144 | |
| ZFIN|ZDB-GENE-990714-4 | 421 | gsk3b "glycogen synthase kinas | 0.952 | 0.859 | 0.636 | 2e-127 |
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1894 (671.8 bits), Expect = 1.5e-195, P = 1.5e-195
Identities = 354/380 (93%), Positives = 368/380 (96%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
MADDKEM AAVVDG D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL
Sbjct: 1 MADDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ LKHCFFSTTSK+ELFLNLVMEYVPE
Sbjct: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPE 120
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
S+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYIH V VCHRDLKPQNLLVDPLTHQV
Sbjct: 121 SLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQV 180
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAKQL+ GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL
Sbjct: 181 KICDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDFRFPQIKAHPWHK+FHKRMPPEAID
Sbjct: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDF 300
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNK 360
ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP PPLFNFKQE++G+SPELVNK
Sbjct: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFKQEVAGSSPELVNK 360
Query: 361 LIPDHVKRQLGLNFLHPAGT 380
LIPDH+KRQLGL+FL+ +GT
Sbjct: 361 LIPDHIKRQLGLSFLNQSGT 380
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1826 (647.8 bits), Expect = 2.3e-188, P = 2.3e-188
Identities = 337/377 (89%), Positives = 364/377 (96%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET
Sbjct: 35 NDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 94
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+SLKHCFFSTT+++ELFLNLVMEYVPE++
Sbjct: 95 GESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETL 154
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYIHT P VCHRD+KPQNLLVDPLTHQ K+
Sbjct: 155 YRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKL 214
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GEANISYICSR+YRAPELIFGATEYT+SIDIWSAGCVLAELLLGQPLFP
Sbjct: 215 CDFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFP 274
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS
Sbjct: 275 GENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 334
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
RLLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQELSGASPEL+N+LI
Sbjct: 335 RLLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELSGASPELINRLI 394
Query: 363 PDHVKRQLGLNFLHPAG 379
P+HV+RQ+ F AG
Sbjct: 395 PEHVRRQMNGGFPFQAG 411
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1806 (640.8 bits), Expect = 3.1e-186, P = 3.1e-186
Identities = 334/367 (91%), Positives = 357/367 (97%)
Query: 4 DKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63
DKEMSAAV++G+D VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY 123
E+VAIKKVLQDRRYKNRELQLMR MDHPNVISLKHCFFSTTS++ELFLNLVMEYVPE++Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183
RVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYIHTVP VCHRD+KPQNLLVDPLTHQVK+C
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
DFGSAK L+ GE NISYICSR+YRAPELIFGATEYT SIDIWSAGCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 303
EN+VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333
Query: 304 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIP 363
LLQYSPSLRCTALEACAHPFF+ELREPNARLPNGRPLPPLFNFKQEL GAS EL+N+LIP
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFKQELGGASMELINRLIP 393
Query: 364 DHVKRQL 370
+HV+RQ+
Sbjct: 394 EHVRRQM 400
|
|
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1641 (582.7 bits), Expect = 9.4e-169, P = 9.4e-169
Identities = 304/368 (82%), Positives = 336/368 (91%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM AAVVDG+ TGHII TTIGGKNG+PKQTISYMAER+VG GSFGIVFQAKCLET
Sbjct: 37 DDKEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLET 96
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQD+RYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 97 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 156
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YRV KHYS ANQRMP+IYVKLYTYQI R LAYIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 157 YRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKL 216
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCVLAELLLGQPLFP
Sbjct: 217 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFP 276
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKR PPEA+DL S
Sbjct: 277 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVS 336
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKL 361
RLLQYSP+LR TA+EA HPFFDELR+PN RLPNGR LPPLFNFK QEL GAS EL++KL
Sbjct: 337 RLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKL 396
Query: 362 IPDHVKRQ 369
IPDH ++Q
Sbjct: 397 IPDHARKQ 404
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 293/368 (79%), Positives = 334/368 (90%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM A +V+G+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 36 DDKEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 95
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 96 GETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 155
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+RV+KHY+ NQRMPL+YVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 156 HRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKL 215
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFP
Sbjct: 216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFP 275
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 276 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 335
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKL 361
RLLQYSP+LRC AL++ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL
Sbjct: 336 RLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKL 395
Query: 362 IPDHVKRQ 369
+P+H ++Q
Sbjct: 396 VPEHARKQ 403
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1613 (572.9 bits), Expect = 8.7e-166, P = 8.7e-166
Identities = 298/374 (79%), Positives = 335/374 (89%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
DDKEM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFG+VFQAKCLET
Sbjct: 32 DDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLET 91
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GETVAIKKVLQDRRYKNRELQ MR++DHPNV+SLKHCFFSTT K+EL+LNLV+EYVPE++
Sbjct: 92 GETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV 151
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+RV+KHY+ NQRMPLIYVKLYTYQIFR L+YIH VCHRD+KPQNLLV+P THQVK+
Sbjct: 152 HRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKL 211
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYTT+ID+WSAGCVLAELLLGQPLFP
Sbjct: 212 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFP 271
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 272 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 331
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKL 361
RLLQYSP+LR AL+ HPFFDELR+PNARLPNGR LPPLFNFK EL G E+V KL
Sbjct: 332 RLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKL 391
Query: 362 IPDHVKRQ---LGL 372
+P+H ++Q LGL
Sbjct: 392 VPEHARKQCPWLGL 405
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1548 (550.0 bits), Expect = 6.8e-159, P = 6.8e-159
Identities = 278/364 (76%), Positives = 324/364 (89%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
+DK+M VV+GS TG +I+TT+GG++G+PKQTISYMA+RVVGTGSFG+VFQAKCLET
Sbjct: 101 EDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLET 160
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE VAIKKVLQD+RYKNRELQ+MR+ DHPNV+ L+H FFSTT K+EL+LNLV+EYVPE++
Sbjct: 161 GEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETV 220
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YR KHY+ NQ MP+I+V+LYTYQI R L Y+H V VCHRD+KPQNLLV+P THQ+KI
Sbjct: 221 YRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKI 280
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE NISYICSR+YRAPELIFGATEYT +ID+WS GCV+AELLLGQPLFP
Sbjct: 281 CDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFP 340
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL S
Sbjct: 341 GESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 400
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKL 361
RLLQYSP+LRCTALEACAHPFFD+LR+PN LPNGR LPPLFNF QEL+GAS EL +L
Sbjct: 401 RLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRL 460
Query: 362 IPDH 365
IP H
Sbjct: 461 IPAH 464
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 3.2e-152, P = 3.2e-152
Identities = 266/375 (70%), Positives = 319/375 (85%)
Query: 3 DDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62
D+++ ++DG+ GH+I TT+ G+NG+ +QT+SY++E VVGTGSFG+VFQAKC ET
Sbjct: 46 DERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRET 105
Query: 63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESM 122
GE VAIKKVLQD+RYKNRELQ+M+++DHPN ++LKH FFS T E++LNLV+E+VPE++
Sbjct: 106 GEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETV 165
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
RV + YS NQ MPLIYVKLYTYQI R LAYIH +CHRD+KPQNLLV+P THQ+KI
Sbjct: 166 NRVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKI 225
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
CDFGSAK L+ GE N+SYICSR+YRAPELIFGA+EYTT+IDIWS GCV+AELLLGQPLFP
Sbjct: 226 CDFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFP 285
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIK HPWHKVF KR+PPEA+DL
Sbjct: 286 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLC 345
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKL 361
R QYSP+LRCTALEAC HP FDELR+PN RLPNGRPLPPLFNFK QELSG PE+VN+L
Sbjct: 346 RFFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRL 405
Query: 362 IPDHVKRQLGLNFLH 376
+P+H ++Q LH
Sbjct: 406 VPEHARKQNLFMALH 420
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1410 (501.4 bits), Expect = 2.8e-144, P = 2.8e-144
Identities = 256/369 (69%), Positives = 311/369 (84%)
Query: 1 MADDKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCL 60
+ DDK+M ++ G+ +G II+T G N + +TISY AE V+GTGSFG+VFQAKCL
Sbjct: 70 LGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGSFGVVFQAKCL 129
Query: 61 ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
ET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ LKH FFSTT K+EL+LNLV+EYVPE
Sbjct: 130 ETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPE 189
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180
++YR + Y+ NQ MPLIY++LYTYQI R + Y+H V VCHRD+KPQNLLV+ +TH+V
Sbjct: 190 TIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEV 249
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240
KICDFGSAK LI GE NISYICSR+YRAPELIFGATEYT++ID+WS GCV+AEL LG PL
Sbjct: 250 KICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPL 309
Query: 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 300
FPGE +VDQLVEIIK+LGTP REEI+ MNP Y DF+FPQIKA PWHK+F +++ PEA+DL
Sbjct: 310 FPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDL 369
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVN 359
ASRLLQYSP+LRCTALEACAHPFFD+LR+P A LPNGR LPPLF+F QEL+GAS EL +
Sbjct: 370 ASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQELAGASVELRH 429
Query: 360 KLIPDHVKR 368
+LIP+H ++
Sbjct: 430 RLIPEHARK 438
|
|
| ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 2.0e-127, P = 2.0e-127
Identities = 236/371 (63%), Positives = 299/371 (80%)
Query: 13 DGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL 72
DGS T +++T G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIKKVL
Sbjct: 33 DGSKVTT--VVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88
Query: 73 QDRRYKNRELQLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSS 131
QD+R+KNRELQ+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
A Q +P++YVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL
Sbjct: 149 AKQTLPMVYVKLYMYQLFRSLAYIHSFG-ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 311
EIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
Query: 312 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQL 370
R T LEACAH FFDELREPN +LPNGR P LFNF QELS ++P L + LIP H + Q
Sbjct: 328 RLTPLEACAHSFFDELREPNVKLPNGREKPSLFNFTTQELS-SNPTLASILIPAHARNQA 386
Query: 371 GLNF-LHPAGT 380
G + +P+ T
Sbjct: 387 GASTPTNPSAT 397
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7918 | 0.9710 | 0.9022 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7925 | 0.9789 | 0.9185 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.5546 | 0.9131 | 0.8966 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9027 | 0.9736 | 0.9090 | no | no |
| A8X5H5 | GSK3_CAEBR | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6041 | 0.8868 | 0.9387 | N/A | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8938 | 0.9921 | 0.9150 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9315 | 1.0 | 1.0 | yes | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7093 | 0.9842 | 0.8883 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5202 | 0.8368 | 0.8594 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6041 | 0.8868 | 0.9309 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.712 | 0.9842 | 0.8904 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.7792 | 0.9789 | 0.9095 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9184 | 0.8309 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6142 | 0.8763 | 0.7130 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7792 | 0.9789 | 0.9051 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7667 | 0.9789 | 0.9051 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7822 | 0.9736 | 0.9002 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7513 | 0.9605 | 0.7799 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9184 | 0.8309 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8216 | 0.9710 | 0.9 | no | no |
| Q91757 | GSK3B_XENLA | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6320 | 0.9263 | 0.8380 | N/A | no |
| Q5YJC2 | GSK3B_SPECI | 2, ., 7, ., 1, 1, ., 1 | 0.6373 | 0.9184 | 0.8309 | N/A | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6402 | 0.9184 | 0.8309 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.993 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 380 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-137 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-90 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-85 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-82 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-78 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-76 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-75 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-75 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-74 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-73 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-71 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-69 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-69 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-68 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-67 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-61 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-61 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-60 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-60 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-60 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-60 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-59 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-59 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-59 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-59 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-58 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-58 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-58 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-58 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-58 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-57 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-55 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-55 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-50 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-50 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-50 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-49 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-48 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-47 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-46 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-43 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-41 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-40 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-39 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-38 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-36 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-34 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-26 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-23 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-20 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-20 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-16 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 398 bits (1024), Expect = e-137
Identities = 176/333 (52%), Positives = 242/333 (72%), Gaps = 6/333 (1%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 98
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 99 CFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+++ KNE +FLN+VME++P+++++ +KHY+ N +PL VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H+ +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYICSRFYRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
+FP +K KVF K P +AI+ S+ L+Y P R +EA A PFFD+LR+P +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 336 NG-RPLPPLFNF-KQELSGASPELVNKLIPDHV 366
LP LFNF E+ S K+IP
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 1e-90
Identities = 114/307 (37%), Positives = 177/307 (57%), Gaps = 24/307 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + +G+G++G+V A TG VAIKK+ L D + RE++L+R + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 94 ISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
I L S N++++ V E + +++V+K Q + +++ + YQI RG
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYR 207
L Y+H+ V HRDLKP N+LV+ +KICDFG A+ + E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APEL+ ++ YT +IDIWS GC+ AELL +PLFPG + +DQL I++VLGTP+ E+++
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 268 M-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + ++ P+ P K+F PEAIDL ++L + P R TA EA AHP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 325 DELREPN 331
+L +P
Sbjct: 293 AQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (679), Expect = 2e-87
Identities = 108/292 (36%), Positives = 171/292 (58%), Gaps = 29/292 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 97
+G G++G+V++A+ +TGE VA+KK+ D + RE+ L++ + HPN++ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
++ +L+L V EY + + L + +K YQ+ RGLAY H+
Sbjct: 65 DVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHS 116
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
R+ HRDLKPQN+L++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 117 H-RILHRDLKPQNILINR-DGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPNY 272
+ Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E P+Y
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FP+ KV R+ PE IDL S++LQY+P+ R +A EA HP+F
Sbjct: 233 KP-TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 259 bits (665), Expect = 3e-85
Identities = 117/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 97
+G G+ GIVF+AK ETGETVA+KKV R RE++ ++ HP V+ L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F + LVMEY+P + VL+ + +P VK Y + +G+AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
+ HRDLKP NLL+ +KI DFG A+ L + E Y + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 271
A +Y +D+W+ GC+ AELL G PLFPGEN ++QL + + LGTP E + + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Y FP+ K P ++F PEA+DL LL Y PS R +A EA HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 3e-82
Identities = 109/294 (37%), Positives = 165/294 (56%), Gaps = 20/294 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRVMDHPNV 93
Y +G G++G+V++A+ TGE VAIKK+ RE++L++ ++HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L F L LV E++ +Y+++K + +P +K Y YQ+ +GLA
Sbjct: 61 IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 212
+ H+ + HRDLKP+NLL++ +K+ DFG A+ Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 271
G Y+T +DIWS GC+ AELL +PLFPG++ +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 272 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
F FP+ P K+F P+A+DL S++L Y P R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 3e-81
Identities = 100/291 (34%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
Y +G GSFG V+ A+ +TG+ VAIK + +DR RE+++++ + HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F L LVMEY ++ +LK R+ + Y QI L
Sbjct: 61 RLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
Y+H+ + HRDLKP+N+L+D VK+ DFG A+QL GE +++ + Y APE++
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
G Y ++DIWS G +L ELL G+P FPG++ QL+E+ K +G P
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ PEA DL +LL P R TA EA HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 7e-78
Identities = 98/289 (33%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
R +G+GSFG V++AK TG+ VA+K + + RE++++R + HPN++ L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F + L LVMEY L Y S + K QI RGL Y+H
Sbjct: 64 IDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGA 215
+ + HRDLKP+N+L+D VKI DFG AK+L+ + +++ + +Y APE++ G
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y +D+WS G +L ELL G+P F GEN +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + EA DL + L PS R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 4e-76
Identities = 109/296 (36%), Positives = 171/296 (57%), Gaps = 32/296 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRVMDHPNVIS 95
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++ L ++ +HPN++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
LK F +EL+ V EY+ ++Y+++K + ++ YQI +GLA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHI 115
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H HRDLKP+NLLV VKI DFG A+++ + Y+ +R+YRAPE++ +
Sbjct: 116 HKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 268
T Y++ +DIW+ GC++AEL +PLFPG + +DQL +I VLGTPT+++ +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FRFPQ H++ PEAIDL +L++ P R TA +A HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 2e-75
Identities = 106/299 (35%), Positives = 161/299 (53%), Gaps = 29/299 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDH 90
Y + +G G++ +V++A+ ETG VAIKK+ R + RE++L++ + H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PN+I L F K+ +NLV E++ + +V+K + + +K Y R
Sbjct: 62 PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYR 207
GL Y+H + HRDLKP NLL+ +K+ DFG A+ G N +R+YR
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APEL+FGA Y +D+WS GC+ AELLL P PG++ +DQL +I + LGTPT E
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 268 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ P+Y +F+ P ++F +A+DL RLL +P+ R TA +A HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 9e-75
Identities = 89/293 (30%), Positives = 156/293 (53%), Gaps = 26/293 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A+ +TGE VA+KK+ + + RE++L++ + HPN++ LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S K +++ V EY+ + +L + +K Y Q+ GL Y+H+
Sbjct: 67 VTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN- 119
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
+ HRD+K N+L++ + +K+ DFG A+ + Y + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 271
AT Y +D+WS GC+LAEL LG+P+F G ++QL +I ++ G+PT E + + P
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + + + + F + P A+DL +LL P R +A +A H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 9e-74
Identities = 102/291 (35%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
VVG G++G+V + + TGE VAIKK + ++ RE++++R + H N+++LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F K L+L V EYV ++ +L+ +P V+ Y +Q+ + +AY H+
Sbjct: 68 AF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGAT 216
+ HRD+KP+N+LV + +K+CDFG A+ L A A+ Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 274
Y +D+W+ GC++AELL G+PLFPG++ +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 275 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FP+ + + ++ A+D L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 5e-73
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 26/305 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y VG+G++G V A +TG VAIKK+ + R Y REL+L++ MDH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F +S + + LV + + ++K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP N+ V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 271 ----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
NY PQ+ + +VF P AIDL ++L P R TA EA AHP+ E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 327 LREPN 331
+P
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 2e-71
Identities = 114/332 (34%), Positives = 178/332 (53%), Gaps = 36/332 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
Y +G G++G+V A TG VAIKK+ R RE++++R H N
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64
Query: 93 VISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+I + + S N++++ V E + +Y+++K +N +++ + YQI R
Sbjct: 65 IIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQYFLYQILR 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFY 206
GL YIH+ V HRDLKP NLL++ +KICDFG A+ + Y+ +R+Y
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
RAPE++ + YT +IDIWS GC+LAE+L +PLFPG++ + QL I+ VLGTP++E++
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235
Query: 267 CM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
C+ + ++ P PW+K+F P+A+DL ++L ++P R T EA AHP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 324 ----FDELREPNARLPNGRPLPPLFNFKQELS 351
D EP A P P F +L
Sbjct: 295 LEQYHDPSDEPVAE----EPFPFDFELFDDLP 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 4e-69
Identities = 118/333 (35%), Positives = 186/333 (55%), Gaps = 21/333 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y+ + +G G++GIV AK ET E VAIKK+ D + RE++L+R +DH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I++K + + +V E + ++++++ ++Q + + + + YQ+ RGL
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLK 122
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH+ V HRDLKP NLL++ +KICDFG A+ G+ Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 271
+EYTT+ID+WS GC+ AELL +PLFPG++ V QL I ++LG+P+ E++ + N
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 272 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ P + ++F P AIDL ++L + PS R T EA AHP+ L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 330 PNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
P+ P F+F E + E + +LI
Sbjct: 300 PSDEPVCQTP----FSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 6e-69
Identities = 105/309 (33%), Positives = 173/309 (55%), Gaps = 31/309 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQLMRVM-DH 90
Y + +G G++GIV++A T E VA+KK+ D R + RE+ ++ + DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PN++ L + ++N+ + LV EY+ ++ V++ AN ++ + YQ+ +
Sbjct: 67 PNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQLLK 118
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YICSR 204
L YIH+ V HRDLKP N+L++ VK+ DFG A+ L E N Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+YRAPE++ G+T YT +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 265 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
I + + P P ++ + +A+DL +LL ++P+ R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 322 PFFDELREP 330
P+ + P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 2e-68
Identities = 118/344 (34%), Positives = 180/344 (52%), Gaps = 32/344 (9%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPN 92
Y +G+G++G+V A +G+ VAIKK V + REL+++R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 93 VISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+I+++ F + +VM+ M L H ++Q + +++ + YQ+ R
Sbjct: 66 IIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRF 205
GL YIH+ V HRDLKP NLLV+ ++I DFG A+ L + Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
YRAPEL+ EYTT+ID+WS GC+ AE+L + LFPG+N V QL I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 266 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
+ Y P+ + PW K+F K PEA+DL S++LQ+ P R T +A H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 322 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 365
PF + +P+ + PP F+F E S E + + I
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 1e-67
Identities = 103/291 (35%), Positives = 164/291 (56%), Gaps = 26/291 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ TGE VA+KK+ + + RE+ L++ ++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S E L LV E++ LK Y SS + +K Y YQ+ +G+AY H+
Sbjct: 67 VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
RV HRDLKPQNLL+D +K+ DFG A+ + + + +YRAPE++ G+
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+T +DIWS GC+ AE++ +PLFPG++ +DQL I + LGTP + + + P+Y
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FP+ KV + + +DL S++L Y P+ R +A A HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 5e-61
Identities = 121/326 (37%), Positives = 181/326 (55%), Gaps = 27/326 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + V+G GS+G+V A TGE VAIKK+ + D RE++L+R++ HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ +KH + + + +V E + +++V+K AN + + + + YQ+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAP 209
YIHT V HRDLKP+N+L + ++KICDFG A+ Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 210 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 266
EL G+ ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL I +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 323
N + K P F ++ P P A+ L RLL + P R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 324 FDELREPNARLPNGRPLPPL-FNFKQ 348
F L + R P+ +P+ L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 7e-61
Identities = 109/290 (37%), Positives = 171/290 (58%), Gaps = 21/290 (7%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKH 98
+VG GS+G+V + K ETG+ VAIKK L+ ++ RE+++++ + H N+++L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F K L+L V E+V ++ L+ Y + + V+ Y +QI RG+ + H+
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS- 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 217
+ HRD+KP+N+LV + VK+CDFG A+ L A GE Y+ +R+YRAPEL+ G T+
Sbjct: 119 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 275
Y ++DIW+ GC++ E+L G+PLFPG++ +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 276 RFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
R P++K P K F K + +DLA + L+ P R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-60
Identities = 97/289 (33%), Positives = 152/289 (52%), Gaps = 25/289 (8%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVM-DHPNVISLKH 98
G G+F V +A+ +TG+ AIK + + +K+ RE+Q +R + HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIH 156
F + L LV E + ++Y ++K ++ PL VK Y YQ+ + L ++H
Sbjct: 66 VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+KP+N+L+ +K+ DFGS + + + YI +R+YRAPE +
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 275
Y +DIW+ GCV E+L PLFPG N +DQ+ +I VLGTP E ++ + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FP K K+ E +DL +LL Y P R TA +A HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 29/303 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G+V++A+ T ET+A+KK+ ++ + RE+ L++ M H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQI 148
+ L+ S E L LV EY+ + KH S+ N R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYR 207
RG+AY H+ RV HRDLKPQNLL+D T+ +K+ DFG A+ I + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APE++ G+ Y+T +DIWS GC+ AE++ +PLFPG++ +D+L +I ++LGTP E
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230
Query: 268 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
+ P+Y FP+ V + P +DL S++L+ PS R TA A H +F
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
Query: 326 ELR 328
+L
Sbjct: 289 DLG 291
|
Length = 294 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 6e-60
Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 46/303 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD---HPN 92
+G G++G V++A+ L TG VA+KKV R RE+ L++ ++ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L + EL L LV E+V + + L +P +K Q+ RG+
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H+ R+ HRDLKPQN+LV QVKI DFG A+ A S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
++ Y T +D+WS GC+ AEL +PLF G + DQL +I V+G P+ EE
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229
Query: 273 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 321
+P+ + P F + E +DL ++L ++P R +A EA H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284
Query: 322 PFF 324
P+F
Sbjct: 285 PYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 7e-60
Identities = 115/306 (37%), Positives = 168/306 (54%), Gaps = 29/306 (9%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVM 88
T Y+ + VG G+FG+V A+ TG+ VAIKK VL R Y REL+L++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
H N+ISL F S + V E + ++R+L Q +++ + YQI
Sbjct: 67 RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
RGL Y+H+ V HRDLKP N+L++ +KICDFG A+ I Y+ +R+YRA
Sbjct: 118 LRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE++ +Y +DIWSAGC+ AE+L G+PLFPG++ V+Q I +LGTP + I +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 269 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
T RF P+ + P+ + F K P AIDL ++L + P R +A EA AHP+
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
Query: 325 DELREP 330
+P
Sbjct: 292 APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-59
Identities = 108/290 (37%), Positives = 166/290 (57%), Gaps = 24/290 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 100
+G G++ V++ + TGE VA+K++ D RE+ LM+ + H N++ L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYVKLYTYQIFRGLAYIHT 157
T +K L LV EY M + LK Y + + + VK +TYQ+ +G+A+ H
Sbjct: 67 IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
RV HRDLKPQNLL++ ++K+ DFG A+ I + + + +YRAP+++ G+
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 274
Y+TSIDIWS GC++AE++ G+PLFPG N DQL++I +++GTPT ++ P Y
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
FP+ ++F P IDL RLLQ +P LR +A +A HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 111/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)
Query: 46 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
+G G++G V++AK G+ AIKK D+ RE+ L+R + H NV+SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 155
F K+ + L+ +Y +++++K + A + P VK +QI G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 156 HTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAGEANISYICSRF 205
H+ V HRDLKP N+LV P VKI D G A K L + + I +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 256
YRAPEL+ GA YT +IDIW+ GC+ AELL +P+F G A DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 257 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 307
LGTPT ++ I+ M P Y DF+ ++ K K + DL +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 308 SPSLRCTALEACAHPFF 324
P+ R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 5e-59
Identities = 100/293 (34%), Positives = 158/293 (53%), Gaps = 19/293 (6%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A+ TG+ VA+KK + + RE+ L++++ I
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 100 FFSTTSKN-ELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
KN + L LV EY+ + + + + + +P +K + YQ+ +G+A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 216
V HRDLKPQNLLVD +KI D G + I ++ I + +YRAPE++ G+T
Sbjct: 129 HG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y+T +DIWS GC+ AE+ QPLFPG++ + QL+ I K+LGTPT + P + R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243
Query: 277 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
FPQ K + + PE +DL ++L+Y P+ R +A A HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 9e-59
Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHCFFS 102
G++G+V++A+ +TGE VA+KK+ ++ + RE+ ++ + HPN++++K
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 162
+ +++++ VMEYV + +++ Q VK Q+ G+A++H +
Sbjct: 76 SNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128
Query: 163 HRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGATE 217
HRDLK NLL L + +KICDFG A++ G Y + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277
Y+T+ID+WS GC+ AELL +PLFPG++ +DQL +I K+LGTPT + P +++
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239
Query: 278 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ K + K F + DL +RLL Y P+ R +A +A HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 107/298 (35%), Positives = 174/298 (58%), Gaps = 40/298 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN++ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ +N+L+L V E+ +++ LK + +S +PL +K Y +Q+ +GLA+ H+
Sbjct: 68 IHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 214
RV HRDLKPQNLL++ +K+ DFG A+ G +Y + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT- 273
Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP + P T
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230
Query: 274 --DFR--FPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFF 324
D++ FP+ + KV +PP + DL S++L Y P+ R +A A AHPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKV----VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-58
Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 31/306 (10%)
Query: 46 VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-VMDHPNVI 94
+G G++GIV A+ ET ETVAIKK+ L R REL+L+R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65
Query: 95 SLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L NEL+L E + ++++++ + Q + + + + YQI GL
Sbjct: 66 CLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLK 119
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICSRFYRA 208
YIH+ V HRDLKP NLLV+ ++KICDFG A+ + Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 267
PE++ YT +ID+WS GC+LAELL +P+F G++ VDQL +I++VLGTP E + R
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237
Query: 268 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
+P ++ P I P+ +F P A+DL +LL + P+ R + EA HP+
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 326 ELREPN 331
+P+
Sbjct: 297 IWHDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-58
Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 22/297 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 93
+Y +G GS+ V++ + TG+ VA+K++ L+ RE L++ + H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + + L LV EY + LK Y + + V+L+ +Q+ RGL
Sbjct: 66 VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
AY H RV HRDLKPQNLL+ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR--CM 268
+ G+TEY+TS+D+W GC+ E+ G+PLFPG + DQL +I +VLGTPT E
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 269 NPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
NP + + FP P + P +LA + LQY P R +A EA HP+F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 5e-58
Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 27/305 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDHP 91
Y + + VG+G++G V A TGE VAIKK + R Y REL L++ M H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F S S +E LVM Y+ + +++ H S ++ V+ YQ+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ +
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 270 ---PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
+Y P+ + +F + P+A+DL ++L+ R TA EA HP+FD
Sbjct: 245 KAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
Query: 327 LREPN 331
R+ +
Sbjct: 303 FRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 8e-58
Identities = 108/299 (36%), Positives = 164/299 (54%), Gaps = 26/299 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHPNVISLK 97
VG+G++G V A TG VAIKK+ R Y REL+L++ M H NVI L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80
Query: 98 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F S + LVM ++ + +++KH + R ++ YQ+ +GL YIH
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 136 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 272
YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ + NY
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+ P+ + + + P A+++ ++L R TA EA AHP+F+E +P
Sbjct: 252 VK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-57
Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 24/290 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S + L LV EY + + K++ S N + VK + +Q+ +GLA+ H+
Sbjct: 68 LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
V HRDLKPQNLL++ ++K+ DFG A+ I + + + +YR P+++FGA Y
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 275
+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E ++ P+Y +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237
Query: 276 -RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+P + V ++ DL LL +P R +A EA HP+F
Sbjct: 238 PMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 4e-57
Identities = 109/304 (35%), Positives = 157/304 (51%), Gaps = 46/304 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++GIV++A+ +GE VA+KKV D RE+ L+ + HPN++ LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ +FL VMEY + + +L + + VK Q+ RGL Y+H
Sbjct: 75 VVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHE-N 127
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--------SRFYRAP 209
+ HRDLK NLL LT + +KI DFG A+ + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 265
EL+ G T YTT+ID+W+ GC+LAELL +PL PG++ ++QL II++LGTP E I
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGF 236
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHP 322
+ P F P+ P++ + HK P EA + L + LL Y P R TA EA
Sbjct: 237 SDL-PLVGKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291
Query: 323 FFDE 326
+F E
Sbjct: 292 YFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 6e-55
Identities = 91/310 (29%), Positives = 161/310 (51%), Gaps = 38/310 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRVMDHPNVIS 95
YM R +G GS G+VF A + + VA+KK++ + K+ RE++++R +DH N++
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 96 LKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + S + +V EY+ + VL+ + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI----C 202
Q+ RGL YIH+ V HRDLKP N+ ++ +KI DFG A+ + ++ Y+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 259
+++YR+P L+ YT +ID+W+AGC+ AE+L G+PLF G + ++Q+ +E + V+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 314
R E+ + P++ ++ + +P PEA+D ++L ++P R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 315 ALEACAHPFF 324
A EA HP+
Sbjct: 294 AEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 8e-55
Identities = 100/295 (33%), Positives = 165/295 (55%), Gaps = 33/295 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 95
+G G++G+V++ + +TG+ VA+KK+ R ++ RE+ L++ + HPN++
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGL 152
L+ ++ L+L + E++ SM LK Y Q M VK Y YQI +G+
Sbjct: 64 LQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 211
+ H+ RV HRDLKPQNLL+D +K+ DFG A+ I + + +YRAPE+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 269
+ G+ Y+T +DIWS G + AE+ +PLF G++ +DQL I ++LGTPT + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P+Y + FP+ K + K + + +DL ++L Y P+ R +A +A HP+F
Sbjct: 233 PDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-54
Identities = 95/291 (32%), Positives = 157/291 (53%), Gaps = 25/291 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 99
+G GS+G+VF+ + ETG+ VAIKK ++ ++ RE+++++ + HPN+++L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
F + + L+LV EY ++ L+ + +P +K +Q + + + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 218
HRD+KP+N+L+ Q+K+CDFG A+ L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 276
+D+W+ GCV AELL GQPL+PG++ VDQL I K LG P ++I N + F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235
Query: 277 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 324
I + + P A+ LQ P+ R + E HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-53
Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 46/291 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLK 97
++G GSFG V+ A +TGE +A+K V L + RE++++ + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ S + + LN+ +EYV S L ++P ++ YT QI GLAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIF 213
+ + HRD+K N+LVD VK+ DFG AK+L GE S + ++ APE+I
Sbjct: 119 S-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
G EY + DIWS GC + E+ G+P + + I G P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P+I H + EA D + L+ P R TA E HPF
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 40/247 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 100
+G G FG V+ A+ +TG+ VAIK + ++ RE+++++ ++HPN++ L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
++E L LVMEY S+ +LK ++ + QI GL Y+H+
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEY 218
+ HRDLKP+N+L+D +VK+ DFG +K L + ++ + I + Y APE++ G Y
Sbjct: 113 -IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 277
+ DIWS G +L EL +L ++I+ + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 278 PQIKAHP 284
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 7e-51
Identities = 104/315 (33%), Positives = 150/315 (47%), Gaps = 51/315 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRV 87
+G G++G V +A TG+ VAIKKV +DR+ REL++M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ H N++ L + F+NLVM+ M LK R+ VK Q
Sbjct: 77 IKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANISYIC 202
I GL +H HRDL P N+ ++ KI DFG A++ + +
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 203 SR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
R +YRAPEL+ GA +Y ++D+WS GC+ AELL G+PLFPGEN +DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 253 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 309
I ++LGTP + + + + P YT+F + K K +AIDL LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301
Query: 310 SLRCTALEACAHPFF 324
R +A EA H +F
Sbjct: 302 LERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 106/304 (34%), Positives = 165/304 (54%), Gaps = 24/304 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y VG+G++G V A + VA+KK+ L R REL+L++ M H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 94 ISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
I L F TS NE++L V + + ++K Q++ +V+ YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP N+ V+ +++I DFG A+Q A + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++V+GTP+ E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 271 NYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ P + K+F + P AIDL ++L R +A EA AHP+F +
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 328 REPN 331
+P
Sbjct: 305 HDPE 308
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (437), Expect = 3e-50
Identities = 93/342 (27%), Positives = 141/342 (41%), Gaps = 46/342 (13%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 91
SY R +G GSFG V+ A+ + VA+K + + RE+Q++ ++HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
I + FF ++E L LVMEYV L + QI
Sbjct: 58 PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-------SYICSR 204
L Y+H+ + HRD+KP+N+L+D VK+ DFG AK L + + + +
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 205 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 259
Y APE++ G + ++S DIWS G L ELL G P F GE A Q ++II L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319
P A P + + A DL +LL P R ++
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 320 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKL 361
+H L+ + L + + L + L++ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 6e-50
Identities = 106/294 (36%), Positives = 164/294 (55%), Gaps = 28/294 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
VVG G++G+V + + ET E VAIKK + REL+++R + N++ LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + +L+L V EYV ++M +L+ + +P V+ Y YQ+ + + + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSYIYQLIKAIHWCHK- 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YICSRFYRAPELIFGAT 216
+ HRD+KP+NLL+ +K+CDFG A+ L G AN + Y+ +R+YR+PEL+ GA
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 274
Y ++D+WS GC+L EL GQPLFPGE+ +DQL I KVLG E+++ NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 275 FRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
RFP + HP + +R + +DL LL+ +P+ R + HP F
Sbjct: 237 LRFPAV-NHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 7e-50
Identities = 95/311 (30%), Positives = 151/311 (48%), Gaps = 49/311 (15%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVISL 96
G G+FG V++A+ ++TG VA+KK+L N RE+++++ + HPNV+ L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 97 KHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
S + +++ V Y+ + +L S I K Y Q+ G
Sbjct: 73 IDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEG 127
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIAGEANISY-- 200
+ Y+H + HRD+K N+L+D +KI DFG A+ + G Y
Sbjct: 128 INYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 201 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
+ +R+YR PEL+ G YTT++DIW GCV AE+ +P+ G++ +DQL I K+ GT
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 260 PTREEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRC 313
PT E P + + + + + F ++ PE +DL S+LL P R
Sbjct: 246 PTEETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRL 300
Query: 314 TALEACAHPFF 324
TA +A HP+F
Sbjct: 301 TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 6e-49
Identities = 98/307 (31%), Positives = 166/307 (54%), Gaps = 21/307 (6%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ V++ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + S L LV EY+ + LK Y + + VKL+ +Q+ RGL
Sbjct: 67 VTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
Y H +V HRDLKPQNLL++ ++K+ DFG A+ + I + + + + +YR P++
Sbjct: 118 NYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 269
+ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E + N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ + +P+ +A H R+ + +L S+LLQ+ R +A EA HP+F L E
Sbjct: 236 EEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
Query: 330 PNARLPN 336
+LP+
Sbjct: 295 RIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 106/326 (32%), Positives = 170/326 (52%), Gaps = 43/326 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A TG+ VAIKK+ R ++N REL LM++++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+I L + F S E + LVME + ++ +V+ ++RM + YQ+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL-----LYQMLC 129
Query: 151 GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
G+ ++H+ + HRDLKP N++V T +KI DFG A+ Y+ +R+YRAP
Sbjct: 130 GIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 186
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E+I G Y ++DIWS GC++ E++ G LFPG + +DQ +II+ LGTP+ E + +
Sbjct: 187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245
Query: 270 P---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCT 314
P NY + R P+ + + ++F +K +A DL S++L P R +
Sbjct: 246 PTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 315 ALEACAHPF----FDELREPNARLPN 336
+A HP+ +D E A P
Sbjct: 305 VDDALQHPYINVWYDP-SEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 2e-48
Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 97
VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H NVI L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82
Query: 98 HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F S E + LV + + ++K Q++ +V+ YQI RGL YIH
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 138 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 272
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++ NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
Q+ + VF P A+DL ++L R TA +A AH +F + +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-48
Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 37/307 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRVMDHPNVI 94
+R +G G+FG+V+ G+ VA+KK V Q+ R + REL+++ H NV+
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62
Query: 95 S--------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
S F E+++ V E M L + Q + +VK++ Y
Sbjct: 63 SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSR 204
QI RGL Y+H+ + HRD+KP NLLV+ +KICDFG A+ E+ + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
+YRAPE++ G+ YT+++DIWS GC+ AELL + LF ++ + QL I +LGTP+ E
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 321
+R P V + EA+ L R+L + P R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288
Query: 322 PFFDELR 328
P+ DE R
Sbjct: 289 PYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 4e-47
Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 20/296 (6%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 93
SY+ +G GS+ V++ G+ VA+K + RE L++ + H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + + L V EY+ + + + + + V+L+ +Q+ RGLA
Sbjct: 66 VLLHDIIHTKET-----LTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKPQNLL+ L ++K+ DFG A+ + I + S + + +YR P+++
Sbjct: 118 YIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN-- 269
GAT+Y++++DIW AGC+ E+L GQP FPG + +QL +I VLG PT + ++
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 270 PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
PNY F K V+ + PP+A DLAS++L P R +A +A HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-46
Identities = 100/299 (33%), Positives = 164/299 (54%), Gaps = 23/299 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L + S L LV EY+ + LK Y M + VK++ YQI RGL
Sbjct: 67 VTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
AY H +V HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 118 AYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G++EY+T ID+W GC+ E+ G+PLFPG D+L I ++LGTPT E ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 272 --YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ ++ FP+ K P + H R+ E I+L ++ LQY R +A EA H +F L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 98/296 (33%), Positives = 161/296 (54%), Gaps = 23/296 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+Y+ +G G++ VF+ + T VA+K++ + RE+ L++ + H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
++L H T E L LV EY+ LK Y + M + VK++ +Q+ RGL
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 211
+Y H ++ HRDLKPQNLL++ ++K+ DFG A+ + + + + + + +YR P++
Sbjct: 117 SYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN 269
+ G+TEY+T ID+W GC+L E+ G+P+FPG ++L I ++LGTPT E N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234
Query: 270 PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + FPQ +A P + H R+ + IDL S LL Y R +A A H +F
Sbjct: 235 EEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 8e-45
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+G G FG V++A+ TG+ VAIK + L+ + K E+Q+++ HPN++
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ K+EL++ VME+ S+ +LK NQ + + ++ +GL Y+H+
Sbjct: 66 YLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 159 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+K N+L LT +VK+ DFG + QL +A + + + ++ APE+I G
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y DIWS G EL G+P + + L +I G P R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P W F D + LQ +P R TA + HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 55/292 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRVMDHPNVISLKH 98
+G GSFG V + +TG+ A+ KK + R+ + E ++ ++HP ++ L H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F T K L LV+EY P E L + S R + Y +I L Y+H
Sbjct: 60 YAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGA 215
++ + +RDLKP+N+L+D H +K+ DFG AK+L + + + C + Y APE++ G
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y ++D WS G +L E+L G+P F E+ ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 324
RFP + + PEA DL S LLQ P+ R + A AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 89/303 (29%), Positives = 150/303 (49%), Gaps = 39/303 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
+G G++G V++A+ +TGE VA+KKV D + RE++++R ++H N+++LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 99 CFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQRMPLIYVKLYTYQIF 149
K++ LV EY+ + +L+ H+S + +K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYR 207
GL Y H HRD+K N+L++ Q+K+ DFG A+ + E+ + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
PEL+ G Y +ID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 320
+ P+ + P K + +R +P A+DL +L PS RCTA EA
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 321 HPF 323
P+
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y + +G GSFG V+ + G+ +K++ ++R E+++++ ++HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I F L +VMEY + + +K + P + + Q+ L
Sbjct: 62 IKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPEL 211
Y+H+ ++ HRD+KPQN+ + VK+ DFG +K L + + + + +Y +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
Y DIWS GCVL EL + F GEN + +L K+L + + +
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
Y E +L S LLQ P R + + PF
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-40
Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 30/300 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH- 98
+G G+FG VF+A+ +T + VA+KKVL + + RE+++++++ H NV++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 99 CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
C T ++ + LV E+ + +L S+ N + L +K + GL YIH
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN--ISYICSRFYRAPEL 211
++ HRD+K N+L+ +K+ DFG A+ + N + + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E + P
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250
Query: 272 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ PQ K ++ P A+DL +LL P+ R A A H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 24/292 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVM---DHPN 92
+G G++G V++A+ +G VA+K V R + RE+ L++ + DHPN
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L ++ + E + LV E+V + + L +P +K Q RGL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H + HRDLKP+N+LV QVK+ DFG A+ A + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
+T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ +
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
F P V + L +L ++P R +A A HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 97/302 (32%), Positives = 157/302 (51%), Gaps = 26/302 (8%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 93
SY +G GS+ V++ K G+ VA+K + LQ+ RE L++ + H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + + L LV EYV + + + + + VKL+ +Q+ RGL+
Sbjct: 66 VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLS 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKPQNLL+ T ++K+ DFG A+ + + + + + +YR P+++
Sbjct: 118 YIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN-- 269
G+TEY+T +D+W GC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235
Query: 270 PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
P++ RF W+K+ + A DLAS+LLQ P R +A A +H +F
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYFS 292
Query: 326 EL 327
+L
Sbjct: 293 DL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 101/314 (32%), Positives = 163/314 (51%), Gaps = 35/314 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A G VA+KK+ R ++N REL L++ ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F S E + LVME + ++ +V+ H ++RM + YQ+
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ EL+ G +F G + +DQ ++I+ LGTP+ E + + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 271 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 316
NY + R PQ + ++F + P +A DL S++L P R +
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310
Query: 317 EACAHPFFDELREP 330
EA HP+ +P
Sbjct: 311 EALRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 88/290 (30%), Positives = 137/290 (47%), Gaps = 48/290 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRVMDHPNVI 94
++G+GSFG V++ L+ G+ A+K+V + +E+ L+ + HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T + E L + +E VP S+ ++LK Y S P ++LYT QI GL
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLE 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
Y+H HRD+K N+LVD VK+ DFG AKQ++ S+ S ++ APE+I
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y + DIWS GC + E+ G+P + + ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P H + EA D + LQ PSLR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 88/320 (27%), Positives = 133/320 (41%), Gaps = 77/320 (24%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRVMDH 90
+ +++G GSF V AK ET + AI K+L R+ Y E L R+ H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P +I L + F ++E L V+EY P + + ++ Y S +++ + Y +I
Sbjct: 62 PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRF 205
L Y+H+ + HRDLKP+N+L+D H +KI DFG+AK L
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 206 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
Y +PEL+ S D+W+ GC++ ++L G+P F G N
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 308
+I+K ++ FP PP+A DL +LL
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260
Query: 309 PSLRCTALEAC----AHPFF 324
P R E AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 101/314 (32%), Positives = 165/314 (52%), Gaps = 35/314 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F S E + LVME + ++ +V++ ++RM + YQ+
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 130
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 271 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 316
NY + R P+ + K+F + P +A DL S++L P+ R +
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 317 EACAHPFFDELREP 330
EA HP+ + +P
Sbjct: 307 EALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 54/292 (18%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHC 99
V+G GS G+V++ + TG+ A+KK+ D + R EL+ +R + P V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F+ +++V+EY+ S+ +LK ++P + QI +GL Y+HT
Sbjct: 68 FYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIF 213
+ HRD+KP NLL++ +VKI DFG +K L N C+ F Y +PE I
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 271
G + Y+ + DIWS G L E LG+ P P +L++ I C P
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+ PE D S LQ P R +A E HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 101/326 (30%), Positives = 167/326 (51%), Gaps = 41/326 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R ++N REL LM+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+I L + F S E + +VME + ++ +V++ ++RM + YQ+
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 271 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 316
Y + R P+ + + K+F + P +A DL S++L S R +
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 317 EACAHPFFD------ELREPNARLPN 336
EA HP+ + E P ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-36
Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 27/294 (9%)
Query: 46 VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRVMD---HPNVIS 95
+G G++G VF+A+ L+ G VA+K+V + RE+ ++R ++ HPNV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 96 L-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L C S T + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAPE++
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 324
P+ H ++ + +L LL ++P+ R +A A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 3e-34
Identities = 79/288 (27%), Positives = 139/288 (48%), Gaps = 48/288 (16%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKH 98
++G G+FG+V++ LETG+ VAIK++ L+ + + +E+ L++ + HPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ L +++EY S+ +++K + + + V +Y YQ+ +GLAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 216
V HRD+K N+L VK+ DFG A +L + S + + ++ APE+I +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
+T+ DIWS GC + ELL G P + N + L I++ + +
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP---P 218
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P + + PE D + Q P+LR TA + HP+
Sbjct: 219 LP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 50/292 (17%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKHC 99
+G G+FG V+ A L+TGE +A+K++ +QD K E++++ ++ HPN++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ + ++ + MEY ++ +L+H + + +++YT Q+ GLAY+H+
Sbjct: 65 YGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS- 117
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPELIF 213
+ HRD+KP N+ +D +K+ DFG A +L GE S + Y APE+I
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 214 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
G + + DIWS GCV+ E+ G+ + + Q++ + P
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P ++ PE D R L+ P R TA E HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 107/316 (33%), Positives = 157/316 (49%), Gaps = 44/316 (13%)
Query: 46 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ RE+ L+R + HPNVISL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 156
S + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 157 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 209
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 261 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 308
E+I+ M + T DFR IK HKV + +A L +LL
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301
Query: 309 PSLRCTALEACAHPFF 324
P R T+ +A P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 90/296 (30%), Positives = 133/296 (44%), Gaps = 59/296 (19%)
Query: 49 GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISLKHCFF 101
G++G VF AK TG+ AIK + D KN+ E ++ P V+ L ++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S K L+L VMEY+P + +L++ S ++ + ++Y +I L Y+H+
Sbjct: 61 SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSRF-----YRAPEL 211
+ HRDLKP N+L+D H +K+ DFG +K + + R Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
I G ++ ++D WS GC+L E L+G P F GE EEI N
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 324
+P+ + EAIDL S+LL P R A E HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 105/314 (33%), Positives = 158/314 (50%), Gaps = 40/314 (12%)
Query: 46 VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ RE+ L+R + HPNVI+L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 156
S + + + L+ +Y ++ ++K + S AN++ +P VK YQI G+ Y+H
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 157 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 209
V HRDLKP N+LV P +VKI D G A+ + A++ + F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 261 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 310
E+IR M P Y DFR K K ++ P++ L +LL P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303
Query: 311 LRCTALEACAHPFF 324
R T+ +A P+F
Sbjct: 304 KRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKH 98
+G G+ G+V + TG+ +A+K + + ++ REL ++ + P ++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 99 CFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F++ ++ + MEY+ S+ ++LK R+P + + +GL Y+H
Sbjct: 67 AFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE 118
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
++ HRD+KP N+LV+ Q+K+CDFG + QL+ A +++ + Y APE I G +
Sbjct: 119 KHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-ND 175
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNY 272
Y+ DIWS G L EL G+ +P EN + L I+ P
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP-- 221
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P++ + + P+ D + L P R + E HPF
Sbjct: 222 -----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-32
Identities = 82/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNV 93
+ +GTG+F +QA+ ++TG +A+K+V R + +E++LM ++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I +T + NL +E++ S+ +L Y + + + + YT Q+ RGL
Sbjct: 66 I---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANISYICSRFYR 207
+Y+H ++ HRD+K NLL+D +++I DFG+A +L AGE + + +
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APE++ G +Y S D+WS GCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 102
+G GS+G V++A ETG+ VAIK V + + +E+ +++ D P ++ +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF- 68
Query: 103 TTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
+L+ +VMEY S+ ++K N+ + + YQ +GL Y+H+ +
Sbjct: 69 --KNTDLW--IVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTT 220
HRD+K N+L++ Q K+ DFG + QL A + I + F+ APE+I Y
Sbjct: 121 IHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178
Query: 221 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 280
DIWS G E+ G+P + + + + I P P
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP-------PPT 218
Query: 281 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ P ++ PE D + L P R +A++ HPF
Sbjct: 219 LSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V++ VA+K + +D + RE ++MR +DHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRG 151
+ L T + L +VMEY+P L Y + + + L + + QI RG
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----YR 207
+ Y+ + HRDL +N LV VKI DFG ++ L + Y + R
Sbjct: 116 MEYLESK-NFIHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYKVKGGKLPIR 169
Query: 208 --APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
APE + ++T+ D+WS G +L E+ LG+ +PG + +++E +K
Sbjct: 170 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 60/296 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
+ +GTGSFG V + +G+ A+K K+++ ++ + E ++++ + HP +++L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +++ L LVMEYVP E L + + R P + Y Q+ L Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H++ V +RDLKP+NLL+D + +KI DFG AK++ + +C + Y APE+I
Sbjct: 117 LHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y ++D W+ G ++ E+L G P F +N Q+ E K+L
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 324
RFP P+A DL LLQ + R L+ HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V++ K + VA+K + +D + RE ++MR +DHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ L T + L+ +VMEY+ L Y N+ ++ L + + QI RG+
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--APE 210
Y+ + + HRDL +N LV VKI DFG ++ L + R APE
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
+ ++T+ D+WS G +L E+ LG+ +PG + ++++E +K
Sbjct: 174 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK-------------- 217
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+R PQ PPE DL + P R T F EL E
Sbjct: 218 ---NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT---------FSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G G+ G V++A TG+ VAIKK+ Q++ E+ +M+ HPN++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIYVKLYTYQIFRGLAYIHT 157
+EL++ VMEY+ S+ ++ RM + YV ++ +GL Y+H+
Sbjct: 86 V---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAYVCR---EVLQGLEYLHS 134
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 214
+ HRD+K N+L L+ VK+ DFG A QL ++ S + + ++ APE+I
Sbjct: 135 QNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+Y +DIWS G + E+ G+P + E + L I G P +
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN---------- 238
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
W F D ++ L P R +A E HPF
Sbjct: 239 -------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 53/303 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 85
++ ++G G++G V+ A + TGE +A+K+V R E++ +
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLY 144
+ +DH N++ E +L++ +EYVP S+ L+ Y +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISYI 201
T Q+ GLAY+H+ + HRDLK NLLVD KI DFG +K+ + + N+S
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 202 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
S F+ APE+I ++ Y+ +DIWS GCV+ E+ G+ + E A+ + ++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224
Query: 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320
+ A P + P A+D + +P R TA E
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
Query: 321 HPF 323
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 58/291 (19%)
Query: 49 GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQ---LMRVMDHPNVISLKHCF 100
G+FG V+ AK TG+ AIK ++ + N + + +M + P V L +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63
Query: 101 FSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+S SK+ L+L VMEY+ S+ + L +P + K Y ++ G+ +H
Sbjct: 64 YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ HRD+KP+NLL+D H +K+ DFG ++ G N ++ + Y APE I G
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVG 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
+ D WS GCV+ E L G P F E D + + I R +N
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 324
W + + PEA+DL +RLL P+ R A E +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-29
Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 67/308 (21%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 86
++ ++G+GSFG V+ +GE +A+K+V +DR+ RE+ L++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
+ H N++ S + LN+ +EYVP S+ +L +Y + + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 198
QI +GL Y+H + HRD+K N+LVD +KI DFG +K+L EAN
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKTNG 167
Query: 199 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
S S F+ APE++ T YT DIWS GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315
+ + P+I ++ + EAID + + + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 316 LEACAHPF 323
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 22/240 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RVMDHPNVISL 96
++G G++G V++ K + TG VA+K + D + RE+ L+ R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ L ++MEY R L ++ Y+ + ++ L YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGA 215
V V HRD+K N+LV T VK+CDFG A L + +++ + ++ APE+I
Sbjct: 119 KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y T DIWS G + E+ G P + +A ++ I K P R E + +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 41/289 (14%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 98
VG G +G VF AK +TGE VA+K++ L + R+ E ++ ++ L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F L+L MEYVP +R L + + + + Y ++F + +H +
Sbjct: 69 AF---QDDEYLYL--AMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
HRDLKP+N L+D H +K+ DFG +K ++ AN S + S Y APE++ G Y
Sbjct: 121 G-YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGY 175
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278
++D WS GC+L E L G P F G + + T R P Y D RF
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF- 227
Query: 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ EA DL ++L+ + + HPFF E+
Sbjct: 228 -------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRVMDHPN 92
+ E+ +G G F +V++A CL G VA+KKV + D + + E+ L++ +DHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
VI F NE LN+V+E + R++KH+ + +P + Y Q+
Sbjct: 64 VIKYLASFI---ENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPE 210
L ++H+ R+ HRD+KP N+ + T VK+ D G + + A S + + +Y +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
I Y DIWS GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 98
+G GSFG V + + G+ + K++ ++++ E+ ++R + HPN++
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+++ L +VMEY + ++++ + + ++ Q+ L H
Sbjct: 67 RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 158 V----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 210
V HRDLKP N+ +D + VK+ DFG AK L G + +Y+ + +Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ + Y DIWS GC++ EL P F N QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-27
Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 53/311 (17%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ 83
+P++ + + E +G GSFG V+ A+ + T E VAIKK+ + N +E++
Sbjct: 10 KDDPEKLFTDLRE--IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 143
++ + HPN I K C+ + LVMEY S +L+ + Q + + +
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTA-----WLVMEYCLGSASDILEVHKKPLQEVEIAAI-- 120
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ +GLAY+H+ R+ HRD+K N LL +P VK+ DFGSA + AN S++
Sbjct: 121 -CHGALQGLAYLHSHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVG 173
Query: 203 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ ++ APE+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 228
Query: 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320
N + P + ++ W F +D LQ P R ++ E
Sbjct: 229 --------NDS------PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEELLK 266
Query: 321 HPFFDELREPN 331
H F R P
Sbjct: 267 HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 94
+++G G+FG V+ ++TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C +++ L++ MEY+P S+ LK Y + + + + YT QI G+
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K+L +G S + ++ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E+I G Y D+WS GC + E+L +P + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
PQ+ +H + P+A + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 85/319 (26%), Positives = 132/319 (41%), Gaps = 77/319 (24%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISLK 97
V+G G+FG V+ + +TG+ A+K + + K ++ +R ++ D P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F ++E L LVMEY+P + +L P + Y ++ L +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------- 205
+ + HRD+KP N+L+D H +K+ DFG K++ + Y+
Sbjct: 119 KLGFI-HRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 206 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
Y APE++ G T Y D WS G +L E+L G P F +
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234
Query: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
L E T +I +N RFP + PEAIDL RLL
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 307 YSPSLR-CTALEACAHPFF 324
P R + E +HPFF
Sbjct: 271 -DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHPNVISLKH 98
+G G FG V K T A+K V + + + E +++ +HP ++ L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F K++ ++ ++MEY E L + Y + Y+H
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ +RDLKP+NLL+D VK+ DFG AK+L +G+ ++ + Y APE+I
Sbjct: 111 NR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y S+D WS G +L ELL G+P F GE+ D + +I N
Sbjct: 169 -YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE--- 214
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 325
FP + A DL +LL+ +P R L+ H +F+
Sbjct: 215 FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 62/302 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRVMDHPNV 93
+V+G GSFG V A+ T E A+K +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L H F T K+ LF VMEYV + M+ + + + R + Y +I G
Sbjct: 59 TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H + +RDLK N+L+D H +KI DFG K+ I G S C + Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ Y ++D W+ G +L E+L GQ F G++ D+L + I
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 325
+ R+P + + EA + L +P R L HPFF
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 326 EL 327
E+
Sbjct: 257 EI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHC 99
V+G G+ +V+ A CL E VAIK++ ++ + +E+Q M +HPNV+ +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F +EL+ LVM Y+ S+ ++K Y +I L ++ +GL Y+H+
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 158 VPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EANISYICSRFYRAPEL 211
++ HRD+K N+L+ VKI DFG + L G + +++ + + APE+
Sbjct: 121 NGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ Y DIWS G EL G + + L+ ++ N
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P ++ +K + K + S LQ PS R TA E H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G G+FG V++ GE VA+K + + + E +M+ + HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA 153
L T L+ +V EY+P L + +++ L + QI +G+
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE 210
Y+ + V HRDL +N LV VKI DFG ++ + + + + APE
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ ++T+ D+WS G +L E+ LG+ +PG
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
G GS+G V++ K L + A+K+V L K R E++++ ++HPN+IS K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 101 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
L +VMEY P + + + + +P + Q+ RGL +H
Sbjct: 69 LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 160 RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
++ HRDLK N LLV VKI D G +K L A + I + Y APE ++ Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ DIWS GC+L E+ P F + D ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 97/335 (28%), Positives = 148/335 (44%), Gaps = 64/335 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+V+G GSFG V A+ T E AIK + +D ++ +++ RV+ +HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L H F + +K LF VMEY+ L + ++ R + Y +I GL ++
Sbjct: 58 LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H + +RDLK N+L+D H +KI DFG K+ + GE S C + Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+Y S+D WS G +L E+L+GQ F GE+ D+L + I +
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR--------- 212
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPNAR 333
P F + + EA D S+L + P+ R + HPFF R +
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWE 257
Query: 334 LPNGRPLPPLF-----------NFKQELSGASPEL 357
R +PP F NF +E + L
Sbjct: 258 RLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-24
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 37/297 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G V + K + TG +A K V R+ RELQ+M P ++S F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
NE + + ME++ S+ R+ K +P+ + + GL Y++ V
Sbjct: 73 L-----NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
R+ HRD+KP N+LV+ Q+K+CDFG + +LI A+ +++ + Y +PE I G +YT
Sbjct: 124 RIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180
Query: 220 TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278
D+WS G + EL LG+ P D + + +L
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----------------LQ 223
Query: 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDELREPNARL 334
QI P ++ P + D L P+ R T + CA PF LR N L
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 58/294 (19%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G++G V++A+ + TGE VAIK + D +E+ +++ HPN++ F
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67
Query: 102 STTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S +++L+ +VMEY + +Y+V + S Q + YV + +GLAY+H
Sbjct: 68 SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 214
++ HRD+K N+L LT VK+ DFG + QL A A S+I + ++ APE+
Sbjct: 120 TGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173
Query: 215 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
A E Y DIW+ G EL QP P + + ++ L ++
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219
Query: 271 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+F P++K W VFH D + L P R TA + HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 9e-24
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y RVVG G+FGIV + + V IK++ +R E Q+++++ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I F + L +VMEY P ++ ++ N + + + QI L
Sbjct: 62 IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++HT + HRDLK QN+L+D VKI DFG +K L + + + + Y +PEL
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
G Y DIW+ GCVL EL + F N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 53/294 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
+ +G GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
F + L ++MEY S +LK ++ Y+ ++ GL
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLE 112
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAP 209
Y+H HRD+K N+L+ VK+ DFG + QL + +S ++ + F+ AP
Sbjct: 113 YLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E+I + Y DIWS G EL G+P + + L I K N
Sbjct: 168 EVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NN 214
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P P ++ + + K F D S L P R +A E H F
Sbjct: 215 P-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 99
+G G+ G+V + +G +A K + + R REL+++ + P ++
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F+S E+ ++ ME++ S+ +VLK R+P + + + RGL Y+
Sbjct: 68 FYS---DGEI--SICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 273
T DIWS G L E+ +G+ P +A E+ + G P +E R ++ +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231
Query: 274 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
D P I P K+ E D + L+ +P R E HPF
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 95
+ +G G+FG V++ K VA+K + +D + R E ++M+ + HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQRMPLIYVKLYTY 146
L T + L+ LV+EY+ L Y S + L + +
Sbjct: 61 LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
QI +G+ Y+ + + HRDL +N LV VKI DFG ++ + + +Y
Sbjct: 113 QIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161
Query: 207 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 37/218 (16%)
Query: 43 ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRVMDHPNVISLK 97
ERVV G G++GIV+ A+ L T +AIK++ +D RY + E+ L + H N++
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69
Query: 98 HCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + S+N F + ME VP S + LK + YT QI
Sbjct: 70 --YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------IIFYTKQIL 118
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 205
GL Y+H ++ HRD+K N+LV+ + VKI DFG++K+L A I+ F
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTL 173
Query: 206 -YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 241
Y APE+I G Y DIWS GC + E+ G+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 93/336 (27%), Positives = 146/336 (43%), Gaps = 66/336 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+++G GSFG VF A+ T + AIK + +D + +++ RV+ +HP
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L H + + +K LF VMEY+ + M+ + + + L Y +I GL
Sbjct: 58 LTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A C + Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G +Y TS+D WS G +L E+L+GQ F G + + + IR NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 331
+ + EA D+ +L P R + HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256
Query: 332 ARLPNGRPLPPL----------FNFKQELSGASPEL 357
+ L PP NF +E P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 96
RV+G G+FG V + +T + A+K K ++ +N E ++++ ++HP +++L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F ++E + LV++ + L+++ S + VK + +I L Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGD---LRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ + HRD+KP N+L+D H V I DF A ++ S + Y APE++
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y+ ++D WS G E L G+ + G + R++IR
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 324
Q A + EAID ++LL+ P R + HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)
Query: 44 RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNV 93
+ +G G FG V + TGE VA+K Q R RE++++R +DH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ K ++ L L+MEY+P L+ Y ++ ++ L + L++ QI +G+
Sbjct: 69 VKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y + F
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIF 177
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVDQLV 251
+ APE + + + S D+WS G L EL + L G+ V +L+
Sbjct: 178 WYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236
Query: 252 EIIK 255
E++K
Sbjct: 237 ELLK 240
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-23
Identities = 97/337 (28%), Positives = 153/337 (45%), Gaps = 68/337 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 95
+V+G GSFG V A+ GE A+K + +D + +++ RV+ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L +C F T K LF VME++ + M+ + R L Y +I GL
Sbjct: 61 L-YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H+ + +RDLK N+++D H +KI DFG K+ + G+ S C + Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G +YT S+D WS G +L E+L+GQ F G++ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 331
+P+ W + E+ D+ +L + P+ R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 332 ARLPNGRPLPPLF-----------NFKQELSGASPEL 357
R L P F NF +E P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISLK--HCFF 101
G G++G+V + + + TG +A+K++ + + K +L+ +D IS++ C +
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLD----ISMRSVDCPY 61
Query: 102 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ T LF + ME + S+ + K +P + I + L Y+H+
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 122 KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 218 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
Y D+WS G + EL G+ FP ++ ++ +V+ P+
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS------------- 225
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334
PQ+ A ++ PE D ++ L+ + R E HPFF+ N +
Sbjct: 226 ---PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274
Query: 335 P 335
Sbjct: 275 A 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 7e-23
Identities = 99/326 (30%), Positives = 145/326 (44%), Gaps = 61/326 (18%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K C+ E LVMEY S +L+ + Q + + + T+ +GLAY+H
Sbjct: 91 KGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
+ + HRD+K N LL +P QVK+ DFGSA IA AN S++ + ++ APE+I
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGTPYWMAPEVILAM 196
Query: 216 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
E Y +D+WS G EL +P NA+ L I + N +
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333
P ++++ W F + LQ P R T+ E H F LRE
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283
Query: 334 LPNGRPLPPLFNFKQELSGASPELVN 359
RP L + Q A EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 90/324 (27%), Positives = 137/324 (42%), Gaps = 61/324 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKH 98
+G GSFG V+ A T E VA+KK+ + N +E++ ++ + HPN I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
C+ + LVMEY S +L+ + Q + + + T+ +GLAY+H+
Sbjct: 89 CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 159 PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ HRD+K N LL +P QVK+ DFGSA + AN S++ + ++ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGTPYWMAPEVILAMDE 194
Query: 218 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y +D+WS G EL +P NA+ L I + N +
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NDS---- 237
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
P ++++ W F LQ P R + E H F +
Sbjct: 238 --PTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDF----------VR 277
Query: 336 NGRPLPPLFNFKQELSGASPELVN 359
RP L + Q A EL N
Sbjct: 278 RDRPARVLIDLIQRTKDAVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-22
Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+G G++G V++ TG T+A+K++ L + ++ EL ++ P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
F + + + MEY+ L A + +P ++ TY + +GL ++
Sbjct: 69 FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGA 215
+ HRD+KP N+LV+ QVK+CDFG + L+A A + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQN 181
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 272
YT D+WS G + E+ LG+ +P E N QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+ +A D ++ L P+ R T + HP+ + + +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-22
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ C+ E LVMEY S +L+ + Q + + V T+ +GLAY+H
Sbjct: 81 RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
+ + HRD+K N LL +P VK+ DFGSA I AN ++ + ++ APE+I
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAM 186
Query: 216 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
E Y +D+WS G EL +P NA+ L I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 9e-22
Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 99
+G GS GIV A TG VA+KK+ D R + R E+ +MR HPN++ +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ S +EL++ VME++ ++ ++ H RM + + + L+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133
Query: 159 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGA 215
V HRD+K ++L LT +VK+ DFG Q+ S + + ++ APE+I
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y T +DIWS G ++ E++ G+P + E + + + IR P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
P++K HKV P R+L P+ R TA E HPF + P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 93/343 (27%), Positives = 144/343 (41%), Gaps = 66/343 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G+ A+ KVLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F T K L V++YV E + + + + P + Y +I L
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASAL 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ Y ++D W G VL E+L G P F + ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDEL 327
+ A L LLQ + R A LE H FF +
Sbjct: 219 IS---------------------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257
Query: 328 REPNARLPNGRPLPPLFNFK----QELSGASPELVNKLIPDHV 366
N + + P FN +L PE + +P+ V
Sbjct: 258 ---NWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 52/312 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 97
+G G FG V + TG+ A KK L +R K R E +++ + ++SL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIH 156
+ F + L LVM + + H + + P Y QI GL ++H
Sbjct: 60 YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
R+ +RDLKP+N+L+D + V+I D G A +L G+ + Y APE++ G
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y S+D ++ GC L E++ G+ F Q E ++ +EE++
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331
+ + PEA DL LLQ P R +A E HP F +L
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263
Query: 332 ARLPNGRPLPPL 343
RL G PP
Sbjct: 264 -RLEAGMLEPPF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRVMDHPNVISLKHC 99
+G GSFG+VF+ A+K++ L +RR + E +++ +D +I
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F LN+VMEY ++++LK + +P V + QI GLA++H+
Sbjct: 68 FLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT 216
++ HRD+K NL +D VKI D G AK L AN + + + +Y +PEL
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELC-EDK 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
Y D+W+ G VL E G+ F N +++II+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-21
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRVMDHPNVI 94
V+G G++G V+ G+ +A+K+V D + Y+ E+ L++ + H N++
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T ++ +++ ME+VP S+ +L + +P YT QI G+A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-------CSRFY 206
Y+H V HRD+K N+++ P +K+ DFG A++L + ++ + ++
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
APE+I + Y DIWS GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 101
G G+ G V + + TG A+K + D ++ REL++ + P ++ F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 102 STTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+S + + + MEY +S+Y +V K ++ L + + +GL+Y+H
Sbjct: 70 DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ ++ HRD+KP N+L+ QVK+CDFG + +L+ A ++ + FY APE I G
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP 179
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT----------- 261
Y+ + D+WS G L E+ + FP E +L+ I + P
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 262 REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 294
EE + C+ + T P + HPW K K+
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-21
Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 98
VGTG+FG V + + A+K + L+ ++ + E ++++ + HP +I L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
T ++ FL ++MEYVP ++ L++ + L Y +I L Y+H+
Sbjct: 68 ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 216
+ +RDLKP+N+L+D H +K+ DFG AK+L +C + Y APE+I +
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ ++D W+ G ++ E+L+G P F +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 94
+++G G+FG V+ +TG +A+K+V D E+QL++ + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C + L++ ME++P S+ LK Y + + + + YT QI G++
Sbjct: 68 QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E+I G Y DIWS GC + E+L +P + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 93
Y+ RV+G G+FG + E V K+V L RR E+ ++ ++ HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I+ + F + L + MEY ++Y + Q V Y +QI +
Sbjct: 62 IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--SRFYRA 208
+YIH + HRD+K N+ LT +K+ DFG +K L E +++ + +Y +
Sbjct: 115 SYIHKA-GILHRDIKTLNIF---LTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMS 169
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PEL G +Y DIW+ GCVL ELL + F N ++ +V+I +
Sbjct: 170 PELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------V 214
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
NYT E I L LLQ P R TA E P
Sbjct: 215 QGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 91
++ E+ +G G F V++A CL G VA+KKV L D + + +E+ L++ ++HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI F NE LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 63 NVIKYYASFI---EDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 209
L ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 99/345 (28%), Positives = 145/345 (42%), Gaps = 78/345 (22%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRVMDHPNV 93
+V+G GSFG V A+ T E AIK +LQD + R L L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+L HC F T K+ LF VMEYV + M+++ + R + Y ++
Sbjct: 59 TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H V +RDLK N+L+D H K+ DFG K+ I + C + Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
I EY S+D W+ G ++ E++ GQP F +N D L E I
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 323
+ D +P W + EA+ + + +P+ R C A + HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 324 FDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 357
F +E + L R + P F NF Q+ + P L
Sbjct: 257 F---KEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVL 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 50/312 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H R+ +RDLKP+N+L+D H ++I D G A ++ GE + + Y APE++
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
YT S D W GC++ E++ G+ F E +K REE+
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 330
++K + + ++ A + +LL P R C A E AHPFF
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269
Query: 331 NARLPNGRPLPP 342
RL G PP
Sbjct: 270 -KRLEAGMLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-20
Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 27/242 (11%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVM 88
I++ +++G G+FG V+ ++TG +A K+V D E+QL++ +
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
H ++ C + E L + MEY+P S+ LK Y + + + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICS 203
I G++Y+H+ + HRD+K N+L D VK+ DFG++K+L ++G S +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
++ +PE+I G Y D+WS GC + E+L +P + A + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228
Query: 264 EI 265
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 83/311 (26%), Positives = 135/311 (43%), Gaps = 65/311 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISL 96
+++ G++G V+ + ET + A+KK+ Q+ +N+ E ++ ++P V+S+
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
C F T L +VMEYV +LK+ + +P+ ++Y + L Y+
Sbjct: 67 -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRF---- 205
H V HRDLKP NLL+ + H +K+ DFG +K + E +I F
Sbjct: 118 HNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 206 ------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
Y APE+I Y +D W+ G +L E L+G F G+ + ++I
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 316
++I P + +P +A DL SRLL+ +P R A
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 317 EACAHPFFDEL 327
E H FF L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 53/302 (17%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRVMDHP 91
RV+GTG++G VF + + + G+ A+K ++Q + + E Q L V P
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++L H F T +K L+L+++YV + + H + V++Y +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVLA 117
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 209
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E +Y C Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 210 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
E+I G + + ++D WS G + ELL G F + + EI + R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFD 325
K+ P F K M EA D +LL+ P R A E HPFF
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 326 EL 327
+
Sbjct: 271 GI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 27/213 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMRVM-DHPNVISLKHCF 100
V+G G++G V++A+ +TG+ VAIK +++D + + E ++R +HPN+ + F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 101 F---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ ++L+ LVME S+ ++K +R+ ++ + RGLAY+H
Sbjct: 73 IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 157 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 212
+V HRD+K QN+L LT +VK+ DFG + QL + G N ++I + ++ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TFIGTPYWMAPEVI 185
Query: 213 FGATE------YTTSIDIWSAGCVLAELLLGQP 239
A + Y D+WS G EL G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)
Query: 46 VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 95
+G G+FG V C TGE VA+KK+ R RE+++++ + H N++
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 154
K +S +N L LVMEY+P Y L+ Y ++ R+ + LY QI +G+ Y
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------AGEANISYICSR 204
+ R HRDL +N+LV+ VKI DFG K L GE+ I
Sbjct: 124 L-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
F+ APE + ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 85/284 (29%), Positives = 130/284 (45%), Gaps = 47/284 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G+ A+K VLQ + NR+ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F TT K L V+++V E + + + S R + Y +I L
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ IA + C + Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII-KVL----GTPTR---- 262
I Y ++D W G VL E+L G P F + + I+ K L G
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226
Query: 263 -----EEIRCMNPNYTDFRFPQIKAHP------WHKVFHKRMPP 295
E+ R + F +I+ HP W + K++PP
Sbjct: 227 LEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 22/221 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G+V + + +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+S +++ ME++ S+ +VLK +R+P + + + RGLAY+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
DIWS G L EL +G+ P +A E+ + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 94/320 (29%), Positives = 137/320 (42%), Gaps = 58/320 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 97
+G GSFG V Q + +T A+K + + E+ L +V + P ++ LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
FS S +L+L L E L H+ R L + YT ++ L +H
Sbjct: 60 ---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 216
V +RDLKP+N+L+D H + +CDFG K + + + C + Y APEL+ G
Sbjct: 112 F-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
YT ++D W+ G +L E+L G P F EN V+++ K+L P R
Sbjct: 170 -YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LR 211
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNAR 333
FP +A DL LL P+ R A E HPFF +L +
Sbjct: 212 FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KK 257
Query: 334 LPNGRPLPPLFNFKQELSGA 353
L PP FK +S A
Sbjct: 258 LLMKGIQPP---FKPAVSSA 274
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 91
++ E+ +G G F V++A CL + VA+KKV + D + + +E+ L++ ++HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI F NE LN+V+E + +++K++ + +P V Y Q+
Sbjct: 63 NVIKYLDSFI---EDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAP 209
+ ++H+ RV HRD+KP N+ + T VK+ D G + + A S + + +Y +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244
E I Y DIWS GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 92/339 (27%), Positives = 146/339 (43%), Gaps = 69/339 (20%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LM---RV------MDHPNVI 94
V+G G FG V A+ +TGE AIK + + E++ LM R+ HP ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+L CF T + F VMEY + M + S + Y + GL
Sbjct: 66 NLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H ++ +RDLK NLL+D VKI DFG K+ + S C + + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ T YT ++D W G ++ E+L+G+ FPG++ + I+ +E+R
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 324
+P + EAI + RLL+ +P R + E A PFF
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262
Query: 325 ---DEL---REPNARLPNGRPLPPLFNFKQELSGASPEL 357
D+L + +P + + NF +E + +P L
Sbjct: 263 INWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVL 301
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 94
+++G G+FG V+ +TG +A+K+V D + E+QL++ + H ++
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
C K L++ +EY+P S+ LK Y + + + + YT QI +G++
Sbjct: 68 QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 209
Y+H+ + HRD+K N+L D VK+ DFG++K++ ++G S + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E+I G Y D+WS C + E+L +P + A + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 8e-19
Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 97
+ +G GSFG ++ AK E IK++ ++++ +E+ L+ M HPN+++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGL 152
F S LF+ VMEY + M R+ + S +Q + + QI GL
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------ILSWFVQISLGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 210
+IH ++ HRD+K QN+ + K+ DFG A+QL ++Y C + +Y +PE
Sbjct: 115 KHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
I Y DIWS GCVL EL + F G N + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 98/345 (28%), Positives = 146/345 (42%), Gaps = 70/345 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRVMDHPNV 93
RV+G GSFG V A+ E+G A+K +LQD + R L L R +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L CF + + LF VME+V + M+ + K ++R + Y +I
Sbjct: 59 TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H + +RDLK N+L+D H K+ DFG K+ I S C + Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
I Y S+D W+ G +L E+L G F EN D L E I +E+
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 324
V+ + +A+D+ + +P++R L HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 325 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 369
EL + N R + P F + + S E V+ PD +K
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIK----SREDVSNFDPDFIKED 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNV 93
+++G G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I+ A + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEI
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEI----- 212
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 324
RFP + + PEA L + LL+ P R A E H FF
Sbjct: 213 -----RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 100
+G G+ G+VF+ +G +A K + + R RELQ++ + P ++ F
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+S +++ ME++ S+ +VLK R+P + + + +GL Y+
Sbjct: 73 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENA 246
DIWS G L E+ +G+ P +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ RV+ P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
H F T + L VMEYV + MY + + + P + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ + +RDLK N+++D H +KI DFG K+ I G C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 44 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
RV+G G FG V + TGE VA+K + ++ +N E+ +++ + H N++
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 152
K C + + L L+MEYVP R + KH + Q + L+ QI G+
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FY 206
AY+H+ HRDL +N+L+D VKI DFG AK + G Y F+
Sbjct: 121 AYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 176
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
A E + S D+WS G L ELL
Sbjct: 177 YAVECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 92/345 (26%), Positives = 150/345 (43%), Gaps = 74/345 (21%)
Query: 44 RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRVMD 89
+V+GTG++G VF K L+ V K ++ R + L+ +R
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVKLYT 145
P +++L H F T +K L+L+++YV M+ L ++S V+ Y+
Sbjct: 64 SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYS 111
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 204
+I L ++H + + +RD+K +N+L+D H V + DFG +K+ ++ E +Y C
Sbjct: 112 GEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGT 169
Query: 205 F-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y APE+I G + ++D WS G ++ ELL G F E + E+ +R
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRR 222
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--- 320
++C P F + PEA DL +LL+ P R A A
Sbjct: 223 ILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264
Query: 321 --HPFFDEL-------REPNARL-PNGRPLPPLFNFKQELSGASP 355
HPFF L R+ N P+ R + NF +E + P
Sbjct: 265 KEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 16/226 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTT 104
+G G+FG V + +G +A+K++ R E + R+ MD V+ C +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 105 SKNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
LF + ME + S+ + K+ Y +P + + L Y+
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATE 217
++ HRD+KP N+L+D +K+CDFG + QL+ A R Y APE I
Sbjct: 128 KIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 262
Y D+WS G L E+ G+ +P N+V DQL +++K G P
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 66/297 (22%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRVMDHPNVISLK 97
+GTGSFG V AK TGE AI K L+ R + K +E ++ + HP ++++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F +N ++ ++E+V + H A R P K Y ++ Y+H+
Sbjct: 85 CSF---QDENRVY--FLLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ +RDLKP+NLL+D H VK+ DFG AK++ + + + Y APE+I +
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEI---RCMNPNY 272
+ ++D W+ G +L E + G P F + TP R E+I R PN+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILAGRLKFPNW 237
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 324
D R A DL LLQ + R L+ HP+F
Sbjct: 238 FDGR--------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 43/294 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 99
++G G+ G V++A L T +A+K + D ++ EL+++ D P +I
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
FF E +++ E++ V + ++P + + +GL Y+ ++
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL- 114
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 219
++ HRD+KP N+LV+ QVK+CDFG + QL+ A +Y+ + Y APE I G +Y
Sbjct: 115 KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 278
D+WS G EL LG+ +P +I K G+ ++ +C+ D P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218
Query: 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 332
+ + + F + ++ ++ P R HPF + + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 71/250 (28%), Positives = 127/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G VF A + TG+ VAIK++ LQ + K E+ +M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+ +PN+++ F +ELF+ VMEY+ S+ V+ ++ +
Sbjct: 73 LKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 266 RCMNPNYTDF 275
++P + DF
Sbjct: 239 EKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 29/223 (13%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRGL 152
H F T + L VMEYV + MY + Q++ Y +I GL
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEPQAVFYAAEISVGL 114
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPEL 211
++H + +RDLK N+++D H +KI DFG K+ ++ G ++ + Y APE+
Sbjct: 115 FFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
I Y S+D W+ G +L E+L GQP F GE+ D+L + I
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 69/250 (27%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
HPN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238
Query: 266 RCMNPNYTDF 275
++ + DF
Sbjct: 239 EKLSAIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 86/313 (27%), Positives = 134/313 (42%), Gaps = 50/313 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A KK L+ +R K R E Q++ ++ V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
YT S D W+ GC+L E++ GQ F Q + IK REE+ +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330
+K + + ++ P+A L LL P R A E HP F ++
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 331 NARLPNGRPLPPL 343
RL G PP
Sbjct: 269 FKRLEAGMLEPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 87/356 (24%), Positives = 133/356 (37%), Gaps = 103/356 (28%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+V+G G+FG V + +TG A+KK+ + + K + E ++ D+P V+ L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYTYQIFRGLA 153
+ F ++E +L L+MEY+P M +L + + Y+ + L
Sbjct: 67 YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------IAGEANIS 199
YIH RD+KP NLL+D H +K+ DFG L +
Sbjct: 122 YIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 200 YICSRF-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+I Y APE +F T Y D WS G ++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEM 232
Query: 235 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 294
L+G P F +N + +I +N T +FP +
Sbjct: 233 LVGYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLS 267
Query: 295 PEAIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPLPP 342
PEA DL RL R E +HPFF + +RE A P+ P
Sbjct: 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 59/299 (19%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRVMDHP 91
+V+G G +G VFQ + + +TG+ A+K VL+ D + E ++ + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
++ L F T K L L++EY+ + H M Y +I
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 210
L ++H + +RDLKP+N+L+D H VK+ DFG K+ I C Y APE
Sbjct: 113 LEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
I + + ++D WS G ++ ++L G P F EN + +I+K + P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 324
Y + PEA DL +LL+ +PS R A E +HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
Y RVVG GSFG + + + + A+K++ + +E L+ M HPN++
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT--------Y 146
+ K F + + L +VMEY Q++ L KL+
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPEDTILQWFV 107
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEANISYICS 203
Q+ G+ +IH RV HRD+K +N+ LT +VK+ DFGSA+ L + G +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+Y PE I+ Y DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 46 VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 97
+G G+FG V + L VA+K + Q+ RE +M +DHP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K E + LVME P + + LK + +P+ +K +Q+ G+AY+
Sbjct: 62 ----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112
Query: 157 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 207
+ HRDL +N LLV+ HQ KI DFG ++ L AG S +YR
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 208 ----APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 239
APE I +++ D+WS G L E G
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 45/296 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 100
+G GS GIV A+ +G VA+K ++ R+ + REL +MR H NV+ + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S EL++ +ME++ + + N+ + + + L Y+H+
Sbjct: 85 KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 219
V HRD+K ++L+ L +VK+ DFG Q+ S + + ++ APE+I T Y
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195
Query: 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 279
T +DIWS G ++ E++ G+P + ++ V + + R+ P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234
Query: 280 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
K HK+ P D R+L P R TA E HPF + P +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 61/255 (23%), Positives = 120/255 (47%), Gaps = 38/255 (14%)
Query: 46 VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-VMD 89
+G+G+FG V++ + G+ +A+K++ +D+R +++ E+ +++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 146
HPN++ ++ T +N+ L +VM+ + + +H++S QR +
Sbjct: 68 HPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
Q+ L Y+H R+ HRDL P N+++ +V I DFG AKQ S + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 265
PE++ Y D+W+ GC+L ++ QP F N + +I++ + P E +
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 266 ---------RCMNPN 271
C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 64/299 (21%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKHC 99
G G+FG V++A+ ETG A K + L+D E+ ++ HPN++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 100 FFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI--YVKLYTYQIFRGLA 153
+F E L +++E+ +S+ L+ L ++ Q+ L
Sbjct: 71 YF-----YENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALN 117
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI 212
++H+ +V HRDLK N+L+ L VK+ DFG SAK + ++I + ++ APE++
Sbjct: 118 FLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
Query: 213 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
F Y DIWS G L EL +P P + ++ + ++K+L +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP------- 225
Query: 269 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
P + W F+ D L P R TA E HPF +
Sbjct: 226 ---------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRVMDHPNV 93
+V+G GSFG VF + + + G+ A+K KV +DR E ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ L H F T K L L+++++ + R+ K + VK Y ++
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 210
L ++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C Y APE
Sbjct: 111 LDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 263
++ +T S D WS G ++ E+L G F G++ + + I+K LG P +
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 264 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 295
+R + NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G++G V++A+ + TGE AIK + +D +E+ +M+ H N+++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S +++L++ ME+ + + H + + YV T Q GL Y+H+ ++
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSKGKM 128
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 217
HRD+K N+L+ H VK+ DFG + Q+ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 218 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y DIW+ G EL QP + + L + K ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227
Query: 277 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P++K W FH L +P R TA + HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
+V+G GSFG V A+ + A+K + + K +E + L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L H F T K L V++Y+ E Y + + R + Y +I L
Sbjct: 61 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H++ + +RDLKP+N+L+D H V + DFG K+ I S C + Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y ++D W G VL E+L G P F N + I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
RV+G G FG V + TG+ A K+ L+ +R K R E Q++ ++ V++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y +I GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H +RDLKP+N+L+D H ++I D G A ++ GE+ + + Y APE++
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
YT S D W GC++ E++ GQ F G E +K REE+ D
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 330
R + + +V+ + EA + LL P R C A E HPFF +
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268
Query: 331 NARLPNGRPLPPL 343
RL G PP
Sbjct: 269 FKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 93
+++G G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+LK+ F + L VMEY E + + + + R + Y +I
Sbjct: 58 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+ +Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 324
F + + PEA L S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 85/311 (27%), Positives = 144/311 (46%), Gaps = 49/311 (15%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 86
G+P++ + + +G GS GIV A TG+ VA+KK + R+ + REL +MR
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMR 74
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 75 DYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCL 125
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSR 204
+ R L+Y+H V HRD+K ++L+ ++K+ DFG Q ++ E S + +
Sbjct: 126 SVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVGTP 182
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ APE+I Y T +DIWS G ++ E++ G+P + E P +
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQA 226
Query: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+R + N P++K HKV + +DL +L PS R TA E HPF
Sbjct: 227 MRRIRDNLP----PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 325 DELREPNARLP 335
P+ +P
Sbjct: 276 KLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+V+G GSFG V AK G A+K VLQ + ++ Q L++ + HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L H F T K L V++YV E + + + R + Y ++ +
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H V + DFG K+ + E S C + Y APE
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 255
+ Y ++D W G VL E+L G P F + V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 295
+L ++ R DF +IK H W ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 87/352 (24%), Positives = 146/352 (41%), Gaps = 100/352 (28%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
+V+G G+FG V + +TG+ A+K +L+ +K +L ++ D P V+SL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F ++ +L L+ME++P + +L Y + ++ + + Y + + +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGEANISYICS 203
H + + HRD+KP N+L+D H +K+ DFG ++L+ G++N + I +
Sbjct: 118 HKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 204 RF------------------------------------YRAPELIFGATEYTTSIDIWSA 227
R Y APE IF Y D WS
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 228 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 287
G ++ E L+G P F EN+ + +II RE + FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH---- 274
Query: 288 VFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNA 332
+ EA DL RL+ + + R A E +HPFF D +R+ A
Sbjct: 275 -----LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
+G G+FG V++AK ETG +A KV++ + + E++++ +HP ++ L F
Sbjct: 20 LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ L +++E+ P + P I ++ Q+ L Y+H++ +
Sbjct: 79 YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSM-K 130
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFGAT--- 216
+ HRDLK N+L+ L +K+ DFG SAK + + S+I + ++ APE++ T
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 217 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 271
Y DIWS G L E+ +P N + L++I K L P++ +
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244
Query: 272 YTDFRFPQIKAHP 284
+ DF + HP
Sbjct: 245 FRDFLKTALDKHP 257
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RVMDHPN---VIS 95
RV+G G FG V + TG+ A KK L+ +R K R+ + M R+++ N V+S
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + + +K+ L L L + + + + Y+ N Y ++ GL +
Sbjct: 65 LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
R+ +RDLKP+N+L+D H ++I D G A Q+ GE + + Y APE+I
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
+YT S D W GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 76/304 (25%), Positives = 139/304 (45%), Gaps = 55/304 (18%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 91
+V+GTG++G VF + + ++G+ A+K ++Q + +V++H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++L H F T +K L+L+++Y+ + H S +R V++Y+ +I
Sbjct: 66 FLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIVLA 117
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 209
L ++H + + +RD+K +N+L+D H V + DFG +K+ E +Y C Y AP
Sbjct: 118 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 210 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
+++ G + ++D WS G ++ ELL G F + + EI + +
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI----------- 224
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPF 323
+K+ P + + M A D+ RLL P R A E HPF
Sbjct: 225 -----------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 324 FDEL 327
F ++
Sbjct: 271 FQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 40 YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDH 90
Y+ ++ +G GSFG V+ + K E + + K + + N+E QL+ +DH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P ++ F ++ + + F ++ EY + L+ + + V + Q+
Sbjct: 62 PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 208
G+ Y+H R+ HRDLK +N+ + + +KI DFG ++ L+ + ++ + +Y +
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE + Y + DIWS GC+L E+ F G+N L +++++ PT
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------- 222
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
P+ + + + +L PSLR +A E +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 85/313 (27%), Positives = 142/313 (45%), Gaps = 53/313 (16%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMR 86
G+P+ + + +G GS GIV A +G+ VA+KK + R+ + REL +MR
Sbjct: 16 GDPRTYLDNFIK--IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMR 72
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
H NV+ + + S +EL++ VME++ + ++ N+ +
Sbjct: 73 DYQHENVVEM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 123
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYIC 202
+ + L+ +H V HRD+K ++L LTH +VK+ DFG Q ++ E S +
Sbjct: 124 AVLKALSVLHA-QGVIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVG 178
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262
+ ++ APELI Y +DIWS G ++ E++ G+P + E P
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPL 222
Query: 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
+ ++ + N P++K HKV P RLL P+ R TA E HP
Sbjct: 223 KAMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHP 271
Query: 323 FFDELREPNARLP 335
F + P+ +P
Sbjct: 272 FLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 92/341 (26%), Positives = 148/341 (43%), Gaps = 56/341 (16%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RVMDHPNVISLKH 98
++G G+FG V +A + E A+K V +Y E+Q M R D + L
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 99 C--FFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+F + + + +VM +Y P + ++KH +++ + I +Q L Y
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDYF 247
Query: 156 HTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQLIAGEANISY 200
HT + H DLKP+N+L VDP+T++ V+ICD G + +
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAI 305
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 259
+ +R YR+PE++ G + S D+WS GC++ EL G+ L+ + ++ L + K LG
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364
Query: 260 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 307
P+ RC Y + P H ++ R E I DL LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424
Query: 308 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRP-LPP 342
R A + HP ++ E R+ PN P+ R L P
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463
|
Length = 467 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+V+G+G+FG V++ + GE VAIK + ++ K E +M +DHP+V+
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L S+ + L+ + +P + +L + + + Y+ + QI +G++Y
Sbjct: 73 RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 211
+ R+ HRDL +N+LV H VKI DFG AK L E + + A E
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
I YT D+WS G + EL+ G + G AV+ L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRVMDHPNVIS 95
+G G+FG V+Q + +T A+K + + +E L + + P ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK FS + ++L+L V +Y+ E + + K + R K Y ++ L
Sbjct: 61 LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLKP+N+L+D H + +CDFG +K + + C + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
YT +D WS G ++ E+ G F E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 59/315 (18%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLK 97
+VG G FG V + TG+ A+K + + + E ++ + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F K+ L+L VMEY P + + + ++ ++ M + Y ++ + +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELI- 212
H + V HRD+KP+N+L+D H +K+ DFGSA +L A + S + + Y APE++
Sbjct: 119 HQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 213 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
G Y D WS G + E++ G+ F + I+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222
Query: 269 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
N+ F +FP+ ++ + +DL LL R C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269
Query: 328 REPNARLPNGRPLPP 342
N R LPP
Sbjct: 270 DWNNIR----NSLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 81/309 (26%), Positives = 144/309 (46%), Gaps = 48/309 (15%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAIK++ LQ + K E+ +MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 123 ECLQALDFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ-- 236
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
NP +R+ D +R L+ R +A E HPF
Sbjct: 237 ---NP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL- 272
Query: 326 ELREPNARL 334
+L +P + L
Sbjct: 273 KLAKPLSSL 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 67/250 (26%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ LQ + K E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 146
+PN+++ + +EL++ VMEY+ S+ V+ ++ +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRF 205
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ S + + +
Sbjct: 124 ECLQALEFLHS-NQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE++ Y +DIWS G + E++ G+P + EN + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 266 RCMNPNYTDF 275
++ + DF
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 60/230 (26%), Positives = 114/230 (49%), Gaps = 32/230 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 95
RV+G GS+ V + +T A+K + ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T S+ LF V+E+V + M+ + + +++P + + Y+ +I L
Sbjct: 61 LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLK N+L+D H +K+ D+G K+ I S C + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 254
G +Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH------- 98
+G+G+ G V++ + +TG +A+K++ RR N+E + R++ +V+ H
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKE-ENKRILMDLDVVLKSHDCPYIVK 78
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHT 157
C+ + +++F+ ME + + ++LK +P I K+ T I + L Y+
Sbjct: 79 CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 216
V HRD+KP N+L+D + VK+CDFG + +L+ +A S C+ Y APE I
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-YMAPERIDPPD 190
Query: 217 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+Y D+WS G L EL GQ FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 95
RV+G GS+ V + +T A+K V ++ + ++ ++ +HP ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L CF + E L V+EYV L + +++P + + Y+ +I L Y+
Sbjct: 61 LHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 214
H + +RDLK N+L+D H +K+ D+G K+ L G+ ++ + Y APE++ G
Sbjct: 113 HE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 254
+Y S+D W+ G ++ E++ G+ F P +N D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 101
VG+G++G V++A+ L TGE A+K + D +E+ +++ H N+++ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S S+ +L+ + MEY + + H + + + YV T Q GLAY+H+ ++
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSKGKM 128
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 217
HRD+K N+L+ VK+ DFG A ++ A A S+I + ++ APE+ A E
Sbjct: 129 -HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 218 -YTTSIDIWSAGCVLAELLLGQP 239
Y DIW+ G EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 7e-15
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 46/288 (15%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 93
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ + + F T K L+L+ + Y + +H + M + Y +I GL
Sbjct: 60 VCMSYAF-HTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 256
Y +S D +S GC+L +LL G F ++ +D++ + V
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 257 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 298
L + C+ + + P ++ W VF ++ PP I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 97
V+G GSFG V A+ T E AIK + +D ++ +++ ++ + P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
H F T + L VMEYV + MY++ + R + Y +I GL ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ + +RDLK N+++D H +KI DFG K+ + C + Y APE+I
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y S+D W+ G +L E+L GQ F GE+ D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 30/295 (10%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108
GS G VF A + V +K + + E L++ ++HP+VI +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC- 133
Query: 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
+V+ + +Y L + ++ +P+ + QI GL Y+H R+ HRD+K
Sbjct: 134 ----MVLPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 228
+N+ ++ + QV I D G+A+ + A + + APE + +Y + DIWSAG
Sbjct: 186 ENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 229 CVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEIRCMNPNYT 273
VL E+L P ++ L++II L P R + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 274 DFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
++ + + + + F + +P + L ++L + ++R +A E +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 90
P++++ ER +G G FG V+ T + VA+K + +E Q+M+ + H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQI 148
++ L ++ S+ E +V EY+ + S+ LK R+P L+ + QI
Sbjct: 61 DKLVQL----YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
G+AY+ + HRDL +N+LV KI DFG A+ LI + + ++F
Sbjct: 113 AEGMAYLESR-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREGAKFPIK 169
Query: 206 YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH--------PNVIS 95
RV+G GS+ V + + + A+K V ++ + + ++ ++ H P ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF TTS+ L LV+EYV + M+ + + +++P + + Y +I L
Sbjct: 61 LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
++H + +RDLK N+L+D H +K+ D+G K+ + G+ ++ + Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 262
G EY S+D W+ G ++ E++ G+ F P N D L ++I L P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 96
+++G G+FG V + TG A+K + ++ E+ ++++ HP + +L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F T + L VMEY E + + + +R + Y +I L Y
Sbjct: 61 KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE +
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
+Y ++D W G V+ E++ G+ F ++ ++L E+I + EEIR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 324
F + + PEA L + LL+ P R A E H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 4e-14
Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 45/252 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRVMDHPNV 93
Y + +G G FG VF K T E K + L++R E+ +MR + H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 94 ISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
+ F + ++ L ++ME+ + ++ + K + + + T Q+
Sbjct: 75 VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127
Query: 149 FRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV---------KICDFG 186
LAY H + RV HRDLKPQN+ + +T Q KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 187 SAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 243
+K + G ++++ C + +Y +PEL+ T+ Y D+W+ GC++ EL G+ F
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 244 ENAVDQLVEIIK 255
N QL+ +K
Sbjct: 246 ANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 97
+G G FG V + TG+ A KK L +R K + E +++ ++ P +++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F S T L LVM + + Y + Y+ + + + V Y+ QI G+ ++
Sbjct: 60 YAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
H++ + +RD+KP+N+L+D ++ D G A +L G+ + Y APE I
Sbjct: 112 HSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLF 241
Y+ +D ++ GC + E++ G+ F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 44 RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
R +G G FG V + + TGE VA+K + + + +E++++R + H N++
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
K T + L+ME++P LK Y N+ ++ L Y QI +G+
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+ + V HRDL +N+LV+ HQVKI DFG K + E + Y + F+
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE + + Y S D+WS G L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 85/317 (26%), Positives = 126/317 (39%), Gaps = 58/317 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 97
+G G FG V + TG+ A KK+ + R K + + L +V H I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F T K +L L + + + Y + + N P YT QI GL ++H
Sbjct: 59 AYAFQT--KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 216
R+ +RDLKP+N+L+D + V+I D G A +L G++ Y + + APEL+ G
Sbjct: 116 -RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
EY S+D ++ G L E++ + F GE KV ++ I + Y D
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVTYPD 222
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFFDEL 327
+ P + LL P R C L HP F +L
Sbjct: 223 -----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLFRDL 263
Query: 328 REPNARLPNGRPLPPLF 344
N R LPP F
Sbjct: 264 ---NWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 92
+Y RVVG GS+G V + G+ IKK+ ++R+ +E QL+ + HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++ + + + L +VM + +Y LK + +P V + QI
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPE 210
L Y+H + HRDLK QN+ + T+ +K+ D G A+ L + + I + +Y +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 211 LIFGATEYTTSIDIWSAGCVLAEL 234
L F Y D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCF 100
VVG G++G V++ + ++TG+ AIK V +D + E+ +++ H I+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 101 FSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F S ++ L LVME+ L + N + ++ +I RGLA++H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH-A 139
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF--- 213
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 140 HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197
Query: 214 -GATEYTTSIDIWSAGCVLAELLLGQP 239
Y DIWS G E+ G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 9e-14
Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 96
+++G G+FG V + +G+ A+K + ++ E+ ++++ HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F +K+ L VMEYV E + + + + R + Y +I L Y
Sbjct: 61 KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H+ ++ +RDLK +NL++D H +KI DFG K+ I A + C + Y APE +
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 100
+G G+FG V++A+ ETG +A KV+ + + E+ ++ DHPN++ L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 101 FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ +N L+ +++E+ V M + + + +++ Q L Y+
Sbjct: 72 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 214
H ++ HRDLK N+L L +K+ DFG SAK + S+I + ++ APE++
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 215 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 266
T Y D+WS G L E+ +P N + L++I K L P+R
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233
Query: 267 CMNPNYTDF 275
+ + DF
Sbjct: 234 -WSSEFKDF 241
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y+ + +G GSFG K E G+ IK++ ++R +E+ ++ M HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 149
+ + F + L +VM+Y Y N + +++ + + QI
Sbjct: 62 VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISYICSRFY 206
L ++H ++ HRD+K QN+ LT +K+ DFG A+ L + E + I + +Y
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+PE I Y DIW+ GCVL E+ + F N + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 93
++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ + + F T K L+L+ + Y + +H + + M + Y +I GL
Sbjct: 60 VCMTYAF-HTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
++H V +RDLKP N+L+D H V+I D G A + + S + + Y APE++
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 249
T Y +S D +S GC+L +LL G F D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVMDHPN---VISL 96
+V+G G+FG V + + + A+K + + K + +M H N ++ L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
H F +++ +L +VMEY+P L +N +P + + YT ++ L IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPEL 211
++ + HRD+KP N+L+D H +K+ DFG+ ++ +AN C Y +PE+
Sbjct: 160 SMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214
Query: 212 IF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
+ G Y D WS G L E+L+G F ++ V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 92
Y +V+G G+FG V + T + A+K + + D + E +M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ L + F +++ +L +VMEY+P + ++ +Y +P + + YT ++
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y +
Sbjct: 155 LDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGTPDYIS 211
Query: 209 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 67/248 (27%), Positives = 113/248 (45%), Gaps = 57/248 (22%)
Query: 46 VGTGSFGIVFQAK-----CLETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPNVI 94
+G G+FG V +A+ TVA+K + D K+ E+++M+++ H N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 95 SLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIYV 141
+L T + L++ V+EY P Y + + +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 142 KLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ YQ+ RG+ ++ + + C HRDL +N+LV H +KI DFG A+ +I +
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFGLAR-------DIHH 184
Query: 201 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 247
I +YR APE +F YT D+WS G +L E+ LG +PG V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 240
Query: 248 DQLVEIIK 255
++L +++K
Sbjct: 241 EELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 92
Y +V+G G+FG V + + + A+K + + D + E +M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ L C F +++ +L +VMEY+P + ++ +Y +P + K YT ++
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 207
L IH++ + HRD+KP N+L+D H +K+ DFG+ ++ E + + + + Y
Sbjct: 155 LDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDTAVGTPDYI 210
Query: 208 APELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+PE++ G Y D WS G L E+L+G F ++ V +I+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 44 RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPNVIS 95
R +GTGSFG V A E VAIK+ + + K + E +++ ++HP ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F K+E +L LV+E+V + + N+R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
++ + +RDLKP+NLL+D +K+ DFG AK + + +C + Y APE++
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLF 241
+ + D W+ G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNVISLKH 98
+G G+FG V++ L+ VA+K +R +E ++++ DHPN++ L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
K +++ VME VP L R+ + + + G+ Y+ +
Sbjct: 58 -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111
Query: 159 PRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------APE 210
+ C HRDL +N LV + +KI DFG +++ E Y S + APE
Sbjct: 112 -KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPE 165
Query: 211 -LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
L +G YT+ D+WS G +L E LG +PG
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHPNVISL 96
+++G G G VF + TG+ A+K K + R R E +++ +DHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F + T +L LVM+Y P ++R+L+ + + + Y ++ L Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL------------------------ 191
H + V +RDLKP+N+L+ H + + DF +KQ
Sbjct: 120 HLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 192 ------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
+ S++ + Y APE+I G + +++D W+ G +L E+L G F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305
+ I+K + FP + A DL +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 306 QYSPSLRC----TALEACAHPFFD 325
PS R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
T L ++MEY+ L ++ +K +I +GL Y+H+ +
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 219
+ HRD+K N+L+ VK+ DFG A QL + +++ + F+ APE+I + Y
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179
Query: 220 TSIDIWSAGCVLAELLLGQP 239
+ DIWS G EL G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 46 VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 97
+G GSFG+V + + +G VA+K + D+ +E +M +DH N+I L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ +V E P S+ L+ A + + Y QI G+ Y+
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------AP 209
+ R HRDL +N+L+ +VKI DFG + L E + Y+ + AP
Sbjct: 115 S-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-MEEHLKVPFAWCAP 169
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 253
E + T ++ + D+W G L E+ G+ + G + L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 65/326 (19%), Positives = 107/326 (32%), Gaps = 52/326 (15%)
Query: 44 RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVIS 95
++G IV AK T VA+KK+ D K E+ R + HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVKLYTYQIFRGLA 153
F +EL++ V + L H+ +P + + + L
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
YIH+ + HR +K ++L+ +V + + +I G+ L
Sbjct: 116 YIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 213 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 260
+ + E Y DI+S G EL G F A L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 261 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 310
+ + R N + + + LQ P
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284
Query: 311 LRCTALEACAHPFFDELREPNARLPN 336
R +A + H FF + + N L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-12
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG VF+ T + VAIK + L++ + +E+ ++ D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 157
T L ++MEY+ S +L + PL ++ T +I +GL Y+H+
Sbjct: 72 LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 216
++ HRD+K N+L+ +VK+ DFG A QL + + ++ + F+ APE+I +
Sbjct: 120 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQP 239
Y + DIWS G EL G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVM-DHPN 92
+ +G G+FG V +A ++ VA+K + R EL++M + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 150
+++L + T + + + EY Y L ++ + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 151 GLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 206
G+A++ + + C HRDL +N+L+ VKICDFG A+ ++ + +R +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 100
+G GSFG V++ T E VAIK + L++ + +E+ ++ D P + +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 101 FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIHT 157
T L ++MEY+ S +LK PL Y+ +I +GL Y+H+
Sbjct: 72 LKGTK-----LWIIMEYLGGGSALDLLK-------PGPLEETYIATILREILKGLDYLHS 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG 214
R HRD+K N+L L+ Q VK+ DFG A QL + +++ + F+ APE+I
Sbjct: 120 -ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-K 174
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQP 239
+ Y DIWS G EL G+P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVM 88
P + ++ +G G++G VF+ + G A+K +L + E++ L +
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
DHPNV+ ++ KN L LV+E S+ ++K + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICS 203
GL ++H V + HRD+K N+L LT + VK+ DFG + QL + N S + +
Sbjct: 133 ALMGLQHLH-VNKTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGT 187
Query: 204 RFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQP 239
F+ APE+I + Y D+WS G EL G P
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 44 RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRVMDHPNVIS 95
R +G G FG V+Q E VA+K RE +MR DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 154
L ++N ++ +VME P L+ Y N+ + L + LY+YQ+ LAY
Sbjct: 72 L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 155 IHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 208
+ + R HRD+ +N+LV P VK+ DFG ++ L E Y S+ + A
Sbjct: 123 LESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176
Query: 209 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 245
PE I +T++ D+W G C+ L+LG +P +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 100
+G G++G V++ + G A+K +L + E++ L + +HPNV+ F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L LV+E S+ ++K QR+ + Y GL ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147
Query: 160 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 215
R+ HRD+K N+L LT + VK+ DFG + QL + N S + + F+ APE+I
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 203
Query: 216 TEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
+Y S D+WS G EL G P + V L +I
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 101
+VG G++G V++ + ++TG+ AIK V D + +E+ +++ H I+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 102 STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
KN ++ LVME+ L + N + ++ +I RGL+++H
Sbjct: 73 --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 213
+V HRD+K QN+L+ +VK+ DFG + QL G N ++I + ++ APE+I
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186
Query: 214 --GATEYTTSIDIWSAGCVLAELLLGQP 239
Y D+WS G E+ G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 33/234 (14%)
Query: 24 STTIGGKNGEPKQTISYMA-ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----R 75
S++ P S ERV +G+G+ G V++ TG A+K + + R
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 76 RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR 135
R RE++++R ++HPNV+ H F + ++ L + E + + + + R
Sbjct: 117 RQICREIEILRDVNHPNVVKC-HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR 175
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IA 193
QI G+AY+H + HRD+KP NLL++ VKI DFG ++ L
Sbjct: 176 -----------QILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTM 222
Query: 194 GEANISYICSRFYRAPELI-----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
N S + + Y +PE I GA + DIWS G + E LG+ FP
Sbjct: 223 DPCN-SSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QLMRVMDHPNVI 94
+V+G+G+FG V++ + GE V I +++ R N+E+ +M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L C ST + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV H VKI DFG AK L A E + + A
Sbjct: 123 NYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108
G+ G F +T E V IK R E ++R ++HP++I LK F T +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156
Query: 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
F L++ +Y Y +A + + + + + R + Y+H R+ HRD+K
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210
Query: 169 QNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFY--------RAPELIFGATEY 218
+N+ ++ H +C DFG+A + AN ++Y APEL+ Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260
Query: 219 TTSIDIWSAGCVLAELLLGQ 238
++DIWSAG VL E+
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 103
+V+G G+FG V K T A+K + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 104 T----SKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
T ++E +L LVM+Y V + +L + R+P + Y ++ + IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL 121
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF--- 213
HRD+KP N+L+D H +++ DFGS K G S + + Y +PE++
Sbjct: 122 -HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 214 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 93
+ +G G FG V +A TVA+K + + + R E L++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 143
I L + S++ L L++EY + Y L+ + ++++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 144 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189
+ +QI RG+ Y+ + V HRDL +N+LV ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175
Query: 190 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ ++ + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISL 96
+V+G G+FG V K TG+ A+K + + K E R V+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 97 KHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ F ++E L LVM+Y V + +L S R+P + Y ++ + +
Sbjct: 67 HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYR 207
H + V HRD+KP N+L+D H +++ DFGS +L+A ++N++ YI +
Sbjct: 119 HQLGYV-HRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
A E G Y D WS G + E+L G+ F E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRVMDHPNVISLKH 98
ER +G+G FG V++ VAIK + D K + E+Q ++ + H ++ISL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 156
F+ S E ++ E + + S+ L+ + LI + Q+ G+AY+
Sbjct: 68 --FAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLE 121
Query: 157 TVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPE 210
HRDL +N+LV + L K+ DFG A+ + ++ + I Y + APE
Sbjct: 122 E-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK----WTAPE 174
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 252
++T D+WS G +L E+ GQ +PG N DQ+
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ +G+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 304
+E R P+YT Q WH +R P +L L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------LMRVMDHPNVI 94
+V+G+G+FG V++ + GETV I K+L + ++ +M MDHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L S T + LV + +P H N L+ + QI +G+ Y
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--WCVQIAKGMMY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 211
+ R+ HRDL +N+LV H VKI DFG A+ L E + + + A E
Sbjct: 125 LEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 212 IFGATEYTTSIDIWSAGCVLAELLL--GQP 239
I ++T D+WS G + EL+ G+P
Sbjct: 183 IH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 306
++ R P +I W +R +++ LLQ
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 69/267 (25%), Positives = 101/267 (37%), Gaps = 63/267 (23%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNREL 82
+ TI R +G G+FG VF +C LE VA+ K L++ R+ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-----------MYRVLKHYSS 131
+L+ H N++ +V EY+ LK S
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQ 190
+ L + QI G+ Y+ HRDL +N LV L VKI DFG ++
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRD 171
Query: 191 LIAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL-- 236
+ Y +YR PE I +TT D+WS G VL E+
Sbjct: 172 V--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYG 221
Query: 237 GQPLFPGENAVDQLVEIIK---VLGTP 260
QP + N ++++E I +L P
Sbjct: 222 KQPWYGLSN--EEVIECITQGRLLQRP 246
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 72/270 (26%), Positives = 112/270 (41%), Gaps = 65/270 (24%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKN 79
P + ++ E +G G+FG V++ + + +VAIK KV Q+ R
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--- 56
Query: 80 RELQLMRVMDHPNVISL--------KHC-FFSTTSKNELFLNLVMEYVPESMYRVLKHYS 130
+E +LM + HPN++ L C F + +L LV P S V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHS--DVGAESG 113
Query: 131 SANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
+ L QI G+ Y+ + HRDL +N LV VKI DFG +
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLS 171
Query: 189 KQLIAGEANISYICSRFYR------------APELI-FGATEYTTSIDIWSAGCVLAELL 235
+ + + + +YR PE I +G ++TT DIWS G VL E+
Sbjct: 172 RDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIF 220
Query: 236 -LG-QPLFPGENAVDQLVEIIK---VLGTP 260
G QP + N +++E+I+ +L P
Sbjct: 221 SYGLQPYYGFSN--QEVIEMIRSRQLLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 55/235 (23%)
Query: 43 ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G GSFG+V++ AK + GE VAIK V +++R E +M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--------SSANQRMPLIYVKLY 144
V+ L S + L +VME + + LK Y + P K
Sbjct: 71 VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 145 TY--QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYI 201
+I G+AY+ + HRDL +N +V + LT VKI DFG + +I
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171
Query: 202 CSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +YR APE + +TT D+WS G VL E+ L + + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 141
QLM+ D+PN I L ++S T+ L +M+Y+ + ++ +LK ++ V
Sbjct: 63 QLMK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEV 111
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
K Q+ L +H + H D+K +N+L D ++ +CD+G K I G Y
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYD 167
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI-------- 253
+ Y +PE I G Y S D W+ G + ELL G+ P + D+ +++
Sbjct: 168 GTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQ 224
Query: 254 -----IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 285
IK + + ++ M N NY + +I HP+
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 54/281 (19%)
Query: 46 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ L + TVA+K + D K+ E+++M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L + T L++ ++EY + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 142 KLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 138 DLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNID 191
Query: 200 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 292
+++K G + C N Y R WH + R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
Y++Q+ RG+ ++ + R C HRDL +N+L+ + VKICDFG A+ + +
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 203 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 258
+R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWH 286
+E R P Y I WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 58/282 (20%)
Query: 44 RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRVMDHPN 92
+G+G+FG V++ + +G VA+K Q+++ +E LM +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK---LYTYQI 148
++ L ++ME + + L+ PL+ +K +
Sbjct: 61 IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEANISYICSR 204
+G Y+ + HRDL +N LV + VKI DFG A+ + S
Sbjct: 116 AKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SD 165
Query: 205 FYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 250
+YR APE L+ G +TT D+WS G ++ E+L LGQ +P N + L
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 292
+ R P + Q+ + W + +R
Sbjct: 224 QHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 83
P+ I Y R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 84 LMRVMDHPNVISL--------KHC----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 131
LM DHPN++ L C + + NE + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 132 ANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189
+PL + Q+ G+AY+ V HRDL +N LV VKI DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSR 178
Query: 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+ + + A+ + + PE IF YTT D+W+ G VL E+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 46/278 (16%)
Query: 61 ETGETVAIKKVLQD-----RRYK--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113
TG VAIK + D + RE L + HPN+++L + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56
Query: 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173
V EYVP R L+ +A+ +P Q+ LA H + HRDLKPQN++V
Sbjct: 57 VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112
Query: 174 DP--LTHQVKICDFGSAKQLI-AGEANIS-------YICSRFYRAPELIFGATEYTTSID 223
+ K+ DFG L +A+++ + + Y APE + G T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171
Query: 224 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 282
+++ G + E L GQ + G + + EI+ + ++P D P I
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215
Query: 283 HPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALE 317
HP +V K + P + A L + +L AL
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 40 YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRVMDHPNVI 94
Y+ +VG F A + + E V K V L D R Y EL + DH ++
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 95 SLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPL--IYVKLYTYQ 147
KH F S ++L L +MEY + + + + LK + +P V L YQ
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQ 177
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSR 204
I L +H+ ++ HRDLK N+ + P T +K+ DFG +KQ ++ + S+ +
Sbjct: 178 IVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
+Y APEL + Y+ D+WS G +L ELL F G
Sbjct: 236 YYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 45 VVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
+G G FG VF AK E GET+ + K LQ + +N REL + R + H NV+
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYT--YQI 148
L + E +++EY + R K + PL + QI
Sbjct: 72 RL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRF 205
G+ ++ R HRDL +N LV +VK+ +K + E + I R
Sbjct: 127 ALGMDHLSNA-RFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNSEYYKLRNALIPLR- 183
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAEL 234
+ APE + +++T D+WS G ++ E+
Sbjct: 184 WLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 66/246 (26%), Positives = 119/246 (48%), Gaps = 38/246 (15%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQ 83
P+++I + + +G G FG V+ K L+ G T++++ L+ E
Sbjct: 4 PRESIKLV--KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EAN 53
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 142
LM+ + H ++ L ++ +K E + ++ EY+ + S+ LK S ++ L +
Sbjct: 54 LMKTLQHDKLVRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLI 106
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
++ QI G+AYI + HRDL+ N+LV KI DFG A+ +I +
Sbjct: 107 DFSAQIAEGMAYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREG 163
Query: 203 SRF---YRAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 257
++F + APE I FG+ +T D+WS G +L E++ G+ +PG + D + + +
Sbjct: 164 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
Query: 258 GTPTRE 263
P E
Sbjct: 222 RMPRME 227
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QLMRVMDHPNVI 94
+V+G+G+FG V++ + GE V I KVL++ N+E+ +M + P V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L C ST + LV + +P Y L Y N+ R+ + + QI +G+
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
+Y+ V R+ HRDL +N+LV H VKI DFG A+ L E + + A
Sbjct: 123 SYLEEV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNVIS 95
RV+G G FG V+ +++ A+K + L++ +E +M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFRG 151
L + LV+ +P + L+++ + P LI L Q+ +G
Sbjct: 61 LLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 211
+ Y+ + + HRDL +N ++D + VK+ DFG A+ + E Y + +L
Sbjct: 111 MEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164
Query: 212 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262
+ A E +TT D+WS G +L EL+ G P +P ++ D V +++ G
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222
Query: 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
+ C +P Y ++ WH R P +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+V+G G+FG V K L+ + V K+L R E ++ D+ + +
Sbjct: 7 KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + F +N L+L VM+Y +L S R+P + Y ++ + +
Sbjct: 66 LHYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF 213
H + V HRD+KP N+L+D + +++ DFGS +L+ S + + Y +PE++
Sbjct: 119 HQLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 214 ----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
G +Y D WS G + E+L G+ F E+ V+ +I+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E+V+G G FG V + + G+ VAIK + + R E +M DHPN+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ +K+ + ++ EY+ S+ + L+ + V + I G+
Sbjct: 69 RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY------ICSRFY 206
Y+ + V HRDL +N+LV+ ++ V K+ DFG +++L ++ +Y I R +
Sbjct: 121 YLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIR-W 174
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE I ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 201
+TYQ+ RG+ ++ + HRDL +N+L L VKICDFG A+ I ++N
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296
Query: 202 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
S F + APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 70/315 (22%)
Query: 46 VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVMD-HPN 92
+G G FG V +A+ + TVA+K + + K+ E++LM+++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L T + L++ ++EY + R Y+ ++P L +
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 142 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L + YQ+ RG+ Y+ + R HRDL +N+LV + +KI DFG A+ G +I
Sbjct: 135 DLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDID 188
Query: 200 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 295
+++ RE R P+ + WH V +R +
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
Query: 296 EAIDLASRLLQYSPS 310
E +DL+ QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y RV+G+G+ G V AK + GE A+K V D+ E+ + D ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 94 ISLKHCFFSTTSKNE---LFLNLVMEYVPESMYRV-LKHYSSANQRMPLIYVKLYTYQIF 149
+ F +N L + LV++Y R +K + N+ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFY 206
+ ++H+ + HRD+K N+L+ VK+ DFG +K ++ + ++ + +Y
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245
APE I+ Y+ D++S G +L ELL + F GEN
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 43 ERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN 92
E+ +G G FG V+ A K ++ G +++++ L E +M+ + H
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
++ L + +K +++ + E++ + S+ LK S + PL + ++ QI G
Sbjct: 63 LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEG 114
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRA 208
+A+I + HRDL+ N+LV KI DFG A+ +I + ++F + A
Sbjct: 115 MAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 171
Query: 209 PELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
PE I FG+ +T D+WS G +L E++ G+ +PG
Sbjct: 172 PEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 71/316 (22%)
Query: 46 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ + + TVA+K + D K+ E+++M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 141
+I+L + T L++ ++EY + R YS ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 142 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
L + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + NI
Sbjct: 135 DLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNID 188
Query: 200 Y----ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 251
Y R + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 294
+++K E R P I WH V +R
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 295 PEAIDLASRLLQYSPS 310
E +DL+ QYSP
Sbjct: 300 DEYLDLSVPFEQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 49 GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105
GS G VF C + G+ I K + + RE+ +++ + H +I+L H +
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155
Query: 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165
+ + + +VM ++ Y + +PL ++ LAY+H + HRD
Sbjct: 156 RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRD 210
Query: 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTT 220
+K +N+ +D + V + DFG+A +L + C + +PEL+ Y
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266
Query: 221 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 279
DIWSAG VL E+ + LF + K + R IRCM + FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PLEFPQ 315
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 201
++YQ+ +G++++ HRDL +N+L LTH KICDFG A+ I ++N Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271
Query: 202 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 254
R APE IF YT D+WS G +L E+ LG +PG + ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330
Query: 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 285
K E R ++P I W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHC 99
++G G+FG VF+ L+ VA+K +D + K + L R++ DHPN++ L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
T + ++ +VME VP + L + + + G+AY+ +
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPE-LIFGA 215
HRDL +N LV + +KI DFG ++Q I + + I + + APE L +G
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYG- 169
Query: 216 TEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y++ D+WS G +L E LG +PG
Sbjct: 170 -RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E V+G G FG V + + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ T S+ + + ME +S R + + +I + I G+
Sbjct: 69 HLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVGMLRGIAAGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYR 207
Y+ + V HRDL +N+LV+ K+ DFG ++ L ++ +Y S +
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELL 235
APE I ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVISLKHCFFS 102
+G G FG V G+ VA+K + D E +M + HPN++ L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL--LGVV 69
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
L +V EY+ + L Y S + L + + G+ Y+
Sbjct: 70 LQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KN 122
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 217
HRDL +N+LV K+ DFG AK EA+ + + APE + +
Sbjct: 123 FVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175
Query: 218 YTTSIDIWSAGCVLAEL 234
++T D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
R +G G FG V++ L T VA+K + E Q+M+ + HP +I L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 100 FFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 156
++ + E + +M+Y S+ L+ + ++P LI + Q+ G+AY+
Sbjct: 67 -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIF 213
+ HRDL +N+LV + K+ DFG A+ + + ++F + APE
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++ D+WS G +L E++ G+ +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDH 90
P++T+ + +G G FG V+ VAIK + Q E LM+ + H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P ++ L ++ ++ +++ + EY+ S+ LK + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIA 112
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 206
G+A+I + HRDL+ N+LV KI DFG A+ LI + ++F +
Sbjct: 113 EGMAFIERKNYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGAKFPIKW 169
Query: 207 RAPELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE I +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 TAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 144 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
++ Q+ +G+ ++ + + C HRD+ +N+L+ KICDFG A+ I ++N Y+
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270
Query: 203 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
++ F ++ E++ +L + N Q + + + QI + Y+ +
Sbjct: 70 VCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 218
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE + ++
Sbjct: 127 -HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 182
Query: 219 TTSIDIWSAGCVLAEL-LLGQPLFPG 243
+ D+W+ G +L E+ G +PG
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRVMDHPNV 93
+++G G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 94 ISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ L F +S ++ +V M++ + + +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ Y R + P
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YYRQGRIAKMP 178
Query: 210 ELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 246
+ + A E YT+ D+W+ G + E+ GQ +PG EN
Sbjct: 179 -VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 27/226 (11%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVI 94
S + +G G FG V+ G T VA+K + E Q+M+ + H ++
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L ++ S+ +++ V EY+ + S+ LK ++P + V + Q+ G+A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 154 YIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
YI + + HRDL+ N+LV D L KI DFG A+ LI + ++F + AP
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAP 172
Query: 210 EL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253
E ++G +T D+WS G +L EL+ G+ +PG N + L ++
Sbjct: 173 EAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 52/243 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 99
+V+G G+FG V + +TG A+K + + + ++ +R ++ + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 100 FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F+S K L+L +ME++P + M ++K + + + Y + + IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 186
+ + HRD+KP NLL+D H VK+ DFG
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 187 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 241
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 242 PGE 244
E
Sbjct: 237 CSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 58/246 (23%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
+V+G G+FG V + +TG A+K + + + ++ +R D V+ +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F+S K L+L +ME++P + M ++K + + + + Y + +
Sbjct: 67 ---FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDA 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---------------------------- 186
IH + + HRD+KP NLL+D H VK+ DFG
Sbjct: 117 IHQLGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 187 ---SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
S ++ + N S + + Y APE +F T Y D WS G ++ E+L+G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 239 PLFPGE 244
P F E
Sbjct: 234 PPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 133 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190
N+ L Y+ L ++YQ+ G+ ++ + V HRDL +N+L+ VKICDFG A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288
Query: 191 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 245
++ IS S F + APE IF YTT D+WS G +L E+ LG +P
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 294
+Q IK R P + +I W + F R
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 66/255 (25%), Positives = 106/255 (41%), Gaps = 54/255 (21%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 93
+R +G G+FG VF A+C T VA+K + L R+ RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 140
+ F+ + + +V EY+ P++M V A + L
Sbjct: 70 VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ QI G+ Y+ + V HRDL +N LV VKI DFG ++ + +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175
Query: 201 ICSRFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP-GEN 245
+ +YR PE I ++TT D+WS G +L E+ QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 246 AVDQLVEIIKVLGTP 260
V + + +VL P
Sbjct: 233 EVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
E+V+G G FG V + G+ VAIK + + RR E +M DHPN+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L+ T SK + +V EY+ S+ L+ + + +I + I G+
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMK 120
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRA 208
Y+ + V HRDL +N+LV+ K+ DFG ++ ++ + +Y + A
Sbjct: 121 YLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTA 177
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELL 235
PE I ++T++ D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 84/331 (25%), Positives = 134/331 (40%), Gaps = 85/331 (25%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQ 83
++ I+ + E +G GSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI 139
+M+ +V+ L SK + L +VME + +S R L+ + N P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 140 YVK---LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
++ +I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD- 173
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFP 242
+YR APE + +TTS D+WS G VL E+ L QP
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
N +Q+++ + M+ Y D P P DL
Sbjct: 225 LSN--EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 303 RLLQYSPSLRCTALEACA------HPFFDEL 327
Q++P +R T LE HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 66
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
++ S+ +++ V EY+ + S+ LK R+P + QI G+AY+ +
Sbjct: 67 -YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVERM 121
Query: 159 PRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 213
V HRDL+ N+LV + L K+ DFG A+ LI + ++F + APE ++
Sbjct: 122 NYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 214 GATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243
G +T D+WS G +L EL G+ +PG
Sbjct: 178 G--RFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 9e-08
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 44 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
R++G G FG V +A+ + + VA+K + D + RE M+ DHPNVI
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 95 SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
L + +K L + +V M++ + ++ +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 207
G+ Y+ + HRDL +N +++ V + DFG +K++ +G+ S+ +
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIKVL--GTPTRE 263
A E + YTT D+W+ G + E++ GQ + G EN+ EI L G ++
Sbjct: 183 ALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIKGNRLKQ 236
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 304
C+ Y ++ W R P L +L
Sbjct: 237 PPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)
Query: 46 VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 96
+G G+FG VF A+C E + + K L++ R+ RE +L+ V+ H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK------HYSSANQRMPLIYVKL-----Y 144
F+ ++ L +V EY+ + R L+ + + + + L
Sbjct: 72 ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 204
QI G+ Y+ ++ V HRDL +N LV VKI DFG ++ + + +
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176
Query: 205 FYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 235
+YR PE I ++TT DIWS G VL E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 65/225 (28%)
Query: 120 ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171
+S++ VL+H + S +P VK + ++ L +H VC RDL P N+
Sbjct: 58 DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116
Query: 172 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 228
L+D H +++ F ++ GEA Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169
Query: 229 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHP 284
+L ELL G+ L + C +P+ +T P+
Sbjct: 170 AILFELLTGKTL------------------------VEC-HPSGINTHTTLNIPEW---- 200
Query: 285 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-----AHPFF 324
+ EA L +LLQ++P+ R A A +HPFF
Sbjct: 201 --------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 63/268 (23%), Positives = 116/268 (43%), Gaps = 35/268 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCFF 101
+G+G FG+V+ LE + VAIK + + + + E Q+M + HP ++ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 102 STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ + LV E++ + L+ + L+ + L + G+AY+ +
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 217
V HRDL +N LV VK+ DFG + + + S ++F + +PE +F ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277
Y++ D+WS G ++ E + + P EN + E+++ + R P
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230
Query: 278 PQIKAHPWHKVFHKRMPPEAIDLASRLL 305
++ H W + PE S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVK-- 142
+L ++ +L L +EY P RVL+ ++ AN + +
Sbjct: 72 NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 143 -LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 200
+ + RG+ Y+ + + HRDL +N+LV + KI DFG S Q + + +
Sbjct: 127 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ R+ L + YTT+ D+WS G +L E++
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)
Query: 46 VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 92
+G G FG V A+ + + VA+K + D K+ E+++M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 139
+I+L + T L++ ++EY P M +++
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
+ YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 141 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKK 198
Query: 200 YICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 255
R + APE +F YT D+WS G +L E+ LG +PG V++L +++K
Sbjct: 199 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLK 256
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 292
G + C N Y R WH V +R
Sbjct: 257 E-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 60/199 (30%)
Query: 67 AIKKVLQDRRYKNRELQLMRVMDHPNVISL-------KHCFFSTTSKNELFLNLVMEYVP 119
A +D +E++++ + PN+ L ++MEY+
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLC------------MIMEYME 102
Query: 120 E-------SMYRVLKHYSSANQRMP----LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
+ + N + L+Y+ QI G+ Y+ ++ V HRDL
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLAT 158
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY----RAP--------ELIFGAT 216
+N LV + +KI DFG ++ L + + +Y RAP E +
Sbjct: 159 RNCLVGKN-YTIKIADFGMSRNLYSSD---------YYRVQGRAPLPIRWMAWESVLL-G 207
Query: 217 EYTTSIDIWSAGCVLAELL 235
++TT D+W+ G L E+L
Sbjct: 208 KFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 58/263 (22%)
Query: 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQ 134
E M+ DHPNV+ L T ++E + + V M++ + + Q
Sbjct: 49 SEAVCMKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 135 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194
+P + + I G+ Y+ + HRDL +N +++ V + DFG +K++ G
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNG 165
Query: 195 EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 246
+ Y R + P + + A E YTT D+WS G + E+ GQ +PG EN+
Sbjct: 166 D---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221
Query: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
EI L R + PP+ +D
Sbjct: 222 -----EIYDYLRQGNR----------------------------LKQPPDCLDGL----- 243
Query: 307 YSPSLRCTALEACAHPFFDELRE 329
YS C L P F+ LR
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 46 VGTGSFGIVFQA--KCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 97
+G+G+FG V + K + VAIK VL++ K+ RE ++M +D+P ++ +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ L LVME K S + + V +Q+ G+ Y+
Sbjct: 62 GVCEAEA------LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 158 VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 209
V HRDL +N LLV+ H KI DFG +K L A + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRVMDHPNVI 94
+++G+G FG V + + G+++ I K +QDR + + M +DH ++
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 95 SLKH-CFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
L C ++ L LV + P + V +H S + + L + QI +G
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN----WCVQIAKG 121
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSR 204
+ Y+ R+ HR+L +N+L+ V+I DFG A K+ E +
Sbjct: 122 MYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPI---K 176
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ ++FG YT D+WS G + E++
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 9e-07
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVI 94
+++M E +G+G FG+V K VAIK + + + E ++M + HP ++
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQ-IFRGL 152
L + T + L++ V E M L +Y Q + L Q + G+
Sbjct: 63 QL---YGVCTQQKPLYI------VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ + HRDL +N LV T VK+ DFG + ++ E S ++F + P
Sbjct: 114 EYLERNSFI-HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170
Query: 210 ELIFGATEYTTSIDIWSAGCVLAEL 234
E +F ++Y++ D+WS G ++ E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 58/220 (26%), Positives = 83/220 (37%), Gaps = 69/220 (31%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 205
QI L +H+ V HRD+KPQN++ + KI D G+A L G I+YI F
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 206 ----YRAPELIFGATEYTTS----------------------IDIWSAGCVLAELLLGQP 239
Y APE +T+ T S DI+SAG L+ Q
Sbjct: 319 LDPRYAAPEQYIMSTQ-TPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQM 372
Query: 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---- 295
FP + L++ R+ R D+ W K+ R P
Sbjct: 373 AFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRASPDLRR 414
Query: 296 --EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 325
E +DL ++++ R +A A AHP+FD
Sbjct: 415 GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454
|
Length = 566 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMR 86
T+ +M E +G FG V++ E + VAIK L+D+ R + + +MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 87 V-MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM 136
+ HPN++ L FS S ++L LVM + + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGE 195
P +V + T QI G+ ++ + V H+DL +N+LV D L VKI D G +++ A +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAAD 178
Query: 196 ----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
S + R+ +++G +++ DIWS G VL E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRV---MDHPNVISL 96
R++G G G V+ A VA+KK+ +D K R L+ ++ + HP ++ +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--------------ESMYRVLKHYSSANQRMPLIYVK 142
+S S + + M Y+ ES+ + L +S + I+ K
Sbjct: 68 ----YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS-IFHK 121
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGE 195
I + Y+H+ V HRDLKP N+L+ L +V I D+G+A L+ +
Sbjct: 122 -----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 196 ANISYICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ IC Y APE + G + S DI++ G +L ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+GTG FG+V K VAIK + + ++ E ++M + H ++ L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 162
T + +++ V EY+ +L + +R + + G+AY+ + +
Sbjct: 68 CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFI 122
Query: 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 219
HRDL +N LVD VK+ DFG ++ ++ E S + S+F + PE + ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179
Query: 220 TSIDIWSAGCVLAEL 234
+ D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 102
++G G FG V Q + TG+ VA+K + D + E +M + H N++ L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL----LG 66
Query: 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
N L++ VME + + ++ L+ + + +I + ++ + G+ Y+ + ++
Sbjct: 67 VILHNGLYI--VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES-KKL 121
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 218
HRDL +N+LV K+ DFG A+ G N S+ + APE + ++
Sbjct: 122 VHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEAL-KHKKF 174
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFP 242
++ D+WS G +L E+ G+ +P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 49 GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPNVISLK------HCFF 101
G+FG V+ + + A+K V + D KN Q V + ++L H ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALALSKSPFIVHLYY 71
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
S S N ++L VMEY+ + L H Y ++ M + Y+ ++ L Y+H
Sbjct: 72 SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ HRDLKP N+L+ H +K+ DFG +K + E N+ I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G G FG V+ T + VAIK + +E Q+M+ + H ++ L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S+ +++ V E++ + S+ LK ++P + V + QI G+AYI + +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124
Query: 162 CHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL-IFGAT 216
HRDL+ N+LV D L KI DFG A+ LI + ++F + APE ++G
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG-- 178
Query: 217 EYTTSIDIWSAGCVLAELLL-GQPLFPG 243
+T D+WS G +L EL+ G+ +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 45 VVGTGSFGIVFQAKCLETG----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVIS 95
++ G+FG +F ++ E V +K V +E L+ + H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY------SSAN--QRMPLIYVKLYTYQ 147
+ H + P + LK + AN Q + + Q
Sbjct: 73 ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----- 202
I G++Y+H V H+D+ +N ++D QVKI D ++ L + Y C
Sbjct: 126 IACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDNE 179
Query: 203 SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 238
+R + A E + EY+++ D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
++V+G G FG VF+ G VAIK + K R E +M H N+I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L+ T K + + ME ++ + L+ + L+ + I G+ Y
Sbjct: 70 RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 209
+ + V HRDL +N+LV+ + K+ DFG ++ ++ + +Y S + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL 235
E I ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 7e-06
Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 93
+R +G G+FG VF A+C E + + K L+D R+ +RE +L+ + H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY-------SSANQRMPLIYVKLY- 144
+ F+ + + + +V EY+ + + L+ + + N+ L ++
Sbjct: 70 VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 145 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 203
QI G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 125 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174
Query: 204 RFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 249
+YR PE I ++TT D+WS G VL E+ QP + N ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230
Query: 250 LVEII---KVLGTP 260
++E I +VL P
Sbjct: 231 VIECITQGRVLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 35/236 (14%)
Query: 46 VGTGSFGIVFQA--KCLETGETVAIKKVLQ----DRRYKN---RELQLMRVMDHPNVISL 96
+G+G+FG V + K ++ +TVA+K +L+ D K+ RE +M+ +D+P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ E ++ LVME + L + N+ + + +Q+ G+ Y+
Sbjct: 62 -----IGICEAESWM-LVMEL---AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 209
V HRDL +N+L+ H KI DFG +K L A E +Y ++ + AP
Sbjct: 113 ETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAP 167
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIKVLGTPTR 262
E + ++++ D+WS G ++ E GQ + G N V Q++E + + P R
Sbjct: 168 ECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 37/126 (29%), Positives = 49/126 (38%), Gaps = 38/126 (30%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y APE++ T YT D WS G +L E+L+GQP F + TP ++
Sbjct: 210 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQL 254
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFH----KRMPPEAIDLASRLLQYSPSLRC---TALEA 318
+ +N W H ++ EA DL RL R A E
Sbjct: 255 KVIN---------------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEI 298
Query: 319 CAHPFF 324
AHPFF
Sbjct: 299 KAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y APE++ YT D WS G +L E+L+GQP F + TPT ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPF 323
+ +N T PQ+K + PEA+DL ++L + R A + AHPF
Sbjct: 259 KVINWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 324 FDEL 327
F E+
Sbjct: 308 FSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 37/152 (24%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+ +G G+FG V + ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
++S K+ L+ VM+Y+P + M +++ + Y ++ +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186
+H + + HRD+KP N+L+D H +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+ +G G+FG V A ++T A+K L+ + NR E ++ D+ V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++S K+ L+ VM+Y+P M +L + + Y+ T I
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186
+H + + HRD+KP N+L+D L +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILID-LDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 94
E V+G G+FG V +A + G AIK + + D R EL+++ ++ HPN+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQ 147
+L +N +L + +EY P RVL+ A + L + Q
Sbjct: 67 NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-TDPAFAKEHGTASTLTSQQ 120
Query: 148 IFR-------GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFG-SAKQLIAGEANI 198
+ + G+ Y+ + + HRDL +N+LV + L KI DFG S + + + +
Sbjct: 121 LLQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTM 177
Query: 199 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ R+ L + YTT D+WS G +L E++
Sbjct: 178 GRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)
Query: 66 VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120
VA+K + D R E+++M + +PN+I L S L ++ EY+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101
Query: 121 -------SMYRVLKHYSSANQ-----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168
S + ++ AN L+Y+ + QI G+ Y+ ++ V HRDL
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV---QIASGMKYLASLNFV-HRDLAT 157
Query: 169 QNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDI 224
+N LV + +KI DFG ++ L +G+ + + R+ ++ G ++TT+ D+
Sbjct: 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDV 214
Query: 225 WSAGCVLAELL 235
W+ G L E+
Sbjct: 215 WAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)
Query: 46 VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RVMDHPNVIS-L 96
+G G FG V + G + A + K L+ + +L + R ++HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM------PLIYVKLYTYQIFR 150
C S LV+E+ P LK+Y +N+ M + ++ ++
Sbjct: 62 GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 151 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 206
GL ++H + H DL +N L L+ VKI D+G A + + I+ C +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 207 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 234
APEL I G + T +IWS G + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 36/204 (17%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 102
+G+G FG+V K + VAIK + + ++ E ++M + HPN++ L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----YG 66
Query: 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTY----QIFRGLAYIH 156
+K + +V EY + + N + + + + Y+
Sbjct: 67 VCTKQRP-IFIVTEY--------MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS---RF---YRAPE 210
+ HRDL +N LV + VK+ DFG A+ ++ + Y S +F + PE
Sbjct: 118 S-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPE 171
Query: 211 LIFGATEYTTSIDIWSAGCVLAEL 234
+F + +++ D+WS G ++ E+
Sbjct: 172 -VFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHCF 100
+G G+FG VF + VA+K + K + LQ R++ HPN++ L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHTVP 159
T K ++ +VME V + ++ LI + G+ Y+ +
Sbjct: 60 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQM---VENAAAGMEYLES-- 112
Query: 160 RVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPE-LIF 213
+ C HRDL +N LV + +KI DFG +++ + A + I + + APE L +
Sbjct: 113 KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNY 170
Query: 214 GATEYTTSIDIWSAGCVLAE 233
G Y++ D+WS G +L E
Sbjct: 171 G--RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 45/197 (22%)
Query: 81 ELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 138
E +L+R + HP V++L T LV+ +Y L + + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-------- 188
V Q+ + YIH + HRD+K +N+LV+ IC DFG+A
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWS 315
Query: 189 ---KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQP 239
IAG + + APE++ G YT S+DIWSAG V+ E L
Sbjct: 316 TPFHYGIAGTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366
Query: 240 LFPGENAVD-QLVEIIK 255
D Q++ II+
Sbjct: 367 RGDERRPYDAQILRIIR 383
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 262
Y APE++ T YT D WS G +L E+L+GQP F + ++ +++I L P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272
Query: 263 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 307
+ ++P +D R P +IKAHP+ K ID +S L Q
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320
Query: 308 SPS 310
S
Sbjct: 321 SAP 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 9e-05
Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
QI G+ Y+ ++ V HRDL +N LV +KI DFG ++ L AG+ +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 207 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 251
R A E I ++TT+ D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 252 E 252
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 96
+ +G G+FG V A+ ++T A+K + + D +N+ E ++ D+ V+ L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
++S K+ L+ VM+Y+P M +L RM + L + I +
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAV 114
Query: 156 HTVPRV--CHRDLKPQNLLVDPLTHQVKICDFG 186
+V ++ HRD+KP N+L+D H +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 45 VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVISL 96
V+G G+FG V +A+ + G AIK++ + D R EL+++ ++ HPN+I+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 97 KHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQIF 149
++ +L L +EY P RVL+ A L + Q+
Sbjct: 62 L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLSSQQLL 115
Query: 150 R-------GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 201
G+ Y+ + + HRDL +N+LV + KI DFG S Q + + + +
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
R+ L + YTT+ D+WS G +L E++
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 45/222 (20%), Positives = 90/222 (40%), Gaps = 35/222 (15%)
Query: 31 NGEPKQTIS---YMAERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVL 72
G P I+ + ++++G G FG V++ +C ET+ ++ ++
Sbjct: 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61
Query: 73 QDRRY-KNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLVM-EYVPESMYRVLKH 128
+ Y ++ + +DH + C + + ++ ++ E + E+ + K
Sbjct: 62 YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFILLEKLVENTKEIFKR 119
Query: 129 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
N+ LI K + L YIH + H D+KP+N++VD ++ I D+G A
Sbjct: 120 IKCKNK--KLI--KNIMKDMLTTLEYIHEHG-ISHGDIKPENIMVDG-NNRGYIIDYGIA 173
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 230
I +I Y + + + T Y +D + CV
Sbjct: 174 SHFIIHGKHIEY-----SKEQKDLHRGTLYYAGLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194
+K Q+ GL +H + + HRD+KP+NLLV + QVKI DFG+A + G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 62/311 (19%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 62 TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115
TGE V ++++ + + EL + ++ +HPN++ + F + NEL++
Sbjct: 24 TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---DNELWVVTSF 80
Query: 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175
+ + H+ + + Y+ + + L YIH + V HR +K ++L+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHMGYV-HRSVKASHILIS- 135
Query: 176 LTHQVKICDFGSAKQLI--AGEANISYICSRF------YRAPELIFGATE-YTTSIDIWS 226
+ +V + S +I + + ++ + +PE++ + Y DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195
Query: 227 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 267
G EL G F A L+E + +L T T EE+
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255
Query: 268 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
+ + R + +HP+++ F P + LQ +P R +A H FF
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
Query: 326 EL-REPNARLP 335
++ R + LP
Sbjct: 312 QIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 44 RVVGTGSFGIVFQ--AKCL---ETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
R +G GSFG+V++ AK + E VAIK V + + R E +M+ + +V
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRM---PLIYVKLYTY 146
+ L S+ + L ++ME + +S R L+ N L +
Sbjct: 72 VRL----LGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 202
+I G+AY++ + HRDL +N +V VKI DFG + + + +
Sbjct: 127 EIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 239
R+ L G +TT D+WS G VL E+ L QP
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 202
QI G+ Y+ ++ V HRDL +N LV + +KI DFG ++ L +G+ + +
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235
R+ ++ G ++TT+ D+W+ G L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.31 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.74 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.67 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.27 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.19 | |
| PLN02236 | 344 | choline kinase | 97.0 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.93 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.88 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.41 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.16 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.49 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.37 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.73 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.7 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.33 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.31 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.75 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-73 Score=498.03 Aligned_cols=360 Identities=70% Similarity=1.180 Sum_probs=342.8
Q ss_pred ccceEEeecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeece
Q 016950 19 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 98 (380)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 98 (380)
.+.+..+...+........-.|.-.+++|.|+||.||+|....+++.||||++..+.+...+|+.+|+.++|||||++..
T Consensus 5 ~~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~ 84 (364)
T KOG0658|consen 5 SGHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLY 84 (364)
T ss_pred ceeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEE
Confidence 44556677777777778888999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
+|+.....+..+..+||||++.+|.+.++++...+..++...++-|.+||++||.|||+ .||+||||||.|+|+|.+.+
T Consensus 85 ~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg 163 (364)
T KOG0658|consen 85 FFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTG 163 (364)
T ss_pred EEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCC
Confidence 98877666567888999999999999999998899999999999999999999999999 79999999999999999889
Q ss_pred cEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016950 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 179 ~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
.+||||||.|+....++.+.++.+|+.|+|||+++|...|+.+.||||.||++.||+.|++.|+|.+..+++..|++.+|
T Consensus 164 ~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 164 VLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCC
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 338 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~ 338 (380)
.|+.+.+.+++++|.+..+|++...+|...+...+++++.+|+.++|+++|.+|+++.|++.||||..++.++...++++
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGR 323 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhccCCHHHHhhhChHHHHhhcCCCCCCCCC
Q 016950 339 PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 379 (380)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (380)
++|++++|.....+..++..+.++|.+.....+....|+++
T Consensus 324 ~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~~~~~~~~~ 364 (364)
T KOG0658|consen 324 PLPPLFNFKRAELGISPELVNVLIPEHLREQEKDKILCESA 364 (364)
T ss_pred cCCCccCchHHHhccchHHHHhhccHhhhhhccccccccCC
Confidence 99999999999999999999999999999999998888753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-62 Score=417.71 Aligned_cols=281 Identities=35% Similarity=0.682 Sum_probs=249.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++.|+.+.++|+|+||+||+|+++.||+.||||++..+.. ...||+++|++++|+|+|.+.++| .....
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrk 75 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRK 75 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhcce
Confidence 3579999999999999999999999999999999965543 234899999999999999999999 66666
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++|+|||+.++++.+..+ ...++.+.++.|++|++.|+.|+|+ ++++||||||+|||++. ++.+||||||+|+.
T Consensus 76 lhLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFART 150 (396)
T ss_pred eEEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHh
Confidence 9999999999988888753 4568899999999999999999999 89999999999999996 88999999999998
Q ss_pred Cc-cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh--h
Q 016950 191 LI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--C 267 (380)
Q Consensus 191 ~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--~ 267 (380)
.. ++...+.++.|+||+|||++.|...|+.++||||+||++.||++|.+.|+|..+.+++..|.+.+|.-.+.... .
T Consensus 151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 87 45556678999999999999998889999999999999999999999999999999999999999988876544 4
Q ss_pred cCCCCCCccCCCCCC-CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.++-|..+.+|+... ++++..++. ++.-+.||+.+||+.||.+|++.+|+|.||||.++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred cCCceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 567788888888654 445555554 788999999999999999999999999999997653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-62 Score=442.98 Aligned_cols=283 Identities=37% Similarity=0.658 Sum_probs=256.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|.+++.||.|.||.||+|+.+.+|+.||||++++.-. ..-||+..|++|+ ||||+++.+++.+.. .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 45789999999999999999999999999999999865432 2238999999998 999999999995433 2
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|||||+.+|+++++.+ +..|++..++.|++||++||+|+|+ +|+.|||+||+|||+.. ...|||+|||+|+
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIADFGLAR 158 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEeccccccc
Confidence 69999999999999999863 6889999999999999999999999 89999999999999996 6789999999999
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 268 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 268 (380)
........+.++.|+||+|||+++....|+.+.||||+|||++|+.+-++.|+|.++.+++.+|...+|+|....+..-
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 9988888889999999999999999889999999999999999999999999999999999999999999998776541
Q ss_pred -CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 269 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
......+.+|+....++...++. .++++.+||.+||+|||.+||||+|+|+||||+.-.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 22335678899988888888887 999999999999999999999999999999998643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-61 Score=419.09 Aligned_cols=319 Identities=39% Similarity=0.678 Sum_probs=270.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
...|..++.||.|+||.|..|.++.+|+.||||++.. ......+|+++|+.++|+||+.+.+++.....+...-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3457778999999999999999999999999999852 2234458999999999999999999997655455566
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+|+|+|+.+|...++ .+..+++..++.+++||+.||+|+|+ .+++||||||+|+|++. +..+||+|||+|+.
T Consensus 101 vYiV~elMetDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHHhhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccceee
Confidence 99999999988888887 45669999999999999999999999 79999999999999997 77899999999998
Q ss_pred Ccc---CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 191 LIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 191 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
... ....+.++.|+||+|||++.....|+.+.||||+|||+.||++|++.|+|.+..+++..|+..+|+|+.+.+..
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 754 34446788999999999998888999999999999999999999999999999999999999999999998887
Q ss_pred cCCCC-CCc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 016950 268 MNPNY-TDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 344 (380)
Q Consensus 268 ~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 344 (380)
+.... ..+ ..|..+..+|...|+ ++++.+.||+.+||.+||.+|+|++|+|+|||+..+..+...... ++.+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~----~~~~ 329 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC----QPIF 329 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC----CCCC
Confidence 65221 112 578888889999998 699999999999999999999999999999999998877654211 1111
Q ss_pred CchhhhccCCHHHHhhhChHHHHh
Q 016950 345 NFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
.. .+.. .+.+.+++++..++.+
T Consensus 330 ~~-~~~~-~~~~~~r~~i~~e~~~ 351 (359)
T KOG0660|consen 330 DS-FEHE-LTEEELRELIYKEILD 351 (359)
T ss_pred cc-cccc-ccHHHHHHHHHHHHHh
Confidence 11 2333 6778888888877543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-60 Score=399.02 Aligned_cols=277 Identities=39% Similarity=0.726 Sum_probs=245.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+|...+.||+|.||.||+|++..+|+.||||++.... ...-||++.|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 57999999999999999999999999999999996442 2335899999999999999999999 444458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
.||+||++.+|...++. ....++...++.|+.+++.||+|||+ +.|+||||||+|+|+++ ++.+||+|||+|+..
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence 89999999999999874 56789999999999999999999999 89999999999999997 889999999999987
Q ss_pred ccCCCcc-eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016950 192 IAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269 (380)
Q Consensus 192 ~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 269 (380)
.+..... ..+.|+||+|||+++|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|...+|+|..+.|+.+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 6554433 34789999999999999999999999999999999999999999999999999999999999999999875
Q ss_pred -CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
++|..+. ..+..+....|+. .++++.||+.+||.+||.+|+|+.|+|+||||+..
T Consensus 232 lpdY~~~~--~~P~~~~~~lf~a-as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 232 LPDYVKIQ--QFPKPPLNNLFPA-ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cccHHHHh--cCCCCcccccccc-ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 4444443 4445555555655 78899999999999999999999999999999974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-59 Score=402.91 Aligned_cols=289 Identities=32% Similarity=0.566 Sum_probs=255.4
Q ss_pred CCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 31 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
.+..+.++.|+.+..|++|+||.||+|+++.|++.||+|+++-+.. ..-||+.+|..++|||||.+.++.....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 4556678899999999999999999999999999999999864321 2249999999999999999999886544
Q ss_pred CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 105 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
.. .+|+|||||+.+|.+++.. ..++|...+++.++.|++.|++|||. +.|+||||||+|+|++. .|.+||+|
T Consensus 149 ~d---~iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaD 220 (419)
T KOG0663|consen 149 MD---KIYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIAD 220 (419)
T ss_pred cc---eeeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecc
Confidence 33 2889999999988888875 34789999999999999999999999 89999999999999995 88899999
Q ss_pred ecccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 185 FGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 185 fg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
||+|+.+..... .+..+.|.||+|||++.+...|+.++|+||+|||+.||+++++.|+|....+++.+|.+.+|.|+..
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999998866543 4557789999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhhcC--CCCCCccCCCCCCCCcccccCCC-CChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 EIRCMN--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.|+... +.+..+.++..+-.+++..|+.. +++...+|++++|.+||.+|+||+|+|+|+||.+.
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 887653 34445677777777888888775 78999999999999999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-60 Score=421.36 Aligned_cols=257 Identities=32% Similarity=0.501 Sum_probs=213.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.+.|.+.+.||+|+||.|.+|..+.||+.||||++.+.. ....+|+++|++|+|||||+++++|
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----- 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----- 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----
Confidence 356999999999999999999999999999999996432 1225899999999999999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI 182 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl 182 (380)
+...+.|+||||++| .|.+.+- .++.+.+...+.+++||+.|++|||+ .||+||||||+|||+..+ +..+||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEe
Confidence 445558999999996 5555543 56788899999999999999999999 799999999999999752 357999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGT 259 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 259 (380)
+|||+|+.........+.+|||.|.|||++.+.. .+..++|+||+||+||.+|+|.+||.+..... ...+|.+
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~---- 396 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK---- 396 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----
Confidence 9999999887777778899999999999996532 24568999999999999999999998765444 3333333
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..|.+ ....+..+|+++++||.+||..||++|||++|+|+||||+...
T Consensus 397 -------------G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 -------------GRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------Ccccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 11111 1123345899999999999999999999999999999999753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-58 Score=429.25 Aligned_cols=248 Identities=33% Similarity=0.554 Sum_probs=222.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+|...+.||+|||++||.+++..+|+.||+|++.+. +....+|++|.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 6799999999999999999999999999999999653 23345899999999999999999999 77777
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|||.|+|. ++|.++++ ....++|.++++|+.||+.||+|||+ ++|+|||||..|+|++. +.+|||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecccceee
Confidence 999999999 56666665 46789999999999999999999999 79999999999999996 7789999999999
Q ss_pred cCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
....+ +...+.+|||.|.|||++.. ...+..+||||+||++|.||+|++||...+-.+++.+|..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------------- 232 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------------- 232 (592)
T ss_pred eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence 87754 66778999999999999975 4589999999999999999999999999988888888876
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+|.+| ..+|.+++|||.+||+.||.+|||++++|.|+||..
T Consensus 233 ----~~Y~~P------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----NEYSMP------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----cCcccc------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 345554 358999999999999999999999999999999944
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=434.94 Aligned_cols=329 Identities=53% Similarity=0.986 Sum_probs=284.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC---CCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT---SKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~l 113 (380)
..+|++++.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++|+||++++++++... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 35799999999999999999999999999999999777666778999999999999999998875432 233456889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 99999999888887766677889999999999999999999999 79999999999999987566799999999987655
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+++.+|.|..+.+..+.+++.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 55555678899999999987766799999999999999999999999999999999999999999999999998899999
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCC-CCCCCCCCCchh-hhc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPLPPLFNFKQ-ELS 351 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~ 351 (380)
++.++......+...++...++++++||.+||++||.+|+|+.|+|+||||..++.+....+. ...+|.++++.. +..
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK 383 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence 999998888888888888899999999999999999999999999999999998776544443 245666777764 444
Q ss_pred cCCHHHHhhhChHHH
Q 016950 352 GASPELVNKLIPDHV 366 (380)
Q Consensus 352 ~~~~~~~~~~~~~~~ 366 (380)
+..++..+.+++...
T Consensus 384 ~~~~~~~~~~~~~~~ 398 (440)
T PTZ00036 384 EMSDACRRKIIPKCT 398 (440)
T ss_pred hCCHHHHHHHhhHHH
Confidence 677777776665543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-58 Score=417.92 Aligned_cols=284 Identities=36% Similarity=0.618 Sum_probs=242.7
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
|...+.|+.+++||+|.||.||+|++..+|+.||+|++.-+. ....+|+.||++|+||||+++.+++....
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~--- 189 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL--- 189 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---
Confidence 556788999999999999999999999999999999996543 34469999999999999999999886642
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...+|+|+|||+.+|..++.. ..-.|++.+++.|+.||+.||+|||+ +||+|||||.+|||||. ++.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEeccccc
Confidence 234999999999988887763 56689999999999999999999999 89999999999999995 88999999999
Q ss_pred cccCccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 188 AKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 188 a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|+.+.... ..++.+.|.||+|||+++|...|+.++|+||+||||.||++|+++|+|.++.+++..|.+.+|.|+...|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99765544 3567788999999999999999999999999999999999999999999999999999999999999887
Q ss_pred hhcC-CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 266 RCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 266 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.... +.+..+.-...-...+.+.| ..+++.+.+|+.+||..||.+|.||.++|+|+||..
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 7221 11222211111133344442 458999999999999999999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-58 Score=403.17 Aligned_cols=259 Identities=30% Similarity=0.499 Sum_probs=224.5
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
....++|+++++||+|+||+||+++.+.+++.||+|++.+.. .....|..+|..++||+||+++-.| +
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence 455789999999999999999999999999999999986543 2334799999999999999999988 5
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+|+||+.| .|...|. ..+.+++..++.|+.+|+.||.|||+ +|||||||||+|||+|. .|.++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEecc
Confidence 55569999999997 5665554 57889999999999999999999999 89999999999999997 888999999
Q ss_pred cccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+|+..... ....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+..+...+|.+.-.
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------ 242 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------ 242 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------
Confidence 999855443 445567999999999999876 499999999999999999999999999999888888876310
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC----CHHHHhcCCCcccccCCCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPNA 332 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~hp~~~~~~~~~~ 332 (380)
...+..++.+++|||+++|+.||++|. ++.++.+||||..++|...
T Consensus 243 ----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 243 ----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred ----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 011223799999999999999999996 6889999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-58 Score=418.64 Aligned_cols=261 Identities=33% Similarity=0.583 Sum_probs=228.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
....+|..++.||+|+|++|++|+++.+++.||||++.+. ..+..+|-..|..| .||.|++++..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3457899999999999999999999999999999998653 23445788999999 899999999999 4
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+|+||++ |.|++++..+ +.|++..+++|+.||+.||+|||+ +|||||||||+|||+|. ++++||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeec
Confidence 4555999999998 6888888754 789999999999999999999999 79999999999999997 889999999
Q ss_pred cccccCccCCC--------------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 016950 186 GSAKQLIAGEA--------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251 (380)
Q Consensus 186 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~ 251 (380)
|.|+.+.+... ..+++||..|++||+|.. ...++.+|+|+||||+|.|+.|.+||.+.++.-+++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 99987643221 145899999999999954 458999999999999999999999999999999999
Q ss_pred HHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
+|+++ +|.|| +.+++.++|||.++|..||++|+|+.||.+||||.++.|.+
T Consensus 298 kI~~l-----------------~y~fp------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------DYEFP------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------cccCC------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 99984 34444 45899999999999999999999999999999999999987
Q ss_pred CCCCC
Q 016950 332 ARLPN 336 (380)
Q Consensus 332 ~~~~~ 336 (380)
.+...
T Consensus 349 lw~~~ 353 (604)
T KOG0592|consen 349 LWQQT 353 (604)
T ss_pred hhhcC
Confidence 55433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=379.60 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=225.9
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
..|...++|++++.||.|+||.|.+++++.+|..||+|++.+.... ..+|..+|+.+.||++++++..+
T Consensus 38 ~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~---- 113 (355)
T KOG0616|consen 38 QNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF---- 113 (355)
T ss_pred CCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee----
Confidence 3345678999999999999999999999999999999999765322 23689999999999999999888
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.+..++|+||||++| .|.+.++ ..+++++..++.|+.||+.||+|||+ ++|++|||||+|||+|. +|.+||+
T Consensus 114 -~d~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKit 186 (355)
T KOG0616|consen 114 -KDNSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKIT 186 (355)
T ss_pred -ccCCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEE
Confidence 555569999999996 5656655 56899999999999999999999999 79999999999999997 7889999
Q ss_pred eecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|||+|+..... ..+.+|||.|+|||++.. ..|+.++|+|||||++|||+.|.+||.+.+...++.+|++
T Consensus 187 DFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~-------- 255 (355)
T KOG0616|consen 187 DFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE-------- 255 (355)
T ss_pred eccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------
Confidence 99999976433 678899999999999965 4599999999999999999999999999999999999987
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 332 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~~ 332 (380)
..+.|| ..++++++|||.++|++|-++|. ...++.+||||+.+.|...
T Consensus 256 ---------~~v~fP------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 256 ---------GKVKFP------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred ---------CcccCC------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 344444 45899999999999999999995 5789999999999888653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=390.86 Aligned_cols=255 Identities=31% Similarity=0.567 Sum_probs=213.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.+.+.++.||+|+.|+||+|+|+.|++.+|+|++... .+...+|+++++..+||+||++|+.|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3678899999999999999999999999999999322 2334589999999999999999999976442 388
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||++ +|..+++. .++++|.....++.++++||.|||..++||||||||+|||++. .+.|||||||.++..
T Consensus 155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGIL 229 (364)
T ss_pred eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHh
Confidence 99999995 66666653 4789999999999999999999994379999999999999997 889999999999877
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
.+. ...+++||..|||||.+.+. .|+.++||||||+.++||.+|+.||... +..+.+..|.. +.|+
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP----- 300 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPP----- 300 (364)
T ss_pred hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCC-----
Confidence 655 56789999999999999765 5999999999999999999999999874 33344433332 1111
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCC-CChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
. ++.. +|+++++||.+||++||.+|+|+.|+++|||+++....+
T Consensus 301 ---------~------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 301 ---------R------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ---------C------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 0 1222 799999999999999999999999999999999865443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=402.46 Aligned_cols=262 Identities=31% Similarity=0.512 Sum_probs=222.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||.||+|+.+.||..||+|++++..... ..|-.+|...++++||+++-.| ++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence 5689999999999999999999999999999999998764333 3678888889999999999999 667
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.++||||||++| ++..+|. ..+.|++.++++|+.+++.|++.||+ .|+|||||||+|+|||. .|++||+|||+
T Consensus 214 ~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeeccccc
Confidence 779999999996 5666665 56889999999999999999999999 79999999999999997 88899999999
Q ss_pred cccCcc-----------------------C-C-----C-------------------cceeeccCCCCChhhhhCCCCCC
Q 016950 188 AKQLIA-----------------------G-E-----A-------------------NISYICSRFYRAPELIFGATEYT 219 (380)
Q Consensus 188 a~~~~~-----------------------~-~-----~-------------------~~~~~~t~~y~aPE~l~~~~~~~ 219 (380)
|..... . . . ..+.+|||.|+|||++.+.. |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 843210 0 0 0 01458999999999998766 99
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHH
Q 016950 220 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 299 (380)
Q Consensus 220 ~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (380)
..+|+||||||+||||.|.+||.+.+..++..+|+.... -+.+|. ...++++++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~fP~----------~~~~s~eA~D 421 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKFPE----------EVDLSDEAKD 421 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccCCC----------cCcccHHHHH
Confidence 999999999999999999999999999999999987421 122222 1246899999
Q ss_pred HHHhhcccCCCCCCC---HHHHhcCCCcccccCCCCCCC
Q 016950 300 LASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLP 335 (380)
Q Consensus 300 li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~~ 335 (380)
||.+||+ ||.+|+. ++||..||||+.+.|......
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREM 459 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcC
Confidence 9999999 9999995 899999999999999876533
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=381.72 Aligned_cols=291 Identities=34% Similarity=0.685 Sum_probs=246.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCc-eeeeceeeeecCC-CCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPN-VISLKHCFFSTTS-KNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-~~~ 108 (380)
...|..+++||+|+||+||+|+.+.+|+.||+|++.-+.. ...+|+.+++.++|+| |+.+++++..... ...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5679999999999999999999999999999999964432 2369999999999999 9999999965542 233
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+++|+||++.+|...+.........++...++.++.||+.||.|||+ ++|+||||||.|||+++ ++.+||+|||+|
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence 4688999999999888887654333567778999999999999999999 89999999999999997 889999999999
Q ss_pred ccCc-cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+... +.......++|.||+|||++.+...|+..+||||+|||++||+++++.|++..+.+++..|.+.+|+|+.+.|+.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8665 333455678899999999999998899999999999999999999999999999999999999999999988876
Q ss_pred cC--CCCCCccCCCCC-CCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 268 MN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 268 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.. +.|.. .++... ...+....+. .+++..+++.+||+.+|.+|.|+..+|.||||..+....
T Consensus 248 v~~~~~~k~-~f~~~~~~~~l~~~~~~-~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 248 VSSLPDYKA-PFPKWPGPKDLSSILPK-LDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred ccccccccc-cCcCCCCccchHHhccc-cCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 53 33332 344443 3344444333 568999999999999999999999999999999875443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=406.58 Aligned_cols=284 Identities=29% Similarity=0.481 Sum_probs=234.0
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
+...++|+++++||+|+||+|++|..+.+++.||||+++++.... ..|.+|+... +||.+++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 455689999999999999999999999999999999998765433 3577777766 599999999999
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...++|+||||+.|+....+ ...+.|++..++.|+++++.||+|||+ +||||||||.+|||+|. .|.+||+||
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence 666679999999998642111 245789999999999999999999999 89999999999999997 788999999
Q ss_pred cccccCc-cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+++... .+....+.+|||.|+|||++.+. .|+.++|+|||||++|+||.|..||+++++.+....|..
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9998765 45566778999999999999665 599999999999999999999999999999999998876
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCCCCC-----
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNARL----- 334 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~~~----- 334 (380)
.+.. +|..+|.++.++++++|.++|++|+. ++++..||||+.+.|.....
T Consensus 583 --------d~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 583 --------DEVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred --------CCCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 2333 33458999999999999999999996 57999999999998864221
Q ss_pred ---CCCCCCCCCCCchhhhccCCHHHH
Q 016950 335 ---PNGRPLPPLFNFKQELSGASPELV 358 (380)
Q Consensus 335 ---~~~~~~~~~~~~~~~~~~~~~~~~ 358 (380)
|.-+...+..||+.++.+..+.+.
T Consensus 643 Pf~P~i~~~~D~snFd~eFt~e~p~Lt 669 (694)
T KOG0694|consen 643 PFVPTIKGPEDVSNFDEEFTSEKPALT 669 (694)
T ss_pred CCCcccCChhhhcccchhhhcCCCccC
Confidence 111122234456666665555444
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=398.54 Aligned_cols=278 Identities=36% Similarity=0.613 Sum_probs=230.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhCC-C-----CceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD-H-----PNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~ 109 (380)
+|++.+.||+|+||.|-+|.+..|++.||||+++....+. ..|+.+|..|+ | -|+|+++++|+. ..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-----r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-----RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-----cc
Confidence 8999999999999999999999999999999998776554 36889999886 3 589999999944 44
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC-CCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~ikl~Dfg~a 188 (380)
++|||+|.++.+|+++++.. ....++...++.++.||+.||.+||+ .||||+||||+|||+.. ....|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 59999999999999999864 34569999999999999999999999 79999999999999953 3457999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... ...+++.++.|+|||+++|.+ |+.+.||||||||++||++|.+.|+|.++.+++..|++.+|.|+...+...
T Consensus 339 c~~~q--~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQ--RVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCC--cceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 75433 333789999999999999876 999999999999999999999999999999999999999999998877643
Q ss_pred CCCCCCcc-----------------------------------CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC
Q 016950 269 NPNYTDFR-----------------------------------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313 (380)
Q Consensus 269 ~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 313 (380)
......+. .|. ....+.......-...+.|||.+||.+||.+|+
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~-~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP-GSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC-CCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 21111110 110 122233333323345679999999999999999
Q ss_pred CHHHHhcCCCccccc
Q 016950 314 TALEACAHPFFDELR 328 (380)
Q Consensus 314 t~~e~l~hp~~~~~~ 328 (380)
|+.|+|+||||....
T Consensus 495 tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 495 TPAQALNHPFLTGTS 509 (586)
T ss_pred CHHHHhcCccccccc
Confidence 999999999998643
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=365.47 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=219.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...+.|.+.+.||+|+|+.||++.+..+|+.||+|++.. +.....+|+.|-+.|+||||+++.+.+ ...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 345789999999999999999999999999999997742 234456899999999999999999988 667
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEee
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 185 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Df 185 (380)
.+.|+|+|++.| .|...+-. ...+++..+.+++.||+.||.|+|. +||+|||+||+|+++-+. +.-+||+||
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred ceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeeccc
Confidence 789999999997 45444432 2567899999999999999999999 899999999999999542 346999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|+|............+|||.|||||++... .|+.++|||+.|||||.|+.|.+||.+.+....+++|++.
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------- 227 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------- 227 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---------
Confidence 999988866666778999999999999665 4999999999999999999999999999988888888772
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+.++. ..+.++++++++||++||..||++|+|+.|+|+|||+.+
T Consensus 228 --------~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 --------AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred --------ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 333322 123458999999999999999999999999999999976
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=398.48 Aligned_cols=254 Identities=34% Similarity=0.549 Sum_probs=224.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
++-|++++.||.|+-|.|.+|++..||+..|||++.+. .....+|+.+|+.+.|||++++++++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 34599999999999999999999999999999999766 44557999999999999999999999 6667
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+|.||++| .|.+.+. ..+++++.++.+++.||+.|+.|||. .+|+||||||+|+|+|. .++|||+|||+|
T Consensus 86 ~lylvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMA 159 (786)
T ss_pred eEEEEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeecccee
Confidence 79999999995 5655554 56889999999999999999999999 69999999999999997 555999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..-.++....+.||+|+|.|||++.|..+.+.++||||+|||||.||+|+.||.+.+-...+.++.+
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------- 226 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------- 226 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-------------
Confidence 8877777777899999999999999988779999999999999999999999997776666666654
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..|.+| ..+|++++|||++||.+||++|+|.+|+++|||+......
T Consensus 227 ----G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 227 ----GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ----CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 334444 3589999999999999999999999999999999886543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-53 Score=391.73 Aligned_cols=253 Identities=33% Similarity=0.505 Sum_probs=218.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCC-CCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMD-HPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 104 (380)
...+.|.+.+.||+|+||+|++|.+..++..||+|++.+. .....+|+.+++.++ ||||+++++++..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-- 91 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-- 91 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--
Confidence 4466899999999999999999999999999999976543 123348999999999 9999999999943
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
...+|+|||||.| .|++.+. ..+++.+..++.++.||+.|++|||+ +||+||||||+|||++.+.+++||+
T Consensus 92 ---~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 92 ---PTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred ---CCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence 3349999999996 7777775 36789999999999999999999999 7999999999999999743889999
Q ss_pred eecccccC-ccCCCcceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 184 DFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 184 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|||++... .......+.+||+.|+|||++.+.. .-+.++||||+||+||.|++|..||...+....+..|.+
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999987 4556667889999999999997766 446899999999999999999999999887777777554
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCC-ChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+.+|. .+ |+++++|+++||..||.+|+|+.++++||||+.
T Consensus 238 -----------~~~~~p~------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -----------GEFKIPS------------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------CCccCCC------------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 2333433 36 999999999999999999999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=377.21 Aligned_cols=256 Identities=30% Similarity=0.529 Sum_probs=220.4
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
....++|.+.+.||.|+||+||+|+++.++..||||.+.+.. .....|+.+|+.++|||||.+++++ ..
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~ 80 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----ED 80 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ec
Confidence 345678999999999999999999999999999999986553 2235799999999999999999999 55
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--C---CcEE
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--T---HQVK 181 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~---~~ik 181 (380)
..++|+|||||+ |+|..+++ ..+.+++..++.++.||+.||++||+ ++||||||||+|||++.. + -.+|
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEE
Confidence 557999999999 57777776 45689999999999999999999999 899999999999999763 1 4699
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||+|+...+.....+.+|+|.|||||++.. .+|+.++|+||+|+|+|+|++|++||...+..+.+..+.+....
T Consensus 156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-- 232 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-- 232 (429)
T ss_pred ecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc--
Confidence 999999999988877788999999999999964 56999999999999999999999999999988888755442111
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
...++..+++.+.+|+..+|+.+|.+|.+..+-+.||++..
T Consensus 233 ------------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 233 ------------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ------------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 11123346788889999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-55 Score=368.55 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=214.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..+|++.++||.|+||.||+|.+..+|+.+|.|.+.- .+.....|+.+|++|+|||||++++.-+. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 3569999999999999999999999999999998852 23334579999999999999999883222 33344
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc--CC-CeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--VP-RVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~--~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
++||||||+ |+|...++++......+++..+|.++.|+|.||.+||+ .+ -|+||||||.||+++. ++.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccch
Confidence 889999999 68999999999999999999999999999999999998 21 3899999999999996 8899999999
Q ss_pred ccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+++....... ..+.+|||+||+||.+.++ .|+.+|||||+||++|||+.-++||.+.+..+.-.+|.+.--.|.
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~---- 248 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL---- 248 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC----
Confidence 9998765543 4578999999999999765 499999999999999999999999999977766666655311111
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
| ....|.++..||.-|+..||..||+. +|++.++..
T Consensus 249 ------------p-----------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 249 ------------P-----------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred ------------c-----------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 1 02368899999999999999999986 566665543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=372.73 Aligned_cols=276 Identities=26% Similarity=0.447 Sum_probs=229.2
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
-....++++++.||.|.-|+||+|+.+.++..+|+|++.+.. ...+.|.+||..++||.++.+++.| +
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----e 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----E 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----e
Confidence 344578999999999999999999999999999999996543 2234689999999999999999999 7
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
.+.+.|++||||+|+-+..+++ ...+..+++..+++|+.+++.||+|||. -|||+|||||+||||.. +|.|.|+||.
T Consensus 148 t~~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFD 224 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFD 224 (459)
T ss_pred ccceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeecc
Confidence 7788999999999744444433 3467889999999999999999999999 59999999999999996 7889999999
Q ss_pred ccccCcc---------------------------------C-C-----------------------CcceeeccCCCCCh
Q 016950 187 SAKQLIA---------------------------------G-E-----------------------ANISYICSRFYRAP 209 (380)
Q Consensus 187 ~a~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aP 209 (380)
++..... . . ...+++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8742200 0 0 01246789999999
Q ss_pred hhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCccccc
Q 016950 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 289 (380)
Q Consensus 210 E~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (380)
|++.|.. .+.++|+|+|||++|||+.|..||.|.+..+++.+|+. .+..||..
T Consensus 305 EvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~--------- 357 (459)
T KOG0610|consen 305 EVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEE--------- 357 (459)
T ss_pred eeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCC---------
Confidence 9998766 79999999999999999999999999999999998876 33444442
Q ss_pred CCCCChHHHHHHHhhcccCCCCCCC----HHHHhcCCCcccccCCCCCCCCCCCCCCCCC
Q 016950 290 HKRMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPLPPLFN 345 (380)
Q Consensus 290 ~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 345 (380)
..++..++|||+++|.+||++|+. |.||.+||||+.++|........+.+|...+
T Consensus 358 -~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 358 -PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred -CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence 137899999999999999999998 9999999999999998655444444444433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=372.38 Aligned_cols=278 Identities=33% Similarity=0.648 Sum_probs=231.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~ 77 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERC 77 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence 3567999999999999999999999999999999885322 2335799999999999999999988 33445
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 78 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~ 152 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARA 152 (288)
T ss_pred EEEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceee
Confidence 889999999988777653 34467899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ......+++.|+|||++.+...++.++|+||+||++|+|++|++||.+.+..+.+..+....+.|+.+.+....
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 43222 22345678999999998766668999999999999999999999999999999999999999999988776543
Q ss_pred --CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 --PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..+..+.++.....++... ...++++++|||.+||++||.+|||++|+++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 2333444554444444332 23578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-52 Score=374.01 Aligned_cols=266 Identities=27% Similarity=0.429 Sum_probs=219.4
Q ss_pred cCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------------cchHHHHHHHHhC
Q 016950 27 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRVM 88 (380)
Q Consensus 27 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------~~~~~e~~~l~~l 88 (380)
........+..++|++++.||.|.||+|.+|++..+++.||||++.+.. ....+|+.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 3444555677899999999999999999999999999999999985431 1235899999999
Q ss_pred CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 89 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
.|+|||+++++.-+. ....+|+|+|||..+ .+.........+++.+++.|+.+++.||+|||. +|||||||||
T Consensus 166 ~H~nVV~LiEvLDDP---~s~~~YlVley~s~G---~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKP 238 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDP---ESDKLYLVLEYCSKG---EVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKP 238 (576)
T ss_pred CCcCeeEEEEeecCc---ccCceEEEEEeccCC---ccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccch
Confidence 999999999988443 344589999999854 222222233339999999999999999999999 7999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCC------CcceeeccCCCCChhhhhCC---CCCCchhhHHHHHHHHHHHHhCCC
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGE------ANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
+|+|++. ++++||+|||.+....... .....+|||.|+|||.+.+. ...+.+.||||+||+||.|+.|+.
T Consensus 239 sNLLl~~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 239 SNLLLSS-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hheEEcC-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 9999997 7899999999987652221 12347899999999999762 335789999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
||.+....+...+|+. ..+.||.. ..+.++++|||.+||++||++|+++.++.
T Consensus 318 PF~~~~~~~l~~KIvn-----------------~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 318 PFFDDFELELFDKIVN-----------------DPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred CcccchHHHHHHHHhc-----------------CcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 9999999999988887 33444432 13689999999999999999999999999
Q ss_pred cCCCcccc
Q 016950 320 AHPFFDEL 327 (380)
Q Consensus 320 ~hp~~~~~ 327 (380)
.|||...-
T Consensus 371 ~Hpwvt~~ 378 (576)
T KOG0585|consen 371 LHPWVTRD 378 (576)
T ss_pred ecceeccC
Confidence 99999764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=381.32 Aligned_cols=250 Identities=30% Similarity=0.549 Sum_probs=217.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
+++|.+.+.||+|+||.||+++.+.+.+.||||.+.+..+. ..+|++|++.++||||+.+++.| +....
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~ 75 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAH 75 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccce
Confidence 36799999999999999999999999999999998765433 45899999999999999999999 66777
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++|+|||.|+|..++. ..+.++++.++.++++++.||.|||+ ++|.|||+||.|||++. ++.+|+||||+|+.
T Consensus 76 ~~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARA 149 (808)
T ss_pred EEEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhh
Confidence 99999999998888876 57889999999999999999999999 79999999999999996 88899999999998
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
+..+.. .++.-|||.|||||++.+ ..|+..+|+||+|||+|||++|++||....-.+....|.+.
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d------------- 215 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD------------- 215 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC-------------
Confidence 766543 345678999999999975 55999999999999999999999999877655555544441
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+.. .+..++..+++|+..+|.+||.+|+|..+++.|||++.-
T Consensus 216 ----~v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 216 ----PVK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ----CCC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 111 123589999999999999999999999999999999863
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=370.26 Aligned_cols=318 Identities=37% Similarity=0.644 Sum_probs=240.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999988532 12235799999999999999999988655444445688
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||++++|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence 999999988877765 34568999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCCC----cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 193 AGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 193 ~~~~----~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
.... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1235789999999998542 4589999999999999999999999999988888888888888888765544
Q ss_pred cCCCCC-Cc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 016950 268 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 344 (380)
Q Consensus 268 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 344 (380)
...... .+ .+......++...++ .+++.+.++|.+||+.||++|||++++++||||+.+...... +...+.+. .
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~-~ 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITK-L 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCcccc-c
Confidence 321100 00 000001111122222 368899999999999999999999999999999987654322 22222222 2
Q ss_pred CchhhhccCCHHHHhhhChHH
Q 016950 345 NFKQELSGASPELVNKLIPDH 365 (380)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~ 365 (380)
.+..+....+.+.+...+.++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~ 332 (338)
T cd07859 312 EFEFERRRLTKEDVRELIYRE 332 (338)
T ss_pred cccHHHHhcCHHHHHHHHHHH
Confidence 333334455556666555444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=363.78 Aligned_cols=258 Identities=32% Similarity=0.532 Sum_probs=209.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|...+.||+|+||.||++.+..+|..+|+|.+... .....+|+.+|+.++|||||++++....... ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence 56799999999999999999999999999999998665 3345799999999999999999886422221 4688
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|||+++ +|.+.+..+ ++.+++..++.+..|++.||+|||+ +|++||||||+|||++..++.+||+|||+++..
T Consensus 93 i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99999995 777777642 2279999999999999999999999 899999999999999964578999999999876
Q ss_pred cc----CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~----~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
.. ........||+.|||||++........++||||+||++.||+||.+||... ...+.+..+...-
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence 53 222345789999999999964322345999999999999999999999873 3333333322210
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. ...++..+|+++++||.+||++||++||||+++|+|||.+.-.
T Consensus 240 ---------~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 ---------S---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ---------C---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 0 1134556899999999999999999999999999999998743
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=365.24 Aligned_cols=282 Identities=33% Similarity=0.568 Sum_probs=219.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence 467999999999999999999999999999999985332 23457999999999999999999884 33458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+.+++.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCcceec
Confidence 99999999988877753 34568899999999999999999999 79999999999999996 778999999998754
Q ss_pred ccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+.. ..+.+..+....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 322 222345678999999998766668999999999999999999999998754 445666677767776655443221
Q ss_pred C--CCCCccCCCCCCCCcccccC-CCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 270 P--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 270 ~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. .+....+.......+...+. ...++.+.+||.+||++||++|+|+.|+++||||+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1 11110111111111111111 12467899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=321.44 Aligned_cols=279 Identities=35% Similarity=0.642 Sum_probs=236.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..|.-.++||+|.||+||+++++.+++.||+|.+.-+. ...-+|+.+++.++|.|||+++++... +..+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----Ccee
Confidence 35777889999999999999999999999999986432 233589999999999999999998833 3337
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
-+|+|||...|...+. ..++.+..+.++.++.|++.||.|+|+ +++.||||||.|.|++. ++.+|++|||+++..
T Consensus 77 tlvfe~cdqdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglaraf 151 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAF 151 (292)
T ss_pred EEeHHHhhHHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhc
Confidence 7999999988766665 357889999999999999999999999 89999999999999997 889999999999866
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.-.-. ....+.|.||++|.+++|..-|+...|+||.|||+.|+.. |++.|++.+..+++.+|.+.+|.|+.+.|+.+.
T Consensus 152 gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 43332 2345679999999999999889999999999999999996 999999999999999999999999999988775
Q ss_pred CCCCCccCCCCCC-CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.--....+|-+.. ..|.++. .+++...+||++++|.-+|.+|++++.+++||||.+.
T Consensus 232 ~lpdyk~yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCCCcccCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 3322223444433 3344444 4588899999999999999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=371.72 Aligned_cols=251 Identities=29% Similarity=0.495 Sum_probs=216.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...|...+.||+|+.|.||.|+...+++.||||.+.... .....|+.+|+..+|+|||.+++.|..... +|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eE
Confidence 356999999999999999999999999999999986433 334589999999999999999999965533 99
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||++| +|.+.+. ...++|.++..++.+++.||+|||. +||+|||||.+|||++. ++.+||+|||+|...
T Consensus 347 VVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeecc
Confidence 99999996 5556554 3459999999999999999999999 89999999999999997 778999999999887
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ...+.+|||+|||||++. ...|++++||||||+++.||+-|++||-..+....++.|.. .|+|...
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk------- 490 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK------- 490 (550)
T ss_pred ccccCccccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC-------
Confidence 6655 456789999999999995 45699999999999999999999999999888877776654 3443321
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+..+|+.++|||.+||+.|+.+|++|.|+|+||||+.
T Consensus 491 ------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 ------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 23458999999999999999999999999999999954
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=345.81 Aligned_cols=259 Identities=31% Similarity=0.535 Sum_probs=222.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------c------cchHHHHHHHHhC-CCCceeeeceeeee
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------RYKNRELQLMRVM-DHPNVISLKHCFFS 102 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~------~~~~~e~~~l~~l-~h~niv~~~~~~~~ 102 (380)
....|...+.||.|..++|.+|.++.+|+.+|+|++... . ....+|+.||+++ .||+|+++.++|
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-- 92 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-- 92 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--
Confidence 345789999999999999999999999999999988421 1 1123689999988 699999999999
Q ss_pred cCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 103 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
+.+.++++|+|.|+ |.|.+.+. ..-.+++...+.|+.|++.|+.|||. ++|+||||||+|||++. +.++|
T Consensus 93 ---es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~ 163 (411)
T KOG0599|consen 93 ---ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIK 163 (411)
T ss_pred ---cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceE
Confidence 77888999999999 66777665 45679999999999999999999999 89999999999999995 88899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhh-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 256 (380)
|+|||+|.....+......+|||.|.|||.+. +.+.|+..+|+||+|||+|.|+.|-+||......-++..|++.
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 99999999998888888899999999999983 3455899999999999999999999999888777778777762
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+.| ..+.| .++|.+.+|||++||+.||++|+|+.|+|.||||..+-..
T Consensus 244 -----------------kyqF---~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 244 -----------------KYQF---RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred -----------------cccc---CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 2222 12222 4579999999999999999999999999999999776444
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=361.03 Aligned_cols=283 Identities=33% Similarity=0.650 Sum_probs=232.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 78 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKS 78 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCe
Confidence 3567999999999999999999999999999999886332 233579999999999999999998843 345
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 153 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (309)
T ss_pred EEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcccccee
Confidence 889999999988777653 34568899999999999999999999 89999999999999996 77899999999875
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...... .....+|+.|+|||++.+...++.++|+||+||++|+|++|+.||.+.+..+.+..+.+.++.+....++...
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 433222 2234678999999998766668999999999999999999999999999989999999999998887766543
Q ss_pred C--CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 270 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 270 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. .+..+.++......+.... ..+++++++||.+||+.||.+|+|+.|+++||||+.+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred chhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 2 2223334443333333322 347999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=357.49 Aligned_cols=276 Identities=36% Similarity=0.699 Sum_probs=222.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||+|+||.||+|+++.+++.||+|++.... ....+|+.+++.++|+||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 46999999999999999999999999999999886432 2235799999999999999999888 344458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||++++++..+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL 150 (287)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence 99999999887666543 34568999999999999999999999 79999999999999986 778999999999865
Q ss_pred ccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+.+..+....+..+.+.+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 4322 12235689999999999654 48999999999999999999999999988888888888777777665554321
Q ss_pred --CCCCCccCCCCC-CCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 --PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+....++... ...+...+...+|.++.+||++||++||++|||++++|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 222222222211 1222333344578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=354.51 Aligned_cols=276 Identities=25% Similarity=0.431 Sum_probs=224.8
Q ss_pred cCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeee
Q 016950 27 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 101 (380)
Q Consensus 27 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~ 101 (380)
......-|...+.|++...||.|..++||+|+++.+++.||||++.-+ .....+|+..|+.++||||++++.+|.
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 334445677788999999999999999999999999999999999533 244568999999999999999999996
Q ss_pred ecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcE
Q 016950 102 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~i 180 (380)
.... +|+||.||. |+++++++.+-. ..+.|..+..|+.+++.||.|||. +|.||||||+.||||+. +|.|
T Consensus 95 v~~~-----LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~V 165 (516)
T KOG0582|consen 95 VDSE-----LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGTV 165 (516)
T ss_pred ecce-----eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCcE
Confidence 5544 999999999 688899887654 349999999999999999999999 89999999999999997 8899
Q ss_pred EEEeecccccCccCCCc-----ceeeccCCCCChhhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 181 KICDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
||+|||.+..+...... ...+||++|||||++.. ...|+.++||||||++..||.+|+.||....+.+.+..-+
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 99999987665443221 34588999999999543 4569999999999999999999999999988887765433
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+.|+.....- ....-.+..+..++.+|..||++||++|||++++|+|+||+..+..
T Consensus 246 --qn~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 246 --QNDPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred --cCCCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 34443211000 0000112367799999999999999999999999999999986543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=344.66 Aligned_cols=288 Identities=37% Similarity=0.632 Sum_probs=230.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCC----cEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
.....|++++.||+|.||.||+|..+.++ +.||||++.... ...-+|+.+++.++|+|++.+..+|...
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 34468999999999999999999766554 378999996542 2335899999999999999999999643
Q ss_pred CCCceEEEEEeecccchHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC---CCcE
Q 016950 105 SKNELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQV 180 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~---~~~i 180 (380)
+..+++++||.+.+|+++++..+.. ...++...++.|+.||+.|+.|||+ +-|+||||||.|||+..+ .++|
T Consensus 100 ---d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 ---DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred ---CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCee
Confidence 4459999999999999999865433 4568999999999999999999999 899999999999999752 3789
Q ss_pred EEEeecccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hH
Q 016950 181 KICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AV 247 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---------~~ 247 (380)
||+|||+++.+.+.-.. ...+.|.||+|||++.|...|+.+.|+||+|||+.||++-.+.|.+.. ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999987554322 235679999999999999999999999999999999999999997653 34
Q ss_pred HHHHHHHHHhCCCCHHHHhhcC--CCCCCc--cCC--CCCCCCcccccC--CCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 248 DQLVEIIKVLGTPTREEIRCMN--PNYTDF--RFP--QIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~--~~~~~~--~~~--~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
+++.+|++.+|.|+...|+.+. |.|... .|+ ......+...+. +.-++.+.+|+.+||++||.+|+|++++|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 7899999999999998776543 222100 111 000111111111 12356699999999999999999999999
Q ss_pred cCCCcccc
Q 016950 320 AHPFFDEL 327 (380)
Q Consensus 320 ~hp~~~~~ 327 (380)
+|+||..-
T Consensus 336 eh~yF~~d 343 (438)
T KOG0666|consen 336 EHPYFTED 343 (438)
T ss_pred cccccccC
Confidence 99999874
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=366.59 Aligned_cols=287 Identities=32% Similarity=0.556 Sum_probs=228.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999999999999999986431 223479999999999999999988744322 223
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+||||+++++...+. ..+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence 4578999999998877664 247888899999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..++..++.|..+.+...
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 865444444456789999999999654 5899999999999999999999999999999999999998888877655443
Q ss_pred CCC----------CCCccCCCCC---CCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 269 NPN----------YTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 269 ~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.+. +..+.+.... ..++........+..+++||.+||+.||.+|||+.++|+||||..+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 221 1111111100 01111112223467899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=356.17 Aligned_cols=280 Identities=34% Similarity=0.585 Sum_probs=221.3
Q ss_pred cceeeeeeeecCCceEEEEEEECC-CCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~ 107 (380)
.+|++.+.||+|+||.||+|++.. +++.||+|.+.... ....+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999865 46889999885322 1234677777665 6999999999875443344
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...+++||||++++|.+.+... ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccc
Confidence 4568899999999888877632 23458999999999999999999999 89999999999999996 77899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.............+|+.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9865544444456789999999998654 589999999999999999999999999999999999998888777655432
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
... .....+......+.... ...+++.+++||.+||+.||++|||+.++|+||||
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVA-LPRQAFHSKSAQPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhc-ccchhccCCCCCCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 110 11111111122222222 23578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=368.25 Aligned_cols=284 Identities=33% Similarity=0.559 Sum_probs=225.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999885421 2335799999999999999999988544322233688
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|+||+.++|...+. ....+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence 999999988777664 35678999999999999999999999 79999999999999996 7889999999997543
Q ss_pred cCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 193 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.++.+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 122346789999999997766689999999999999999999999999999999999999999988766543211
Q ss_pred CCCCcc--CCCC-CCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFR--FPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...... .+.. ........+....++++.+||.+||++||.+|||+.++++||||+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 100000 0000 000000112344689999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=364.24 Aligned_cols=258 Identities=31% Similarity=0.533 Sum_probs=220.5
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCC-CCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 105 (380)
......|++.+.||.|.||.||+|.++.+|+.+|+|.+.+... ...+|+.+|+.+. |||||.+++.|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----- 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----- 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----
Confidence 3455689999999999999999999999999999999965433 4568999999998 99999999999
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC---CcEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVK 181 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~---~~ik 181 (380)
++...+++|||+|.| .|.+.+... .+++..+..++.|++.|++|||+ .|++||||||+|+|+.... +.+|
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik 179 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIK 179 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEE
Confidence 555569999999995 666666543 39999999999999999999999 7999999999999996532 4799
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
++|||+|............+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+......++...
T Consensus 180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----- 253 (382)
T KOG0032|consen 180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----- 253 (382)
T ss_pred EeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----
Confidence 999999998877556677899999999999954 45999999999999999999999999999988888766652
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
++.| .... +..++..+++||++||..||.+|+|+.++|+|||++...
T Consensus 254 ------------~~~f---~~~~-----w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 254 ------------DFDF---TSEP-----WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ------------CCCC---CCCC-----ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 1211 1222 234799999999999999999999999999999998763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=366.76 Aligned_cols=286 Identities=32% Similarity=0.555 Sum_probs=225.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 467899999999999999999999999999999998542 1223479999999999999999998854332 122
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+||||+++++...+. ..+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 3478999999998776653 347888999999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.............+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.+.++.+..+.+...
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 765444444456789999999999654 5899999999999999999999999999988888888888888876544322
Q ss_pred C----------CCCCCccCCCCC-C--CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 N----------PNYTDFRFPQIK-A--HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~----------~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
. +.+..+.+...- . .+.........++++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1 111111111000 0 000011122357889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=362.69 Aligned_cols=286 Identities=33% Similarity=0.567 Sum_probs=227.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4678999999999999999999999999999999886432 223478999999999999999998854332 223
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
...|+||||+++++...+. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence 4578999999998776664 247888999999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+............+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+++.++.+..+.+..+
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 865444444456789999999999654 5899999999999999999999999999999999999888888877655443
Q ss_pred CC----------CCCCccCCCCCC---CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NP----------NYTDFRFPQIKA---HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~----------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+ .+....++.... .+.........+.++++||.+||+.||++|||+.|+|+||||.....+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 22 222222221100 011112223356789999999999999999999999999999866443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=351.55 Aligned_cols=279 Identities=30% Similarity=0.547 Sum_probs=221.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|++.+.||+|+||+||+|.++.+++.||+|.+.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5999999999999999999999999999999885421 1234677776665 799999999988655444556
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++++|||+.+++...+... ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence 68899999999887777532 23458999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
............+|..|+|||++.+. .++.++||||+||++|+|++|.+||.+....+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 66544444456779999999999654 48999999999999999999999999998888888888888877665543211
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
. .....+.......+.. ....+++.+.+||.+||++||.+|||+.+++.||||
T Consensus 236 ~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0001111111112222 223478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=330.02 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=220.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||.|-||.||+|+.+.++-.||+|++.++. ....+|++|...|+||||++++++|.+..
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~---- 95 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK---- 95 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc----
Confidence 4578999999999999999999999999999999986543 34468999999999999999999995544
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+|+++||.. |.++..+.. ....++++..++.|+.|++.||.|+|. ++++||||||+|+|++. .+.+||+|||-
T Consensus 96 -riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAdfGw 170 (281)
T KOG0580|consen 96 -RIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIADFGW 170 (281)
T ss_pred -eeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccCCCc
Confidence 4999999998 577777763 245679999999999999999999999 89999999999999997 78899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+-... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||.+....+.+.+|.+.
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------- 237 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------- 237 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------
Confidence 87654 5556678999999999998654 4899999999999999999999999999988888888773
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
++.+ +..++.++.|||.+||.++|.+|++..|++.|||+...
T Consensus 238 ------~~~~------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 ------DLKF------------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ------cccC------------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 3333 34589999999999999999999999999999999763
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=352.79 Aligned_cols=285 Identities=32% Similarity=0.618 Sum_probs=231.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ....
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~ 78 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKS 78 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCe
Confidence 4678999999999999999999999999999999885332 23357999999999999999999983 3445
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+||||++++|...+.. ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus 79 ~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 153 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA 153 (301)
T ss_pred EEEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhc
Confidence 889999999988777653 34568899999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+...++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred cCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 43222 22234568899999998776668899999999999999999999999999888888888888888776665432
Q ss_pred C--CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 270 P--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 270 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
. .+..+.++....... ......+++.+++||.+||+.||.+|||+.|+++||||+.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~ 296 (301)
T cd07873 234 SNEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI 296 (301)
T ss_pred ccccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence 1 222233333222222 122345789999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=353.64 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=209.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 46999999999999999999999999999999985421 2245799999999999999998877 44456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+.+ +|.+.+. ....+++..++.++.|++.||+|||+ +|++||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence 8999999985 6766665 34578999999999999999999999 89999999999999986 7889999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------- 213 (291)
T cd05612 150 KLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------------- 213 (291)
T ss_pred hccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 65332 2345789999999998654 4899999999999999999999999988776666555431
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++.+++||++||+.||.+|++ ++++++||||+.+.+.
T Consensus 214 ----~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ----KLE------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ----CcC------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 011 23346889999999999999999995 9999999999987664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=359.47 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=210.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ....+|+.+++.++||||+++++++. ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cC
Confidence 4578999999999999999999999999999999986432 22357999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg~ 164 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFGF 164 (329)
T ss_pred CEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeeccC
Confidence 458999999985 6666665 34678999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9865332 2345789999999999654 4799999999999999999999999887766655544331
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
... ++..++..+++||.+||+.||.+|++ ++++++||||.+..+.
T Consensus 231 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ------RLK------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------CcC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 111 12237889999999999999999997 7999999999986554
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=355.09 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=230.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..+-|.+.+.||+|-|+.|.+|++..+|+.||||++.+... ...+|+..|+.++|||||++|++. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 34459999999999999999999999999999999976432 235899999999999999999988 4444
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
-+|+|+|.-++ +|.+++.. ....+++..++.|+.||+.|+.|+|+ -.++||||||+|+.+-+.-+-|||.|||++
T Consensus 91 KlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred eEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeecccc
Confidence 58999999885 88888864 45679999999999999999999999 599999999999988776889999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..+.++....+.+|+..|-|||++.|...-.+++||||||||||-|++|++||...+..+.+-.|+.+
T Consensus 167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC------------ 234 (864)
T KOG4717|consen 167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC------------ 234 (864)
T ss_pred ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc------------
Confidence 99988888889999999999999999887789999999999999999999999999999999999874
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.|.. |..++.+|+|||..||..||.+|.+.+++..|+|++.+....
T Consensus 235 -----KYtv------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 235 -----KYTV------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred -----cccC------------chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 2233 345899999999999999999999999999999999876554
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=356.36 Aligned_cols=285 Identities=36% Similarity=0.631 Sum_probs=228.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++.+.||.|+||+||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 467999999999999999999999999999999986432 223479999999999999999988753321 2233
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..|++++++.++|...+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~ 166 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLAR 166 (343)
T ss_pred cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccce
Confidence 478999999888776654 3569999999999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+....
T Consensus 167 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6533 23346789999999999765668999999999999999999999999999888888888888888776554432
Q ss_pred CCCCCc---cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 270 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 270 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...... ..+......+...+ ...++.+.+||.+||+.||.+|||+.|+++||||.....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~ 308 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE 308 (343)
T ss_pred hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence 211100 11222222222222 23678899999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=348.14 Aligned_cols=248 Identities=28% Similarity=0.481 Sum_probs=220.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..+|++.+.||.|.||+|-+|.....|+.||||.+.++.. ...+|++||..|+||||+.++++| ++..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence 4589999999999999999999999999999998876532 335899999999999999999999 6666
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
-+.|||||.. |.|++++. ..+.+++.++++++.||..|+.|||. ++++|||||.+|||+|. ++++||+|||++
T Consensus 127 KIvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGLS 200 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGLS 200 (668)
T ss_pred eEEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccchh
Confidence 6889999998 57888776 46789999999999999999999999 89999999999999997 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..+.......+++|+|.|.+||++.|.+.-++.+|-|||||+||.|+.|..||.|.+....+.+|...
T Consensus 201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------------ 268 (668)
T KOG0611|consen 201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------------ 268 (668)
T ss_pred hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc------------
Confidence 98888888888999999999999988876789999999999999999999999999988888777652
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
.|.-| .-+.++.-||+.||.+||++|.|++++-.|=|.+
T Consensus 269 -----aYrEP-------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 -----AYREP-------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----cccCC-------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 22222 2477899999999999999999999999997765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=357.40 Aligned_cols=246 Identities=28% Similarity=0.457 Sum_probs=203.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|++..+|+.||+|++.+.. ....+|+.+++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 1234688999999999999999888 34446899999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~- 194 (380)
|+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence 9986 5555554 35678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 22335678999999999865 45899999999999999999999999887766555444321 1
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||.+||+.||++|| ++.++++||||..+.+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2345799999999999999999999 89999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=348.27 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=207.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|++.+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++.+++ ......
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3889999999999999999999999999999885432 1234799999999999999998888 333458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++||||+.+ +|...+.. .....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ 151 (285)
T ss_pred EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence 899999986 55555542 123468999999999999999999999 79999999999999986 77899999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05631 152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED---------- 220 (285)
T ss_pred cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence 5444333456789999999999654 58999999999999999999999998765433333222211100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 331 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 331 (380)
...++..+++++.+||++||+.||.+|++ ++++++||||..+++..
T Consensus 221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~ 271 (285)
T cd05631 221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR 271 (285)
T ss_pred ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence 01123457999999999999999999997 89999999999986553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=336.20 Aligned_cols=262 Identities=29% Similarity=0.471 Sum_probs=213.6
Q ss_pred cccceeee-eeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|.+- ++||-|-.|+|..|.++.|++.||+|++. +....++|+++.-.. .|+|||.++++|-... .+..++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEe
Confidence 55778874 58999999999999999999999999775 444566888765554 6999999999884332 55678889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeeccccc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQ 190 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~a~~ 190 (380)
|||.++| .|.+-+.. .....+++.++..|+.||+.|+.|||+ .+|+||||||+|+|+... +..+||+|||+|+.
T Consensus 137 VmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence 9999996 56666653 245679999999999999999999999 699999999999999642 34699999999998
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHh
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~ 266 (380)
........+.+.||+|.|||++ +...|+..+|+||+||++|.|++|.+||.+.... .+..+|..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~----------- 281 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT----------- 281 (400)
T ss_pred cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-----------
Confidence 7666666778889999999998 6777999999999999999999999999877542 22222222
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..|.||. +.| ..+|++++|+|+++|..+|++|+|++++++|||+....
T Consensus 282 ------gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 282 ------GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred ------cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 2333432 233 33799999999999999999999999999999998753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=359.44 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=207.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 47999999999999999999999999999999986532 2234689999999999999999988 44445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence 8999999985 6666665 34679999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC------------------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHH
Q 016950 190 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 233 (380)
Q Consensus 190 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ 233 (380)
...... .....+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e 228 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence 542210 01235789999999999654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--
Q 016950 234 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL-- 311 (380)
Q Consensus 234 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~-- 311 (380)
|++|..||.+.+..+....+...... ..+|. ...+++++++||.+|+. +|.+
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~ 282 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRI 282 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence 99999999988877776665542110 11111 01268999999999886 4554
Q ss_pred -CCCHHHHhcCCCcccccCCC
Q 016950 312 -RCTALEACAHPFFDELREPN 331 (380)
Q Consensus 312 -R~t~~e~l~hp~~~~~~~~~ 331 (380)
||+++|+++||||+.+.+..
T Consensus 283 ~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 283 GAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred CCCCHHHHhCCCCCCCCCHHH
Confidence 57999999999999887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=362.65 Aligned_cols=276 Identities=23% Similarity=0.336 Sum_probs=212.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
..+|.+++.||+|+||.||+|.+..+++.||+|.... ....+|+.+++.++||||++++++|.. ....++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence 4579999999999999999999999999999997643 335689999999999999999998843 334889999
Q ss_pred cccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC--
Q 016950 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-- 194 (380)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-- 194 (380)
++.++|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||+|......
T Consensus 164 ~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccc
Confidence 99988877665 34568899999999999999999999 79999999999999996 778999999999653222
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHHhh
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|..||... +....+..++...|.++.+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22234578999999999865 45899999999999999999999887543 23456666777777654321100
Q ss_pred cCC----CC----CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNP----NY----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
... .+ ............|... ..++.++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 000 00 0000000001112111 12577899999999999999999999999999998854
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=349.98 Aligned_cols=278 Identities=33% Similarity=0.556 Sum_probs=210.5
Q ss_pred eeeeecCCceEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
.+.||+|+||.||+|.++ .+++.||+|.+.... ....+|+.+++.++||||+++++++.... ...+|++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEecc
Confidence 467999999999999976 467899999886543 23468999999999999999998885432 34588999999
Q ss_pred cchHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC---CCCcEEEEeeccccc
Q 016950 119 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQ 190 (380)
Q Consensus 119 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~ikl~Dfg~a~~ 190 (380)
++++...+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 9988877753221 12358999999999999999999999 79999999999999942 356899999999976
Q ss_pred CccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 016950 191 LIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 257 (380)
Q Consensus 191 ~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 257 (380)
..... ......+|+.|+|||++.+...++.++|+||+||++|+|++|++||.+... .+.+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54322 123457799999999997766689999999999999999999999975442 35677788888
Q ss_pred CCCCHHHHhhcCCCCC------Cc---cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 258 GTPTREEIRCMNPNYT------DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
|.|....+........ .+ .........+........+.++.+||++||++||.+|+|++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8877665543321000 00 0000000000111112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=337.07 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=220.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
-.++|..+++||+|.||+|-+|+.+.+++.||||++++.....+ .|-++|+..+||.+..+.-.| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 45789999999999999999999999999999999987655444 366789999999999988888 555
Q ss_pred eEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||..|+ |.-.+. ....+++..++.|-.+|+.||.|||+ ++|++||||.+|+|+|. ++.|||+|||+
T Consensus 241 drlCFVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGL 314 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGL 314 (516)
T ss_pred ceEEEEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeeccc
Confidence 5699999999964 444443 45779999999999999999999999 89999999999999997 78899999999
Q ss_pred cccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++.... +....+++|||.|+|||++. ...|+.++|+|.+||++|||++|+.||.+.+....+..|..
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------- 382 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------- 382 (516)
T ss_pred chhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------
Confidence 986443 44556789999999999995 55699999999999999999999999999998887777765
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA 332 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~ 332 (380)
.++.| |..++++++.|+..+|.+||.+|+. +.|+.+|+||..++|...
T Consensus 383 ------ed~kF------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 383 ------EDLKF------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred ------hhccC------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 23333 4569999999999999999999984 789999999999998754
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=342.00 Aligned_cols=276 Identities=35% Similarity=0.576 Sum_probs=219.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 5899999999999999999999999999999885431 22357999999999999999999883 344588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|+||+++++.+.+.. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence 9999999988776653 34568999999999999999999999 79999999999999996 7789999999987543
Q ss_pred cCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 193 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... .....+++.|+|||.+.+...++.++|+||+||++|+|++|..| |.+.+..+.+..+.+.++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 3221 22346688999999987766679999999999999999998877 566677778888888888777665543321
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.-....++..............+++++++||++||+.||.+|||+++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111122111111122234589999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=353.77 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=209.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCC-cEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
...++|.+.+.||+|+||.||+|.+..++ ..||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~----- 101 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK----- 101 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----
Confidence 34578999999999999999999876655 789999885432 12346999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DF 175 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDF 175 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecC
Confidence 34458999999975 6666665 34578999999999999999999999 79999999999999986 788999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|++..... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 176 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--------- 243 (340)
T PTZ00426 176 GFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--------- 243 (340)
T ss_pred CCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC---------
Confidence 99976532 23456789999999999654 4899999999999999999999999988776655555431
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++.+.++|++||+.||.+|+ |++++++||||+++.+.
T Consensus 244 --------~~~------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 244 --------IIY------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred --------CCC------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 011 2234789999999999999999996 89999999999987654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=359.32 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=207.3
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||.|+||+||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 46999999999999999999999999999999986432 1234799999999999999999988 34456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence 8999999985 6666654 34579999999999999999999999 79999999999999996 7889999999986
Q ss_pred cCccCC---------------------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHH
Q 016950 190 QLIAGE---------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 230 (380)
Q Consensus 190 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvi 230 (380)
...... .....+||+.|+|||++.+ ..++.++|||||||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 228 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVI 228 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhH
Confidence 542211 0112468999999999855 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCC
Q 016950 231 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 310 (380)
Q Consensus 231 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 310 (380)
+|+|++|..||.+.+..+....+..... ...+|. ...+++++++||.+||. +|.
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~ 282 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAE 282 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHh
Confidence 9999999999998887766655543110 011111 11368999999999997 999
Q ss_pred CCCC---HHHHhcCCCcccccCC
Q 016950 311 LRCT---ALEACAHPFFDELREP 330 (380)
Q Consensus 311 ~R~t---~~e~l~hp~~~~~~~~ 330 (380)
+|++ +.++++||||+...+.
T Consensus 283 ~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 283 RRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred hcCCCCCHHHHhcCCCcCCCCHH
Confidence 9998 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=364.33 Aligned_cols=281 Identities=24% Similarity=0.379 Sum_probs=212.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~ 107 (380)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. ++++++++|.. .
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence 467999999999999999999999999999999986432 2234677777777554 47777777632 2
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC---------
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--------- 178 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--------- 178 (380)
...+|+|||++.++|.+.+.. ...+++..++.++.||+.||+|||+..||+||||||+|||++..+.
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 335889999998888877753 4578999999999999999999997139999999999999985321
Q ss_pred ------cEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016950 179 ------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (380)
Q Consensus 179 ------~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 252 (380)
.+||+|||.+... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4999999987643 2223456889999999999765 489999999999999999999999999998888888
Q ss_pred HHHHhCCCCHHHHhhcCCC-----CCCc--cCCCCCCCCcccc-----cC-CCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 253 IIKVLGTPTREEIRCMNPN-----YTDF--RFPQIKAHPWHKV-----FH-KRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~-----~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
+.+.+|.++.......... +... ..+......+... .. ...++.+.|||.+||++||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 8888887765433211100 0000 0000000000000 00 01256788999999999999999999999
Q ss_pred cCCCccccc
Q 016950 320 AHPFFDELR 328 (380)
Q Consensus 320 ~hp~~~~~~ 328 (380)
+||||....
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998753
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=358.12 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=203.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|++++.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5899999999999999999999999999999986432 12357999999999999999999883 34458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence 999999985 6666664 34568999999999999999999999 79999999999999996 78899999999753
Q ss_pred CccC------------------------------------------------CCcceeeccCCCCChhhhhCCCCCCchh
Q 016950 191 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI 222 (380)
Q Consensus 191 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~ 222 (380)
.... ......+||+.|+|||++.+ ..++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCcc
Confidence 2100 00123468999999999865 4589999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHH
Q 016950 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302 (380)
Q Consensus 223 DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 302 (380)
|||||||++|+|++|..||...+..+....+...... ..+|. ...+++++++||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999887766655544431110 01111 1237899999999
Q ss_pred hhcccCC--CCCCCHHHHhcCCCcccccCC
Q 016950 303 RLLQYSP--SLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 303 ~~L~~dp--~~R~t~~e~l~hp~~~~~~~~ 330 (380)
+||..++ ..|+++.++++||||+.+.+.
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9765544 459999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=351.99 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=210.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 36999999999999999999999999999999986432 2234689999999999999999888 34445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+++ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence 8999999985 6766664 34578999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------- 217 (333)
T cd05600 150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL--------- 217 (333)
T ss_pred cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------
Confidence 5533 23356789999999999665 58999999999999999999999999887776665554321100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..|.... ....+++++.+||.+||+.+|.+|+++.++++||||..+.+.
T Consensus 218 ------~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 218 ------QRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred ------cCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 0000000 002368999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=359.28 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=204.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|++++.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+. +...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5999999999999999999999999999999986432 23357999999999999999999984 34458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+|||||++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence 999999985 6666664 23568999999999999999999999 79999999999999996 78899999999753
Q ss_pred CccC------------------------------------------------CCcceeeccCCCCChhhhhCCCCCCchh
Q 016950 191 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI 222 (380)
Q Consensus 191 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~ 222 (380)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001134689999999999654 589999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHH
Q 016950 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302 (380)
Q Consensus 223 DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 302 (380)
||||+||++|+|++|+.||.+.+..+....+...... ..+|. ...+++++.++|.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPP----------QAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCC----------cccCCHHHHHHHH
Confidence 9999999999999999999988776655554431110 01110 1247899999999
Q ss_pred hhcccCCCCCCC---HHHHhcCCCcccccCC
Q 016950 303 RLLQYSPSLRCT---ALEACAHPFFDELREP 330 (380)
Q Consensus 303 ~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 330 (380)
+|+ .+|.+|++ ++++++||||+.+.+.
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 986 59999997 9999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=358.70 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=204.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++++.||.|+||+||+|.+..+++.||||++.+.. ....+|+.+++.++||||+++++.+ .+..+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 36999999999999999999999999999999986432 2234689999999999999999988 34456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence 8999999975 6766665 34678999999999999999999999 79999999999999996 7889999999986
Q ss_pred cCccCC------------------------------------------------CcceeeccCCCCChhhhhCCCCCCch
Q 016950 190 QLIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTS 221 (380)
Q Consensus 190 ~~~~~~------------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~ 221 (380)
...... .....+||+.|+|||++.+ ..++.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 228 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQE 228 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCc
Confidence 321100 0012468999999999865 458999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHH
Q 016950 222 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 301 (380)
Q Consensus 222 ~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 301 (380)
+|||||||++|+|++|..||.+.+..+.+..+..... ...+|. ...++.++++||
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli 283 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLI 283 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHH
Confidence 9999999999999999999998877666655543110 011111 113689999999
Q ss_pred HhhcccCCCCC---CCHHHHhcCCCcccccCC
Q 016950 302 SRLLQYSPSLR---CTALEACAHPFFDELREP 330 (380)
Q Consensus 302 ~~~L~~dp~~R---~t~~e~l~hp~~~~~~~~ 330 (380)
.+||+ +|.+| +|+.+++.||||+.+.+.
T Consensus 284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 99998 67765 599999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=379.47 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=223.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|.++++||+|+||.|.+++++.+++.||+|++.+- ...+..|-.+|-.-+.+-|+.++-.| +++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 347899999999999999999999999999999998652 33456788898888899999998888 777
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.++|+||||++| +|+.++..+ .++++.++++|+.+|+.||.-||++ |+|||||||+|||+|. .|.|||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccchh
Confidence 789999999985 788887643 3799999999999999999999995 9999999999999997 88899999999
Q ss_pred cccCccCCC--cceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 188 AKQLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 188 a~~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+-.+..++. ....+|||.|.|||++.. ...|+..+|+||+||++|||+.|..||....-.+++.+|+..-
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 987765443 335789999999999943 2458999999999999999999999999999999999998731
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC---HHHHhcCCCcccccCCCCC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNAR 333 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~~~~ 333 (380)
..+.||.. ..+|+++++||+++++ +|+.|.+ ++++..||||.++.|.+.+
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIR 350 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhh
Confidence 12344421 2389999999999997 7899998 9999999999999996544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=346.78 Aligned_cols=319 Identities=35% Similarity=0.636 Sum_probs=245.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..+|.+.+.||.|+||+||+|.+..+++.||||.+... .....+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999999999999987542 122346999999999999999999875544333345
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+|+||+.++|...+. ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence 88999999988877765 34679999999999999999999999 79999999999999996 77899999999986
Q ss_pred CccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5433 222345678899999998654558999999999999999999999999988888888888888887766553221
Q ss_pred CC-CCCc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
.. ...+ ..+......+.. ....+++++.+||++||+.||++|||+.++++||||..++....... .+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~----~~~~~~~ 312 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV----CQTPFSF 312 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc----CCCccch
Confidence 11 0000 011111111111 22358999999999999999999999999999999998866654321 1233455
Q ss_pred hhhhccCCHHHHhhhChHHH
Q 016950 347 KQELSGASPELVNKLIPDHV 366 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~ 366 (380)
+-+..+.+.+.+++++-.+.
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 313 DFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred hhhhhhcCHHHHHHHHHHHH
Confidence 55555577778887776653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=354.73 Aligned_cols=256 Identities=31% Similarity=0.517 Sum_probs=210.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||+||+|++..+++.||||++.+.. ....+|+.++..++|+||+++++++ .+..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 46999999999999999999999999999999986432 2235789999999999999999888 44456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence 8999999975 67666653 3678999999999999999999999 89999999999999996 7889999999997
Q ss_pred cCccCC------------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Q 016950 190 QLIAGE------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 190 ~~~~~~------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence 654333 12345789999999999655 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-HHHH
Q 016950 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEA 318 (380)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~ 318 (380)
||.+.+..+....+..... ...+|. ...+++++.+||.+||. ||.+|++ +.++
T Consensus 229 Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 229 PFYSDTLQETYNKIINWKE---------------SLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred CCCCCCHHHHHHHHhccCC---------------cccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 9998886666655543111 011111 11268999999999998 9999999 9999
Q ss_pred hcCCCcccccCCC
Q 016950 319 CAHPFFDELREPN 331 (380)
Q Consensus 319 l~hp~~~~~~~~~ 331 (380)
++||||+.+.+..
T Consensus 283 l~hp~~~~~~~~~ 295 (350)
T cd05573 283 KSHPFFKGIDWEN 295 (350)
T ss_pred hcCCCcCCCCHHH
Confidence 9999999876654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=337.78 Aligned_cols=276 Identities=34% Similarity=0.667 Sum_probs=217.7
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 5899999999999999999999999999999885321 234579999999999999999998843 34588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||+.+++...+.... ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence 999999988877765322 23578999999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC-
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP- 270 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 270 (380)
... ......+++.|+|||++.+...++.++|+||+||++|+|++|++||.+....+....+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 222 122345688899999987666678999999999999999999999999888888877777777665544432110
Q ss_pred -CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 -NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
++.. .++....... ......+++++++||++||+.||++|||+.++++||||
T Consensus 233 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKN-TFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHh-hccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 1111111111 11123479999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=358.02 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
+|++++.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++|+||+++++.+ .+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 699999999999999999999999999999998542 12345799999999999999999888 344468
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCcc
Confidence 999999985 6767665 34568999999999999999999999 79999999999999996 78899999999742
Q ss_pred CccC--------------------------------------------CCcceeeccCCCCChhhhhCCCCCCchhhHHH
Q 016950 191 LIAG--------------------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWS 226 (380)
Q Consensus 191 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~Diws 226 (380)
.... ......+||+.|+|||++.+ ..++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeee
Confidence 2100 00113468999999999965 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcc
Q 016950 227 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306 (380)
Q Consensus 227 lGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 306 (380)
|||++|+|++|+.||.+.+..+....+..... ...++ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCC----------CCCCCCHHHHHHHHHHh-
Confidence 99999999999999998877665544432100 00111 01247899999999987
Q ss_pred cCCCCCC---CHHHHhcCCCcccccCC
Q 016950 307 YSPSLRC---TALEACAHPFFDELREP 330 (380)
Q Consensus 307 ~dp~~R~---t~~e~l~hp~~~~~~~~ 330 (380)
.+|.+|+ |+.++++||||+.+.+.
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCHH
Confidence 5999999 99999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=347.59 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=202.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999999999999986432 12236889999999999999998883 3345899999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~- 194 (380)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence 9986 5554443 34578999999999999999999999 79999999999999996 778999999998753222
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345789999999998654 5899999999999999999999999887766555544321 1
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||.+||+.||.+|+ ++.++++||||.+..+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 212 IR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CC------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 11 2335799999999999999999998 89999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=343.74 Aligned_cols=286 Identities=36% Similarity=0.688 Sum_probs=226.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++...........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999885321 123469999999999999999988755444444568
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+|+||+.+++...+. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceeec
Confidence 8999999998776664 3568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 192 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 192 ~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
..... .....+|+.|+|||++.+...++.++|+||+||++|+|++|+.||.+.+.......+...++.+..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33221 12346788999999986655689999999999999999999999999888888888888888877766543
Q ss_pred cCCCCC-Cc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 268 MNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
...... .+ ..+.....++... ....++++.+||.+||+.||++|||+.++++||||+.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 321110 00 0111111122211 12368899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=345.76 Aligned_cols=243 Identities=30% Similarity=0.519 Sum_probs=200.0
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 699999999999999999999999986431 1224689999999999999998888 3344589999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-CC
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 196 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~ 196 (380)
++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence 85 6666664 34578999999999999999999999 79999999999999996 778999999998754322 22
Q ss_pred cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCcc
Q 016950 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 276 (380)
.....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... ..
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~~- 210 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------PL- 210 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------CC-
Confidence 3345789999999999654 5899999999999999999999999987766655544331 11
Q ss_pred CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC---CHHHHhcCCCcccccC
Q 016950 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELRE 329 (380)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~~~ 329 (380)
.++..+++++.+||.+||+.||.+|+ ++.++++||||....+
T Consensus 211 -----------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 211 -----------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred -----------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 12334789999999999999999997 5899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=348.14 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=201.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||++++..+ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 1234688999999999999998888 34445899999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~- 194 (380)
|+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.....
T Consensus 76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence 9986 5555443 34678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.. ..
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-----------------~~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-----------------ED 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-----------------CC
Confidence 222345789999999998654 589999999999999999999999988776555443322 11
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||.+||+.||++|+ ++.++++||||....+.
T Consensus 212 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 212 IK------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cc------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 2335799999999999999999997 89999999999886553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.09 Aligned_cols=286 Identities=34% Similarity=0.592 Sum_probs=224.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46999999999999999999999999999999875432 22357999999995 699999998886554444456
Q ss_pred EEEEeecccchHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +|++||||+|+||+++.+++.+||+|||++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8899999999888877643322 4568999999999999999999999 7999999999999999657789999999987
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ......+++.|+|||++.+...++.++|+||+||++|+|++|..||.+.+..+.+..+....+.++...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543321 1223456888999999876666899999999999999999999999999888888888887777766544322
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
........++......... ....+++++.+||.+||..||.+||++.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1111111122222111111 1234789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=345.63 Aligned_cols=246 Identities=29% Similarity=0.495 Sum_probs=201.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|+++.+++.||+|++.+.. .....|..++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 1223577777765 799999999988 3344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..++.++.|++.||+|||+ +|++||||||+|||++. ++.+||+|||++......
T Consensus 76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence 99986 5655554 34678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----------------- 211 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 211 (320)
T ss_pred CCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 22334578999999999864 45899999999999999999999999988877666555431
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH------HHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~~~ 330 (380)
... ++..+++++.+||++||+.||.+|+++ +++++||||..+.+.
T Consensus 212 ~~~------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 212 EVV------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred CCC------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 011 123478999999999999999999998 899999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=345.12 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=204.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCC-ceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 110 (380)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. .....|..++..++|+ +|+.+++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 5899999999999999999999999999999986432 1234678888888765 5778877773 3345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|...+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence 8899999985 6665554 34568999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------ 216 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------ 216 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 4322 2223346789999999999654 4899999999999999999999999988877666555431
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-----HHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~ 330 (380)
.. .++..+++++.++|.+||..||.+|+++ .++++||||+.+.+.
T Consensus 217 -----~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 217 -----NV------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred -----CC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01 1223478999999999999999999976 899999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=352.12 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=210.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~ 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QD 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 44678999999999999999999999999999999986421 2234789999999999999999888 44
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++|+||||+++ +|...+.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~DfG 187 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEecc
Confidence 4568999999985 66666542 458899999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC--cceeeccCCCCChhhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
++........ .....||+.|+|||++.+.. .++.++|+|||||++|+|++|..||.+.+....+..+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05596 188 TCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred ceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC---
Confidence 9976543321 23457899999999986532 378899999999999999999999998887666665543110
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP 330 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~ 330 (380)
.+.+|. ...+|.++++||.+||+.+|.+ |+|++++++||||++..+.
T Consensus 265 ------------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 265 ------------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred ------------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 011111 1136899999999999999988 9999999999999885543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=345.48 Aligned_cols=249 Identities=29% Similarity=0.500 Sum_probs=202.3
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH---HhCCCCceeeeceeeeecCCCCce
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+|+.++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 788999999999999999999999999999986432 1123454444 5668999999999883 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+||||+++ +|...+. ...+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~ 148 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC 148 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence 58999999996 4444432 3578999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
...... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+...
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~----------- 216 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND----------- 216 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 754322 22334678999999999865 45899999999999999999999999988877666555441
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++.+.+||.+||+.||.+|| ++.++++||||+++.+.
T Consensus 217 ------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 217 ------EVR------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 011 2234789999999999999999999 69999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.92 Aligned_cols=284 Identities=35% Similarity=0.577 Sum_probs=226.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 80 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---L 80 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---C
Confidence 35678999999999999999999999999999999885322 12347999999999999999999875322 2
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+++||||+.++|.+.+... ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~ 155 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLA 155 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcccee
Confidence 347899999998887777642 3568999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
....... ......+++.|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 8654332 222334578899999987666689999999999999999999999999999999999998888877655433
Q ss_pred cC--CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.. +....+..+......+...+ ...++.+.+||.+||++||++|||+.+++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 21 11111222221111122211 2268899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=349.90 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=210.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|.+.+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 36999999999999999999999999999999986532 2345788999999999999998887 33445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence 8999999975 67776653 23578999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCc--ceeeccCCCCChhhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 190 QLIAGEAN--ISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 190 ~~~~~~~~--~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
........ ....+|+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---- 226 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---- 226 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC----
Confidence 65433322 23468999999999853 34578899999999999999999999998877766665543210
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...+|. ...+++++.+||.+||+ +|.+|+|++++++||||..+.+..
T Consensus 227 -----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 227 -----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred -----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 011111 12378999999999998 999999999999999999876553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=352.05 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=208.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ .+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence 3457899999999999999999999999999999998642 12234799999999999999999988 34
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++|+||||+++ +|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG 187 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFG 187 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecc
Confidence 4568999999985 67766642 358899999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC--cceeeccCCCCChhhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+|........ .....||+.|+|||++.+.. .++.++|+||+||++|+|++|..||.+.+.......+......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (370)
T cd05621 188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS-- 265 (370)
T ss_pred cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc--
Confidence 9986543222 23457899999999996532 3788999999999999999999999988877666665542111
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 329 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~ 329 (380)
+.+|. ...++..++++|.+||+.++.+ |+|+.++++||||+...+
T Consensus 266 -------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 -------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 11111 1136899999999999866654 889999999999987544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=348.35 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=222.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|..++.+|+|+||.+++++++..++.|++|++.-. ++....|+.++.++.|||||.+.+.|. .+..+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 56899999999999999999999999999999998533 234468999999999999999999994 33445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+||||+||+| ++.+.++... +..++++.+..++.|++.|+.|||+ ++|.|||||+.|||++. +..|||+|||+|+
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAK 154 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhh
Confidence 9999999996 6777776532 5789999999999999999999999 89999999999999997 6668999999999
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ...+.+||+.|++||++.+ ..|+.++|||||||++|||++-+++|.+.+......+|.+....|.
T Consensus 155 ~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 155 ILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred hcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 987776 6678899999999999965 4599999999999999999999999999999999988887653333
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+...+.+++.+|..||..+|..||++.++|.+|.+...
T Consensus 227 ---------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 ---------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred ---------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 23468999999999999999999999999999998754
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=343.65 Aligned_cols=286 Identities=33% Similarity=0.581 Sum_probs=225.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++|+||++++++|..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3567999999999999999999999999999999885421 123469999999999999999998753322 223
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
...|+||||+.+++...+.. .+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 45789999999988777642 28889999999999999999999 79999999999999997 778999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.............+++.|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+.......+...++.|..+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 865444333445678899999999654 5899999999999999999999999999988889999998998877654433
Q ss_pred CCCCCCcc--CCCCCCCCccccc------------CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NPNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
......+. .+.....++...+ ....++.+++||.+||+.||++|||+.|+|.||||+.+-.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 22111110 0000011111111 22356789999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.89 Aligned_cols=278 Identities=32% Similarity=0.570 Sum_probs=207.9
Q ss_pred eeeeecCCceEEEEEEECC--CCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
...||+|+||+||+|.++. ++..||+|.+.... ....+|+.+++.++||||+++++++... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3579999999999999764 56889999886543 2345899999999999999999988543 233578999999
Q ss_pred cchHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc---CCCCcEEEEeeccccc
Q 016950 119 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ 190 (380)
Q Consensus 119 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~ikl~Dfg~a~~ 190 (380)
++++...+..... ....+++..++.++.||+.||.|||+ +|++||||||+|||+. ..++.+||+|||+++.
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 9988877753221 12358899999999999999999999 7999999999999994 2356899999999986
Q ss_pred CccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 016950 191 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL 257 (380)
Q Consensus 191 ~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 257 (380)
...... .....+|+.|+|||++.+...++.++||||+||++|+|++|.+||..... ...+..+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543321 22456799999999997766689999999999999999999999975432 34566677777
Q ss_pred CCCCHHHHhhcCC--CCCCc----cCCCCCCCC---cccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 258 GTPTREEIRCMNP--NYTDF----RFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 258 ~~~~~~~~~~~~~--~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+....+..... .+... ......... .........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7766655443211 11000 000000000 0111112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=344.09 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=201.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|++..+++.||+|++.+.. .....|..++..+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 46999999999999999999999999986532 1123577777765 7999999999883 344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence 99986 5655554 34678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22334568999999999854 45899999999999999999999999998877776655431
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-------CHHHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++++.+||.+||+.||++|+ ++.++++||||..+.+.
T Consensus 212 ~~~------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 212 DVL------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 111 1223789999999999999999999 89999999999887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=348.42 Aligned_cols=278 Identities=26% Similarity=0.413 Sum_probs=207.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|+||+++++++.. ....++|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEE
Confidence 45799999999999999999999999999999976433 33579999999999999999998843 334789999
Q ss_pred cccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC
Q 016950 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (380)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~ 196 (380)
++.++|...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||++........
T Consensus 138 ~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 138 HYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred ccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccCcc
Confidence 999988877753 34678999999999999999999999 79999999999999996 77899999999975443333
Q ss_pred cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCHHHHh
Q 016950 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENA---------VDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~ 266 (380)
.....||+.|+|||++.+. .++.++|||||||++|+|+++. ++|..... ...+..++..++..+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 4456789999999998654 5899999999999999999854 44443221 23344444444433221110
Q ss_pred hcCCCC-CC-ccCCCCCCCC---cccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNY-TD-FRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~-~~-~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...... .. +.+......+ +...-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 00 0000000000 0111112468889999999999999999999999999999863
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=350.71 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=207.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.++..++|+||+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 46999999999999999999999999999999986421 2234688999999999999999888 44456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence 8999999985 6666664 34678999999999999999999999 79999999999999996 7889999999986
Q ss_pred cCccCC------------------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHH
Q 016950 190 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE 233 (380)
Q Consensus 190 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ 233 (380)
...... .....+||+.|+|||++.+. .++.++|+|||||++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye 228 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE 228 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence 432110 01134689999999999654 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC
Q 016950 234 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313 (380)
Q Consensus 234 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 313 (380)
|++|..||.+.+..+....+..... ...+|. ...+++++++||.+|+. ||.+|+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~ 282 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRI 282 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcC
Confidence 9999999998887776665543110 011111 01268999999999874 999998
Q ss_pred ---CHHHHhcCCCcccccCCC
Q 016950 314 ---TALEACAHPFFDELREPN 331 (380)
Q Consensus 314 ---t~~e~l~hp~~~~~~~~~ 331 (380)
+++++++||||+++.|..
T Consensus 283 ~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 283 GSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred CCCCHHHHhcCCCCCCCCHHH
Confidence 489999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=345.70 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=201.8
Q ss_pred ceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.. ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999874 478999999986421 1234688999999 589999998887 4
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....+|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence 44458899999985 6666664 34578999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 186 GSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 186 g~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+...+..
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 9997653332 2234578999999999976555789999999999999999999999754322111111111000
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
....++..+++.+.+||.+||+.||++|+ +++++++||||+...+.
T Consensus 226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 00112334789999999999999999999 88999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=335.15 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=200.6
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||+|+||+||+|.+..+++.||+|++.+.. .....|+.+++.++|+||+++.+++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999986432 1224689999999999999998887 3344588999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC-
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 196 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~- 196 (380)
++ +|...+.........+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence 85 5655554433445679999999999999999999999 79999999999999986 77899999999876543322
Q ss_pred cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCcc
Q 016950 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 276 (380)
.....+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||...+.......+....... .
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~-- 217 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------S-- 217 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-------------C--
Confidence 2345789999999999654 58999999999999999999999998654332222222110000 0
Q ss_pred CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCC
Q 016950 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331 (380)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 331 (380)
..++..+++++.+++.+||+.||++|+ +++++++||||+.+.+..
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 012334789999999999999999999 889999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.51 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=205.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC-CCCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 110 (380)
+|++.+.||+|+||.||+|++..+++.||+|++.+... ....|..++..+ .|++|+++++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 58999999999999999999999999999999865321 123466666666 578899988887 33445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|...+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence 8999999985 6665554 34568999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------ 216 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------------ 216 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 54322 223345789999999999654 5899999999999999999999999988877766665541
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 331 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++.+|+.+||+.||.+|++ ..++++||||+.+.|..
T Consensus 217 -----~~~------------~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 217 -----NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred -----CCC------------CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 111 22347899999999999999999998 48999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=340.80 Aligned_cols=246 Identities=29% Similarity=0.489 Sum_probs=200.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+++.||+|++.+.. ....+|..+++.+ +||||+++++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999987532 1224677888877 7999999999883 344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..+..++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence 99985 5555554 34579999999999999999999999 79999999999999996 778999999998753222
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345689999999999654 5899999999999999999999999887766555444321
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-----HHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~ 330 (380)
.. .++..++.++.+||.+||+.||.+|||+ .++++||||+.+.+.
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 212 EV------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred CC------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01 1223478999999999999999999999 999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=332.23 Aligned_cols=276 Identities=42% Similarity=0.751 Sum_probs=227.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|++|.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 5899999999999999999999999999999986443 233579999999999999999998843 44589
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|+||+.++|.+.+.. ....+++..++.++.||+.||+|||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence 9999997788877753 23668999999999999999999999 79999999999999996 7789999999988654
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 269 (380)
.... .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4331 2345678899999998766667899999999999999999999999988888888888888888776655432
Q ss_pred -CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 270 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
..+....++.....++...+ ...+..+.+||++||+.||++|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 22333344443333343333 34689999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=340.98 Aligned_cols=245 Identities=31% Similarity=0.503 Sum_probs=197.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+++.||+|++..... ....|..++.. .+||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999999864321 12245555554 4899999999888 3344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence 99985 6655554 34578999999999999999999999 79999999999999996 778999999999754332
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+.+..+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R-------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence 223345789999999999654 4899999999999999999999999988876665554321 0
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-HHHhcCCCcccccC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE 329 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp~~~~~~~ 329 (380)
..++..++.++.+||.+||+.||++|+++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01223478999999999999999999986 58999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=345.52 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=200.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986432 1224688899999999999998887 33445899999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG- 194 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~- 194 (380)
|+++ +|...+. ....+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence 9986 5544443 34578999999999999999999996249999999999999996 788999999998753322
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~ 212 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 212 (325)
T ss_pred cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345789999999998654 5899999999999999999999999887765554443221 1
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||.+||+.||++|+ ++.++++||||..+.+.
T Consensus 213 ~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 213 IR------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred CC------------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 11 2334789999999999999999997 89999999999986554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.92 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=207.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|++.+.||+|+||+||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++.+ .....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4899999999999999999999999999999885432 1234699999999999999998887 333458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 999999985 56555542 123568999999999999999999999 79999999999999996 67899999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------- 220 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence 5444333445789999999998654 58999999999999999999999998876544443333221100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
...++..++..+.+||.+||..||.+|| ++.++++||||....+.
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 0012234789999999999999999999 89999999999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=340.80 Aligned_cols=311 Identities=35% Similarity=0.656 Sum_probs=240.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+|++.+.||.|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.... .....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 67999999999999999999999999999999886432 12346899999999999999998774333 344568
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+.++|...+. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEecccccceee
Confidence 8999999987766664 34568999999999999999999999 79999999999999996 788999999998755
Q ss_pred ccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
..... .....++.+|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....|.|+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 33221 1234678899999998665568999999999999999999999999998888888888888988876654
Q ss_pred hcCCCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCC
Q 016950 267 CMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPL 343 (380)
Q Consensus 267 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~ 343 (380)
........ -.++.....+|... ....++++.++|.+||+.||.+|||+.+++.||||+....+.... .-.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~----~~~~~ 312 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEP----TCPPP 312 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccc----cCCCC
Confidence 33211100 01122222223222 234689999999999999999999999999999999876554422 12244
Q ss_pred CCchhhhccCCHHHHhh
Q 016950 344 FNFKQELSGASPELVNK 360 (380)
Q Consensus 344 ~~~~~~~~~~~~~~~~~ 360 (380)
.+++.+....+.+.+..
T Consensus 313 ~~~~~~~~~~~~~~~~~ 329 (334)
T cd07855 313 FDFDFEAIELSREQLKE 329 (334)
T ss_pred CCCChhhhhcChhhHHH
Confidence 55555555455554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=339.92 Aligned_cols=246 Identities=29% Similarity=0.498 Sum_probs=198.4
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|+++.+|+.||+|++.+.. .....|..++.. ++|+||+++++++ ....++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986432 122356666665 4899999999988 3445689999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+.+ +|...+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++.....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence 99986 6655554 34678999999999999999999999 79999999999999996 77899999999874322
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... .+
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~------------- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP------------- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence 2223346789999999999654 5899999999999999999999999888766555444321 00
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-HHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~e~l~hp~~~~~~~~ 330 (380)
.++..++.++++||.+||+.||++|+++ +++++||||+.+.+.
T Consensus 214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 1122378999999999999999999998 589999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=343.74 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=210.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...|+..+.||+|+||.||+|.+..+++.||||++.-+.. ..++|+.+|..++++||.++|+.|+.... +
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----L 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----H
Confidence 3468889999999999999999999999999999964432 33589999999999999999999966554 8
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++||||.| ++.++++ .+..+.+..+..++.+++.||.|||. .+.+|||||+.|||+.. .+.+||+|||.+..
T Consensus 87 wiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceeee
Confidence 999999996 5666665 45556888889999999999999999 79999999999999997 58999999999987
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...... ..+++|||.|||||++. ...|+.++||||||++++||++|.+|+....++..+..|-+
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------- 225 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------- 225 (467)
T ss_pred eechhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------------
Confidence 655433 36789999999999997 45699999999999999999999999988776444333222
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...+. +....|+.+++||..||.+||+.||+|.++|+|+|++..
T Consensus 226 ----------~~PP~----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 226 ----------SAPPR----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred ----------CCCCc----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 11111 122478999999999999999999999999999999874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=337.90 Aligned_cols=246 Identities=30% Similarity=0.504 Sum_probs=198.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHh-CCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+++.||+|++.... .....|..++.. ++||||+++++++. +...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986532 122356667765 48999999999884 334588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..+..++.|++.||.|||+ +|++||||||+|||++. ++.+||+|||++......
T Consensus 76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence 99985 6666654 34578899999999999999999999 79999999999999996 778999999998753222
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N-------------- 212 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 223346789999999998654 5899999999999999999999999988766555444321 0
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH-HHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~~ 330 (380)
.. ++..++.++++||.+||+.||.+|+++. ++++||||+.+.+.
T Consensus 213 -~~------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 213 -PC------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred -CC------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 00 1223688999999999999999999996 99999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=338.93 Aligned_cols=275 Identities=27% Similarity=0.453 Sum_probs=205.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence 468999999999999999999999999999999886432 234579999999999999999998843 3348
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++||||+++ +|.+.+. ....+++..+..++.|++.||.|||+.++|+||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccc
Confidence 899999986 6766665 34568999999999999999999998236999999999999996 77899999999876
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh---
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC--- 267 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~--- 267 (380)
.... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+... .++.+.......
T Consensus 154 ~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 227 (331)
T cd06649 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA----IFGRPVVDGEEGEPH 227 (331)
T ss_pred cccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhcccccccccCCcc
Confidence 5332 23345789999999999654 58999999999999999999999998776544322 222211100000
Q ss_pred -cCCCCCC-------c---cCCC---------CCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 -MNPNYTD-------F---RFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 -~~~~~~~-------~---~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.... . ..+. .............+++++++||.+||++||++|||+.++++||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000 0 0000 000000000112368899999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=338.03 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=218.0
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.|...+.|+.-++||+|+||.||-|..+.||+.||+|++.+.+. ....|..+|..++.+.||.+--.|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 45556779999999999999999999999999999998854332 223688999999999999997777
Q ss_pred CCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
+....+|+|+..|+|+ |--.|.+ ..+..+++..+++|+++|+.||++||+ .+|++|||||+|||+|. .|++.|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeec
Confidence 4444599999999974 3333322 234689999999999999999999999 89999999999999996 88899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
+|+|..+..+......+||..|||||++.+.. |+...|+|||||++|+|+.|+.||..........++-+..-..
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~---- 405 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED---- 405 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc----
Confidence 99999988888888889999999999996554 9999999999999999999999997665443332222211110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 332 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~~ 332 (380)
...++.++|+++++|++.+|++||++|+ +++++.+||||+.++|...
T Consensus 406 ---------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 406 ---------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred ---------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 1123456899999999999999999998 4689999999999998754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=339.82 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=207.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||+||++++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 47999999999999999999999999999999986421 2234788899999999999999988 34456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence 8999999975 67666653 34578999999999999999999999 79999999999999986 7889999999987
Q ss_pred cCccCCCc--ceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 190 QLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 190 ~~~~~~~~--~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
........ ....||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 225 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----- 225 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 55433221 23468999999999863 24478899999999999999999999988876666655543110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 331 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 331 (380)
.+.++. ....+++.+++||++||+.++.+ |+++.++++||||..+.+..
T Consensus 226 ----------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 226 ----------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred ----------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 011111 01237899999999999875554 78999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=341.59 Aligned_cols=247 Identities=26% Similarity=0.480 Sum_probs=196.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986432 1234688888888 799999999988 3344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+++ +|...+. ....+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||+++....
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence 99986 5655553 34679999999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 265 (380)
........||+.|+|||++.+ ..++.++|+||+||++|+|++|..||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 223345678999999999965 4589999999999999999999999963211 1111111110
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC------HHHHhcCCCcccccCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 330 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~ 330 (380)
.... ++..++..+.+||++||+.||.+|+| ++++++||||..+.+.
T Consensus 220 -------~~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 220 -------KQIR------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred -------CCCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 0011 23347899999999999999999997 7899999999887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=329.81 Aligned_cols=277 Identities=35% Similarity=0.665 Sum_probs=218.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|++|.||+|.++.+++.||+|.+.... ....+|+.+++.++|+||+++++++. ...+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeE
Confidence 467999999999999999999999999999999885432 22347999999999999999999883 34468
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+.++|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence 89999999988777653 23468899999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......++..|+|||++.+...++.++|+||+||++|+|++|..||.+.. ..+.+..+.+.++.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 2221 11223467889999998765668899999999999999999999998765 566677777777877766654432
Q ss_pred CC--CCCccCCCCCCCCcccccCCCCC--hHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 PN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.. +....++.....+....++ .++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hccccccccccccCChhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 21 2222222222222222221 244 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.47 Aligned_cols=246 Identities=29% Similarity=0.465 Sum_probs=198.3
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHH-HHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+|+.||+|++.+.... ...|. .+++.++||||+++++.+. ....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 4699999999999999999999999998643211 11233 3567889999999998883 344588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence 99986 5655554 35678999999999999999999999 79999999999999996 778999999998754322
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------- 211 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK----------------- 211 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345789999999998654 5899999999999999999999999988776665554431
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 330 (380)
.. .++..+++.+.++|.+||+.||.+|+++ .++++||||..+.+.
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 212 PL------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred CC------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 00 0123478999999999999999999987 699999999887654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=340.16 Aligned_cols=246 Identities=29% Similarity=0.492 Sum_probs=200.4
Q ss_pred eeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 43 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++.+. ....+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence 367999999999999864 478999999986421 12346999999999999999998883 33458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus 76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence 899999986 6655554 34568889999999999999999999 79999999999999996 78899999999875
Q ss_pred CccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~------------- 215 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG------------- 215 (323)
T ss_pred cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 4322 223345789999999998654 4789999999999999999999999988776655554431
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE 329 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~ 329 (380)
... ++..+++++.+||.+||+.||++|+ ++.++++||||....+
T Consensus 216 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 216 ----KLN------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----CCC------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 011 2234789999999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=327.60 Aligned_cols=276 Identities=33% Similarity=0.640 Sum_probs=214.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||+|++|.||+|.++.+++.||+|++.... ....+|+.+++.++|+|++++++++. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence 47999999999999999999999999999999885332 12357999999999999999999883 33458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++||||++++++..+. .....+++..++.++.||+.||+|||+ .|++||||||+||+++. ++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07847 76 HLVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence 8999999987655543 234568999999999999999999999 79999999999999996 778999999999866
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 269 (380)
.... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+.+..+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 4433 22334578889999998765668899999999999999999999999888877777776665544332211111
Q ss_pred -CCCCCccCCCCCC-CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 -PNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..+.....+.... .++.. ....++..+.+||.+||+.||++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0011111111111 11111 123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.48 Aligned_cols=275 Identities=35% Similarity=0.635 Sum_probs=219.2
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||+|+||.||+|.+..+++.||+|++.+... ...+|+.+++.+. |+|++++++++.+.. ...+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 7889999999999999999999999999998864321 1236888888885 999999999885431 134789
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
||||+++++++.+.. ....+++..++.++.|++.||+|||+ +|++||||+|+||+++. +.+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence 999999988877753 23568999999999999999999999 79999999999999996 8899999999986654
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC-C
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 272 (380)
........+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+.+..+....+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444444567889999998765556789999999999999999999999999988888888888887776543322211 1
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..+.++......... ....++.++.+||.+||+.||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 122233222211111 123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=332.04 Aligned_cols=281 Identities=35% Similarity=0.625 Sum_probs=226.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ...+|+.+++.++||||+++++++.... ..
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~ 79 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LD 79 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CC
Confidence 34689999999999999999999999999999998853321 2247999999999999999999875432 24
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..|+|+||+.++|.+.+.. ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~ 154 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLAR 154 (293)
T ss_pred cEEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCcee
Confidence 5889999999888777753 23468999999999999999999999 79999999999999996 7889999999988
Q ss_pred cCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+....+.+.++....+.+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 155 EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred eccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 66443 22233567888999999876655789999999999999999999999999888888888888888777665432
Q ss_pred C--CCCCCccCCCCCCCCcccccCCC-CChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 269 N--PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 269 ~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
. +......+.......+...++.. +++.+.++|++||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1 11111122222223334445544 68999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=344.94 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=207.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ....+|+.+++.++||||+++++.+ .+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence 44578999999999999999999999999999999985421 2234789999999999999999888 34
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++|+||||+++ +|...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCC
Confidence 4568999999985 66666542 358899999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC--cceeeccCCCCChhhhhCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~---~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
++........ .....||+.|+|||++.+.. .++.++||||+||++|+|++|..||.+.+.......+......
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-- 265 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-- 265 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--
Confidence 9986543322 23457899999999986432 3788999999999999999999999988876666655542110
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE 329 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~ 329 (380)
..+|. ...+++.+++||.+||..++.+ |++++++++||||++..+
T Consensus 266 -------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 266 -------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred -------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 11111 1247999999999999854443 789999999999988543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=311.03 Aligned_cols=284 Identities=31% Similarity=0.593 Sum_probs=236.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.++|++.+++|+|-|+.||.+.+..+++.++||+++.- .....+|+.||+.|. ||||+++.++..+..+.. ..+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chhH
Confidence 56899999999999999999999999999999988542 344579999999996 999999999986655443 6699
Q ss_pred eecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
+||++..-...+ -+.++...++.++.|++.||.|||+ .||+|||+||.|+++|....+++|+|+|+|..+.++
T Consensus 114 FE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999986422222 2567888999999999999999999 699999999999999987788999999999998888
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHh-----hc
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-----CM 268 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-----~~ 268 (380)
..-...+.+++|-.||++..-+.|+.+-|+|||||++..|+..+.|| .|.+..+++.+|.+.+|+......- .+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 77777888999999999988888999999999999999999987665 6889999999999999976543321 12
Q ss_pred CCCCCCccCCCCCCCCcccccCCC----CChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
++.|.++ +......+|...+.+. +++++.||+.++|.+|..+|+||.|++.||||..+....
T Consensus 267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 3444432 2334455666665542 579999999999999999999999999999998876543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=330.43 Aligned_cols=280 Identities=36% Similarity=0.641 Sum_probs=221.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc---------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|.+.+.||.|++|.||+|.+..+++.||+|.+...... ...|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 488999999999999999999999999999998654322 2468999999999999999998843 44
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..++||||+.++|.+.+.. ....+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence 5889999997788777753 12368999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
....... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 6544322 223456788999999866666899999999999999999999999988888888888777777766554322
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
...-...........+... .....+..+.+||.+||++||++|||+.+++.||||++...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 1110111111111112222 22346889999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.36 Aligned_cols=281 Identities=36% Similarity=0.660 Sum_probs=221.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||.|++|+||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 57999999999999999999999999999999885432 23457999999999999999999884 33458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+++++.+.+... ....+++..++.++.||+.||+|||+ +|++|+||+|+||+++..++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 999999998877776532 23346788899999999999999999 899999999999999865678999999999754
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 269 (380)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3222 12234668899999998765668899999999999999999999999988888888888888877665543211
Q ss_pred -CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 270 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
+.+. ..++....... ......+++++.++|.+||+.+|++||++.++++||||.++.
T Consensus 234 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 234 LPDYK-SAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred chhhh-hhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0110 01111111111 112234789999999999999999999999999999999864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=342.59 Aligned_cols=245 Identities=30% Similarity=0.488 Sum_probs=197.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHH-HHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+|+.||+|++.+... ....|. .+++.++||||+++++.+ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 469999999999999999999999999864321 112333 356778999999999888 3344588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence 99986 5554443 45678999999999999999999999 79999999999999996 77899999999875332
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----------------- 211 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----------------- 211 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223346789999999998654 4899999999999999999999999988776666555431
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCCcccccC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE 329 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~ 329 (380)
.. .+....+..+.++|++||+.||.+||++ .++++||||....+
T Consensus 212 ~~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 212 PL------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred Cc------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00 0122368899999999999999999976 59999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=334.91 Aligned_cols=245 Identities=31% Similarity=0.467 Sum_probs=199.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcE-EEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
....+.+.||.|+||+||++.. .|+. +|+|++.... ....+|+.+|.+++|||||++++++..... .
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----S 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----c
Confidence 4456667799999999999987 4555 9999986432 245689999999999999999998843321 4
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-eeecCCCCCCEEEcCCCC-cEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTH-QVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-iiH~Dlkp~Nill~~~~~-~ikl~Dfg~ 187 (380)
+++||||+++ +|.+++... ....++...+..++.||+.||+|||+ ++ ||||||||+|||++. .. ++||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEECCCcc
Confidence 8899999995 666666532 46789999999999999999999999 79 999999999999997 54 899999999
Q ss_pred cccCccC-CCcceeeccCCCCChhhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 188 AKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 188 a~~~~~~-~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
++..... ...+...||+.|||||++.+ ...|+.++||||||+++|||+||..||.+.........+.....+|+
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~---- 266 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP---- 266 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 9876544 33344789999999999974 35699999999999999999999999999988555555544322222
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
++..+++.+..|+.+||..||.+||+..+++
T Consensus 267 -----------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 267 -----------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred -----------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 2334789999999999999999999998876
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=351.01 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=212.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---CC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 107 (380)
..+|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.++..++|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 468999999999999999999999999999999985432 223468889999999999998877643321 22
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+++||||+. |+|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEecc
Confidence 235789999998 47888887655556779999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccC---CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 187 SAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 187 ~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~----- 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY----- 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-----
Confidence 98765332 222346789999999999654 489999999999999999999999998876665554433100
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..++..+++++.+|+.+||+.||.+||++.++++|||++..
T Consensus 263 -----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 263 -----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 01233478999999999999999999999999999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=337.84 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=207.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+++++.+++.||+|++.+.. ....+|+.++..++|++|+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 47999999999999999999999999999999985421 1234688899999999999999888 33445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence 8999999984 77777653 24578999999999999999999999 79999999999999996 7889999999987
Q ss_pred cCccCCC--cceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 190 QLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 190 ~~~~~~~--~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
....... .....||+.|+|||++.+ ...++.++|+|||||++|+|++|+.||.+.+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----- 225 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----- 225 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence 5433222 123568999999999852 34578999999999999999999999998887776665543110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 331 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 331 (380)
.+.+|. ....+++++++||++||+.++.+ |+++.++++||||.++.+..
T Consensus 226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 111111 11247999999999999776655 68999999999999876544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=345.62 Aligned_cols=277 Identities=23% Similarity=0.348 Sum_probs=211.8
Q ss_pred cceeeeeeeecCCceEEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
.+|.+++.||.|+||.||+|... .+++.||+|.+... ....+|+.+++.++|+||+++++.+ ......|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEEe
Confidence 47999999999999999999764 35678999988654 3456899999999999999999888 3344588999
Q ss_pred ecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
|++.+++...+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .+.++|+|||++.......
T Consensus 166 e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccCccc
Confidence 999998877773 35678999999999999999999999 79999999999999996 7789999999987554332
Q ss_pred C---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 196 A---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 196 ~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
. .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.. ....+..+++.++..+.+......
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2 2245789999999998654 58999999999999999999999997654 345666677666654432111000
Q ss_pred C----CCCCccCCCCCCCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 P----NYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. .+..+.............+ ...++.++.+||.+||++||.+|||+.++|+||||.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 0000111000000111111 12357889999999999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=318.27 Aligned_cols=285 Identities=30% Similarity=0.529 Sum_probs=233.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeec---CCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFST---TSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~ 107 (380)
...|+-..+||+|.||.||+|+++.+|+.||+|++.-+ .....+|+++|..++|+|++.+++++-.. ....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 45689999999999999999999999999999876321 12235899999999999999998876432 2334
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...+|+||.+|+.+|..++.+ ...+++...++.++.+++.||.|+|+ +.|+|||+||.|+||+. ++.+||+|||+
T Consensus 96 r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeecccc
Confidence 556899999999988877763 44689999999999999999999999 79999999999999996 78999999999
Q ss_pred cccCccCC-----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
++...... ..+..+.|.||++||.+.|...|+++.|||+.|||+.+|.+|.+.|.++++..++..|....|..+.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97654322 2234567999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcC--CCCCCccCC---CCCCCCcccccCC-CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 263 EEIRCMN--PNYTDFRFP---QIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 263 ~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
+.|+++. +-|..+..+ +...+...+.... .-++++.||+.+||..||.+|++++++++|.||..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 8887654 223333222 2222222222111 12578999999999999999999999999999975
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.62 Aligned_cols=275 Identities=36% Similarity=0.690 Sum_probs=218.7
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++++.||.|++|.||+|.+..+++.||||++..+. ....+|+.+++.++|+||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4899999999999999999999999999999885432 23457999999999999999999873 344588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||+.+++...+.. .....+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence 9999999887776653 234568999999999999999999999 79999999999999996 7789999999987543
Q ss_pred cCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 016950 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 269 (380)
Q Consensus 193 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 269 (380)
.... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+.++.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3221 2234567889999988665557889999999999999999999999998888888888888877654332211
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+. ..++.......... ...++++++++|.+||+.||++|||+.++++||||
T Consensus 232 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYK-PSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHH-hhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 01222222222222 23478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.85 Aligned_cols=251 Identities=29% Similarity=0.458 Sum_probs=203.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 110 (380)
+|+..+.||+|+||.||+|.++.+++.||+|++.++. .....|..+++.+. |++|+++++++ .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 4788999999999999999999999999999986432 12235777887776 46777888777 33345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||+++ +|...+. ....+++..+..++.||+.||+|||+ +|++||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence 8999999985 6655554 34679999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------ 216 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------ 216 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 543222 2334568999999999865 45899999999999999999999999988876666655541
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++++.+++.+||+.||.+|++ ..++++||||+.+.+.
T Consensus 217 -----~~~------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 217 -----NVS------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred -----CCC------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 111 22347899999999999999999997 5799999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=331.82 Aligned_cols=282 Identities=38% Similarity=0.641 Sum_probs=215.8
Q ss_pred ceeeeeeeecCCceEEEEEEECC--CCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48999999999999999999988 89999999986532 2335799999999999999999988543 224
Q ss_pred EEEEEeecccchHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC---CCCcEEEEee
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDF 185 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~---~~~~ikl~Df 185 (380)
.+++||||+++++...+....... ..+++..++.++.|++.||.|||+ ++++||||||+||+++. ..+.+||+||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 588999999988887776444333 378999999999999999999999 79999999999999985 1567999999
Q ss_pred cccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 016950 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE 252 (380)
Q Consensus 186 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---------~~~~~ 252 (380)
|++........ .....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.+.. ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886533222 223467889999999877666899999999999999999999999866532 35566
Q ss_pred HHHHhCCCCHHHHhhcC--CCCCC----ccCCCCCCCCcccccCC--CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 253 IIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+...++.+....+.... +.+.. ..............+.. ..+..+.++|.+||+.||++|||+.++++||||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66667766655443211 11111 00000110111111111 568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=339.59 Aligned_cols=247 Identities=28% Similarity=0.462 Sum_probs=202.0
Q ss_pred eeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 43 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
++.||+|+||.||++++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++. ....+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEE
Confidence 367999999999999874 578999999986432 22346899999999999999998883 3445889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus 76 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 76 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESI 149 (318)
T ss_pred EEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccC
Confidence 9999985 6666554 34578999999999999999999999 79999999999999996 7789999999987654
Q ss_pred cC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+...
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--------------- 213 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--------------- 213 (318)
T ss_pred CCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC---------------
Confidence 33 22334678999999999865 44789999999999999999999999988776666555431
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++.+.+||++||+.||++||+ +.+++.||||..+.+.
T Consensus 214 --~~~------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 214 --KLG------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred --CCC------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 111 22347899999999999999999999 7889999999887543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.01 Aligned_cols=275 Identities=24% Similarity=0.347 Sum_probs=206.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
...|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+.+++.++|+||+++++++.. ....++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence 4579999999999999999999999999999996532 234689999999999999999998743 234789999
Q ss_pred cccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC
Q 016950 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (380)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~ 196 (380)
++.++|...+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceecccccc
Confidence 999888877753 23468999999999999999999999 79999999999999996 77899999999976533221
Q ss_pred ---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHH--
Q 016950 197 ---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-------AVDQLVEIIKVLGTPTREE-- 264 (380)
Q Consensus 197 ---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~-- 264 (380)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..|+.... ....+.++++..+....+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2235689999999999654 48999999999999999999876543221 1234445544433221110
Q ss_pred ------HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 265 ------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 265 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.............+......|.... .++.++.+||.+||++||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000111122222233222 36789999999999999999999999999999974
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=325.95 Aligned_cols=252 Identities=35% Similarity=0.578 Sum_probs=205.1
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch------HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++++.||+|+||+||+|++..+++.||+|++....... .+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997553222 248899999999999999999854 444889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC-
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL- 191 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~- 191 (380)
||||+.+ +|.+.+. ....+++..+..++.||+.||++||+ +|++|+||||+||+++. ++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence 9999997 7877776 34678999999999999999999999 79999999999999995 788999999999753
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
..........++..|+|||++.....++.++|+||+|+++|+|++|..||......+....+.+............
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 225 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ---- 225 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----
Confidence 2223333467788999999986345689999999999999999999999998754555444444322221111100
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
....++.+.++|.+||+.||++|||+.++++||||
T Consensus 226 ------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 ------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00124799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=337.46 Aligned_cols=247 Identities=26% Similarity=0.476 Sum_probs=194.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986532 1234677777666 89999999998843 34589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+++....
T Consensus 76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence 99996 5554443 34679999999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 265 (380)
........||+.|+|||++.+. .++.++|+|||||++|+|++|..||..... .+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------- 219 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence 2223346789999999999654 589999999999999999999999953211 1111111110
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC------HHHHhcCCCcccccCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP 330 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~ 330 (380)
... .++..++..+.+||.+||+.||.+|+| +.++++||||+.+.+.
T Consensus 220 -------~~~------------~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 220 -------KQI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred -------CCC------------CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 001 133457899999999999999999998 5799999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=361.23 Aligned_cols=266 Identities=27% Similarity=0.406 Sum_probs=213.9
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.+...++|++++.||.|+||+||+|.+..+++.||+|++.... .....|+.+++.++||||++++++|....
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-- 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-- 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC--
Confidence 3455678999999999999999999999999999999885321 22347999999999999999999886432
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-------eeecCCCCCCEEEcCC--
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-------VCHRDLKPQNLLVDPL-- 176 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-------iiH~Dlkp~Nill~~~-- 176 (380)
...+||||||+.+ +|...+.........+++..++.|+.||+.||.|||+ .+ |+||||||+||||+..
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs-~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN-LKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-cccccccCCceeccCcHHHeEeecCcc
Confidence 3358899999984 7888887655556789999999999999999999998 34 9999999999999631
Q ss_pred --------------CCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 016950 177 --------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 241 (380)
Q Consensus 177 --------------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf 241 (380)
...+||+|||++.............+|+.|+|||++.+. ..++.++|||||||++|+|++|..||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 234899999999866444444456789999999998643 34789999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+....+...+... +. ++ ....+.++.+||.+||+.+|.+||++.|+|.|
T Consensus 244 ~~~~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 8766555444333210 00 00 01258899999999999999999999999999
Q ss_pred CCcccccCC
Q 016950 322 PFFDELREP 330 (380)
Q Consensus 322 p~~~~~~~~ 330 (380)
|||..+..+
T Consensus 296 ~~ik~i~~p 304 (1021)
T PTZ00266 296 QIIKNVGPP 304 (1021)
T ss_pred HHHhhcCCC
Confidence 999876544
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.52 Aligned_cols=289 Identities=38% Similarity=0.694 Sum_probs=233.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|++|.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++.+++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5899999999999999999999999999999886432 2345799999999999999999988655433334588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
++|||+++++.+.+. ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence 999999987777665 34479999999999999999999999 79999999999999997 6889999999998765
Q ss_pred cCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 193 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 193 ~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2334567889999999976646899999999999999999999999999999999999998888887665422
Q ss_pred CCC-CCCc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCC
Q 016950 269 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334 (380)
Q Consensus 269 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~ 334 (380)
... ...+ ..+.....++...+ ..+++++.+||++||+++|.+|||+.+++.||||++++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~ 302 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCC
Confidence 111 1111 11222222333322 33789999999999999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=327.48 Aligned_cols=285 Identities=29% Similarity=0.512 Sum_probs=219.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 105 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 44678999999999999999999999999999999885322 122469999999999999999988754332
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
......++||||+.+++...+.. ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 163 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADF 163 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcC
Confidence 22345789999999887777653 33468999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++........ .....++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+....+..+....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99876533221 1234567889999998766667899999999999999999999999988887777777777766
Q ss_pred CHHHHhhcC--CCCCCccCCCCCCCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 261 TREEIRCMN--PNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 261 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+.++... ..+....++........... +...+..+.+||.+||+.||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 655433221 01111122221111111111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.26 Aligned_cols=317 Identities=35% Similarity=0.614 Sum_probs=243.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+|+.+++.++|+|++++.+++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999999999999999875421 123469999999999999999887743322 223
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
...|+|+||++++|.+.+. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++
T Consensus 93 ~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEcccccc
Confidence 3478999999888877765 2568999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+.+..+....+.+....+...
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 765332 234567889999999866556789999999999999999999999999888888888888887776554433
Q ss_pred CCCCC-Cc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCC
Q 016950 269 NPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 345 (380)
Q Consensus 269 ~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 345 (380)
..... .+ ..+......+...+ ...++.+.+||.+||+.||.+|||+.++++||||+....+.. .+.++.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~-----~~~~~~~~ 317 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED-----EPVAPPYD 317 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc-----cccccccC
Confidence 21110 00 01111111222222 236899999999999999999999999999999998654432 22344444
Q ss_pred chhhhccCCHHHHhhhChHHHH
Q 016950 346 FKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
..-+..+....+++.++..++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07851 318 QSFESRDLTVDEWKELVYKEIM 339 (343)
T ss_pred cchhhhhcCHHHHHHHhHHHHH
Confidence 4445556777777777766654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.41 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=199.4
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
......+|+.++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+||+++++++ ..
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 143 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DH 143 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----cc
Confidence 3444678999999999999999999999999999999985432 2245799999999999999999988 34
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...+|+||||+.++.+. ......+..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 144 ~~~~~lv~e~~~~~~L~-------~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~ 214 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGV 214 (353)
T ss_pred CCeEEEEEecCCCCccc-------ccccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccccc
Confidence 44588999999975321 12345677888999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+....... ......||..|+|||++... ...+.++|||||||++|+|++|+.||......+....+.......
T Consensus 215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 292 (353)
T PLN00034 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-- 292 (353)
T ss_pred ceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC--
Confidence 97654322 22345789999999987421 224568999999999999999999997433222111111110000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
....+..++.++++||.+||+.||++|||+.|+++||||....
T Consensus 293 -----------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -----------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -----------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011234789999999999999999999999999999998853
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.76 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=210.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-CcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+.... ....+|+.+++.++||||+++++.+.. ...+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEE
Confidence 34599999999999999999998877 7889999764332 233579999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+.........+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~ 218 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCcee
Confidence 999999984 7877776555556678999999999999999999999 79999999999999996 77899999999986
Q ss_pred CccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 191 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 191 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------- 289 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 54332 1334568999999999865 45899999999999999999999999888776666555431100
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.++..++.++.+||.+||+.||++||++.+++.|||++.+
T Consensus 290 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 290 --------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred --------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0123478999999999999999999999999999999753
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=324.30 Aligned_cols=276 Identities=35% Similarity=0.661 Sum_probs=222.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
+|++.+.||.|++|.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++.+... ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 5899999999999999999999999999999886432 2334799999999999999999988443 34789
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
||||+++++.+.+.... ....+++..+..++.|++.||+|||+ .|++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence 99999998887775432 23468999999999999999999999 79999999999999996 77899999999875433
Q ss_pred CC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
.. ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+....+....+.|....+.... ..
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 22 12234568889999998776667899999999999999999999999998888888888888888776654432 11
Q ss_pred CC--ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 273 TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.. ..++......... +...+++.++++|.+||+.||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11 1222222222222 223468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=340.80 Aligned_cols=245 Identities=27% Similarity=0.489 Sum_probs=196.6
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHhC---CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVM---DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
||+|+||+||+|++..+++.||+|++.+.... ...|..++..+ +||||++++..+ .....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 69999999999999999999999998643211 12355566554 699999999888 3344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99985 6655554 35678999999999999999999999 79999999999999996 778999999998754332
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22334678999999999976656899999999999999999999999887766555444321
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC----CHHHHhcCCCcccccC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELRE 329 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~e~l~hp~~~~~~~ 329 (380)
...++. ..+++++.+||.+||+.||.+|+ ++.++++||||....+
T Consensus 213 ~~~~~~-----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 213 KVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred CCCCCC-----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 111111 13689999999999999999998 7999999999987653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=334.61 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=196.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +|+||+.+++++. ....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999997532 1234678888777 6999999999883 334589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +|++||||||+|||++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence 99986 5655554 34579999999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.... ..+.+.+.+..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 217 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE----------- 217 (327)
T ss_pred CCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-----------
Confidence 223334678999999999965 458999999999999999999999996422 11222222210
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC------HHHHhcCCCcccccCCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREPN 331 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~~~ 331 (380)
... .++..++..+.++|.+||+.||.+|++ .+++++||||+.+.+..
T Consensus 218 -----~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 218 -----KPI------------RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred -----CCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 001 123347899999999999999999998 57999999999887553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=330.70 Aligned_cols=287 Identities=37% Similarity=0.644 Sum_probs=225.7
Q ss_pred ceeeeeeeecCCceEEEEEEECCC--CcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|++.+.||+|+||.||++.+..+ ++.||+|++.... ....+|+.+++.+ +|+||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 489999999999999999999888 8999999886421 1234689999988 5999999988654322 2233
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|++++|++++|...+. ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence 478999999988877765 35678999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
....... .....+|+.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+....+..++..+|.++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5533211 12346789999999986655689999999999999999999999999998899999999999888766
Q ss_pred HhhcCCCCC-Cc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCC
Q 016950 265 IRCMNPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333 (380)
Q Consensus 265 ~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 333 (380)
+..+..... .+ .........+... ...++..+.+|+.+||+.||.+|||+.+++.||||+.++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~ 304 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESI-FPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhh-CCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence 554321100 00 1111111111111 22368899999999999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=326.41 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=203.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|++++.+.+.+. .....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEE
Confidence 3788999999999999999999999999999885432 12346899999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence 999999985 66665543 223468999999999999999999999 79999999999999996 77899999999876
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........|+..|+|||++.+. .++.++|+||+||++|+|++|..||..................
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------- 219 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 219 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence 5433333345789999999999654 4899999999999999999999999865432111111110000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
....++..+++++.+|+.+||+.||++|+| +.|+++||||+.+.+.
T Consensus 220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 001123347889999999999999999999 9999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.86 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=207.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|..++..++|+||+.+++++ .+..+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986421 1234688899999999999999888 44456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+.| +|...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence 8999999985 67666653 24578999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCc--ceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 190 QLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 190 ~~~~~~~~--~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
........ ....||+.|+|||++.+. ..++.++|+||+||++|+|++|+.||.+.+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----- 225 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE----- 225 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-----
Confidence 65433221 234689999999998542 3478899999999999999999999998877666655543110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 331 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 331 (380)
.+.+|. ....+++++++||.+||+.++.+ |++++++++||||+.+.+..
T Consensus 226 ----------~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 226 ----------RFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred ----------cccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 011111 01236899999999999976655 46899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.71 Aligned_cols=319 Identities=31% Similarity=0.539 Sum_probs=246.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 109 (380)
..+|.-++.+|.|+- .|--|.+.-.++.||+|++.. ..+...+|..++..++|+||++++.+|...... ...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357999999999998 788889999999999998843 234556899999999999999999988543321 223
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..|+|||++..+|...+. -.+.-..++.+++|++.|++|||+ .||+||||||+||++.. ++.+||.|||+|+
T Consensus 95 e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGLAR 166 (369)
T ss_pred hHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchhhc
Confidence 378999999998887775 346667889999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.....-..+.++.|+.|+|||++.+.+ |...+||||+||++.||++|...|+|.+..++..++.+.+|.|.+..+..+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 655444556788999999999998877 9999999999999999999999999999999999999999999998877654
Q ss_pred CC----------CCCccCCCC-CCCCcccccCC--CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 016950 270 PN----------YTDFRFPQI-KAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 336 (380)
Q Consensus 270 ~~----------~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 336 (380)
+. |..+.+... ++.-|...... .-+..++||+.+||..||++|++++++|+||||+=+-.... ..
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~e--v~ 323 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDE--VE 323 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccc--cc
Confidence 22 222222221 11111111111 12456899999999999999999999999999983211111 11
Q ss_pred CCCCCCCCCchhhhccCCHHHHhhhChHHHHh
Q 016950 337 GRPLPPLFNFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
.+.|+...-..+....+++.++.++-+++.+
T Consensus 324 -ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~ 354 (369)
T KOG0665|consen 324 -APPPEIYDKQLDEREHTIEEWKELIFKEVQR 354 (369)
T ss_pred -CCCCchhhhhcccccCCHHHHHHHHHHHHHh
Confidence 1122222222344556688888888777665
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.18 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=198.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chH-HHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKN-RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~-~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|++..+++.||+|++.+... ... ++..+++.++|+||+++++++. ....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 469999999999999999999999999864321 111 2233567889999999998883 334588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+.+ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence 99996 5655554 34668899999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 222334678999999999965 45899999999999999999999999988877666555431 0
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH----HHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----e~l~hp~~~~~~~~ 330 (380)
. .++..+++.+.++|.+||+.||.+|+++. ++++|+||..+.|.
T Consensus 213 -~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 213 -L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred -c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 0 01234789999999999999999999875 89999999876553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=322.49 Aligned_cols=278 Identities=35% Similarity=0.615 Sum_probs=212.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence 467999999999999999999999999999999885432 12357999999999999999999883 33458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+|+||+.++++..+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence 89999999887766542 23457888899999999999999999 79999999999999986 778999999998754
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+ ..+.+.++....+.|.........
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3222 12234568899999998665567899999999999999999999997654 345666666667766655433221
Q ss_pred --CCCCCccCCCCCCCCcccccC-CCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 --PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+....++............ -..+..+.+++.+||+.||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 122211111111111111100 0136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=324.82 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=197.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||+|+||.||++.++.+|+.||+|.+.... .....|+.+++.++||||+++++.+ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885321 1223589999999999999998888 3445689999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
++ +|...+.. .....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence 85 56555542 123458889899999999999999999 79999999999999996 778999999998766544333
Q ss_pred ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccC
Q 016950 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277 (380)
Q Consensus 198 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 277 (380)
....+++.|+|||++.+.. ++.++|+||+||++|+|++|..||...........+....-. .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence 4456889999999986554 899999999999999999999999765432221222111000 00000
Q ss_pred CCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCCcccccCCC
Q 016950 278 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREPN 331 (380)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~~ 331 (380)
....+++++++||.+||++||.+||++ ++++.||||+.+.++.
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 012378999999999999999999999 7788999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.87 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=196.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|++..+++.||+|++.+... ...+| ..+++.++|+||+++++.+ .+....|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 469999999999999999999999999864321 11223 3467889999999999887 3344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc-
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA- 193 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~- 193 (380)
||+++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++.....
T Consensus 76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence 99986 5555443 34678899999999999999999999 79999999999999996 77899999999875322
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK----------------- 211 (321)
T ss_pred CCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 222334578999999999865 45899999999999999999999999988765555444321
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~ 330 (380)
.. .++...+..+.++|.+||+.||.+|+++ .++++||||..+.+.
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 212 PL------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred CC------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 00 1223468899999999999999999975 599999999887654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=331.97 Aligned_cols=287 Identities=31% Similarity=0.545 Sum_probs=217.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCC------
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------ 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------ 106 (380)
..+|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367999999999999999999999999999999885432 2245799999999999999998876432211
Q ss_pred ---CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 107 ---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 107 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.....|+||||++++|.+.+. ...+++..++.++.||+.||.|||+ +|++||||||+||+++..+..++|+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence 123578999999987766654 3468999999999999999999999 7999999999999998656789999
Q ss_pred eecccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 184 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 184 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|||.+........ .....++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+....+......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875432211 122356888999998866566889999999999999999999999988877777766665444
Q ss_pred CCHHHHhhcCCCCCCc-c-CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 260 PTREEIRCMNPNYTDF-R-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
+............... . .......+... +...++.++.+||.+||+.||.+|||+.+++.||||+.+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 3332221111000000 0 00001111111 123478999999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=331.02 Aligned_cols=280 Identities=36% Similarity=0.581 Sum_probs=221.0
Q ss_pred ccccceee-eeeeecCCceEEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHhCCCCceee
Q 016950 35 KQTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRVMDHPNVIS 95 (380)
Q Consensus 35 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~ 95 (380)
...++|.. .+.||.|+||+||+|.+..+++.||+|++..... ...+|+.+++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 34567875 5779999999999999999999999998854321 1347999999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC
Q 016950 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (380)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~ 175 (380)
+++++. ...+.|+||||+.++|.+.+. ....+++..+..++.|++.||+|||+ +|++|+||+|+||+++.
T Consensus 85 ~~~~~~-----~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~ 154 (335)
T PTZ00024 85 LVDVYV-----EGDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS 154 (335)
T ss_pred eeEEEe-----cCCcEEEEEeccccCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC
Confidence 999884 334588999999998877775 34568999999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeecccccCccC---------------CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 016950 176 LTHQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (380)
Q Consensus 176 ~~~~ikl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p 240 (380)
++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+|
T Consensus 155 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 155 -KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred -CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 778999999998754311 1111234578899999987666679999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcC--CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 241 FPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
|.+.+..+.+..+....+.+....+.... +.+..+ .......... .....+.++.++|.+||+.+|++|||++++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 99999988888888888877765443221 111110 0001111111 123468899999999999999999999999
Q ss_pred hcCCCccccc
Q 016950 319 CAHPFFDELR 328 (380)
Q Consensus 319 l~hp~~~~~~ 328 (380)
+.||||+...
T Consensus 311 l~~~~~~~~~ 320 (335)
T PTZ00024 311 LKHEYFKSDP 320 (335)
T ss_pred hcCcccCCCC
Confidence 9999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=326.13 Aligned_cols=281 Identities=29% Similarity=0.539 Sum_probs=219.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCC--C----ceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDH--P----NVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~ 107 (380)
..+|.+++.+|+|.||+|-.|.+..++..||||+++.- +....-|+++|+++.+ | -+|.+.++| +.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence 56899999999999999999999999999999988532 3334468899999832 2 256666666 56
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC------------
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 175 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~------------ 175 (380)
....|||+|.++-++.+.+... .-.+++...++.+.+||+.++++||+ .+++|-||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred cCceEEEEeccChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCc
Confidence 6679999999998988888743 34678999999999999999999999 79999999999999842
Q ss_pred -------CCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016950 176 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248 (380)
Q Consensus 176 -------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~ 248 (380)
.+..|+|+|||.|... .......+.|+.|+|||++++-+ ++.++||||+||||+|+.+|...|++.++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 1235899999999854 33345678899999999998866 9999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCHHHHhhc-CCCCC---CccCCCCC-----------CCCcccccCC--CCChHHHHHHHhhcccCCCC
Q 016950 249 QLVEIIKVLGTPTREEIRCM-NPNYT---DFRFPQIK-----------AHPWHKVFHK--RMPPEAIDLASRLLQYSPSL 311 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~ 311 (380)
.+..+...+|..+...+... ...|- .+.+|... ..++...+.. ..-.++.|||++||.+||++
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 99888899997776655543 10000 11111110 1112221111 11235889999999999999
Q ss_pred CCCHHHHhcCCCccccc
Q 016950 312 RCTALEACAHPFFDELR 328 (380)
Q Consensus 312 R~t~~e~l~hp~~~~~~ 328 (380)
|+|+.|+|.||||+.+.
T Consensus 397 RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 397 RITLREALSHPFFARLT 413 (415)
T ss_pred cccHHHHhcCHHhhcCC
Confidence 99999999999998753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=325.19 Aligned_cols=257 Identities=29% Similarity=0.453 Sum_probs=216.8
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-------HHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-------~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.....+|..+.+||.|+||+|.+|..+.+.+.||||+++++.... ..|.++|... +-|.+++++.+|.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ---- 420 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ---- 420 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh----
Confidence 344568999999999999999999999999999999997765333 2466666555 5678899988884
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
.-..+|+||||+.| +|.-.++ .-+.+.+..+..|+.+|+-||-+||+ +||++||||.+|||++. .+.|||+|
T Consensus 421 -TmDRLyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~D 493 (683)
T KOG0696|consen 421 -TMDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIAD 493 (683)
T ss_pred -hhhheeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeee
Confidence 33449999999996 5555555 35778999999999999999999999 89999999999999997 78899999
Q ss_pred ecccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 185 FGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 185 fg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
||+++.-.- .....+.+|||.|+|||++.- +.|+.++|+||+||+||||+.|++||.+.++.+.++.|+..
T Consensus 494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------- 565 (683)
T KOG0696|consen 494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------- 565 (683)
T ss_pred cccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------
Confidence 999985433 344567899999999999954 45999999999999999999999999999999999999872
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-----HHHhcCCCcccccCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 331 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~~ 331 (380)
... +++.+|.++.+++..+|.+.|.+|+.+ .++..||||+.+.|..
T Consensus 566 ----------nvs------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 566 ----------NVS------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred ----------cCc------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 222 445689999999999999999999864 6899999999998864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.44 Aligned_cols=283 Identities=32% Similarity=0.590 Sum_probs=221.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---C
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---K 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~ 106 (380)
..++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+|+.+++.++|+||+++++++..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 3678999999999999999999999999999999885321 234579999999999999999987754332 2
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....+++|+||+.+++...+.. ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg 160 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFG 160 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCc
Confidence 3446789999999887766642 34579999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC------------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 187 SAKQLIAGEA------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 187 ~a~~~~~~~~------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
++........ .....+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9875433221 1223568889999998766568999999999999999999999999998888888888
Q ss_pred HHhCCCCHHHHhhcC--CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 255 KVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
...+.+....+.... +..............+...+ ..+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877776655443211 11111000000111122222 2356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=327.96 Aligned_cols=283 Identities=37% Similarity=0.638 Sum_probs=222.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 110 (380)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57999999999999999999999999999999885421 123479999999999999999998754322 12234
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+|+||+..++.... ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++..
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence 6899999987654432 2468899999999999999999999 79999999999999996 78899999999875
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..++...+.+..+.......
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 422 223456788999999986655688999999999999999999999999888888888888887777655443321
Q ss_pred CC-CC--ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 271 NY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 271 ~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.. .. ...+......+...+ ...++++.+||.+||+.||.+||++.+++.||||+.++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 10 00 011111222222222 23688999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=322.23 Aligned_cols=277 Identities=35% Similarity=0.667 Sum_probs=214.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+++++.++|+||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 46999999999999999999999999999999875432 1235799999999999999999988 444458
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+|+||++++++..+.. ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~ 150 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL 150 (286)
T ss_pred EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence 99999999865544432 34458999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 269 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 269 (380)
..... .....++..|+|||++.+...++.++|+||+||++|+|++|.+||.+....+....+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 33322 2235678899999998765667899999999999999999999999888777777777666554332211111
Q ss_pred -CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.......+..............++..+.+|+.+||..+|++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011112222111111111233578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=313.83 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=205.6
Q ss_pred ccceee-eeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+-|.+ .+.||+|+|+.|-.|....+++.||||++.+. +....+|++++..+ .|+||+.++++| +++..
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTR 150 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccce
Confidence 345665 46899999999999999999999999999764 23445899999988 599999999999 66667
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~ikl~Dfg~ 187 (380)
.|+|||-|.| .|+..+. ....|++.++..+..+|+.||+|||. +||.||||||+|||...-+ .-|||+||.+
T Consensus 151 FYLVfEKm~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEEecccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeecccc
Confidence 9999999985 6776665 35679999999999999999999999 8999999999999986422 2499999998
Q ss_pred cccCccC--------CCcceeeccCCCCChhhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------
Q 016950 188 AKQLIAG--------EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------- 247 (380)
Q Consensus 188 a~~~~~~--------~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-------- 247 (380)
....... ....+.+|+..|||||+.. ....|+.++|.||||||+|.||.|.+||.|.-..
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 7543221 1223567788899999972 2345899999999999999999999999865221
Q ss_pred -------HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 248 -------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 248 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..|.+ ..|.||+ ..| ..+|.+++|||+.+|..|+.+|.++.++++
T Consensus 306 ~Cr~CQ~~LFesIQE-----------------GkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQE-----------------GKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccHHHHHHHHHHHhc-----------------cCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11222222 2334443 233 348999999999999999999999999999
Q ss_pred CCCcccccCC
Q 016950 321 HPFFDELREP 330 (380)
Q Consensus 321 hp~~~~~~~~ 330 (380)
|||++.....
T Consensus 361 hPw~~~~~~e 370 (463)
T KOG0607|consen 361 HPWVQRCAPE 370 (463)
T ss_pred Cccccccchh
Confidence 9999987543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=331.25 Aligned_cols=279 Identities=26% Similarity=0.420 Sum_probs=203.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+.+++.++|+||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEE
Confidence 468999999999999999999999999999999876432 224579999999999999999998844 3358
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+.+ +|.+.+. ....+++..+..++.|++.||.|||+.++++||||||+|||++. ++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchh
Confidence 899999985 7776665 34568899999999999999999997237999999999999986 77899999999875
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHHHHhhc-
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK-VLGTPTREEIRCM- 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~- 268 (380)
.... ......+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||......+....+.. ..+.+........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 154 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 4322 22345688999999998654 589999999999999999999999987654332211110 0011100000000
Q ss_pred C------CCCCCccCCCCC--------CCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 N------PNYTDFRFPQIK--------AHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~------~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. ..+..-..|... .......+ ....+.++++||.+||++||++|||+.|++.||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0 000000000000 00000001 11357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=343.34 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=213.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.+.|.|+..||.|+||+||+|.++.++-.-|-|++.... ....-|++||..++||+||++++.||..+. ++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence 456999999999999999999999998888888874322 122358999999999999999998876554 89
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|+.|||+|+-.+.+. ..-+..+++.+++.+++|+|.||.|||+ ++|||||||..|||++- +|.|+|+|||.+-...
T Consensus 106 iliEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~ 181 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNK 181 (1187)
T ss_pred EEEeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccch
Confidence 999999986555443 2357889999999999999999999999 89999999999999997 7889999999875432
Q ss_pred -cCCCcceeeccCCCCChhhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 193 -AGEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 193 -~~~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
......+++|||+|||||+.. ....|++++||||||++|.+|..+.+|-...+.+..+.+|.+.-. |+.
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP-PTL----- 255 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTL----- 255 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC-Ccc-----
Confidence 223445789999999999973 345699999999999999999999999999999988888776311 110
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.-|.+.+..+.||+.+||.+||..||+++++|+||||+++
T Consensus 256 --------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 256 --------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred --------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 0123357889999999999999999999999999999865
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=337.95 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=221.5
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++.++.|.+.+.||.|.|++|.++++..++..||||.+.+.. ....+|+++|+.++|||||+++.+...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--- 126 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--- 126 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee---
Confidence 56677889999999999999999999999999999999986543 224589999999999999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
...+|+||||+.+ .+.+.+ ...+++.+..++.++.|++.|++|||+ ++|+|||||++|||++. +.++||+|
T Consensus 127 --~~~lylV~eya~~ge~~~yl----~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaD 198 (596)
T KOG0586|consen 127 --EATLYLVMEYASGGELFDYL----VKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIAD 198 (596)
T ss_pred --cceeEEEEEeccCchhHHHH----HhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeec
Confidence 3449999999986 444444 467788889999999999999999999 89999999999999996 67799999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||++..+.......+++|++.|.|||++.+....++.+|+||+|+++|.|+.|..||.+.+-.+.....+.
T Consensus 199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--------- 269 (596)
T KOG0586|consen 199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--------- 269 (596)
T ss_pred cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------
Confidence 99999988777788899999999999998888778999999999999999999999998765443322221
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..+.+ +--++.++.++|+++|..+|.+|++.+++..|.|.......
T Consensus 270 --------gk~rI------------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 270 --------GKYRI------------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------eeecc------------cceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 11111 22379999999999999999999999999999999886655
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.58 Aligned_cols=274 Identities=39% Similarity=0.732 Sum_probs=223.4
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||.|++|.||+|.+..+++.+|+|.+..... ...+|+.+++.++|+||+++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999998864432 234789999999999999999988433 44889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|+||+++++.+.+.. ....+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence 999999988777654 23578999999999999999999999 79999999999999996 77899999999876644
Q ss_pred CC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC--
Q 016950 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-- 270 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 270 (380)
.. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 33 222345788899999987664689999999999999999999999999998888888888888877666554433
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+..+.++......... ....++.++++||.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 22223333332222222 233478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=329.91 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=197.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..|++++.||+||.+.||++..- +.+.||+|++.... .....|+.+|.+| .|.+|+.++++- -.+.+
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence 36999999999999999999854 44567777663221 2235899999999 589999999877 33567
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+||||-+.+|...|+.. ....+...++.|..|++.|++++|. +||||.||||.|+|+. .|.+||+|||+|..
T Consensus 435 lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGIANA 508 (677)
T ss_pred EEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeechhcc
Confidence 9999999999999988753 2334445899999999999999999 8999999999999998 57899999999988
Q ss_pred CccCCC---cceeeccCCCCChhhhhCCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016950 191 LIAGEA---NISYICSRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (380)
Q Consensus 191 ~~~~~~---~~~~~~t~~y~aPE~l~~~~----------~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 257 (380)
+..... ..+.+||+.|||||.+.... +.+.++||||||||||+|+.|++||.... ....++ ..+
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl-~aI 585 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKL-HAI 585 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHH-Hhh
Confidence 765543 33578999999999984321 15678999999999999999999996432 122222 222
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..|. .++.||++.. ..++.++++.||++||.+|+|+.++|+|||++-.
T Consensus 586 ~~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 586 TDPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cCCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 2222 2345554311 2249999999999999999999999999999863
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.05 Aligned_cols=260 Identities=29% Similarity=0.497 Sum_probs=211.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+|+.+++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 369999999999999999999999999999999865432 234689999999999999999887 34456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+.+ +|.+.+.. .....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence 8999999986 77666652 234678999999999999999999999 79999999999999996 7789999999986
Q ss_pred cCccCCC------------------------------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Q 016950 190 QLIAGEA------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 190 ~~~~~~~------------------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
....... .....||..|+|||++.+. .++.++|||||||++|+|++|..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCC
Confidence 5422111 1123578889999999654 47999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC----H
Q 016950 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----A 315 (380)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~ 315 (380)
||.+.+....+..+... ...++. ...+++.+.++|.+||+.||++||| +
T Consensus 231 pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 231 PFKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred CCCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 99888776665554421 011111 0126899999999999999999999 9
Q ss_pred HHHhcCCCcccccCCCCCC
Q 016950 316 LEACAHPFFDELREPNARL 334 (380)
Q Consensus 316 ~e~l~hp~~~~~~~~~~~~ 334 (380)
+++++||||+...++....
T Consensus 284 ~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 284 AEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHHcCchhhcCChhhccc
Confidence 9999999999988776655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=320.00 Aligned_cols=274 Identities=35% Similarity=0.677 Sum_probs=217.3
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||.|++|.||+|.+..+|+.||+|++.... ....+|+.+++.++|+|++++++++. +....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999999999999999886432 22357999999999999999999883 3345889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+|||++++|.+.+... ....+++..+..++.|++.||+|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence 9999988887776532 12468999999999999999999999 79999999999999997 78899999999875432
Q ss_pred CC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--C
Q 016950 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 270 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~ 270 (380)
.. ......++..|+|||++.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+.... +
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 12233568889999988665557899999999999999999999999988888888888887777765543211 1
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
++. ..++......... ....+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYK-PTFPKWARQDLSK-VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhh-hhcccccccchhh-hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 110 0112111111111 234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=317.15 Aligned_cols=248 Identities=28% Similarity=0.487 Sum_probs=201.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+.|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence 46999999999999999999999999999999875321 12356899999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...|+|+||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence 468999999985 66666653 3568899999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+......... ....++..|+|||++.+.. ++.++|+||+||++|+|++|+.||...+.......+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------ 223 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------ 223 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC------
Confidence 8754332111 2345678899999996644 8999999999999999999999998765554443332210
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
....++..+++.+.++|.+||..+|.+|||+.++++||||
T Consensus 224 ---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 ---------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0111234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=319.81 Aligned_cols=277 Identities=35% Similarity=0.673 Sum_probs=220.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 36999999999999999999999999999999875321 234579999999999999999999844 3348
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++||||++++++..+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~ 150 (288)
T cd07833 76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL 150 (288)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence 89999999876665442 34568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......++..|+|||++.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 4443 23345678899999999766468999999999999999999999999888888777777776665554333221
Q ss_pred --CCCCCccCCCCC-CCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 270 --PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 270 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.+....++... ...+...++..+++++++||++||..+|++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 112111222211 1222333455568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=346.32 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=199.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCC-CCceeeece-eeeecCCCC-ceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMD-HPNVISLKH-CFFSTTSKN-ELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~ 110 (380)
.+++|.+.|.+|||+.||+|.+...|..||+|++... .....+|+++|+.|+ |+|||.+++ ........+ ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4789999999999999999999988899999987432 234468999999996 999999999 443333333 356
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
+.|+||||. |+|.+++..+.. ..|++.++..|++|+|+|+.+||. .. |||||||-|||||+. ++..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeCcccc
Confidence 779999999 699999987654 449999999999999999999999 46 999999999999996 77899999999
Q ss_pred cccCccCCCc----------ceeeccCCCCChhhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016950 188 AKQLIAGEAN----------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 188 a~~~~~~~~~----------~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 255 (380)
|......... .....|+.|+|||.+. .....+.|+|||+|||+||.|+....||.......++
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----- 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----- 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-----
Confidence 8754332211 1234599999999983 2344799999999999999999999999776432221
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+ ..|.+|.. .+.+..+++||+.||+.||.+||++.|++.
T Consensus 268 -------------n---g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 268 -------------N---GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -------------e---ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 1 23444442 246899999999999999999999999885
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.26 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=206.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|+..+.||.|+||+||++.+..+++.||+|.+.... ....+|+.+++.++|+||+.+.+.+. .....
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEE
Confidence 3788899999999999999999999999999885432 12346999999999999999988873 33458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+.+ +|...+.. .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~ 151 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence 899999996 55545432 123468999999999999999999999 79999999999999996 67899999999876
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........++..|+|||++.+. .++.++|+||+||++|+|++|..||.+.........+........
T Consensus 152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--------- 221 (285)
T cd05632 152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--------- 221 (285)
T ss_pred cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence 5433333445789999999999654 589999999999999999999999988766544444333211100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
..++..+++++.+|+.+||+.||++||+ +.++++||||+...+.
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0122347889999999999999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=321.26 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=203.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++.+.||+|+||.||+|.+..+|+.||||.+..... ....|+. .++.++|+||+++++.+.. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence 469999999999999999999999999999998865422 1123444 4667799999999998843 2348
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|++|||++++|.+.+.........+++..++.++.|++.||+|||+ + +++||||||+||+++. ++.+||+|||++..
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~ 153 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY 153 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence 8999999998888877654455779999999999999999999998 7 9999999999999996 77899999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHh
Q 016950 191 LIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...........++..|+|||.+.+. ..++.++|+||+||++|+|++|+.||.... ..+.+..+... .+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~----- 226 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP----- 226 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-----
Confidence 5433333335678899999988542 336889999999999999999999996532 22333222210 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.++ ...+|+++.+||.+||..+|.+||++.++++||||....
T Consensus 227 ---------~~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 ---------QLP-----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ---------CCC-----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 123688999999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=319.31 Aligned_cols=262 Identities=24% Similarity=0.368 Sum_probs=208.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.+ +|+|++++++++...........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3678999999999999999999999999999999886432 2334688899988 89999999998865443334568
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchh
Confidence 899999985 7777766544456678999999999999999999999 79999999999999986 77899999999876
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
...... .....++..|+|||++.... .++.++|+||+||++|+|++|+.||...+....+..+.+. .+.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~---- 251 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PPP---- 251 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CCC----
Confidence 543221 22346788899999985432 2678999999999999999999999877655544433221 000
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
....+...+..+.+||.+||+.||++||++.++++||||+
T Consensus 252 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 --------------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0001223577899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=329.56 Aligned_cols=289 Identities=35% Similarity=0.681 Sum_probs=227.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
+...++|++.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.+ +|+||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~ 79 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---E 79 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---C
Confidence 34567899999999999999999999999999999988532 12234799999999 99999999988743 2
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
+....|+||||+.++|...+.. ..+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeecc
Confidence 2345789999999887776642 267888899999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCC------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 187 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 187 ~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
++....... ......+++.|+|||++.+...++.++|+||+||++|+|++|+.||.+....+....+....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 987653322 12235678899999988665668899999999999999999999999988888888888888877
Q ss_pred CHHHHhhcCCCCCCc---cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCC
Q 016950 261 TREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 333 (380)
..+.+..+....... ..+..........++ .++.++.++|.+||+.||++|||+.++++||||+.+..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~ 307 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE 307 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence 765544332111110 011111111222222 378999999999999999999999999999999998665444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=300.39 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=206.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|++.+.||+|||+.||++++..++..||+|++.-. .....+|++..++++|||+++++++......+.....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 35899999999999999999999999999999998533 33446899999999999999999988777766777899
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
|+++|.. |+|++.+......+..+++.++..|+.+|+.||++||+ .. ++||||||.|||+.. ++.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEeccCcc
Confidence 9999988 68999998887778899999999999999999999999 68 999999999999996 7889999999987
Q ss_pred cCccCCC----------cceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016950 190 QLIAGEA----------NISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (380)
Q Consensus 190 ~~~~~~~----------~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 257 (380)
...-.-. .....+|..|+|||++.-. ...+.++|||||||+||+|+.|..||...-. .
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------~ 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------Q 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------c
Confidence 5422111 1234578999999997322 3368899999999999999999999953210 0
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
|.... +. -....+.+|.. ...|+.+.+||..||+.||.+||++.+++.+
T Consensus 248 GgSla--LA---v~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLA--LA---VQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEE--Ee---eeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000 00 00012233321 2379999999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=319.50 Aligned_cols=277 Identities=31% Similarity=0.603 Sum_probs=218.9
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 788999999999999999999999999999997542 12347999999999999999999884331 245889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|+||+++++.+.+.. ....+++..++.++.||+.||+|||+ .|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence 999999887777653 23578999999999999999999999 79999999999999996 78899999999986644
Q ss_pred CC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 194 GE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 194 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+....+..+....+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 33 1223456788999998866666899999999999999999999999999888888888887777766554332110
Q ss_pred --CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+................+...+++.+.++|++||+.+|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00110000001111222223348999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=318.45 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=208.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 109 (380)
+...++|++.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+.+++.+ +|+||+++++++.........
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 345678999999999999999999999999999999875432 2345788999998 699999999988655444556
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ ++++||||||+||+++. .+.++|+|||++
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~ 171 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVS 171 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCce
Confidence 78999999985 6767666544456678999999999999999999999 79999999999999996 677999999998
Q ss_pred ccCccCC-CcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 189 KQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 189 ~~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
....... ......+++.|+|||++.. ...++.++|+||+||++|+|++|..||...+....+..+... .+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~-- 247 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP-- 247 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC--
Confidence 7654322 2233468899999999743 234788999999999999999999999876544333221110 000
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
....+...+..+.+||.+||+.||++|||+.++++||||
T Consensus 248 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 248 ----------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 000122357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.68 Aligned_cols=284 Identities=36% Similarity=0.651 Sum_probs=221.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 109 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 467999999999999999999999999999999885421 1234799999999999999999988543221 123
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++||||+++++...+. ...+++..++.++.|++.||+|||+ .||+||||||+||+++. ++.++|+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccccc
Confidence 468999999877766654 3568999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+....+..+++..+.+..+....+.
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 65332 2234678899999998664558899999999999999999999999988888888877766665544332221
Q ss_pred CCCC-C--ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 270 PNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 270 ~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.... . ...+......+ ..+...+++.+.++|.+||+.||++|||+.+++.||||+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 1100 0 01111111111 11234578899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=332.57 Aligned_cols=253 Identities=30% Similarity=0.552 Sum_probs=213.0
Q ss_pred ceee--eeeeecCCceEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 39 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
-|+| .++||+|.||+||-++++.+|+.||||++.+ .....+.|+.||+.+.||.||.+--.| +....
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCce
Confidence 3555 5799999999999999999999999999854 344556899999999999999987666 44455
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcEEEEeeccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSA 188 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~ikl~Dfg~a 188 (380)
+++|||-+.|++++.+.. ...+++++...++++.||+.||+|||- ++|+|+||||+|||+.+.+ ..+||||||+|
T Consensus 638 vFVVMEKl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEEEehhhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccce
Confidence 889999999999888753 467889999999999999999999999 8999999999999997533 37999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+......-..+.+|||.|.|||++... .|...-|+||.|||+|.-+.|..||....+. -.+|.+
T Consensus 715 RiIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN------------- 778 (888)
T KOG4236|consen 715 RIIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN------------- 778 (888)
T ss_pred eecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccch--hHHhhc-------------
Confidence 998888778889999999999999754 5999999999999999999999999754322 222222
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.+| ..+|.+ +++++.|||..+|+..-++|.|+++.|.|||+++.
T Consensus 779 ----AaFMyP---p~PW~e-----is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 ----AAFMYP---PNPWSE-----ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ----cccccC---CCchhh-----cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 112222 234543 79999999999999999999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=318.90 Aligned_cols=250 Identities=30% Similarity=0.517 Sum_probs=207.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|++|.||++.+..+++.||+|++.... ....+|+++++.++||||+++++++. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence 36999999999999999999999999999999886432 22347899999999999999999884 3345
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||++ ++|.+.+.. ...+++..+..++.||+.||+|||+ +|++|+||+|+||+++. ++.+||+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence 889999996 577666653 4678999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.. +
T Consensus 150 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~----------- 213 (290)
T cd05580 150 RVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--G----------- 213 (290)
T ss_pred ccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-----------
Confidence 65443 3345678899999998554 578999999999999999999999988775544444432 1
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. .++..+++.++++|.+||+.||.+|+ +++++++||||+.+.|.
T Consensus 214 ----~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 214 ----KV------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ----Cc------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 00 12234689999999999999999999 99999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.44 Aligned_cols=285 Identities=35% Similarity=0.592 Sum_probs=223.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 468999999999999999999999999999999886432 223469999999999999999988753321 2223
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..|++++++.++|.+.+. ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEecccccc
Confidence 478999999888766654 2468999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+++.|+|||++.+...++.++|+||+||++|+|++|..||.+.+....+..+....+.+.........
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 5432 22345678899999998665568899999999999999999999999888888888888877777766554332
Q ss_pred CCCCCc---cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 270 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 270 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...... ..+......+... ....++++.+||.+||+.||.+|+|+.++++||||++...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 211000 0011111111111 113688999999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=334.86 Aligned_cols=249 Identities=30% Similarity=0.480 Sum_probs=213.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|.-++.||.|+||.||.|++..+.+.||||++.-... ...+|+..|+.++|||++.+.+||..... .
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence 47778999999999999999999999999999954322 22379999999999999999999965554 8
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+|||||-|+-.+++.. ...++-+.++..|..+.+.||.|||+ .+.||||||..|||++. .+.|||+|||.|...
T Consensus 102 WLVMEYClGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence 89999999987777764 34678899999999999999999999 79999999999999996 889999999999765
Q ss_pred ccCCCcceeeccCCCCChhhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
. ...+++|||+|||||++. ..+.|+-++||||||++..+|.-.++|+.+.+.+..++-|...-
T Consensus 177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------ 241 (948)
T KOG0577|consen 177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 241 (948)
T ss_pred C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC------------
Confidence 3 344789999999999984 34569999999999999999999999999999999888887631
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
-|.+....| |..++.||..||++-|.+|||.+++|.|+|+..-
T Consensus 242 -------sPtLqs~eW--------S~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 242 -------SPTLQSNEW--------SDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -------CCCCCCchh--------HHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 122222333 7889999999999999999999999999999763
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.93 Aligned_cols=283 Identities=29% Similarity=0.516 Sum_probs=220.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC----
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---- 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 105 (380)
..++|++.+.||.|+||.||+|.++.+++.||+|.+.... ....+|+.+++.++||||+++++++....+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999999999999999885432 123479999999999999999988754331
Q ss_pred -CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 -KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 -~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
.+...+|+|+||+++++...+.. ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~d 159 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLAD 159 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCc
Confidence 12236889999999987766653 24568999999999999999999999 79999999999999996 78899999
Q ss_pred ecccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 185 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 185 fg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
||++........ .....++..|+|||.+.+...++.++|+||+||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999876543321 122345778999999866555789999999999999999999999988888888888887777765
Q ss_pred HHHhhcCC--CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 263 EEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..++.... .+............+.. ....++..+.++|.+||+.||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 54432211 11110000000111111 122468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=317.14 Aligned_cols=275 Identities=40% Similarity=0.703 Sum_probs=221.4
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||.|++|+||+|....+++.||||.+..... ...+|+..++.++ |+|++++++++.. ....|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 7889999999999999999999999999998854322 2346888999998 9999999998844 344889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
||||+.+++.+.+... ....+++..+..++.|++.+|.|||+ +|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence 9999988888777632 13578999999999999999999999 79999999999999996 78899999999986654
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC--C
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--N 271 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~ 271 (380)
........++..|+|||++.+...++.++|+||+|+++++|++|++||.+....+.+.++...++.+....+..... .
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 44444566788999999886666689999999999999999999999999998889999888888887654432211 1
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
...+.++..........++ ..+..+.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 1112222222222222222 247899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.30 Aligned_cols=263 Identities=29% Similarity=0.437 Sum_probs=209.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCc
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 108 (380)
|...++|++.+.||.|++|.||+|.+..+++.+++|++.... ....+|+.+++.+ +|+||+++++++..... ...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 455789999999999999999999999999999999886543 2345799999998 79999999998865443 345
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~ 159 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGV 159 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcc
Confidence 568899999996 6666665444345788999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+....... ......++..|+|||++... ..++.++|+||+||++|+|++|..||........+..+.... +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~-- 235 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--P-- 235 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--C--
Confidence 87543322 22345678899999997432 346788999999999999999999998765554444433210 0
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+.. ..+...++++++||.+||..||++|||+.++++|||+
T Consensus 236 ---------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ---------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0011257899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=314.71 Aligned_cols=274 Identities=38% Similarity=0.705 Sum_probs=224.9
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||+|++|.||+|++..+++.||+|++.... .....|+.+++.++|+|++++++++.. ....++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 678899999999999999999999999999886532 123468999999999999999998843 345889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|+||++++|.+.+... ...+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence 9999999888877642 2568999999999999999999999 79999999999999996 78899999999876543
Q ss_pred CC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC-
Q 016950 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 271 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 271 (380)
.. .......+..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....+......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223445778999999876656899999999999999999999999999999999999998888888766544322
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+....++..........++. ++..+.++|.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 12233444444444344433 58899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.19 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCC-CceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~ 111 (380)
.+.|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....|+.+++.+ +|+||+++.+.+...... ....+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 457999999999999999999999999999999986442 2345788888888 699999999988654322 23468
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ ++|+|+||||+||+++. ++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence 899999985 676666531 23568999999999999999999999 79999999999999996 77899999999875
Q ss_pred CccC-CCcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 191 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 191 ~~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
.... .......+++.|+|||++.+ ...++.++|+||+||++|+|++|..||...........+... +
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 4332 22234567889999999853 234788999999999999999999999765544333222110 0
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus 233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0001122368899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=323.61 Aligned_cols=276 Identities=21% Similarity=0.325 Sum_probs=198.4
Q ss_pred eeeeeecC--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 42 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 42 ~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
++++||+| +|++||++.++.+|+.||+|.+.... ....+|+.+++.++||||+++++++.. ....|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence 56789999 78899999999999999999986432 234579999999999999999998843 334889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ ++.+.+... ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence 9999985 666666432 23458899999999999999999999 79999999999999996 7789999998654332
Q ss_pred cCCC--------cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC--
Q 016950 193 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT-- 261 (380)
Q Consensus 193 ~~~~--------~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-- 261 (380)
.... .....++..|+|||++.+. ..++.++||||+||++|+|++|..||.............. +..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 230 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccc
Confidence 1111 1123456779999998653 3588999999999999999999999987654443333221 1110
Q ss_pred -------HHHHhhcC------CCCCCccC----CCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 262 -------REEIRCMN------PNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 262 -------~~~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+.+.... ..+..... ...........+...+++.+.+||.+||++||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 00000000 00000000 00000000111223467899999999999999999999999999999
Q ss_pred cccc
Q 016950 325 DELR 328 (380)
Q Consensus 325 ~~~~ 328 (380)
+++.
T Consensus 311 ~~~~ 314 (327)
T cd08227 311 KQIK 314 (327)
T ss_pred hhcc
Confidence 8754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=316.50 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=204.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.+.|++++.||.|+||.||++++..+++.+|+|.+..... ...+|+.+++.++|+||+++++.+.. ...+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEE
Confidence 3679999999999999999999999999999999864432 23468899999999999999998843 33588
Q ss_pred EEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||++++ +...+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~ 160 (292)
T cd06644 86 IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKN 160 (292)
T ss_pred EEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCccceec
Confidence 999999975 4334332 34568999999999999999999999 79999999999999986 778999999998654
Q ss_pred ccC-CCcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
... .......+++.|+|||++.+ ...++.++|+|||||++|+|++|..||...+......++... .++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~----- 233 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP----- 233 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc-----
Confidence 322 12234567889999999842 234688999999999999999999999876654444333221 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
. ...+..++.++.++|.+||..||++||++.++++||||..+.+.
T Consensus 234 -------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 234 -------T------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred -------c------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 0 00122468899999999999999999999999999999887543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=317.79 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=209.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+-|.++++||+|+||.||+|.++.+|..+|||++.-+ .+...+|+.++++++.+++|++++.|+...+ ++|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeeh
Confidence 3489999999999999999999999999999998654 3455689999999999999999999976555 99999
Q ss_pred eccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|||+ |+..++++. .+..+++.++..++..-+.||+|||.+ .-+|||||..|||++. .+..||+|||.|....+-
T Consensus 108 EYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhhh
Confidence 9999 677777764 467899999999999999999999995 8899999999999997 788999999999866432
Q ss_pred -CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 -~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
....+.+|||.|||||++..- .|+..+||||||++..||..|++||..-.+...+..| |+
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------PT------------ 243 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------PT------------ 243 (502)
T ss_pred HHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------cC------------
Confidence 234467899999999999654 4999999999999999999999999876654433221 11
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+...+. -++.-|.++.|||++||.+.|++|-|+.++++|||+++.
T Consensus 244 ------~PPPTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 244 ------KPPPTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ------CCCCCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 0000000 012247899999999999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.63 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=192.1
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 368999999999999999999753 345789999886432 2234799999999 899999999877432
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh-----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (380)
...+++||||+++ +|.+.+.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2247899999984 77777653211
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC---cceeecc
Q 016950 132 -----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 203 (380)
Q Consensus 132 -----~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t 203 (380)
....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCC
Confidence 02347888899999999999999999 89999999999999996 77899999999976533221 1123346
Q ss_pred CCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCC
Q 016950 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKA 282 (380)
Q Consensus 204 ~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (380)
+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.. +. ..
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~--------------~~------- 296 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT--------------RM------- 296 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC--------------CC-------
Confidence 789999998654 48999999999999999997 99999876544433332221 00 00
Q ss_pred CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 283 HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 283 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++++.+|+.+||+.||.+|||+.++++
T Consensus 297 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=307.55 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=202.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|++|.||++.+..+++.||+|++..+. ....+|+.+++.++|+|++++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 4999999999999999999999999999999985432 12356889999999999999987662 2234578
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|||+++ ++.+.+... ....+++..++.++.|++.||.+||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence 99999985 676666532 34568999999999999999999999 79999999999999986 788999999998765
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ......+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------ 219 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------ 219 (257)
T ss_pred cccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 3322 2233467889999999865 4588999999999999999999999987776555444433100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+ ..+..+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0122468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.59 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=204.3
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..+..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++... +|+||+++++++ .+....
T Consensus 317 ~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~ 391 (612)
T KOG0603|consen 317 TAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI 391 (612)
T ss_pred cCCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence 34567889999999999999999999999999999999988767777888655544 899999999999 666669
Q ss_pred EEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+|||.+.|. +++.+. ....+. ..+..|++||+.|+.|||+ +|++||||||+|||++.+.++++|+|||.++.
T Consensus 392 ~~v~e~l~g~ell~ri~----~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIR----SKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeeehhccccHHHHHHH----hcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999974 333332 233333 7788899999999999999 89999999999999953478899999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ..+.+-|..|.|||++. ...|+.++||||||++||+||+|+.||...... .++...++.+.
T Consensus 466 ~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 466 LERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK--------- 530 (612)
T ss_pred Cchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc---------
Confidence 6444 23345688899999996 556999999999999999999999999877655 33333333332
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
|...+|..++|||++||+.||.+|+++.+++.||||
T Consensus 531 ------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 ------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 113489999999999999999999999999999999
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=317.72 Aligned_cols=253 Identities=25% Similarity=0.459 Sum_probs=197.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence 36889999999999999999999999999999886442 223479999999999999999998844 33478
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||++++.+... ..+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 76 ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecc
Confidence 99999997544322 246788899999999999999999 79999999999999996 7889999999997653
Q ss_pred cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 269 (380)
.. ......+|..|+|||.+.+. .++.++|+||+||++|+|++|..||........ ..........+.
T Consensus 147 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 216 (279)
T cd06619 147 NS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------- 216 (279)
T ss_pred cc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------
Confidence 32 23345788999999998654 489999999999999999999999965322110 001111110000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.+ .......++++.+++.+||+.||.+||++.++++||||+....
T Consensus 217 -------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 217 -------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred -------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 00 0011236789999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.22 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=204.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||.|++|.||+|.+..+++.||+|.+..+. ....+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 46999999999999999999999999999999886442 1235789999999999999999988433 4589
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+++ +|.+.+.. ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence 99999986 66666542 278999999999999999999999 79999999999999996 788999999999766
Q ss_pred ccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------ 215 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------------ 215 (274)
T ss_pred cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC------------
Confidence 443 2233456788899999996544 89999999999999999999999987765544433322100
Q ss_pred CCCCccCCCCCCCCcccccCCC-CChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+... +++++.+++.+||..||++|||++++++||||++..
T Consensus 216 ----------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 216 ----------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ----------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 001112 688999999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=316.39 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=204.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. ....+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence 46999999999999999999999999999999886432 22347999999999999999999884 344588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|...+.. ......+++..+..++.|++.||.|||+..|++|+||||+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 153 (286)
T cd06622 76 MCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence 99999996 55555542 1123478999999999999999999996249999999999999997 788999999998755
Q ss_pred ccCCCcceeeccCCCCChhhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
... ......+++.|+|||.+.+.. .++.++|+||+||++|+|++|..||...........+......+.
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 227 (286)
T cd06622 154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP----- 227 (286)
T ss_pred cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence 322 222346788899999985432 257899999999999999999999977654443333322111110
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..++..+++++.+||.+||+.+|++||++.++++||||......
T Consensus 228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 01223478999999999999999999999999999999886533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=317.76 Aligned_cols=282 Identities=38% Similarity=0.716 Sum_probs=222.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||.|+||.||+|.+..+++.||+|++.+. .....+|+.+++.++||||+++.+++... ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~ 83 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LE 83 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CC
Confidence 356799999999999999999999999999999987532 12334799999999999999999987432 22
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..|+++||++++|...+. ...+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.
T Consensus 84 ~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCcccccc
Confidence 378999999888776664 3467888899999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+.+.++.++.+.+....
T Consensus 157 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 157 IQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5432 22345678889999988654568999999999999999999999999988888888888888887765544321
Q ss_pred CC-CCCc--cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 270 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 270 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.. ..++ ..+.....+....+ ..+++.+.++|++||+.+|++|||+++++.||||...+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 11 0000 01111111111112 24789999999999999999999999999999998876553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=311.11 Aligned_cols=278 Identities=36% Similarity=0.627 Sum_probs=216.0
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhC---CCCceeeeceeeeecCCCCceE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 110 (380)
|++.+.||+|+||.||+|++..+++.||+|.+..... ...+|+.+++.+ +|+|++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998999999999863211 223577776665 6999999999987655445556
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++++|||+.+++.+.+... ....+++..++.++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||.+..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence 8899999998887776532 22368999999999999999999999 79999999999999997 68899999999977
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........++..|+|||++.+. .++.++|+||+||++|+|++|.+||.+....+.+..+....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 6544433445678889999999654 48899999999999999999999999988888888887766655443322110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
......++......+.. ....+++.+.++|.+||+.||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKS-FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhh-hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000111111112211 122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.92 Aligned_cols=256 Identities=29% Similarity=0.430 Sum_probs=204.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||.|+||+||+|.+..++..+|+|++.... ....+|+.+++.++|+|++++++.+.. ....|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 47999999999999999999999999999999886432 234579999999999999999988743 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+|++.+ +|.+.+... .....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~ 152 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL 152 (267)
T ss_pred EEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence 99999986 666666532 123568999999999999999999999 79999999999999996 678999999998765
Q ss_pred ccCCCc-----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...... ....++..|+|||++.....++.++|+||+||++|+|++|+.||...+....+.+.... .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 225 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPP----- 225 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCC-----
Confidence 443222 23467889999999866546899999999999999999999999877665544443331 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+ +. ......+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 226 -------~~--~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 -------SL--ET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------Cc--CC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 00 00012478999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=307.62 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=206.4
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... .....|+.+++.++|+||+++++.+... .....|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 5899999999999999999999999999999885432 1234688999999999999998877532 234578
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-----cCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH-----~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
++|||+++ +|.+.+.........+++..++.++.||+.||.||| + .+++|+||+|+||+++. ++.+||+|||
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g 155 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG 155 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence 99999985 787787765555678999999999999999999999 8 79999999999999996 7889999999
Q ss_pred ccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-------- 226 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence 9987654433 3345688999999998554 48899999999999999999999998877544433332210
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
. ..++...+..+.+++.+||+.+|++|||+.++++|||+
T Consensus 227 -----------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 -----------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0 01233468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.08 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=205.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.++|++.+.||.|+||.||++.+..+++.+|+|.+..... ...+|+.+++.++|+||+++++.+.. ....|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEE
Confidence 5679999999999999999999998999999998854322 23468999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence 99999996 56555542 34568999999999999999999999 79999999999999986 788999999988654
Q ss_pred ccCC-CcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
.... ......+++.|+|||.+.. ...++.++|+||+||++|+|++|..||...+....+..+... .++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~----- 226 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP----- 226 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC-----
Confidence 3322 2234567899999999842 234678999999999999999999999887665544433221 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+. .+..++.++.++|.+||+.+|.+||++.++++||||.+.
T Consensus 227 -------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 -------TLD------------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -------CcC------------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 122368899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=313.87 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=205.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|++.+.||.|++|.||++.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+.. ...+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEE
Confidence 457999999999999999999999999999999885432 223468999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+.+ +|...+. ...+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~ 165 (296)
T cd06655 93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQI 165 (296)
T ss_pred EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhc
Confidence 99999986 5555443 2458999999999999999999999 79999999999999986 788999999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+... +.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------- 234 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------- 234 (296)
T ss_pred ccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------
Confidence 43322 223467889999999854 44889999999999999999999999887765554433221 1100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+..+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 235 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 235 ----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 001234788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=327.11 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=226.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..+..++..||-|+||.|=++........+|+|++++... ....|..+|..++.+.||++|..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 4567888999999999999998776666799998865432 223688899999999999999998 7778
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
++|++||-|-| .++..++ ..+.|.+..+++|+.+++.|++|||+ +|||+|||||+|++++. .+-+||.|||+|
T Consensus 494 yvYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFA 567 (732)
T ss_pred hhhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhH
Confidence 89999999875 6777776 56889999999999999999999999 89999999999999996 778999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+....+....+++|||.|.|||++.... .+.++|.||||+++|||++|.+||.+.+++.++..|.+.+..
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------- 637 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------- 637 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh---------
Confidence 9999999999999999999999998655 789999999999999999999999999999999998874321
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNAR 333 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~~~ 333 (380)
+. ||+.++..+.+||+++-..+|.+|+. +.++.+|-||.+..|....
T Consensus 638 ------i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr 689 (732)
T KOG0614|consen 638 ------IE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR 689 (732)
T ss_pred ------hh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence 12 34568999999999999999999996 8999999999999887543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.02 Aligned_cols=284 Identities=19% Similarity=0.283 Sum_probs=198.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCC-cEEEEE------------------Eeecc---ccchHHHHHHHHhCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---RRYKNRELQLMRVMDHPNV 93 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK------------------~~~~~---~~~~~~e~~~l~~l~h~ni 93 (380)
..++|++++.||+|+||+||+|..+... ...+.| .+... .....+|+.+++.++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998765332 122222 11111 1223579999999999999
Q ss_pred eeeceeeeecCCCCceEEEEEeecccchHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEE
Q 016950 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (380)
Q Consensus 94 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nil 172 (380)
+++++++.. ....|+|++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||
T Consensus 226 v~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NIL 299 (501)
T PHA03210 226 LKIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIF 299 (501)
T ss_pred CcEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEE
Confidence 999998843 33478999999988877664321 112334567788899999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCC--CChH
Q 016950 173 VDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPG--ENAV 247 (380)
Q Consensus 173 l~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~--~~~~ 247 (380)
++. ++.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |.. .+..
T Consensus 300 l~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 300 LNC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred ECC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 996 77899999999986544322 2345789999999999654 589999999999999999998754 432 2344
Q ss_pred HHHHHHHHHhCCCCHHHHhh---cCCCCCCccCCCCCCCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 248 DQLVEIIKVLGTPTREEIRC---MNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
..+.+++..++....+.... .........+.... ......+ ...++.++.++|.+||++||.+|||+.|+|.|||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 55666665544332211000 00000000000000 0000111 1236788999999999999999999999999999
Q ss_pred ccccc
Q 016950 324 FDELR 328 (380)
Q Consensus 324 ~~~~~ 328 (380)
|....
T Consensus 457 f~~~~ 461 (501)
T PHA03210 457 FSAEE 461 (501)
T ss_pred hhcCC
Confidence 98753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=309.65 Aligned_cols=246 Identities=32% Similarity=0.534 Sum_probs=198.9
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4888999999999999999999999999999885332 123478999999999999999998743
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
..+.++++||+++ +|...+. ....+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence 3458899999986 6666665 33568899999999999999999999 79999999999999986 77899999
Q ss_pred ecccccCccCCC-------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016950 185 FGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (380)
Q Consensus 185 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 257 (380)
||.++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+....+..+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence 999876542211 1123567889999998654 47899999999999999999999998766544443322210
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
...++..++..+.++|++||+.||.+||++.++++||||
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=306.96 Aligned_cols=249 Identities=31% Similarity=0.457 Sum_probs=204.9
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 5999999999999999999999999999999885432 22357899999999999999998873 344588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +|++|+||+|+||+++.+++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999985 777776532 23458899999999999999999999 799999999999999875667899999999876
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
..........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------- 218 (256)
T ss_pred CCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence 55444444567889999999865 4478999999999999999999999988776555544432100
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..++..+++++.+++.+||+.||++|||+.++++||||
T Consensus 219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.61 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=203.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|...+.||+|+||.||++.+..+++.+|+|.+.... ....+|+.++.++. |+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcE
Confidence 46778889999999999999999999999999886432 22346888888885 99999999988543 337
Q ss_pred EEEeecccchHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++|||+..++..+.... ......+++..+..++.|++.||+|||+..+++||||||+||+++. ++.++|+|||++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~ 157 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHH
Confidence 799999987665544321 2234679999999999999999999997249999999999999996 77899999999876
Q ss_pred CccCCCcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...........+++.|+|||++.+. ..++.++|+||+||++|+|++|+.||..... ....+.+......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~------- 228 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP------- 228 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-------
Confidence 5444333445678899999998655 3689999999999999999999999976542 2222222111000
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
+. .....+..++.++.+||.+||+.||++|||+.+++.||||+...+.
T Consensus 229 ---------~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 229 ---------PI-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276 (288)
T ss_pred ---------Cc-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence 00 0011123478999999999999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=313.67 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=203.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|++.+.||.|++|.||++.+..+++.||+|.+.... ....+|+.+++.++|+|++++++.+.. ....|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence 457999999999999999999999999999999886433 233478999999999999999998843 33588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+.+ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhc
Confidence 99999985 6666554 2457889999999999999999999 79999999999999986 778999999998754
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+.. .+.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 235 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE--------- 235 (296)
T ss_pred cccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC---------
Confidence 33322 223467889999999854 4478999999999999999999999987765444332221 01100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...+..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00123478899999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=327.17 Aligned_cols=238 Identities=28% Similarity=0.435 Sum_probs=204.2
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-ch
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ES 121 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 121 (380)
++.||.|+.|.||+++. .++.||||++.. ....+++-|+.|+|+||+.+.+++ ....++|||||||. |.
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 78899999999999986 678999998853 345789999999999999999998 55667999999999 67
Q ss_pred HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceee
Q 016950 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201 (380)
Q Consensus 122 l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~ 201 (380)
|.++|+ ....++......+..+|+.|+.|||. +.|||||||.-||||.. +..|||+|||-++.........+++
T Consensus 199 L~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhhhh
Confidence 888887 57788999999999999999999999 89999999999999996 7789999999999887777788899
Q ss_pred ccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCC
Q 016950 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 281 (380)
Q Consensus 202 ~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (380)
||..|||||++... .++.++|||||||+|||||||..||..-+...++- .. .
T Consensus 273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GV-----------------------G 324 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GV-----------------------G 324 (904)
T ss_pred hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----ec-----------------------c
Confidence 99999999999654 59999999999999999999999998766443221 11 1
Q ss_pred CCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 282 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+.++-..+..++..++-||++||+-.|..||+..++|.|==+
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 2233344566789999999999999999999999999998443
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=309.06 Aligned_cols=250 Identities=30% Similarity=0.500 Sum_probs=197.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 36999999999999999999999999999999875321 1235799999999999999999877432 23
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+++++||+++ +|.+.+. ....+++...+.++.|++.||+|||+ ++++||||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~ 152 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCC
Confidence 357899999985 6766664 33468899999999999999999999 79999999999999986 77899999999
Q ss_pred cccCccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+.......+... +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~-- 226 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT-- 226 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC--
Confidence 87543211 1122457888999999865 45899999999999999999999999876554443332211 00
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
...++..+++.++++| +||..+|++||++.++++||||+
T Consensus 227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0112234688899999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.28 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=202.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+.+++.++|+||+++++.+. .....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 488999999999999999999999999999988532 222346889999999999999999883 334588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence 99999975 777766532 24678999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....+++.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43322 2234678899999998654 488999999999999999999999988876555544432100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+ .++..+++.+.+++.+||+.+|++||++.++++|||+
T Consensus 219 -------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -------P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 0112368899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=311.36 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
-|++.+.||.|+||.||++.+..++..+++|.+.... ....+|+.+++.++|+|++++++.+.. ....|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence 4789999999999999999999999999999885432 223468999999999999999998843 3358899
Q ss_pred eecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+||++++ +...+.. ....+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTR 155 (282)
T ss_pred EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEccccccccccc
Confidence 9999964 4344432 34578999999999999999999999 79999999999999986 77899999999875432
Q ss_pred CC-CcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 194 GE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.. ......+++.|+|||++.. ...++.++|+||+||++|+|++|.+||...+..+....+.......
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (282)
T cd06643 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------- 227 (282)
T ss_pred cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence 21 1223467889999999742 2346789999999999999999999998877666555543311100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...+..++.++.+||.+||+.||.+||++.++++||||+..
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00122368899999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=314.81 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=203.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...+|++.+.||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. .....
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence 3467999999999999999999999999999999886432 22346889999999999999999884 33458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||++..
T Consensus 92 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~ 164 (297)
T cd06656 92 WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 164 (297)
T ss_pred EEeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceE
Confidence 899999986 5655553 2457889999999999999999999 79999999999999986 78899999999876
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+....+..+.. .+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~-------- 234 (297)
T cd06656 165 ITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE-------- 234 (297)
T ss_pred ccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC--------
Confidence 533322 223467889999999854 4588999999999999999999999977654332221111 01100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+..++..+.+|+.+||..||.+||++.++++||||+..+
T Consensus 235 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 -----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 011234688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=310.92 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=203.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCC-CCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~ 110 (380)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....|+.+++.+ +|+||+++++++..... ....+
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 3467999999999999999999999999999999885442 2334688888888 79999999998864322 23456
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|++|||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~ 169 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchh
Confidence 8899999986 676666532 24568889999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccC-CCcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
..... .......+++.|+|||.+.. ...++.++|+|||||++|+|++|..||...........+... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~--- 243 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP--- 243 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC---
Confidence 54322 22234568889999999852 234788999999999999999999999766544333322110 00
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.......++.++.+||++||..||.+|||+.++++||||
T Consensus 244 ---------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ---------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ---------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000112468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=316.49 Aligned_cols=277 Identities=26% Similarity=0.404 Sum_probs=202.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ....+|+++++.++||||+++++++.. ...+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEE
Confidence 36999999999999999999999999999999885432 223479999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+.. ...+++..+..++.|++.||.|||+..+++||||||+||+++. ++.++|+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence 99999985 66666652 3678999999999999999999997248999999999999996 778999999998755
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..... ....................
T Consensus 151 ~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 151 IDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCccccc
Confidence 332 22345778999999998554 4889999999999999999999999876533322 22211000000000000000
Q ss_pred CCCccCCC----------CCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 272 YTDFRFPQ----------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 272 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
......+. .........-...++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000000 000000000011267889999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.24 Aligned_cols=252 Identities=29% Similarity=0.526 Sum_probs=200.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+|+..+.||+|++|.||++.+..+++.+|+|++.... ....+|+.+++.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 4888999999999999999999999999999886432 2235799999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+++|+||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++..++|+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 458899999996 66666652 3568899999999999999999999 79999999999999987555799999999
Q ss_pred cccCccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+........ .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 226 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--- 226 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence 876543211 123456888999999865 45889999999999999999999999765433322222211000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
.....++..+++++.+++.+||..+|++|||+.++++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000112234789999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=309.88 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=199.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.+++.++||||+++++.+.. ...+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEE
Confidence 4589999999999999999999999999999998864321 23578999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+. ..+.+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeEc
Confidence 99999986 6666654 34578999999999999999999999 79999999999999996 778999999998654
Q ss_pred ccCC-CcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ......++..|+|||++.. ...++.++|+||+||++|+|++|..||........+......
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------ 224 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc------------
Confidence 3221 2234578899999999742 334788999999999999999999999766544333222111
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
.+..+. +.. ...++..+.++|.+||+.||++|||++++++|||
T Consensus 225 -----~~~~~~-----~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -----NFQPPK-----LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----CCCCCc-----ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000000 000 1136788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=307.47 Aligned_cols=246 Identities=28% Similarity=0.479 Sum_probs=199.7
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||.|++|.||+|.+..+++.||+|++.+.. ....+|+.+++.++|+||+++++.+.. ....|+++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 689999999999999999999999986432 223578999999999999999998743 34488999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
++ +|.+.+.. ...+++..+..++.||+.||+|||+ +|++|+||+|+||+++. ++.++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence 85 67666652 3458999999999999999999999 89999999999999996 778999999999876544333
Q ss_pred ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCCCCCCc
Q 016950 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275 (380)
Q Consensus 198 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 275 (380)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.... ..+....+.... ...
T Consensus 150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~ 213 (262)
T cd05572 150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN---------------GKL 213 (262)
T ss_pred ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC---------------CCC
Confidence 44567889999999854 448999999999999999999999998766 333333332100 001
Q ss_pred cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
.++...++++.++|.+||+.||++|++ +.|+++||||++++|.
T Consensus 214 ------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 214 ------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 122335889999999999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=310.10 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=198.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|+||+++++.+.. ...+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEE
Confidence 457999999999999999999999999999999886432 234579999999999999999988843 33588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+. ....+++..+..++.|++.||+|||+ +||+||||+|+||+++. ++.++|+|||++...
T Consensus 83 iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCccceee
Confidence 99999985 6666554 34568999999999999999999999 79999999999999986 778999999999765
Q ss_pred ccCC-CcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ......+++.|+|||.+.+ ...++.++|+||+||++|+|++|..||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 224 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------ 224 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------
Confidence 3322 2234567889999998742 334788999999999999999999999655433222111110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
.+..+. +. ....++..+.+||++||+.||++|||++++++|+|
T Consensus 225 -----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 -----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 00 01236889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.31 Aligned_cols=248 Identities=33% Similarity=0.533 Sum_probs=201.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|+..+.||+|++|+||+|.+..+++.|++|.+.... ....+|+.+++.++|+||+++++.+. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4888899999999999999999899999999875432 22457999999999999999998773 334
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+++||+++ +|.+.+. ....+++..+..++.||+.||+|||+ .|++|+||+|+||+++. ++.+||+|||.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence 58899999986 6666664 33568899999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.............++..|+|||.+.....++.++|+||+||++|+|++|..||......+....+......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------- 220 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--------- 220 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence 76544443345567889999999854434889999999999999999999999776644444333221000
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..++..+++.+.+++.+||+.+|.+||++.+++.|||+
T Consensus 221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 01233478999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=306.16 Aligned_cols=250 Identities=29% Similarity=0.473 Sum_probs=202.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
++|++.+.||.|+||.||+|....+++.+|+|.+.... ....+|+.+++.++|+||+++++.+.. ...+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence 57999999999999999999999989999999986543 345689999999999999999998843 34588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhcccC
Confidence 99996 66666542 34678999999999999999999999 79999999999999996 778999999998865443
Q ss_pred C-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
. ......++..|+|||++.+. .++.++|+||+||++|+|++|..||...+.......+... . ..
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------~~ 217 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---P-----------PP 217 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---C-----------CC
Confidence 3 22334578889999998654 5899999999999999999999999876544332221110 0 00
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+ ..+..++..+.++|.+||+.||++|||+.+++.||||
T Consensus 218 ~~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 TL------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CC------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 0122367899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=306.68 Aligned_cols=247 Identities=28% Similarity=0.472 Sum_probs=197.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+|++.+.||.|+||.||+|.. .+++.+|+|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 588999999999999999986 578899999875332 12357999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...++++||+++ +|.+.+. ....+++..++.++.|++.||+|||+ .+++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence 568899999986 6666654 33568899999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccC-------CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 188 AKQLIAG-------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 188 a~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
+...... .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8754211 11123457889999999855 44889999999999999999999999876655444333221110
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
...++..++.++.++|++||+.+|.+||++.++++||||
T Consensus 227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011223478999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=294.59 Aligned_cols=268 Identities=25% Similarity=0.421 Sum_probs=214.6
Q ss_pred eecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch--H---HHHHH-HHhCCCCceeeece
Q 016950 25 TTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK--N---RELQL-MRVMDHPNVISLKH 98 (380)
Q Consensus 25 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~---~e~~~-l~~l~h~niv~~~~ 98 (380)
.++++....+...++...+..||.|+.|+|++++.+.+|...|||.+....... + ..+.+ ++....|+||+.++
T Consensus 79 lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 79 LTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred EEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 366655566667788899999999999999999999999999999996432211 1 22222 22335899999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
+|....+ +++.||.|..=+..+++. ..++++|..+-.+...++.||.||...+||+|||+||+|||+|. .+
T Consensus 159 yFi~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~G 229 (391)
T KOG0983|consen 159 YFITNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RG 229 (391)
T ss_pred EEeeCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CC
Confidence 9976554 678899987544444442 34679999999999999999999998689999999999999996 88
Q ss_pred cEEEEeecccccCccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHH
Q 016950 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIK 255 (380)
Q Consensus 179 ~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-~~~~~~~i~~ 255 (380)
++||||||++..+.+....+...|-+.|||||.+.- ...|+.++||||||+.++||.||..||.+.+ +.+.+.++.+
T Consensus 230 niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 230 NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 999999999998887777777889999999999843 3458999999999999999999999999854 4566666655
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. .|+. ++ ....+|+.+++|+..||++|+.+||.-.++|+|||+...
T Consensus 310 ~--ePP~--------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 310 E--EPPL--------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred c--CCCC--------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 2 1110 00 012379999999999999999999999999999999865
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=307.09 Aligned_cols=246 Identities=27% Similarity=0.444 Sum_probs=201.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++||||+++++.+ .+....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 5899999999999999999999999999999886432 2335789999999999999999887 444568
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+|+||+.+ +|...+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence 999999986 66655542 3578999999999999999999999 79999999999999996 77899999999886
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+. .+.+......
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 6544333445678889999998554 489999999999999999999999987764 2222211110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH--HHHhcCCCc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF 324 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~e~l~hp~~ 324 (380)
....++..++..+.++|.+||+.||.+|+++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0111233468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=309.56 Aligned_cols=251 Identities=29% Similarity=0.427 Sum_probs=198.6
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||+|+||+||+|.+..+|+.||+|.+.... .....|+.+++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999999999999885421 1224689999999999999998888 3344588999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
++ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||.+.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence 85 666666532 22468999999999999999999999 79999999999999996 778999999998765443333
Q ss_pred ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccC
Q 016950 198 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277 (380)
Q Consensus 198 ~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 277 (380)
....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...........+.....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 211 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------------- 211 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------
Confidence 3456788899999986554 89999999999999999999999977654222222111000
Q ss_pred CCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCC
Q 016950 278 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331 (380)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 331 (380)
.....++..+++.+.++|.+||+.||++|| ++.++++||||..+.+..
T Consensus 212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 212 ------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred ------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 000112334689999999999999999999 899999999999887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=329.12 Aligned_cols=248 Identities=27% Similarity=0.481 Sum_probs=203.7
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 120 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (380)
+||+|.||+||-|++..+...+|||.+.... +-..+|+.+.+.|+|.|||++.+++ ..+.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 7999999999999999999999999986432 2345899999999999999999987 555578899999996
Q ss_pred -hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC-
Q 016950 121 -SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA- 196 (380)
Q Consensus 121 -~l~~~l~~~~~~~~~l--~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~- 196 (380)
+|.++++. .=+++ .+..+.+|..||+.||+|||. +.|+|||||-+|+|++.-+|.+||+|||-++....-..
T Consensus 657 GSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 66666653 23455 788899999999999999999 89999999999999998889999999999987655433
Q ss_pred cceeeccCCCCChhhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCc
Q 016950 197 NISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 275 (380)
..++.||..|||||++.. ...|+.++|||||||++.||.||++||..........-.....
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------ 794 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------ 794 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------
Confidence 446789999999999954 3569999999999999999999999998655433221111100
Q ss_pred cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.-+..+|..+|.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus 795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 01222455689999999999999999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=308.70 Aligned_cols=310 Identities=28% Similarity=0.419 Sum_probs=236.4
Q ss_pred ccCCCCCcccceEEeecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHh
Q 016950 11 VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRV 87 (380)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~ 87 (380)
-++-.++..|++.++.+++.-. ..+|.+.++||-|-|++||+|.+..+.+.||+|+++....+. ..|+++|++
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~----~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~ 130 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFN----GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQ 130 (590)
T ss_pred ccChhhhhcCCCceeecccccc----CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHH
Confidence 3445568889999998887744 258999999999999999999999999999999997665443 479999998
Q ss_pred CC--------CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 88 MD--------HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 88 l~--------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
++ ..+||++++.|-... .+..++|+|+|+++.+|+.+|... .-+.++...++.|+.||+.||.|||+..
T Consensus 131 v~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 131 VREGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred HHhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 83 346999999885443 667789999999999999999864 4467899999999999999999999867
Q ss_pred CeeecCCCCCCEEEcC----------------------------------------------------------------
Q 016950 160 RVCHRDLKPQNLLVDP---------------------------------------------------------------- 175 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~---------------------------------------------------------------- 175 (380)
||||-||||+|||+..
T Consensus 208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~ 287 (590)
T KOG1290|consen 208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS 287 (590)
T ss_pred CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence 9999999999999840
Q ss_pred --------------------------------------------------C-----------------------------
Q 016950 176 --------------------------------------------------L----------------------------- 176 (380)
Q Consensus 176 --------------------------------------------------~----------------------------- 176 (380)
.
T Consensus 288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s 367 (590)
T KOG1290|consen 288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS 367 (590)
T ss_pred hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence 0
Q ss_pred ----------------------CCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHH
Q 016950 177 ----------------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234 (380)
Q Consensus 177 ----------------------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~l 234 (380)
+-++||+|||.|.... ...+.-+.|+.|+|||++.|.. |+..+||||++|++|||
T Consensus 368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FEL 444 (590)
T KOG1290|consen 368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFEL 444 (590)
T ss_pred cCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHh
Confidence 0025666666654431 1223346789999999999876 99999999999999999
Q ss_pred HhCCCCCCCC------ChHHHHHHHHHHhCCCCHHHHhhcCCC------CCC-ccCCCCCCCCcccccC------CCCCh
Q 016950 235 LLGQPLFPGE------NAVDQLVEIIKVLGTPTREEIRCMNPN------YTD-FRFPQIKAHPWHKVFH------KRMPP 295 (380)
Q Consensus 235 l~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~------~~~~~ 295 (380)
+||...|... ...+-+..|++.+|..+......=... ..+ ..+..++..++...+. ..-..
T Consensus 445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~ 524 (590)
T KOG1290|consen 445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ 524 (590)
T ss_pred hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence 9999999522 356789999999999887654321100 000 0112222222222221 12345
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 296 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 296 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
++.|||.-||+++|++|+||.++|+|||++.+-.+
T Consensus 525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 68899999999999999999999999999986443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=319.22 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=199.0
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
.+.+++.||+|.||.|+.+....+ ..||+|.+... .....+|+.+|+.|+|+|||++++++.... -+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence 456688999999999999987432 37899988643 233458999999999999999999984322 489999
Q ss_pred eccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+. |+|++.|+. ..+..+.......++.|||.|++||++ +++|||||-..||||+. +..+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccccccCCC
Confidence 9998 789998875 356788999999999999999999999 79999999999999996 789999999999944333
Q ss_pred CCcceeec---cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 195 EANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 195 ~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... ...+ ..-|.|||.+.. ..++.+||||||||+||||+| |+.||.+.+..+.+..+.+....|-
T Consensus 357 ~Y~-~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------- 425 (468)
T KOG0197|consen 357 EYT-ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------- 425 (468)
T ss_pred cee-ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence 222 2222 345999999954 559999999999999999998 9999999999999888876432222
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
|..+|+++-+++..||+.+|++|||.+.+.
T Consensus 426 -------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 -------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 345899999999999999999999998654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.32 Aligned_cols=250 Identities=27% Similarity=0.387 Sum_probs=191.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHH---hCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---VMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.||+|+||.||++.+..+++.+|+|.+.+... ...+|..+++ ..+|+||+.+++.+.. ....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 48999999999999999999999998854321 1123333333 3479999999888843 3348899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+.+ +|...+. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 999996 5555554 34579999999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.. .....+|+.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~--------------- 212 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL--------------- 212 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence 22 223468999999999864455889999999999999999999999765322111 1111000
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 332 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~~ 332 (380)
.....++..+++++.++|.+||..||++|+ |+.++++||||+.+++...
T Consensus 213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 266 (279)
T cd05633 213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266 (279)
T ss_pred ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence 000112334789999999999999999999 6999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=302.35 Aligned_cols=248 Identities=31% Similarity=0.479 Sum_probs=204.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 5999999999999999999999999999999875332 223579999999999999999999843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|||+++ +|.+.+... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence 99999985 777776532 24568999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+... ....
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~-------- 220 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTP-------- 220 (256)
T ss_pred ccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC--------
Confidence 4333 22345678999999998654 4789999999999999999999999887766666555431 1100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+..++.++.++|.+||+.+|.+||++.++++|||+
T Consensus 221 ------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 ------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 012368899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=306.21 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=203.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ...+|+++++.++|+||+++++++... ....+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence 469999999999999999999999999999998864322 345799999999999999999887543 233478
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+.........+++..+..++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~ 155 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence 99999985 6766665544456678999999999999999999999 79999999999999996 778999999998754
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 266 (380)
..... ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||..... .+....+.. .....+
T Consensus 156 ~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~- 228 (287)
T cd06621 156 VNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL- 228 (287)
T ss_pred ccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence 33221 23456788999999854 4589999999999999999999999976522 121111111 000000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
+. .. ......++.+.+||.+||..+|++|||+.|++.||||++..
T Consensus 229 -----------~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 229 -----------KD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred -----------cc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 00 00 00012467899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=312.09 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=203.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.+.|.....||+|+||.||++.+..+++.||||.+.... ....+|+.+++.++|+||+++++.+.. ....|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEE
Confidence 345777788999999999999999999999999885432 223478999999999999999998843 34588
Q ss_pred EEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||++++ |.+.+. ...+++..+..++.||+.||+|||+ +|++||||||+||+++. ++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~ 168 (292)
T cd06658 96 VVMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhc
Confidence 999999874 444442 3468899999999999999999999 79999999999999996 678999999998754
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+....+..+........
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 238 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV--------- 238 (292)
T ss_pred ccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc---------
Confidence 3322 2234567899999999854 4588999999999999999999999988766555443332111000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
+ .....+..+.+++.+||..||++|||+.++++||||+....+
T Consensus 239 -------~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 239 -------K----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred -------c----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 011368899999999999999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=304.56 Aligned_cols=246 Identities=32% Similarity=0.512 Sum_probs=194.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||.|+||.||+|.+..+++.||+|.+.+... ....|.. +....+|+|++++++++. ....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 568999999999999999999999998864321 1122333 334558999999999883 344589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|...+. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence 99986 6666654 33568999999999999999999999 79999999999999996 77899999999875432
Q ss_pred CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 195 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 195 ~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 210 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------- 210 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 22345788899999986654 89999999999999999999999988776655544432100
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC---HHHHhcCCCcccccC
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE 329 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~ 329 (380)
. +.......+++.+.++|.+||+.||++||+ ++|+++||||++++|
T Consensus 211 -~--------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 211 -N--------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred -C--------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 0 111112247899999999999999999995 579999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=303.35 Aligned_cols=291 Identities=33% Similarity=0.573 Sum_probs=231.7
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..|.+.-+.+..+-||-|+||.||.+.+..+|+.||+|++..- .....+|+++|..++|.|++...++.....-
T Consensus 47 h~Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~ 126 (449)
T KOG0664|consen 47 HPPQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP 126 (449)
T ss_pred CCccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc
Confidence 3455556677888999999999999999999999999998532 2334589999999999999998887644332
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.-...+|+++|.+..+|..++- ..+.++...++-+++||++||+|||+ .+|.||||||.|+|+++ +..+|||||
T Consensus 127 dfFqEiYV~TELmQSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDF 200 (449)
T KOG0664|consen 127 SFFQELYVLTELMQSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDF 200 (449)
T ss_pred hHHHHHHHHHHHHHhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEeccc
Confidence 2223367888888877665553 56789999999999999999999999 79999999999999997 888999999
Q ss_pred cccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 186 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|+++....... .+..+.|.+|+|||+++|...|+.++||||.|||+.||+..+..|...+..+++..|...+|+|+.+
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 99986544332 2345679999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCccCCCC-CCCCccccc----CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 264 EIRCMNPNYTDFRFPQI-KAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.++...+......+..- +...+...+ +..-..+..+++.+||..||..|++.++++.|++..+.+
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 88754333222111111 111111111 112345788999999999999999999999999997754
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.18 Aligned_cols=248 Identities=25% Similarity=0.434 Sum_probs=202.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++.+++ ......|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 5999999999999999999999999999999885321 2345789999999999999999988 4445689
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence 99999985 67666653 123467899999999999999999999 79999999999999986 778999999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....+++.|+|||++.+. .++.++|+||+||++|+|++|..||...+..+....+... ..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SYP--------- 219 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CCC---------
Confidence 43322 1234578889999998654 4788999999999999999999999877766655554331 000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus 220 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=304.54 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=192.9
Q ss_pred ccceeeeeee--ecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.+.|++.+.+ |+|+||.||++.++.+++.+|+|.+...... ..|+.....+ +|+||+++++.+.. ...+|+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~i 86 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVL 86 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEE
Confidence 4567777776 9999999999999999999999998654322 1233333323 79999999998843 335899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.+++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 9999984 77777653 3478999999999999999999999 7999999999999999744489999999987553
Q ss_pred cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. ....++..|+|||++.+. .++.++|+||+||++|+|++|..||........ ..........
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 225 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------------ 225 (267)
T ss_pred CC---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc------------
Confidence 22 234678899999999654 489999999999999999999999986543321 1111111000
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-HHHHhcCCCccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE 326 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~hp~~~~ 326 (380)
....++.+++.+.+||.+||+.||.+|++ ++++|+||||++
T Consensus 226 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 --------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred --------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112247999999999999999999996 599999999974
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=309.54 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=203.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 36999999999999999999999999999999886432 1223788999999999999999887 33446
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||++| +|.+.+. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCcc
Confidence 8999999986 6666664 34568999999999999999999999 79999999999999986 7889999999986
Q ss_pred cCccCC----------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 016950 190 QLIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (380)
Q Consensus 190 ~~~~~~----------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i 253 (380)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 321100 0112356778999999865 45899999999999999999999999887766555544
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC---HHHHhcCCCcccccCC
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 330 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 330 (380)
.... ...+. ....++.++.++|.+||+.||++||+ +.++++||||....+.
T Consensus 229 ~~~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 229 ISDD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred Hhcc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 3311 00010 00136889999999999999999997 7899999999775543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=304.32 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=198.4
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 5899999999999999999999999999999874211 1234688999999999999999887
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
......++||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ ++++||||+|+||+++. ++.++|+
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~ 150 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS 150 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence 333458899999985 66666653 3578999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCccCC---CcceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 184 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 184 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|||++....... ......++..|+|||.+.... .++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 229 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS- 229 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence 999987543221 122345688899999986543 478999999999999999999999976554433332211000
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.. .+...+...++..+.++|.+||..+|.+|||+.++++||||
T Consensus 230 --------------~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 --------------AP--------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------CC--------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 01111223468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=303.25 Aligned_cols=253 Identities=28% Similarity=0.422 Sum_probs=202.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+|+.+++.++|+||+++++.+.. ...+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEE
Confidence 357999999999999999999999999999999986432 234579999999999999999988843 33588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~ 151 (262)
T cd06613 77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQL 151 (262)
T ss_pred EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhh
Confidence 99999996 55555542 23578999999999999999999999 79999999999999996 778999999998765
Q ss_pred ccCC-CcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ......++..|+|||.+.+. ..++.++|+||+||++|+|++|..||...+.......+....-.+.
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 224 (262)
T cd06613 152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------- 224 (262)
T ss_pred hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------
Confidence 4322 22335678889999998543 2578899999999999999999999988776555444332100000
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
. .......+.++.+||.+||+.+|.+|||+.+++.|||
T Consensus 225 ----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ----------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0011235788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=316.35 Aligned_cols=280 Identities=31% Similarity=0.515 Sum_probs=227.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCC------CCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD------HPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~~ 108 (380)
.+|.+....|.|-|++|.+|.+...|+.||||++..... ...+|+++|+.|+ --|.++++..| ...
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~hk 506 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KHK 506 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hhc
Confidence 479999999999999999999999999999999976543 2348999999995 35788888888 455
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.++|+|+|-+.-+|.++++.+.. +-.|....++.|+.||..||+.|.. .||+|.||||+|||++.....+||||||.|
T Consensus 507 nHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCccc
Confidence 56999999999999999998764 4568889999999999999999999 699999999999999987889999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.....+. .+.++.+..|+|||++.|-+ |+...|+||.||+||||.||+..|+|.+...++...+.+-|..+...++.-
T Consensus 585 ~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 8765443 34577788999999998866 999999999999999999999999999999999999999999888766531
Q ss_pred -------CCCCCCc--c------------CCCCCC-CCcccccCC--CC-------ChHHHHHHHhhcccCCCCCCCHHH
Q 016950 269 -------NPNYTDF--R------------FPQIKA-HPWHKVFHK--RM-------PPEAIDLASRLLQYSPSLRCTALE 317 (380)
Q Consensus 269 -------~~~~~~~--~------------~~~~~~-~~~~~~~~~--~~-------~~~~~~li~~~L~~dp~~R~t~~e 317 (380)
..++.-+ . +...+. ..+...+.. .+ -..+++||.+||..||++|+|+.|
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 1111100 0 000000 111111110 11 245889999999999999999999
Q ss_pred HhcCCCccc
Q 016950 318 ACAHPFFDE 326 (380)
Q Consensus 318 ~l~hp~~~~ 326 (380)
+|.||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=303.33 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=198.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++.+.||+|+||.||++.+..+++.||||.+.... ....+|+.+++.++|+||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 46999999999999999999999999999999874321 1234699999999999999998877332 23
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..++++|||+++ +|.+.+. ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~ 152 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA 152 (265)
T ss_pred ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence 457899999985 6666654 23457889999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT-- 226 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence 87543211 1223457888999999865 4589999999999999999999999987654444332221 110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
...++..++..+.++|++||. +|.+||+++++++|||+.
T Consensus 227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011223468899999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=310.05 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=202.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence 45999999999999999999999999999999885322 1234789999999999999999988543 34
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+|+||+.+++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++..
T Consensus 90 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCccee
Confidence 789999999988776653 23568999999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ....+++.|+|||++.+ ...++.++|+||+|+++|+|++|..||.+.+.......+... ..+
T Consensus 165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~-------- 232 (307)
T cd06607 165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------- 232 (307)
T ss_pred cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC--------
Confidence 4322 23467888999998742 345788999999999999999999999877665544333221 000
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.. .....+..+.++|.+||+.||.+||++.+++.||||..-
T Consensus 233 -------~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 233 -------TL-----------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -------CC-----------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00 011257889999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=305.44 Aligned_cols=240 Identities=17% Similarity=0.196 Sum_probs=192.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
..||+|++|.||++.. +|+.||+|.+.... ....+|+.+++.++||||+++++++.+.. ++..++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5789999999999987 78999999986432 22348999999999999999999885422 22345789999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
|+++ +|.+.+. ....+++.....++.|++.||.|||+..+++||||||+||+++. ++.+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhccc-
Confidence 9996 5666665 34578899999999999999999997238999999999999996 788999999998765332
Q ss_pred CcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 196 ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 196 ~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
.....+++.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 2345678899999998642 458999999999999999999999999887666655544321111
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ++..+++++.+|+.+||+.||++|||+.++++
T Consensus 242 -~------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -K------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -C------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 12246899999999999999999999999974
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=305.26 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=193.0
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHH---HHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNREL---QLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.||+|+||.||+|.+..+++.||+|.+.+.... ...|. .+++...|++|+.+.+.+ ......|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999999999999988643211 12232 344456899999998888 334458899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+.| +|...+. ....+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||++.....
T Consensus 76 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 76 LDLMNGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 999986 5544443 34679999999999999999999999 79999999999999996 77899999999875433
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
. ......++..|+|||++.+...++.++|+||+||++|+|++|..||.......... +...... .
T Consensus 150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~-------------~ 214 (278)
T cd05606 150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT-------------M 214 (278)
T ss_pred c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc-------------c
Confidence 2 22345789999999998655558899999999999999999999998763221111 0000000 0
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA 332 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~~ 332 (380)
...++..+++++.+++.+||..+|.+|+ ++.++++||||+...+...
T Consensus 215 ------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 215 ------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred ------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 0112234689999999999999999999 9999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=299.33 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=201.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|.+.+.||.|+||.||++.+..++..+|+|.+... .....+|+.+++.++|+||+++++.+ ......|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 589999999999999999999999999999988542 22345799999999999999999887 3344589
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+.+ +|.+.+.. .....+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++..++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999985 67666643 123457899999999999999999999 799999999999999875556899999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 43322 1234578889999998544 48899999999999999999999998776555444332210
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
. ..+...++.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 00112368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=303.60 Aligned_cols=251 Identities=29% Similarity=0.530 Sum_probs=200.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||.|++|.||+|.++.+++.+|+|.+.... ....+|+.+++.++|+||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence 36889999999999999999999999999999886542 123478999999999999999988843 34588
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+++||++ ++|.+.+... ...+++..+..++.|++.||.|||+..|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~ 151 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence 9999999 5777666532 2678999999999999999999999239999999999999997 778999999998755
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+ ..+.+..+.. .+.
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----- 221 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP----- 221 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-----
Confidence 332222 26678889999998654 58999999999999999999999997652 1122211111 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCC-CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+. .+. .++++++++|.+||..||.+|||+.+++.||||+..
T Consensus 222 -----------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 222 -----------PR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -----------CC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 111 168899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=304.33 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=202.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..|+..+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence 45889999999999999999999999999999886432 123478999999999999999998843 34589
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+. ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06640 79 IIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceec
Confidence 99999986 6666554 2468889999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... .
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~------------ 217 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-N------------ 217 (277)
T ss_pred cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-C------------
Confidence 43332 2234568889999998654 4899999999999999999999999876654433222110 0
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+...++..+.+++.+||+.+|.+||++.++++||||.+..
T Consensus 218 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 218 ---------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ---------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 0012223678999999999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.76 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=200.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+.|+..+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. .....|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence 35888899999999999999999999999999886432 12357999999999999999999884 344588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+. ...+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccc
Confidence 99999996 5555543 3568899999999999999999999 89999999999999986 778999999998765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------- 216 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------------- 216 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence 43322 2234578889999998554 5889999999999999999999999765544333221110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
....+...++..+.++|.+||+.+|++|||+.++++||||....
T Consensus 217 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 217 --------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred --------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 00011234688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=319.97 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=205.4
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
-|..++.||-|+||.|.++...+|...||+|.+.+.... .+.|.+||..-+.+-||+++-.| +++..+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 488999999999999999999999999999988654322 24688899999999999999998 555569
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||+|++| ++..+|- .-+-|.|..+++|+.+|..|+++.|.+ |+|||||||+|||||. +|.|||+|||++..
T Consensus 705 YFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDr-dGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDR-DGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEcc-CCceeeeecccccc
Confidence 999999996 5666554 357799999999999999999999995 9999999999999997 78899999999853
Q ss_pred Cc---------cC-------------------C---------------CcceeeccCCCCChhhhhCCCCCCchhhHHHH
Q 016950 191 LI---------AG-------------------E---------------ANISYICSRFYRAPELIFGATEYTTSIDIWSA 227 (380)
Q Consensus 191 ~~---------~~-------------------~---------------~~~~~~~t~~y~aPE~l~~~~~~~~~~Diwsl 227 (380)
+. .+ + ...+.+||+.|+|||++.. ..|+..+|+||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHh
Confidence 20 00 0 0014578999999999965 459999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhccc
Q 016950 228 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 307 (380)
Q Consensus 228 Gvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 307 (380)
|||||+|+.|++||......+.-.+++.... .++-.+..++|.++.+||.++.+
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-------------------------~l~~~~~~~ls~e~~~li~kLc~- 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWRN-------------------------FLHIPYQGNLSKEALDLIQKLCC- 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehhh-------------------------ccccccccccCHHHHHHHHHHhc-
Confidence 9999999999999988876665554443110 01111234689999999999765
Q ss_pred CCCCCCC---HHHHhcCCCcccccCCC
Q 016950 308 SPSLRCT---ALEACAHPFFDELREPN 331 (380)
Q Consensus 308 dp~~R~t---~~e~l~hp~~~~~~~~~ 331 (380)
+++.|+. ++|+..||||+.+.+..
T Consensus 912 sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccchHh
Confidence 7889984 67899999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=306.78 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 95 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~ 95 (380)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998532 34579999886432 12347999999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS---------------ANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~---------------~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
+++++... ...++||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~ 157 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-L 157 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-C
Confidence 99988433 348899999985 77776653211 12346788899999999999999999 7
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 236 (380)
||+||||||+|||++. ++.+||+|||+++....... .....++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHH
Confidence 9999999999999996 77899999999976533321 1123346789999998654 58999999999999999986
Q ss_pred --CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC
Q 016950 237 --GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 314 (380)
Q Consensus 237 --g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 314 (380)
+..||.+.+..+.+..+.......... .....+..+++.+.+|+.+||+.||.+|||
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 668888776655554443321100000 000112347889999999999999999999
Q ss_pred HHHHh
Q 016950 315 ALEAC 319 (380)
Q Consensus 315 ~~e~l 319 (380)
+.++.
T Consensus 295 ~~~i~ 299 (304)
T cd05096 295 FSDIH 299 (304)
T ss_pred HHHHH
Confidence 99984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=316.62 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=192.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|.+... ++.||+|++.... ....+|+.+++.+ +|+||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence 45799999999999999999986543 3579999986432 1234799999999 89999999998833
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh-----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (380)
...+|+||||+.+ +|.+.+.....
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 3348899999984 77777643211
Q ss_pred -------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcc
Q 016950 132 -------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 198 (380)
Q Consensus 132 -------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~ 198 (380)
....+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCccee
Confidence 12347888899999999999999999 89999999999999996 7889999999987653332111
Q ss_pred ---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 199 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 199 ---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
...+++.|+|||++.+ ..++.++||||+||++|+|++ |..||........+..+......
T Consensus 270 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~--------------- 333 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ--------------- 333 (374)
T ss_pred eccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC---------------
Confidence 1223567999999865 458999999999999999997 99999876554444333331000
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++++.+++.+||+.||.+|||+.++++
T Consensus 334 ------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 ------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011236899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.70 Aligned_cols=247 Identities=29% Similarity=0.481 Sum_probs=192.6
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
...||+|+||.||++.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. .....++|+||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEecC
Confidence 457999999999999999999999999886432 23457999999999999999998873 334588999999
Q ss_pred cc-hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 119 PE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l--~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
.+ +|...+... ...+ ++..+..++.||+.||.|||+ +||+||||||+||+++...+.++|+|||++.......
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 85 676666531 2334 788888999999999999999 8999999999999998656789999999987553322
Q ss_pred C-cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 196 A-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 196 ~-~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
. .....+++.|+|||++.+. ..++.++|+||+|+++|+|++|..||...+.............
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--------------- 228 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc---------------
Confidence 2 2234578899999998543 3478999999999999999999999976443221111000000
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
....++..+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 229 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 229 -----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0011234478999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=306.60 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=201.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..|.....||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|||++++++++.. ....|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEE
Confidence 34666678999999999999999999999999885322 233478899999999999999998843 344889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|+||+++ +|...+. ...+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++....
T Consensus 96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS 168 (297)
T ss_pred EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence 9999996 5544443 2568899999999999999999999 79999999999999996 7889999999987543
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||...+..+.+..+... +..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~--------- 235 (297)
T cd06659 169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP--------- 235 (297)
T ss_pred cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------
Confidence 322 22345678999999998654 4899999999999999999999999877665554433210 000
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. ......+++.+.++|.+||+.+|.+||++.++++||||.+...
T Consensus 236 ------------~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 ------------K--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred ------------C--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0 0011236889999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=312.92 Aligned_cols=278 Identities=20% Similarity=0.303 Sum_probs=197.1
Q ss_pred eeeecC--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
..||.| +||+||+|++..+++.||+|++.... ....+|+.+++.++|+||++++++|.. ....++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 456666 99999999999999999999886432 223578888889999999999999843 34488999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+.+ ++...+.... ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhcc
Confidence 99985 7776665432 3458899999999999999999999 79999999999999996 778999999865432211
Q ss_pred CCc--------ceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 016950 195 EAN--------ISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-- 263 (380)
Q Consensus 195 ~~~--------~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 263 (380)
... ....++..|+|||++.+. ..++.++|+||+||++|+|++|..||.+.................+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 011235569999998654 347899999999999999999999998876655444333211110000
Q ss_pred -------HHhhcCCCCC----CccC-----CCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 -------EIRCMNPNYT----DFRF-----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+......+. +-.. .......+.......+++.+++||++||+.||++|||+.++++||||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 0000 00000111112223467889999999999999999999999999999987
Q ss_pred cCC
Q 016950 328 REP 330 (380)
Q Consensus 328 ~~~ 330 (380)
...
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.80 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=205.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|.+.+.||.|+||.||++.+..+++.||+|++..... ...+|+++++.++|+|++++.+.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58999999999999999999999999999999864322 235789999999999999999988433 4588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+++ +|...+.........+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence 99999985 7777776544345789999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 219 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------- 219 (258)
T ss_pred ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence 4433 22335678899999998554 48899999999999999999999998776554444433210
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.+ .++..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 0122468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.42 Aligned_cols=251 Identities=32% Similarity=0.510 Sum_probs=204.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ....+|+..+..++|+|++++++++.. ....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEE
Confidence 36899999999999999999999999999999886543 234578999999999999999998843 34589
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-CCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~-~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+||||++ ++|.+.+.. ...+++..+..++.|++.||+|||+ . |++|+||+|+||+++. ++.++|+|||.+..
T Consensus 76 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~ 149 (264)
T cd06623 76 IVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKV 149 (264)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCcccee
Confidence 9999999 577766653 3678999999999999999999998 6 9999999999999996 78899999999886
Q ss_pred CccCCCcc-eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHh
Q 016950 191 LIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 191 ~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~ 266 (380)
........ ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+ ..+....+.. ...
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~----- 220 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP----- 220 (264)
T ss_pred cccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC-----
Confidence 64433332 4567889999999854 458999999999999999999999998774 2222222221 000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCC-CChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..++.. ++..+.++|.+||..+|++|||+.++++||||+..+
T Consensus 221 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 221 --------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred --------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 001223 688999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=304.43 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=202.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|...+.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++|+|++++++++.. ....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence 47778889999999999999999999999998864221 23478999999999999999998844 3448
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+.+++.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 97 ~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~ 171 (313)
T cd06633 97 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASKS 171 (313)
T ss_pred EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCccc
Confidence 89999999988777653 34568999999999999999999999 79999999999999986 778999999998643
Q ss_pred ccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.. .....++..|+|||.+.. ...++.++|+||+||++|+|++|..||...+.......+... ..+
T Consensus 172 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~--------- 238 (313)
T cd06633 172 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP--------- 238 (313)
T ss_pred CC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC---------
Confidence 22 224567889999999742 345788999999999999999999999887766555544321 000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. ......+..+++|+.+||+.+|.+||++.+++.||||+..
T Consensus 239 ---------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ---------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ---------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 0 0112357789999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=297.38 Aligned_cols=245 Identities=27% Similarity=0.455 Sum_probs=198.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
+|++.+.||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+ .....+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence 5899999999999999999999999999999885322 2234688999999999999999988 33445899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+++ ++.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++++|||.+....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence 9999985 67666643 234568899999999999999999999 79999999999999986 7789999999987654
Q ss_pred cCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.... .....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 217 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------- 217 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence 3322 2345678899999998554 489999999999999999999999988776555444432100
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..++..++..+.+||.+||+.||.+|||+.+++.-
T Consensus 218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00123468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=305.24 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=201.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.++|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|||++++++.+.. ....|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence 468999999999999999999999999999999885332 223468899999999999999998843 33488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+++ +|.+.+. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceecc
Confidence 99999985 6666554 2457888999999999999999999 79999999999999996 778999999988655
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+.+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------- 234 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------- 234 (293)
T ss_pred cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence 43322 223457888999999855 4588999999999999999999999987665433322111 00000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+..++..+.++|++||..+|++||++.+++.||||+..+
T Consensus 235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001223688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.24 Aligned_cols=250 Identities=29% Similarity=0.515 Sum_probs=197.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|.+.+.||+|+||.||++.+..+++.||+|.+..... ...+|+.+++.++|+||+++++.+ .....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 58999999999999999999999999999999865433 234799999999999999999877 3334588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+.+ +|.+.+. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence 99999985 5666554 34568899999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCCcc-----eeeccCCCCChhhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 192 IAGEANI-----SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 192 ~~~~~~~-----~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
....... ...+++.|+|||++.+.. .++.++|+||+|+++|+|++|..||...+........... +..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~---- 224 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK---- 224 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence 4332211 245678899999985432 3788999999999999999999999765432222211111 100
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..+|. ...+++.+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 225 ----------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ----------PPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------CCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01111 11258899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.11 Aligned_cols=256 Identities=30% Similarity=0.482 Sum_probs=199.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||+||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEE
Confidence 467999999999999999999999999999999875432 233579999999999999999998843 3458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++||||+++ +|...+. ..+.+++..++.++.|++.||.|||+.++++||||+|+||+++. ++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccc
Confidence 899999996 5555544 24568999999999999999999996248999999999999986 78899999999865
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCHH
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-------LVEIIKVLGTPTRE 263 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~~~~ 263 (380)
..... .....++..|+|||++.+. .++.++|+||+||++|+|++|..||......+. +.......-...
T Consensus 154 ~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd06620 154 LINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-- 229 (284)
T ss_pred hhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence 43222 2245678999999998654 588999999999999999999999986544211 111111000000
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...++ ...++.++.+|+.+||+.||.+|||+.++++||||..-
T Consensus 230 ----------~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 230 ----------PPRLP-----------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ----------CCCCC-----------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00000 01267899999999999999999999999999999663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=294.81 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=204.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 5899999999999999999999999999999886432 122468899999999999999988843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||+++ +|...+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence 99999975 7777776544455778999999999999999999999 79999999999999996 778999999999766
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+....
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------------- 217 (256)
T ss_pred ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 444 3333567889999999855 458889999999999999999999998877654443332210
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
++. .+...+.++++++.+||+.+|.+|||+.++++||++
T Consensus 218 -----~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -----YPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----CCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000 112368899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=298.65 Aligned_cols=245 Identities=33% Similarity=0.556 Sum_probs=198.0
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||.|+||.||++.+..+++.+|+|.+..... ...+|+.+++.++|+||+++++.+ ......|+++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 6899999999999999999999998864432 234688999999999999998877 3444588999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC--
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-- 195 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-- 195 (380)
.+ +|.+.+.. ...+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence 85 67666653 3478999999999999999999999 79999999999999997 7789999999987543331
Q ss_pred -------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 196 -------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 196 -------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+.. +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------- 216 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--G---------- 216 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C----------
Confidence 112345678899999986544 88999999999999999999999988776655544432 0
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH---HHHhcCCCcccccC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE 329 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~hp~~~~~~~ 329 (380)
...++.. ..++..+.+++.+||+.+|.+|||+ .++++||||+++.|
T Consensus 217 -----~~~~~~~----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 217 -----KIEWPED----------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred -----CcCCCcc----------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 0111110 1148899999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=300.37 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=199.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ...+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 35689999999999999999997653 345799998754332 22468889999999999999998733
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
....|+||||+. ++|.+.+...... ...++...+..++.|++.||.|||+ ++++||||||+||+++. ++
T Consensus 81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~-~~ 156 (288)
T cd05061 81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH-DF 156 (288)
T ss_pred --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC-CC
Confidence 234789999998 5787777643211 2345677888999999999999999 89999999999999996 78
Q ss_pred cEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016950 179 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (380)
Q Consensus 179 ~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 254 (380)
.++|+|||+++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999875433221 1122345679999998654 48999999999999999998 789998877655444332
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc------CCCccccc
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDELR 328 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------hp~~~~~~ 328 (380)
.. +.+ .++..+++.+.+++.+||+.||++|||+.++++ ||||..+.
T Consensus 236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 21 000 012236789999999999999999999999986 99998875
Q ss_pred C
Q 016950 329 E 329 (380)
Q Consensus 329 ~ 329 (380)
|
T Consensus 288 ~ 288 (288)
T cd05061 288 F 288 (288)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=299.72 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=202.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.|...+.||+|++|.||++.+..+++.+|+|++.... ....+|+.+++.++|+||+++++.+.. ....+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence 4666789999999999999999999999999875322 223578999999999999999998843 3348899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence 999985 66665542 568899999999999999999999 79999999999999996 78899999998865433
Q ss_pred CC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
.. ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... ..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 234 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK----------- 234 (285)
T ss_pred CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence 22 12234678899999998654 4889999999999999999999999887765555443321 0000
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. .....++..+.+|+++||+.+|++|||+.++++||||++.+.
T Consensus 235 -------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 235 -------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 001226889999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=298.95 Aligned_cols=245 Identities=19% Similarity=0.220 Sum_probs=192.2
Q ss_pred ccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..+|++.+.||+|+||.||+|..+ ..+..||+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence 457999999999999999999865 356789999886442 123479999999999999999998843 3
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence 348899999996 55555542 23578999999999999999999999 79999999999999986 77899999998
Q ss_pred cccCccCCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 188 AKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 188 a~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
+.......... ...++..|+|||++.+ ..++.++||||+||++|++++ |..||.+.+..+.+..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----- 227 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL----- 227 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-----
Confidence 76532221111 1233567999999865 458999999999999999775 99999888766655544321100
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 228 -----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 -----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.21 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=192.1
Q ss_pred ccceeeeeeeecCCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||+||+|.. ..++..||+|++.... ....+|+.+++.+ +||||+++++.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence 34799999999999999999974 3467789999885432 1234799999999 89999999998833
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh-----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (380)
....++|||||++ +|.+.+.....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 3348899999984 77777653210
Q ss_pred ------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 132 ------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 132 ------------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
....+++..+..++.||+.||+|||+ +|++||||||+|||++. +..+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCccceeccC
Confidence 12257888899999999999999999 79999999999999996 77899999999976543
Q ss_pred CCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 194 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 194 ~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.+......+.+.+.....
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 335 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---------- 335 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------
Confidence 3211 112335679999999654 58999999999999999998 89999876554444333321000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+...+.++.+|+.+||+.||++|||+.++++.
T Consensus 336 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 -----------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00112357899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=292.73 Aligned_cols=260 Identities=25% Similarity=0.445 Sum_probs=209.3
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 104 (380)
......+|.++++||+|+|++|.++++++|.+.||+|++++.. ...+.|..+...- +||.+|.++.+|
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf---- 320 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF---- 320 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh----
Confidence 3445578999999999999999999999999999999886532 2334555555544 799999999999
Q ss_pred CCCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
+.+..+++|.||++|+ |.-.+. ....++++.++.|..+|+.||.|||+ +||++||||.+|+|+|. .+.+||+
T Consensus 321 -qtesrlffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghiklt 393 (593)
T KOG0695|consen 321 -QTESRLFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLT 393 (593)
T ss_pred -cccceEEEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeec
Confidence 5555699999999974 333332 46789999999999999999999999 89999999999999997 7789999
Q ss_pred eecccccCc-cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC-------CCChHHHHHHHHH
Q 016950 184 DFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-------GENAVDQLVEIIK 255 (380)
Q Consensus 184 Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~-------~~~~~~~~~~i~~ 255 (380)
|+|.++.-. ++....+++|||.|.|||++.+. .|+..+|+|+|||+++||+.|+.||. ..+..+.+.+++-
T Consensus 394 dygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil 472 (593)
T KOG0695|consen 394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL 472 (593)
T ss_pred ccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh
Confidence 999998654 34456678999999999999775 49999999999999999999999995 1223333333322
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC------HHHHhcCCCcccccC
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE 329 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~e~l~hp~~~~~~~ 329 (380)
. ..+. ++..+|-.+..+++..|++||.+|+. ..++..||||+.+.|
T Consensus 473 e----------------kqir------------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 473 E----------------KQIR------------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred h----------------hccc------------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 1 1111 33457888999999999999999984 589999999999988
Q ss_pred CCC
Q 016950 330 PNA 332 (380)
Q Consensus 330 ~~~ 332 (380)
...
T Consensus 525 d~l 527 (593)
T KOG0695|consen 525 DLL 527 (593)
T ss_pred HHH
Confidence 643
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.70 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=200.4
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
-|++.+.||.|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++.+. .....|+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence 4888999999999999999999999999999875332 22347899999999999999999884 3345889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+. ...+++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceecc
Confidence 9999986 5555553 3468899999999999999999999 89999999999999996 7789999999987554
Q ss_pred cCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+... +.
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------ 218 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------ 218 (277)
T ss_pred cchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC------------
Confidence 3321 223467888999999854 45788999999999999999999999876654444332110 00
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+...++.++.+++.+||+.+|.+||++.++++||||.+.
T Consensus 219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01123468899999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.76 Aligned_cols=251 Identities=27% Similarity=0.462 Sum_probs=200.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCC---CCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 110 (380)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++ |+|++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 4888999999999999999999999999999885432 22457888988886 9999999998743 345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+.+ +|.+.+. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 8899999986 5655543 2368899999999999999999999 79999999999999996 7889999999987
Q ss_pred cCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
....... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 6544332 233467889999999866555789999999999999999999999876543322211110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+.. .....+.++.+++.+||+.||++||++.+++.||||++..
T Consensus 218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000 0112678999999999999999999999999999997743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=295.73 Aligned_cols=249 Identities=28% Similarity=0.494 Sum_probs=198.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 46999999999999999999999999999999874321 12346999999999999999998874322 2
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+++++||+++ +|.+.+. ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||+
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~ 152 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA 152 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence 347799999985 6666654 23458899999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccC----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.. .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-- 226 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-- 226 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence 9765321 111234578899999998654 478999999999999999999999987665544433221 111
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
...++..+++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus 227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112344578999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.68 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=197.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC-----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..+|++.+.||+|+||.||+|.+...+ +.+|+|.+..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK---- 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----
Confidence 457999999999999999999976555 6899998864321 23579999999999999999998733
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
....|++|||+++ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++|+||||+||++
T Consensus 80 -~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~ 157 (283)
T cd05048 80 -EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLV 157 (283)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEE
Confidence 3347899999984 77777754211 11568889999999999999999999 899999999999999
Q ss_pred cCCCCcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 249 (380)
+. ++.++|+|||++....... ......+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus 158 ~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 7789999999987543322 12234557889999998554 58999999999999999998 9999988776655
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..... ...+..+++++.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 544332100 00123478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.58 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=199.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||.|++|.||+|.+..+++.||+|.+...... ..+|+.++... .|+||+++++++.. .
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 3457899999999999999999999999999999998643211 22455555555 59999999998843 3
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
...|++|||+++.+..++.. ....+++..+..++.|++.||.|||+.+|++||||+|+||+++. ++.+||+|||++
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~ 162 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGIS 162 (296)
T ss_pred CeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccc
Confidence 45899999998876666553 23478999999999999999999996249999999999999986 788999999998
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHH
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~---~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 264 (380)
.............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+.+..+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~--- 236 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP--- 236 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC---
Confidence 765443333334567889999998543 2378899999999999999999999976432 2223222221 00
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. ..+ ....+++++.+|+.+||..||.+||++.+++.||||....
T Consensus 237 --------~--~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 237 --------P--SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred --------C--CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 0 000 0113688999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=296.84 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=196.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+|++..+++.||||.+.... ....+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 57999999999999999999999999999999875321 1234699999999999999999988433 34
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++++||+++ +|...+.........+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence 8899999995 6776776544455668999999999999999999999 89999999999999986 7789999999987
Q ss_pred cCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 016950 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 190 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 267 (380)
....... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ..+...+...+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543222 1234578889999998654 4889999999999999999999999655321 12222222111111
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
......+..+.+++.+||+.+|++||++.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011235788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=295.64 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=196.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|.+.+.||+|+||.||+|.+..+++.+|+|.+..+.. ...+|+.+++.++|+||+++++++.. ...++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCCcEEE
Confidence 469999999999999999999999999999998865432 23579999999999999999988733 3347899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCcccccccc
Confidence 999974 676666432 23468899999999999999999999 89999999999999986 78899999999876543
Q ss_pred CCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 222 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------- 222 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 32111 1223567999999855 458899999999999999998 999998877655544433210
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...++..++.++.++|.+||+.||++|||+.++++
T Consensus 223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00122347899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=329.45 Aligned_cols=142 Identities=23% Similarity=0.371 Sum_probs=122.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|.+++.||.|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||++++.++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 578999999999999999999999999999999986542 33457889999999999999988773 334
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+||||+.+ +|..++.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence 58999999975 67766653 3568899999999999999999999 79999999999999986 778999999987
Q ss_pred c
Q 016950 189 K 189 (380)
Q Consensus 189 ~ 189 (380)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.54 Aligned_cols=246 Identities=33% Similarity=0.595 Sum_probs=202.3
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 109 (380)
++|.+.+.||.|+||.||+|.+..+++.||+|++.+.. ....+|..+++.++ |+||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 36999999999999999999999999999999886421 22347889999998 99999999887 3444
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..++|||++. ++|.+.+.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence 5889999995 577777653 3479999999999999999999999 79999999999999986 778999999998
Q ss_pred ccCccCCC---------------------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 016950 189 KQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (380)
Q Consensus 189 ~~~~~~~~---------------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 247 (380)
........ .....++..|+|||++.+ ..++.++|+||+|++++++++|..||...+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 75533221 122356788999999854 44889999999999999999999999988765
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCC
Q 016950 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPF 323 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~ 323 (380)
..+..+... .+. ++..+++.+.+||.+||+.||.+|||+ .++++|||
T Consensus 229 ~~~~~~~~~-----------------~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 229 LTFQKILKL-----------------EYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHHHHHhc-----------------CCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 555444321 111 223468999999999999999999999 99999999
Q ss_pred c
Q 016950 324 F 324 (380)
Q Consensus 324 ~ 324 (380)
|
T Consensus 280 ~ 280 (280)
T cd05581 280 F 280 (280)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.07 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=198.4
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+|.+.+.||+|+||.||++.+..++..+++|++... .....+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 589999999999999999999888777777765421 1123468889999999999999988743 33
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..++|+||+++ +|...+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++. +.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCce
Confidence 47899999985 7777776555556789999999999999999999999 79999999999999974 56999999998
Q ss_pred ccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+.. +.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~------- 222 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT------- 222 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-------
Confidence 76543322 223456888999999854 4478899999999999999999999987665444433322 100
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..++..++.++.++|.+||..||++||++.++++||||
T Consensus 223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.21 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=193.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcE--EEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ....+|+.++..+ +|+||+++++++ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~ 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CC
Confidence 456899999999999999999999887764 5777664321 1234689999999 899999999988 33
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
...+|+||||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~ 158 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 158 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEec
Confidence 445889999998 477777754221 12368899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016950 175 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 253 (380)
. ++.+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 159 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred C-CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 6 77899999999864322111112223567999999854 448899999999999999998 99999877665544332
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.... . ...+..+++++.+|+.+||+.+|++||++++++.+
T Consensus 237 ~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGY----------------R------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCC----------------c------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1100 0 00112368899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=300.15 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=201.1
Q ss_pred ceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
.|++.+.||.|+||.||+|.+. .+|+.||+|.+.... ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4899999999999999999975 478999999886421 2234689999999 589999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....|+|+||+++ +|.+.+. ....+++..+..++.|++.||.|||+ +|++||||+|+|||++. ++.+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence 44568899999995 6666664 34568899999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC--cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 186 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|++........ .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...+.......+.......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 99876543221 2235678899999998543 246789999999999999999999997543322222222211000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 331 (380)
...++..+++.+.+++.+||+.||++|+ ++.+++.||||+.++|..
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 0002234788999999999999999997 889999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=302.60 Aligned_cols=249 Identities=30% Similarity=0.438 Sum_probs=203.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.|...+.||+|+||.||++.+..++..+|+|++..... ...+|+.+++.++|+|++++++++.. ....
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence 38899999999999999999999999999998864321 23468999999999999999998843 3347
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++||||+.|++.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.++|+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCcccc
Confidence 89999999988776653 34568999999999999999999999 79999999999999986 778999999998654
Q ss_pred ccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.. .....+++.|+|||.+.. ...++.++|+||+||++|+|++|..||...+....+..+......+.
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 244 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-------- 244 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--------
Confidence 32 223467889999999742 34578899999999999999999999988766665555443211000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.....++.++++|.+||+.+|.+||++.++++|||+...
T Consensus 245 -------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 -------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 012357889999999999999999999999999999663
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.27 Aligned_cols=248 Identities=30% Similarity=0.494 Sum_probs=201.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
+|++.+.||+|++|.||++.+..+++.+++|++.... ....+|+.+++.++|+|++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 4889999999999999999999999999999986544 3345799999999999999999988433 448899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+||+++ +|.+.+.. ....+++..+..++.|++.||++||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence 999994 66666543 22578999999999999999999999 89999999999999996 78899999999876654
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......... ...+.
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~------------ 216 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPG------------ 216 (253)
T ss_pred cccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCC------------
Confidence 4323455678899999998654 488999999999999999999999987755444433322 00000
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
. + ....++..+.++|.+||+.||++|||+.++++|||
T Consensus 217 -~--~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 -L--R----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -c--C----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 0 01114789999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.16 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=196.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..+|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ...+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 4579999999999999999998753 467899998865322 335799999999999999999988443
Q ss_pred CceEEEEEeecccc-hHHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~ 175 (380)
...++||||+++ +|.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+||+++.
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGY 157 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcC
Confidence 348899999985 6777765421 123457889999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016950 176 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (380)
Q Consensus 176 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 251 (380)
++.++|+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 78899999999875432221 1233456789999998654 48999999999999999998 999998877665544
Q ss_pred HHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+... .. ...+..++..+.+++++||+.||++|||+.|+++
T Consensus 236 ~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43321 00 0012247899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=328.93 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=192.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+++|++.+.||+|+||.||+|.+..+++.||+|++..+. ....+|+.+++.++||||+++++++. +..
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~ 75 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGD 75 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCC
Confidence 367999999999999999999999999999999986432 12347999999999999999998873 334
Q ss_pred EEEEEeecccc-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
..|+||||++| +|.+.+..... ....++...+..++.||+.||+|||+ +||+||||||+||+++. ++.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEE
Confidence 58899999985 67776654221 12345667788899999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCC-------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 016950 182 ICDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242 (380)
Q Consensus 182 l~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~ 242 (380)
|+|||++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 99999997552110 01124689999999998654 48999999999999999999999998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+..+.... .....|. . . . -...+++.+.+++.+||+.||++|++..+.+.+
T Consensus 233 ~~~~~ki~~~--~~i~~P~--~------------~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 233 RKKGRKISYR--DVILSPI--E------------V-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred Ccchhhhhhh--hhccChh--h------------c-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7554332211 1000000 0 0 0 012478899999999999999999987665543
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=307.30 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=192.3
Q ss_pred cceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
++|++.+.||.|+||.||+|.+.. +++.||+|++..... ...+|+.+++.+ +|+||+++++++...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 579999999999999999997543 457899998864321 234688999999 899999999877432
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhh------------------------------------------------------
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 131 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 131 (380)
...++++|||+++ +|.+.+.....
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 2347899999985 67666643211
Q ss_pred ---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCC
Q 016950 132 ---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRF 205 (380)
Q Consensus 132 ---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~ 205 (380)
....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||++........ .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12368899999999999999999999 79999999999999996 77899999999986533221 112344667
Q ss_pred CCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCC
Q 016950 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP 284 (380)
Q Consensus 206 y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (380)
|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.+...+.....
T Consensus 241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 294 (337)
T cd05054 241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------------------------- 294 (337)
T ss_pred ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-------------------------
Confidence 9999998654 48999999999999999997 99999875544443333221000
Q ss_pred cccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 285 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+...++++.+++.+||+.+|++||++.++++|
T Consensus 295 --~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 --MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00122368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=322.51 Aligned_cols=283 Identities=20% Similarity=0.250 Sum_probs=185.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCC----CcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 110 (380)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++.............++...+.++..+...+..... .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 467899999999999999999999988 9999999875432211111112222233334433333322111 34445
Q ss_pred EEEEeecccc-hHHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
+++|+||+++ +|.+.+..... .........+..++.||+.||.|||+ +||+||||||+|||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~NILl 288 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQNIIF 288 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHHHEEE
Confidence 8899999985 66666643110 01112344567899999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccC--CCcceeeccCCCCChhhhhCCC---------------------CCCchhhHHHHHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAG--EANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWSAGCV 230 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~l~~~~---------------------~~~~~~DiwslGvi 230 (380)
+.+++.+||+|||+|+..... .......+|+.|+|||.+.... .++.++||||+||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 865678999999999754322 2233567899999999763321 13445699999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCccc--ccCCCCChHHHHHHHhhcccC
Q 016950 231 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK--VFHKRMPPEAIDLASRLLQYS 308 (380)
Q Consensus 231 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~d 308 (380)
+|+|+++..++ .+....+..++...+.... .+....... ....+.. .+....+..+.+||.+||++|
T Consensus 369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYDLV-AWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHhCcCCC--chHHHHHHHHHHhcCCcHH-HHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999876554 3444444444444333221 111111000 0000000 011123456779999999999
Q ss_pred CCCCCCHHHHhcCCCcccccCC
Q 016950 309 PSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 309 p~~R~t~~e~l~hp~~~~~~~~ 330 (380)
|++|||+.++|+||||+.....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999886443
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.61 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=202.0
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEee-----cc---ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-----~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+...+||+|+|-+||+|.+..+|..||.-.++ +. ......|+.+|+.|+|+||++++.++.+... .++.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 34568999999999999999999999864332 11 2455689999999999999999999976554 4577
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+|.+. |+|..+++ ..++.+...++.|+.||+.||.|||+. ..|||||||.+||||+...|.|||+|+|+|..
T Consensus 120 ~iTEL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 9999998 55555544 567788999999999999999999983 36999999999999998889999999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ...+.+|||.|||||++. ..|+..+||||||+.+.||+|+..||..-....++++.+.. |..+..
T Consensus 196 ~r~s-~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~s------- 264 (632)
T KOG0584|consen 196 LRKS-HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAA------- 264 (632)
T ss_pred hhcc-ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHH-------
Confidence 5433 334579999999999984 56999999999999999999999999876555444443321 222111
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
|.+--++++++||.+||.. .++|+|+.|+|.||||..-
T Consensus 265 ------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 ------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1112378999999999999 9999999999999999873
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.61 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=191.3
Q ss_pred CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hH
Q 016950 50 SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SM 122 (380)
Q Consensus 50 ~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 122 (380)
++|.||++++..+++.||+|++.... ....+|+.+++.++|+||+++++++.. ....+++|||+++ ++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEEEeccCCCCH
Confidence 44566777777799999999986441 234579999999999999999998843 3348899999995 56
Q ss_pred HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC------
Q 016950 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------ 196 (380)
Q Consensus 123 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~------ 196 (380)
.+.+... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||.+........
T Consensus 87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeeccccccccccc
Confidence 6666532 23458899999999999999999999 79999999999999995 78899999998865432211
Q ss_pred --cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH----HhhcC
Q 016950 197 --NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE----IRCMN 269 (380)
Q Consensus 197 --~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----~~~~~ 269 (380)
.....++..|+|||++.+. ..++.++|+||+||++|+|++|..||........+..... +...... .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccccccCchhhhc
Confidence 1223457789999998653 3478999999999999999999999987665444332221 1111000 00000
Q ss_pred CCCCC----ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 270 PNYTD----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 270 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
..... ...+ .............++.++.+|+.+||++||++|||+.++|+||||+.++.
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 241 DSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred CCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 00000 0000 00111111222335678999999999999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=290.37 Aligned_cols=246 Identities=33% Similarity=0.566 Sum_probs=202.0
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ...+|+++++.++|+|++++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 58999999999999999999999999999999865432 23578999999999999999988743 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|||+++ +|.+.+. ....+++..++.++.|++.||.+||+ +|++||||+|+||+++. ++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence 99999986 6666554 23678999999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-------------- 214 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence 44332 22346788899999986544 889999999999999999999999876654444332210
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
....++..+++.+.+++.+||..+|++|||+.+++.||||
T Consensus 215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0011233478999999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.01 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=193.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 35679999999999999999998652 456799998854321 234788999999999999999887
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
......++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~-~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC-CC
Confidence 333458899999985 777776542211 2345778888999999999999999 79999999999999996 78
Q ss_pred cEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 016950 179 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 254 (380)
Q Consensus 179 ~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~ 254 (380)
.++|+|||++........ .....+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 899999999875432221 112234677999999865 448999999999999999998 789998877655554333
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.. +.+ .++..+++.+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 000 0123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=302.21 Aligned_cols=251 Identities=28% Similarity=0.429 Sum_probs=202.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
...|...+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+|++++.+++.. ..
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CC
Confidence 345888999999999999999999999999999885321 122468999999999999999998844 33
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..++||||+.+++...+.. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCcccce
Confidence 4889999999887776643 34568899999999999999999999 79999999999999986 7889999999987
Q ss_pred cCccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 190 QLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
..... ....+++.|+|||.+.+ ...++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~------- 232 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P------- 232 (308)
T ss_pred eecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C-------
Confidence 54322 23467889999999853 23478899999999999999999999987665554444332100 0
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. ......+..+.+||.+||+.+|.+||++.++++|||+...
T Consensus 233 -----------~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -----------A--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -----------C--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 0012368889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=290.27 Aligned_cols=250 Identities=33% Similarity=0.524 Sum_probs=201.2
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+|.+.+.||+|++|.||+|.+..+++.+++|++.... ....+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4889999999999999999999999999999886543 23457999999999999999998884331 24588
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+++||++ ++|.+.+.. ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence 9999996 466666653 3388999999999999999999999 89999999999999997 788999999998876
Q ss_pred ccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.. .........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc----------
Confidence 55442 3345678889999998554 4899999999999999999999999876621 111111100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
......++..++..+.++|.+||+.||++||++.+++.||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111334468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=298.74 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=199.0
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
|.....||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+|++++++.+.. ....++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence 445578999999999999999999999999875322 223468999999999999999998843 34588999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+++ +|.+.+. ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceecccc
Confidence 99987 4544432 3468899999999999999999999 79999999999999996 678999999998755432
Q ss_pred C-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 195 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 195 ~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
. ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+..... .
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--~------------ 234 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--P------------ 234 (292)
T ss_pred cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--c------------
Confidence 2 1233567889999998854 4578999999999999999999999988766555443322110 0
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+. ....+++.+.+++.+||+.||.+||++.+++.||||....
T Consensus 235 --~~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 --KLK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred --ccC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 000 0123688999999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=297.87 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=194.3
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|.+.+.||+|+||+||++.+. .++..+|+|.+..... ...+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE----- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 357999999999999999999863 3456799998864322 24579999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
...+++||||+++ +|.+.+.... .....+++..+..++.|++.||+|||+ +|++||||||+||+++. +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~-~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc-C
Confidence 3448899999984 7777765322 112358999999999999999999999 89999999999999996 7
Q ss_pred CcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016950 178 HQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 253 (380)
+.++|+|||++........ .....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8899999999975533221 112334678999999865 458999999999999999998 99999887766555444
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
... ... ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 236 ~~~--~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 236 TQG--RVL--------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HcC--CcC--------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 331 000 012236889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.59 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=192.3
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 109 (380)
++|++.+.||+|+||.||+|....++. .+++|.+.... ....+|+.++.++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 479999999999999999999887765 46888775321 2235688999888 7999999999873 334
Q ss_pred EEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~ 176 (380)
.+|+++||++ ++|.+.+..... ....+++..++.++.|++.||+|||+ +|++||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence 5889999998 577777754221 12358899999999999999999999 89999999999999986
Q ss_pred CCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016950 177 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 177 ~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 255 (380)
++.+||+|||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 77899999999864322111111222456999999854 448999999999999999997 9999988876665544332
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
... ...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus 234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 00123478999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.04 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=194.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 4679999999999999999999987 77889999875432 1234688999999999999999987433
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcE
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQV 180 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~i 180 (380)
...++||||+.+ +|.+.+..... ....+++..+..++.||+.||+|||+ ++++||||||+||+++..+ ..+
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcce
Confidence 236899999974 77777754321 12358899999999999999999999 7999999999999998532 369
Q ss_pred EEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 016950 181 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV 256 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~ 256 (380)
||+|||+++....... ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986532211 1112234579999999654 48999999999999999997 99999887765544332221
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.. ..++..++..+.+++.+||+.+|++|||+.++++|
T Consensus 238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 00123478899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=301.80 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=191.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcE----EEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|++.+.||+|+||+||+|.+..+++. ||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence 45799999999999999999998766654 8999885332 2334688999999999999999887432
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++++||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ +|++||||||+|||++. ++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~DfG 154 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKITDFG 154 (316)
T ss_pred --CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEcccc
Confidence 1568999988 467776653 23468888999999999999999999 79999999999999986 7789999999
Q ss_pred ccccCccCCCcce---eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+++.......... ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.. .+......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~--- 229 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGER--- 229 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCC---
Confidence 9986644332211 223567999999865 458999999999999999997 99999876654432 22221000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+ .+..++.++.+++.+||..||.+|||+.+++.+
T Consensus 230 --------------~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 --------------LP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 112367899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.18 Aligned_cols=243 Identities=21% Similarity=0.299 Sum_probs=192.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
++|++.+.||+|+||.||++..+ ++..+|+|.+.... ....+|+.+++.++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 56999999999999999999865 45679999876432 23457999999999999999998873 33348899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCccccCC
Confidence 999984 67666642 23468899999999999999999999 79999999999999996 77899999999876533
Q ss_pred CCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||...+..+.+..+......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------- 220 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------- 220 (256)
T ss_pred CceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------
Confidence 2221 12234567999999854 458999999999999999999 99999888776666554431000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 221 -----------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 -----------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011225788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.82 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=193.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++++.||+|+||.||+|... ++..||+|.+.... ....+|+.+++.++|+||+++++.+. .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence 468999999999999999999864 56779999876432 23357999999999999999988873 3344789
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+.+ +|.+.+... ....+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccceecC
Confidence 9999974 777766532 34568888999999999999999999 79999999999999996 7889999999997654
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----------- 222 (261)
T ss_pred CCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 3221 112234567999999855 448899999999999999998 9999988776655544432110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+ ....++.++.+++.+||..+|++|||++++++
T Consensus 223 -------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------MP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------CC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 11236889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.52 Aligned_cols=245 Identities=20% Similarity=0.287 Sum_probs=193.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..+|++.+.||+|+||+||++.... +..+|+|.+..... ...+|+.+++.++||||+++++++.. ....++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 76 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-----QRPIYI 76 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-----CCCcEE
Confidence 3579999999999999999998653 45699998864432 23579999999999999999998732 334789
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+.+ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.+....
T Consensus 77 v~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 77 VTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceecC
Confidence 9999985 66666643 23468999999999999999999999 79999999999999996 7789999999987554
Q ss_pred cCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+......
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 220 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------- 220 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------
Confidence 33211 122345679999998654 48999999999999999998 99999877765555544331110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+...++.+.+++.+||+.||.+|||+.+++.+
T Consensus 221 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112257899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=290.49 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=196.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++|+|++++++.+.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 5799999999999999999999999999999987531 2234579999999999999999998843 345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||||+++ +|...+.........+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence 8899999985 7877776554455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHh
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~ 266 (380)
...... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||..... .+....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC---------- 223 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence 553322 22345678899999998654 489999999999999999999999965431 1111111110
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.++. ......+..+.++|.+||..+|++|||+.++++
T Consensus 224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001136789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=295.07 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=195.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 57999999999999999999999999999999875321 123468999999999999999998843 334
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++|||+++ +|.+.+.........+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence 8899999985 7777776544455678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 016950 190 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 190 ~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 267 (380)
....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--------- 224 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC---------
Confidence 6543322 2234678899999998554 4889999999999999999999999765422 11111111000
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+. ..+..+++.+.++|.+||+.||++|||+.++++
T Consensus 225 ---------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 ---------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ---------CCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000 011236889999999999999999999997763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.19 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=207.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+.|++.+.||.|++|.||++.+..+++.+|+|++..... ...+|+.+++.++|+|++++++.+... ...|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEE
Confidence 34569999999999999999999998999999999875432 345799999999999999999988543 4588
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||++ ++|.+.+... ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence 9999999 5777777642 1478999999999999999999999 89999999999999996 778999999988654
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... +.+.
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------- 235 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP--------- 235 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC---------
Confidence 33221 1234567889999998654 4899999999999999999999999877665544433221 1000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. .....++..+.++|.+||+.+|.+|||+.++++||||+...+
T Consensus 236 ---------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 236 ---------L-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred ---------C-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 0 001226789999999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=291.03 Aligned_cols=238 Identities=22% Similarity=0.321 Sum_probs=186.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ....|+||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence 46899999999999999999999999875432 234579999999999999999998843 33488999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence 85 66666542 34568899999999999999999999 79999999999999986 778999999998754322111
Q ss_pred c---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 198 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 198 ~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
. ....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+.....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 214 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------------- 214 (252)
T ss_pred ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence 1 11224569999998554 48999999999999999997 9999977665443333222100
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..++...+..+.+|+.+||+.||++|||+.++++
T Consensus 215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112246889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=340.17 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=208.2
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..+..-+|.-...||.|.||.||.|.+..+|+..|+|.+.-. .....+|..++..++|||+|+++++-.+.+.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek- 1308 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK- 1308 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-
Confidence 344566888999999999999999999999999999977422 2233589999999999999999987754433
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
++|.||||.| +|.+++. .++-..+...+.|-.|++.|+.|||+ +||+||||||.||+++. ++.+|++||
T Consensus 1309 ----v~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DF 1378 (1509)
T KOG4645|consen 1309 ----VYIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDF 1378 (1509)
T ss_pred ----HHHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecc
Confidence 7899999996 5555554 34557788888899999999999999 79999999999999996 779999999
Q ss_pred cccccCccCC-----CcceeeccCCCCChhhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016950 186 GSAKQLIAGE-----ANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 186 g~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
|.|....+.. ......||+.|||||++.+.. ....+.|||||||++.||+||+.||...+..-++--......
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH 1458 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC
Confidence 9998765542 123578999999999997643 356789999999999999999999987665433322222211
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.| .+|.++|++.+|||.+||..||.+|.++.|+|+|.|-+.-
T Consensus 1459 ~P---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1459 KP---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred CC---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 11 2455689999999999999999999999999999987653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.04 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=194.0
Q ss_pred eeeeeeeecCCceEEEEEEECCC---CcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 40 YMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
|.+.+.||+|+||.||+|....+ +..||+|.+..+.. ...+|+.+++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999997654 47899998864321 23478999999999999999987754433 2334
Q ss_pred EEEEEeecccc-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++++||+.+ +|...+.... .....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence 57899999985 6666664322 123468999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+++........ .....+..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 99865433211 11233567999999854 458999999999999999999 999998877655544333210
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.. ..+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 233 -----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 -----------RL------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------CC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0123478899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.81 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=195.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||.||++..+.. +..||+|.+..... ...+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 46899999999999999999998643 47899999864432 23478899999999999999998843
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
....++||||++ ++|...+..... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-~~~ 157 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-DLT 157 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-CCC
Confidence 344889999997 577777754322 12347888999999999999999999 89999999999999996 788
Q ss_pred EEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 255 (380)
+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 99999999875533221 1223457789999998544 48999999999999999998 9999988776555443331
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+.+ .++..++..+.+++.+||+.+|++|||+.++++
T Consensus 237 -~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 -GGHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -CCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 012236889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.74 Aligned_cols=238 Identities=34% Similarity=0.591 Sum_probs=195.4
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
||.|+||.||++.+..+++.+|+|.+..... ....|+.+++.++|+||+++++.+ ......|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 6899999999999998999999998865422 345788999999999999999887 4455689999999
Q ss_pred c-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC-CC
Q 016950 119 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EA 196 (380)
Q Consensus 119 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~ 196 (380)
. ++|.+.+.. ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||.+...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence 5 577776653 3468999999999999999999999 89999999999999996 778999999998765443 22
Q ss_pred cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCcc
Q 016950 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 276 (380)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+.. + ...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~~~ 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------PLR 211 (250)
T ss_pred ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------CCC
Confidence 3345678889999998554 478899999999999999999999987765444433332 0 111
Q ss_pred CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH---HHHhcCCCc
Q 016950 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 324 (380)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~e~l~hp~~ 324 (380)
++..++..+.++|++||..||++||++ .++++||||
T Consensus 212 ------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 223468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.32 Aligned_cols=242 Identities=27% Similarity=0.392 Sum_probs=196.1
Q ss_pred eeeecCCceEEEEEEECCC---CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|.+... +..||+|.+..... ...+|+.+++.++|+|++++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4689999999999999866 89999999865432 33579999999999999999998843 44588999
Q ss_pred eccc-chHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 116 EYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
||++ ++|.+.+...... ...+++..++.++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence 9996 5787777643211 4779999999999999999999999 89999999999999997 6889999999998
Q ss_pred cCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 190 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
...... ......++..|+|||.+.+. .++.++|+||+||++|+|++ |..||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------- 224 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 765432 12334567889999998654 58999999999999999999 699998887665554443310
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....+..+++++.+++.+||+.||++|||+.++++|
T Consensus 225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 --------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred --------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001223468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.33 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=193.6
Q ss_pred ccceeeeeeeecCCceEEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|++.+.||+|+||+||+|... .+++.+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 78 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----- 78 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----
Confidence 467999999999999999999853 456789999886422 234579999999999999999998743
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSS-------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~-------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
....|+||||+.+ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili 157 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI 157 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence 3348899999985 67666642110 12347888899999999999999999 899999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 249 (380)
+. ++.+||+|||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus 158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 96 77899999999976533221 1223446679999998654 48999999999999999998 9999988765544
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+... ..+ ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4333221 000 0123478999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=306.21 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=191.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 105 (380)
.++|++++.||+|+||.||+|.+... +..||||++..... ...+|+.+++.+. ||||+++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---- 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---- 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence 46799999999999999999987533 35799998864322 2347999999996 999999999883
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh-----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------------------------------------------------- 131 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------------------------------------------------- 131 (380)
.....|+|||||++ +|.+.+.....
T Consensus 112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 33458999999984 77766653211
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEE
Q 016950 132 ---------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (380)
Q Consensus 132 ---------------------------------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nil 172 (380)
....+++..+..++.|++.||+|||+ ++++||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhEE
Confidence 12347888889999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016950 173 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (380)
Q Consensus 173 l~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 248 (380)
++. ++.+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 996 77899999999876533222 1223456789999998654 48999999999999999997 999998765444
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+...+.... .. ..+..+++++.+++.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~-----------------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGY-----------------RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCC-----------------CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333222100 00 012347889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.76 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=194.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++..... ...+|+.++..++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~---- 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK---- 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----
Confidence 45799999999999999999987543 57899999864432 23478889999999999999998833
Q ss_pred CceEEEEEeecccc-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
....++++||+.+ +|...+.... .....+++..+..++.|++.||+|||+ +|++||||||+||++
T Consensus 80 -~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~ 157 (283)
T cd05091 80 -EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLV 157 (283)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEe
Confidence 3347899999985 5666653211 112457888899999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 249 (380)
+. ++.+||+|||+++....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+.
T Consensus 158 ~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 86 77899999999876533221 1123446789999998654 48999999999999999998 8999988776665
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+..+...... .++..+++.+.+|+.+||+.+|.+||++.+++..
T Consensus 236 ~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 236 IEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 5554431100 1223478999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.78 Aligned_cols=244 Identities=19% Similarity=0.283 Sum_probs=192.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ...+|+.+++.++|+||+++++++ ......|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence 46899999999999999999875 567899998864322 335799999999999999998887 333458899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceeccc
Confidence 999975 67666653 23468999999999999999999999 79999999999999996 78899999999876533
Q ss_pred CCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... ...++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------ 219 (256)
T ss_pred ccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------
Confidence 22111 1123456999999865 458999999999999999999 8999987766555444322100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+...++.+.+++.+||+.+|++|||+.++++.
T Consensus 220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01122368999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=290.73 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=191.0
Q ss_pred eeeeeeeecCCceEEEEEEECCCCc--EEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 110 (380)
+.+.+.||+|+||.||+|....++. .+|+|.+.... ....+|+.+++.++|+||+++++.++.... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999877765 68999875431 223468899999999999999987644322 22234
Q ss_pred EEEEeecccc-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+++|||+.+ +|...+.... .....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence 6799999984 6666553211 123458899999999999999999999 89999999999999986 77899999999
Q ss_pred cccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+........ .....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+...-.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR----- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 986543321 112234667999999854 458999999999999999999 8999988766554443322100
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00122468899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=289.00 Aligned_cols=244 Identities=26% Similarity=0.315 Sum_probs=191.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|.+..+ ..||+|++..... ...+|+.+++.++|+||+++++.+. . ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEE
Confidence 35799999999999999999988665 4599998865332 2457999999999999999987652 1 12679
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+... ....+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 153 (262)
T ss_pred EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCceeecc
Confidence 9999985 777777532 23457889999999999999999999 89999999999999996 7789999999997553
Q ss_pred cCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.+....+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 222 (262)
T ss_pred ccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC----------
Confidence 33221 12344667999998854 448999999999999999999 89999887765555443221000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.....++..+.+++.+||+.||++||++.++++
T Consensus 223 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011236889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=289.41 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|++|.||+|... +++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeee
Confidence 356999999999999999999864 45789999986543 234579999999999999999987733 334789
Q ss_pred Eeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+. ++|.+.+... ....+++..+..++.|++.||.+||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEEcc
Confidence 999995 5777777532 23568999999999999999999999 79999999999999996 7789999999998654
Q ss_pred cCCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...... ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+....+..+......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM---------- 223 (261)
T ss_pred CCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 322111 1122346999999854 458999999999999999999 99999887766555544321100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 224 ------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011236889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.04 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=197.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..+|++.+.||.|+||.||+|.+.. ++.+|+|.+..... ...+|+.+++.++|+||+++++.+. .....+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence 4579999999999999999999887 88999999865432 3457899999999999999988873 333488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+... ....+++..+..++.||+.||.|||+ +|++|+||+|+||+++. ++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhc
Confidence 99999985 777777632 34568999999999999999999999 89999999999999996 778999999999765
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 223 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM---------- 223 (261)
T ss_pred CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence 33221 112334567999999854 458999999999999999998 89999888766666555431110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012247899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=294.77 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=195.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||++..... ...+|+|.+..... ...+|+.+++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---- 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---- 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence 46799999999999999999997643 37899998864321 234789999999 8999999999873
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nil 172 (380)
....++++|||+.+ +|...+.... .....+++..+..++.|++.||.|||+ +||+||||||+||+
T Consensus 87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil 164 (293)
T cd05053 87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL 164 (293)
T ss_pred -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence 33348899999984 7777775421 234578999999999999999999999 89999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016950 173 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (380)
Q Consensus 173 l~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 248 (380)
++. ++.+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 VTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 986 788999999999865433211 11223567999999854 458999999999999999997 999998877655
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....+..... . ..+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~----------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR----------------M------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc----------------C------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5543322100 0 0122368899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=289.58 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=193.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC---CcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|++.+.||+|+||+||+|....+ ...+|+|.+..... ...+|+.+++.++|+||+++++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence 35799999999999999999998654 45799998864322 2246899999999999999999873 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg~ 152 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGL 152 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccch
Confidence 348899999985 67666653 23478999999999999999999999 89999999999999996 77899999999
Q ss_pred cccCccCCCc-c--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGEAN-I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~~~-~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+......... . ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--- 228 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP--- 228 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9876422211 1 1233567999999854 458999999999999999998 999998776555444433211000
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+...++.+.+|+.+||+.+|++||++.+++++
T Consensus 229 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 -------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.05 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=192.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
..+|.+.+.||+|+||.||++.. .+..+|+|.+..+.. ...+|+.+++.++|+|+++++++++.. ....|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEE
Confidence 45799999999999999999976 477899998865432 245799999999999999999876432 2347899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+||+++ +|.+.+... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 79 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 154 (256)
T ss_pred EECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccceeccc
Confidence 999985 777776532 23357889999999999999999999 89999999999999996 78899999999875432
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
.. ....++..|+|||++.+ ..++.++|+||+||++|+|++ |+.||...+..+....+.+..
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 216 (256)
T ss_pred cC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 22 22334567999999854 458999999999999999997 999998776555444332210
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....+..+++.+.+++.+||+.+|++|||+.++++
T Consensus 217 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 -------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112347899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=292.73 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=194.0
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+|+.+++.++|+||+++++++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----D 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----c
Confidence 356999999999999999999864 345678999886443 23457999999999999999999883 3
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
....++||||++ ++|.+.+..... ....+++..++.++.||+.||+|||+ +|++||||||+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVG 157 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEc
Confidence 334889999997 477777754221 23458899999999999999999999 8999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016950 175 PLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 250 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~ 250 (380)
. ++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+..
T Consensus 158 ~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 158 A-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred c-CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 6 77899999999975533221 123345778999999865 458999999999999999998 99999877765544
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+... .. + ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 236 ECITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 332210 00 0 011236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=290.20 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=190.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
...+|++.+.||+|+||+||+|.+..+++ .||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 34679999999999999999999877776 48999885432 2234688899999999999998877421
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
..++++||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+|||++. ++.+||+||
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~df 153 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKITDF 153 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEECCC
Confidence 2568999998 577766653 24568999999999999999999999 89999999999999985 678999999
Q ss_pred cccccCccCCCcc---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+++......... ...+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .+.....++
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~ 231 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP 231 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC
Confidence 9998654332211 12335679999998654 58999999999999999998 999997765544332 222111000
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+...+.++.+++.+||+.||++||++.+++.
T Consensus 232 ---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 ---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11236889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.49 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=194.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 103 (380)
...++|.+.+.||+|+||.||++.+. .++..+|+|.+..... ...+|+.+++.+ +|+||+++++++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI- 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence 34568999999999999999999853 3456899998864322 235799999999 79999999998743
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 104 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
....|+||||+. ++|.+.+... ....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.++|
T Consensus 111 ----~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l 182 (302)
T cd05055 111 ----GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIVKI 182 (302)
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeEEE
Confidence 334889999998 4777766531 22348999999999999999999999 79999999999999986 778999
Q ss_pred EeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+|||++........ .....++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+.+...... +
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~ 260 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-G 260 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-C
Confidence 99999976543321 1122346789999998654 48999999999999999998 99999887665544443321 0
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ....+...++++.+|+.+||..+|++|||+.++++
T Consensus 261 ~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 Y--------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred C--------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00012236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=294.51 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=192.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 103 (380)
.++|.+.+.||+|+||.||+|++.. +...+|+|.+..... ...+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4689999999999999999998643 235799998864321 234688999999 79999999998833
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
....|+||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus 96 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 170 (307)
T cd05098 96 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 170 (307)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence 3348899999985 78777764321 12358889999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
|+++. ++.+||+|||++........ .....+++.|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+.
T Consensus 171 ill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 99996 67899999999875533211 1112234679999998654 48999999999999999998 8999987665
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+....+... . ...++..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4443332210 0 001123478999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=292.94 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=197.4
Q ss_pred ceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
+|++.+.||+|++|.||++.+. .+++.||+|.+.+.. ....+|+.++..+ +|+||+++.+.+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4899999999999999999864 467899999886421 1234688999999 599999998887 3
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....|+||||+.+ +|...+. ....+++..++.++.|++.||.|||+ .|++||||+|+||+++. ++.++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence 34458899999985 6655554 24568899999999999999999999 79999999999999996 678999999
Q ss_pred cccccCccCCC--cceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 186 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|++........ .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+..-.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 99876543322 12345788999999985432 3688999999999999999999999754332222222111000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC---HHHHhcCCCcccccCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP 330 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~hp~~~~~~~~ 330 (380)
.. ...+..++..+.++|.+||+.||++||| +.++|+||||+.+.|.
T Consensus 227 ----------~~------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 ----------SK------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ----------cC------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 00 0012336889999999999999999998 5678999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.84 Aligned_cols=265 Identities=25% Similarity=0.400 Sum_probs=209.5
Q ss_pred CCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeecee
Q 016950 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHC 99 (380)
Q Consensus 31 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~ 99 (380)
...|...++|.++.+||+|+|+.||+|.+....+.||+|+-.... ...-+|..|.+.|+||.||+++++
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 356777889999999999999999999999999999999763221 112379999999999999999999
Q ss_pred eeecCCCCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCeeecCCCCCCEEEcCC-
Q 016950 100 FFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPL- 176 (380)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-~~iiH~Dlkp~Nill~~~- 176 (380)
|.-..+ .+|-|+|||+|+ |.-.++ .+..+++.+++.|+.||+.||.||... ..|||-||||.|||+...
T Consensus 536 fslDtd----sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 536 FSLDTD----SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeccc----cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 853332 378999999985 444444 567899999999999999999999973 479999999999999532
Q ss_pred -CCcEEEEeecccccCccCCCc--------ceeeccCCCCChhhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016950 177 -THQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (380)
Q Consensus 177 -~~~ikl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~l~~---~~~~~~~~DiwslGvil~~ll~g~~pf~~~ 244 (380)
.+.|||+|||+++.+..+... ....||.||++||.+.- .+..+.++||||+|||+|.++.|+.||..+
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 357999999999988654332 24578999999998743 345789999999999999999999999776
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 245 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
.....+.+--..+ +..+..||.. ..+++++++||++||++--++|..+.++-.||||
T Consensus 688 qsQQdILqeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 688 QSQQDILQENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hhHHHHHhhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 5443332211110 1123344431 2489999999999999999999999999999999
Q ss_pred cc
Q 016950 325 DE 326 (380)
Q Consensus 325 ~~ 326 (380)
.-
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 65
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=293.57 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=195.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC----------------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS 95 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~ 95 (380)
..+|++++.||+|+||.||+|.+...+ ..||+|.+.... ....+|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999876544 568999886542 22346899999999999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCC
Q 016950 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (380)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlk 167 (380)
+++++.. ....+++|||+.+ +|...+..... ....+++..++.++.|++.||.|||+ +|++|||||
T Consensus 84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlk 157 (296)
T cd05051 84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLA 157 (296)
T ss_pred EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccc
Confidence 9988843 2348899999985 77777754321 12368999999999999999999999 799999999
Q ss_pred CCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 016950 168 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP 242 (380)
Q Consensus 168 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~ 242 (380)
|+||+++. ++.++|+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999996 68899999999875433221 1233456789999998654 58999999999999999998 778998
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+.+............ ......+..++.++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 77666555544332111000 0000012236789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.78 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=193.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++++.||+|+||.||+|... +++.||+|.+..... ...+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcEE
Confidence 457999999999999999999854 578899998865433 33579999999999999999887521 13789
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+.+ +|.+.+.. .....+++..+..++.|++.||+|||+ .|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCcceeecC
Confidence 9999974 77776643 234568899999999999999999999 79999999999999996 7789999999987654
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+......+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 223 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP--------- 223 (260)
T ss_pred CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---------
Confidence 2221 112344667999999854 448899999999999999998 999998877655554433211100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+...+.++.+++.+||+.+|++|||++++++
T Consensus 224 -------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 12236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.43 Aligned_cols=235 Identities=26% Similarity=0.329 Sum_probs=184.0
Q ss_pred eeecCCceEEEEEEE--CCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 45 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
.||+|+||.||+|.. ..+++.+|+|++..... ...+|+.+++.++|+||+++++.+. +. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999964 46788999998854321 2347889999999999999988662 11 2679999
Q ss_pred cccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 117 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
|+++ +|.+.+. ....+++..+..++.|++.||+|||+ +|++||||||.||+++. ++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence 9995 5666664 34568999999999999999999999 79999999999999996 7789999999997654332
Q ss_pred Cc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 196 AN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 196 ~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.. ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+.. .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-~----------- 216 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-R----------- 216 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-C-----------
Confidence 21 11223568999998854 458899999999999999998 999998876655544433210 0
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++++.++|.+||+.||++||+++++..
T Consensus 217 ----------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 ----------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0122347899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.58 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=191.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+.... ....+|+.+++.++|+|++++++++. . ...|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEE
Confidence 457999999999999999999865 56679999886532 23458999999999999999988662 1 12679
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+.+ +|.+.+.. .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 78 VTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeeeecc
Confidence 9999985 77776653 124568999999999999999999999 79999999999999996 7789999999997653
Q ss_pred cCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 222 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---------- 222 (260)
T ss_pred CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 32211 12234567999999854 458999999999999999999 99999887766655544321000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
..+...+..+.+|+.+||+.||++|||+.++.
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 ------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 01224688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=283.57 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=191.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ...+|+.+++.++|+|++++++++. . ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEE
Confidence 35799999999999999999987655 4699998764432 2357999999999999999987762 1 12679
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceEcc
Confidence 9999985 787777542 23457889999999999999999999 79999999999999996 7889999999997553
Q ss_pred cCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+..... +
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--------- 222 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR-M--------- 222 (260)
T ss_pred CCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C---------
Confidence 32211 12334667999998854 448999999999999999999 9999988776655544332100 0
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+...+..+.+++.+||++||.+||+++++++
T Consensus 223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 ------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012246889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.60 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=192.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-------CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 103 (380)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.+..... ...+|+.+++.+ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 4689999999999999999998642 345799998764322 234788999999 6999999999883
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
....+|++|||+.+ +|.+.+..... ....+++..+..++.|++.||.|||+ +|++||||||+|
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N 164 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARN 164 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccccee
Confidence 33348899999984 77777764321 23458889999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
|+++. ++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+...
T Consensus 165 ill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99986 77899999999976533211 111223457999999865 458999999999999999999 8999988766
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+....+.... . ..++..++.++.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~----------------~------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREGH----------------R------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcCC----------------C------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55554332210 0 0012346889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.91 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=193.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..+|++.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence 45799999999999999999986 478999999876543 34579999999999999999998844 334889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEcccccccccc
Confidence 9999984 777776532 22368999999999999999999999 89999999999999996 7889999999998653
Q ss_pred cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.... ....+..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------------- 215 (256)
T ss_pred cccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence 2221 2334567999999854 458899999999999999997 99999877655443332210
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+ ....+..+++.+.++|.+||..+|++|||+.++++
T Consensus 216 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 Y-------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred C-------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00012346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.13 Aligned_cols=254 Identities=17% Similarity=0.198 Sum_probs=184.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCC---CcEEEEEEeeccccchH---------------HHHHHHHhCCCCceeeecee
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN---------------RELQLMRVMDHPNVISLKHC 99 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~~~~~---------------~e~~~l~~l~h~niv~~~~~ 99 (380)
.+|.+.+.||+|+||+||+|.+..+ +..+|+|+......... .+...++.+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999998877 67778876432222111 12234455689999999886
Q ss_pred eeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
..... ....+.+++++++..++...+.. ....++..++.++.|++.||+|||+ ++++||||||+|||++. ++.
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-~~~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-NNR 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCc
Confidence 64333 22345678899887776655543 2345788889999999999999999 79999999999999986 678
Q ss_pred EEEEeecccccCccCC--------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 016950 180 VKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~ 251 (380)
++|+|||+|+...... ......||+.|+|||+..+ ..++.++||||+||++|+|++|..||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999997653221 1123468999999999865 458999999999999999999999998774322222
Q ss_pred HHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+. +.+..+... .. .....++.+.+++..|++.+|++||+.+++++
T Consensus 244 ~~~~~------~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKC------DFIKRLHEG--KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHH------HHHHHhhhh--hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21110 000000000 00 01236889999999999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=321.11 Aligned_cols=258 Identities=31% Similarity=0.451 Sum_probs=194.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecC------
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT------ 104 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 104 (380)
-..+|+.++.||+||||.||+|+++-+|+.||||+++... ....+|+.+|.+|+|||||+++..+....
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467889999999999999999999999999999996442 22348999999999999999874431000
Q ss_pred -----------------------------------------------C--------------------------------
Q 016950 105 -----------------------------------------------S-------------------------------- 105 (380)
Q Consensus 105 -----------------------------------------------~-------------------------------- 105 (380)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred C---------------------Cc--------eEEEEEeecccchHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHHHh
Q 016950 106 K---------------------NE--------LFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 155 (380)
Q Consensus 106 ~---------------------~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~l-~~~~~~~i~~ql~~al~~L 155 (380)
+ .. .++||=||||+.+++..+-.. +... ....+|+++.||+.||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHHH
Confidence 0 01 578999999998766655432 2222 4677899999999999999
Q ss_pred HcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc-------------------cCCCcceeeccCCCCChhhhhCCC
Q 016950 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------------AGEANISYICSRFYRAPELIFGAT 216 (380)
Q Consensus 156 H~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~l~~~~ 216 (380)
|+ .|||||||||.||++++ .+.|||+|||+|.... +....++.+||.-|+|||++.+..
T Consensus 714 H~-~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 HD-QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred Hh-CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 79999999999999997 7789999999997611 111335678999999999996665
Q ss_pred --CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCC
Q 016950 217 --EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 294 (380)
Q Consensus 217 --~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (380)
.|+.++||||||||++||+. ||.. .++....+.+. ..+. +|.. ..|...--
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~L-R~g~---------------iP~~------~~f~~~~~ 844 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNL-RKGS---------------IPEP------ADFFDPEH 844 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhc-ccCC---------------CCCC------cccccccc
Confidence 69999999999999999994 4643 34433333221 1111 1110 11122234
Q ss_pred hHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 295 PEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 295 ~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
+.-..+|+.||+.||++||||.|+|++.||-
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 5677899999999999999999999999996
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=284.74 Aligned_cols=245 Identities=27% Similarity=0.346 Sum_probs=195.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||.|+||.||+|.+. +++.+|+|.+..+.. ...+|+.+++.++|+||+++++++. .....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceE
Confidence 3568999999999999999999975 557899998865432 3457999999999999999998873 333488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+.. .....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus 78 ~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~ 153 (261)
T cd05034 78 IVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLARLI 153 (261)
T ss_pred EEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccceec
Confidence 99999985 77777653 123568999999999999999999999 79999999999999996 788999999998765
Q ss_pred ccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... ......+..|+|||.+.+ ..++.++|+||+||++|+|++ |+.||.+.+....+..+......+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------- 224 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-------- 224 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 43211 112233567999999865 448999999999999999998 999998877666665543311110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.+...+.++.+++.+||+.+|.+||++.+++
T Consensus 225 --------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 225 --------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred --------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 1123578999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=292.11 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=194.9
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeee
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF 101 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 101 (380)
...++|.+.+.||+|+||.||+|++. .++..+|+|.+.... ....+|+.+++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34578999999999999999999753 234579999885432 2245799999999 8999999999883
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
. ....|+||||+.+ +|.+.+..... ....+++..+..++.||+.||.|||+ +|++||||||
T Consensus 92 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp 165 (304)
T cd05101 92 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAA 165 (304)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeeccccc
Confidence 3 3458899999985 77777764321 12457888899999999999999999 7999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 244 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~ 244 (380)
+||+++. ++.+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 166 ~Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999986 78899999999986543221 112234567999999865 448999999999999999998 88999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 245 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+..+....+..... ...+..++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 244 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76555544322100 00123478999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.00 Aligned_cols=258 Identities=28% Similarity=0.368 Sum_probs=189.0
Q ss_pred cce-eeeeeeecCCceEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 38 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 38 ~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
++| .+.+.||+|+||+||++. ...+++.||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---G 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 455 999999999999998865 34578899999886432 2234799999999999999998876432 2
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...++++|||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg 152 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG 152 (283)
T ss_pred CceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence 3457899999985 5655554 2458999999999999999999999 89999999999999996 6789999999
Q ss_pred ccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Q 016950 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~ 261 (380)
++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +...... .+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~ 229 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT 229 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence 9976543221 112234567999999854 45899999999999999999999998654321 1111110 00000
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+.. ..........+..++.++.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIE------------LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhh------------hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000 00000111123457899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.05 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=192.3
Q ss_pred cceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|.+.+.||+|+||.||++... .++..+|+|.+.... ....+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 46899999999999999999753 356789999875432 234578999999999999999888733 3
Q ss_pred eEEEEEeecccc-hHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~ 176 (380)
...+++|||+.+ +|.+.+..... ....+++..+..++.||+.||+|||+ +|++||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~- 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQ- 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcC-
Confidence 347899999984 77777653211 11357899999999999999999999 79999999999999996
Q ss_pred CCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016950 177 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 252 (380)
Q Consensus 177 ~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~ 252 (380)
++.+||+|||++........ .....+++.|+|||.+.+. .++.++|+|||||++|+|++ |.+||......+....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 78899999999875433221 1123346789999998654 48999999999999999998 9999987766655544
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+..... ...+..+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332100 0012247899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.78 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=191.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.+|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .....|+.+++.++|+|++++.+++. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence 478999999999999999999876654 79999885432 22346889999999999999999883 333
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..|+||||+++ +|...+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCCccc
Confidence 47899999986 56555542 34568999999999999999999999 79999999999999996 778999999998
Q ss_pred ccCccCCCcc----eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 189 KQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 189 ~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
.......... ....+..|+|||++.+ ..++.++|+||+||++|+|++ |..||...+..+....+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--- 230 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--- 230 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence 7654322211 1112446999999865 458999999999999999997 999998777655554443211110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....++.++.+++.+||+.+|++||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=286.22 Aligned_cols=228 Identities=25% Similarity=0.337 Sum_probs=180.5
Q ss_pred CCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHH
Q 016950 49 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK 127 (380)
Q Consensus 49 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 127 (380)
|.+|.||+|.+..+++.||+|.+..... ..+|...+....||||+++++++. .....|+||||+++ +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999976543 234555555667999999999884 33458899999985 6766665
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCC
Q 016950 128 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207 (380)
Q Consensus 128 ~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~ 207 (380)
. ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence 3 3458999999999999999999999 79999999999999996 778999999987654332 12334567799
Q ss_pred ChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCccc
Q 016950 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 287 (380)
Q Consensus 208 aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (380)
|||.+.+ ..++.++|+||+||++|+|++|..||...... . . ....+
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~----~---------------~~~~~------------ 195 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG--I----N---------------THTTL------------ 195 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c----c---------------ccccc------------
Confidence 9998844 44789999999999999999999887532110 0 0 00000
Q ss_pred ccCCCCChHHHHHHHhhcccCCCCCCCH-----HHHhcCCCc
Q 016950 288 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF 324 (380)
Q Consensus 288 ~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~ 324 (380)
.++..+++.++++|.+||+.||++|+++ +++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1223478999999999999999999985 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=286.77 Aligned_cols=245 Identities=25% Similarity=0.328 Sum_probs=192.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..+|++.+.||+|+||.||+|.++.++. .+|+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 3579999999999999999999875543 79999885432 23357899999999999999998873 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...|+||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg~ 152 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFGL 152 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCCc
Confidence 358899999985 66666643 23568899999999999999999999 79999999999999986 77899999999
Q ss_pred cccCccCCCcc----eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+.......... ...++..|+|||.+.+ ..++.++|+|||||++|++++ |..||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 227 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---- 227 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc----
Confidence 98654332211 1122457999999865 448999999999999999886 9999987766555444432111
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+ .+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 228 --------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 --------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 00 11236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.64 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=191.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC--------------cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeec
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLK 97 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~ 97 (380)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 357999999999999999999875432 3589998865321 234699999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
+++.. ....++||||+.+ +|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||
T Consensus 84 ~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp 157 (295)
T cd05097 84 GVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLAT 157 (295)
T ss_pred EEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccCh
Confidence 98843 3348899999985 67666643211 11246888899999999999999999 7999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 243 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~ 243 (380)
+||+++. ++.+||+|||++........ .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999996 77899999999875433221 1122346689999998654 48999999999999999988 6788987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+.+..+.+........ . ....+...++.+.+|+.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQ-------I--------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhcccc-------c--------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 76665555443321100000 0 00012236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.67 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=189.5
Q ss_pred ceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ...+|+.+++.++||||+++++.+. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 48899999999999999998753 235688888754322 2347999999999999999998873 33
Q ss_pred eEEEEEeeccc-chHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCC
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlk 167 (380)
...++++||+. ++|.+.+.... .....+++..+..++.|++.||+|||+ +|++|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence 34789999998 46766665321 112357889999999999999999999 799999999
Q ss_pred CCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 016950 168 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243 (380)
Q Consensus 168 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~ 243 (380)
|+||+++. ++.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999986 77899999999875433221 112234667999999854 458999999999999999998 9999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....+....+.... ....+..++.++.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76554443222100 00112347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.79 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=192.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..+|++.+.||+|+||.||+|.++.+++ .||+|.+.... .....|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~ 77 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS 77 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CC
Confidence 3569999999999999999999887665 59999886432 22346899999999999999998873 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg~ 152 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFGL 152 (269)
T ss_pred CceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCcc
Confidence 448899999986 56665543 24568999999999999999999999 79999999999999986 77899999999
Q ss_pred cccCccCCCcce---ee---ccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 188 AKQLIAGEANIS---YI---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 188 a~~~~~~~~~~~---~~---~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
+........... .. .+..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+..+....+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-- 229 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-- 229 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--
Confidence 875533222111 11 1346999999854 458999999999999999886 9999988776655544432111
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+ .+..++..+.+++.+||+.+|++||++.+++.
T Consensus 230 ----------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 ----------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 11236889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=286.82 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=184.6
Q ss_pred eeeecCCceEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~--~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+|+.+++.+ +||||+++++++. .....|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence 368999999999999988875 46888775321 2234689999999 8999999999883 333488999
Q ss_pred eccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 116 EYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
||++ ++|.+.+..... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl 153 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI 153 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence 9998 578777764321 12357899999999999999999999 89999999999999996 788999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+|||++..............+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~----- 227 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 227 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence 99999864322111111223556999999854 458999999999999999997 99999877655544433210
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+.. ..+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 228 -------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -------------YRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------CCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 000 011236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.61 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=189.7
Q ss_pred cceeeeeeeecCCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
++|++.+.||.|+||.||+|.+ ..+++.||||.+.... ....+|+.++..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 5799999999999999999984 3467899999986432 1234799999999 689999999877432
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhh------------------------------------------------------
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSS------------------------------------------------------ 131 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~------------------------------------------------------ 131 (380)
...+++||||+++ +|.+.+.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 2347899999985 67666653210
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC---cce
Q 016950 132 ---------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 199 (380)
Q Consensus 132 ---------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~ 199 (380)
....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCC
Confidence 01246788889999999999999999 79999999999999996 77899999999876432221 111
Q ss_pred eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCC
Q 016950 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (380)
Q Consensus 200 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (380)
..++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+......+...+..... ..
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~-- 302 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR---------------MR-- 302 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC---------------CC--
Confidence 2345679999998654 58999999999999999997 99999876543333222221000 00
Q ss_pred CCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+...++++.+++.+||+.||.+|||+.++++|
T Consensus 303 ----------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112257899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.68 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=193.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECC----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4689999999999999999999876 35789999876432 2234789999999999999999876432
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
....+++++|++ ++|...+...... ...+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcEEE
Confidence 233679999998 5777776543222 1568999999999999999999999 79999999999999986 788999
Q ss_pred EeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 183 CDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+|||+++........ ....++..|+|||++.+. .++.++|||||||++|++++ |+.||...+..+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence 999999865433211 122346679999998654 48999999999999999998 999998876655433222210
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+ .+..+++++.+++.+||+.||++|||+.++++
T Consensus 237 -----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 -----------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -----------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 11236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=299.65 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=193.5
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhCC-CCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 105 (380)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ...+|+.++..+. |+||+++++.+..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence 457899999999999999999854 3557899999964422 2347999999997 9999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhh-----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSS----------------------------------------------------- 131 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~----------------------------------------------------- 131 (380)
....++||||+. |+|.+.+.....
T Consensus 113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 234889999998 477777753211
Q ss_pred -----------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 132 -----------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 132 -----------------------------------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
....+++..+..++.||+.||+|||+ ++++||||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~N 269 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAARN 269 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcce
Confidence 11246777888999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
||++. ++.+||+|||+++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.....
T Consensus 270 iLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99996 77899999999975432211 123456778999999865 448999999999999999998 8999987655
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+.+...+.. +. ....+..++.++.+|+.+||+.+|.+||++.++++.
T Consensus 348 ~~~~~~~~~~-~~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKR-GY--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHc-CC--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5544433321 00 001223478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=285.34 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=187.6
Q ss_pred eeeeeeecCCceEEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 41 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+.+.||.|+||.||+|... ..+..|+||.+.... ....+|+..++.++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 46789999999999999987 456789999995421 234579999999999999999999863222 7
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++|+||++ |+|.+.+... ....+++.....++.|++.||.|||+ ++++|++|+++||+++. ++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence 89999998 5788888742 34678999999999999999999999 79999999999999996 77999999999986
Q ss_pred CccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 191 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 191 ~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...... .........|+|||.+.+.. ++.++||||||+++||+++ |..||...+..+....+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------- 223 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------- 223 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence 522211 12234566799999986544 8999999999999999999 7899988877766655532100
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..++..++..+.++|.+||..||.+|||+.++++
T Consensus 224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1123347899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=289.23 Aligned_cols=248 Identities=26% Similarity=0.328 Sum_probs=193.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 4679999999999999999999753 67889999886432 224469999999999999999988733
Q ss_pred CceEEEEEeecccc-hHHHHHHHhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCC
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYS------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK 167 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlk 167 (380)
....+++|||+++ +|.+.+.... .....+++..+..++.|++.||.|||+ +|++|||||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~ 157 (288)
T cd05050 80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLA 157 (288)
T ss_pred -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccccc
Confidence 3347899999985 7777775321 112347888899999999999999999 899999999
Q ss_pred CCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 016950 168 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG 243 (380)
Q Consensus 168 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~ 243 (380)
|+||+++. ++.++|+|||++........ ......+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986 77899999999875432211 1122345679999998654 58999999999999999997 8899988
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+....+..... . ..+..++.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRDGNV----------------L------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhcCCC----------------C------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 776655544322100 0 012236889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=283.49 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=206.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++.+-+..||.|+||+|++..++.+|+..|||.+..... +...|.+ +++.-+.||||++++..+...+ .
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence 344557789999999999999999999999999864332 1223443 4445579999999998866544 8
Q ss_pred EEEeecccchHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
||-||.|+-++..+-+ .+......++|..+-.|....+.||.||.....|||||+||+|||++. .|.+||||||++..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccchHh
Confidence 8999999977655443 344566789999999999999999999997569999999999999997 88899999999987
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~ 268 (380)
....-..+.-.|-+.|||||.+..... |+.+||+||||++|||+.||..||.+.+. .+.++... .|.|+.-...
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~-- 293 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD-- 293 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc--
Confidence 665555555678888999999965444 89999999999999999999999988765 44444332 2333321100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.. .-+.+..++.+|..||.+|-+.||...+++++||++.....
T Consensus 294 ---~~----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 294 ---KE----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred ---cc----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 00 01268899999999999999999999999999999876443
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=284.38 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=196.1
Q ss_pred ceeeeeeeecCCceEEEEEEECC-CCcEEEEEEeeccc--------------cchHHHHHHHHh-CCCCceeeeceeeee
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMRV-MDHPNVISLKHCFFS 102 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~--------------~~~~~e~~~l~~-l~h~niv~~~~~~~~ 102 (380)
.|++.+.||+|+||.||++.+.. +++.+|+|.+.... .....|+.++.. ++|+||+++++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 48899999999999999999987 67899999874221 112356666654 79999999999883
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
.....+++|||+++ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++. ++.++
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~ 154 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT 154 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence 34458899999985 6777765544456779999999999999999999995258999999999999996 77899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+.
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 999999986554443345567889999999965 4489999999999999999999999987765554443332111100
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.....++.+.++|.+||+.||++||++.|+..+
T Consensus 234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 ---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 011368899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=304.86 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=190.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
+...+...||+|.||+||++++.. .||||++..+. ...+.|+..++.-+|.||+-+.+++. ... +
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~-~ 462 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPP-L 462 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCc-e
Confidence 355678999999999999999753 59999985432 34468999999999999999988883 222 3
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.||+.+|+| +|+..+.. ....|.......|+.|+++|+.|||. ++|||||||..||++.. +++|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEecccceee
Confidence 799999998 67777764 34678899999999999999999999 89999999999999996 68999999999864
Q ss_pred Ccc---CCCcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 191 LIA---GEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 191 ~~~---~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
-.. ........|...|||||+++.. ..|+..+|||||||++|||++|..||...+...++-.+=+..+.|..
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~--- 614 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL--- 614 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc---
Confidence 321 1122234556779999999543 34899999999999999999999999855544333222221111111
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.....+++.++++|+..||.+++++||...++|.
T Consensus 615 ---------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 ---------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ---------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1122347889999999999999999999998875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=286.14 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=187.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.++|++.+.||+|+||+||+|....+++ .+++|.+.... .....|+.++..++|+||+++++++. +
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C
Confidence 4579999999999999999999887776 47777764321 12235666788899999999998762 1
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
. ..++++||+. ++|.+.+.. ....+++..+..++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 ~-~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~Dfg 154 (279)
T cd05111 81 A-SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFG 154 (279)
T ss_pred C-ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEcCCc
Confidence 1 2568899988 577777653 34568999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+........ ++.....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-- 230 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD-LLEKGERL-- 230 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC--
Confidence 9976533322 1123456689999998654 48999999999999999998 999998876544322 22210000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. .+...+.++.+++.+||..||++|||+.++++
T Consensus 231 -------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 -------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 01125778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=293.38 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=192.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 104 (380)
.+|++.+.||+|+||.||+|.+... +..+|+|.+.... ....+|+.+++.+ +|+||+++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence 4799999999999999999986432 2368999876432 2234789999999 89999999998833
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Ni 171 (380)
....++++||+++ +|.+.+..... ....++...+..++.|++.||.|||+ +|++||||||+||
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~Ni 165 (334)
T cd05100 90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARNV 165 (334)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceE
Confidence 3348899999985 77777754221 23357888889999999999999999 8999999999999
Q ss_pred EEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChH
Q 016950 172 LVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV 247 (380)
Q Consensus 172 ll~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~ 247 (380)
+++. ++.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 166 ll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 166 LVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9996 77899999999875533221 111223457999999865 458999999999999999998 89999887766
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+....+..... ...+..++.++.+|+.+||+.+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 244 ELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55444322100 00122468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=281.15 Aligned_cols=236 Identities=24% Similarity=0.294 Sum_probs=183.2
Q ss_pred eeecCCceEEEEEEEC--CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 016950 45 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
.||+|+||.||+|.+. .++..||+|++..... ...+|+.+++.++|+||+++++++. . ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence 4899999999999765 4456799998854421 2347899999999999999988762 1 137899999
Q ss_pred ccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC
Q 016950 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (380)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~ 196 (380)
+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence 985 66665542 34578999999999999999999999 79999999999999986 77899999999875433221
Q ss_pred c----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 197 N----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 197 ~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
. ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+....+....+.+. .+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~----------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR----------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC-----------
Confidence 1 111225679999998544 48999999999999999996 99999887765544333221 00
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..++...++++.++|.+||..||++||++.++.+
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122346899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=284.61 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=193.5
Q ss_pred cceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.+|++.+.||.|+||.||+|+.+. +.+.+++|.+..... ...+|+.+++.++|+||+++++.+ .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 579999999999999999999764 346799998854332 245799999999999999999877 33
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
....|+||||++ ++|.+.+...... ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CCcEE
Confidence 345889999998 4777777543211 1268999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 182 ICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 182 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
++|||++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999986543221 12233556779999998654 47899999999999999998 88999776554444332210
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+ ..+..++..+.+++.+||+.||.+|||+.+++.+
T Consensus 235 ---------------~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ---------------KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000 1123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=285.67 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=188.9
Q ss_pred cceeeeeeeecCCceEEEEEEE----CCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.+|++.+.||+|+||.||++.. ..+++.||+|.+..... ...+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 4799999999999999999974 45788999999864322 3357999999999999999988764432 23
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+++|+||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCccc
Confidence 4789999997 477777653 23468899999999999999999999 89999999999999986 778999999999
Q ss_pred ccCccCCCcc----eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHH
Q 016950 189 KQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTRE 263 (380)
Q Consensus 189 ~~~~~~~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~ 263 (380)
.......... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..|+...... ....+.... +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence 8654332211 11223459999998654 5899999999999999999988776543211 111000000 000000
Q ss_pred HHh-hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 264 EIR-CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 264 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+. .+... .....+..++.++.+|+.+||..+|++|||+.++++
T Consensus 234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 00000 000112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=280.34 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=192.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|++.+.||.|+||.||++.+. ++..+|+|.+.... ....+|+.+++.++|+|++++++++. .....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEE
Confidence 47999999999999999999875 46789999886432 23457999999999999999998873 33358899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+.+ +|.+.+.. ....+++..++.++.|++.||++||+ ++++|+||||+||+++. ++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeeccc
Confidence 999986 55555542 23467899999999999999999999 79999999999999986 77899999999875433
Q ss_pred CCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||......+.+..+.+...
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 219 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR------------ 219 (256)
T ss_pred CcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC------------
Confidence 2211 12234567999999865 458899999999999999998 9999987776555544322100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 220 ----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 ----------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00112358899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=288.43 Aligned_cols=254 Identities=21% Similarity=0.283 Sum_probs=190.0
Q ss_pred cceeeeeeeecCCceEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeee
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL 96 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~ 96 (380)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 469999999999999999986532 34579999886432 223579999999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
++++... ...++||||+.+ +|.+.+...... ...+++..+..++.|++.||+|||+ +|++||||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp 158 (296)
T cd05095 85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLAT 158 (296)
T ss_pred EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCh
Confidence 9988433 347899999984 777777543211 1347788899999999999999999 7999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPG 243 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~ 243 (380)
+||+++. ++.++|+|||++........ ......+..|+|||...+. .++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 9999986 77899999999876533221 1112335679999987654 48999999999999999998 7799987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+............ ......+ .+..+++.+.+|+.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFRDQ-----------GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHhhc-----------cccccCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66555443322211000 0000000 11236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.20 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=181.2
Q ss_pred eeeecCCceEEEEEEECCCCc-------EEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 44 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~-------~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+.||.|+||.||+|.+...+. .+|+|.+..... ...+|+.+++.++||||+++++.+.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 368999999999999866544 388887754322 2356888999999999999999885432 377
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC-------cEEEEe
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKICD 184 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-------~ikl~D 184 (380)
+||||+++ +|...+.. ....+++..+..++.||+.||+|||+ +||+||||||+||+++.++. .++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999986 56666652 23468899999999999999999999 79999999999999986332 279999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
||.+...... ....+++.|+|||++.+...++.++|+||+||++|+|++| ..||...+....... ...
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~------- 220 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED------- 220 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc-------
Confidence 9998654322 2346788899999997655689999999999999999998 567765554433221 110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.. .++...+.++.+||.+||+.||++|||++++++.
T Consensus 221 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------RH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------cc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 1122356789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=280.57 Aligned_cols=243 Identities=28% Similarity=0.396 Sum_probs=193.4
Q ss_pred eeeeeeeecCCceEEEEEEECCCC----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
+++.+.||.|+||.||++.+..++ ..+|+|.+..... ....|+.+++.++|+||+++++.+... ..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 357789999999999999998766 8999999865432 335799999999999999999988433 45
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|++|||+++ +|.+.+.... ...+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCce
Confidence 8899999985 6766665321 1228999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 190 QLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 190 ~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
......... ...+++.|+|||.+. ...++.++|+||+||++|+|++ |.+||...+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------- 222 (258)
T ss_pred ecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence 654432211 123567899999984 4558999999999999999998 8999988766555554433110
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+...+.++.+++.+||..||++|||+.++++
T Consensus 223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0012236889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=280.96 Aligned_cols=239 Identities=26% Similarity=0.358 Sum_probs=189.4
Q ss_pred eeeecCCceEEEEEEECC-CC--cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~-~~--~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|++|.||+|.+.. .+ ..+|||.+..... ...+|+.+++.++|+||+++++.+.. ...++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999865 33 3699998865543 33479999999999999999988743 4588999
Q ss_pred eccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||++ ++|.+.+..... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence 9997 577777764221 568999999999999999999999 89999999999999997 688999999999866432
Q ss_pred CCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 195 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 195 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------- 218 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------- 218 (257)
T ss_pred ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 211 12345678999999854 458999999999999999998 9999988777665555433100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
... .+...+..+.+++.+||+.+|++|||+.++++
T Consensus 219 ----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----RLE------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----cCC------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000 11236889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=281.37 Aligned_cols=236 Identities=28% Similarity=0.379 Sum_probs=184.9
Q ss_pred eeeecCCceEEEEEEECCCC---cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|....++ ..+|+|.+..... ...+|+.+++.++|+||+++++++. .. ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 47999999999999876555 7899998865443 2347899999999999999988662 11 268999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+.+ +|.+.+.. ...+++..+..++.|++.||+|||. ++++|+||||+||+++. ++.+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99984 67777653 3478999999999999999999999 79999999999999996 778999999998765433
Q ss_pred CCcc----eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 195 EANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 195 ~~~~----~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....+... . +
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~-~--------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E-R--------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-c---------
Confidence 2211 1122457999999854 458999999999999999998 99999877665444333221 0 0
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..++..+.++|.+||..+|.+||++.++++
T Consensus 217 -----------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -----------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0012346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.92 Aligned_cols=206 Identities=27% Similarity=0.406 Sum_probs=171.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 111 (380)
.-|..-+.||+||||.||+++++.+|+.||||.+.+. ...--+|+++|++++|+|||+++++--... ..-....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4588899999999999999999999999999988652 222347999999999999999977542111 0001224
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC---CCcEEEEeecc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGS 187 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~---~~~ikl~Dfg~ 187 (380)
.+|||||.| +|...+.. ..+...+++.++..++..++.||.|||+ +||+||||||.||++-.. ....||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 599999995 66666653 3456779999999999999999999999 899999999999998431 23589999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~ 245 (380)
|+...++....+.+||+.|.+||++..+..|+..+|.||+||++|+++||..||....
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999888888899999999999999655679999999999999999999999996543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.42 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=218.1
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhC-CCCceeeeceeeeecCCCCc
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 108 (380)
-|...+-|++.++||.|.+|+||+++++.+++..|+|+..-+. .....|.++|+.. .|||++.++++|+-......
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3455677999999999999999999999999999999885443 2334577788877 69999999999987666667
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|||||||+| +..++++... +.++.|..+.+|++.++.|+.+||. +.++|||+|-.|||++. .+.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeee
Confidence 779999999995 7778888765 8899999999999999999999999 89999999999999997 77899999999
Q ss_pred cccCccC-CCcceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAG-EANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~-~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+...... ....+.+|||+|||||++... ..|+..+|+||||++..||.-|.+|+-.......+..|.. -|++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCc
Confidence 8766443 334567899999999998443 2367899999999999999999999988877766654432 1111
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
. + .-+++-++++.+||..||.+|..+||+..++|.|||+..
T Consensus 247 k----------------L-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 K----------------L-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred c----------------c-------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 0 0 002234789999999999999999999999999999974
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=283.61 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=192.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|++.+.||+|+||+||+|.++.+++ .+|+|....... ...+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 4679999999999999999999877665 589998765432 23478999999999999999998753
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...++||||+.+ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEECCCc
Confidence 237899999984 77766653 34468999999999999999999999 89999999999999986 7789999999
Q ss_pred ccccCccCCCcce---eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~~~~---~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
.+........... ..++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+....+....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 229 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER---- 229 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC----
Confidence 9986543322111 122457999999854 458999999999999999998 9999988776555444332100
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.. .+...+.++.+++.+||..||.+|||+.++++
T Consensus 230 ------------~~------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ------------LP------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------CC------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 11236789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.45 Aligned_cols=246 Identities=21% Similarity=0.294 Sum_probs=183.0
Q ss_pred eeeecCCceEEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|.... ....+|+|.+.... ....+|+.+++.++|+||+++++.+.. ...+|+|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence 368999999999996533 34578888775332 123468899999999999999998843 334889999
Q ss_pred cccc-hHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 117 YVPE-SMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 117 ~~~~-~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|+++ +|.+.+..... .....++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE 153 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence 9985 77777754322 12345677888999999999999999 79999999999999996 778999999998654322
Q ss_pred CC---cceeeccCCCCChhhhhC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 195 EA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 195 ~~---~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
.. .....+++.|+|||++.. ...++.++||||+||++|+|++ |..||......+.+..........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---- 229 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---- 229 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence 11 122344667999999743 2346889999999999999999 889998877666555544321110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+ ...+...+++.+.+++..|+ .||++|||++++++
T Consensus 230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 01123347889999999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=279.07 Aligned_cols=237 Identities=25% Similarity=0.359 Sum_probs=186.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
+.||.|+||.||+|.+.. ++.||+|++..... ...+|+.+++.++|+||+++++++.. ....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence 468999999999999877 99999998764322 33579999999999999999988743 33488999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
.+ +|.+.+.. ....+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||.+.........
T Consensus 75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence 75 66666642 23467889999999999999999999 89999999999999986 778999999998754322111
Q ss_pred ---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 198 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 198 ---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.....+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------- 213 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------- 213 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence 111224569999998554 58999999999999999999 8999987765544433322100
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012346889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=283.10 Aligned_cols=237 Identities=16% Similarity=0.185 Sum_probs=176.8
Q ss_pred eeeecCCceEEEEEEECC------------CCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 44 RVVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~------------~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
+.||+|+||.||+++... ....+|+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 368999999999998432 223588887754322 234678899999999999999987432
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC------cEE
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH------QVK 181 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~------~ik 181 (380)
...++||||++++.+..+.. .....+++..+..++.||+.||+|||+ +|++||||||+|||++.++. .++
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred -CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 33679999999643333321 234568999999999999999999999 89999999999999975221 389
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+... ....
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---- 224 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---- 224 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----
Confidence 9999998654322 23456788999999865566899999999999999998 5889987654332211 1110
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
... .....++++.+||.+||+.||.+||+..+++++
T Consensus 225 -------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 -------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 011246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.62 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=184.8
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
+.||.|+||.||++.. .++..+|+|.+..... ...+|+.+++.++|+||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 4689999999999985 4688999998754321 23478999999999999999998743 33478999999
Q ss_pred cc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCc
Q 016950 119 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197 (380)
Q Consensus 119 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~ 197 (380)
++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||+|+||+++. ++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence 85 66665542 23467899999999999999999999 89999999999999986 778999999998754322111
Q ss_pred c--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCC
Q 016950 198 I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274 (380)
Q Consensus 198 ~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 274 (380)
. ...++..|+|||++.+ ..++.++|+||+||++|++++ |..||.+.........+....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------- 211 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------- 211 (250)
T ss_pred cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 1 1233567999999854 458999999999999999998 999998876655444332210
Q ss_pred ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...++..++..+.+++.+||+.+|++||++.++++
T Consensus 212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00112347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.44 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=191.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..+|.+.+.||.|+||.||+|.+... ...+|+|...... ....+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~ 79 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N 79 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C
Confidence 35699999999999999999987654 3568999875433 133579999999999999999987732 1
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..|+||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. .+.++|+|||+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~ 153 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDFGL 153 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccCce
Confidence 25799999984 67777653 23468999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCCcc--eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 188 AKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 188 a~~~~~~~~~~--~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
+.......... ...++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----- 227 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----- 227 (270)
T ss_pred eeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC-----
Confidence 87654332211 1223457999999854 458999999999999999996 99999888766555443321000
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++.+.+++.+||..+|.+|||+.+++.
T Consensus 228 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 -----------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=309.78 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=200.9
Q ss_pred ceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+-...+.||+|+||+||+|+... ....||||.+++.. ..+++|++++..++|||||++++++.. .
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----~ 561 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----G 561 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----C
Confidence 45678899999999999998653 34679999986543 335699999999999999999999943 3
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhc------CC----CCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSA------NQ----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~------~~----~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
..+|+|+|||. |+|.++|+..... +. .++..+...|+.||+.|++||-+ +.++||||-..|+||.+ +
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge-~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE-N 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc-c
Confidence 34899999998 7898888754321 22 38899999999999999999999 79999999999999996 8
Q ss_pred CcEEEEeecccccCccCCCcc---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016950 178 HQVKICDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 253 (380)
..|||+|||+++.....+... ...-...|||||.|+- .+++.+|||||+||+|||+++ |..||.+....+.++.+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 899999999998765443221 1233567999999975 459999999999999999997 99999999998888877
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
.+..- +. -++++|.++.+|+..||+.+|.+||+..||
T Consensus 719 ~~g~l----------------L~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQL----------------LS------------CPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCCc----------------cc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 65210 01 134689999999999999999999999887
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.73 Aligned_cols=243 Identities=25% Similarity=0.354 Sum_probs=190.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||++... .+..+|+|.+..... ...+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 467999999999999999999854 456799998865432 34579999999999999999888743 23789
Q ss_pred Eeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|||++ ++|.+.+... ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. .+.+||+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCcceeecc
Confidence 999998 4777777532 34567888899999999999999999 79999999999999986 7889999999987543
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 221 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------- 221 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence 3221 112234567999999854 458899999999999999998 9999988766555443322100
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.+ .+...+.++.+++.+||+.+|++||++.+++
T Consensus 222 -------~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 222 -------MP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred -------CC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 00 1123688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=279.21 Aligned_cols=246 Identities=20% Similarity=0.232 Sum_probs=182.0
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.||+|+||.||+|... .++..+|+|.+.... ....+|+.+++.++||||+++++.+. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 46899999999999864 355789999885432 12346899999999999999998873 3334789999
Q ss_pred ccc-chHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 117 YVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 117 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|++ ++|.+.+..... .....++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence 998 477777654322 22345677888899999999999999 79999999999999996 788999999998754322
Q ss_pred CC---cceeeccCCCCChhhhhCCC------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 195 EA---NISYICSRFYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 195 ~~---~~~~~~t~~y~aPE~l~~~~------~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
.. .....++..|+|||++.+.. .++.++|+||+||++|+|++ |..||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 21 11234577899999985321 25789999999999999996 99999877655544332221000
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+ ...+....++.+.+++.+|+ .+|++|||+++++.
T Consensus 229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00011235788999999999 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=282.75 Aligned_cols=235 Identities=19% Similarity=0.231 Sum_probs=178.0
Q ss_pred eeecCCceEEEEEEECCC------------------------CcEEEEEEeecccc----chHHHHHHHHhCCCCceeee
Q 016950 45 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISL 96 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~------------------------~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~ 96 (380)
.||+|+||.||++....+ ...+|+|.+..... ...+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999975321 23588888754322 23467889999999999999
Q ss_pred ceeeeecCCCCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC
Q 016950 97 KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (380)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~ 175 (380)
++++... ...++||||++++ |...+. .....+++..+..++.|++.||+|||+ +||+||||||+|||++.
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence 9988433 3478999999964 444443 234578899999999999999999999 79999999999999974
Q ss_pred CC------CcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChHH
Q 016950 176 LT------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 248 (380)
Q Consensus 176 ~~------~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll-~g~~pf~~~~~~~ 248 (380)
.+ ..+|++|||++...... ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||.+....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 21 24899999988643222 12356778999999866566899999999999999995 6999998765443
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
........ .. ++...++.+.++|.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~------------------~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 230 KERFYEKK------------------HR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHhc------------------cC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 32211110 00 112246789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.81 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=187.7
Q ss_pred ceeeeeeeecCCceEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
-|++++.||+|+||.||+|+. ..+++.||+|.+.... ....+|+.+++.++|+|++++.+++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 478999999999999999984 4578899999885332 2345799999999999999998877432 223
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..++||||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCCccc
Confidence 47899999985 66666542 23468899999999999999999999 89999999999999986 778999999999
Q ss_pred ccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 016950 189 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE- 263 (380)
Q Consensus 189 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 263 (380)
......... ....++..|+|||.+.+. .++.++|+|||||++|+|+++..|+..... .. .+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence 865433221 123456679999998654 488999999999999999998776533211 11 1111110000
Q ss_pred ----HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 264 ----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 264 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+...... .....+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus 231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000000 0001123478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=281.82 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=186.3
Q ss_pred eeeecCCceEEEEEEECCCC------cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 44 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~------~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
+.||+|+||.||+++..... +.+|+|.+.... ....+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 36899999999999986544 789999875432 233478999999999999999988743 33488
Q ss_pred EEeecccc-hHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC-----cEEEE
Q 016950 113 LVMEYVPE-SMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKIC 183 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-----~ikl~ 183 (380)
+||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++ .++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence 99999984 77777754322 22457889999999999999999999 79999999999999986 44 79999
Q ss_pred eecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 016950 184 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 184 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|||++........ .....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||...+..+....+... .
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~- 230 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G- 230 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C-
Confidence 9999875533221 112344678999999865 458999999999999999998 99999877765544433210 0
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ...+..+++.+.++|.+||+.+|.+||++.++++
T Consensus 231 --------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 --------------R------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --------------c------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 0112346889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.24 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=189.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|+..+.||+|+||.||+|.+..+++ .+|+|.+..... ...+|+.+++.++|+||+++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 4578999999999999999999887776 468887754322 234788999999999999999877421
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++++||++ |+|.+.+.. ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~Dfg 154 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKITDFG 154 (303)
T ss_pred --CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEcccc
Confidence 1458999998 567666652 23468899999999999999999999 79999999999999986 6789999999
Q ss_pred ccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+.. .++.....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~-- 230 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL-- 230 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC--
Confidence 99865433221 12334678999999854 448999999999999999997 99999876543332 222211000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+ .+...+..+.+++.+||..+|++||++.++++.
T Consensus 231 ---------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ---------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ---------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 112357899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=278.00 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=190.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
..+|++.+.||+|+||.||++. .+++.||+|.+..+. ....+|+.+++.++|+|++++++.+.. . ..++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEE
Confidence 4679999999999999999986 478899999886432 234579999999999999999887732 1 16799
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+.+ +|.+.+... ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccceeccc
Confidence 999985 777777542 23457889999999999999999999 89999999999999986 77899999999875432
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
. ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||...+..+....+.+...
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 215 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------------- 215 (254)
T ss_pred c--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC--------------
Confidence 2 112233567999999854 458999999999999999997 9999988776554433322100
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ..+..++..+.+++.+||+.+|.+||++.+++.
T Consensus 216 ----~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ----M----------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----C----------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 011236889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=289.68 Aligned_cols=260 Identities=26% Similarity=0.343 Sum_probs=190.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+++|.....||+|+||.||++... ++..||||++.... .....|+.++.+++|||+|++++++.+... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 3467888899999999999999864 44899999885433 346789999999999999999999954332 37
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--CeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~--~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
+||+||++ |+|.+.+...... .++|.....|+.+++.||+|||... .|+||||||+|||+|. +...||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCc
Confidence 79999999 6887777642111 8899999999999999999999943 3999999999999996 889999999999
Q ss_pred ccCcc-CCCccee-eccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH-HHHhCCCCHH
Q 016950 189 KQLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEI-IKVLGTPTRE 263 (380)
Q Consensus 189 ~~~~~-~~~~~~~-~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~--~~~~~~~i-~~~~~~~~~~ 263 (380)
+.... ....... .||.+|+|||.+.. ...+.++|||||||++.|+++|+.+..... ....+... ...+...
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--- 300 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--- 300 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence 76543 2222223 78999999999854 558999999999999999999998876432 11111111 1111111
Q ss_pred HHhhcCCCCCCccCCCCCCCCcc-cccCC-CCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWH-KVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.+..+.+..+. ..+.. ..-..+..+..+|++.+|..||+..|++
T Consensus 301 ------------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 301 ------------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred ------------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 11111111111 00110 0122366788999999999999999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=277.08 Aligned_cols=239 Identities=24% Similarity=0.383 Sum_probs=180.5
Q ss_pred eeeecCCceEEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||.||+|.+.. .+..+|+|.+.... ....+|+.+++.++||||+++++++... +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 468999999999998754 34579999874321 2234688899999999999998866422 22367999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
||+.+ +|...+.. ....+++..+..++.|++.||.|||+ .+++||||||+|||++. ++.+||+|||++......
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99984 77666653 23446777788899999999999999 79999999999999996 778999999998754332
Q ss_pred CC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 195 EA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 195 ~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+... .+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR-------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 11 112234667999999855 458999999999999999999 57788776655444333221 00
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.. .+..+++.+.+++.+||+.+|++||++.++++
T Consensus 221 ------~~------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 ------LL------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------CC------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 11236789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.02 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=189.6
Q ss_pred eeeeeeeecCCceEEEEEEECC---CCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCC-ce
Q 016950 40 YMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN-EL 109 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 109 (380)
|.+.+.||+|+||.||+|.... +++.+|||.+..+.. ...+|+.+++.++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998653 578999998864321 2347899999999999999999875543222 22
Q ss_pred EEEEEeecccc-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++++||+.+ ++...+.... .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence 35788999984 5555543211 122357889999999999999999999 89999999999999986 7789999999
Q ss_pred ccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+++....... .....+++.|++||.+.+. .++.++|+|||||++|+|++ |.+||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN----- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9886533221 1122345679999998544 47899999999999999999 899998776655444333210
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
... .+...++.+.+++.+||+.+|++|||+.+++.
T Consensus 233 -----------~~~------------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 233 -----------RLK------------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -----------cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 11236789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=292.88 Aligned_cols=245 Identities=26% Similarity=0.363 Sum_probs=194.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCc---E-EEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
++-.+.+.||+|+||.||++..+..+. . ||+|....+. ...-+|+++|+.++|||||+++++.....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-- 234 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-- 234 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--
Confidence 344557899999999999999876432 3 8999876422 12237999999999999999999884433
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.+++|||+|.| +|.+.|+. ....++..+...++.+.+.||+|||+ ++++||||-..|+|++. ++.+||+||
T Consensus 235 ---Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~vKISDF 306 (474)
T KOG0194|consen 235 ---PLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVVKISDF 306 (474)
T ss_pred ---ccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeEEeCcc
Confidence 38899999996 77777774 23368999999999999999999999 89999999999999996 677899999
Q ss_pred cccccCccCCCcc-eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 186 GSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 186 g~a~~~~~~~~~~-~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|+++......... ..--...|+|||.+.. ..|+.++||||+||++||+++ |..||.+....+....+...
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~------- 378 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN------- 378 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc-------
Confidence 9987654221111 1122456999999954 479999999999999999998 89999999998888887542
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+.. .++...+.++..++.+|+..||++|+|+.++.+
T Consensus 379 ----------~~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 379 ----------GYRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------CccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1111 122346889999999999999999999988763
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=275.18 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=181.3
Q ss_pred eeecCCceEEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 016950 45 VVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~--~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
.||+|+||.||++..... ...+++|.+.... ....+|+.+++.++||||+++++.+. .....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence 589999999999975433 3456677665332 23347888899999999999999884 33448899999
Q ss_pred ccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC-
Q 016950 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE- 195 (380)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~- 195 (380)
+++ +|.+.+.........+++..++.++.||+.||+|||+ ++++||||||+|||++. ++.++|+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcchh
Confidence 995 7777776433333456777888999999999999999 79999999999999986 7789999999986432211
Q ss_pred --CcceeeccCCCCChhhhhCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 196 --ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 196 --~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
......++..|+|||++... ..++.++|||||||++|+|++ |..||...+..+.+..+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------ 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence 12234668889999997421 235778999999999999997 578998777666665544321100
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+...+....++.+.+++..|| .+|.+||++.++++
T Consensus 229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0011122236788999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=275.49 Aligned_cols=233 Identities=18% Similarity=0.213 Sum_probs=179.5
Q ss_pred eeeecCCceEEEEEEECCCC----------cEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 44 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~----------~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
+.||+|+||.||++.+..++ ..+++|.+.... ....+|+.+++.++|+||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 46899999999999998776 357888765433 234578899999999999999998744 2 2
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC-------cEEE
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKI 182 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-------~ikl 182 (380)
.++||||+.+ +|...+.. ....+++..+..++.||+.||+|||+ +|++||||||+||+++. .+ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence 6799999985 56555543 22268899999999999999999999 79999999999999986 44 6999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
+|||++..... .....++..|+|||++.+. ..++.++|+||+||++|+|++ |..||...+..+....... .
T Consensus 150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~ 222 (259)
T cd05037 150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q 222 (259)
T ss_pred CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C
Confidence 99999876533 2234566789999998655 358999999999999999999 6888876643222211110 0
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.. .+......+.++|.+||..+|.+|||+.++++
T Consensus 223 ------------~~--------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ------------HR--------------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------CC--------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00112378999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=282.86 Aligned_cols=283 Identities=28% Similarity=0.475 Sum_probs=215.7
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECC---CCcEEEEEEee--ccccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVL--QDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
.|...+.|.++++||+|.|++||++.+.. ..+.||+|.+. ........|+++|..+ .+.||+++.+++ .
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----R 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----c
Confidence 45667789999999999999999999987 78899999884 3345567899999998 588999998888 5
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
......+|+||++. ...++.. .++...++.|++.++.||+++|. +|||||||||+|+|.+...++-.|+||
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEec
Confidence 55558899999995 4334433 46688899999999999999999 899999999999999988888999999
Q ss_pred cccccC-----------------cc-C---------------------------CCcceeeccCCCCChhhhhCCCCCCc
Q 016950 186 GSAKQL-----------------IA-G---------------------------EANISYICSRFYRAPELIFGATEYTT 220 (380)
Q Consensus 186 g~a~~~-----------------~~-~---------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~ 220 (380)
|+|... .. . .......||++|+|||+++..+.-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 998611 00 0 00113468999999999998888899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhc------------------CCCCCCccCCCCC
Q 016950 221 SIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRCM------------------NPNYTDFRFPQIK 281 (380)
Q Consensus 221 ~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~ 281 (380)
++||||.|||+..++++..||- ..+..+.+.+++..+|...-...... ..+|.........
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 9999999999999999999975 45666677777766665433322211 1111111101110
Q ss_pred C-C---CcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 282 A-H---PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 282 ~-~---~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. . .+........+..+.||+.+||..||.+|+|++++|.||||....
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 0 1 133333344567999999999999999999999999999998653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=305.89 Aligned_cols=247 Identities=22% Similarity=0.367 Sum_probs=199.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCC-----cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..-+..+.||+|+||.||.+...... ..||+|.+.+... ...+|..+|..++|||||+++++.++...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 45778899999999999999876533 3499998865432 23479999999999999999999976433
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.+|++|||. |+|+.+|+..+. ....++......++.||+.|++||++ +++|||||...|+|++. ...+||+
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VKIa 844 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVKIA 844 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEEEc
Confidence 779999999 588888875321 14568999999999999999999999 79999999999999997 6889999
Q ss_pred eecccccCccCCCcce--e-eccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 016950 184 DFGSAKQLIAGEANIS--Y-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~--~-~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|||+|+.....+.... . .-..-|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+....+.-.
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR- 922 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR- 922 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc-
Confidence 9999995543332211 1 11345999999965 569999999999999999998 9999999998888775554211
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.. .+..++..+.+++.+||+.+|++||+...+++
T Consensus 923 ---------------L~------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ---------------LD------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------------cC------------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 01 13458999999999999999999999998886
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.17 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=189.6
Q ss_pred cceeeeeeeecCCceEEEEEEEC----CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++.+.||+|+||.||+|... .+++.+|+|.+..... ...+|+.+++.++|+||+++++++... +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 46888999999999999999864 3478999999865433 345799999999999999998877432 23
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+.+++|||+++ +|.+.+.. ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~ 155 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFGL 155 (284)
T ss_pred CceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEccccc
Confidence 458899999975 77776653 23368999999999999999999999 79999999999999996 68899999999
Q ss_pred cccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 016950 188 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~-~~~~~~ 262 (380)
+......... ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||......... +... .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~ 232 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIV 232 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccH
Confidence 9866432221 112335569999998554 5899999999999999999999998654321100 0000 000000
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+........ .. ..+..++.++.+|+.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~--~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 233 TRLLELLKEGE--RL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHcCC--cC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000000000 00 011236789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=288.44 Aligned_cols=274 Identities=23% Similarity=0.302 Sum_probs=182.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC----------------CCCcEEEEEEeecccc------------------chHH
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR 80 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~aiK~~~~~~~------------------~~~~ 80 (380)
...++|++.++||+|+||+||++... ..++.||||++..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34678999999999999999999752 2456799999853321 1123
Q ss_pred HHHHHHhCCCCce-----eeeceeeeecCC---CCceEEEEEeecccc-hHHHHHHHhhh--------------------
Q 016950 81 ELQLMRVMDHPNV-----ISLKHCFFSTTS---KNELFLNLVMEYVPE-SMYRVLKHYSS-------------------- 131 (380)
Q Consensus 81 e~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------- 131 (380)
|+.++..++|.++ +++.+++..... ......++|+||+++ +|.+.+.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766654 455555432111 112347899999985 67666642110
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcce--eeccCCCCCh
Q 016950 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAP 209 (380)
Q Consensus 132 ~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~~t~~y~aP 209 (380)
....+++..++.++.|++.+|.|||+ ++|+||||||+|||++. ++.+||+|||++........... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 11234677888999999999999999 79999999999999996 67899999999975433322222 2347899999
Q ss_pred hhhhCCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 210 ELIFGATE-------------------Y--TTSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 210 E~l~~~~~-------------------~--~~~~DiwslGvil~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
|.+..... + ....|+||+||++|+|++|.. ||.+....... .+... .....++.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~-~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYD-NDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhcc-chHHHHHh
Confidence 99853211 1 124799999999999999885 77543221111 00000 00011111
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCC---CCCCCHHHHhcCCCccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE 326 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~t~~e~l~hp~~~~ 326 (380)
... ..+.+ ......++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 456 ~~~--~~~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 YKG--QKYDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hcc--cCCCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000 01111 1223478999999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=259.59 Aligned_cols=238 Identities=38% Similarity=0.644 Sum_probs=190.5
Q ss_pred CceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHH
Q 016950 50 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMY 123 (380)
Q Consensus 50 ~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 123 (380)
+||.||+|....+++.+|+|++.... ....+|+..++.++|+|++++++.+.. ....++++||+++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence 58999999999999999999986442 344689999999999999999988843 2458899999997 777
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeecc
Q 016950 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 203 (380)
Q Consensus 124 ~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t 203 (380)
+.+.. ...+++..+..++.+++.++.+||+ .+++|+||+|+||+++. ++.++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence 76653 2338899999999999999999999 79999999999999996 678999999999876554444456678
Q ss_pred CCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCC
Q 016950 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 283 (380)
Q Consensus 204 ~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (380)
..|+|||.+.+ ..++.++|+||+|+++++|++|..||....................
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 206 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------------------- 206 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence 89999999864 4478899999999999999999999987433333333222100000
Q ss_pred CcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 284 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
......++.++.+++.+||..+|++||++.++++||||
T Consensus 207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=293.32 Aligned_cols=248 Identities=32% Similarity=0.491 Sum_probs=189.8
Q ss_pred eeeeeeeecCCceE-EEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEee
Q 016950 40 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 40 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
|.-.+++|.|+.|+ ||++.. .|+.||||.+.... ....+|+..|+.- +|||||+++..- .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 55567889999986 688876 78899999886544 4678999999988 699999986644 66778999999
Q ss_pred cccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC----CCcEEEEeecccccCc
Q 016950 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQLI 192 (380)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~----~~~ikl~Dfg~a~~~~ 192 (380)
.|..+|.+++...............+.++.|++.||++||+ .+|+||||||.||||+.. ..+++|+|||+++...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99999999987531111122224567788999999999999 699999999999999752 2479999999999876
Q ss_pred cCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 193 AGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 193 ~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
.+.. .....||-+|+|||++.+.. -+.++||||+||++|+.++| ..||...- +.-.+|.. |
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~--~--------- 728 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILT--G--------- 728 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--Hhhhhhhc--C---------
Confidence 5543 23457899999999997654 57799999999999999985 89996542 22222222 0
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+ +..-.+ ......++.|||.+||+.||..||+|.++|.||||
T Consensus 729 ---~---~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 729 ---N---YTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred ---c---cceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 1 111110 01112389999999999999999999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=277.57 Aligned_cols=241 Identities=23% Similarity=0.387 Sum_probs=199.0
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+..+..+||.|.||.||.+..++-.-.||||.++.+.... .+|+.+|+.++|||+|++.+++. .+.-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeEEEE
Confidence 4556789999999999999999999999999998775443 47999999999999999999983 333488999
Q ss_pred eccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|||. |+|+++++.. ....++.....+++.||..|++||.. +++|||||-..|+|+.+ ++.||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchhhhhcCC
Confidence 9998 7999999864 33457777888999999999999999 89999999999999996 788999999999987544
Q ss_pred CCcceeec---cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 195 EANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 195 ~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... ...| ..-|.|||.+. -..++.++|||+|||+|||+.| |-.||++.+..+.+..+.+.
T Consensus 419 TYT-AHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------- 482 (1157)
T KOG4278|consen 419 TYT-AHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------- 482 (1157)
T ss_pred cee-cccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence 322 2222 45599999984 3458999999999999999998 99999999877666554442
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
|.+.. +..+++...+|++.||+|+|++||+..|+
T Consensus 483 ----yRM~~----------PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 483 ----YRMDG----------PEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----ccccC----------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 22211 34589999999999999999999998776
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=277.58 Aligned_cols=239 Identities=31% Similarity=0.460 Sum_probs=191.5
Q ss_pred eeeeeeeecCCceEEEEEEECC--CC--cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLE--TG--ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~--~~--~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++.+.||+|-||.||.+.... .| -.||||..+.+. ...-.|+.+|+.++||||+++++++... .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence 4456789999999999998643 23 358899876532 2334799999999999999999988321 2
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
++||||.++ |.|.+.++. ....++......|++||+.||.|||+ ++++||||-..|||+.+ ...|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecccchhh
Confidence 889999999 677777764 45678888899999999999999999 89999999999999997 6679999999999
Q ss_pred cCccCCCcceeec--cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 190 QLIAGEANISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 190 ~~~~~~~~~~~~~--t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
............| ..-|||||.+. -..++.+||||-|||.+||++. |..||.+-...+.+..+.+.-..|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP------ 612 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP------ 612 (974)
T ss_pred hccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC------
Confidence 8766554333333 34599999994 4558999999999999999986 999999987776665554421111
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
.|.++++.+..|+.+||++||.+||+..++
T Consensus 613 ----------------------~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 613 ----------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ----------------------CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 245699999999999999999999987654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=276.49 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=202.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCC-C--cEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
++..+.++||+|.||.|+++..... | ..||||.+..+.. .+.+|+.+|..|+|+|++++|+++.+.-
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 4567788999999999999988753 3 4589999865543 2458999999999999999999986421
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
+.+|||++. |+|++-|.. .....|.......|+.||+.|+.||.+ +++|||||-..|+|+-. ...|||+|||+.
T Consensus 185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKICDFGLM 259 (1039)
T ss_pred -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeeecccce
Confidence 569999999 688887775 355678889999999999999999999 89999999999999986 678999999999
Q ss_pred ccCccCCCcceeec----cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 189 KQLIAGEANISYIC----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 189 ~~~~~~~~~~~~~~----t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+....++....... ...|+|||.+.. ..++.++|+|++||++|||++ |+.||.|.....++.+|-+..
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------ 332 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------ 332 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc------
Confidence 98766655432221 345999999954 569999999999999999998 899999999888887765321
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
...- ++.+++++.+++..||+.+|.+|||...|.+.-+..
T Consensus 333 ----------rLpR------------Pk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 333 ----------RLPR------------PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred ----------cCCC------------CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 1111 234899999999999999999999999887554443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.31 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=205.6
Q ss_pred ceeeeeeeecCCceEEEEEEECCCC---cEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.-.|.++||.|.||.|++++.+..+ ..||||.++.. ++.+-.|+.||-+++||||+++.++.. ...-
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT-----ks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT-----KSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe-----cCce
Confidence 5678999999999999999988766 46999998643 333447999999999999999999883 2333
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+.||+|||+ |+|..+|+. ..+.|+..++..+++.|+.|++||-+ -|++||||-..|||+++ +-..|++|||+++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNs-nLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeecc-ceEEEecccccee
Confidence 789999998 678888875 45779999999999999999999999 59999999999999997 7889999999999
Q ss_pred cCccCCC-cceeec---cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAGEA-NISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~~~-~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
...++.. ..+..| ...|.|||.+. -.+++.+||+||+|+++||.++ |..||-...+.+.+..|.+..+.|++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-- 856 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-- 856 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--
Confidence 7755442 222222 45699999995 4569999999999999999875 99999999999999999886666553
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
-+++..+-.|+..||++|-.+||...|++++
T Consensus 857 --------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3489999999999999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=268.83 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=197.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
....++++||+|-||.|.+|. ...+..||+|+++.+. ....+|+++|.+|+||||+.+++++...+. ++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence 357889999999999999998 4457899999986432 344589999999999999999999854443 88
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||++ |+|..++..... ..+.-....+|+.||+.|++||.+ .+++||||.+.|+|++. ..++||+|||.++..
T Consensus 612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCccccccc
Confidence 9999998 677777764321 223445556799999999999999 59999999999999996 889999999999976
Q ss_pred ccCCCcc---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 192 IAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 192 ~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...+... ..+-...|||+|.+.-. +++.+||+|++|+++||+++ ...||......+...+....+..+....+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 5544322 23446789999999754 59999999999999999875 889998888777776665554443322211
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.-|.-++..+.+++.+||..|-++||+.+++.
T Consensus 767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 11234789999999999999999999999984
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=239.25 Aligned_cols=213 Identities=23% Similarity=0.400 Sum_probs=173.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHh-CCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+....+..||+|++|.|=+.++..+|+..|+|.+..... ..-+|+++..+ ..+|.+|++++.+++..+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd----- 119 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD----- 119 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence 4556677889999999999999999999999998853321 11235544333 368999999998866554
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++|.||.|.-+|..+-++....++.++|..+-.|+..++.||.|||+.-.++|||+||+|||++. .+++|+||||.+..
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEccccccee
Confidence 88999999998888877777789999999999999999999999998569999999999999997 88999999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHH
Q 016950 191 LIAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIK 255 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~---~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~ 255 (380)
..+.-..+...|-..|||||.+.. +..|+.++||||||+.+.||.+++.||... ++.+++.++.+
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 654443333566677999999843 335899999999999999999999999865 45566655554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.06 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=182.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
..|...+.||+|+||.||+|++..+++.||+|++.........|+..++.++||||+++++++... ...|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeC
Confidence 346677899999999999999999999999999876555556789999999999999999998443 337899999
Q ss_pred ccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH---cCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH---~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+++ +|.+.++ .+++..+..++.|++.||+||| + .+++||||||+||+++. +...++. ||.+.....
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc
Confidence 985 6666664 3788899999999999999999 6 69999999999999986 5556654 665543221
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
.....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+....+..-... ..
T Consensus 835 ---~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~------- 901 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL------- 901 (968)
T ss_pred ---CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch-------
Confidence 123367899999999865 45899999999999999999999998532111 11111111000000 00
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+.-+..... .........++.+++.+||+.||++|||+.|+++.
T Consensus 902 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 902 DMWIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred hheeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000000000 00001123467889999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.32 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=175.4
Q ss_pred CCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchH------------HHHHHHHhCC---CCceee
Q 016950 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------------RELQLMRVMD---HPNVIS 95 (380)
Q Consensus 31 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~------------~e~~~l~~l~---h~niv~ 95 (380)
...+.+..+|..++.+|+|+||.|++|.++.++..|+||.+.+.+.... .|+.||..++ |+||++
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence 3456677789999999999999999999999999999998876543332 5999999997 999999
Q ss_pred eceeeeecCCCCceEEEEEeecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 96 LKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 96 ~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
+.++| +++.++||+||--.. +|.+++. ....++|.+++.|+.|++.|+++||+ .||+|||||-+|+.+
T Consensus 634 lLdfF-----Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenviv 703 (772)
T KOG1152|consen 634 LLDFF-----EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIV 703 (772)
T ss_pred hhhee-----ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEE
Confidence 99999 888889999998874 5555554 67889999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 243 (380)
+. ++-+||+|||.|.... ......++||..|.|||++.|....+..-|||++|++||.++....||..
T Consensus 704 d~-~g~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 DS-NGFVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ec-CCeEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 97 7889999999987543 34445789999999999998877779999999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=266.28 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=208.2
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
+-.++|+.+..+|.|.||.||+|+++.+++..|+|+++-. ....+.|+-+++..+|+||+.+++.+.....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk----- 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK----- 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----
Confidence 3357899999999999999999999999999999998643 3445689999999999999999999965444
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++.||||+|+-++.+- ...+.+++.++.+...+.+.+|+|||+ .|-+|||||-.||+++. .+.+|+.|||.+..
T Consensus 87 lwicMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaq 161 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQ 161 (829)
T ss_pred cEEEEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhh
Confidence 89999999975444443 256889999999999999999999999 69999999999999995 78899999999876
Q ss_pred CccC-CCcceeeccCCCCChhhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 191 LIAG-EANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 191 ~~~~-~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+..- ....++.||++|||||+.. ....|...+|+|++|+...|+---++|-.....+..+..+-+..
T Consensus 162 itati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~---------- 231 (829)
T KOG0576|consen 162 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG---------- 231 (829)
T ss_pred hhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC----------
Confidence 5432 3455789999999999962 23458999999999999999998888876666655554443321
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
|.. |.+++ +.+-++.+-+|++.+|.++|.+|||++.+|.|||...
T Consensus 232 ----~qp---p~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 232 ----FQP---PTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ----CCC---CcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 111 11111 1124778899999999999999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-31 Score=261.70 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=188.5
Q ss_pred eeeeeeecCCceEEEEEEECC-------CCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 41 MAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
.+.+.||+|+||+|+++.... ....||+|.++... .....|+++|+.+ .|+||+.+.+++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-----
Confidence 566799999999999997541 14569999886433 2335799999988 59999999998844
Q ss_pred ceEEEEEeeccc-chHHHHHHHhh---h-------cC--CCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYS---S-------AN--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~---~-------~~--~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
...+++|+||+. |+|+..++... . .. ..++......++.||+.|++||++ .+++||||-..|||+.
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARNVLIT 452 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhhEEec
Confidence 344889999998 78888887654 1 11 238899999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCCcc--eeec--cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-hHH
Q 016950 175 PLTHQVKICDFGSAKQLIAGEANI--SYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN-AVD 248 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~~~--~~~~--t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~-~~~ 248 (380)
. +..+||+|||+|+......... ...+ ...|||||.+.. ..|+.++||||+||+|||+++ |..||++.. ..+
T Consensus 453 ~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 453 K-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred C-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 6 7789999999998654433221 1122 223999999966 669999999999999999998 999999865 333
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
. .+.++.... .. .|..+++++.++++.||+.+|++||+..++.
T Consensus 531 l-~~~l~~G~r---------------~~------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 531 L-LEFLKEGNR---------------ME------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred H-HHHHhcCCC---------------CC------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 3 332221110 01 1345899999999999999999999998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=243.33 Aligned_cols=258 Identities=27% Similarity=0.333 Sum_probs=184.3
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHH--hCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR--VMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~--~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
....+.+.+|+|.||.||+|.. +++.||||+++... .....|.+|.. .++|+||++++..--... .....++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 4567788999999999999986 66999999997543 33445666555 458999999876543222 224458899
Q ss_pred eeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------CCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 115 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------PRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 115 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~--------~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
++|.+ |+|.+.|+. ..+++....+++..+++||+|||+- ..|+|||||..||||.. +.+..|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeecc
Confidence 99998 789898874 5789999999999999999999983 46999999999999986 889999999
Q ss_pred cccccCccCCC---cceeeccCCCCChhhhhCCCCCC-----chhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHH
Q 016950 186 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKV 256 (380)
Q Consensus 186 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~-----~~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~ 256 (380)
|+|..+..... ....+||..|||||++.+.-++. .+.||||+|.++|||+++-.-+. +.-..-++---.+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99987754433 33478999999999997765544 46999999999999997543321 11111111111112
Q ss_pred hCCCCHHHHhhc------CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH
Q 016950 257 LGTPTREEIRCM------NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316 (380)
Q Consensus 257 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 316 (380)
-..|+.+.+... .|.+.+ .|... .-...+++.+.-||..||+-|+|+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~---------~W~~h---~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPD---------AWRKH---AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChh---------hhhcC---ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 223333333221 111111 11111 1245789999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=231.87 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=185.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhC-CCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..+.|.|.+.||+|-||++.+|+|+.++..+++|.+..... ...+|...--.| -|.||+.-+++.+... .++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceE
Confidence 45789999999999999999999999999999999875433 233555543344 4899999888765433 367
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE-cCCCCcEEEEeecccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill-~~~~~~ikl~Dfg~a~ 189 (380)
.+++||++ |+|.+-+. ...+.+...+.++.|++.|+.|||+ ++++|||||.+|||| +++..+|||||||.+.
T Consensus 98 vF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeeccccc
Confidence 79999999 56555443 2567889999999999999999999 899999999999998 5555689999999987
Q ss_pred cCccCCCcceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHH
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~ 264 (380)
....--. ..--+..|.+||++... -...+.+|+|.||+++|.++||.+||......+. +.+.++..+.-..
T Consensus 172 k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 172 KVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 5421111 11124558999987432 2246789999999999999999999974432221 2222222221110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC---CHHHHhcCCCccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDE 326 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~ 326 (380)
..| ..| ..+++.+..+.++-|..+|.+|. ++..-...-|...
T Consensus 248 -----------~~P--------~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 248 -----------ALP--------KKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred -----------cCc--------hhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 001 111 23799999999999999999995 4455555566543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=251.44 Aligned_cols=241 Identities=27% Similarity=0.367 Sum_probs=192.3
Q ss_pred eeeeeeeecCCceEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+..++||.|+||+||++.....|+ +||||++.... ...-+|+-+|..++|||++++.++.....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 4557899999999999998876554 58888875432 23347889999999999999999885433
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+-||++|++ |.|++.++. ....+..+....|.+||+.|++|||. ++++||||-..|+||.+ -..+||.|||+++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchhh
Confidence 559999999 678888875 45678888899999999999999999 79999999999999986 6779999999999
Q ss_pred cCccCCCcceeec---cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 190 QLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 190 ~~~~~~~~~~~~~---t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
............+ .+-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....++-..+.+.
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------- 916 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------- 916 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------
Confidence 8776655444332 445889998854 559999999999999999998 99999988765544333221
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..... |..++.++--++.+||..|+..||++.++..
T Consensus 917 -------eRLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -------ERLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------ccCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11122 2348889999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=217.23 Aligned_cols=208 Identities=37% Similarity=0.589 Sum_probs=174.1
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP- 119 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~- 119 (380)
||+|++|.||++....+++.+++|++..... ...+|+..++.++|++++++++++.. ....++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 6899999999999988899999999976543 46789999999999999999988843 245889999999
Q ss_pred chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC-Ccc
Q 016950 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANI 198 (380)
Q Consensus 120 ~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~ 198 (380)
++|.+.+... ...++...++.++.+++.++++||+ +|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 5777766532 1468899999999999999999999 7999999999999998535789999999987654332 123
Q ss_pred eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCC
Q 016950 199 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (380)
Q Consensus 199 ~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (380)
...+...|++||.+.....++.++|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 345677899999985543678999999999999999
Q ss_pred CCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCC
Q 016950 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322 (380)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 322 (380)
..+.+++.+||+.||++||++.++++|+
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1456899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=271.91 Aligned_cols=207 Identities=17% Similarity=0.179 Sum_probs=145.6
Q ss_pred hCCC-CceeeeceeeeecC--CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeee
Q 016950 87 VMDH-PNVISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 163 (380)
Q Consensus 87 ~l~h-~niv~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH 163 (380)
.++| +||+++++.|-... ......+++++|+++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence 3345 46777777652111 111234668899999998888853 34569999999999999999999999 89999
Q ss_pred cCCCCCCEEEcC------------------CCCcEEEEeecccccCccCC-----------------CcceeeccCCCCC
Q 016950 164 RDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYRA 208 (380)
Q Consensus 164 ~Dlkp~Nill~~------------------~~~~ikl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a 208 (380)
|||||+|||++. ....+|++|||+++...... .....++|++|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999953 13356666777665321100 0012357899999
Q ss_pred hhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccc
Q 016950 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV 288 (380)
Q Consensus 209 PE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (380)
||++.+. .|+.++|||||||++|||++|.+|+.... .....+.... .++ .
T Consensus 184 PE~~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~------------------------- 233 (793)
T PLN00181 184 PEEDNGS-SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q------------------------- 233 (793)
T ss_pred hhhhccC-CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h-------------------------
Confidence 9998665 48999999999999999999998875322 1121111110 000 0
Q ss_pred cCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 289 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 289 ~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.. ...+...+++.+||+.||.+||++.|+++||||....
T Consensus 234 ~~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 IL-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred hh-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 00 0245677899999999999999999999999998743
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-29 Score=217.64 Aligned_cols=197 Identities=34% Similarity=0.579 Sum_probs=164.4
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
|.+.+.||.|++|.||++.+..+++.+|+|.+.... ....+|+..++.++|+|++++++.+.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence 678899999999999999999889999999986542 344579999999999999999988733 2348899
Q ss_pred eecccc-hHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+|++++ +|.+.+.. ... +++..+..++.+++.++.+||+ ++++|+||+|.||+++. .+.++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence 999997 77777653 223 7899999999999999999999 79999999999999996 6889999999988765
Q ss_pred cCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChH
Q 016950 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAV 247 (380)
Q Consensus 193 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~-~~~~ 247 (380)
... ......++..|++||.+.+...++.++|+||+|+++++|++|+.||.+ .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 443 334456788899999874444578899999999999999999999977 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=223.82 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=184.8
Q ss_pred ecCCCCCCCccc-----cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHH--hCCCCceeeec
Q 016950 26 TIGGKNGEPKQT-----ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMR--VMDHPNVISLK 97 (380)
Q Consensus 26 ~~~~~~~~~~~~-----~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~--~l~h~niv~~~ 97 (380)
+++.-+|.|..+ .+..+.+.||+|-||.||++.. .|+.||||++..... .-.+|.+|.+ .|+|+||+.++
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhh
Confidence 444455555443 4688999999999999999987 688999999965433 2345666655 56999999987
Q ss_pred eeeeecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCeeecCCCCC
Q 016950 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQ 169 (380)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-------~~iiH~Dlkp~ 169 (380)
..-.... ..-..++||++|-+ |+|.++|.. ..++......++..++.||.+||.. ..|+|||||..
T Consensus 272 aaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 272 AADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 7543332 33456899999998 799998863 5788888999999999999999962 36999999999
Q ss_pred CEEEcCCCCcEEEEeecccccCccCC-----CcceeeccCCCCChhhhhCCCCC-----CchhhHHHHHHHHHHHHh---
Q 016950 170 NLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEY-----TTSIDIWSAGCVLAELLL--- 236 (380)
Q Consensus 170 Nill~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~-----~~~~DiwslGvil~~ll~--- 236 (380)
|||+.+ ++...|+|+|+|-...... .....+||..|||||++...-.. -..+||||||+++||++.
T Consensus 346 NILVKk-n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 346 NILVKK-NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred cEEEcc-CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 999996 8889999999996554331 23457899999999999543221 236899999999999874
Q ss_pred --C-----CCCCCCCC----hHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhc
Q 016950 237 --G-----QPLFPGEN----AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 305 (380)
Q Consensus 237 --g-----~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 305 (380)
| ++||.+.- ..+...+++-. +.+.|+. ...|... ..-..+..+++-||
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv---------~~~RP~i---------pnrW~s~---~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCV---------QKLRPNI---------PNRWKSD---PALRVMAKLMKECW 483 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceee---------cccCCCC---------CcccccC---HHHHHHHHHHHHhh
Confidence 2 36765432 11111111100 0001111 1111110 01124556899999
Q ss_pred ccCCCCCCCHHHHh
Q 016950 306 QYSPSLRCTALEAC 319 (380)
Q Consensus 306 ~~dp~~R~t~~e~l 319 (380)
.-+|.-|.|+--+.
T Consensus 484 ~~Np~aRltALriK 497 (513)
T KOG2052|consen 484 YANPAARLTALRIK 497 (513)
T ss_pred cCCchhhhHHHHHH
Confidence 99999999986654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=247.85 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=193.1
Q ss_pred cce-eeeeeeecCCceEEEEEEECCCCcEEEEEEeec----cccc------hHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 38 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..| .....+|.|++|.|+.+......+.++.|.+.. .... ...|..+-..+.|+|++.....++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~- 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG- 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-
Confidence 445 567789999999999998887777777776541 1110 1245556667899999877666643222
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
.+-+||||+++|...+. ....++...+..++.||+.|++|||+ .||.|||+||+|++++. ++.+||+|||
T Consensus 396 ----~~~~mE~~~~Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ----ILQSMEYCPYDLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFG 465 (601)
T ss_pred ----chhhhhcccHHHHHHHh----cccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecC
Confidence 33349999997777775 23578889999999999999999999 69999999999999997 7799999999
Q ss_pred ccccCccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
.+........ ....+|+..|+|||++.+...-....||||.|+++..|++|+.||......+....-..
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~------ 539 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN------ 539 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc------
Confidence 9876543322 34568899999999997766556789999999999999999999976543322210000
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
+.. +.....-...+...++...+.+|.+||++||.+|+|+++|++.+||+.+.-
T Consensus 540 ----------~~~----~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 ----------YSD----QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ----------ccc----ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000 000000111122347889999999999999999999999999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=207.69 Aligned_cols=167 Identities=20% Similarity=0.169 Sum_probs=124.7
Q ss_pred chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcce
Q 016950 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199 (380)
Q Consensus 120 ~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~ 199 (380)
|+|.+.+.. .+..+++..++.++.|++.||+|||+ ++ ||+|||++. ++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~----~ 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPE----Q 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeeccc----c
Confidence 456666653 24569999999999999999999999 67 999999986 777888 9998765332 2
Q ss_pred eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCCCCCCccCC
Q 016950 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (380)
Q Consensus 200 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (380)
..+|+.|+|||++.+. .++.++||||+||++|+|++|..||...... ..+..+.........
T Consensus 64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP---------------- 126 (176)
T ss_pred CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----------------
Confidence 3678999999999654 5899999999999999999999999765432 222222221110000
Q ss_pred CCCCCCcccccCCCCCh--HHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 279 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 279 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
. .......++. ++.++|.+||..||.+||++.++++|+|+..
T Consensus 127 ~------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 127 R------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred c------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 0000111333 6999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=212.96 Aligned_cols=247 Identities=19% Similarity=0.238 Sum_probs=190.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCC-----cEEEEEEeeccccch-----HHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~-----~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.+++....+-+|.||.||.+..++.. +.+.+|.++...... -.|..++..+.|||++.+.++... +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie----~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE----D 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee----c
Confidence 46778888999999999999665332 345667665443333 257777888899999999887753 3
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
....+.++.+.+ |+|-.++...+. ..+.++-.+...++.|++.|++|||+ +|++|.||-..|.+|+. .-++||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~LqVkl 437 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQVKL 437 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-heeEEe
Confidence 334667888888 677777764332 13446777788899999999999999 89999999999999995 789999
Q ss_pred EeecccccCccCCCcc---eeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 183 CDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+|=.+++...+.+..- ..-...-|||||.+.. ..|+.++|+|||||++|||+| |+.||..-++.++...+.+..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy- 515 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY- 515 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence 9999998765543221 1112445999999964 569999999999999999998 999999999888776655421
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.+. -|-++|.++..++.-||+.+|++||+.+|+.
T Consensus 516 -----------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 516 -----------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred -----------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 111 1235899999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-28 Score=228.47 Aligned_cols=236 Identities=26% Similarity=0.416 Sum_probs=189.9
Q ss_pred eeecCCceEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEE
Q 016950 45 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|.|+||.|+++... ..+..||+|+..+.. .....|..++...+ ||.+++++..| +.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 3799999999988643 467889999775421 22335777777776 99999998888 334448899
Q ss_pred eecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
+++..|+ +...+ .....+.+...+.+...++.|++++|+ .+|+|||+|++||+++. .|.+++.|||+++....
T Consensus 76 ld~~rgg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 76 LDFLRGGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhcccchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHh
Confidence 9999874 33322 356678888999999999999999999 79999999999999997 78899999999987654
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 273 (380)
.... +||..|||||++. ....++|+||+|++.++|++|..||.+ +....|.+..
T Consensus 150 ~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~---------------- 203 (612)
T KOG0603|consen 150 EKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE---------------- 203 (612)
T ss_pred hhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc----------------
Confidence 4433 8899999999985 367889999999999999999999988 5555555521
Q ss_pred CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
.. ++..++..+++++++++..+|..|.. +.++++|+||+.+.|.
T Consensus 204 -~~------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 -LE------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -cC------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 11 22347899999999999999999985 4799999999999887
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=188.06 Aligned_cols=208 Identities=23% Similarity=0.326 Sum_probs=166.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCC-CceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 111 (380)
...+.|.+++.||+|+||.+|++....+|+.||||+-.+... ....|..+.+.|++ ..|..+.++. .+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence 345679999999999999999999999999999998765443 34578888888864 4555655555 444456
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEeecccc
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Dfg~a~ 189 (380)
.+||+.++.+|.+++.- ....++...+.-++-|++.-++|+|. ++++||||||+|+|..- ...++.++|||+|+
T Consensus 87 vlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchh
Confidence 69999999998887763 35678999999999999999999999 89999999999999743 34579999999998
Q ss_pred cCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016950 190 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (380)
Q Consensus 190 ~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 252 (380)
.+.+... .....||..|.+--...+.. -+...|+-|+|.+|..+.-|..||.+.......++
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 7654332 34567899998876665433 57889999999999999999999998765544443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-25 Score=202.00 Aligned_cols=251 Identities=19% Similarity=0.190 Sum_probs=186.7
Q ss_pred ceeeeeeeecCCceEEEEEEECCCC-cEEEEEEeeccc----cchHHHHHHHHhCCC----CceeeeceeeeecCCCCce
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRVMDH----PNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~----~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 109 (380)
+|.+.+.||+|+||.||+|.+..++ +.+|+|...... .....|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999988775 678999775431 146678998888863 46666665552 2455
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC----CcEEEEee
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT----HQVKICDF 185 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~----~~ikl~Df 185 (380)
+.|+||+.++.+|.++.+... .+.++...+..++.|++.+|++||+ .|++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 678999999999988776543 6789999999999999999999999 7999999999999997533 56999999
Q ss_pred cccc--cCccCC--------C-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 186 GSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 186 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
|+|+ ...... . .....||..|.++.+-.+. ..+.+.|+||++.++.+++.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 1234589999999987554 47999999999999999999999997765433333322
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+...... ... +....+.++..+...+-..+...+|....+...
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2110000 000 111245677777777777888899987766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=228.15 Aligned_cols=229 Identities=27% Similarity=0.475 Sum_probs=172.5
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..-+.-.+|..++.|-.|+||.||+++|+.+.+.+|+| +.++....++ ++.....|.
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npf------------------- 133 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPF------------------- 133 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCcc-------------------
Confidence 34455678999999999999999999999999999994 5544433222 222222222
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
.| |+....++ .-+.++. +++.|++|||+ -||+|||+||+|.+|+. -+.+|++|||+++..
T Consensus 134 -vv-----gDc~tllk----~~g~lPv--------dmvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 134 -VV-----GDCATLLK----NIGPLPV--------DMVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKG 193 (1205)
T ss_pred -ee-----chhhhhcc----cCCCCcc--------hhhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhh
Confidence 22 32222333 2233433 33789999999 79999999999999997 788999999998643
Q ss_pred ccC--------C--------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016950 192 IAG--------E--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 192 ~~~--------~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 255 (380)
.-. . .....+|||.|+|||++.- +.|+..+|||++|+|+|+.+.|..||.+.+.++.+...+.
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 110 0 0123478999999999965 4599999999999999999999999999999999988877
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC---CHHHHhcCCCcccccCC
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP 330 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~~~~ 330 (380)
... .+|+- ...++++++++|.++|+.+|..|. .+.++.+|+||+.+.|.
T Consensus 273 d~i-----------------~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 273 DDI-----------------EWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhc-----------------ccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 322 22221 123689999999999999999997 46789999999998876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=194.20 Aligned_cols=201 Identities=22% Similarity=0.318 Sum_probs=164.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec--cccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.....|+++++||+|+||.++.+++..+++.||||.-+. +......|....+.|. .++|..++-+- +...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchh
Confidence 445679999999999999999999999999999996543 3344567888888774 57777654322 333445
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC----CCCcEEEEeecc
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGS 187 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~----~~~~ikl~Dfg~ 187 (380)
.+|+|.++.+|.+++.- .+.+|+...+..++.|++.-++++|+ +.+|+|||||+|+||.. +.+.|.++|||+
T Consensus 100 iLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 100 ILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 59999999999888874 57889999999999999999999999 89999999999999953 234699999999
Q ss_pred cccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 016950 188 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 245 (380)
Q Consensus 188 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~ 245 (380)
|+.+.+... ..+..||..||+--.-+|.. -+...|+-|||-+++..|-|..||.|..
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 998765433 34567899999987766654 6889999999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-26 Score=208.15 Aligned_cols=160 Identities=19% Similarity=0.270 Sum_probs=121.8
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECC-CCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceee-eceeee
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVIS-LKHCFF 101 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~niv~-~~~~~~ 101 (380)
.+...++|.+.+.||+|+||+||+|.++. +++.+|||++... .....+|+.+|+.++|+|++. ++. +
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-
Confidence 45567889999999999999999999876 6788899986422 123468999999999999985 332 1
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCC-CCCCEEEcCCCCcE
Q 016950 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQV 180 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dl-kp~Nill~~~~~~i 180 (380)
. ..|+||||++|..+..+. .. . ...++.|++.||.|||+ +||+|||| ||+|||++. ++.+
T Consensus 91 ----~---~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~i 151 (365)
T PRK09188 91 ----G---KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEA 151 (365)
T ss_pred ----C---CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCE
Confidence 1 268999999975333221 11 1 14678899999999999 79999999 999999985 6789
Q ss_pred EEEeecccccCccCCCc---------ceeeccCCCCChhhhh
Q 016950 181 KICDFGSAKQLIAGEAN---------ISYICSRFYRAPELIF 213 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~l~ 213 (380)
||+|||+|+........ ....+++.|+|||.+.
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999999865433211 2345677899999873
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-24 Score=194.71 Aligned_cols=259 Identities=34% Similarity=0.477 Sum_probs=194.4
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCC-ceeeeceeeeecCCCCceEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 111 (380)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+|+.++..+.|+ +++++.+.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-----EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----CCEE
Confidence 889999999999999999987 7889998854322 245788899999988 79999988822 2227
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++++++.+ .+...+...... ..+....+..++.|++.+++|+|+ .+++|||+||+||+++.....++++|||.+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~ 151 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence 899999996 444333321100 378999999999999999999999 79999999999999997333799999999875
Q ss_pred CccCC-------CcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhC
Q 016950 191 LIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLG 258 (380)
Q Consensus 191 ~~~~~-------~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 258 (380)
..... ......+|..|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 54332 23567889999999999763 4689999999999999999999999887764 334444333322
Q ss_pred CC-CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 259 TP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 259 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+ .... .. ..........+.+++.+++..+|..|.+..+...++|.....
T Consensus 232 ~~~~~~~------------~~--------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 232 TPSLASP------------LS--------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred Ccccccc------------cC--------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22 0000 00 000011236889999999999999999999999887776543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=186.84 Aligned_cols=237 Identities=24% Similarity=0.308 Sum_probs=144.5
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHhCC----------CCceeeeceeee
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMD----------HPNVISLKHCFF 101 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------~e~~~l~~l~----------h~niv~~~~~~~ 101 (380)
.....+.||.|+++.||.+.+..||+.+|+|++........ +|.-....+. |-.++...+...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 57889999999999999999999999999999853332211 2221111111 111222222211
Q ss_pred --------ecCC-CCce---EEEEEeecccchHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHhHcCCCeeecCC
Q 016950 102 --------STTS-KNEL---FLNLVMEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 166 (380)
Q Consensus 102 --------~~~~-~~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dl 166 (380)
.... .... ..+++|+-+.++|..++......... +.......+..|++..+++||+ .|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence 1110 1111 24688898888887776543222222 3333334555899999999999 79999999
Q ss_pred CCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 016950 167 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 167 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
+|+|++++. +|.+.|+||+.......... ....+..|.+||..... -.++.+.|.|+||+++|.|.+|..
T Consensus 172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-T-TS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcC-CCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999997 78899999988764322111 12345779999987432 236889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCC
Q 016950 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 312 (380)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 312 (380)
||......... ++ .|... .++|+..++||++||+.||.+|
T Consensus 249 Pf~~~~~~~~~-----------------------~~--------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADP-----------------------EW--------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTS-----------------------GG--------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccc-----------------------cc--------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 99765322100 00 11111 1479999999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=187.08 Aligned_cols=199 Identities=22% Similarity=0.323 Sum_probs=144.1
Q ss_pred CCCceeeeceeeeecC----------------------CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHH
Q 016950 89 DHPNVISLKHCFFSTT----------------------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146 (380)
Q Consensus 89 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ 146 (380)
+|||||.+...|++.. -.....+|+||.-...+|.+++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~-----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLW-----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHh-----cCCCchHHHHHHHH
Confidence 5999999988875321 12345689999999988877774 34566677788999
Q ss_pred HHHHHHHHhHcCCCeeecCCCCCCEEEcCCC---CcEEEEeecccccCccC-------CCcceeeccCCCCChhhhhCCC
Q 016950 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAG-------EANISYICSRFYRAPELIFGAT 216 (380)
Q Consensus 147 ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~---~~ikl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~l~~~~ 216 (380)
|+++|+.|||+ +|+.|||+|.+|||+.-++ ..+.|+|||++-....- ......-|+-.-||||+....+
T Consensus 349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999999 7999999999999984322 35889999997533221 1122345677799999974332
Q ss_pred CC-----CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCC
Q 016950 217 EY-----TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 291 (380)
Q Consensus 217 ~~-----~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (380)
.. -.++|.|+.|.+.||++....||.+......- ..+|.+-..|. +++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence 21 24789999999999999999999874422110 01122222332 355
Q ss_pred CCChHHHHHHHhhcccCCCCCCCHH---HHhc
Q 016950 292 RMPPEAIDLASRLLQYSPSLRCTAL---EACA 320 (380)
Q Consensus 292 ~~~~~~~~li~~~L~~dp~~R~t~~---e~l~ 320 (380)
.+++.+++|+..+|+.||++|+++. .+|+
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 6899999999999999999999853 5554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-24 Score=208.95 Aligned_cols=241 Identities=28% Similarity=0.408 Sum_probs=171.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc--------hHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.|...+.||.+-|=+|.+|++. .| .|++|++-+.... .-+|++ ...+++||.+.+.... ..+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 6888999999999999999864 33 4899998543311 113444 5566899999876654 33444
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+|-+|...+|++-+. ..+-+...+.+.|+.||+.||..+|. .||+|||||.+||||++ -+=+.|+||..-+.
T Consensus 96 AylvRqyvkhnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence 77999999988888775 44567788888999999999999999 79999999999999996 55588999987654
Q ss_pred CccCCC---cce-eec----cCCCCChhhhhCCC----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016950 191 LIAGEA---NIS-YIC----SRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (380)
Q Consensus 191 ~~~~~~---~~~-~~~----t~~y~aPE~l~~~~----------~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 251 (380)
..-... ... +.. -.+|.|||.+.... ..+++.||||+||+++||++ |++||.- .++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence 321111 111 122 33699999984411 15678999999999999998 8999941 1111
Q ss_pred HHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.... .+....+..- .+--+..++.||..|++.||++|++|++.|+-
T Consensus 246 aYr~-~~~~~~e~~L-----------------------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRS-GNADDPEQLL-----------------------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhc-cCccCHHHHH-----------------------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 0011111100 00125578999999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.1e-23 Score=173.44 Aligned_cols=135 Identities=18% Similarity=0.241 Sum_probs=103.1
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHhCCCCc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHPN 92 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n 92 (380)
...||+|++|.||+|.+. +|+.||+|++..+.. ....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 899999999864321 0123889999998777
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCeeecCCCCCCE
Q 016950 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNL 171 (380)
Q Consensus 93 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~iiH~Dlkp~Ni 171 (380)
+....... .. . .++||||++|+.+.... .....+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus 81 v~~p~~~~--~~-~----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LK-S----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ec-C----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence 64432221 11 1 36999999975322111 1235788999999999999999999 78 7999999999999
Q ss_pred EEcCCCCcEEEEeecccccC
Q 016950 172 LVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 172 ll~~~~~~ikl~Dfg~a~~~ 191 (380)
|++. +.++|+|||+|...
T Consensus 150 li~~--~~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYHD--GKLYIIDVSQSVEH 167 (190)
T ss_pred EEEC--CcEEEEEccccccC
Confidence 9983 67999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=174.32 Aligned_cols=170 Identities=12% Similarity=0.117 Sum_probs=124.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cc---------hHHHHHHHHhCCCCceeeeceeeeec
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~---------~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
.++|++.+.||.|+||.||++.. ++..+|+|++.... .. ..+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46899999999999999999765 47789999985321 11 35788899999999999998876543
Q ss_pred CCC---CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 104 TSK---NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 104 ~~~---~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
... .....++||||++| +|.+.. .+++ ....+++.+|..||+ +|++|||++|+||++++ ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-NG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-CC-
Confidence 211 12347799999998 443331 1223 245699999999999 79999999999999986 56
Q ss_pred EEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll 235 (380)
++|+|||.+......... ..++. ...|..++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-----------d~~vl-er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-----------DRIDL-ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-----------HHHHH-HhHhcccccccceeEeehHHH
Confidence 999999988654222111 01222 334678999999999887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=162.79 Aligned_cols=182 Identities=16% Similarity=0.107 Sum_probs=133.0
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+...|++|+||+||++.. .+..++.+.+..... ...+|+++|+.|. |++++++++.. . .
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence 4567899999999998765 677888777754432 3468999999995 47788876631 1 5
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCC-CCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dl-kp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|++|||+.|..+.... .. . ...++.|++.+|+++|+ +||+|||| ||+|||++. ++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~----~~-----~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRP----PR-----G-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhh----hh-----h-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence 7999999985332111 00 1 13467899999999999 79999999 799999986 67899999999985
Q ss_pred CccCCCcc--------------eeeccCCCCChhhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 016950 191 LIAGEANI--------------SYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN 245 (380)
Q Consensus 191 ~~~~~~~~--------------~~~~t~~y~aPE~l~~~~~~~-~~~DiwslGvil~~ll~g~~pf~~~~ 245 (380)
........ ....++.|++|+...-....+ ...++++.|+.+|.++|+..++-+.+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 44333110 012377788887653322234 57899999999999999998876554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=163.33 Aligned_cols=136 Identities=18% Similarity=0.205 Sum_probs=104.5
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHhCCCC
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHP 91 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------------------------------~~~~e~~~l~~l~h~ 91 (380)
+.+.||+|++|.||+|.+. +|+.||||++..... ...+|...+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3568999999999999987 899999999864311 113678888889888
Q ss_pred ceeeeceeeeecCCCCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 92 NVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 92 niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
++.....+... . .|+||||++|. +..... ....++...+..++.|++.++.+||+.+||+||||||+|
T Consensus 80 ~i~~p~~~~~~---~----~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N 148 (190)
T cd05145 80 GVPVPEPILLK---K----NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN 148 (190)
T ss_pred CCCCceEEEec---C----CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence 87544333211 1 36999999975 222211 234577888999999999999999982399999999999
Q ss_pred EEEcCCCCcEEEEeecccccC
Q 016950 171 LLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+++ ++.++|+|||++...
T Consensus 149 Ill~--~~~~~liDFG~a~~~ 167 (190)
T cd05145 149 ILYH--DGKPYIIDVSQAVEL 167 (190)
T ss_pred EEEE--CCCEEEEEcccceec
Confidence 9998 567999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=186.89 Aligned_cols=199 Identities=21% Similarity=0.338 Sum_probs=149.2
Q ss_pred CCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-HHHHHHHHhCC---CCceeeeceeeeecC
Q 016950 29 GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVMD---HPNVISLKHCFFSTT 104 (380)
Q Consensus 29 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~e~~~l~~l~---h~niv~~~~~~~~~~ 104 (380)
....-....+.|.|.+.||+|+||+||+|.+.. |+.||||+-+...... .--..++.+|+ -+.|..+...+...+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 333444556789999999999999999999876 9999999765432211 11122333444 233444443332222
Q ss_pred CCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC------CC
Q 016950 105 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LT 177 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~------~~ 177 (380)
. -++|+||.+ |+|++++. ....+++..+..+..|++.-++.||. .+|||+||||+|+||.. +.
T Consensus 768 ~-----S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 768 A-----SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred c-----ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcc
Confidence 2 459999999 78888776 67789999999999999999999999 69999999999999942 23
Q ss_pred CcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Q 016950 178 HQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
.-++|+|||.|..+..-. ......+|-.+-.+|...|.+ +++.+|.|.++.+++.||.|+.
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence 359999999997664332 233456688899999986654 9999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-19 Score=153.51 Aligned_cols=136 Identities=18% Similarity=0.251 Sum_probs=101.6
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhC-----CCCceeeeceeeeecCCCCceEE
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-----DHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.-.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ +||||+++++++.+.... ...+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~-g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT-GYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC-eEEE
Confidence 3456899999999995 7777766 69987643 33456899999999 679999999988554321 2223
Q ss_pred EEEeeccc---chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHhHcCCCeeecCCCCCCEEEcCC---CCcEEEEe
Q 016950 112 NLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHRDLKPQNLLVDPL---THQVKICD 184 (380)
Q Consensus 112 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al-~~LH~~~~iiH~Dlkp~Nill~~~---~~~ikl~D 184 (380)
.+|+||++ ++|.+.++. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++.. ...++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 47899955 578887753 235555 35678888888 99999 899999999999999742 34799999
Q ss_pred eccc
Q 016950 185 FGSA 188 (380)
Q Consensus 185 fg~a 188 (380)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=173.88 Aligned_cols=179 Identities=28% Similarity=0.432 Sum_probs=132.0
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++||.|++|.. +|.+.+.. .......+......++.|+..|++| +|.+|+|+||.||++.. +..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence 4468899999995 55555543 3445667888899999999999999 49999999999999985 6689999999
Q ss_pred ccccCccCC-------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 187 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 187 ~a~~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+........ ..+..+||.+||+||.+.++. |+.++||||||+||+|++. =...|..... +..+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t---~~d~----- 472 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIAT---LTDI----- 472 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHh---hhhh-----
Confidence 987665544 445678999999999997654 9999999999999999997 2222221111 1111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
+...|...+..+ -+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus 473 ----------------------r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 ----------------------RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ----------------------hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111111111111 2455689999999999999988887777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=158.60 Aligned_cols=139 Identities=16% Similarity=0.120 Sum_probs=104.8
Q ss_pred ceeeeeeeecCCceEEEEEE-ECCCCcEEEEEEeecccc----------------------------chHHHHHHHHhCC
Q 016950 39 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMD 89 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~aiK~~~~~~~----------------------------~~~~e~~~l~~l~ 89 (380)
-|.+.+.||+|++|.||+|. +..+|+.||+|++..... ...+|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 778999999998864310 1246888998887
Q ss_pred CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-eeecCCCC
Q 016950 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKP 168 (380)
Q Consensus 90 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-iiH~Dlkp 168 (380)
+. .+.+..++.. . ..++||||++|..+.... .....+....+..++.|++.++++||+ +| ++||||||
T Consensus 109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp 177 (237)
T smart00090 109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE 177 (237)
T ss_pred hc-CCCCCeeeEe-c-----CceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence 53 2232233311 1 146999999984322211 123445666778899999999999999 79 99999999
Q ss_pred CCEEEcCCCCcEEEEeeccccc
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+||+++ ++.++|+|||.+..
T Consensus 178 ~NIli~--~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH--DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE--CCCEEEEEChhhhc
Confidence 999998 56799999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=152.57 Aligned_cols=240 Identities=18% Similarity=0.254 Sum_probs=174.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..+..+..+|.+...|..|+++.. |..++.|++.-. .+....|.-.|+.+.||||+.+.+.+ .....
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppn 261 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPN 261 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCC
Confidence 345667778999999999999874 445566655321 23345788889999999999999887 33344
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec-CCCCCCEEEcCCCCcEEE--Eeec
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR-DLKPQNLLVDPLTHQVKI--CDFG 186 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~-Dlkp~Nill~~~~~~ikl--~Dfg 186 (380)
+.++..|++ |+|+..+... .+-...-.++.+++.+++.|+.|||+...++-| -|....+++|. +.+.+| +|--
T Consensus 262 lv~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~k 338 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTK 338 (448)
T ss_pred ceEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccce
Confidence 779999999 6888888642 334456778899999999999999996555554 57788899985 544443 3433
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
++... ....-.|.||+||.+...+. .-.++|+|||++++|||.|...||....+.+.-.++.-
T Consensus 339 fsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--------- 403 (448)
T KOG0195|consen 339 FSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--------- 403 (448)
T ss_pred eeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------
Confidence 33211 12334788999999955432 23579999999999999999999988776654333321
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
+-++..++..++.....|+.-|+.-||.+||..+.++
T Consensus 404 ------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1223445667899999999999999999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-20 Score=181.91 Aligned_cols=256 Identities=24% Similarity=0.321 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-CcEEEEEEeecc---ccch---HHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD---RRYK---NRELQLMRVMD-HPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~---~~~~---~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 108 (380)
...|.+.+.||+|+|+.|-++....+ ...+|.|.+... .... ..|..+-+.+. |.|++++++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 45699999999999999988876543 445667755332 1211 24677777776 99999998877 555
Q ss_pred eEEEEEeecccch-HHHHHHHhhhcCC-CCCHHHHHHHHHHHHHHHHHhH-cCCCeeecCCCCCCEEEcCCCC-cEEEEe
Q 016950 109 LFLNLVMEYVPES-MYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH-QVKICD 184 (380)
Q Consensus 109 ~~~~lv~e~~~~~-l~~~l~~~~~~~~-~l~~~~~~~i~~ql~~al~~LH-~~~~iiH~Dlkp~Nill~~~~~-~ikl~D 184 (380)
.+.+++++|..|+ +...+. .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++. ++ .+++.|
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d 168 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD 168 (601)
T ss_pred cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence 5688999997763 333331 1222 5677778899999999999999 8 89999999999999997 56 899999
Q ss_pred ecccccCcc-CCC---cceeec-cCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 185 FGSAKQLIA-GEA---NISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 185 fg~a~~~~~-~~~---~~~~~~-t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
||+|..... ... ....+| ++.|+|||...+........|+||+|+++..+++|..|+......+...
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------- 240 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------- 240 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------
Confidence 999987755 322 224577 9999999999775556889999999999999999999997654332110
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+.... .......+..++....+++.++|..+|..|.+..++-.+||+..
T Consensus 241 ---------------~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 241 ---------------SSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---------------eeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000000 11122234558999999999999999999999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=157.50 Aligned_cols=203 Identities=27% Similarity=0.416 Sum_probs=148.0
Q ss_pred HHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCe-e
Q 016950 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-C 162 (380)
Q Consensus 85 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~i-i 162 (380)
|+.+.|.|+.++++..++. ..+++|.+||. |+|.+.+.. ....+++.....++.+|+.||.|||.. .| .
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~ 71 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS-PIGY 71 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC-ccee
Confidence 4568999999999988765 23789999999 688888764 456788888888999999999999994 55 9
Q ss_pred ecCCCCCCEEEcCCCCcEEEEeecccccCccC---CCcceeeccCCCCChhhhhCCC--C----CCchhhHHHHHHHHHH
Q 016950 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGAT--E----YTTSIDIWSAGCVLAE 233 (380)
Q Consensus 163 H~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~--~----~~~~~DiwslGvil~~ 233 (380)
|+.++..|.++|. ...+||+|||+....... ...........|.|||.+.+.. . .+.+.|+||+|++++|
T Consensus 72 hg~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 72 HGALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999999999996 889999999998765321 1111112244599999996531 1 4677999999999999
Q ss_pred HHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCC
Q 016950 234 LLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 309 (380)
Q Consensus 234 ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 309 (380)
+++...||...... +.+..+.+ .+..+ ..|.+. ... .+.+++..++.+||.-+|
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~--------------~rP~i~------~~~-e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKK-GGSNP--------------FRPSIE------LLN-ELPPELLLLVARCWEEIP 208 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHh-cCCCC--------------cCcchh------hhh-hcchHHHHHHHHhcccCh
Confidence 99999999764322 23333222 11110 011100 000 256689999999999999
Q ss_pred CCCCCHHHHh
Q 016950 310 SLRCTALEAC 319 (380)
Q Consensus 310 ~~R~t~~e~l 319 (380)
..||+++++.
T Consensus 209 ~~rPs~~~i~ 218 (484)
T KOG1023|consen 209 EKRPSIEQIR 218 (484)
T ss_pred hhCccHHHHH
Confidence 9999998875
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-17 Score=141.85 Aligned_cols=129 Identities=20% Similarity=0.312 Sum_probs=100.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
+.||+|++|.||+|.. .|..+++|+..... ....+|+.++..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999987 77789999764221 12346888999999988876655553322 26
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+++|||++| +|.+.+.. . .. ....++.+++.+|.+||+ .|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 799999987 56555542 1 11 677889999999999999 7999999999999998 56799999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=141.66 Aligned_cols=132 Identities=19% Similarity=0.160 Sum_probs=99.1
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--------------------------cchHHHHHHHHhCCCCc
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRVMDHPN 92 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------------------~~~~~e~~~l~~l~h~n 92 (380)
.|.+.+.||+|+||.||++... +|+.+|||++..+. ....+|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999864 79999999865322 01246778888887764
Q ss_pred e--eeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 93 V--ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 93 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
+ ...++ .. ..++||||++|..+..+.. ......++.+++.++.++|+ .|++||||+|+|
T Consensus 95 i~v~~~~~----~~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N 155 (198)
T cd05144 95 FPVPKPID----WN-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN 155 (198)
T ss_pred CCCCceee----cC-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence 3 22221 11 1479999999843322211 02356788899999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccC
Q 016950 171 LLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+++. ++.++|+|||.+...
T Consensus 156 ill~~-~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDD-DEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcC-CCcEEEEECCccccC
Confidence 99996 788999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=137.58 Aligned_cols=126 Identities=20% Similarity=0.299 Sum_probs=93.8
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.||+|++|.||++.. ++..+++|...... ....+|+.+++.+.|+++....-++.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 489999999999984 67889999864321 12236899999998876554433332222 256
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||++| ++.+.+.. ... .++.|++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcCC
Confidence 99999987 45444431 110 678899999999999 7999999999999998 577999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=154.38 Aligned_cols=132 Identities=19% Similarity=0.252 Sum_probs=99.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEee-cc-----------ccchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~-~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
...|...+.||+|+||+||++..... .+++|+.. +. .....+|+.+++.++|++++....+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34567789999999999999886433 34444321 11 112347999999999999887655443322
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
..++||||++| +|.+.+. ....++.|++.+|.+||+ .|++||||||+|||++ ++.++|+
T Consensus 410 -----~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~li 469 (535)
T PRK09605 410 -----EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLI 469 (535)
T ss_pred -----CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEE
Confidence 25699999987 5555443 245688999999999999 7999999999999994 5679999
Q ss_pred eeccccc
Q 016950 184 DFGSAKQ 190 (380)
Q Consensus 184 Dfg~a~~ 190 (380)
|||+++.
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=130.59 Aligned_cols=132 Identities=24% Similarity=0.204 Sum_probs=90.4
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccccch----------------------------HHHHHHHHhCCCCc--
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRVMDHPN-- 92 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------------------------~~e~~~l~~l~h~n-- 92 (380)
.+.||+|+||+||+|.+. +++.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999976 89999999876432111 12334444443322
Q ss_pred eeeeceeeeecCCCCceEEEEEeecccch-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 93 VISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 93 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
+.+.+.. . ..++||||++++ +. ..+.... .. ..++.++.+++.++.++|...|++|+||||+|
T Consensus 81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 2222111 1 147999999972 11 1222111 11 55788999999999999983499999999999
Q ss_pred EEEcCCCCcEEEEeecccccCc
Q 016950 171 LLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|+++ ++.++|+|||.+....
T Consensus 146 ili~--~~~~~liDfg~a~~~~ 165 (187)
T cd05119 146 ILVD--DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEE--CCcEEEEECccccccc
Confidence 9998 6679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=155.01 Aligned_cols=268 Identities=24% Similarity=0.311 Sum_probs=192.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
-.+.+.+.+-+-+|+++.++.+.-..+|-..++|+...... ....+-.++-.-.+|.++...-.+ .-.
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 45678888899999999999998878886777765533221 112222232223345555433222 112
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...+++++|.++ ++...+. ..+..+.+.++.++..+.+++++||+ ..+.|+|++|.|++... .+..++.|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCcccc
Confidence 227799999975 5555554 34567778888999999999999999 57999999999999986 77799999984
Q ss_pred cccCcc------C--------------------------CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHH
Q 016950 188 AKQLIA------G--------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 235 (380)
Q Consensus 188 a~~~~~------~--------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll 235 (380)
...... . .......+|+.|.+||.+.+.. ....+|+|+.|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 321100 0 0112346799999999997765 688899999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH
Q 016950 236 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315 (380)
Q Consensus 236 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 315 (380)
+|.+||........+..+... ...+|. -+...+.++++++.++|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~-----------------~~~~p~---------g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR-----------------DIPWPE---------GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccC-----------------CCCCCC---------CccccChhhhhhhhhhhccCchhccCc
Confidence 999999999888888766552 111111 122368999999999999999999988
Q ss_pred H---HHhcCCCcccccCCCCCCCCCCCCC
Q 016950 316 L---EACAHPFFDELREPNARLPNGRPLP 341 (380)
Q Consensus 316 ~---e~l~hp~~~~~~~~~~~~~~~~~~~ 341 (380)
. ++-.||||+.+.|.+........+|
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCC
Confidence 7 9999999999988765544333333
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-14 Score=128.44 Aligned_cols=133 Identities=18% Similarity=0.228 Sum_probs=95.5
Q ss_pred eeee-cCCceEEEEEEECCCCcEEEEEEeecc-----------------ccchHHHHHHHHhCCCCce--eeeceeeeec
Q 016950 44 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRVMDHPNV--ISLKHCFFST 103 (380)
Q Consensus 44 ~~lg-~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 103 (380)
..|| .|+.|+||.+.. .+..++||.+... .....+|+.++..+.|+++ +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 788889998876 4778999877421 1123469999999998875 4554443221
Q ss_pred CCCCceEEEEEeecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 104 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
. ......++|||+++| +|.+.+.. ..+++.. +.|++.+|.+||+ +||+||||||.|||++. ++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence 1 111223599999996 56555532 3455443 5689999999999 89999999999999986 56899
Q ss_pred EEeeccccc
Q 016950 182 ICDFGSAKQ 190 (380)
Q Consensus 182 l~Dfg~a~~ 190 (380)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=140.79 Aligned_cols=250 Identities=24% Similarity=0.275 Sum_probs=188.3
Q ss_pred ccceeeeeeeec--CCceEEEEEEE--CCCCcEEEEEEee------ccccchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~~aiK~~~------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
...+.+.+.+|. |.+|.||.+.+ ..++..+|+|.-+ .......+|+.-.+.+ .|++.++.+..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 346778889999 99999999999 8899999999742 2233344677666666 488888866665
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~----al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
.+....|+-+|+|+.++..... .....++...++.++.+... ||.++|+ ++++|-|+||.||+...+....+
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccccchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccceee
Confidence 5555588999999977655543 23455888899999999999 9999999 89999999999999987447899
Q ss_pred EEeecccccCccCCCcce------eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 016950 182 ICDFGSAKQLIAGEANIS------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVEI 253 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~------~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~--~~~~~~~~i 253 (380)
++|||+...+........ ..+..-|++||++.+ -++..+|++++|.++.+..+|..++... +.+..+...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 999999887765542221 145566999999843 4799999999999999999987665443 222222111
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. ....+-...+.++...+..|+..+|..|++++.+++|+++...
T Consensus 342 ~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 342 Y------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred c------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0 1111222356777789999999999999999999999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=119.11 Aligned_cols=131 Identities=20% Similarity=0.241 Sum_probs=101.5
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHhCCC--CceeeeceeeeecCCCCceEEEEEeec
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
+++.||.|.++.||++.... ..+++|....... ...+|+.+++.+++ .++++++.... .....++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence 46789999999999999743 7899998866543 45689999999976 47777766552 22347899999
Q ss_pred ccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 118 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 118 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~--~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+.+.....+ +......++.+++.+++.||.. .+++|+|++|+||+++. .+.++++|||.+..
T Consensus 75 ~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 987422111 4455567888999999999983 26999999999999996 67899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.6e-15 Score=127.98 Aligned_cols=211 Identities=18% Similarity=0.203 Sum_probs=147.9
Q ss_pred HHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCe
Q 016950 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRV 161 (380)
Q Consensus 84 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-~~i 161 (380)
-|-.+-|.|||+++.++.+....+.....+++||+. |++...|+.-......+.....++++.||+.||.|||++ .-|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 334557999999999887766667777889999998 688888887777788899999999999999999999984 369
Q ss_pred eecCCCCCCEEEcCCCCcEEEEeecccccCccC-----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh
Q 016950 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (380)
Q Consensus 162 iH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 236 (380)
+|+++..+.|++.. ++-||+.--........- .......+-++|.|||.= .....+.++|||++|....+|..
T Consensus 200 ihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHH
Confidence 99999999999995 676766422211110000 011122346779999963 22346789999999999999998
Q ss_pred CCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH
Q 016950 237 GQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315 (380)
Q Consensus 237 g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 315 (380)
|..- -.+......-..+...+ + .--..--++++++||+-.|..||++
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i-------------------~-------------~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVI-------------------I-------------GLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred heeccCCCcceeehhhhhhhhe-------------------e-------------eccCccccCcCcccccCCCCCCcch
Confidence 8743 22222111111111100 0 0011223568999999999999999
Q ss_pred HHHhcCCCccccc
Q 016950 316 LEACAHPFFDELR 328 (380)
Q Consensus 316 ~e~l~hp~~~~~~ 328 (380)
.+++-||.+-++.
T Consensus 326 r~llfHpllfeVh 338 (458)
T KOG1266|consen 326 RLLLFHPLLFEVH 338 (458)
T ss_pred hhhhcCceeeecc
Confidence 9999999987653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.6e-12 Score=124.42 Aligned_cols=180 Identities=22% Similarity=0.276 Sum_probs=128.3
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
|.+ ...+-++.+..-.+..+.++.++.+........ ...+-++.|+.++||||+++++.+ +....+|+|+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 666 444444444222456677888888887754333 235677889999999999999888 4445699999
Q ss_pred ecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
|-+.- |...++. ++...+..-+.||+.||.|||.-++++|++|.-+.|+|+. .+..||++|.++.......
T Consensus 89 ErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFN 159 (690)
T ss_pred ecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCC
Confidence 99863 3334443 2256677788999999999984379999999999999997 8899999999886543322
Q ss_pred C-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC
Q 016950 196 A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 237 (380)
Q Consensus 196 ~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g 237 (380)
. .....---.|..|+.+.. -....|.|.|||++++++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 2 111112223777776522 12567999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-12 Score=110.01 Aligned_cols=132 Identities=20% Similarity=0.241 Sum_probs=93.3
Q ss_pred eeeeecCCceEEEEEEECC------CCcEEEEEEeec--------------cccc----------------hHHHHHHHH
Q 016950 43 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQ--------------DRRY----------------KNRELQLMR 86 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~--------------~~~~----------------~~~e~~~l~ 86 (380)
...||.|--+.||.|.... .+..+|||+.+. +.+. ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357899997731 1110 026888888
Q ss_pred hCCC--CceeeeceeeeecCCCCceEEEEEeecccch-HH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCe
Q 016950 87 VMDH--PNVISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRV 161 (380)
Q Consensus 87 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~i 161 (380)
++.. -++..++.+. . .+|||||++++ +. ..++ ...++...+..+..+++.+|..| |+ .|+
T Consensus 82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl 146 (197)
T cd05146 82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL 146 (197)
T ss_pred HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence 8853 3344444321 1 45999999863 11 1222 22345566777889999999998 89 799
Q ss_pred eecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 162 iH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+|+||++.||+++ ++.+.|+|||.+-..
T Consensus 147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 147 VHADLSEYNMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred ecCCCCHHHEEEE--CCcEEEEECCCceeC
Confidence 9999999999997 457999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=126.41 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=90.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc--------------------------------------hH
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------KN 79 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------------------------------~~ 79 (380)
..|.. +.||+|++|+||+|+.+.+|+.||||+....... ..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999888999999988533100 01
Q ss_pred ------HHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcC---CCCCHHHHHHHH
Q 016950 80 ------RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSAN---QRMPLIYVKLYT 145 (380)
Q Consensus 80 ------~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~---~~l~~~~~~~i~ 145 (380)
+|+.-+.++ .+.+.+.+-.++.+.++. -++||||+.| .+.+ +......+ ..+.+..+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~----~VLvmE~i~G~~l~d-~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSE----TVMVMERMYGIPVSD-VAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCC----ceEEEeeecCccHHh-HHHHHhcCCCHHHHHHHHHHHHH
Confidence 222222222 233334444444322221 4599999998 4433 21111111 135555556666
Q ss_pred HHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC----cEEEEeecccccCc
Q 016950 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLI 192 (380)
Q Consensus 146 ~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~----~ikl~Dfg~a~~~~ 192 (380)
.|++ . .|++|+|+||.||+++. ++ +++++|||++....
T Consensus 274 ~Qif-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECC
Confidence 6654 4 69999999999999986 44 89999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-12 Score=121.51 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=87.4
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecccc-ch-------------------------------------------
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YK------------------------------------------- 78 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~------------------------------------------- 78 (380)
.+.||.|++|.||+|+. .+|+.||||+...... ..
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 45799999999999986 4789999998743210 00
Q ss_pred HHHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HH
Q 016950 79 NRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR-GL 152 (380)
Q Consensus 79 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~-al 152 (380)
.+|+..+..+ ++.+-+.+-.++...++ ..++||||++| ++.+.... .. .... ...++.+++. .+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence 1233333333 23333444444422222 14699999997 44333321 11 1111 2334555555 46
Q ss_pred HHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 153 ~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
..+|. .|++|+|++|.||+++. +++++++|||++....
T Consensus 271 ~ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 271 NQVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence 78899 79999999999999986 7789999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7e-13 Score=127.31 Aligned_cols=154 Identities=19% Similarity=0.326 Sum_probs=114.2
Q ss_pred HHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC--------cce--eeccCCCCChhhhhCCCC
Q 016950 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NIS--YICSRFYRAPELIFGATE 217 (380)
Q Consensus 148 l~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~--~~~t~~y~aPE~l~~~~~ 217 (380)
+..|+.|+|...+++|+.|.|++|.++. ++.+||+.|+++.....+.. ... ......|.|||++.+ ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 3489999998789999999999999997 78899999998765433111 111 122556999999966 55
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChH
Q 016950 218 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE 296 (380)
Q Consensus 218 ~~~~~DiwslGvil~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (380)
.+.++|++|+||++|.+. .|+..+.+.+.......-....+ .-...+..+++++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~-------------------------~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN-------------------------AGAFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc-------------------------cccccccccCcHH
Confidence 799999999999999999 57777765543322211111100 0011123568999
Q ss_pred HHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 297 AIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 297 ~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
+++=|.++|..++..||++.+++..|||.+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999999998854
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.9e-12 Score=105.71 Aligned_cols=124 Identities=15% Similarity=0.167 Sum_probs=89.0
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
++.|+.|.++.||++.. .++.|++|...... ....+|+.+++.+.+.+++ +++... . .. .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~---~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P---ET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C---CC--CeEEEEec
Confidence 45689999999999986 47789999875443 3356899999988655543 333222 1 11 35999999
Q ss_pred cchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCe-----eecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 119 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 119 ~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~i-----iH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|...... . .....++.+++.+|..||+ .++ +|+|++|+||+++ ++.++++||+.+.
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence 98421110 0 1123456789999999999 574 9999999999998 4569999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-10 Score=107.17 Aligned_cols=215 Identities=18% Similarity=0.235 Sum_probs=154.2
Q ss_pred ceEEEEEEECCCCcEEEEEEeeccccc----hHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc--hHHH
Q 016950 51 FGIVFQAKCLETGETVAIKKVLQDRRY----KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYR 124 (380)
Q Consensus 51 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~----~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~ 124 (380)
-.+.|+|....+|..|++|.+..++.. ...-+++++++.|.|+|.+.++|. ...-++..+++|++|.++ +|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHH
Confidence 357899999999999999998433221 235688999999999999999996 333566778999999985 6665
Q ss_pred HHHHh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 125 VLKHY-----------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 125 ~l~~~-----------~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
..-.. ...+...++..+|.|+.||..||.++|+ .|+.-+-|.|.+|+++. +.+++|+..|.......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecC
Confidence 54211 1234557899999999999999999999 79999999999999995 55899988887765433
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
+. . |.+.+ ..+-|.=.||.+++.|.||..- +............+.
T Consensus 446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~----------------- 491 (655)
T KOG3741|consen 446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT----------------- 491 (655)
T ss_pred CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------------
Confidence 32 0 11211 2356899999999999999643 222222222111111
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+.+++++|.-+...++++ -++.+++.|
T Consensus 492 ------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 ------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 236788888888888888776 566666643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=96.86 Aligned_cols=140 Identities=17% Similarity=0.216 Sum_probs=97.2
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
....+-+|+-+.|+++.. .|+.+.||.- .+. +....+|+++|.++.--.|.-..-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 567788999999998865 7888888853 222 1223468888887754444333333433332
Q ss_pred EEEEEeecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcE--EEEee
Q 016950 110 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDF 185 (380)
Q Consensus 110 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~i--kl~Df 185 (380)
-.|+|||++| ++...+.... ...........++..|-..+.-||. ++|+|+||..+||++.+++..+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence 4489999998 5555554322 2223333336788888899999999 8999999999999998766554 89999
Q ss_pred cccccC
Q 016950 186 GSAKQL 191 (380)
Q Consensus 186 g~a~~~ 191 (380)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.6e-12 Score=120.78 Aligned_cols=249 Identities=19% Similarity=0.178 Sum_probs=171.2
Q ss_pred cccceeeeeeeecCCceEEEEEEEC-CCCcEEEEEEeeccccch------HHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~------~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
...++..+..||.|.|+.|+.+... .++..|++|.+.+..... -.|+-+...+ .|.+++.....+.....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-- 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-- 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--
Confidence 3467889999999999999988765 678899999775543322 2455554444 58888887776643322
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.|+=.|||.+...++-. .....+.+...+.+..|++.++.++|+ ..++|+|++|+||++..+++..++.|||+
T Consensus 341 ---~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 ---GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ---ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccc
Confidence 55888999864333222 223456777788999999999999999 79999999999999986447789999999
Q ss_pred cccCccCCCcceeeccCCCC-ChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~-aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
.....-. .......-.+. .+|++.....+..+.|++|||..+.+.++|...-...... ..+...
T Consensus 414 ~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~---------- 478 (524)
T KOG0601|consen 414 WTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSG---------- 478 (524)
T ss_pred cccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecc----------
Confidence 8642111 11122233344 3666656666889999999999999999987543222111 111000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+. ......++..+...++..++..|+.+.++..|+=|...
T Consensus 479 ---------~~p~----------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 479 ---------DTPN----------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ---------cccC----------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 0000 01134678889999999999999999999888776543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.6e-10 Score=92.45 Aligned_cols=126 Identities=17% Similarity=0.255 Sum_probs=84.1
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEe-eccc-----------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~-~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..+++|+-+.+|.+.. -|..+++|.- ++.- ....+|+.++..+.--.|....-++++... .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence 3578999999999855 3445666643 2221 222368888888754333322222222222 4
Q ss_pred EEEeecccchHHH-HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+|||++|.++. .+.. . . ..++..+-..+.-||. +||+|+||.++||++.. +.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence 4999999997544 4432 1 1 3455667777788999 89999999999999984 4599999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=91.74 Aligned_cols=121 Identities=26% Similarity=0.311 Sum_probs=75.6
Q ss_pred EEEEEEECCCCcEEEEEEeecc--------------cc----------------chHHHHHHHHhCCCCc--eeeeceee
Q 016950 53 IVFQAKCLETGETVAIKKVLQD--------------RR----------------YKNRELQLMRVMDHPN--VISLKHCF 100 (380)
Q Consensus 53 ~Vy~~~~~~~~~~~aiK~~~~~--------------~~----------------~~~~e~~~l~~l~h~n--iv~~~~~~ 100 (380)
.||.|.. .+|..+|+|+.... .+ ...+|.+.|..+...+ +.+++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888885 56779999987321 01 1136999999997653 44544322
Q ss_pred eecCCCCceEEEEEeeccc--chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-hHcCCCeeecCCCCCCEEEcCCC
Q 016950 101 FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~-LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
. .+|||||++ |..+..+... .++......++.+++..+.. +|. .||+|+||++.||+++. +
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~ 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred -----C----CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence 2 349999999 6333333321 11133456677788886555 579 79999999999999985 3
Q ss_pred CcEEEEeecccccC
Q 016950 178 HQVKICDFGSAKQL 191 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~ 191 (380)
.+.|+|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 7999999988644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.7e-09 Score=92.16 Aligned_cols=139 Identities=18% Similarity=0.192 Sum_probs=89.2
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+.|+.|..+.||++... +|+.+++|..... .....+|..+++.+.+.+ +.+++...... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 56899999999999864 3688999987543 234568999999987643 44444433111 11123579999
Q ss_pred cccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------------------------------------
Q 016950 117 YVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------- 158 (380)
Q Consensus 117 ~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~------------------------------------- 158 (380)
|++|. +...+. ...+++.....++.+++.+|..||+.
T Consensus 81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 99874 211110 02234444444455555555555431
Q ss_pred ------------------CCeeecCCCCCCEEEcCC-CCcEEEEeeccccc
Q 016950 159 ------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQ 190 (380)
Q Consensus 159 ------------------~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~~ 190 (380)
..++|+|++|.||+++.+ ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 357999999999999863 34588999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-08 Score=90.98 Aligned_cols=133 Identities=11% Similarity=0.063 Sum_probs=88.3
Q ss_pred EEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeee--ceeeeecCCCCceEEEEEe
Q 016950 53 IVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 53 ~Vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv~ 115 (380)
.|.++.. .|+.|.||...... ....+|...+..|...+|... +.+...........-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3445433 56677788552211 124588888887754444333 2222221212123466999
Q ss_pred ecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC------CCCcEEEEeecc
Q 016950 116 EYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVKICDFGS 187 (380)
Q Consensus 116 e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~------~~~~ikl~Dfg~ 187 (380)
|++++ +|.+.+.... ....+......++.+++..+.-||. +||+|+|+++.|||++. +...+.++||+.
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99997 5666664321 2345567778899999999999999 89999999999999974 245799999998
Q ss_pred ccc
Q 016950 188 AKQ 190 (380)
Q Consensus 188 a~~ 190 (380)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.4e-08 Score=88.18 Aligned_cols=132 Identities=20% Similarity=0.163 Sum_probs=93.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--------------------------ccchHHHHHHHHhCCCC-
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRVMDHP- 91 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--------------------------~~~~~~e~~~l~~l~h~- 91 (380)
-+.+...||-|--|.||.|.+. .|..+|||.-... +...++|.++|+.|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3667889999999999999865 7889999943210 11224799999988644
Q ss_pred -ceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 92 -NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 92 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
.+.+.++ .+...+|||+++|..+.-+ +++.+....++..|+.-+..+-. .|++|+|+++-|
T Consensus 171 ~~VP~P~~---------~nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIA---------WNRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFN 232 (304)
T ss_pred CCCCCccc---------cccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH-cCccccCCchhe
Confidence 4444422 1225699999998422111 12344455666677777766667 699999999999
Q ss_pred EEEcCCCCcEEEEeeccccc
Q 016950 171 LLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~ 190 (380)
|+++. ++.+.++||--+..
T Consensus 233 IlV~~-dg~~~vIDwPQ~v~ 251 (304)
T COG0478 233 ILVTE-DGDIVVIDWPQAVP 251 (304)
T ss_pred EEEec-CCCEEEEeCccccc
Confidence 99997 67799999987754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.3e-08 Score=89.11 Aligned_cols=197 Identities=14% Similarity=0.168 Sum_probs=128.6
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-HHHHHHHHhC-CCCceee----eceeeeecCCCCceEEEEE
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVIS----LKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~e~~~l~~l-~h~niv~----~~~~~~~~~~~~~~~~~lv 114 (380)
...+.||+|+-+-+|-.-.. +.. +.|+........ .+.+..|-.. .||-+.. -....+.. .....+.++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hch-hheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC--CccceeEEe
Confidence 34567999999999965432 223 447775433222 1222233222 4443322 11111111 122226788
Q ss_pred eecccc--hHHHHHH--HhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 115 MEYVPE--SMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 115 ~e~~~~--~l~~~l~--~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+.+.| ....+.. ..........+..+.+....|+.+...||. .|.+-+|+.++|+|++. ++.+.|.|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEcccceee
Confidence 888875 2222221 222334557889999999999999999999 79999999999999985 78899988665444
Q ss_pred CccCCCcceeeccCCCCChhhhh-C---CCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 016950 191 LIAGEANISYICSRFYRAPELIF-G---ATEYTTSIDIWSAGCVLAELLLG-QPLFPGE 244 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~-~---~~~~~~~~DiwslGvil~~ll~g-~~pf~~~ 244 (380)
..++......+|.+.|.+||.-. + ...-+..+|.|.||+++++++.| +.||.|-
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 44444455667889999999853 1 12246789999999999999986 9999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-07 Score=80.52 Aligned_cols=107 Identities=18% Similarity=0.247 Sum_probs=75.8
Q ss_pred hHHHHHHHHhCCCCcee--eeceeeeecCCCCceEEEEEeecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 016950 78 KNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153 (380)
Q Consensus 78 ~~~e~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~ 153 (380)
..+|...+..|....|. ..+.+....... ....++|+|++++ +|.+.+... ...+......++.++...+.
T Consensus 58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 58 AKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHH
Confidence 45788877777543333 333333222222 2446799999987 566666531 22566677889999999999
Q ss_pred HhHcCCCeeecCCCCCCEEEcCCC--CcEEEEeeccccc
Q 016950 154 YIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQ 190 (380)
Q Consensus 154 ~LH~~~~iiH~Dlkp~Nill~~~~--~~ikl~Dfg~a~~ 190 (380)
-||. +||+|+|+++.|||++.++ ..+.++||+.++.
T Consensus 133 ~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 8999999999999998633 2699999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=5.4e-07 Score=76.53 Aligned_cols=137 Identities=12% Similarity=0.082 Sum_probs=95.6
Q ss_pred ecCCceEEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHhCCCCce--eeeceeeeecCCCCceEEEEE
Q 016950 47 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 47 g~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv 114 (380)
|+||.+.|+.... .|+.|-+|.-.. ......+|...++.|...+| .++. ++-.........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5688899998765 444688886531 22334689999888854443 3333 1111222334456799
Q ss_pred eecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc--EEEEeeccccc
Q 016950 115 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQ 190 (380)
Q Consensus 115 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~--ikl~Dfg~a~~ 190 (380)
+|-++| +|.+.+... .-.+.+......++.+++.++.-||+ .|+.|+|+-+.||+++. .+. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 998884 676665421 12345667778899999999999999 79999999999999985 345 99999998764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.7e-07 Score=77.19 Aligned_cols=136 Identities=15% Similarity=0.171 Sum_probs=84.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchH-------------HHHHHHHhCCCC---ceeeeceee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRVMDHP---NVISLKHCF 100 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------------~e~~~l~~l~h~---niv~~~~~~ 100 (380)
..+|.+.+++-......|.+..- +|+.+++|.........+ +++..+..+... ....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35688889998888787776653 778999998754332222 233333333222 222211111
Q ss_pred eecCCCCceEEEEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 101 FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
.-....-....+++|||++|- +.+.. .+++ .+...+..++.-||+ .|+.|+|.+|.|++++. +.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~--~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN--NG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC--Cc
Confidence 111112223355899999983 22221 1222 234567788999999 79999999999999984 44
Q ss_pred EEEEeecccc
Q 016950 180 VKICDFGSAK 189 (380)
Q Consensus 180 ikl~Dfg~a~ 189 (380)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-07 Score=91.06 Aligned_cols=136 Identities=21% Similarity=0.312 Sum_probs=81.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccccc--------------------------------------------hH
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------------------------KN 79 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--------------------------------------------~~ 79 (380)
+-|+.++-|+||+|+.+ +|+.||||+...+-.. ..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999965 5999999987321100 01
Q ss_pred HHHHHHHhC----CCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHH--HHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 016950 80 RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRV--LKHYSSANQRMPLIYVKLYTYQIFRGL 152 (380)
Q Consensus 80 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~--l~~~~~~~~~l~~~~~~~i~~ql~~al 152 (380)
+|+.-+.++ ....-+.+-.++.+.+++ -.++|||+.| .+.+. ++........+....+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~--- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL--- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence 344433333 223333444444332222 3499999998 33333 221111111122333333333333
Q ss_pred HHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 153 ~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
. .|++|+|.+|.||+++. ++++.+.|||+......
T Consensus 283 ----~-dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 ----R-DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ----h-cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence 3 59999999999999997 78899999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.6e-07 Score=77.14 Aligned_cols=132 Identities=19% Similarity=0.187 Sum_probs=87.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeecccc----------------------------chHHHHHHHHhCCCC--cee
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMDHP--NVI 94 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----------------------------~~~~e~~~l~~l~h~--niv 94 (380)
.|.+|--+.||+|.. .++..+|+|++..... ...+|..-|+++... .+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 666788889999884 5688999998842211 012567777766432 333
Q ss_pred eeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
+.+.+. . -.|||||++... ...-....-.+....+..+..+++..+.-|-...+++|+||+.-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 333332 1 339999998531 0000011223344467788889999988776536999999999999998
Q ss_pred CCCCcEEEEeecccccC
Q 016950 175 PLTHQVKICDFGSAKQL 191 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~ 191 (380)
++.+.|+|||-|...
T Consensus 202 --~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 --DGEPYIIDVSQAVTI 216 (268)
T ss_pred --CCeEEEEECcccccc
Confidence 567999999998644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.3e-09 Score=98.49 Aligned_cols=244 Identities=20% Similarity=0.186 Sum_probs=162.3
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCc-eeeeceeeeecCCCCceEEEEEeec
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN-VISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
-|....-+++|+++++++.+...+.... .+.+... ....-++++|.+++||| .+...+. .+.+.+.++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhh
Confidence 4667778899999999998865555444 5655443 34456899999999999 4433332 2556678899999
Q ss_pred ccch--HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC
Q 016950 118 VPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195 (380)
Q Consensus 118 ~~~~--l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~ 195 (380)
++++ ..... ......+...+...+...-+.+++++|+ -.-+|+| ||+..+ +..+..||+.........
T Consensus 316 ~s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSE--EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccc--cccccccccCCcccCccc
Confidence 9854 11000 0111223334444556666778999998 4567888 888764 568999999988776555
Q ss_pred CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCc
Q 016950 196 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275 (380)
Q Consensus 196 ~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 275 (380)
...+..+|+.++|||+.... .+....|.|++|+-..+|.-|.+|-...-. .. ...|..+
T Consensus 386 ~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p-------------- 444 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGP-------------- 444 (829)
T ss_pred ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCC--------------
Confidence 56678899999999998554 488899999999988888878777544110 00 0000000
Q ss_pred cCCCCCC-CCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 276 RFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 276 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.-+.+.. ..|...+.. ++...|+..-|..|+....++-|-+|+..
T Consensus 445 ~s~~L~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 NSPMLTDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred CccccchhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0111111 223222222 67889999999999999999999999764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.9e-07 Score=92.43 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=134.4
Q ss_pred HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc
Q 016950 79 NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157 (380)
Q Consensus 79 ~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~ 157 (380)
..|+..+..+.|+|++.++.+-......+ ..+.+..++|.. ++...+. .-...+...++.+..+++.||.++|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 35777888889999999876654333222 122244566664 4444444 34678888999999999999999999
Q ss_pred CCCeeecCCCCC---CEEEcCCCCcEEEE--eecccccCccCCCcceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHH
Q 016950 158 VPRVCHRDLKPQ---NLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVL 231 (380)
Q Consensus 158 ~~~iiH~Dlkp~---Nill~~~~~~ikl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil 231 (380)
....|.-|..+ +.-.+. .+.+.++ ||+.+..............+.-+.+||...... ..+...|+|.+|..+
T Consensus 305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 55555544444 222232 3345555 888888776666555566667788888874322 123346999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC
Q 016950 232 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 311 (380)
Q Consensus 232 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 311 (380)
..+..|..+-.... .....+ +........+++.+|+.-++++
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc---chhhhh-----------------------------------ccccchhhhhhhhhhcchhhhh
Confidence 99998775431111 000000 0011226788999999999999
Q ss_pred CCCHHHHhcCCCcccc
Q 016950 312 RCTALEACAHPFFDEL 327 (380)
Q Consensus 312 R~t~~e~l~hp~~~~~ 327 (380)
|+++.+++.|||.+.-
T Consensus 425 Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFP 440 (1351)
T ss_pred ccchhhhhhchhcccc
Confidence 9999999999998753
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.1e-06 Score=81.77 Aligned_cols=136 Identities=19% Similarity=0.264 Sum_probs=80.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccccch-----------------------------------H------HH
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----------------------------------N------RE 81 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----------------------------------~------~e 81 (380)
.+.||..+.|.||+|+.+. |+.||||+-..+-... . +|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4679999999999999765 9999999763221100 0 22
Q ss_pred HH----HHHhCCCCc---eeeeceeeeecCCCCceEEEEEeecccch---HHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Q 016950 82 LQ----LMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPES---MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151 (380)
Q Consensus 82 ~~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~l~~~~~~~i~~ql~~a 151 (380)
++ +.+.+.|-+ -|.+-.++.+.... -.|+||||+|- -.+.++. ..++...+. ..+.++
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~----RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~---~~l~~~ 312 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTK----RVLTMEYVDGIKINDLDAIDK-----RGISPHDIL---NKLVEA 312 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcc----eEEEEEecCCccCCCHHHHHH-----cCCCHHHHH---HHHHHH
Confidence 22 222334444 22233344322221 34999999972 2233332 234443332 233333
Q ss_pred HH-HhHcCCCeeecCCCCCCEEEcC---CCCcEEEEeecccccCc
Q 016950 152 LA-YIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQLI 192 (380)
Q Consensus 152 l~-~LH~~~~iiH~Dlkp~Nill~~---~~~~ikl~Dfg~a~~~~ 192 (380)
.. -|=. .|++|+|=+|.||++++ .+..+.+.|||+.....
T Consensus 313 ~~~qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 313 YLEQIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHh-cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 21 1223 59999999999999984 36789999999987553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.1e-06 Score=72.35 Aligned_cols=74 Identities=19% Similarity=0.189 Sum_probs=48.7
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++.... ........+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEEEEEe
Confidence 4679999999999998754 58999987654 234457888888875333 344443221 112233478999999
Q ss_pred cc
Q 016950 119 PE 120 (380)
Q Consensus 119 ~~ 120 (380)
+|
T Consensus 78 ~g 79 (239)
T PF01636_consen 78 PG 79 (239)
T ss_dssp SS
T ss_pred cc
Confidence 87
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=68.33 Aligned_cols=69 Identities=14% Similarity=0.077 Sum_probs=44.5
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCce--eeeceeeeecCCCCceEEEEEeeccc
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVP 119 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~ 119 (380)
..||.|..+.||+. .+..+++|...... ....+|.++++.+..-.+ .+.+++. ......++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 46899999999974 24567889875432 234689999888754333 3333333 12222568999999
Q ss_pred ch
Q 016950 120 ES 121 (380)
Q Consensus 120 ~~ 121 (380)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 83
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.3e-05 Score=62.06 Aligned_cols=126 Identities=21% Similarity=0.319 Sum_probs=83.1
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeec
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
-++.+.||+|.+|.||++.. .|..+|+|+-..+ +.....|+++|..++..++-.=+- ++. . .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy-~yg---~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVY-FYG---E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEE-Eec---h----hhhhhhh
Confidence 45577899999999999986 5668999977544 344568999999987665543211 111 1 2367999
Q ss_pred ccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC--CCEEEcCCCCcEEEEeecccc
Q 016950 118 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP--QNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 118 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp--~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+.| .|...... ... .-+..++.+---|-. .||-|+.|+- .||++. ++.+.|+||..|+
T Consensus 94 i~G~~L~~~~~~-------~~r----k~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG-------GDR----KHLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc-------ccH----HHHHHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchh
Confidence 998 44332210 012 222345555455666 5999999864 456665 4479999999987
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00019 Score=74.84 Aligned_cols=77 Identities=18% Similarity=0.195 Sum_probs=50.2
Q ss_pred eeeeecCCceEEEEEEECCCC--cEEEEEEeecc-----ccchHHHHHHHHhCC-CCce--eeeceeeeecCCCCceEEE
Q 016950 43 ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRVMD-HPNV--ISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~--~~~aiK~~~~~-----~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~ 112 (380)
++.++.|.++.+|++.....+ ..+++|+.... .....+|..+++.+. |.++ .+++..+.+. ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 567899999999998765432 46788876432 234568999999995 6654 4444333221 1112367
Q ss_pred EEeecccch
Q 016950 113 LVMEYVPES 121 (380)
Q Consensus 113 lv~e~~~~~ 121 (380)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00017 Score=60.94 Aligned_cols=126 Identities=23% Similarity=0.354 Sum_probs=84.7
Q ss_pred cceeeeeeeecCCc-eEEEEEEECCCCcEEEEEEeec----c-----ccc----------------hHHHHH---HHHhC
Q 016950 38 ISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ----D-----RRY----------------KNRELQ---LMRVM 88 (380)
Q Consensus 38 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~aiK~~~~----~-----~~~----------------~~~e~~---~l~~l 88 (380)
.+++.++.||.|.- |.||+++. .|+.||||.+.. . ... ...|-+ .|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 99999987 778999998421 0 000 113333 44455
Q ss_pred CCCce--eeeceeeeecC-------------CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 016950 89 DHPNV--ISLKHCFFSTT-------------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153 (380)
Q Consensus 89 ~h~ni--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~ 153 (380)
.+.++ |+.++++.-.. ........||.||+...- .++... +.+|+.-+.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence 56666 78877764331 012223457888876531 222222 347778888
Q ss_pred HhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 154 ~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|. .||+-+|+++.|.. + -+|+|||.+
T Consensus 179 ~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS 206 (207)
T ss_pred HHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence 9999 79999999999985 2 379999975
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00019 Score=63.59 Aligned_cols=69 Identities=16% Similarity=0.065 Sum_probs=42.3
Q ss_pred eecCCc-eEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEEEeecccch
Q 016950 46 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLVMEYVPES 121 (380)
Q Consensus 46 lg~G~~-g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 121 (380)
|..|.. +.||++... +..+.+|..... .....+|+.+++.+. +-.+.+++.+... ....++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCCc
Confidence 444555 789998753 367888877543 123467999888884 2233344443311 12356899999873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.88 E-value=7.5e-05 Score=68.09 Aligned_cols=135 Identities=20% Similarity=0.269 Sum_probs=92.4
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------c------------------------cchHHHHHHHHhCCC
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------------------------RYKNRELQLMRVMDH 90 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~------------------------~~~~~e~~~l~~l~h 90 (380)
.+-..|..|--+.||.|. ..+|..+|||+++.+ + .+..+|+.-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 345567788889999988 567888999987421 0 011257777777765
Q ss_pred CceeeeceeeeecCCCCceEEEEEeecccchHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMY--RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 91 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
..|.-.--+.... ..|||+|++..-+ -.| ....++...+..+-.|++.-+.-|-+.++++|.||+=
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSE 293 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSE 293 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhh
Confidence 4443222222111 3499999984211 122 2445677778888888888887776547999999999
Q ss_pred CCEEEcCCCCcEEEEeeccccc
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
-|+|+- ++.+.|+|.+-+-.
T Consensus 294 fN~Lyh--dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 294 FNLLYH--DGKLYIIDVSQSVE 313 (520)
T ss_pred hhheEE--CCEEEEEEcccccc
Confidence 999997 57899999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0007 Score=59.52 Aligned_cols=69 Identities=17% Similarity=0.306 Sum_probs=44.2
Q ss_pred eeeeecCCceEEEEEEECC-CCcEEEEEEeeccc---cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEEEEEeec
Q 016950 43 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR---RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
++.|..|-...+|++.... .++.|++|+..... ....+|+.+++.+...++ .+++..+ .+ .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 4567888888999997543 35789999775432 223478888888854443 3332221 11 279999
Q ss_pred ccc
Q 016950 118 VPE 120 (380)
Q Consensus 118 ~~~ 120 (380)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00036 Score=61.45 Aligned_cols=30 Identities=40% Similarity=0.579 Sum_probs=24.9
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++|+|+.|.||+++. +...-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence 45899999999999984 4445699999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00067 Score=57.75 Aligned_cols=127 Identities=19% Similarity=0.296 Sum_probs=80.0
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeeccc--------------------cchHHHHHHHHhCC------CCceeeec
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRVMD------HPNVISLK 97 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------------~~~~~e~~~l~~l~------h~niv~~~ 97 (380)
..||+|+.=.||. |. .+....||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4689999999985 33 34456778875544 33346776666555 77888888
Q ss_pred eeeeecCCCCceEEEEEeeccc---chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 98 HCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
+...+... ..+|+|.+. |+....+..+. ....+++ .... .+-.-.++|-. ++|+.+|++|.||++.
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~---~L~~f~~~l~~-~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQ---ALDEFKRYLLD-HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHH---HHHHHHHHHHH-cCCeecCCCcccEEEE
Confidence 88744333 668888774 33333333333 2344555 3333 33344567788 7999999999999995
Q ss_pred CCC--C-cEEEEe
Q 016950 175 PLT--H-QVKICD 184 (380)
Q Consensus 175 ~~~--~-~ikl~D 184 (380)
..+ . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 422 2 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=1.8e-05 Score=83.32 Aligned_cols=213 Identities=16% Similarity=0.029 Sum_probs=137.8
Q ss_pred HHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 81 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
|.+.++...|+++.....-..... ....|.+++|+. |.+.+.+..-......+....+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 444555568888877655443222 223568899988 5676777655555555655555555555577777777643
Q ss_pred C----eeecCCCCCCEEEcCCCCcEEEEeecccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHH
Q 016950 160 R----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 234 (380)
Q Consensus 160 ~----iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~l 234 (380)
+ -+|+++|+-|.+|.. +..+|+.++|+.+...+. ......++++.|++|++.. .-.++.++|+|..|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence 3 478999999999996 778999999999833222 2233467788899999874 34578889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC
Q 016950 235 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 314 (380)
Q Consensus 235 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 314 (380)
..|..+|. ..++...+. ...+-.....+.+ -|.++-.....+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe~l------------~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIEKL------------KPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHcC-----------ccccccccccccc------------CCCcccHHHHHHHHHHhhhcch
Confidence 99988873 223322221 1111111122211 2334444555556666678999
Q ss_pred HHHHhcCCCccc
Q 016950 315 ALEACAHPFFDE 326 (380)
Q Consensus 315 ~~e~l~hp~~~~ 326 (380)
-...+.-+.|.-
T Consensus 1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred hhhhcccccccc
Confidence 999988888754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00061 Score=60.85 Aligned_cols=132 Identities=17% Similarity=0.232 Sum_probs=72.9
Q ss_pred eecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecccc
Q 016950 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYVPE 120 (380)
Q Consensus 46 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (380)
+..|-.+.+|++. .+++.+++|....... ...+|..+++.+....++ +++... . -++|+||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 4567888999887 3567888997643321 246799999988644332 222211 1 2489999987
Q ss_pred hHHH---------------HHHHhhh---cCCCCCH-HHHHHHHHHH---------HHHHHHhHc-------CCCeeecC
Q 016950 121 SMYR---------------VLKHYSS---ANQRMPL-IYVKLYTYQI---------FRGLAYIHT-------VPRVCHRD 165 (380)
Q Consensus 121 ~l~~---------------~l~~~~~---~~~~l~~-~~~~~i~~ql---------~~al~~LH~-------~~~iiH~D 165 (380)
.... .+...-. ....++. ..+..+..++ ...++.+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 3211 1111000 1111111 1122222121 111222211 02589999
Q ss_pred CCCCCEEEcCCCCcEEEEeeccccc
Q 016950 166 LKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 166 lkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+.|.||+++. ++ +.|+||..|..
T Consensus 153 l~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeC-CC-CEEEeccccCc
Confidence 9999999986 44 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00022 Score=67.73 Aligned_cols=171 Identities=21% Similarity=0.257 Sum_probs=108.9
Q ss_pred HHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 80 ~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
-...+++.+.|+|.....++-- .......+|+|+++-++.+.++... +... +++ . +
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-~ 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-H 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-c
Confidence 3567888899999998776542 2222377999999999888876321 1110 111 1 2
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~ 239 (380)
++.| -|+ ++.+| -++. . | |-. ..+++||||+|.++.++..|..
T Consensus 87 ~~~~-----~~~--------~~~td-~~~t----~-----------~--~~~------~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLH-----LNI--------IYITD-HFLT----K-----------Y--PSP------IGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccce-----ehh--------hhccc-cccc----c-----------C--CCC------CCcchhhhhHHHHHHHHHHhhH
Confidence 3322 122 23333 0000 0 1 111 1249999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 240 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.+......+.+..+.+..-.+....+--+. + .+...++.....+..+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e----------------~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAME----------------H-LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHH----------------H-HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 998888777777776654333321111000 0 12223678889999999999999999999999
Q ss_pred cCCCccccc
Q 016950 320 AHPFFDELR 328 (380)
Q Consensus 320 ~hp~~~~~~ 328 (380)
+|+-|.++.
T Consensus 193 k~~i~~ev~ 201 (725)
T KOG1093|consen 193 KRCSFTEVY 201 (725)
T ss_pred cCccHHHHH
Confidence 999998763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0026 Score=60.07 Aligned_cols=71 Identities=23% Similarity=0.328 Sum_probs=46.4
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCCc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 108 (380)
.+.||.|.+..||++.....++.++||.-.. .......|.+.|+.+. ..++.+++++- ..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~---- 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EE---- 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CC----
Confidence 3578999999999999864446899997431 1122346788887763 23455555432 11
Q ss_pred eEEEEEeecccc
Q 016950 109 LFLNLVMEYVPE 120 (380)
Q Consensus 109 ~~~~lv~e~~~~ 120 (380)
..++|||++++
T Consensus 105 -~~~lVME~L~~ 115 (401)
T PRK09550 105 -LAVTVMEDLSD 115 (401)
T ss_pred -CCEEEEecCCC
Confidence 14599999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00022 Score=64.10 Aligned_cols=131 Identities=16% Similarity=0.174 Sum_probs=85.9
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec----------c----------------ccchHHHHHHHHhCCC-C
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------D----------------RRYKNRELQLMRVMDH-P 91 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~----------------~~~~~~e~~~l~~l~h-~ 91 (380)
-|.++..||-|--+.||.+-+ ..|+++++|.-.- . +....+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 477889999999999999975 4678888884311 0 1111367888887742 1
Q ss_pred -ceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 92 -NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 92 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
.+.+.++ ....++|||++.|--+..+.+ ... +..+...++.-+.-|-. +|+||+|..-=|
T Consensus 172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPID---------HNRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN 232 (465)
T ss_pred CCCCCccc---------ccceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence 2333322 223679999998732222211 111 22334445555667778 799999999999
Q ss_pred EEEcCCCCcEEEEeeccccc
Q 016950 171 LLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~ 190 (380)
|+++. ++.++++||--...
T Consensus 233 imv~d-d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 233 IMVKD-DDKIVVIDFPQMVS 251 (465)
T ss_pred eEEec-CCCEEEeechHhhc
Confidence 99995 77899999986543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0011 Score=56.17 Aligned_cols=100 Identities=19% Similarity=0.167 Sum_probs=73.7
Q ss_pred HHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc
Q 016950 80 RELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157 (380)
Q Consensus 80 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~ 157 (380)
.|.-+++.+.+ +++.++++.+ . -++|.||.+. +++.. ......-...++.....++.+++..+++++.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 58888898876 5888988877 3 3478899884 33211 0000011346788899999999999999987
Q ss_pred C--CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 158 V--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 158 ~--~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
. ..+...|++|+|+-++. ++++|++|.+.+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeC-CCcEEEEechhcch
Confidence 2 24667899999999995 78899999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0057 Score=56.50 Aligned_cols=30 Identities=30% Similarity=0.261 Sum_probs=25.4
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||+|+.|.||+++. +...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence 48999999999999984 4445799999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0037 Score=57.45 Aligned_cols=145 Identities=16% Similarity=0.063 Sum_probs=75.7
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc--eeeeceeeeec-CCCCceEEEEEee
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVME 116 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e 116 (380)
.++.++.|....+|++.. . +..+++|+.... ......|..+++.|.... +.+++...-.. ........+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677887789999864 3 346888977542 233346777777774322 23332211000 0011234679999
Q ss_pred cccchH-----H-------HHHHHhhhcCCCC--------C-HHHH----H----------HHHHHHHHHHHHhHc----
Q 016950 117 YVPESM-----Y-------RVLKHYSSANQRM--------P-LIYV----K----------LYTYQIFRGLAYIHT---- 157 (380)
Q Consensus 117 ~~~~~l-----~-------~~l~~~~~~~~~l--------~-~~~~----~----------~i~~ql~~al~~LH~---- 157 (380)
|++|.- . ..+...-.....+ . ..+. . .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 987621 0 1111100000000 0 0000 0 001112234444432
Q ss_pred --CCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 158 --VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 158 --~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..+++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 158999999999999986 5556899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0043 Score=56.57 Aligned_cols=143 Identities=14% Similarity=0.033 Sum_probs=75.9
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeec-cccchHHHHHHHHhCCCCc--eeeeceeeeecC--CCCceEEEEEeec
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPN--VISLKHCFFSTT--SKNELFLNLVMEY 117 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~--~~~~~~~~lv~e~ 117 (380)
.+.|..|....+|++.. ++..+++|+... .......|+.+++.+.+.. +.+++... ... .......+.|+++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceEEEEEe
Confidence 55677888889998864 345789998764 2233456888888875433 33332210 000 0111235789999
Q ss_pred ccchHH------------HHHH---Hhhhc-CCC----CCHHHHHH------------HHHHHHHHHHHhHc------CC
Q 016950 118 VPESMY------------RVLK---HYSSA-NQR----MPLIYVKL------------YTYQIFRGLAYIHT------VP 159 (380)
Q Consensus 118 ~~~~l~------------~~l~---~~~~~-~~~----l~~~~~~~------------i~~ql~~al~~LH~------~~ 159 (380)
++|... +.+. ..... ... ........ ....+..+++++.. ..
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 976211 1111 10000 000 00000000 01112223333332 14
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 7999999999999985 5556899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0079 Score=54.94 Aligned_cols=75 Identities=7% Similarity=-0.032 Sum_probs=48.6
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCC---CceeeeceeeeecCCCCceEEEEEee
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH---PNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
-.+.||.|..+.||..... ++ .+++|..+.. ......|...|+.+.. -.+.++++++..... ....++|||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~~LVmE 93 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPDVLLLE 93 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCeEEEEe
Confidence 3567999999999998642 23 4677765432 2356789999998853 245555554422211 223679999
Q ss_pred cccc
Q 016950 117 YVPE 120 (380)
Q Consensus 117 ~~~~ 120 (380)
+++|
T Consensus 94 ~i~G 97 (297)
T PRK10593 94 RLRG 97 (297)
T ss_pred ccCC
Confidence 9886
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.016 Score=54.04 Aligned_cols=30 Identities=33% Similarity=0.617 Sum_probs=26.4
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++|+|+++.|||++..++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 689999999999998645679999999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.023 Score=51.97 Aligned_cols=31 Identities=32% Similarity=0.494 Sum_probs=26.4
Q ss_pred CCeeecCCCCCCEEEcCC---CCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~---~~~ikl~Dfg~a~ 189 (380)
..++|+|+.|.||+++.+ .+.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 368999999999999863 2679999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.014 Score=54.14 Aligned_cols=29 Identities=24% Similarity=0.371 Sum_probs=25.8
Q ss_pred eeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 161 iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|+.+.|||++++++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 79999999999997545789999999985
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.019 Score=53.22 Aligned_cols=69 Identities=25% Similarity=0.267 Sum_probs=42.7
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhCC--CC-ceeeeceeeeecCCCCceE
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~ 110 (380)
.||.|....||++.....++.++||.-.. +..+..-|...|+... -| .+.++++ ++...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~----- 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEM----- 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Ecccc-----
Confidence 57999999999999754446899996421 1122345777777653 23 3444433 22221
Q ss_pred EEEEeecccc
Q 016950 111 LNLVMEYVPE 120 (380)
Q Consensus 111 ~~lv~e~~~~ 120 (380)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 4489999963
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.026 Score=51.79 Aligned_cols=29 Identities=28% Similarity=0.558 Sum_probs=25.1
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 48999999999999985 458999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.023 Score=53.49 Aligned_cols=71 Identities=18% Similarity=0.236 Sum_probs=45.0
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHhCC--CC-ceeeeceeeeecCCCCce
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----------~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~ 109 (380)
.+.||.|.-..||++.+...++.++||.-.. +..+..-|.+.|+... .| .+.+++. ++...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~---- 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVM---- 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHH----
Confidence 5678999999999999854467899996421 1222345778887663 23 4555543 22221
Q ss_pred EEEEEeecccc
Q 016950 110 FLNLVMEYVPE 120 (380)
Q Consensus 110 ~~~lv~e~~~~ 120 (380)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 4488999863
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.055 Score=51.23 Aligned_cols=70 Identities=19% Similarity=0.247 Sum_probs=45.1
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~ 107 (380)
..+.||.|....||++.+ .+..++||.-.. +......|...|+.+. ..++.+++.+. ++
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence 366789999999999986 345689996541 2223345777776653 23555665443 21
Q ss_pred ceEEEEEeecccc
Q 016950 108 ELFLNLVMEYVPE 120 (380)
Q Consensus 108 ~~~~~lv~e~~~~ 120 (380)
. .+++||++++
T Consensus 109 ~--~vlvME~L~~ 119 (418)
T PLN02756 109 M--ALIGMRYLEP 119 (418)
T ss_pred C--CEEEEeecCC
Confidence 1 4588999965
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.034 Score=50.16 Aligned_cols=32 Identities=28% Similarity=0.458 Sum_probs=25.2
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
..++|+|++|.||+++.++...-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999985323356999999863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.064 Score=49.07 Aligned_cols=31 Identities=29% Similarity=0.501 Sum_probs=26.6
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
.++|+|+.+.|++++. +..+-++||+.+..-
T Consensus 199 ~lvHGD~~~gNlii~~-~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDP-GRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeC-CCeeEEEeccccccC
Confidence 4899999999999997 445899999999753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.066 Score=49.20 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.4
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++|+|+.+.|++++. ++.+.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence 47999999999999986 5678999999885
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.047 Score=50.30 Aligned_cols=76 Identities=18% Similarity=0.196 Sum_probs=57.1
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.+..+.|++|++-.+++.. ++ ....+++..++.+.+.-+.-+...-..-|||+...||||+ .|+|.|+||
T Consensus 296 de~~y~yl~~kdhgt~is~-ik-------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-IK-------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeee-ee-------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence 4566788999998876432 21 2345667778888877777776633678999999999998 577999999
Q ss_pred cccccC
Q 016950 186 GSAKQL 191 (380)
Q Consensus 186 g~a~~~ 191 (380)
-+++..
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999843
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.45 Score=45.08 Aligned_cols=28 Identities=32% Similarity=0.387 Sum_probs=23.9
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..+|.|+-+.||+.+ +..+.++||..|.
T Consensus 228 VfCHNDL~~gNIL~~--~~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDF--NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEec--CCCEEEEEecccc
Confidence 579999999999986 3459999999875
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.051 Score=50.87 Aligned_cols=60 Identities=30% Similarity=0.328 Sum_probs=39.5
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~ 175 (380)
..++-+|..| ++...++. ...+++..+.++.-...|+--|--..+.+|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3466677776 66666652 334555566666666666544433369999999999999964
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.63 Score=42.17 Aligned_cols=72 Identities=13% Similarity=0.138 Sum_probs=42.1
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC---CCceeeeceeeeecCCCCceEEEEEee
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVME 116 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e 116 (380)
+-.+.++.|....+|++. .+++.+.+|+-... ......|..-|+.|. --.+.+++.+.... +. .++|+|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~--~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DD--AFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SC--CEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CC--ceEEEE
Confidence 345678889999999887 67889999987643 334567888888873 33355555544221 11 369999
Q ss_pred ccc
Q 016950 117 YVP 119 (380)
Q Consensus 117 ~~~ 119 (380)
|++
T Consensus 93 ~l~ 95 (288)
T PF03881_consen 93 FLE 95 (288)
T ss_dssp ---
T ss_pred eec
Confidence 986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.05 Score=49.66 Aligned_cols=79 Identities=20% Similarity=0.222 Sum_probs=47.4
Q ss_pred EEeecccchHHHHHH-HhhhcCCCCCHHHHHHHHHHHHHHHH---HhHcCCCeeecCCCCCCEEEcCCCC----------
Q 016950 113 LVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLA---YIHTVPRVCHRDLKPQNLLVDPLTH---------- 178 (380)
Q Consensus 113 lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~ql~~al~---~LH~~~~iiH~Dlkp~Nill~~~~~---------- 178 (380)
+|++.+.++..++-. .....+-..-.+.++.++.|++.-.- .|-.+.+.+|.||||+|||+-+...
T Consensus 248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~ 327 (434)
T PF05445_consen 248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN 327 (434)
T ss_pred EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence 788887654322211 11122233345667888888876541 2332357899999999999842221
Q ss_pred -------cEEEEeecccccC
Q 016950 179 -------QVKICDFGSAKQL 191 (380)
Q Consensus 179 -------~ikl~Dfg~a~~~ 191 (380)
+.+|.||.+|+..
T Consensus 328 ~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 328 YVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEecccceeeecccCHHHhc
Confidence 3567788887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.40 E-value=0.039 Score=50.02 Aligned_cols=132 Identities=23% Similarity=0.269 Sum_probs=84.7
Q ss_pred eeeeeeecCCceEEEEEEEC------C----CCcEEEEEEeecc--------------ccch----------------HH
Q 016950 41 MAERVVGTGSFGIVFQAKCL------E----TGETVAIKKVLQD--------------RRYK----------------NR 80 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~------~----~~~~~aiK~~~~~--------------~~~~----------------~~ 80 (380)
.|..+|..|--+.|+-|.-- . ....||||+++.. -++. .+
T Consensus 255 ~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEk 334 (531)
T KOG2269|consen 255 SIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEK 334 (531)
T ss_pred hhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHH
Confidence 34567888888888887421 1 2245899977311 0100 13
Q ss_pred HHHHHHhC-----CCCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh
Q 016950 81 ELQLMRVM-----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155 (380)
Q Consensus 81 e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~L 155 (380)
|+.-|.++ ..|-+|.+...+ +||.|++.. .+..-....-.++..+.+..-.|+..++.-|
T Consensus 335 EmhNL~RMq~~GlpcP~vV~lkkhv------------LVMsFiGd~---~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~l 399 (531)
T KOG2269|consen 335 EMHNLSRMQKHGLPCPQVVKLKKHV------------LVMSFIGDQ---GLAAPKLKNVELTDDERRNAYDQVQSIMCRL 399 (531)
T ss_pred HHHHHHHHHhcCCCCCceeeeecce------------EEEEeecCC---CCCCccccccccChHHHHHHHHHHHHHHHHH
Confidence 44333333 467777765433 899999742 1111112344577788887778888887655
Q ss_pred -HcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 156 -HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 156 -H~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|. .-++|.|++--|+|..+ +++.++|..-+-.
T Consensus 400 Y~E-c~LVHADlSEyN~Lw~~--gKvw~IDVsQsve 432 (531)
T KOG2269|consen 400 YKE-CLLVHADLSEYNLLWTP--GKVWVIDVSQSVE 432 (531)
T ss_pred HHh-hheeecchhhhhheecC--CceEEEechhccC
Confidence 55 68999999999999985 5899999887643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.91 Score=42.04 Aligned_cols=28 Identities=25% Similarity=0.315 Sum_probs=23.9
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~--d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc--C-CcEEEeCCCCC
Confidence 4789999999999995 3 47899999875
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.14 Score=48.87 Aligned_cols=31 Identities=26% Similarity=0.292 Sum_probs=24.3
Q ss_pred eeecCCCCCCEEEcCCCC----cEEEEeecccccC
Q 016950 161 VCHRDLKPQNLLVDPLTH----QVKICDFGSAKQL 191 (380)
Q Consensus 161 iiH~Dlkp~Nill~~~~~----~ikl~Dfg~a~~~ 191 (380)
++|+||..+|||.+.++. -..|+||-.+...
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~G 304 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHRG 304 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhcC
Confidence 689999999999987443 3567898877643
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=2.6 Score=40.79 Aligned_cols=70 Identities=14% Similarity=0.148 Sum_probs=42.3
Q ss_pred eeeeeecCCceEEEEEEECC--------CCcEEEEEEeecccc---chHHHHHHHHhCCCCcee-eeceeeeecCCCCce
Q 016950 42 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNEL 109 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~ 109 (380)
-++.|..|-.-.+|++.... .++.|.+|+.-.... ....|..+++.+...+|- ++++.+ .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~--- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF-----S--- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe-----C---
Confidence 45566778788899987542 256899998744322 234688888877544443 333333 1
Q ss_pred EEEEEeecccc
Q 016950 110 FLNLVMEYVPE 120 (380)
Q Consensus 110 ~~~lv~e~~~~ 120 (380)
-+.|.||++|
T Consensus 181 -gg~I~efi~g 190 (442)
T PTZ00296 181 -GGRIEEWLYG 190 (442)
T ss_pred -CCEEEEeeCC
Confidence 1256777764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.21 Score=46.18 Aligned_cols=29 Identities=38% Similarity=0.544 Sum_probs=24.8
Q ss_pred eeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 161 iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+||+|+.|.||+++.++..+.++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999633348899999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 380 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-138 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-138 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-138 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-138 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-138 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-138 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-138 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-137 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-137 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-137 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-137 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-137 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-137 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-136 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-136 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-136 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-136 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-135 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-135 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-135 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-133 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-130 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-91 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-82 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-46 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-45 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-45 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-45 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-45 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-45 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-44 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-44 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-44 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-44 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-44 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-44 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-44 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-44 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-44 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-44 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-44 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-44 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-44 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-44 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-44 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-44 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-44 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-44 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-44 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-44 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-44 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-44 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-44 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-44 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-44 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-44 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-44 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-44 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-44 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-44 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-44 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-44 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-44 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-44 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-44 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-44 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-44 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-44 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-44 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-43 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-43 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-43 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-42 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-41 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-41 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-41 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-41 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-41 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-41 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-41 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-40 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-40 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-40 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-40 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-40 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-40 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-40 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-40 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-40 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-40 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-39 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-39 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-39 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-39 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-39 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-39 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-39 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-39 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-39 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-39 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-39 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-39 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-39 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-39 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-39 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-39 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-39 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-39 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-39 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-39 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-39 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-39 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-39 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-39 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-39 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-39 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-39 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-39 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-39 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-39 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-39 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-39 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-39 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-39 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-39 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-39 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-39 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-38 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-38 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-38 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-38 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-38 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-38 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-36 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-35 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-35 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-35 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-35 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-35 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-34 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-34 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-34 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-34 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-34 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-33 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-33 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-33 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-33 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-33 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-33 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-33 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-33 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-33 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-33 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-33 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-33 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-33 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-33 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-33 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-32 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-32 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-31 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-31 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-30 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-30 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-30 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-30 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-30 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-30 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-30 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-30 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-30 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-29 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-29 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-29 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-29 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-29 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-29 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-29 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-29 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-29 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-29 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-29 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-29 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 8e-29 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-28 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-28 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-28 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-28 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-28 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-28 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-28 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-27 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-27 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-27 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-27 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-27 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-27 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-27 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-26 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-26 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-25 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-20 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-20 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-18 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-18 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-18 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 7e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-18 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-17 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-17 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-16 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 622 bits (1607), Expect = 0.0
Identities = 217/371 (58%), Positives = 284/371 (76%), Gaps = 4/371 (1%)
Query: 4 DKEMSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63
+ ++ ++ D I GK GE ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65
Query: 64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESM 122
E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ LK F+S K +E+FLNLV+EYVPE++
Sbjct: 66 E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
YR +HY+ Q MP++ +KLY YQ+ R LAYIH++ +CHRD+KPQNLL+DP + +K+
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSGVLKL 183
Query: 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
DFGSAK LIAGE N+SYICSR+YRAPELIFGAT YTT+IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302
GE+ +DQLVEIIKVLGTP+RE+I+ MNPNY + +FPQI+ HP+ KVF R PP+AIDL S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
RLL+Y+PS R TA+EA HPFFDELR AR+PNGR LPPLFN+ +E P+L+++L+
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363
Query: 363 PDHVKRQLGLN 373
P H + +L
Sbjct: 364 PQHAEAELLSR 374
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 622 bits (1607), Expect = 0.0
Identities = 228/372 (61%), Positives = 290/372 (77%), Gaps = 4/372 (1%)
Query: 12 VDGSDHVTGHIISTTIG--GKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK 69
+ S G ++T + G+ + Q +SY +V+G GSFG+V+QAK ++GE VAIK
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK 85
Query: 70 KVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKH 128
KVLQD+R+KNRELQ+MR +DH N++ L++ F+S+ K +E++LNLV++YVPE++YRV +H
Sbjct: 86 KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH 145
Query: 129 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188
YS A Q +P+IYVKLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSA
Sbjct: 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
KQL+ GE N+SYICSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VD
Sbjct: 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 308
QLVEIIKVLGTPTRE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 309 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 368
P+ R T LEACAH FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI 384
Query: 369 QLGLNFLHPAGT 380
Q + A
Sbjct: 385 QAAASTPTNATA 396
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 589 bits (1521), Expect = 0.0
Identities = 154/357 (43%), Positives = 222/357 (62%), Gaps = 13/357 (3%)
Query: 20 GHIISTTIGGKNGEP--KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 77
G ++S E K+ + ER+ G G+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 78 KNRELQLMRVM---DHPNVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSA 132
+NRELQ+M+ + HPN++ L+ F++ + +++LN+VMEYVP++++R ++Y
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
P I +K++ +Q+ R + +H VCHRD+KP N+LV+ +K+CDFGSAK+L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E N++YICSR+YRAPELIFG YTT++DIWS GC+ AE++LG+P+F G+N+ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYS 308
EI++VLG P+RE +R +NP++TD K PW VF + EA DL S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 309 PSLRCTALEACAHPFFDELREPNARLPNGRPLPP-LFNF-KQELSGASPELVNKLIP 363
P R EA HP+FDEL +P +LPN + LP LF F E+ S KL+
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 568 bits (1466), Expect = 0.0
Identities = 166/381 (43%), Positives = 241/381 (63%), Gaps = 44/381 (11%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHP 91
G + Y + +GTGSFGIV + +E+G+ A+KKVLQD RYKNREL +M+V+DH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 92 NVISLKHCFFSTTSK---------------------------------NELFLNLVMEYV 118
N+I L F++T + +LN++MEYV
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 119 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178
P+++++VLK + + + +P+ + +Y YQ+FR + +IH++ +CHRD+KPQNLLV+ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDN 179
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
+K+CDFGSAK+LI E +++YICSRFYRAPEL+ GATEYT SID+WS GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 239 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 298
PLF GE ++DQLV II+++GTPT+E++ MNP+YT+ RFP +KA W K+ + P AI
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 299 DLASRLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPPLFNF-KQ 348
DL ++L+Y P LR EA AHPFFD LR N+ P+G + +P LFNF
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 349 ELSGASPELVNKLIPDHVKRQ 369
ELS ++N+++P +
Sbjct: 360 ELSIIPGNVLNRILPKNFSPN 380
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-100
Identities = 98/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G GS+G+VF+ + +TG+ VAIKK L+ RE+++++ + HPN+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
F K L L V EY ++ L Y + +P VK T+Q + + + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
HRD+KP+N+L+ +K+CDFG A+ L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 276
+D+W+ GCV AELL G PL+PG++ VDQL I K LG ++ N ++ +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 277 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
P + P F + A+ L L P+ R T + HP+F+ +RE L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 336 NGRPLPPLFNFKQ 348
P + Q
Sbjct: 299 KEHDKPAENLYFQ 311
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 3e-98
Identities = 96/295 (32%), Positives = 155/295 (52%), Gaps = 21/295 (7%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
VG GS+G+V + + +TG VAIKK L+ K RE++L++ + H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
K +L V E+V ++ L+ + + V+ Y +QI G+ + H+
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 218
+ HRD+KP+N+LV + VK+CDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 276
++D+W+ GC++ E+ +G+PLFPG++ +DQL I+ LG E+ NP + R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 277 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
P+IK P + + ++ IDLA + L P R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-97
Identities = 99/326 (30%), Positives = 169/326 (51%), Gaps = 33/326 (10%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMD 89
+Y+ +G G++ V++ K T VA+K++ R ++ RE+ L++ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
H N+++L + S L LV EY+ + + + L + + VKL+ +Q+
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLL 110
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFY 206
RGLAY H +V HRDLKPQNLL++ ++K+ DFG A+ +Y + + +Y
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 263
R P+++ G+T+Y+T ID+W GC+ E+ G+PLFPG +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
I + + +P+ +A R+ + DL ++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 324 FDELREPNARLPNGRPLPPLFNFKQE 349
F L E +LP+ + L + +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQ 310
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 1e-96
Identities = 88/313 (28%), Positives = 154/313 (49%), Gaps = 30/313 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 93
YM + +G G G+VF A + + VAIKK+ L D RE++++R +DH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 94 ISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 144
+ + + S+ + +V EY+ + VL+ + + +L+
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 200
YQ+ RGL YIH+ V HRDLKP NL ++ +KI DFG A+ + ++
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ +++YR+P L+ YT +ID+W+AGC+ AE+L G+ LF G + ++Q+ I++ +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 261 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318
E+ + + + P ++ + EA+D ++L +SP R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303
Query: 319 CAHPFFDELREPN 331
+HP+ P
Sbjct: 304 LSHPYMSIYSFPM 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 9e-96
Identities = 105/346 (30%), Positives = 181/346 (52%), Gaps = 34/346 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ + ++G G++G+V A TGE VAIKK+ R RE+++++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I++ + + +N + ++ E + ++RV+ Q + +++ + YQ R +
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YI 201
+H V HRDLKP NLL++ +K+CDFG A+ + A+ S ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+R+YRAPE++ + +Y+ ++D+WS GC+LAEL L +P+FPG + QL+ I ++GTP
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 262 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
+ +P ++ P A P K+F + + P+ IDL R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 318 ACAHPFFDELREPNARLPNGRPLPPL-FNFKQELSGASPELVNKLI 362
A HP+ +PN P G P+PP F F + + + KLI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-94
Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 96
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
F ++ ++LV +++ + ++K + + ++K Y +GL Y+H
Sbjct: 78 LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 213
+ HRDLKP NLL+D +K+ DFG AK G N +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 270
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
+Y F P H +F + +DL L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 331 NARLPNGRPLPP 342
P P
Sbjct: 300 GPTPGCQLPRPN 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 3e-94
Identities = 87/303 (28%), Positives = 151/303 (49%), Gaps = 23/303 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVISLK 97
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 98 DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207
Query: 218 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 271
Y S+D+WS GC+LA ++ +P F G + DQLV I KVLGT + ++P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267
Query: 272 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ D + W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 328 REP 330
+
Sbjct: 327 VKD 329
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 6e-94
Identities = 97/332 (29%), Positives = 159/332 (47%), Gaps = 33/332 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 84
Y +R + +GS+G V G VAIK+V RE++L
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 142
+ HPN++ L+ F L LV E + + +V+ QR+ + +++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ Y I GL +H V HRDL P N+L+ + + ICDF A++ A Y+
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262
R+YRAPEL+ +T +D+WSAGCV+AE+ + LF G +QL +I++V+GTP
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 263 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318
E++ +P +Y + A W V P A+DL +++L+++P R + +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 319 CAHPFFDELREPNARLPNGRPLPPLFNFKQEL 350
HP+F+ L +P L G F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 2e-93
Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G V++A T ETVAIK++ + + RE+ L++ + H N+I LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L L + EY LK Y N + + +K + YQ+ G+ + H+
Sbjct: 102 I---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 160 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 212
R HRDLKPQNLL+ +KI DFG A+ G + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 269
G+ Y+TS+DIWS C+ AE+L+ PLFPG++ +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
P++ FP+ + +V + E +DL + +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 330 PNARLPNGRPLPP 342
P
Sbjct: 326 ---------DFDP 329
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-92
Identities = 109/341 (31%), Positives = 177/341 (51%), Gaps = 36/341 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
Y +G G++G+V A VAIKK+ R RE++++ H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I + + T + + +V + + +Y++LK Q + ++ + YQI RGL
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 208
YIH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 269 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
N ++ P PW+++F +A+DL ++L ++P R +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318
Query: 326 ELR----EPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
+ EP A F F EL E + +LI
Sbjct: 319 QYYDPSDEPIA--------EAPFKFDMELDDLPKEKLKELI 351
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 3e-92
Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
VG G++G+V++AK G VA+K++ D + RE+ L++ + HPN++SL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S L LV E++ + + +VL + +K+Y YQ+ RG+A+ H
Sbjct: 88 IHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
R+ HRDLKPQNLL++ +K+ DFG A+ G SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+TS+DIWS GC+ AE++ G+PLFPG DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
F + PW + E IDL S +L + P+ R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-91
Identities = 97/294 (32%), Positives = 160/294 (54%), Gaps = 28/294 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N++ L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L LV E++ + + ++L + + K + Q+ G+AY H
Sbjct: 69 IHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
RV HRDLKPQNLL++ ++KI DFG A+ G Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 273
+Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-91
Identities = 105/304 (34%), Positives = 162/304 (53%), Gaps = 25/304 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y++ VG+G++G V A +GE VAIKK+ R Y REL L++ M H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F +S + LVM ++ + +++ + ++ YQ+ +
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ V HRDLKP NL V+ ++KI DFG A+ A Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
+I Y ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 270 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ PQ + ++F R P+A DL ++L+ R TA +A HPFF+
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312
Query: 328 REPN 331
R+P
Sbjct: 313 RDPE 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 3e-91
Identities = 104/335 (31%), Positives = 173/335 (51%), Gaps = 29/335 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y + VG+G++G V A TG VAIKK+ R Y REL+L++ M H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F + ++ LVM ++ + +++K ++++ ++ YQ+ +
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH + HRDLKP NL V+ ++KI DFG A+Q A Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVTRWYRAPE 195
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
+I YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 270 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
++ P+++ + + P A++L ++L R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 328 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
+ P ++ + + + ++
Sbjct: 315 HDTED-----EPQVQKYDDSFDDVDRTLDEWKRVT 344
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 6e-90
Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 99
+G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S L LV E+ + + + S N + VK + +Q+ +GL + H+
Sbjct: 70 LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 216
V HRDLKPQNLL++ ++K+ +FG A+ G Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 217 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 272
Y+TSID+WSAGC+ AEL G+PLFPG + DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
+ V ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 7e-90
Identities = 96/320 (30%), Positives = 159/320 (49%), Gaps = 41/320 (12%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 96
+G G++ V++ TG VA+K+V + + RE+ LM+ + H N++ L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAY 154
+ L LV E++ + + + + N + + L VK + +Q+ +GLA+
Sbjct: 69 YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 211
H ++ HRDLKPQNLL++ Q+K+ DFG A+ G ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G+ Y+TSIDIWS GC+LAE++ G+PLFPG N +QL I ++GTP E + P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235
Query: 272 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
T Q +V + +D LLQ +P +R +A +A HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 323 FFDELREPNARLPNGRPLPP 342
+F E A + R
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 3e-89
Identities = 107/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y VG+G++G V A +TG VA+KK+ + R Y REL+L++ M H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 92 NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI L F S E + LV + + ++K Q++ +V+ YQI R
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL YIH+ + HRDLKP NL V+ ++KI DFG A+ + Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPE 199
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 269
++ Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 270 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ ++ Q+ + VF P A+DL ++L R TA +A AH +F +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318
Query: 328 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
+P+ P+ ++ E + L
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 4e-89
Identities = 99/337 (29%), Positives = 163/337 (48%), Gaps = 39/337 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ R Y REL LM+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 92 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQI 148
N+I L + F S E + +VME + ++ +V+ +M L + YQ+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------QMELDHERMSYLLYQM 136
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRA
Sbjct: 137 LCGIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE+I G Y ++DIWS GC++ E++ G LFPG + +DQ ++I+ LGTP E ++ +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 269 NPNYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTA 315
P + P+ + + K+F + +A DL S++L S R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 316 LEACAHPFFDELREPNARLPNGRPLPPLFNF-KQELS 351
EA HP+ + +P+ P P ++E +
Sbjct: 314 DEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-88
Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 31/300 (10%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRVMDHPNV 93
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L ++ + E+ + LV E+V + + L + +P +K Q RGL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPE 210
++H + HRDLKP+N+LV VK+ DFG A+ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVVVTLWYRAPE 189
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ +T Y T +D+WS GC+ AE+ +PLF G + DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 271 NYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
FP P V M L +L ++P R +A A H + +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-88
Identities = 99/325 (30%), Positives = 157/325 (48%), Gaps = 34/325 (10%)
Query: 46 VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRVMDHPNVI 94
+G G++G VF+A+ G VA+K+V + RE L+ + +HPNV+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L + + E L LV E+V + + L +P +K +Q+ RGL +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 211
+H+ RV HRDLKPQN+LV + Q+K+ DFG A+ ++ + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 190
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ ++ Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ P
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245
Query: 272 YT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
Query: 329 EPNARLPNGRPLPPLFNFKQELSGA 353
L P EL+ A
Sbjct: 305 RCKENLD---SHLPPSQNTSELNTA 326
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 2e-88
Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 79/382 (20%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHP 91
Y ++GTGS+G V +A VAIKK+L+ R RE+ ++ ++H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+V+ + + L +V+E ++ + + +++K Y + G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVG 168
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------------ 199
+ Y+H+ + HRDLKP N LV+ VK+CDFG A+ + E S
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 200 ----------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 236
++ +R+YRAPELI YT +ID+WS GC+ AELL
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 237 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 271
PLFPG + DQL I +LGTP+ E+I + +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 272 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ FP+ + + F +AI L R+L ++P+ R T E AHPFF E+R
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405
Query: 330 PNARLPNGRPLPPLFNFKQELS 351
+ FN +
Sbjct: 406 AEVETNATEKVRLPFNDWMNMD 427
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 272 bits (696), Expect = 9e-88
Identities = 96/332 (28%), Positives = 166/332 (50%), Gaps = 36/332 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 91
Y + +G+G+ GIV A VAIKK+ + R Y REL LM+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 92 NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+ISL + F + E + LVME + ++ +V++ + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
G+ ++H+ + HRDLKP N++V +KI DFG A+ Y+ +R+YRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 271 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 317
++ P+ + K+F +K +A DL S++L P+ R + +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 318 ACAHPFFDELREPNARLPNGRPLPPLFNFKQE 349
A HP+ + +P P P +++ + +
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLD 381
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-86
Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 36/320 (11%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 95
+G G+FG VF+A+ +TG+ VA+KKV +N RE+++++++ H NV++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80
Query: 96 LK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRG 151
L S ++ + + LV ++ L S+ + L +K + G
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANISY---ICSRFY 206
L YIH ++ HRD+K N+L+ +K+ DFG A+ L Y + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 263
R PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
+ Y + + P A+DL +LL P+ R + +A H
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 323 FFDELREPNARLPNGRPLPP 342
FF +P G
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 3e-86
Identities = 91/361 (25%), Positives = 171/361 (47%), Gaps = 61/361 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRVM-DH 90
Y + +G G++GIV+++ TGE VA+KK+ Q+ R + RE+ ++ + H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N+++L + + + +++L V +Y+ ++ V++ + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----------- 199
+ Y+H+ + HRD+KP N+L++ VK+ DFG ++ + +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 200 -----------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
Y+ +R+YRAPE++ G+T+YT ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 249 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 294
QL II V+ P+ E++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 295 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 350
EA+DL +LLQ++P+ R +A +A HPF PN + N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
Query: 351 S 351
S
Sbjct: 359 S 359
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 3e-85
Identities = 98/376 (26%), Positives = 164/376 (43%), Gaps = 75/376 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRVMDHP 91
Y+ + ++G GS+G V+ A T + VAIKKV L D R RE+ ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 92 NVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+I L +EL++ V+E + ++ K + ++K Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIKTILYNLL 139
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 199
G +IH + HRDLKP N L++ VK+CDFG A+ + + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 200 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-------- 238
++ +R+YRAPELI YT SIDIWS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 239 ---PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF-- 275
PLFPG ++ DQL I ++GTPT ++++ + P +
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335
FP K + + + + I+L +L+++P+ R T +A HP+ ++R+
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376
Query: 336 NGRPLPPLFNFKQELS 351
+ + + F+ LS
Sbjct: 377 STKKIILPFDDWMVLS 392
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 2e-81
Identities = 94/345 (27%), Positives = 157/345 (45%), Gaps = 40/345 (11%)
Query: 46 VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 101
VG G++G V++AK + + A+K++ + RE+ L+R + HPNVISL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIH 156
S + + L+ +Y ++ ++K + ++ ++P VK YQI G+ Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 157 TVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSR----FYRAP 209
V HRDLKP N+LV +VKI D G A+ + ++ + +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 260
EL+ GA YT +IDIW+ GC+ AELL +P+F DQL I V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 261 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 311
+ E + ++ + + + + +A L +LL P
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 312 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 356
R T+ +A P+F E +P + ++ L+ P+
Sbjct: 325 RITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 6e-66
Identities = 97/339 (28%), Positives = 160/339 (47%), Gaps = 54/339 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 90
Y +V+G GSFG V +A + + VA+K V ++R+ E++++ + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
NVI + F T +N + + E + ++Y ++K + Q L V+ + + I +
Sbjct: 159 MNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQ 211
Query: 151 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
L +H R+ H DLKP+N LL +K+ DFGS+ + +YI SRFYRAP
Sbjct: 212 CLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--- 266
E+I GA Y ID+WS GC+LAELL G PL PGE+ DQL +I++LG P+++ +
Sbjct: 269 EVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 267 --------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA----ID 299
P Y R +++ P + + + +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 300 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 338
+ L++ P++R T +A HP+ R + P G
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-65
Identities = 87/339 (25%), Positives = 146/339 (43%), Gaps = 42/339 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 91
Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 92 NVISLKHC-----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + H F+ N + + +V E + E++ ++K Y ++ +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYI 201
Q+ GL Y+H + H D+KP+N+L++ + +KI D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSI 196
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 255
+R YR+PE++ GA + DIWS C++ EL+ G LF + D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 256 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 302
+LG +R N ++K P V ++ E D S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315
Query: 303 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 341
+LQ P R A HP+ + R L
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-65
Identities = 96/333 (28%), Positives = 150/333 (45%), Gaps = 56/333 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 90
Y + ++G GSFG V +A E VAIK + + + N E++L+ +M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ LK F +N L L V E + ++Y +L++ + + + L + + Q+
Sbjct: 116 YYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCT 168
Query: 151 GLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 208
L ++ T + H DLKP+N LL +P +KI DFGS+ Q G+ YI SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRS 226
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-- 266
PE++ G Y +ID+WS GC+L E+ G+PLF G N VDQ+ +I++VLG P +
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 267 ---------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA------------ 297
+ + + K P + H + P
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 298 ----IDLASRLLQYSPSLRCTALEACAHPFFDE 326
DL R+L Y P R A H FF +
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-63
Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 54/334 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 89
Y +G G+FG V + + G VA+K V RY E+Q++ +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + F + + V E + S Y +K L +++ YQI
Sbjct: 76 TFRCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQIC 128
Query: 150 RGLAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQL 191
+ + ++H+ ++ H DLKP+N L V + +K+ DFGSA
Sbjct: 129 KSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E + + + +R YRAPE+I ++ D+WS GC+L E LG +FP ++ + L
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 252 EIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP-------------E 296
+ ++LG + I+ Y R + + + P
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304
Query: 297 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
DL ++L+Y P+ R T EA HPFFD L++
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 75/335 (22%), Positives = 135/335 (40%), Gaps = 60/335 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 91
++ R +G G+FG V + ++ + A+K V ++Y E +++ + ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
N++ F + + L + E + S+Y ++ + + +KLY +I +
Sbjct: 97 NIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKA 149
Query: 152 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICDFGS 187
L Y+ + + H DLKP+N LL DP +K+ DFG
Sbjct: 150 LNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
A + + S I +R YRAPE+I + S D+WS GCVLAEL G LF +
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 248 DQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA- 297
+ L + ++ + + +N + +P+ + K+ P
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 298 -------IDLASRLLQYSPSLRCTALEACAHPFFD 325
D +LQ P+LR + E H F +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-62
Identities = 77/343 (22%), Positives = 130/343 (37%), Gaps = 54/343 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 89
Y +G G+FG V + G VA+K + +Y+ E+ +++ + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+ + F + + E + ++ + LK + Q PL +V+ YQ+
Sbjct: 81 KFLCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLC 133
Query: 150 RGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQL 191
L ++H ++ H DLKP+N L V+ +++ DFGSA
Sbjct: 134 HALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190
Query: 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
E + + + +R YR PE+I + D+WS GC+L E G LF + LV
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 252 EIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA----- 297
+ K+LG I + + K M ++
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309
Query: 298 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 339
DL R+L++ P+ R T EA HPFF L R
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 92
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 93 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+I L + ++ +VME + LK + + K Y +
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 209 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 257
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281
Query: 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
+PN+ FP I + D+ L+ P R + E
Sbjct: 282 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 317
Query: 318 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 377
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 318 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-58
Identities = 74/348 (21%), Positives = 124/348 (35%), Gaps = 67/348 (19%)
Query: 17 HVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAIKKV 71
H H S G Q++S Y + +G+G VFQ E + AIK V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 72 ----LQDRRYKN--RELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPESMY 123
++ + E+ + + + +I L + ++ +VME +
Sbjct: 61 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLN 115
Query: 124 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183
LK + + K Y + + IH + H DLKP N L+ +K+
Sbjct: 116 SWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLI 168
Query: 184 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCV 230
DFG A Q+ ++ S + + Y PE I ++ + D+WS GC+
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 231 LAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF 289
L + G+ F N + +L II +PN+ FP I
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAII--------------DPNHE-IEFPDI--------- 264
Query: 290 HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 337
+ D+ L+ P R + E AHP+ P ++ G
Sbjct: 265 ---PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-58
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 92
Y + +G+G VFQ E + AIK V + E+ + + +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 93 -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+I L + ++ +VME + LK + + K Y +
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 208
+ IH + H DLKP N L+ +K+ DFG A Q+ ++ S + + Y
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 209 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 257
PE I ++ + D+WS GC+L + G+ F N + +L II
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234
Query: 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
+PN+ FP I + D+ L+ P R + E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270
Query: 318 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 377
AHP+ P ++ G + Q + SP + K + G +
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-56
Identities = 71/341 (20%), Positives = 115/341 (33%), Gaps = 55/341 (16%)
Query: 14 GSDHVTGHIISTTIGGKNGEPKQTIS-----YMAERVVGTGSFGIVFQAKCLETGETVAI 68
GS H H S + Y+ + +G G F V + L G A+
Sbjct: 2 GSSHHHHHHSSGREN--LYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 69 KKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF-STTSKNELFLNLVMEYVPE-SM 122
K++L QDR RE + R+ +HPN++ L +K+E + L++ + ++
Sbjct: 60 KRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTL 117
Query: 123 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
+ ++ + + I RGL IH HRDLKP N+L+ Q +
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVL 175
Query: 183 CDFGSAK----------QLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCV 230
D GS Q + + + C+ YRAPEL D+WS GCV
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 231 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 290
L ++ G+ + V + V PQ
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALA-VQN---------------QLSIPQ----------S 269
Query: 291 KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
R L + ++ P R + + P
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-56
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 52/299 (17%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRVMDHP 91
S+ +G GS+G VF+ + E G A+K+ + +DR K E+ +V HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ L+ + L L E S+ + + + +P V Y
Sbjct: 118 CCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 211
LA++H+ + H D+KP N+ + P + K+ DFG +L A Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ Y T+ D++S G + E+ L G QL +
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
F + E + +L+ P LR TA A P R+P
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-55
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 45/299 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 68 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 153 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 207
H V HRDLKP N+ +D VK+ DFG A+ L + + +Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
+PE + Y DIWS GC+L EL P F + +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
+ +F +I R E ++ +R+L R + E +P E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-54
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 51/301 (16%)
Query: 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVIS 95
IS+ + V+G G+ G + + + VA+K++L + + +RE+QL+R D HPNVI
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
K+ F + +E ++ V + + P+ ++ Q GLA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 155 IHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY---IC-SRFY 206
+H++ + HRDLKP N+L+ + I DFG K+L G + S + + +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 207 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263
APE++ + T ++DI+SAGCV ++ G F +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+ + P K A +L +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 324 F 324
F
Sbjct: 287 F 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 182 bits (462), Expect = 3e-54
Identities = 44/333 (13%), Positives = 90/333 (27%), Gaps = 57/333 (17%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHP 91
+ G +VF + +E E A+K + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 92 NVISLKHCFFSTTSKNELFLN---------------------LVMEYVP---ESMYRVLK 127
+ + + + + L+M E ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 128 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187
++ + + T Q+ R A + + + H P NL + P ++ + D +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240
Query: 188 AKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
+ G + Y E + +T +++ W G + + F
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
+ L P + +P L R L
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338
Query: 307 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 338
+ R LEA P F +L+ E ++ L G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-54
Identities = 57/301 (18%), Positives = 119/301 (39%), Gaps = 21/301 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L TT+++ L+ME+ P S+Y VL+ S+A +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMN 126
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
++ + HR++KP N++ K+ DFG+A++L E +S + Y P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 211 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
+ A +Y ++D+WS G G F + E++ + T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+ P + + + + +L+ + A
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 324 F 324
Sbjct: 306 D 306
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-54
Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 59/312 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 96
+ V+G G+FG V +A+ AIKK+ + E+ L+ ++H V+
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 97 KHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ T K + L + MEY ++Y ++ + QR Q
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR--- 204
I L+YIH+ + HRDLKP N+ +D + VKI DFG AK + +
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 205 ------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
Y A E++ G Y ID++S G + E++ P G V
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236
Query: 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 312
I+K L + FP P F + L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275
Query: 313 CTALEACAHPFF 324
A +
Sbjct: 276 PGARTLLNSGWL 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-52
Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 44/294 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ E+ +G G F V++A CL G VA+KKV + R +E+ L++ ++HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
VI F LN+V+E + R++KH+ + +P V Y Q+
Sbjct: 94 VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPE 210
L ++H+ RV HRD+KP N+ + T VK+ D G + + S + + +Y +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 269
I Y DIWS GC+L E+ Q F G+ + L + I +C
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+P + + E L + + P R
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-52
Identities = 83/323 (25%), Positives = 137/323 (42%), Gaps = 60/323 (18%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-VM 88
N E ++E+++G GS G V + G VA+K++L D E++L+
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESD 66
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYVKLYT 145
DHPNVI +C +T + FL + +E ++ V +
Sbjct: 67 DHPNVIRY-YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAKQLIA 193
QI G+A++H++ ++ HRDLKPQN+LV ++ I DFG K+L +
Sbjct: 122 RQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 194 GEANISYICSRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLF 241
G+++ + +RAPEL+ + T SIDI+S GCV +L G+ F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA 301
+ + II+ F ++K + EA DL
Sbjct: 241 GDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLI 276
Query: 302 SRLLQYSPSLRCTALEACAHPFF 324
S+++ + P R TA++ HP F
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-52
Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 50/297 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 99
+ ++G+G FG VF+AK G+T IK+V + RE++ + +DH N++ C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 100 F-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ +++ L + ME+ + ++ + ++ +++ + Q
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207
I +G+ YIH+ ++ +RDLKP N+ + T QVKI DFG L + Y
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
+PE I +Y +D+++ G +LAELL ++
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + L +LL P R E
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-52
Identities = 77/325 (23%), Positives = 127/325 (39%), Gaps = 50/325 (15%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 85
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 144
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 70 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 120
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 203
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 121 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 179 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 230
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
++ P + P A L ++LQ P+ R T E F
Sbjct: 231 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 324 FDELREPNARLPNGRPLPPLFNFKQ 348
F P +PP F+
Sbjct: 269 FTSGYIPARLPITCLTIPPRFSIAP 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-51
Identities = 69/318 (21%), Positives = 120/318 (37%), Gaps = 47/318 (14%)
Query: 21 HIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQ 73
H S G Q++ Y+ + +G GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 74 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSA 132
+R RE+ ++ M HPN++ + F S L +VM+Y +++ +
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK-- 118
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ + QI L ++H ++ HRD+K QN+ + V++ DFG A+ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLN 176
Query: 193 AGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
+ + +Y +PE+ Y DIW+ GCVL EL + F + + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 311
I ++ +Y + L S+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 312 RCTALEACAHPFFDELRE 329
R + F + E
Sbjct: 268 RPSVNSILEKGFIAKRIE 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 67/313 (21%), Positives = 116/313 (37%), Gaps = 48/313 (15%)
Query: 20 GHIISTTIGGKNGEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRY 77
G +++ + + E ++ + + VG GSFG V + K +TG A+KKV L+ +
Sbjct: 39 GVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--F 96
Query: 78 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRM 136
+ EL + P ++ L +N+ ME + S+ +++K +
Sbjct: 97 RVEELVACAGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMG----CL 147
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
P Y Q GL Y+HT R+ H D+K N+L+ + +CDFG A L
Sbjct: 148 PEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 197 NISYICSR------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250
S + + APE++ G +DIWS+ C++ +L G +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265
Query: 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 310
++I P +I P L+ P
Sbjct: 266 LKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPV 299
Query: 311 LRCTALEACAHPF 323
R +A+E
Sbjct: 300 HRASAMELRRKVG 312
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 50/304 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 99
V+G G++GIV+ + L +AIK++ +D RY E+ L + + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ + S+N F+ + ME VP S+ +L+ + I YT QI GL Y+H
Sbjct: 84 YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGAT 216
++ HRD+K N+L++ + +KI DFG++K+L ++ + Y APE+I
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 217 E-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y + DIWS GC + E+ G+P F +L E + F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236
Query: 276 RFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+ K HP +P EA + + P R A + F +
Sbjct: 237 KVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289
Query: 332 ARLP 335
P
Sbjct: 290 KTQP 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-51
Identities = 77/326 (23%), Positives = 127/326 (38%), Gaps = 50/326 (15%)
Query: 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLM 85
+P+ Y+ R +G G F F+ +T E A K +L + E+ +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLY 144
R + H +V+ F + +F +V+E S+ + K + + + Y
Sbjct: 96 RSLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYY 146
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-S 203
QI G Y+H RV HRDLK NL ++ +VKI DFG A ++ +C +
Sbjct: 147 LRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGT 204
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y APE++ ++ +D+WS GC++ LL+G+P F + + I K
Sbjct: 205 PNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------- 256
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
++ P + P A L ++LQ P+ R T E F
Sbjct: 257 ----------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 324 FDELREPNARLPNGRPLPPLFNFKQE 349
F P +PP F+
Sbjct: 295 FTSGYIPARLPITCLTIPPRFSIAPS 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-50
Identities = 64/318 (20%), Positives = 120/318 (37%), Gaps = 60/318 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 94
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 95 SLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 146
+ + S +++L + M+ E++ + + +R
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 204
QI + ++H+ + HRDLKP N+ VK+ DFG + E + +
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 205 -----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
Y +PE I G Y+ +DI+S G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
++ + +FP + + P + +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 314 TALEACAHPFFDELREPN 331
A+ + F++L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-50
Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 50/303 (16%)
Query: 32 GEPKQTIS-YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQ 83
+ I + ++G GSF V++A+ + TG VAIK K + E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK 142
+ + HP+++ L + F N ++ LV+E M R LK + + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLK---NRVKPFSENEAR 115
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ +QI G+ Y+H+ + HRDL NLL+ +KI DFG A QL +C
Sbjct: 116 HFMHQIITGMLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ Y +PE+ + + D+WS GC+ LL+G+P F + + L +++
Sbjct: 174 GTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----- 227
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
D+ P + + EA DL +LL+ +P+ R + H
Sbjct: 228 ------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 322 PFF 324
PF
Sbjct: 264 PFM 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-50
Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
R +G G FG V+ A+ ++ +A+K ++ + RE+++ + HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F ++ L++EY P ++YR L+ + Y ++ L+Y
Sbjct: 75 YGYFH---DATRVY--LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H+ RV HRD+KP+NLL+ ++KI DFG + + +C + Y PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+ +D+WS G + E L+G+P F + I +V +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334
F FP + + A DL SRLL+++PS R E HP+ +
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271
Query: 335 PN 336
N
Sbjct: 272 QN 273
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 53/307 (17%), Positives = 117/307 (38%), Gaps = 28/307 (9%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
++ ++G G+ VF+ + +TG+ AIK L+ + RE ++++ ++H N++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L TT+++ L+ME+ P + + ++ +P + + G+
Sbjct: 71 KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
++ + HR++KP N++ K+ DFG+A++L E +S + Y P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 210 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262
++ A +Y ++D+WS G G F + E++ + T
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
+ P + + + + +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ----- 299
Query: 323 FFDELRE 329
FF E +
Sbjct: 300 FFAETSD 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-50
Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 98
+G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ ST + + LV E + ++ LK + + M + ++ + QI +GL ++HT
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 158 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
+Y S+D+++ G + E+ + + Q+ + T
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
PE ++ ++ + R + + H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-49
Identities = 78/341 (22%), Positives = 135/341 (39%), Gaps = 55/341 (16%)
Query: 23 ISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD 74
+ T G K +S Y + +G+G++G V + T AIK +
Sbjct: 20 LQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS 79
Query: 75 RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYS 130
E+ +++++DHPN++ L F +++ LVME E ++ ++
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 131 SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA 188
+ Q+ G+ Y+H + HRDLKP+NLL++ +KI DFG +
Sbjct: 135 EV-------DAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
Query: 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
+ + + +Y APE++ +Y D+WS G +L LL G P F G+ D
Sbjct: 187 AVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--D 242
Query: 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 308
Q EI+ ++ + W V A DL ++LQ+
Sbjct: 243 Q--EIL--------RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFD 279
Query: 309 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF-NFKQ 348
R +A +A HP+ E+ L N ++
Sbjct: 280 SQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 87/322 (27%), Positives = 138/322 (42%), Gaps = 53/322 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
Y +RV+G GSFG V K TG+ A+K + D+ RE+QL++ +DHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQI 148
++ L F +++ + LV E E ++ +S Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 206
G+ Y+H ++ HRDLKP+NLL++ + ++I DFG + A + I + +Y
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
APE++ G Y D+WS G +L LL G P F G N D L ++ K
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
+ F W KV A DL ++L Y PS+R +A +A H +
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 327 LREPNARLPNGRPLPPLFNFKQ 348
+ + + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 82/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 93
Y ++G GSFG V + K T + A+K + +D RE++L++ +DHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L ++ +V E E ++K +S Q+F
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 207
G+ Y+H + HRDLKP+N+L++ +KI DFG + I + +Y
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
APE++ G Y D+WSAG +L LL G P F G+N D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ F W + +A DL ++L + PSLR TA + HP+ +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 328 REPNARLPNGRPLPPLF-NFKQ 348
+ + L N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 62/328 (18%), Positives = 127/328 (38%), Gaps = 52/328 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN----------------REL 82
R + G F + + + + A+K + + R + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMP 137
Q++ + + ++ + T+ +E+++ + EY+ + + +P
Sbjct: 95 QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 138 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197
+ +K + +YIH +CHRD+KP N+L+D +VK+ DFG ++ ++ +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIK 208
Query: 198 ISYIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
S + + PE + Y +DIWS G L + F + ++ +L I+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315
+ I P + F + + + E ID L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 316 LEACAHPFF-----DELREPNARLPNGR 338
+A H + ++LRE + L R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 83/308 (26%), Positives = 130/308 (42%), Gaps = 54/308 (17%)
Query: 32 GEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM 85
G K I+ Y E +G GS+G V A T A K ++D +E+++M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 141
+ +DHPN+I L F ++ + LVME E RV+ + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANIS 199
+ +AY H + V HRDLKP+N L + +K+ DFG A + G+ +
Sbjct: 109 ARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMR 166
Query: 200 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258
+ +Y +P+++ G Y D WSAG ++ LL G P F + +++I +
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG-- 222
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318
F FP W V P+A L RLL SP R T+L+A
Sbjct: 223 ---------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQA 259
Query: 319 CAHPFFDE 326
H +F++
Sbjct: 260 LEHEWFEK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 76/323 (23%), Positives = 129/323 (39%), Gaps = 58/323 (17%)
Query: 21 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ 73
H + G +N + TI ++ +R +G+G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 74 DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRV 125
E+++++ +DHPN+I + F ++ + +VME S
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 126 LKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKIC 183
K S YV Q+ LAY H+ V H+DLKP+N+L + +KI
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKII 169
Query: 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
DFG A+ + E + + + Y APE+ + T DIWSAG V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 303
+ + + + + + P+A+DL +
Sbjct: 228 TSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQ 261
Query: 304 LLQYSPSLRCTALEACAHPFFDE 326
+L P R +A + H +F +
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFKQ 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 4e-48
Identities = 79/317 (24%), Positives = 131/317 (41%), Gaps = 19/317 (5%)
Query: 28 GGKNGEPKQTI--SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----R 80
GG++ + + +GTG FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPL 138
E+Q+M+ ++HPNV+S + L L MEY + + L + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKE 120
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEA 196
++ I L Y+H R+ HRDLKP+N+++ P + KI D G AK+L GE
Sbjct: 121 GPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
++ + Y APEL+ +YT ++D WS G + E + G F Q ++
Sbjct: 180 CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR- 237
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316
+ E I + +F + P H + + +L + R T
Sbjct: 238 --EKSNEHIVVYDDLTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDP 293
Query: 317 EACAHPFFDELREPNAR 333
+ F L +
Sbjct: 294 QNPNVGCFQALDSILSL 310
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-48
Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 63/332 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 82
Y R +G+G++G V K AIK + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPL 138
L++ +DHPN+I L F +++ + LV E+ E +++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 196
QI G+ Y+H + HRD+KP+N+L++ +KI DFG +
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ + +Y APE++ +Y D+WS G ++ LL G P F G+N DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316
+++ + + W + EA +L +L Y + RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 317 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 348
EA + + + L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-48
Identities = 76/342 (22%), Positives = 120/342 (35%), Gaps = 64/342 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVM-DHPNVI 94
RV+ G F V++A+ + +G A+K++L + R +E+ M+ + HPN++
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 95 SLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
S T + E L+ E + LK + + V YQ
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146
Query: 150 RGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------------E 195
R + ++H P + HRDLK +NLL+ +K+CDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 196 ANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
I+ + YR PE+I + DIW+ GC+L L Q F +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
R +N Y P H L +LQ +P R
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 314 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASP 355
+ E E+ P P+ L A+
Sbjct: 295 SIAEVVHQLQ--EIAAARNVNPK-SPITELLEQNGGYGSATL 333
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 7e-48
Identities = 78/348 (22%), Positives = 132/348 (37%), Gaps = 84/348 (24%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRVMDH 90
Y + +G GS+G+V A +T AIK + +D E++LM+ + H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL----- 143
PN+ L + ++E ++ LVME + ++ + + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 144 ------------------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173
QIF L Y+H +CHRD+KP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201
Query: 174 D-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTTSIDIWS 226
+ ++K+ DFG +K+ Y + ++ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 227 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 286
AG +L LL+G FPG N D + +++ F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 287 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334
+ P A DL S LL + R A+ A HP+ + + ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 52/323 (16%), Positives = 93/323 (28%), Gaps = 80/323 (24%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVM-DHPN 92
+ +G+G FG VF+ G AIK+ D + RE+ V+ H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
V+ + + + EY S+ + +K Q+ RG
Sbjct: 73 VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIA 193
L YIH+ + H D+KP N+ + KI D G ++
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
+ + A E++ + DI++ + +PL
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233
Query: 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 306
WH++ R+P E +L ++
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265
Query: 307 YSPSLRCTALEACAHPFFDELRE 329
P R +A+ H
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 96
R +G G FG V+ A+ + +A+K ++ ++ RE+++ + HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ +F + + L++E+ P +Y+ L+ + R + ++ L Y
Sbjct: 80 -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 214
H +V HRD+KP+NLL+ ++KI DFG + + C + Y PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+ +D+W AG + E L+G P F + + I+ V D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
+FP P+ + + DL S+LL+Y P R HP+
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 65/355 (18%), Positives = 112/355 (31%), Gaps = 83/355 (23%)
Query: 24 STTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVL 72
+ + GE +T + V+G +A ETGE+ + +
Sbjct: 61 PFRVESELGERPRT--LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118
Query: 73 QDRRYKNR---------------------ELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111
Q + R L++ +I ++ + FL
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 171
M+ ++ VL +SS ++ + T Q+ R LA +H + H L+P ++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDI 237
Query: 172 LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----------FGATEYTTS 221
++D V + F + A + SR + PEL T T S
Sbjct: 238 VLDQ-RGGVFLTGFEHLVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFS 293
Query: 222 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 281
D W+ G V+ + + A+ E I FR
Sbjct: 294 FDAWALGLVIYWIWCADLPITKDAALG------------GSEWI---------FRSC--- 329
Query: 282 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 335
K +P L L+Y R L+A P +++LR +A LP
Sbjct: 330 ---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 56/306 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 87
Y+ + +G+G+ G V A +T + VAI+ + + E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 145
++HP +I +K+ F + +V+E + E +V+ + +R+ KLY
Sbjct: 197 LNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC- 202
YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +C
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303
Query: 203 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360
Query: 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320
+ F W +V +A+DL +LL P R T EA
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 321 HPFFDE 326
HP+ +
Sbjct: 400 HPWLQD 405
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-47
Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 46/339 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 95
Y +G+G+FG+V + TG K D+ E+ +M + HP +I+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F K E+ L++E++ E R+ ++ V Y Q GL
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 154 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H + H D+KP+N++ VKI DFG A +L E + + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
D+W+ G + LL G F GE+ ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 332
D+ F + V PEA D LLQ P R T +A HP+ L+ ++
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPW---LKGDHS 313
Query: 333 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG 371
L + P +Q++ +
Sbjct: 314 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFS 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 60/333 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 87
Y+ + +G+G+ G V A +T + VAIK + + E+++++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKL 143
++HP +I +K+ FF +V+E + E +V+ A + L
Sbjct: 72 LNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 144 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 201
Y YQ+ + Y+H + HRDLKP+N+L+ +KI DFG +K L + +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 202 C-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258
C + Y APE++ Y ++D WS G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318
+ F W +V +A+DL +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 319 CAHPFFDELREPNARLPNGRPLPPLFNFKQELS 351
HP+ + Q L+
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-46
Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 54/320 (16%)
Query: 21 HIISTTIGGKNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQD 74
H + G +N + T + Y ++G GSFG V + K T + A+K ++
Sbjct: 3 HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62
Query: 75 RRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--H 128
+ RE++L++ +DHPN++ L ++ +V E E ++K
Sbjct: 63 KDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 129 YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 186
+S Q+F G+ Y+H + HRDLKP+N+L++ +KI DFG
Sbjct: 118 FSEH-------DAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
+ I + +Y APE++ G Y D+WSAG +L LL G P F G+N
Sbjct: 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 306
D L + + F W + +A DL ++L
Sbjct: 228 YDILKRVET-----------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLT 262
Query: 307 YSPSLRCTALEACAHPFFDE 326
+ PSLR TA + HP+ +
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-46
Identities = 78/323 (24%), Positives = 130/323 (40%), Gaps = 51/323 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRVMDHP 91
Y+ ++G GS+G V + ET A+K K+ + + +E+QL+R + H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
NVI L ++ K ++++ VMEY M +L +R P+ Y Q+ G
Sbjct: 67 NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRA 208
L Y+H+ + H+D+KP NLL+ +KI G + + S ++
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 209 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
PE+ G ++ +DIWSAG L + G F G+N + +L E I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ P P DL +L+Y P+ R + + H +F +
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
Query: 328 REPNARLPNGRPLPPLFNFKQEL 350
P P+PP + K
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 52/306 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 95
++ V+G+G+F VF K TG+ A+K E+ +++ + H N+++
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 151
L+ + S + LVM+ V E R+L+ Y+ + L Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSA 118
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 208
+ Y+H + HRDLKP+NLL ++ I DFG +K + +S C + Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVA 175
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE + Y+ ++D WS G + LL G P F E +I +
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328
+ F + W + A D LL+ P+ R T +A +HP+ D
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269
Query: 329 EPNARL 334
+ +
Sbjct: 270 ALHRDI 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 75/317 (23%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 18 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY 77
V H I + + + Y + +G GS+ + + T A+K + + +R
Sbjct: 4 VGVHSIVQQLHRNSIQFTDG--YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 78 KNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSA 132
E++++ R HPN+I+LK + + ++ +V E + E + ++L+ +S
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSER 116
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 189
+ I + + Y+H V HRDLKP N+L ++ICDFG AK
Sbjct: 117 EASA-------VLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 190 QLIAGEANISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248
QL A + C + + APE + Y + DIWS G +L +L G F
Sbjct: 169 QLRAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227
Query: 249 QLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 307
+ ++ G F W+ V A DL S++L
Sbjct: 228 PEEILARIGSG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHV 264
Query: 308 SPSLRCTALEACAHPFF 324
P R TA HP+
Sbjct: 265 DPHQRLTAALVLRHPWI 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 75/312 (24%), Positives = 122/312 (39%), Gaps = 58/312 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG+ A K + R RE+ ++R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPN+I+L F +K ++ L ++E V E + + + +
Sbjct: 67 HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+H+ R+ H DLKP+N+++ + ++K+ DFG A ++ AG I
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ + APE I D+WS G + LL G F GE + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
++ F + A D RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 322 PFFDELREPNAR 333
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-45
Identities = 76/345 (22%), Positives = 132/345 (38%), Gaps = 47/345 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
Y +GTG+FG+V + TG A K V D+ +E+Q M V+ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L F + ++ E++ E +V ++ ++ + Y++ Q+ +GL
Sbjct: 219 LHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269
Query: 154 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
++H H DLKP+N++ ++++K+ DFG L ++ + + APE+
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G D+WS G + LL G F GEN + T ++ + N
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 332
D F I + D +LL P+ R T +A HP+ L NA
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPW---LTPGNA 419
Query: 333 RLPNGR-PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 376
+ + P + + L P H
Sbjct: 420 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 50/301 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRVMDHPNVISL 96
YM +G G FGIV + + +T +K D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLIYVKLYTYQIFRG 151
F S EL ++ E++ + R+ + + Y +Q+
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114
Query: 152 LAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAP 209
L ++H+ + H D++P+N++ + +KI +FG A+QL G+ N + + Y AP
Sbjct: 115 LQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP 172
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E + +T+ D+WS G ++ LL G F E +Q +II E I
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAE 219
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ + F +I EA+D RLL R TA EA HP+ + E
Sbjct: 220 YTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
Query: 330 P 330
Sbjct: 267 R 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-45
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 45/319 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 101
++V+G G G V + TG+ A+K +L D +E+ + P+++ + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 102 STTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
+ L ++ME + R + ++ I + ++
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIMRDIGTAIQFL 144
Query: 156 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
H+ + HRD+KP+NLL +K+ DFG AK+ + C + +Y APE +
Sbjct: 145 HSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-V 200
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G +Y S D+WS G ++ LL G P F + + R Y
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY 250
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 331
F P W +V +A L LL+ P+ R T + HP+ + P
Sbjct: 251 -GFPNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
Query: 332 ARLPNGRPLPPLFNFKQEL 350
L R L + E+
Sbjct: 300 TPLHTARVLQEDKDHWDEV 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-45
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 93
Y + +G G+F +V + TG A K K L R ++ RE ++ R + HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L + E F LV + V E ++ YS A+ QI
Sbjct: 68 VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+AY H+ + HR+LKP+NLL+ VK+ DFG A ++ EA + Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
+PE + Y+ +DIW+ G +L LL+G P F E+ +I
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ +P + W V PEA L +L +P R TA +A P+
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-45
Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 64/311 (20%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 85
Y + ++G G +V + T + A+K +V + R +E+ L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 141
+V HPN+I LK + + F LV + + E + + S R
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + +H + + HRDLKP+N+L+D +K+ DFG + QL GE + +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183
Query: 202 C-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
C + Y APE+I + Y +D+WS G ++ LL G P F + L I+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315
+++F + W DL SR L P R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278
Query: 316 LEACAHPFFDE 326
EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-45
Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 59/327 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
H NVI+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
+ F + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 322 PFFDELREPNARLPNGRPLPPLFNFKQ 348
P+ + + + L NF++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRK 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-45
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 60/347 (17%)
Query: 21 HIISTTIGGKNGEPKQTIS---------YMAERVVGTGSFGIVFQAKCLETGETVAIK-- 69
H+ S T G + G + + Y + +G G+F +V + TG A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 70 --KVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMY 123
K L R ++ RE ++ R + HPN++ L + E F LV + V E
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFE 117
Query: 124 RVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQ 179
++ YS A+ QI +AY H+ + HR+LKP+NLL+
Sbjct: 118 DIVAREFYSEADAS-------HCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAA 169
Query: 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 239
VK+ DFG A ++ EA + + Y +PE + Y+ +DIW+ G +L LL+G P
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYP 228
Query: 240 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 299
F E+ +I + +P + W V PEA
Sbjct: 229 PFWDEDQHRLYAQIKAG-----------------AYDYP---SPEWDTV-----TPEAKS 263
Query: 300 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346
L +L +P R TA +A P+ + + + L F
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKF 310
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 52/320 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G+F +V + + G+ A + + RE ++ R++ HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 149
+ L E L+ + V E ++ +YS A QI
Sbjct: 73 VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120
Query: 150 RGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + H + V HR+LKP+NLL L VK+ DFG A ++ + + Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
+PE + Y +D+W+ G +L LL+G P F E+ +I
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
+ FP + W V PEA DL +++L +PS R TA EA HP+
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273
Query: 327 LREPNARLPNGRPLPPLFNF 346
+ + + L F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 60/335 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRVMDH 90
Y V+G G F +V + ETG+ A+K RE + ++ H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY----VKLY 144
P+++ L + ++ L +V E++ + + ++K + Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 145 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYI 201
QI L Y H + HRD+KP +L+ + + VK+ FG A QL
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 202 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ + APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245
Query: 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320
++ W + A DL R+L P+ R T EA
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286
Query: 321 HPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 353
HP+ E ++ + L FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-44
Identities = 77/330 (23%), Positives = 134/330 (40%), Gaps = 34/330 (10%)
Query: 26 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNR 80
T K GE K + +G G+ G+VF+ +G +A K + R R
Sbjct: 22 TQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLI 139
ELQ++ + P ++ F+S +++ ME++ S+ +VLK R+P
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQ 131
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
+ + + +GL Y+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-S 189
Query: 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
++ +R Y +PE + G Y+ DIWS G L E+ +G+ P +A + + +
Sbjct: 190 FVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVF---------------HKRMPPEAIDLASRL 304
E + + P +F E D ++
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308
Query: 305 LQYSPSLRCTALEACAHPFFDELREPNARL 334
L +P+ R + H F
Sbjct: 309 LIKNPAERADLKQLMVHAFIKRSDAEEVDF 338
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-44
Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F IV + + TG A K + R RE+ ++R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPN+I+L + ++ ++ L ++E V E + + S +
Sbjct: 74 HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+HT ++ H DLKP+N+++ + +K+ DFG A ++ G I
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ + APE I D+WS G + LL G F G+ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
+ F + + A D +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 322 PFFDELREPNARLPNGRPLPPLFNFKQ 348
P+ + + + L NFK+
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKK 299
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 73/327 (22%), Positives = 126/327 (38%), Gaps = 59/327 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 89
Y +G+G F +V + + TG A K + R RE+ +++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 145
HPNVI+L + +K ++ L ++E V E + + + +
Sbjct: 73 HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 202
QI G+ Y+H++ ++ H DLKP+N+++ + ++KI DFG A ++ G I
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 203 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ + APE I D+WS G + LL G F G+ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
NY +F + A D RLL P R T ++ H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 322 PFFDELREPNARLPNGRPLPPLFNFKQ 348
P+ ++ L + FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 6e-44
Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 98
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 99 CFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L +VME + R + ++ I +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKSIGEAI 174
Query: 153 AYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
Y+H++ + HRD+KP+NLL P +K+ DFG AK+ + + + + +Y AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E + G +Y S D+WS G ++ LL G P F + + + R
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RIRM 281
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 282 GQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-43
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G G++G+V + + + +G+ +A+K++ Q+++ +L MR +D P ++
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + + ME + S+ + K Q +P + I + L ++H+
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---A 215
V HRD+KP N+L++ QVK+CDFG + L+ A + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
Y+ DIWS G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
PQ+ A + E +D S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 63/308 (20%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 86
Y + V+G G +V + TG A+K ++ + R RE ++R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 142
V HP++I+L + S++ F+ LV + + E + + S R
Sbjct: 156 VAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 202
+ ++++H + HRDLKP+N+L+D Q+++ DFG + L GE + +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260
Query: 203 -SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
+ Y APE++ + + Y +D+W+ G +L LL G P F + L I++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316
++F + W DL SRLLQ P R TA
Sbjct: 321 -----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAE 355
Query: 317 EACAHPFF 324
+A HPFF
Sbjct: 356 QALQHPFF 363
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 24 STTIGGKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRY 77
T G + Y + +G+G+FG+ + T E VA+K + +
Sbjct: 5 PVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ 64
Query: 78 KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQR 135
RE+ R + HPN++ K + L ++MEY E L R
Sbjct: 65 --REIINHRSLRHPNIVRFKEVI---LTPTHLA--IIMEYASGGE-----LYERICNAGR 112
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAG 194
+ + Q+ G++Y H++ ++CHRDLK +N L+D ++KICDFG +K +
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 195 EANISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253
S + + Y APE++ EY D+WS G L +L+G F
Sbjct: 172 SQPKSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-------- 222
Query: 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
T + I + + P R+ PE L SR+ P+ R
Sbjct: 223 EPRDYRKTIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRI 267
Query: 314 TALEACAHPFF 324
+ E H +F
Sbjct: 268 SIPEIKTHSWF 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 80/318 (25%), Positives = 136/318 (42%), Gaps = 45/318 (14%)
Query: 27 IGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNREL 82
+ K G + ++G G FG V + + TG +A K + ++D+ E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY 140
+M +DH N+I L F SKN++ LVMEYV E R++ + + +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANIS 199
+K QI G+ ++H + + H DLKP+N+L V+ Q+KI DFG A++ E +
Sbjct: 193 MK----QICEGIRHMHQM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK 246
Query: 200 YIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258
+ + APE + + D+WS G + LL G F G+N + L I+
Sbjct: 247 VNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-- 303
Query: 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318
+ D + + EA + S+LL S R +A EA
Sbjct: 304 ------------RW-DLEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEA 340
Query: 319 CAHPFFDELREPNARLPN 336
HP+ + + +
Sbjct: 341 LKHPWLSDHKLHSRLSAQ 358
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 76/312 (24%), Positives = 128/312 (41%), Gaps = 44/312 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLM-RVMDHPNVISL 96
+ ++ +G GSF I + ++ + A+ K++ R N +E+ + HPN++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGL 152
F ++L LVME + E R+ K H+S ++ +
Sbjct: 72 HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119
Query: 153 AYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 209
+++H V V HRDLKP+NLL D + ++KI DFG A+ + C + Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E + Y S D+WS G +L +L GQ F + ++++ ++I+
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
DF F W V EA DL LL P+ R + + + +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 330 -PNARLPNGRPL 340
+ L L
Sbjct: 280 LSSNPLMTPDIL 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-43
Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 31 NGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR 86
+G + +S + E +G G+ IV++ K T + A+K + + K E+ ++
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 142
+ HPN+I LK F + E+ L V+E V E R+++ +YS +
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA------- 151
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISY 200
QI +AY+H + HRDLKP+NLL P +KI DFG +K + +
Sbjct: 152 DAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 201 IC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
+C + Y APE I Y +D+WS G + LL G F E + I
Sbjct: 210 VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL---- 264
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319
C ++ F + W +V A DL +L+ P R T +A
Sbjct: 265 ------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQAL 304
Query: 320 AHP 322
HP
Sbjct: 305 QHP 307
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 55/343 (16%), Positives = 101/343 (29%), Gaps = 84/343 (24%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 86
V+G +A ETGE+ + R + ++ M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 87 ---------------VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 131
+I ++ + FL M+ ++ VL +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
++ + T Q+ R LA +H + H L+P ++++D V + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV-- 259
Query: 192 IAGEANISYICSRFYRAPELI---------FGATEYTTSIDIWSAGCVLAELLLGQPLFP 242
G + +S R + PE T T + D W+ G + +
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDL 300
+ A+ +F K +P L
Sbjct: 319 DDAALGGS-----------------------------------EWIFRSCKNIPQPVRAL 343
Query: 301 ASRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPLPP 342
L+Y R L+A P +++LR +A LP +
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 52/297 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 209
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 210 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 267
EL+ E+ +D+WS G VL +L G+ P ++ + + +
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
PW K + + L ++L +PS R T + ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 84/330 (25%), Positives = 138/330 (41%), Gaps = 53/330 (16%)
Query: 26 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-N 79
+I E +Y + +G G+F V A+ + TG VAIK ++ K
Sbjct: 3 SIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF 62
Query: 80 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMP 137
RE+++M++++HPN++ L ++ L+ L+MEY E + Y A+ RM
Sbjct: 63 REVRIMKILNHPNIVKLFEVI---ETEKTLY--LIMEYASGGE-----VFDYLVAHGRMK 112
Query: 138 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 197
+ QI + Y H R+ HRDLK +NLL+D +KI DFG + + G
Sbjct: 113 EKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK- 169
Query: 198 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
+ C + Y APEL G +Y +D+WS G +L L+ G F G+N + +L E +
Sbjct: 170 LDAFCGAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL 227
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315
+R P + M + +L R L +P R T
Sbjct: 228 ----------------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTL 259
Query: 316 LEACAHPFFDELREPNARLPNGRPLPPLFN 345
+ + + E + P P + +
Sbjct: 260 EQIMKDRWINAGHEEDELKPFVEPELDISD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-42
Identities = 84/308 (27%), Positives = 121/308 (39%), Gaps = 54/308 (17%)
Query: 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 80
G K+ + Y+ +G G+FG V + TG VA+K K+ R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 138
E+Q +++ HP++I L ++ + F +VMEYV E L Y + R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEE 110
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 197
+ + QI + Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 168
Query: 198 ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
S C S Y APE+I G +DIWS G +L LL G F E+ V L + I+
Sbjct: 169 TS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR- 224
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316
F P + + L +LQ P R T
Sbjct: 225 ---------------GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIK 257
Query: 317 EACAHPFF 324
+ H +F
Sbjct: 258 DIREHEWF 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 50/313 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K + + +E+ + ++++H NV+
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
N +L +EY E L + MP + + +Q+ G+
Sbjct: 69 KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 209
Y+H + + HRD+KP+NLL+D +KI DFG A ++ +C + Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 210 ELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328
PW K + + L ++L +PS R T + ++++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 329 EPNARLPNGRPLP 341
+ A+ P
Sbjct: 270 KKGAKRPRVTSGG 282
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 56/311 (18%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 93
+ + +G G F +V Q TG+ A K + + RR ++ E+ ++ + P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
I+L + + +E+ L ++EY + + + S + V Q
Sbjct: 92 INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYIC-SR 204
I G+ Y+H + H DLKPQN+L+ + +KI DFG ++++ + I +
Sbjct: 140 ILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
Y APE I TT+ D+W+ G + LL F GE+ + + I +V
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248
Query: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + + V A D LL +P R TA +H +
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
Query: 325 DELREPNARLP 335
+ N P
Sbjct: 292 QQWDFENLFHP 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-41
Identities = 73/311 (23%), Positives = 112/311 (36%), Gaps = 58/311 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RVMDHPNVISLK 97
E V+G G+ V L T + A+K + R RE++++ + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 98 HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 153
F + E LV E + + + K H++ + + L
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSR---- 204
++H + HRDLKP+N+L H VKICDF +
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 205 ----FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256
Y APE++ A+ Y D+WS G +L LL G P F G D + +
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 257 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
E I+ + FP W + A DL S+LL R
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288
Query: 314 TALEACAHPFF 324
+A + HP+
Sbjct: 289 SAAQVLQHPWV 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-41
Identities = 78/329 (23%), Positives = 129/329 (39%), Gaps = 53/329 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
RV+G G FG VF + TG+ A KK+ + R K + Q V + ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F T + L LVM + + Y + + N YT QI GL +
Sbjct: 251 AYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H + +RDLKP+N+L+D + V+I D G A +L AG+ + + APEL+
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
G EY S+D ++ G L E++ + F +E+
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL-------- 401
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 328
++ + + P + D LLQ P R + HP F ++
Sbjct: 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI- 455
Query: 329 EPN-ARLPNGRPLPPLFNFKQELSGASPE 356
+ +L G PP + + + +
Sbjct: 456 --SWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-41
Identities = 70/332 (21%), Positives = 125/332 (37%), Gaps = 73/332 (21%)
Query: 28 GGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--- 79
G +G+ Q Y + +G GS+G+V A A+K K+++ +
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 80 ----------------------RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY 117
+E+ +++ +DHPNV+ L +++ L++ V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFEL 119
Query: 118 VP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175
V M + + + Y + +G+ Y+H ++ HRD+KP NLLV
Sbjct: 120 VNQGPVMEVP------TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE 172
Query: 176 LTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLA 232
+KI DFG + + +A +S + + APE + ++ ++D+W+ G L
Sbjct: 173 -DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 233 ELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 292
+ GQ F E + L IK FP
Sbjct: 232 CFVFGQCPFMDER-IMCLHSKIK----------------SQALEFPD----------QPD 264
Query: 293 MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ + DL +R+L +P R E HP+
Sbjct: 265 IAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-41
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 39/300 (13%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G G++G V + +G+ +A+K++ ++++ +L +MR D P ++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
F + ME + S + K+ YS + +P + T + L ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
++ HRD+KP N+L+D + +K+CDFG + QL+ A R Y APE I +
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 218 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
Y D+WS G L EL G+ +P N+V + + V G P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334
PQ+ + F P I+ + L S R E HPF E +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 76/299 (25%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 98
+ +V+G G G V Q T E A+K +LQD RE++L R P+++ +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 99 CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT--------YQI 148
+ L +VME + E R+ A +T I
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASEIMKSI 126
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICS 203
+ Y+H++ + HRD+KP+NLL T + +K+ DFG AK+ +
Sbjct: 127 GEAIQYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFGFAKETTGEK-------- 174
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y S D+WS G ++ LL G P F + + +
Sbjct: 175 --------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------- 212
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
R Y +F P W +V E L LL+ P+ R T E HP
Sbjct: 213 --RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 92
Y+ +G GSFG V A +T + VA+K + + + RE+ ++++ HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I L T+ ++ + V+EY ++ Y +RM + + QI +
Sbjct: 71 IIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRAPE 210
Y H ++ HRDLKP+NLL+D VKI DFG S S C S Y APE
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+ P + + P A L R++ P R T E P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 66/341 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 96
RV+G G FG V + TG+ A KK+ + R K + + ++ V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + T L LV+ + + + + Y P Y +I GL
Sbjct: 250 AYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+H R+ +RDLKP+N+L+D H ++I D G A + G+ + + Y APE++
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
YT S D W+ GC+L E++ GQ F REE+
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV--------- 397
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELRE 329
+K P + + +R P+A L S+LL P+ R +A E HP F +L
Sbjct: 398 --ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL-- 451
Query: 330 PN-ARLPNGRPLPP------------LFNFKQELSGASPEL 357
N RL G PP + + +Q + EL
Sbjct: 452 -NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 61/318 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 89
Y ++G+G FG V+ + VAIK ++ N E+ L++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 90 H--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
VI L F + L ++E L + + + + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + + H V HRD+K +N+L+D ++K+ DFGS L + +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214
Query: 207 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
PE I Y S +WS G +L +++ G F + EII+
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
F +R+ E L L PS R T E HP+
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
Query: 326 ELREPNARLP-NGRPLPP 342
++ P + L P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 64/304 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+++G GSF V A+ L T AIK ++++ Y RE +M +DHP + L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +++ L + Y E L Y + YT +I L Y
Sbjct: 96 YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRDLKP+N+L++ H ++I DFG+AK L + F Y +P
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSP 201
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
EL+ S D+W+ GC++ +L+ G P F N + + I
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII-------------- 245
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPF 323
++ FP ++ P+A DL +LL + R AHPF
Sbjct: 246 --KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
Query: 324 FDEL 327
F+ +
Sbjct: 292 FESV 295
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 58/302 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPN 92
R++G G FG V+ + +TG+ A+K L +R K ++ L L+ D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ + + F + ++L +++ + + Y + +H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
GL ++H V +RDLKP N+L+D H V+I D G A + + + + + Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ Y +S D +S GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 325
PE L LLQ + R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454
Query: 326 EL 327
L
Sbjct: 455 SL 456
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-39
Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 46/301 (15%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 98
+G+G+ G V++ + +TG +A+K++ ++ + +L +++ D P ++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
F + T + + ME + K +P + T I + L Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----FG 214
V HRD+KP N+L+D Q+K+CDFG + +L+ +A Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYT 273
+Y D+WS G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333
P + H + L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 334 L 334
+
Sbjct: 297 V 297
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-38
Identities = 88/309 (28%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 29 GKNGEPKQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--R 80
+ + + I Y+ +G G+FG V K TG VA+K K+ R
Sbjct: 6 KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPL 138
E+Q +++ HP++I L ++ +++F+ VMEYV E L Y N R+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDE 115
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEAN 197
+ QI G+ Y H V HRDLKP+N+L+D KI DFG S
Sbjct: 116 KESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLR 173
Query: 198 ISYIC-SRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255
S C S Y APE+I G Y +DIWS+G +L LL G F ++ V L + I
Sbjct: 174 TS--CGSPNYAAPEVISG-RLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC 229
Query: 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315
F P + + P I L +LQ P R T
Sbjct: 230 ----------------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATI 261
Query: 316 LEACAHPFF 324
+ H +F
Sbjct: 262 KDIREHEWF 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 58/297 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+++G G+FG V K TG A+K +L+ + E ++++ HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK+ F T + L VMEY E + + S + + Y +I L
Sbjct: 213 LKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H+ V +RDLK +NL++D H +KI DFG K+ I A + C + Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------M 363
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 324
+ RFP + + PEA L S LL+ P R A E H FF
Sbjct: 364 EEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 3e-38
Identities = 34/316 (10%), Positives = 92/316 (29%), Gaps = 66/316 (20%)
Query: 39 SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRVMD 89
++G G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+ +N L V E + + + ++ + MP V + +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLIAGEAN 197
+ + +H + H D+KP N ++ + + + D G + +
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 198 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 253
+ + ++ E++ + ID + + +L G + E + +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
+ R P + W++ FH +L
Sbjct: 299 FR--------------------RLPHL--DMWNEFFHV------------MLNIPDCHHL 324
Query: 314 TALEACAHPFFDELRE 329
+L+ ++
Sbjct: 325 PSLDLLRQKLKKVFQQ 340
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
E VVG G+FG+V +AK + VAIK++ + K EL+ + ++HPN++
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----L 66
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--T 157
+ + LVMEY S+Y VL H + + + Q +G+AY+H
Sbjct: 67 YGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ HRDLKP NLL+ +KICDFG+A + + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252
Y+ D++S G +L E++ + F +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 4e-38
Identities = 81/364 (22%), Positives = 136/364 (37%), Gaps = 84/364 (23%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVM-----DHP 91
Y R +G G F V+ + ++ + VA+K V Y E++L++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 92 N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
N V+ L F + N + +V E + + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLV----------------------------------- 173
+GL Y+HT R+ H D+KP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 174 -------------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 220
+ +VKI D G+A + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 221 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 267
DIWS C+ EL G LF + D + II++LG R+ I
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 321
++K +V ++ D +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 322 PFFD 325
P+ +
Sbjct: 393 PWLN 396
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 59/297 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 95
+++G G+FG V + TG A+K +L+ + E ++++ HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
LK+ F T + L VMEY E + + + + + Y +I L
Sbjct: 70 LKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H+ V +RD+K +NL++D H +KI DFG K+ I+ A + C + Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
+Y ++D W G V+ E++ G+ F ++ ++L E+I
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 324
+ RFP + + PEA L + LL+ P R A E H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 73/320 (22%), Positives = 113/320 (35%), Gaps = 62/320 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 89
Y ++G G FG VF L VAIK +VL + E+ L+ +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 90 ----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 145
HP VI L +F T LV+E + L Y + + + +
Sbjct: 93 AGGGHPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 204
Q+ + + H+ V HRD+K +N+L+D K+ DFGS L + +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202
Query: 205 FYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y PE I +Y +WS G +L +++ G F + EI++
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+ FP + P+ L R L PS R + E P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
Query: 324 FDELREPNARLPNGRPLPPL 343
E P+ PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 60/299 (20%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 87
Y +G+G+FG V+ A E + V +K KVL+D ++ E+ ++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
++H N+I + F +N+ F LVME + L + + R+ Q
Sbjct: 86 VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ + Y+ + HRD+K +N+++ +K+ DFGSA L G+ C + Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195
Query: 207 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
APE++ G Y +++WS G L L+ + F +L E ++
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P + E + L S LLQ P R T + P+
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 64/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ + +G G FG+VF+AK AIK++ R RE++ + ++HP ++
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 95 SLKH----------------------------------------------------CFFS 102
+
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 103 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 161
S +++L + M+ E++ + S R + + ++ QI + ++H+ +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185
Query: 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSRFYRA 208
HRDLKP N+ VK+ DFG + A + + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE I G Y+ +DI+S G +L ELL E ++++ ++R
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
+ +FP + + P+ + +L SP+ R A + + F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 54/298 (18%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
R +G GSFG V + +T + A+K K ++ R +ELQ+M+ ++HP +++L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +F +V++ + + Y + + N VKL+ ++ L Y
Sbjct: 81 WYS-FQDEED--MF--MVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF- 213
+ R+ HRD+KP N+L+D H V I DF A L + ++ Y APE+
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 214 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 270
Y+ ++D WS G ELL G+ + ++ ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 327
T +P E + L +LL+ +P R + L P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 30/219 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHP 91
E+ +G G FG+V + + ++ VAIK ++ RE+ +M ++HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
N++ + +VME+VP +Y L + I
Sbjct: 84 NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133
Query: 151 GLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANISYICSRF 205
G+ Y+ P + HRDL+ N+ + K+ DFG ++ + + + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 206 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 243
+ APE I E YT D +S +L +L G+ F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-37
Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 56/294 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 94
+++G GSFG VF A+ +T + AIK L+ + L +HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ F T L VMEY+ + MY + + L Y +I GL
Sbjct: 82 HMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
++H+ + +RDLK N+L+D H +KI DFG K+ + G+A + C + Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ G +Y S+D WS G +L E+L+GQ F G++ ++L I+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 324
+ +P + + EA DL +L P R HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 59/298 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GSFG V A+ ETG+ A+K + +D ++ +++ L +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF + + LF VME+V + M+ + K +R + Y +I L
Sbjct: 89 LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++H + +RDLK N+L+D H K+ DFG K+ I + C + Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y ++D W+ G +L E+L G F EN D L E I
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 324
+ +P + +A + + +P++R HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 59/297 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRVMDHPNVI 94
+V+G GSFG V A+ A+K VLQ K +E + L++ + HP ++
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L F T K L V++Y+ E Y + + + + Y +I L
Sbjct: 103 GLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
Y+H++ + +RDLKP+N+L+D H + + DFG K+ I + S C + Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ Y ++D W G VL E+L G P F N ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 324
+ + A L LLQ + R +E +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 67/314 (21%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISL 96
+V+G G+F V K +TG+ A+K + + K E+ V+ D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F +N L+ LVMEY + + S +R+P + Y +I +
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRD+KP N+L+D H +++ DFGS +L A S + Y +P
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV---AVGTPDYLSP 232
Query: 210 ELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
E++ G Y D W+ G E+ GQ F ++ + I
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI--------- 282
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACA 320
++ P + +P EA D RLL P R A +
Sbjct: 283 ----VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327
Query: 321 HPFF-----DELRE 329
HPFF D LR+
Sbjct: 328 HPFFFGLDWDGLRD 341
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 86 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 324
+P K M EA+ + L+ P R + H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRVMDHPNVISL 96
+V+G G+FG V K + A+K ++L+ + E ++ D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +++ L LVM+Y + + S R+P + Y ++ +
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
+H + HRD+KP N+L+D H +++ DFGS +L+ S + Y +P
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV---AVGTPDYISP 245
Query: 210 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E++ G Y D WS G + E+L G+ F E+ + + I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI----------- 293
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHP 322
MN F+FP + A DL RL+ S R + HP
Sbjct: 294 --MNHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHP 340
Query: 323 FF-----DELRE 329
FF D +R
Sbjct: 341 FFSGIDWDNIRN 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 69/304 (22%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRVMDHPN 92
RV+G G +G VFQ + + TG+ A+K ++++ + E ++ + HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++ L + F T K L L++EY+ E ++ + Y +I
Sbjct: 83 IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----- 205
L ++H + +RDLKP+N++++ H VK+ DFG K+ I F
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTFCGTIE 186
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y APE++ + + ++D WS G ++ ++L G P F GEN + ++ I + ++
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL 238
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 320
P + EA DL +LL+ + + R A E A
Sbjct: 239 ----------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 321 HPFF 324
HPFF
Sbjct: 277 HPFF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 50/305 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 91
Y + V+G+G+ +V A C E VAIK++ + + +E+Q M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI----YVKLYTY 146
N++S F K+EL+ LVM+ + S+ ++KH + + + +
Sbjct: 74 NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 204
++ GL Y+H HRD+K N+L+ V+I DFG + L A +I+ R
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDITRNKVRKT 185
Query: 205 -----FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319
N P ++ K K+ + S LQ P R TA E
Sbjct: 242 ---------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 320 AHPFF 324
H FF
Sbjct: 287 RHKFF 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVI 94
E ++G G FG V++A + G+ VA+K D +E +L ++ HPN+I
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+L+ N L LVME+ + RVL +R+P + + QI RG+
Sbjct: 70 ALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 154 YIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAGEANISYICSR 204
Y+H + + HRDLK N+L+ +KI DFG A+ +S +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GS+ V + +T A+K V ++ + ++ + +HP ++
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 75 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 324
F I + + +A + L P R + HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 6e-35
Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 59/298 (19%)
Query: 44 RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRVMDHPNVI 94
+V+G GSFG VF K + + A+K + R + + E ++ ++HP ++
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
L + F T K L L+++++ + R+ K VK Y ++ L
Sbjct: 90 KLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 211
++H++ + +RDLKP+N+L+D H +K+ DFG +K+ I E C + Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ +T S D WS G ++ E+L G F G++ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 324
PQ + PEA L L + +P+ R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G GSFG V +A+ G VA+K +++ + RE+ +M+ + HPN++
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 97 K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
T L + V EY+ S+YR+L H S A +++ Y + +G+ Y
Sbjct: 100 MGAV----TQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 155 IHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELI 212
+H P + HR+LK NLLVD + VK+CDFG ++ + + S + + APE++
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
D++S G +L EL Q +
Sbjct: 212 RD-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 62/304 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+V+G G+FG V + T + A+K ++++ + E +M + P V+ L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F +++ +L +VMEY+P + + ++ N +P + + YT ++ L
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 209
IH++ HRD+KP N+L+D H +K+ DFG+ ++ Y +P
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT---AVGTPDYISP 238
Query: 210 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
E++ G Y D WS G L E+L+G F ++ V T +I
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYSKI- 285
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPF 323
MN FP + EA +L L +R E H F
Sbjct: 286 -MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332
Query: 324 FDEL 327
F
Sbjct: 333 FKND 336
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
V+G GSFG V ++ T E A+K + +D ++ +++ L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L CF T + L VMEYV + MY + + R + Y +I GL
Sbjct: 407 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
++ + + +RDLK N+++D H +KI DFG K+ I C + Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y S+D W+ G +L E+L GQ F GE+ D+L + I +
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 559
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 324
+P K M EA+ + L+ P R + H FF
Sbjct: 560 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 95
RV+G GS+ V + +T A++ V ++ + ++ + +HP ++
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L C F T S+ L V+EYV + M+ + + +++P + + Y+ +I L
Sbjct: 118 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 212
Y+H + +RDLK N+L+D H +K+ D+G K+ + S C + Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G +Y S+D W+ G ++ E++ G+ F + D + T + +
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 324
F I + + +A + L P R C HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 56/338 (16%), Positives = 111/338 (32%), Gaps = 47/338 (13%)
Query: 47 GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
G V A+ TGE V ++++ + EL + ++ +HPN++ + F
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 101 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
+ L +V ++ S ++ + M + + + + L YIH +
Sbjct: 96 IADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--------GEANISYICSRFYRAPEL 211
HR +K ++L+ + +V + S +I+ + + + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 212 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--------------- 255
+ Y DI+S G EL G F A L+E +
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266
Query: 256 --VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 313
+ ++ + T +H+ P + LQ +P R
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326
Query: 314 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 351
+A H FF + LP L ++
Sbjct: 327 SASTLLNHSFFK-----QIKRRASEALPELLRPVTPIT 359
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 60/299 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
+ +GTGSFG V K E+G A+K KV++ + + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ F K+ L +VMEYV E + + R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H++ + +RDLKP+NLL+D + +++ DFG AK++ + +C + APE+I
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIIL 211
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y ++D W+ G ++ E+ G P F + Q+ E I
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 327
RFP + DL LLQ + R L + H +F
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 7e-34
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 74/306 (24%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 96
R +GTGSFG V + G A+K V++ + + N E ++ ++ HP +I +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F ++ + ++M+Y+ E + K +QR P K Y ++ L Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANISYICSRFY 206
+H+ + +RDLKP+N+L+D H +KI DFG AK + + Y
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD----------Y 169
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
APE++ Y SID WS G ++ E+L G F N + E I
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------- 216
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAH 321
+ RFP + DL SRL+ S R L + H
Sbjct: 217 -----NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259
Query: 322 PFFDEL 327
P+F E+
Sbjct: 260 PWFKEV 265
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 53/296 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I + C+ ++ + LVMEY S +L+ + + + + + T+ +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPE 210
AY+H+ + HRD+K N+L L+ VK+ DFGSA + AN S++ + ++ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVGTPYWMAPE 220
Query: 211 LIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
+I E Y +D+WS G EL +P NA+ L I +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------N 268
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
P +++ W + F + LQ P R T+ H F
Sbjct: 269 ES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 65/306 (21%)
Query: 44 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHP 91
+V+GTG++G VF + + +TG+ A+K + + + + L + P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+++L + F T +K L+L+++Y+ E + + +R V++Y +I
Sbjct: 120 FLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 205
L ++H + + +RD+K +N+L+D H V + DFG +K+ +A E F
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AYDFCGTI 224
Query: 206 -YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263
Y AP+++ G + ++D WS G ++ ELL G F + + EI
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------R 276
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEA 318
I ++ +PQ M A DL RLL P R A E
Sbjct: 277 RIL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319
Query: 319 CAHPFF 324
H FF
Sbjct: 320 KEHLFF 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 86
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
+PN+++ + +EL+ +VMEY+ S+ V+ M +
Sbjct: 73 ENKNPNIVNYLDSYL---VGDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 204
+ + L ++H+ +V HRD+K N+L+ + VK+ DFG Q+ ++ + + +
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ APE++ Y +DIWS G + E++ G+P + EN + L I GTP +
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238
Query: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+F D +R L+ R +A E H F
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 50/303 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G GSFG VF+ T + VAIK + + +E+ ++ D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ T L ++MEY+ S +L+ + + +I +GL
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLD 133
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYICSRFYRAPEL 211
Y+H+ + HRD+K N+L+ +VK+ DFG A QL + N +++ + F+ APE+
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEV 190
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
I + Y + DIWS G EL G+P + + L I K PT E
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG------- 241
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+ K + L PS R TA E H F +
Sbjct: 242 ------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281
Query: 332 ARL 334
+ L
Sbjct: 282 SYL 284
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
+ +G G +G V+ K GE VA+K + RE + +M H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
T S +L+L + +Y S+Y LK + A + L Y GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
T P + HRDLK +N+LV I D G A + I+ + + +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 205 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 235
Y PE++ + + D++S G +L E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-32
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-VMDHPNVIS 95
+ +VG G++G V++ + ++TG+ AIK + + +E+ +++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 96 LKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
F L LVME+ S+ ++K ++ + ++ +I RGL+
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAP 209
++H +V HRD+K QN+L LT +VK+ DFG + QL G N ++I + ++ AP
Sbjct: 144 HLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 198
Query: 210 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
E+I Y D+WS G E+ G P + + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325
NP P++K+ W K F L + S R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 326 ELREPNARLP 335
+
Sbjct: 292 DQPNERQVRI 301
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 22/211 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 96
+ G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
S L+ ++P S+Y VL + N + + + RG+A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 156 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
HT+ P + L +++++D +I + + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 215 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
S D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMR 86
G+P+ + +G GS GIV A+ +G VA+K + Q R E+ +MR
Sbjct: 40 QGDPRLL--LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR 97
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 145
H NV+ + + EL+ ++ME++ ++ ++ R+ +
Sbjct: 98 DYQHFNVVEMYKSYL---VGEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVC 147
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSR 204
+ + LAY+H V HRD+K ++L+ L +VK+ DFG Q+ S + +
Sbjct: 148 EAVLQALAYLHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264
++ APE+I + Y T +DIWS G ++ E++ G+P + ++ V + + P +
Sbjct: 206 YWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN 263
Query: 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+H V D R+L P R TA E HPF
Sbjct: 264 -----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
VG G +G V++ GE VA+K +D + RE L ++ H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
S S +L+L + Y S+Y L+ + + ++ I GLA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
P + HRDLK +N+LV Q I D G A + + +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 205 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 235
Y APE++ + +DIW+ G VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 47/292 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
+ +G GS+G V++A ETG+ VAIK+V + + +E+ +M+ D P+V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+F +L+ +VMEY S+ +++ N+ + + +GL Y+H
Sbjct: 91 GSYF---KNTDLW--IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 157 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 212
+ R HRD+K N+L L K+ DFG A QL + N + I + F+ APE+I
Sbjct: 143 FM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVI 197
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y DIWS G E+ G+P + + + + I PT +
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
W F D + L SP R TA + HPF
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKH 98
V+G G FG + ETGE + +K++++ +R +E+++MR ++HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71
Query: 99 CFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F K LN + EY+ ++ ++K S + + P + I G+AY+
Sbjct: 72 -FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 207
H++ + HRDL N LV V + DFG A+ ++ + + S
Sbjct: 125 HSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 208 -------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 251
APE+I G Y +D++S G VL E++ P
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 39/303 (12%)
Query: 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNV 93
++ V G FG V++A+ E VA+K QD++ E + + M H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 94 IS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFR 150
+ + T+ +L+L + + + S+ LK S N+ + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132
Query: 151 GLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANIS 199
GLAY+H P + HRD+K +N+L+ I DFG A + AG +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTH 191
Query: 200 YIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
+R Y APE++ GA + ID+++ G VL EL G L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 314
++ P+ E+++ + P ++ + W K M + + R +
Sbjct: 252 EIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEARLS 305
Query: 315 ALE 317
A
Sbjct: 306 AGC 308
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 98
+ +G G FG V++ K GE VA+K ++ R RE + ++ H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 156
+ +L+L V +Y S++ L Y+ + + L GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156
Query: 157 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 204
P + HRDLK +N+LV I D G A + + I + +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 205 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 235
Y APE++ + E DI++ G V E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-32
Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G+GSFG V++ K VA+K + E+ ++R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F ++ +L + V ++ S+Y L ++ + + + Q RG+ Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI 212
H + HRDLK N+ + + VKI DFG A + + + + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 213 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254
Y+ D+++ G VL EL+ GQ + N DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 52/298 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 95
+ +G G+FG V++AK ETG A K + ++ E++++ DHP ++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++ +L+ +++E+ P ++ ++ ++ + +++ Q+ L +
Sbjct: 81 LLGAYY---HDGKLW--IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNF 132
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPE 210
+H+ R+ HRDLK N+L +T +++ DFG + + + + + S+I + ++ APE
Sbjct: 133 LHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWMAPE 187
Query: 211 LIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
++ T Y DIWS G L E+ +P N + L++I K PT
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT-- 244
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
W F D L +P R +A + HPF
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFV 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 41/245 (16%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
++G G FG V+ + VAI+ + +R ++ RE+ R H NV+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 97 K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
C S L + + ++Y V++ A + + + +I +G+ Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YRA 208
+H + H+DLK +N+ D +V I DFG +A R + A
Sbjct: 146 LHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 209 PELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
PE+I + ++ D+++ G + EL + F + A II +GT
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTG 258
Query: 261 TREEI 265
+ +
Sbjct: 259 MKPNL 263
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-29
Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 48/306 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHC 99
++G G +G V++ VA+K +R+ E + RV M+H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT- 157
T+ + LVMEY P S+ + L ++S + + + RGLAY+HT
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130
Query: 158 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYI 201
P + HRDL +N+LV I DFG + +L A IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 202 CSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEI 253
+ Y APE++ GA +D+++ G + E+ + LFPGE+ + Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 254 IKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 310
+V PT E+++ R P+ W + + +
Sbjct: 250 TEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDAE 301
Query: 311 LRCTAL 316
R TA
Sbjct: 302 ARLTAQ 307
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 37/240 (15%)
Query: 21 HIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------ 74
H+I I + Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 75 ---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 131
+R++ RE+ + H N++S+ +++ + LVMEY+ L Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM----IDVDEEDDCYY-LVMEYIEG---PTLSEYIE 103
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
++ + + +T QI G+ + H + R+ HRD+KPQN+L+D +KI DFG AK
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAK-- 159
Query: 192 IAGEANISY----ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
E +++ + + Y +PE G + DI+S G VL E+L+G+P F GE AV
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 90
Y ++G G V A+ L VA+K VL+ R++ RE Q ++H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71
Query: 91 PNVISLKHCFFSTTSKNELFLN---LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
P ++++ + T +VMEYV L+ M
Sbjct: 72 PAIVAV----YDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIAD 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICS 203
+ L + H + HRD+KP N+++ T+ VK+ DFG A+ + +++ I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247
Y +PE G + S D++S GCVL E+L G+P F G++ V
Sbjct: 183 AQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 91
Y + + G G ++ A G V +K L E Q + + HP
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139
Query: 92 NVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
+++ + F T ++ + +VMEYV +S+ R Q++P+ Y +I
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSR 204
L+Y+H++ V + DLKP+N+++ Q+K+ D G+ ++ + G
Sbjct: 193 PALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-E 263
++APE++ T + DI++ G LA L L P G VD L E VL T
Sbjct: 243 -FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYG 298
Query: 264 EI--RCMNPNYTDFRFP 278
+ R ++P+ RF
Sbjct: 299 RLLRRAIDPDPRQ-RFT 314
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 26/219 (11%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRVMDHP 91
Y R+VG G G V++A+ VA+K ++ D ++ RE + + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+V+ + + L + M + L + QI
Sbjct: 95 HVVPI----HDFGEIDGQ-LYVDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 207
L H HRD+KP+N+LV + DFG A + + + + + +Y
Sbjct: 147 LDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246
APE + T DI++ CVL E L G P + G+
Sbjct: 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 30/210 (14%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+ +G G+FG V + TGE VA+KK LQ ++ RE+++++ + H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 74 VKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ T R HRDL +N+LV+ ++VKI DFG K L + + + F
Sbjct: 128 EYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIF 182
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + ++++ + D+WS G VL EL
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G FG V TGE VA+K + D ++ +E+ ++R + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I K C L LVMEYVP L+ Y + + L + L+ QI G+A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+H HRDL +N+L+D VKI DFG AK + Y R F+
Sbjct: 149 YLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFW 203
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 253
APE + + + D+WS G L ELL +L+ I
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRVMDHPNVI 94
+ +G G+FG V + TGE VA+KK + R RE+++++ + H N++
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
K ++ L+MEY+P Y L+ Y ++ R+ I + YT QI +G+
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 206
Y+ T R HRDL +N+LV+ ++VKI DFG K L + Y + F+
Sbjct: 160 YLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFW 214
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELL 235
APE + ++++ + D+WS G VL EL
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 43 ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G FG V + TGE VA+K + + + +E++++R + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGL 152
+ K T L+ME++P LK Y N ++ L Y QI +G+
Sbjct: 86 VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + + HRDL +N+LV+ HQVKI DFG K + E + Y + F
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVF 194
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + + + + D+WS G L ELL
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
R++G G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 94 ISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIF 149
L S +++ ++ ++ L L L + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-- 207
G+ Y+ + HRDL +N ++ V + DFG ++++ +G+ +YR
Sbjct: 148 CGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YYRQG 196
Query: 208 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L YT D+W+ G + E++ GQ + G
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 43 ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+G G+FG V + TG VA+K LQ RE+Q+++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ + + ++ L LVMEY+P L+ + ++ R+ + LY+ QI +G+
Sbjct: 87 VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 205
Y+ + R HRDL +N+LV+ VKI DFG AK L + Y R F
Sbjct: 141 EYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIF 195
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELL 235
+ APE + ++ D+WS G VL EL
Sbjct: 196 WYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 39/227 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
+++G G FG V + + VA+K + ++ E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 150
I L +S+ +++ ++ ++ L + + L + I
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 207
G+ Y+ HRDL +N ++ V + DFG +K++ +G+ +YR
Sbjct: 159 GMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYRQGR 207
Query: 208 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L YT+ D+W+ G + E+ G +PG
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 93
+V+G+G+FG V++ + GE VAIK + + E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L + + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 210 E-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E ++ YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPL 138
N+++L + L ++ EY + + + L
Sbjct: 88 NIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 139 IYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L + YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 197 NISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 253 IIK 255
+IK
Sbjct: 260 MIK 262
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 158
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 80 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 189
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++T D+WS G +L E+ G+ +P
Sbjct: 190 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
HR+L +N LV H VK+ DFG + +L+ G+ ++ ++F + APE +
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++ D+W+ G +L E+ G +PG
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLM 85
P + + ++RV+G G FG+V+ + ++ + AIK + + + RE LM
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 86 RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYV 141
R ++HPNV++L E ++++ Y+ + L + + QR P LI
Sbjct: 77 RGLNHPNVLAL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ Q+ RG+ Y+ + HRDL +N ++D + VK+ DFG A+ ++ E Y
Sbjct: 129 --FGLQVARGMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----YY 180
Query: 202 CSRFYR---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +R A E L +TT D+WS G +L ELL G P +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 93
+V+G+G FG V + + GE V IK + R+ + + +DH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
+ L + L LV +Y+P L + ++ + + + QI +G+
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ + HR+L +N+L+ QV++ DFG A L + + Y ++ + A
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E I YT D+WS G + EL+ G + G + L+E
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 152
L TS + L+ + +P + L Y ++ + Y+ + QI +G+
Sbjct: 80 CRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 209
Y+ R+ HRDL +N+LV VKI DFG AK L A E + + A
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 252
E I YT D+WS G + EL+ G + G A + ++E
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 355
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+T D+WS G +L EL G+ +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 100
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 158
+ + L +V EY+ L Y + R L L ++ + + Y+
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
HRDL +N+LV + K+ DFG K+ + + + + APE L
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 361
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++T D+WS G +L E+ G+ +P
Sbjct: 362 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-19
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ F ++ E++ Y L Y R + V L QI + Y+
Sbjct: 75 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 213
HRDL +N LV H VK+ DFG ++ L+ G+ ++ ++F + APE L +
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+++ D+W+ G +L E+ G +PG
Sbjct: 187 N--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRVMDHPN 92
+ ++ +G+G+FG V + VA+K + + E +M+ +D+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ + LVME L Y N+ + + +Q+ G+
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HRDL +N+L+ H KI DFG +K L A E +Y ++ +
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + + ++++ D+WS G ++ E GQ + G
Sbjct: 186 WYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ S+ ++ +V EY+ L + L +L QI G+AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 214
+ HRDL+ N+LV K+ DFG A+ LI + ++F + APE
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 438
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+T D+WS G +L EL G+ +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 51/229 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 150
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 139
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 207
G+ Y+ + + HRDL +N ++D VK+ DFG A+ + E +Y
Sbjct: 140 GMKYLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHN 188
Query: 208 -----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 189 KTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 97
+G G+FG VF + VA+K + + E ++++ HPN++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
++ + +VME V L+ + R+ + + G+ Y+
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LI 212
+ + HRDL +N LV + +KI DFG +++ G S + + APE L
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 213 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+G Y++ D+WS G +L E LG +P
Sbjct: 289 YG--RYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 5e-18
Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)
Query: 46 VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 84
+G G FG VFQ VAIK + ++ N L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 85 MRVMDHPNVISLKHCFF---------------------------STTSKNELFLNLVMEY 117
I L ++LF+ L E+
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 118 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177
+ ++ SS K +Q+ LA R HRDL N+L+ T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198
Query: 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 237
K+ + K L +YT S V ++ +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 238 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 288
+ LF G+ D +I +++ +P +Y + + +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 289 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
K++ + + +L +S +A +
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 44 RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 93
R +G GSFG+V++ + VAIK V +++R E +M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLIYVKL--YTY 146
+ L S+ + L ++ME + + L+ ++ P K+
Sbjct: 91 VRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 147 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 206
+I G+AY++ V HRDL +N +V VKI DFG + + + +Y
Sbjct: 146 EIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD---------YY 194
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
R +PE L G +TT D+WS G VL E+ L + + G + +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251
Query: 253 IIK 255
+
Sbjct: 252 FVM 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)
Query: 44 RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMD-HPN 92
+ +G G+FG V +A T TVA+K + + R EL+++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 139
V++L T L +++E+ E + + + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 140 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY----KDP 202
Query: 200 YICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 246
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 D-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 247 VDQLVEIIK 255
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E+ +G G FG V+ A + VA+K + E +M+ + H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
+ +K ++ ++ E++ L + +++ KL ++ QI G+A+I
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 213
HRDL+ N+LV + KI DFG A ++I + ++F + APE + F
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
G +T D+WS G +L E++ G+ +PG
Sbjct: 360 G--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 150
SL S+ +V+ Y+ + L+++ P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 207
G+ ++ + + HRDL +N ++D VK+ DFG A+ + E +
Sbjct: 204 GMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----FDSVHNKTGAK 257
Query: 208 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
A E L ++TT D+WS G +L EL+ G P +P
Sbjct: 258 LPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A G+ VA+K + ++ EL++M + H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSSANQRMPLIYVK 142
N+++L + L ++ EY + + A
Sbjct: 111 NIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 143 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
L ++ Q+ +G+A++ + HRD+ +N+L+ H KI DFG A+ ++ N S
Sbjct: 166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIM----NDSN 219
Query: 201 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 246
Y APE IF YT D+WS G +L E+ LG P +PG
Sbjct: 220 -----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272
Query: 247 VDQLVEIIK 255
+ +++K
Sbjct: 273 NSKFYKLVK 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 63/258 (24%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+V+G+G+FG V A VA+K + +R EL++M ++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESMYRVLKHYSSAN 133
N+++L T ++ L+ EY E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 134 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
L + L + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222
Query: 192 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 237
++ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 238 QPLFPGENAVDQLVEIIK 255
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 157
++ ++ ++ ++ EY+ L + + L KL QI G+A+I
Sbjct: 74 -YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIF 213
HRDL+ N+LV T KI DFG A +LI + ++F + APE + +
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 214 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
G +T D+WS G +L E++ G+ +PG
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 43/346 (12%), Positives = 76/346 (21%), Gaps = 88/346 (25%)
Query: 7 MSAAVVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 66
S+A D V G G+ Y G +QA V
Sbjct: 12 ESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTALDRQV 59
Query: 67 AIKKVL----QDRRYKNR---ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP 119
A+ V + +D P V + L +V E++
Sbjct: 60 ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV----LDVVHTRAGGL-VVAEWIR 114
Query: 120 -ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178
S+ V + + H V P + V
Sbjct: 115 GGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRAG-VALSIDHPSRVRVSI-DG 166
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 238
V + DI G L LL+ +
Sbjct: 167 DVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYALLVNR 199
Query: 239 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI 298
P L + E ++ + +P +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD---------------------IPFQIS 237
Query: 299 DLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 344
+A+R +Q +R + + +++ A L P+
Sbjct: 238 AVAARSVQGDGGIRSASTLL------NLMQQATAVADRTEVLGPID 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L L LVME +++ L + +P+ V +Q+ G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGM 449
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HR+L +N+L+ H KI DFG +K L A + SY +R
Sbjct: 450 KYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F ++++ D+WS G + E L GQ +
Sbjct: 505 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
E+++G+G G V + G+ VAIK + + R E +M DHPN+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L ++ L + +V EY+ S+ L+ + M L+ + G+
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGMR 165
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR--A 208
Y+ + HRDL +N+LVD K+ DFG ++ ++ + + +Y + + R A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 209 PE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
PE + F ++++ D+WS G V+ E+L G+ +
Sbjct: 223 PEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-17
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 64/258 (24%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
+ +G G FG V +A TVA+K + + R E +++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRVLKHYSSAN 133
VI L + L L++EY S
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 134 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
L L + +QI +G+ Y+ + ++ HRDL +N+LV ++KI DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200
Query: 192 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 237
Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 Y----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 238 QPLFPGENAVDQLVEIIK 255
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 41 MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 93
+A+ +G G+FG V Q + VAIK + Q + E Q+M +D+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 152
+ L L LVME L + + +P+ V +Q+ G+
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 207
Y+ HRDL +N+L+ H KI DFG +K L A ++ +Y
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 208 -------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F ++++ D+WS G + E L GQ +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 58/259 (22%), Positives = 103/259 (39%), Gaps = 59/259 (22%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQL 84
++ I R +G G+FG VF A+C VA+K + L R+ RE +L
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 85 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSAN 133
+ + H +++ + + +V EY+ +L
Sbjct: 71 LTNLQHEHIVKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 134 QRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
+ L ++ QI G+ Y+ + HRDL +N LV VKI DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDV 183
Query: 192 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 237
+ + +YR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 238 -QPLFPGENAVDQLVEIIK 255
QP + + +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
++VVG G FG V + + +VAIK + K R E +M DHPN+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
L +K++ + +V EY+ S+ L+ + + + L+ I G+
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGMK 161
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + HRDL +N+L++ K+ DFG + L + + +R +
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWT 217
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+PE + + ++T++ D+WS G VL E++ G+ +
Sbjct: 218 SPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G+G FG+V L + VAIK + + + E ++M + HP ++ L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ + LV E++ + L+ L+ + G+AY+
Sbjct: 69 -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIFG 214
V HRDL +N LV +K+ DFG + + + S ++F + +PE F
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y++ D+WS G ++ E+ G+ +
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISL- 96
+ ++G G FG V++ L G VA+K+ + E + L HP+++SL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101
Query: 97 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IYVKLYTYQI 148
C +NE+ L + +Y+ ++ R L Y S M + I +
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICI-----GA 148
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 205
RGL Y+HT + HRD+K N+L+D KI DFG +K E + +++ +
Sbjct: 149 ARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTHLSTVVKGT 204
Query: 206 --YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 239
Y P EY T D++S G VL E+L +
Sbjct: 205 LGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 56/249 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 93
+ +G G+FG VF A+C VA+K + R+ RE +L+ ++ H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQRMPLIYVKL 143
+ ++ L +V EY+ L PL +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 144 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
Q+ G+ Y+ + HRDL +N LV VKI DFG ++ + + +
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212
Query: 202 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 246
+YR PE +++ ++TT D+WS G VL E+ G QP + +
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 247 VDQLVEIIK 255
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 46/250 (18%), Positives = 83/250 (33%), Gaps = 49/250 (19%)
Query: 19 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK 78
G ++ G + ++ + +G+G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 79 N---RELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPES 121
EL+ + + + I + T K + +VME +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQV 180
L+ S N V ++ L YIH V H D+K NLL+ QV
Sbjct: 138 ----LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQV 192
Query: 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSAG 228
+ D+G + + + Y + G E+ TS+ D+ G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 229 CVLAELLLGQ 238
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + V HRD+ +N+LV VK+ DFG ++ + + +Y + +
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWM 559
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F +T++ D+W G + E+L G F G
Sbjct: 560 APESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G+G FG+V K VA+K + + ++ +E Q M + HP ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ SK +V EY+ + L+ + + L+ Y + G+A++ +
Sbjct: 69 -YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLESH 123
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------APE-L 211
+ HRDL +N LVD VK+ DFG + ++ + Y+ S + APE
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ +Y++ D+W+ G ++ E+ LG+ +
Sbjct: 178 HYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 44/227 (19%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRVMDHP 91
+G G+F +F+ E G+ V +K + + R + +M + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
+++ + + + LV E+V S+ LK + + + Q+
Sbjct: 73 HLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQLAA 124
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEANISYICS 203
+ ++ + H ++ +N+L+ + +K+ D G + ++ +
Sbjct: 125 AMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175
Query: 204 RFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+ PE I + D WS G L E+ G
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 148
++ + ++ +++E + + L + +Q L + L I
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 206
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 191 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 43 ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+G GSFG+V + + +G+T VA+K + D + RE+ M +DH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRG 151
+I L + + +V E P L +Q L + Y Q+ G
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR---- 207
+ Y+ + R HRDL +NLL+ VKI DFG + L + Y+ +
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFA 189
Query: 208 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE L ++ + D W G L E+ GQ + G
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G G+FG V++ + + VA+K + QD E ++ +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 148
++ + ++ ++ME + + L + +Q L + L I
Sbjct: 95 IVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 206
G Y+ HRD+ +N L+ KI DFG A+ + +Y
Sbjct: 150 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199
Query: 207 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
R PE + G +T+ D WS G +L E+ LG +P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 96
Y R +G GSFG++F+ L + VAIK + E + +++ + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 157 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 207
V +RD+KP N L+ + + + DFG K Y YR
Sbjct: 124 EKSLV-YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173
Query: 208 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 238
+ + G Y SI D+ + G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G+FG V A+ + VA+K + +D E+++M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + S N L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+Y+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 244 ENAVDQLVEIIK 255
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R++G G FG V++ VA+K +D N+ E +M+ +DHP+++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L + + ++ME P Y L HY N+ + ++ + LY+ QI + +A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ ++ HRD+ +N+LV VK+ DFG ++ + + Y + R
Sbjct: 128 YLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM 181
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
+PE + F +TT+ D+W + E+L G+ F
Sbjct: 182 SPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 9e-16
Identities = 55/239 (23%), Positives = 88/239 (36%), Gaps = 57/239 (23%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
+G FG V++ E + VAIK + R E L + HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYV 141
V+ L +K++ ++ Y V + L
Sbjct: 74 VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 142 KL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199
QI G+ Y+ + V H+DL +N+LV VKI D G +++ A +
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182
Query: 200 YICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 243
+Y+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 93
++V+G G FG V++ + VAIK + + R E +M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I L SK + + ++ EY+ ++ + L+ + L+ I G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGM 160
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR-- 207
Y+ + HRDL +N+LV+ K+ DFG ++ ++ + +Y S + R
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217
Query: 208 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + + +T++ D+WS G V+ E++ G+ +
Sbjct: 218 APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 94
R +G G FG V Q + VAIK R E MR DHP+++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 153
L ++N ++ ++ME L+ + + + L + LY YQ+ LA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 207
Y+ + R HRD+ +N+LV VK+ DFG ++ + +Y+
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 208 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
APE + F +T++ D+W G + E+L G F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 68/268 (25%)
Query: 34 PKQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQ 83
P+ I Y+ R +G G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 84 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYS 130
LM D+PN++ L + + L+ EY+ P ++ +
Sbjct: 103 LMAEFDNPNIVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 131 SANQRMPLIYVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182
S R+ + Q+ G+AY+ + HRDL +N LV VKI
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKI 215
Query: 183 CDFGSAKQLIAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGC 229
DFG ++ + + + +Y+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 230 VLAELL-LG-QPLFPGENAVDQLVEIIK 255
VL E+ G QP + G ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDH-PNVISL 96
+ + +G G+FG + K L T E VAIK + + E + + + + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + +V+E + S+ + ++ L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122
Query: 157 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 207
+ + +RD+KP+N L+ + + I DF AK+ YI YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 208 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 238
+ + G Y SI D+ + G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 57/252 (22%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G FG V A+ + + TVA+K + +D E+++M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + + + +
Sbjct: 146 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDIN---- 254
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 255 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 244 ENAVDQLVEIIK 255
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)
Query: 43 ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 89
+ +G G+FG V A+ + + TVA+K + +D E+++M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 138
H N+I+L +++ +++EY + + + +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 139 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
+ L TYQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDI----N 208
Query: 197 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
NI Y Y+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 209 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 70/296 (23%)
Query: 45 VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRVMDHPNVIS 95
+G G FG+V++ + TVA+KK + +++ E+++M H N++
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQ 147
L S+ + LV Y+P S +L S + PL I
Sbjct: 95 LLGF--SSDGDDLC---LVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQG----- 141
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
G+ ++H + HRD+K N+L+D KI DFG A+ + + + + SR
Sbjct: 142 AANGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVG 197
Query: 206 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 256
Y APE + G E T DI+S G VL E++ G P AVD+ L++I +
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249
Query: 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 312
+ + ++ D ++ +AS+ L + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84
Query: 100 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 158
+ +K ++ EY+ + L+ Q L+ + + Y+ +
Sbjct: 85 -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139
Query: 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 214
+ HRDL +N LV+ VK+ DFG ++ + + S + S+F R PE L++
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
++++ DIW+ G ++ E+ LG+ +
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 41/252 (16%), Positives = 82/252 (32%), Gaps = 50/252 (19%)
Query: 19 TGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG--------ETVAIKK 70
TG +++ G + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 71 VLQDRRYKNRELQLMRVMDHPNVISLK-----------HCFFSTTSKNELFLNLVMEYVP 119
+D R N + R V K C +++ LV+ +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 120 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-H 178
S+ L + V ++ L ++H V H ++ +N+ VDP
Sbjct: 142 RSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQS 198
Query: 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWS 226
QV + +G A + +++Y G E+ S+ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 227 AGCVLAELLLGQ 238
G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 96
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ C + +VME + S+ + +++ L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 157 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ HRD+KP N L+ + V I DFG AK+ + +I YR + + G
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177
Query: 215 ATEYTTSI------------DIWSAGCVLAELLLGQ 238
Y SI D+ S G VL LG
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 97
+ ++G G FG V++ + L G VA+K++ ++R E++++ + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 98 HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQIF 149
T L LV Y+ S+ L + PL I +
Sbjct: 94 GF--CMTPTERL---LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG-----SA 141
Query: 150 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
RGLAY+H P++ HRD+K N+L+D + + DFG AK + + +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197
Query: 206 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 238
+ APE L G + + D++ G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 56/236 (23%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVKL 143
+L + L+ L +EY P + + + L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 144 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSR-------GQEV- 194
Query: 202 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 243
Y A E L + YTT+ D+WS G +L E++ LG + G
Sbjct: 195 ----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVM-DHPNVISL 96
+ R +G+GSFG ++ ++T E VAIK ++ E ++ R++ + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + LVM+ + S+ + ++++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 157 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ HRD+KP N L+ +QV I DFG AK+ + +I YR + + G
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTG 175
Query: 215 ATEYTTSI------------DIWSAGCVLAELLLGQ 238
Y S+ D+ S G VL L G
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 46/251 (18%), Positives = 79/251 (31%), Gaps = 50/251 (19%)
Query: 20 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQD 74
G II+ + +G G FG ++ A + + + +K D
Sbjct: 26 GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76
Query: 75 RRYKNRELQLMRVMDHPNVISLK--------------HCFFSTTSKNELFLNLVMEYVPE 120
EL+ + P I + + ++M+
Sbjct: 77 NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136
Query: 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQ 179
+ K Y + +R V + +I L YIH V H D+K NLL++ Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQ 192
Query: 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI------------DIWSA 227
V + D+G A + + +Y G E+ TSI D+
Sbjct: 193 VYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEIL 247
Query: 228 GCVLAELLLGQ 238
G + + L G
Sbjct: 248 GYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 12/187 (6%)
Query: 77 YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 134
YK + + + D+ I LK S TS + +E S +
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED-LY 186
Query: 135 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ L L Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244
Query: 193 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 248
+ +R + APE IF YT D+WS G +L E+ LG +PG +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 249 QLVEIIK 255
+ +K
Sbjct: 304 EFCRRLK 310
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.0 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.54 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.25 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.17 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.04 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.9 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.54 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.13 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-64 Score=476.86 Aligned_cols=320 Identities=33% Similarity=0.611 Sum_probs=257.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecC-CCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 110 (380)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||++++++.... ..+...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999964422 2347999999999999999999875432 123445
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|||||||+|+|...+. ..+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceeee
Confidence 89999999999888775 45789999999999999999999999 89999999999999996 78899999999986
Q ss_pred CccC-----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 191 LIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 191 ~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
.... ....+.+||++|||||++.+...|+.++||||+||++|+|++|++||.+.+..+++..|....|.|+...+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 23346789999999999988777899999999999999999999999999999999999999999987665
Q ss_pred hhcCCCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCC
Q 016950 266 RCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPP 342 (380)
Q Consensus 266 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 342 (380)
......... ..++.....+|...++ .++++++|||.+||++||++|||+.|+|+||||++...+.... ...+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p----~~~~ 362 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP----DCAP 362 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC----CCSS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc----CCCC
Confidence 433211110 1334444445555544 4899999999999999999999999999999999987654332 2234
Q ss_pred CCCchhhhccCCHHHHhhhChHHHHh
Q 016950 343 LFNFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
.+++..+....+.+.+++++.+++.+
T Consensus 363 ~~~~~~~~~~~~~~~~k~~i~~ei~~ 388 (398)
T 4b99_A 363 PFDFAFDREALTRERIKEAIVAEIED 388 (398)
T ss_dssp CCCCHHHHSCCCHHHHHHHHHHHHHH
T ss_pred CCCCccchhhcCHHHHHHHHHHHHHH
Confidence 45555555666777777776666543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-65 Score=455.08 Aligned_cols=251 Identities=28% Similarity=0.432 Sum_probs=203.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++|||||++++++. +.
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~ 85 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SK 85 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence 4578999999999999999999999999999999986432 23458999999999999999999983 34
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+|||||+|+|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC
T ss_pred CEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCC
Confidence 45899999999998888763 5679999999999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+.........+.+||+.|||||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------ 227 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------ 227 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------
Confidence 87766655667899999999999977665678999999999999999999999998877777666541
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+. ++..+|+++++||.+||++||++|||++|+++||||+.
T Consensus 228 -----~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 228 -----VYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111 23348999999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-65 Score=460.20 Aligned_cols=257 Identities=30% Similarity=0.520 Sum_probs=222.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++|||||+++++| ++.
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~ 104 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD 104 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence 347899999999999999999999999999999999643 12346899999999999999999999 444
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|||||||+| +|.+.+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGl 178 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGT 178 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCC
Confidence 569999999985 88888763 4679999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 188 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 188 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+...... ...+.+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+.++.+.
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------- 249 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-------- 249 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 98764332 23467899999999999765 4899999999999999999999999999988888877762
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHH------HhcCCCcccccCCCCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNAR 333 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------~l~hp~~~~~~~~~~~ 333 (380)
.+. ++..+|+++++||.+||++||++|+|++| +++||||++++|....
T Consensus 250 ---------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 250 ---------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp ---------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred ---------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 122 23458999999999999999999999987 6899999999887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-63 Score=455.00 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=215.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..|++++.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+ ...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence 4699999999999999999999999999999998532 3345689999999999999999999954 334899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||+| +|.+++.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence 9999995 67776652 469999999999999999999999 89999999999999996 7889999999998765
Q ss_pred cC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. ....+.+||++|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+........
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~---------- 290 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL---------- 290 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred CCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence 43 33456789999999999965 4599999999999999999999999999988888777655211000
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus 291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 01224799999999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-63 Score=456.72 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=211.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|.+ .
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~ 95 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----N 95 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----C
Confidence 34578999999999999999999999999999999996542 234589999999999999999999943 3
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|||||||+| +|.+.+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 96 ~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGl 171 (350)
T 4b9d_A 96 GSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGI 171 (350)
T ss_dssp TEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTE
T ss_pred CEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEccccc
Confidence 458999999985 88888863 234567999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
|+...... .....+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++....-
T Consensus 172 a~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-------- 242 (350)
T 4b9d_A 172 ARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-------- 242 (350)
T ss_dssp ESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred ceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--------
Confidence 98764332 23356899999999999664 599999999999999999999999999998888887766211
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
+ .++..+|+++++||.+||++||++|||++|+|+||||++
T Consensus 243 -----------~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 243 -----------P---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -----------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -----------C---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0 012347999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=456.56 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=215.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..|++++.||+|+||+||+|+++.+|+.||||++... .....+|+.+|+.++|||||+++++|.+. ..+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 4699999999999999999999999999999998543 33456899999999999999999999543 34899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||+| +|.+++.. ..+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence 9999995 67776652 469999999999999999999999 89999999999999996 7889999999998765
Q ss_pred cC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. ....+.+||++|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------- 366 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------- 366 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------
T ss_pred CCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------
Confidence 43 33456799999999999965 4599999999999999999999999999988888777655211 00
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+..+|+++++||.+||++||++|+|++|+|+||||++..
T Consensus 367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 001234799999999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-61 Score=454.83 Aligned_cols=349 Identities=62% Similarity=1.094 Sum_probs=308.5
Q ss_pred cccceEEeecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeec
Q 016950 18 VTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLK 97 (380)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~ 97 (380)
+...+......+..+. ....+|++.+.||+|+||+||+|++..+++ +|+|++..+.....+|+.+++.++||||++++
T Consensus 21 ~~~~~~~~~~~~~~~~-~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~ 98 (394)
T 4e7w_A 21 PNKVIKVLASDGKTGE-QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLK 98 (394)
T ss_dssp CCCCEEEEEEESSSCC-EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEE
T ss_pred CCceEEEEecCCCCCC-cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEE
Confidence 3333333444444444 456789999999999999999999887776 89998877777777899999999999999999
Q ss_pred eeeeecCC-CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC
Q 016950 98 HCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (380)
Q Consensus 98 ~~~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~ 176 (380)
+++..... .+..++|+||||++++++..+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 99 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 99 AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp EEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETT
T ss_pred EEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCC
Confidence 99876554 5566788999999999888887776677889999999999999999999999 799999999999999955
Q ss_pred CCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016950 177 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (380)
Q Consensus 177 ~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 256 (380)
++.+||+|||+|+............+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+++.
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 178 SGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 78999999999987766666667889999999999977767999999999999999999999999999999999999999
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 336 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 336 (380)
+|.|+.+.+..+++++....++.....+|...++..+++++.+||.+||++||.+|||+.|+++||||+.+++.....+.
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~ 337 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPN 337 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998888888
Q ss_pred CCCCCCCCCchhhhccCCHHHHhhhChHHHHhh
Q 016950 337 GRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 369 (380)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (380)
.+.+++++++..+.....++++.+++|++..+.
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (394)
T 4e7w_A 338 GRELPPLFNWTKEELSVRPDLISRLVPQHAEAE 370 (394)
T ss_dssp SSCCCCSCCCCHHHHHTCGGGHHHHSCGGGCSS
T ss_pred CCCCCCcCCCCHHHhhcCHHHHHhhccHhhhhh
Confidence 888999999998777788899999988876433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-62 Score=445.62 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=211.5
Q ss_pred ccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.++|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+.+|+.++|||||+++++|.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----- 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----
Confidence 368999999999999999999985 46889999998543 2334679999999999999999999944
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+|+|||||+| +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFG 171 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFG 171 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEESSE
T ss_pred CCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEecccc
Confidence 3458999999995 78777763 4679999999999999999999999 89999999999999996 7889999999
Q ss_pred ccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+|+..... ....+.+||+.|||||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------- 241 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--------- 241 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred cceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC---------
Confidence 99865433 334567899999999999764 5999999999999999999999999999988888877652
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 331 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 331 (380)
.+. ++..+|+++++||.+||++||++||| ++|+++||||++++|..
T Consensus 242 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 242 --------KLG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred --------CCC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 111 23358999999999999999999998 58999999999987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=435.57 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=208.5
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+.+++.++|||||+++++|.... .+...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 22458999999999999999999885433 34556899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|||||+| +|.+.+.. ...+++..++.|+.||+.||+|||+ +| |+||||||+|||++..++.+||+|||+|+.
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999985 78777763 4679999999999999999999999 78 999999999999985467899999999975
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.. .....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+....+...+.....|
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~---------- 248 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence 43 334456789999999999854 49999999999999999999999998766555544433211100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..++..+++++++||.+||++||++|||++|+|+||||++
T Consensus 249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123347899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=453.40 Aligned_cols=332 Identities=67% Similarity=1.179 Sum_probs=294.4
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEE
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFL 111 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 111 (380)
......+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+.+++.++|+||++++++++... ..+..++
T Consensus 49 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp CCCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred CCcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 344566899999999999999999999999999999999877777778999999999999999999886543 3456678
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+++..
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 8999999999888888777778889999999999999999999999 799999999999999975677999999999876
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
..........+|++|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++++.+|.|..+.+..+.+.
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 65555666789999999999977667999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 351 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (380)
+.++.++.....+|...++..+++++++||.+||++||.+|||+.|+++||||+.++++....+.....+..+++.....
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHH
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHh
Confidence 99999999999999999999999999999999999999999999999999999999888777777777788888775544
Q ss_pred cCCHHHHhhhChHH
Q 016950 352 GASPELVNKLIPDH 365 (380)
Q Consensus 352 ~~~~~~~~~~~~~~ 365 (380)
...+.....++|.+
T Consensus 368 ~~~~~~~~~~~~~~ 381 (420)
T 1j1b_A 368 SSNPPLATILIPPH 381 (420)
T ss_dssp TTCGGGHHHHSCTT
T ss_pred ccChhHHHhhCCHh
Confidence 45555555555443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-61 Score=445.13 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=214.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
..+.|++.+.||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.++|||||++++++.+ ...+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivm 129 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFM 129 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEE
Confidence 34679999999999999999999999999999999976543 3579999999999999999999843 34589999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|||+| +|.+.++. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+.....
T Consensus 130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99995 88888863 3579999999999999999999999 899999999999999974447999999999876443
Q ss_pred CC------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 195 EA------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 195 ~~------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.. ....+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+... .++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~------- 274 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP------- 274 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-------
T ss_pred CcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 22 1235799999999999764 5999999999999999999999999988776666666541 110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH-------------hcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~-------------l~hp~~~~~~~~ 330 (380)
...++..+|+++.+||.+||++||.+|||+.|+ |+|||+...+.+
T Consensus 275 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 -----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp -----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred -----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 011344589999999999999999999999997 679999887654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=450.84 Aligned_cols=332 Identities=50% Similarity=0.961 Sum_probs=285.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCC-----------
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS----------- 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----------- 105 (380)
.++|++.+.||+|+||+||+|.+..+|+.||||++..+.....+|+.+++.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 467999999999999999999999999999999998877777799999999999999999999865433
Q ss_pred ----------------------CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeee
Q 016950 106 ----------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 163 (380)
Q Consensus 106 ----------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH 163 (380)
.+..++++||||++++|.+.+..+......+++..++.++.||+.||+|||+ +||+|
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi~H 164 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICH 164 (383)
T ss_dssp ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEEC
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcCcc
Confidence 3455688999999999999988877778899999999999999999999999 79999
Q ss_pred cCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016950 164 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (380)
Q Consensus 164 ~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 243 (380)
|||||+|||++..++.+||+|||+|+............+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998657899999999998776666666778899999999997766799999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
.+..+.+..+++.+|.|+.+.+..+++.+....++......|...++..+++++.+||.+||++||.+|||+.|+|+|||
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccC-------CCCCCCCC--CCCCCCCCchh-hhccCCHHHHhhhChHHHHhh
Q 016950 324 FDELRE-------PNARLPNG--RPLPPLFNFKQ-ELSGASPELVNKLIPDHVKRQ 369 (380)
Q Consensus 324 ~~~~~~-------~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 369 (380)
|+.+++ .....+.. ..+|.++++.. +++...++..+.++|++....
T Consensus 325 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 380 (383)
T 3eb0_A 325 FDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPN 380 (383)
T ss_dssp GHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC-----
T ss_pred HHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhccc
Confidence 998765 23333443 66788888874 555568999999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=443.56 Aligned_cols=282 Identities=28% Similarity=0.460 Sum_probs=218.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeecccc--chHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRR--YKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
|...++|++.+.||+|+||+||+|+++ .+++.||+|++.+... ...+|+.+|+.+ +||||++++++|.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~----- 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK----- 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----
Confidence 455678999999999999999999875 4678999998865432 345899999988 69999999999943
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+|+|||||+| +|.+.+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 4458999999985 676665 258999999999999999999999 8999999999999999755899999999
Q ss_pred ccccCccCC-----------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC
Q 016950 187 SAKQLIAGE-----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 237 (380)
Q Consensus 187 ~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g 237 (380)
+|+...... ...+.+||++|+|||++.+...|+.++||||+||++|+|++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 997543221 122457999999999998777799999999999999999999
Q ss_pred CCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCCC-------C--------------CCccCCCCC----CCCcccccCC
Q 016950 238 QPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPN-------Y--------------TDFRFPQIK----AHPWHKVFHK 291 (380)
Q Consensus 238 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~~----~~~~~~~~~~ 291 (380)
+.|| .+.+..+++..|.+.+|.+........... . .+...|... ........+.
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9998 456788899999998886554332211000 0 000111100 0011111234
Q ss_pred CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 292 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 292 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+|++++|||.+||++||++|+|++|+|+||||++++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 5899999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=421.49 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=193.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC------
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------ 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 105 (380)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++|||||+++++|.....
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 467999999999999999999999999999999986432 223579999999999999999999865442
Q ss_pred -CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 106 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 106 -~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
....++|+|||||++ +|.+.+.... ......+..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEc
Confidence 234568999999985 7777776321 11234556788999999999999999 89999999999999996 7789999
Q ss_pred eecccccCccCCC-------------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 016950 184 DFGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 250 (380)
Q Consensus 184 Dfg~a~~~~~~~~-------------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~ 250 (380)
|||+|+....... ..+.+||+.|||||++.+. .|+.++|||||||++|+|++ ||.+. .+..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHH
Confidence 9999987643321 2345799999999999764 59999999999999999996 77543 2333
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..+........+..+ ...++.+.+||.+||++||++|||+.|+++||||+++.++
T Consensus 235 ~~~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 235 RTLTDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 322222111111110 1246788999999999999999999999999999998765
Q ss_pred C
Q 016950 331 N 331 (380)
Q Consensus 331 ~ 331 (380)
.
T Consensus 290 ~ 290 (299)
T 4g31_A 290 G 290 (299)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=451.82 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=214.1
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchH---HHHHHHHhCCCCceeeeceeee
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRVMDHPNVISLKHCFF 101 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~---~e~~~l~~l~h~niv~~~~~~~ 101 (380)
..+...++|++++.||+|+||+||+|+++.+|+.||||++.+.. .... .++.+++.++|||||+++++|
T Consensus 183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f- 261 (689)
T 3v5w_A 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF- 261 (689)
T ss_dssp TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-
T ss_pred CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-
Confidence 34556789999999999999999999999999999999996432 1112 345666778999999999999
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcE
Q 016950 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~i 180 (380)
++...+|+|||||+| +|...+.. .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+
T Consensus 262 ----~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~v 331 (689)
T 3v5w_A 262 ----HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHV 331 (689)
T ss_dssp ----ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCE
T ss_pred ----EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCE
Confidence 444569999999995 78877763 4679999999999999999999999 89999999999999996 7889
Q ss_pred EEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Q 016950 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVL 257 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~ 257 (380)
||+|||+|+..... ...+.+||+.|||||++.+...|+.++|||||||++|+|++|.+||.+.+.. +....+..
T Consensus 332 KL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-- 408 (689)
T 3v5w_A 332 RISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-- 408 (689)
T ss_dssp EECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--
T ss_pred EecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--
Confidence 99999999876443 3456799999999999965556999999999999999999999999765332 22222222
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCC
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 331 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 331 (380)
..+ .++..+|+++++||.+||++||.+|++ ++|+++||||++++|..
T Consensus 409 ---------------~~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 409 ---------------MAV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp ---------------CCC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred ---------------CCC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 011 133458999999999999999999998 79999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-57 Score=445.83 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=223.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++++.||+|+||+||+|.++.+|+.||+|++.... ....+|+.+|+.++|||||+++++| .+...+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~ 229 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 229 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence 3578999999999999999999999999999999986543 2345899999999999999999999 444569
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC-CCcEEEEeecccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~ 189 (380)
|||||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+
T Consensus 230 ~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 999999985 77776642 34679999999999999999999999 799999999999999853 3689999999999
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...........+||+.|||||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..+......++
T Consensus 306 ~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 376 (573)
T 3uto_A 306 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD-------- 376 (573)
T ss_dssp ECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------
T ss_pred EccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--------
Confidence 87766666678999999999999764 589999999999999999999999999998888877765321111
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...+..+|+++++||.+||++||.+|||+.|+|+||||+...++.
T Consensus 377 -----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 377 -----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp -----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 112234899999999999999999999999999999999876553
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=403.30 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=207.4
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
.++|.+.+.||+|+||+||+|++. .+++.||||++.... ....+|+.+|+.++|||||++++++.+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~---- 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---- 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS----
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC----
Confidence 367999999999999999999875 367889999986432 2345899999999999999999998433
Q ss_pred ceEEEEEeeccc-chHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
..+|||||||+ |+|.+.+.... .....+++..+..|+.||+.||+|||+ ++|+||||||+|||++. +
T Consensus 88 -~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~-~ 164 (299)
T 4asz_A 88 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-N 164 (299)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-G
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECC-C
Confidence 34889999998 58888886532 234579999999999999999999999 89999999999999996 7
Q ss_pred CcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016950 178 HQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 253 (380)
+.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 8899999999986543322 2235689999999999765 59999999999999999998 99999999888777766
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+.... ..+..+|+++.+|+.+||+.||++|||+.++ |+|++++.
T Consensus 244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 552110 1234589999999999999999999999999 57887754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=419.89 Aligned_cols=322 Identities=30% Similarity=0.510 Sum_probs=239.9
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++++.||+|+||+||+|.++.+++.||||++.... ....+|+.+|+.++|+||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999999999999999986432 2334799999999999999999998765545555
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||++++|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 131 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~ 204 (458)
T 3rp9_A 131 ELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLAR 204 (458)
T ss_dssp CEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred eEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccch
Confidence 689999999999888776 45679999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC----------------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-----
Q 016950 190 QLIAGE----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL----- 236 (380)
Q Consensus 190 ~~~~~~----------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~----- 236 (380)
...... .....+||++|+|||++.....++.++|||||||++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 654221 12345789999999988666679999999999999999998
Q ss_pred ------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCCCCC---CccCCCCCCCCccc
Q 016950 237 ------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYT---DFRFPQIKAHPWHK 287 (380)
Q Consensus 237 ------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 287 (380)
|.++|.+.+ ..+++..+.+.+|.|+.+.+........ ...++......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 788887765 3578888999999999887764431100 01223333333444
Q ss_pred ccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhChHHHH
Q 016950 288 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 288 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
.++ .+++++++||.+||++||.+|||++|+|+||||+.+++............. .+. +....+.+.++..+.+++.
T Consensus 365 ~~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 365 RFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRL--PFN-DWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp GST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCC--SSC-TTSCCCHHHHHHHHHHHHT
T ss_pred HCC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCC--Ccc-ccccCCHHHHHHHHHHHHH
Confidence 443 479999999999999999999999999999999999877654332222221 122 2345667777777777764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=422.02 Aligned_cols=286 Identities=31% Similarity=0.557 Sum_probs=229.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~ 108 (380)
..++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... +..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999999999999999996432 233479999999999999999999855432 233
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+||||+++++...+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a 211 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA 211 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC
T ss_pred CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEee
Confidence 5688999999998777663 358999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+...........+||++|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+++..+++.+|.|..+.+...
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 877655555667899999999999765 5999999999999999999999999999999999999999999998877654
Q ss_pred CCCCCCc--cCCCCCCCCcccccCCC-----------CChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 269 NPNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+....+ ..+......+...++.. .++++++||.+||++||++|||++|+|+||||+.+..+
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 3211111 11111222222222221 15689999999999999999999999999999976544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=410.26 Aligned_cols=323 Identities=29% Similarity=0.491 Sum_probs=248.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||+|+||.||+|.++.+++.||||++.... ....+|+.+++.++|+||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3568999999999999999999999999999999996432 2335899999999999999999998655433335
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||++++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 104 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla~ 177 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLAR 177 (432)
T ss_dssp CEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCcc
Confidence 589999999999888876 45679999999999999999999999 79999999999999996 7889999999998
Q ss_pred cCccCC-----------------------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh----------
Q 016950 190 QLIAGE-----------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL---------- 236 (380)
Q Consensus 190 ~~~~~~-----------------------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~---------- 236 (380)
...... .....+||++|+|||++.....++.++||||+||++|+|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 654332 12457889999999998666779999999999999999998
Q ss_pred -CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCCCCC-C--ccCCCCCCCCcccccCCCCCh
Q 016950 237 -GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYT-D--FRFPQIKAHPWHKVFHKRMPP 295 (380)
Q Consensus 237 -g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~ 295 (380)
|.++|.+.+ ..+++..+...+|.|+.+.+........ . ..++.....++...+ ..+++
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~ 336 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISD 336 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCH
Confidence 556666654 4678899999999999887765432100 0 012222223333333 34899
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhChHHHHh
Q 016950 296 EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 296 ~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
++.+||.+||++||.+|||++|+|+||||+.++++............ .+. +....+.+.++.++.+++..
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~e~~~ 406 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIIL--PFD-DWMVLSETQLRYIFLKEVQS 406 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCC--SSC-TTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCC--Chh-hcccCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999877544222222221 222 22456677777777776653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=401.85 Aligned_cols=305 Identities=46% Similarity=0.869 Sum_probs=250.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHhCCCCceeeeceeeeecCC--CCce
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTS--KNEL 109 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~ 109 (380)
...++|++.+.||+|+||+||+|.+..+++.||||++..+... ..+++..+..++||||+++++++..... ....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 4567899999999999999999999999999999998655433 3456667778899999999999865432 4456
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--cCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH--~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
++++||||+++++...+..+......+++..++.++.|++.||.||| + +||+||||||+|||++..++.+||+|||+
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 68899999999988888776667788999999999999999999999 9 79999999999999986578999999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+..
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98776665555678899999999997766689999999999999999999999999999999999999999999999888
Q ss_pred cCCCCCCccCCCCCCCCcccccCC---CCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 340 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~ 340 (380)
..+......+......+|...++. ..++++.+||.+||++||.+|||+.|+|+||||+++..+....+....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~ 334 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDL 334 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCC
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCC
Confidence 877766666666556666665544 3678999999999999999999999999999999988776655444433
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=406.03 Aligned_cols=319 Identities=29% Similarity=0.566 Sum_probs=234.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC-CCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++.... .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~ 83 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---S
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---C
Confidence 4578999999999999999999999999999999985432 22347999999997 999999999885432 2
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+||||++++|...+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCccc
Confidence 34889999999998888763 478999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccC----------------------CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 016950 189 KQLIAG----------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (380)
Q Consensus 189 ~~~~~~----------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~ 246 (380)
+..... ......+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 754321 1123457899999999998766799999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccC------CCCCCCCccccc------------CCCCChHHHHHHHhhcccC
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYS 308 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~d 308 (380)
.+++..++..++.|..+.+......+..... .......+...+ ...+++++.+||.+||++|
T Consensus 237 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 237 MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 9999999999999998877544322111000 000001111111 1257999999999999999
Q ss_pred CCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhChHHHH
Q 016950 309 PSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 309 p~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
|++|||++|+|+||||+.+..+.........+...+. +....+.+..+.++-+++.
T Consensus 317 P~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 372 (388)
T 3oz6_A 317 PNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN---DNVKHSIDDYRNLVYSEIS 372 (388)
T ss_dssp GGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---------CCHHHHHHHHHHHHH
T ss_pred cccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCcc---ccccCCHHHHHHHHHHHHH
Confidence 9999999999999999988766543322222222111 1123445555555555443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=398.44 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=198.9
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|.+.+.||+|+||+||+|+++ .+++.||||++.... ....+|+.+|+.++|||||++++++.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 467999999999999999999865 368899999996432 234589999999999999999999843
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 175 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~ 175 (380)
...+|||||||+ |+|.+++..... ....+++..+..|+.|++.||.|||+ ++|+||||||+|||++.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence 334889999999 588888764321 23569999999999999999999999 79999999999999996
Q ss_pred CCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 016950 176 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV 251 (380)
Q Consensus 176 ~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~ 251 (380)
++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 78999999999986543322 2345789999999999654 59999999999999999999 999999988887777
Q ss_pred HHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+.+.... .++..+++++.+|+.+||+.||++|||+.|++++
T Consensus 272 ~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 66552110 1234589999999999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=393.01 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=196.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+++++.+.||+|+||+||+|+.. ..||||+++... ....+|+.+++.++|||||++++++.. + .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence 357889999999999999999854 359999885322 234589999999999999999997621 1 2
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|||||||+ |+|.+.+.. ....+++..+..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeeccCce
Confidence 679999999 578777753 35679999999999999999999999 79999999999999996 7899999999998
Q ss_pred cCccCC---CcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
...... .....+||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..++.....
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----- 255 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----- 255 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----
Confidence 654322 23356899999999999653 34899999999999999999999999987776666555442111
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.|.. ..++..+++++.+||.+||+.||++|||+.|++++
T Consensus 256 ------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 256 ------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1110 11234589999999999999999999999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=388.37 Aligned_cols=281 Identities=34% Similarity=0.575 Sum_probs=229.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++++.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 57999999999999999999999999999999986432 223479999999999999999999843 3358
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence 89999999988777653 45679999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4332 233467899999999997766689999999999999999987665 77788888899999999988876655432
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
........+..............+++++++||.+||++||++|||++|+++||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 21111122222222222333446899999999999999999999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=394.78 Aligned_cols=249 Identities=23% Similarity=0.277 Sum_probs=203.7
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++++.+.||+|+||+||+|... .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 457899999999999999999864 467899999985432 2346899999999999999999998433
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
..+|+|||||+ |+|.+.+..... ....+++..+..|+.||+.||+|||+ ++|+||||||+|||+
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLV 178 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEE
Confidence 33789999998 588888864321 13468999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 249 (380)
+. ++.+||+|||+|+...... ......||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 179 ~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 7889999999998654332 23346789999999999765 59999999999999999998 8999999988777
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+..+...... ..+..+++++.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6655431110 0234589999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=390.41 Aligned_cols=282 Identities=35% Similarity=0.667 Sum_probs=230.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++++.||+|+||+||+|++. +++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCC
Confidence 3578999999999999999999985 58999999985432 23458999999999999999999983 344
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||+++++.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCce
Confidence 5889999999998887763 34569999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+....+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 654332 2334578999999999977667899999999999999999999999999999999999999998887655433
Q ss_pred CCC--CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 269 NPN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 269 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
... +....+......+|... ...+++++.+||.+||++||++|||+.|+|+||||+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSI-IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHH-STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hccchhhhcccccccCCcHHHh-CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 211 11112222333334333 3458999999999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=390.64 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=219.9
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
......++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---- 84 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE---- 84 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 344567889999999999999999999999999999999865422 2347999999999999999999983
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
....+|+||||+++ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~D 157 (328)
T 3fe3_A 85 -TEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIAD 157 (328)
T ss_dssp -CSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECS
T ss_pred -ECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEee
Confidence 34458999999974 77777753 3579999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------- 229 (328)
T 3fe3_A 158 FGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-------- 229 (328)
T ss_dssp TTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred ccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------
Confidence 999987665555566789999999999987665568999999999999999999999998887777666551
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+. ++..+++++.+||.+||+.||.+|||++|+++||||+.....
T Consensus 230 ---------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 230 ---------KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 111 122479999999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=395.20 Aligned_cols=292 Identities=33% Similarity=0.630 Sum_probs=233.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++... ..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence 579999999999999999999999999999998854321 223699999999999999999998433 3488
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence 9999999998888764 34568999999999999999999999 79999999999999996 7789999999997654
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.|..+.+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 2234577999999999977667899999999999999999999999999999999999999999887665433211
Q ss_pred --CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCC
Q 016950 272 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 340 (380)
Q Consensus 272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~ 340 (380)
+..+.++......+.. ....+++++.+||.+||++||.+|||+.|+|+||||.++.......+....+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~ 301 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI 301 (324)
T ss_dssp HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence 1122333332222222 2345899999999999999999999999999999999987766555444433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=395.30 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=203.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHhCCC-CceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~ 106 (380)
++|++.+.||+|+||+||+|.+..+ ++.||||.+.... ....+|+.+|..++| ||||++++++....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-- 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence 6899999999999999999997654 4689999986532 234579999999976 89999999874322
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
..+|||||||+ |+|.+.++.... ....+++..+..|+.||+.||+|||+ ++|+||||||+|||+
T Consensus 142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 218 (353)
T ss_dssp --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccceee
Confidence 23789999999 588888875432 13458999999999999999999999 899999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~ 249 (380)
+. ++.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.+..+.
T Consensus 219 ~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 219 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp CG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 78899999999987644432 2245789999999999765 59999999999999999998 9999998775555
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+..++..-..+ .++..+++++.+||.+||+.||++|||+.|+++|
T Consensus 297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55544421111 1233479999999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=394.09 Aligned_cols=316 Identities=32% Similarity=0.559 Sum_probs=240.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999999999999999985432 223479999999999999999999854422 1223
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeeccc
Confidence 4689999998888887763 568999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+++..+.+..|.|+.+.+..+.
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 177 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred cccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 6533 23456789999999999876679999999999999999999999999999999999999999999987765443
Q ss_pred CCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
..... ..++......+...+ ..+++.+.+||.+||+.||.+|||+.++|+||||+.+........ ...+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~-----~~~~~~ 328 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-----VQKYDD 328 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-----CCCCCC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCC-----CCCCCC
Confidence 21000 022333334444433 358999999999999999999999999999999999876543211 112233
Q ss_pred hhhhccCCHHHHhhhChHHHH
Q 016950 347 KQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~ 367 (380)
..+....+.+.+++++.+++.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~ 349 (367)
T 1cm8_A 329 SFDDVDRTLDEWKRVTYKEVL 349 (367)
T ss_dssp C-----CCHHHHHHHHHHHHH
T ss_pred ChhhhcCCHHHHHHHHHHHHH
Confidence 333334566677776666554
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=393.28 Aligned_cols=320 Identities=33% Similarity=0.620 Sum_probs=252.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999999999999999986432 223479999999999999999999865544444568
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence 89999999998888753 468999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 192 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 192 ~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...++.|..+.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43322 23457899999999987766689999999999999999999999999999999999999999999887654
Q ss_pred cCCCCC---CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 016950 268 MNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 344 (380)
Q Consensus 268 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 344 (380)
...... ....+.....+|...+ ..+++++.+||.+||++||++|||+.|+|+||||+....+.... .....+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~ 333 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF 333 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence 321100 0122222233333333 34799999999999999999999999999999999875443221 122334
Q ss_pred CchhhhccCCHHHHhhhChHHHHh
Q 016950 345 NFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
.++.+......+.+++++.+++++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~e~~~ 357 (364)
T 3qyz_A 334 KFDMELDDLPKEKLKELIFEETAR 357 (364)
T ss_dssp CCC-----CCHHHHHHHHHHHTGG
T ss_pred CcccccccCCHHHHHHHHHHHHHH
Confidence 555566667788888887776544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=383.68 Aligned_cols=285 Identities=30% Similarity=0.524 Sum_probs=231.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCC---CCceeeeceeeeec
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMD---HPNVISLKHCFFST 103 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 103 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999999999999999986322 23457887777664 99999999999776
Q ss_pred CCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 104 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.......+++||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEEEC
T ss_pred CCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEEe
Confidence 66666678999999999988888642 23349999999999999999999999 79999999999999986 7789999
Q ss_pred eecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++..
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999877655555667889999999999765 48999999999999999999999999999999999999998888765
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+..... .....++.....++.. ....+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus 242 ~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5432111 1111222222222222 334589999999999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=381.48 Aligned_cols=277 Identities=35% Similarity=0.660 Sum_probs=222.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++++.||+|+||+||+|++ .+++.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5799999999999999999998 678999999985432 2335899999999999999999998443 348
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence 89999999998887763 34678999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 322 2233457899999999997766689999999999999999999999999999999999999888877654432211
Q ss_pred --CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 271 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 271 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+. ..++.....+|.. +...+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus 231 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 231 LPKYD-PNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTCC-TTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccc-cccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 110 0112222223332 334589999999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=390.97 Aligned_cols=285 Identities=33% Similarity=0.601 Sum_probs=230.9
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
....++|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 104 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----- 104 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----
Confidence 345689999999999999999999999999999999985432 223589999999999999999999843
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC----CCCcEEEE
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKIC 183 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~----~~~~ikl~ 183 (380)
...+|+||||++++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+
T Consensus 105 ~~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 105 NHRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp TTEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred CCEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 334889999999998888763 4569999999999999999999999 79999999999999953 24469999
Q ss_pred eecccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 184 DFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 184 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 99999765432 22334577999999999977666899999999999999999999999999999999999999888876
Q ss_pred HHHhhcC--CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 263 EEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 263 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
..+.... +.+. ..++......+...+...+++++.+||.+||++||.+|||+.|+|+||||++..+
T Consensus 260 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 260 TTWPGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTSTTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 6544321 1111 1344444555555566668999999999999999999999999999999998755
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=384.12 Aligned_cols=289 Identities=32% Similarity=0.575 Sum_probs=218.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++++.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence 467999999999999999999999999999999986432 23458999999999999999999983 34458
Q ss_pred EEEeecccchHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 112 NLVMEYVPESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
|+||||++++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSCE
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccce
Confidence 89999999999888865432 22458999999999999999999999 79999999999999996 7789999999998
Q ss_pred cCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+...
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 65433 22335678999999999976666899999999999999999999999999999999999998888876554432
Q ss_pred CC--CCCCccCCCCCCCCc----ccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCC
Q 016950 269 NP--NYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333 (380)
Q Consensus 269 ~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 333 (380)
.. .+.. .++......+ .......+++++.+||.+||+.||++|||+.|+|+||||++..++...
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 237 TKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp GGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 11 1110 1111111111 122334689999999999999999999999999999999998766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=393.06 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=212.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
...++|++++.||+|+||+||+|+++.+++.||||++.+.. ....+|..+++.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~----- 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ----- 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----
Confidence 44678999999999999999999999999999999986532 2234788899887 7999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence 34458999999985 77777653 3679999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+|+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 999864332 334456899999999999654 4899999999999999999999999999988888777662
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH------HHHhcCCCcccccCCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREPN 331 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++.+||.+||++||.+|+++ .++++||||+++.|..
T Consensus 240 ---------~~~------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 240 ---------EVV------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 111 223479999999999999999999998 8999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=393.71 Aligned_cols=317 Identities=33% Similarity=0.554 Sum_probs=237.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999999999999999986432 223479999999999999999998854321 1223
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|+|+++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC-----
T ss_pred eEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeeccccc
Confidence 4789999998887777652 579999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.|..+.+....
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 181 HTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 6432 23456889999999999775678999999999999999999999999999999999999999999988776543
Q ss_pred CCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
..... -.++......+...++ .+++.+.+||.+||++||.+|||+.|+|+||||+.+..+... +....+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~-----~~~~~~~~ 332 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQ 332 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTT-TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGC-----CCCCCCCG
T ss_pred hHHHHHHHhccCCCCCCCHHHHCC-CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCC-----CCCCCCCc
Confidence 21100 0122333334444433 479999999999999999999999999999999998766432 12223444
Q ss_pred hhhhccCCHHHHhhhChHHHHh
Q 016950 347 KQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
..+......+.+++++-+++..
T Consensus 333 ~~~~~~~~~~~~~~~~~~e~~~ 354 (367)
T 2fst_X 333 SLESRDLLIDEWKSLTYDEVIS 354 (367)
T ss_dssp GGSSCCCCHHHHHHHHHHHHHH
T ss_pred chhhccCCHHHHHHHHHHHHHH
Confidence 4444566777788887777664
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=388.48 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=218.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
...++|++.+.||+|+||+||+|.++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--- 85 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--- 85 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE---
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE---
Confidence 45678999999999999999999999999999999986532 22458999999999999999999983
Q ss_pred CCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC---cE
Q 016950 105 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QV 180 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~i 180 (380)
+...+|+||||++ ++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+
T Consensus 86 --~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 86 --NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCE
T ss_pred --eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCE
Confidence 3445899999997 57777664 35679999999999999999999999 79999999999999986332 79
Q ss_pred EEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
||+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+.......
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999999987766555566789999999999965 458999999999999999999999999988887777765532211
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
+ ..++..+++++++||.+||+.||.+|||+.|+++||||+.+.
T Consensus 238 ~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 238 D-------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp C-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred C-------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1 112235799999999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=384.06 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=215.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 578999999999999999999999999999999986431 23457999999999999999999884 334
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccch
Confidence 58999999986 77666653 4578999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 86433 333456789999999999865 45899999999999999999999999988877776666541
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++++.+||.+||+.||.+|| ++.++++||||+.+.|.
T Consensus 221 ------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 111 2335799999999999999999999 89999999999988764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=392.93 Aligned_cols=335 Identities=30% Similarity=0.495 Sum_probs=240.6
Q ss_pred cceEEeecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCce
Q 016950 20 GHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNV 93 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~ni 93 (380)
+...+..+++. .....++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||
T Consensus 9 ~~~~~~~~~~~--~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 86 (371)
T 2xrw_A 9 NNFYSVEIGDS--TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86 (371)
T ss_dssp GGEEEEEETTE--EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred CcceEeecCCc--ccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc
Confidence 34444444432 1234578999999999999999999999999999999986532 223479999999999999
Q ss_pred eeeceeeeecCC-CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEE
Q 016950 94 ISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (380)
Q Consensus 94 v~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nil 172 (380)
+++++++..... .....+|+||||++++|.+.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus 87 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 87 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIV 159 (371)
T ss_dssp CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEE
T ss_pred cceEEeeccccccccccceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEE
Confidence 999998854331 2234688999999999887774 358899999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016950 173 VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (380)
Q Consensus 173 l~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 252 (380)
++. ++.+||+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus 160 ~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 237 (371)
T 2xrw_A 160 VKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237 (371)
T ss_dssp ECT-TSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EcC-CCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 996 778999999999876544444567889999999999764 589999999999999999999999999999999999
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCc--cCCCCCCCCcccccCC-----------CCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHKVFHK-----------RMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
+++.++.+..+.+..+.+....+ ..+......+...++. ..++++++||.+||++||++|||++|+|
T Consensus 238 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 317 (371)
T 2xrw_A 238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317 (371)
T ss_dssp HHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHh
Confidence 99999988877665432211000 0111111111111111 1257899999999999999999999999
Q ss_pred cCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhhChHHHHh
Q 016950 320 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 320 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
+||||+....+.... .+.|.......+....+.+..++++.+++.+
T Consensus 318 ~hp~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (371)
T 2xrw_A 318 QHPYINVWYDPSEAE---APPPKIPDKQLDEREHTIEEWKELIYKEVMD 363 (371)
T ss_dssp HSHHHHTTCCHHHHT---CCCCCCCTTTTCCCCCCHHHHHHHHHHHHHH
T ss_pred CCcchhhhcCccccC---CCCCCCCChhhccccCcHHHHHHHHHHHHHH
Confidence 999998765432211 1112222223333456777888887776543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=389.92 Aligned_cols=259 Identities=24% Similarity=0.454 Sum_probs=210.6
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeec
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFST 103 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 103 (380)
......++|++++.||+|+||+||+|+++.+++.||+|++.+.. ....+|..+++.+ +||||+++++++.
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-- 123 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-- 123 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--
Confidence 34455789999999999999999999999999999999986532 2245788888776 8999999999984
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
....+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 124 ---~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL 194 (396)
T 4dc2_A 124 ---TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKL 194 (396)
T ss_dssp ---CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEE
T ss_pred ---ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEE
Confidence 34458999999986 77666653 3579999999999999999999999 79999999999999996 788999
Q ss_pred EeecccccCc-cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHH
Q 016950 183 CDFGSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VD-QLVE 252 (380)
Q Consensus 183 ~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------~~-~~~~ 252 (380)
+|||+|+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .+ ....
T Consensus 195 ~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp CCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred eecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 9999998633 33445567899999999999654 589999999999999999999999964321 11 2222
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH------HHHhcCCCccc
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDE 326 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~ 326 (380)
+.. .... ++..+++++++||++||++||.+|+++ +|+++||||++
T Consensus 274 i~~-----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 274 ILE-----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp HHH-----------------CCCC------------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred Hhc-----------------cccC------------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 222 1111 234589999999999999999999985 79999999999
Q ss_pred ccCCC
Q 016950 327 LREPN 331 (380)
Q Consensus 327 ~~~~~ 331 (380)
+.|..
T Consensus 325 i~w~~ 329 (396)
T 4dc2_A 325 VDWDM 329 (396)
T ss_dssp CCHHH
T ss_pred CCHHH
Confidence 87653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=384.19 Aligned_cols=284 Identities=34% Similarity=0.598 Sum_probs=228.9
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---- 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee----
Confidence 4568999999999999999999999999999999985321 234589999999999999999999843
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....++||||++++|...+.. ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 84 -~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 157 (346)
T 1ua2_A 84 -KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFG 157 (346)
T ss_dssp -TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCG
T ss_pred -CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEecc
Confidence 334789999999988777653 34568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 998664332 3345678999999999977666899999999999999999999999999999999999999888887665
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
...........+......++... ...+++++++||.+||+.||++|||+.|+|+||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhhccCcccccccccCCCChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 54332222222222222333322 34578999999999999999999999999999999886544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=382.00 Aligned_cols=324 Identities=30% Similarity=0.560 Sum_probs=248.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..........
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999999999999999985432 12347999999999999999999875443334456
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+||||+.++|.+.+.. ..+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 89 ~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEecccccc
Confidence 889999999998887763 468999999999999999999999 79999999999999996 77899999999976
Q ss_pred CccCCC-----------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 191 LIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 191 ~~~~~~-----------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
...... .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 123467999999999877667899999999999999999999999999998888888888887
Q ss_pred CCHHHHhhcCCC--CCC--ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCC
Q 016950 260 PTREEIRCMNPN--YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335 (380)
Q Consensus 260 ~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~ 335 (380)
+........... ... -..+......+.. ....+++++.+||.+||+.||++|||+.++++||||+...++.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~ 320 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc
Confidence 763211100000 000 0111111222222 22358999999999999999999999999999999999877654432
Q ss_pred CCCCCCCCCCchhhhccCCHHHHhhhChHHHH
Q 016950 336 NGRPLPPLFNFKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
.....+..+.+.......+.+.+++++.+++.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 321 GEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred cCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 22222234455555566788888888777653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=373.13 Aligned_cols=285 Identities=32% Similarity=0.592 Sum_probs=222.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.++||||+++++++.. ...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence 4689999999999999999999999999999998855432 23479999999999999999999843 334
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.++||||++++++..+. .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL 151 (311)
T ss_dssp EEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence 88999999986544443 245679999999999999999999999 79999999999999996 78899999999986
Q ss_pred CccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 016950 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM- 268 (380)
Q Consensus 191 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 268 (380)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.+..+..........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 54332 2334678999999999987677899999999999999999999999999999999888888887766543322
Q ss_pred -CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 269 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 269 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...+.....+..............+++++.+||.+||++||.+|||+.|+++||||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 111222222222211111222245899999999999999999999999999999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=380.88 Aligned_cols=320 Identities=30% Similarity=0.563 Sum_probs=241.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHhCCCCceeeeceeee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCFF 101 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~~~~~~ 101 (380)
.++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+|+.+++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4679999999999999999999755 8999999885321 23458999999999999999999997
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
.........+|+||||++++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCEE
Confidence 766566667899999999998887763 34579999999999999999999999 79999999999999986 77899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998665555555678899999999997756689999999999999999999999999999999999999999988
Q ss_pred HHHHhhcCCC----CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCC
Q 016950 262 REEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNG 337 (380)
Q Consensus 262 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~ 337 (380)
.+.+...... +..-.........|.. ....+++.+.+||.+||+.||.+|||+.|+++||||+.+..+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~--- 330 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT--- 330 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT---
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc---
Confidence 7655422110 0001111122222322 3345789999999999999999999999999999999986554322
Q ss_pred CCCCCCCCchhhhccCCHHHHhhhChHHHHh
Q 016950 338 RPLPPLFNFKQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
..+...+.+.. ...+...+.+.+..++.+
T Consensus 331 ~~~~~~~~~~~--~~~~~~~~~~~~~~e~~~ 359 (362)
T 3pg1_A 331 EGLSERFHFDE--SVTDVYDMHKIFTAEVER 359 (362)
T ss_dssp TTCCCCCCCCT--TCCCHHHHHHHHHHHHHH
T ss_pred cccccccChhh--hhhhHHHHHHHHHHHHHH
Confidence 12222222222 445566666666666543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=375.14 Aligned_cols=253 Identities=29% Similarity=0.486 Sum_probs=216.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eC
Confidence 3578999999999999999999999999999999986431 23357999999999999999999884 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||++| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~ 152 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGF 152 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSS
T ss_pred CEEEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCc
Confidence 458999999985 7777775 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
++.... .....+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 153 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------- 218 (318)
T 1fot_A 153 AKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------- 218 (318)
T ss_dssp CEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------
T ss_pred ceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence 986532 23456889999999999654 5899999999999999999999999998888777777652
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++.+||.+||+.||++|+ +++++++||||+++.|..
T Consensus 219 ------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 219 ------ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred ------CCC------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 111 2234799999999999999999999 899999999999887653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=383.65 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=214.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .....|..++..+ +||||+++++++.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----- 88 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----- 88 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----
Confidence 34678999999999999999999999999999999996532 2234688888876 9999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF 162 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF 162 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence 34458999999975 77777753 3578999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+...
T Consensus 163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 233 (345)
T 1xjd_A 163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------- 233 (345)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986433 2334467899999999999654 5899999999999999999999999998887777666541
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH-HHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~~ 330 (380)
... ++..+++++++||.+||+.||++||++. ++++||||+.+.|.
T Consensus 234 ---------~~~------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 234 ---------NPF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred ---------CCC------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 111 2234799999999999999999999998 99999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=388.66 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=217.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||+++++++. +.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-----DD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----EC
Confidence 457899999999999999999999999999999998542 233568999999999999999999984 44
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||++ |+|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccce
Confidence 45899999997 477777653 468999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC--cceeeccCCCCChhhhhCCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~---~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|+....... ....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+...++......
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--- 291 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--- 291 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---
Confidence 986544332 235689999999999975432 789999999999999999999999999988888877653110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPN 331 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~ 331 (380)
+.+|. ...+++++++||.+||+.+|.+ |++++|+++||||+++.|..
T Consensus 292 ------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 292 ------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 11111 1247999999999999999988 99999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=388.05 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=212.0
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
+...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---- 80 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT---- 80 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----
Confidence 35678899999999999999999999999999999998542 2235689999999999999999999843
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+|+||||++|+|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 81 -~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG 153 (336)
T 3h4j_B 81 -PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFG 153 (336)
T ss_dssp -SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSS
T ss_pred -CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEec
Confidence 334889999999998887763 3579999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+...
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------- 218 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------
Confidence 99877665555667899999999999765544789999999999999999999997654221110
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.. ......++..+++++.+||++||+.||.+|||+.|+++||||+.
T Consensus 219 -------~i-------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 219 -------KV-------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp -------CC-------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred -------HH-------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 00 00011234458999999999999999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=377.57 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=210.5
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC-CCCceeeeceeeeecC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 104 (380)
.+...++|++++.||+|+||.||+|+++.+++.||+|++.+... ...+|..+++.+ +||||+++++++.
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--- 80 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--- 80 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE---
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE---
Confidence 34567899999999999999999999999999999999975421 234788899887 8999999999984
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
....+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 81 --~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~ 152 (345)
T 3a8x_A 81 --TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLT 152 (345)
T ss_dssp --CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEEC
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEE
Confidence 34458999999985 77776653 3579999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 016950 184 DFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQLVEI 253 (380)
Q Consensus 184 Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---------~~~~~~~i 253 (380)
|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+
T Consensus 153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred eccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 9999986432 3334456899999999999654 58999999999999999999999997532 11222222
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH------HHHhcCCCcccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDEL 327 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~e~l~hp~~~~~ 327 (380)
.. .... ++..+++++++||.+||+.||.+||++ .++++||||+++
T Consensus 232 ~~-----------------~~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 232 LE-----------------KQIR------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HH-----------------CCCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred Hc-----------------CCCC------------CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 22 0111 234579999999999999999999995 899999999998
Q ss_pred cCC
Q 016950 328 REP 330 (380)
Q Consensus 328 ~~~ 330 (380)
.|.
T Consensus 283 ~w~ 285 (345)
T 3a8x_A 283 DWD 285 (345)
T ss_dssp CHH
T ss_pred CHH
Confidence 764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=378.46 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=217.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence 468999999999999999999999999999999886432 234589999999999999999999843 334889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC-CCcEEEEeecccccC
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQL 191 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~~~ 191 (380)
||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.. ++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999986 77776642 34579999999999999999999999 799999999999999853 578999999999877
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
..........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence 655555567889999999999654 479999999999999999999999999988888777776433222221
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...+++++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 12479999999999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=390.81 Aligned_cols=262 Identities=25% Similarity=0.395 Sum_probs=219.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++.+. .....+|..++..++||||+++++++. +..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence 46899999999999999999999999999999998642 233568999999999999999999884 344
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+||||+. |+|...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchhhh
Confidence 5899999997 578777763 24679999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCCCc--ceeeccCCCCChhhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 189 KQLIAGEAN--ISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 189 ~~~~~~~~~--~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+........ ...+||+.|+|||++. +...++.++|||||||++|+|++|..||.+.+..+...+++....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---- 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence 765443322 2357999999999996 244589999999999999999999999999998888887764211
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCC--CCCHHHHhcCCCcccccCCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNA 332 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~e~l~hp~~~~~~~~~~ 332 (380)
.+.+|. ....+++++++||++||+.+|.+ |++++|+++||||+++.|...
T Consensus 299 -----------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 -----------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp -----------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred -----------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 011111 11237999999999999999988 999999999999999988765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=382.37 Aligned_cols=316 Identities=34% Similarity=0.582 Sum_probs=242.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 109 (380)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999986532 2234799999999999999999998544321 112
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||+.++|.+.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 121 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC-
T ss_pred eEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCccc
Confidence 24899999999876655 2459999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+....
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 193 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5432 23346789999999999775678999999999999999999999999999999999999999999877665432
Q ss_pred CCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
..... ...+......+.. +...+++++.+||.+||++||.+|||+.|+|+||||+.+..+........++. .
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~----~ 345 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD----D 345 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC----C
T ss_pred hhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcC----c
Confidence 11000 0111111222222 23457999999999999999999999999999999998876654432222222 1
Q ss_pred hhhhccCCHHHHhhhChHHHH
Q 016950 347 KQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~ 367 (380)
..+....+.+.+++.+.+++.
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 4exu_A 346 SLEHEKLTVDEWKQHIYKEIV 366 (371)
T ss_dssp TTSSCCCCHHHHHHHHHHHHH
T ss_pred chhhcccchHHHHHHHHHHHH
Confidence 223344556667766666554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=373.88 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=216.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--- 84 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--- 84 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE---
Confidence 45678999999999999999999999999999999986432 23458999999999999999999884
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC----c
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----Q 179 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~----~ 179 (380)
....+|+||||+++ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++ .
T Consensus 85 --~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 156 (326)
T 2y0a_A 85 --NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPR 156 (326)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCC
T ss_pred --eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCC
Confidence 33458899999975 7777664 35679999999999999999999999 79999999999999986 44 7
Q ss_pred EEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp EEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 99999999987655555556789999999999854 45899999999999999999999999998887777766553221
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
... .....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 236 ~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 236 FED-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCH-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCc-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 111 12234789999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=376.90 Aligned_cols=289 Identities=28% Similarity=0.487 Sum_probs=227.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 105 (380)
...++|++++.||+|+||+||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45789999999999999999999999999999999885432 123589999999999999999998865432
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....+|+||||+++++...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Df 168 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADF 168 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCC
T ss_pred cCCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEccc
Confidence 11345889999999988877763 34569999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC-----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999765322 222345779999999999776668999999999999999999999999999999999999988887
Q ss_pred CHHHHhhcCCC--CCCccCCCCCCCCcccccC-CCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 261 TREEIRCMNPN--YTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 261 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
+.+.+...... +................+. ...++.+.+||.+||++||++|||++|+|+||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 76544332110 1111111111111110000 01378899999999999999999999999999998743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=380.70 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=214.4
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.....++|++++.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~---- 85 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ---- 85 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 3445689999999999999999999999999999999986432 23457999999999999999999884
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
+...+|+||||+.| +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 86 -~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~D 158 (384)
T 4fr4_A 86 -DEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITD 158 (384)
T ss_dssp -CSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred -eCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEec
Confidence 33458999999975 6766665 45679999999999999999999999 79999999999999996 78899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGT 259 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~~~ 259 (380)
||++............+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.. +....+...
T Consensus 159 FG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~--- 235 (384)
T 4fr4_A 159 FNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT--- 235 (384)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---
T ss_pred cceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---
Confidence 9999877666666678899999999998642 34889999999999999999999999754322 222222210
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-HHHHhcCCCcccccCC
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELREP 330 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~e~l~hp~~~~~~~~ 330 (380)
.. .++..+++++.+||.+||+.||.+||+ ++++++||||+++.|.
T Consensus 236 --------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 236 --------------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp --------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred --------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 01 123347999999999999999999998 8999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=377.93 Aligned_cols=261 Identities=27% Similarity=0.379 Sum_probs=213.2
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
...++|++.+.||+|+||+||+|.++.+++.||||++... .....+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 97 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--- 97 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence 4457899999999999999999999999999999998532 2334689999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcEEE
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKI 182 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~ikl 182 (380)
...+|+|||||+ ++|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||
T Consensus 98 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 98 --DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp --TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred --CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEE
Confidence 335899999998 47877776655556679999999999999999999999 7999999999999997532 34999
Q ss_pred EeecccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 183 CDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. .+....+........
T Consensus 175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN 252 (351)
T ss_dssp CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred ecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence 99999986654332 3356789999999999654 58999999999999999999999998753 344444443211111
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.. .+..+++++++||.+||+.||++|||+.++++||||+...
T Consensus 253 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 253 PR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred cc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 11 1124799999999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=376.51 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=217.8
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.....++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 111 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK---- 111 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE----
Confidence 3456789999999999999999999999999999999986432 23357999999999999999999884
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
+...+|+||||++ ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 112 -~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~D 184 (350)
T 1rdq_E 112 -DNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD 184 (350)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred -cCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcc
Confidence 3445899999997 578777763 3569999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 185 Fg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------- 253 (350)
T 1rdq_E 185 FGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-------- 253 (350)
T ss_dssp CTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cccceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--------
Confidence 9999865332 3456899999999999654 5899999999999999999999999998887777776652
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++++.+||.+||+.||.+||+ ++++++||||+.+.|.
T Consensus 254 ---------~~~------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 254 ---------KVR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ---------CCC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 111 23357999999999999999999998 9999999999987664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=386.61 Aligned_cols=292 Identities=32% Similarity=0.530 Sum_probs=214.3
Q ss_pred cccceee-eeeeecCCceEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..+.|++ .++||+|+||+||+|+++ .+++.||||++.... ....+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~ 94 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRK 94 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCe
Confidence 3456887 558999999999999976 578999999986543 23468999999999999999999986533 335
Q ss_pred EEEEeecccchHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc---CCCCcEEE
Q 016950 111 LNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKI 182 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~---~~~~~ikl 182 (380)
+|+||||+.++|.+.+...... ...+++..++.++.||+.||+|||+ +||+||||||+|||+. ...+.+||
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 8899999999998888644322 2348999999999999999999999 7999999999999993 23678999
Q ss_pred EeecccccCccC----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHH
Q 016950 183 CDFGSAKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQ 249 (380)
Q Consensus 183 ~Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---------~~~ 249 (380)
+|||+|...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 999999865432 2223467899999999997766699999999999999999999999987654 478
Q ss_pred HHHHHHHhCCCCHHHHhhcCCC---------CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 250 LVEIIKVLGTPTREEIRCMNPN---------YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+..+...+|.|....+...... +....+.......+........++.+.+||.+||++||.+|||++|+|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 8899999998887655432110 0000000000001111112234789999999999999999999999999
Q ss_pred CCCcccccCCC
Q 016950 321 HPFFDELREPN 331 (380)
Q Consensus 321 hp~~~~~~~~~ 331 (380)
||||.....+.
T Consensus 334 hp~f~~~~~~~ 344 (405)
T 3rgf_A 334 DPYFLEDPLPT 344 (405)
T ss_dssp SGGGTSSSCCC
T ss_pred ChhhccCCCCc
Confidence 99999865543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=381.89 Aligned_cols=258 Identities=25% Similarity=0.430 Sum_probs=212.6
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHH-HHhCCCCceeeeceeeeecC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-------KNRELQL-MRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-------~~~e~~~-l~~l~h~niv~~~~~~~~~~ 104 (380)
.....++|++++.||+|+||+||+|+++.+++.||||++.+.... ..+|..+ ++.++||||+++++++.
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--- 109 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--- 109 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE---
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE---
Confidence 345668999999999999999999999999999999999654321 1234444 46679999999999884
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
....+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 110 --~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~ 181 (373)
T 2r5t_A 110 --TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLT 181 (373)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEEC
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEe
Confidence 34458999999985 77777653 3578999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 184 DFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 184 Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|||+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------ 254 (373)
T 2r5t_A 182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------ 254 (373)
T ss_dssp CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------
T ss_pred eCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------
Confidence 9999986432 3344567899999999999654 5899999999999999999999999998888877777652
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH----HHHhcCCCcccccCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREPN 331 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++++||.+||+.||.+|+++ .++++||||+.+.|..
T Consensus 255 -----------~~~------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 255 -----------PLQ------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp -----------CCC------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred -----------ccC------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 111 233579999999999999999999986 6999999999987653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=388.68 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=214.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||+||+|.++.+|+.||+|++.... ....+|+.+++.++||||+++++++ .+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~ 82 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE 82 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence 45678999999999999999999999999999999986543 2345899999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEee
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 185 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Df 185 (380)
...|+||||+.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+||
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred CEEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 458899999985 7777765 34679999999999999999999999 79999999999999984 2467999999
Q ss_pred cccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+.......
T Consensus 158 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---- 232 (444)
T 3soa_A 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF---- 232 (444)
T ss_dssp SSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----
T ss_pred ceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC----
Confidence 99976654332 3456889999999999654 58999999999999999999999999988888777776532111
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+. .....+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 233 -------------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 -------------PS--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp -------------CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred -------------Cc--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 10 0113479999999999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=387.76 Aligned_cols=280 Identities=32% Similarity=0.570 Sum_probs=227.9
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhC------CCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVM------DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 106 (380)
...+|++++.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.+ +|+||+++++.+...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence 44679999999999999999999999999999999975432 334688888877 577999999988443
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc--EEEEe
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICD 184 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~--ikl~D 184 (380)
..+|+||||+.++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|
T Consensus 172 --~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~D 245 (429)
T 3kvw_A 172 --NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVID 245 (429)
T ss_dssp --TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEECC
T ss_pred --CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEee
Confidence 348899999999998888753 23458999999999999999999999 79999999999999996 544 99999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||+|.... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.|+...
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99997543 233456889999999999765 489999999999999999999999999999999999999999999876
Q ss_pred HhhcCCC--------CCCc----------------------cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC
Q 016950 265 IRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 314 (380)
Q Consensus 265 ~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 314 (380)
+...... +..+ .........|...+....++++.+||.+||++||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 6532110 0000 000112234555555667899999999999999999999
Q ss_pred HHHHhcCCCcccc
Q 016950 315 ALEACAHPFFDEL 327 (380)
Q Consensus 315 ~~e~l~hp~~~~~ 327 (380)
+.|+|+||||++.
T Consensus 403 a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 403 PGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHTSTTTC--
T ss_pred HHHHhCChhhccC
Confidence 9999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=379.74 Aligned_cols=257 Identities=28% Similarity=0.423 Sum_probs=215.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. +.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~ 100 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE 100 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence 34578999999999999999999999999999999996543 23357999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEee
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDF 185 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Df 185 (380)
...|+||||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +..+||+||
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 458899999986 7766664 35678999999999999999999999 799999999999999753 246999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 176 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~------ 248 (362)
T 2bdw_A 176 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 248 (362)
T ss_dssp TTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred CcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 999877655555567899999999999654 5899999999999999999999999998877777666552111
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
++. . .+..+++++++||.+||+.||.+|||+.++|+||||...
T Consensus 249 -----------~~~---~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 -----------YPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp -----------CCT---T-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred -----------CCc---c-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 110 0 112379999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=382.47 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=218.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|..++..++|+||+++++++. +.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-----DE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-----CS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eC
Confidence 457899999999999999999999999999999998642 233568999999999999999999883 44
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||++ |+|...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeechh
Confidence 45899999997 588887764 23579999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC--cceeeccCCCCChhhhhC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 188 AKQLIAGEA--NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 188 a~~~~~~~~--~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
++....... ....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+.++......
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 986644332 224588999999999963 345899999999999999999999999999888887777642100
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC---CHHHHhcCCCcccccCCCCC
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNAR 333 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~hp~~~~~~~~~~~ 333 (380)
+.+|. +...+|+++++||++||+ +|.+|+ +++|+++||||+.+.|....
T Consensus 289 ---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 ---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp ---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred ---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 01111 123479999999999999 999984 89999999999999887653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=378.42 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=215.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
...++|++++.||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~----- 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ----- 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----
Confidence 34578999999999999999999999999999999986532 2234788888877 7999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....+|+||||++| +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF 165 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF 165 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeC
Confidence 34458999999985 77777753 3569999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 236 (353)
T 2i0e_A 166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------- 236 (353)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred CcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986432 2334467899999999999654 5899999999999999999999999998888877777651
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN 331 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++++||.+||+.||.+||+ +.++++||||+.+.|..
T Consensus 237 ---------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 237 ---------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred ---------CCC------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 111 23358999999999999999999994 69999999999887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=367.47 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=212.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEE
Confidence 4568999999999999999999999999999999985432 2345799999999999999999988543 348
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+. ++|.+.+.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165 (297)
T ss_dssp EEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCcee
Confidence 89999997 477777653 368999999999999999999999 79999999999999996 77899999999876
Q ss_pred CccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
...... .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+..... +.
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~-------- 235 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE-------- 235 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------
T ss_pred cCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC--------
Confidence 544332 3456789999999999764 589999999999999999999999999887776666554211 10
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. ..+..+++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 236 -----~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 -----L------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----C------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----C------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 0 0123478999999999999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=375.69 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=211.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
...++|++.+.||+|+||+||+|.++.+++.||+|++.+......+|+.++..+ +||||+++++++ .+...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEE
Confidence 456789999999999999999999999999999999988777778899998888 799999999998 34456899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC---cEEEEeecccc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAK 189 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~ikl~Dfg~a~ 189 (380)
||||+.| +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+...++ .+||+|||++.
T Consensus 94 v~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 94 VTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999985 7777765 35679999999999999999999999 79999999999999854333 59999999998
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHH
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~ 265 (380)
...... .....++|+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--------- 238 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------- 238 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---------
T ss_pred cCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---------
Confidence 654432 33456789999999999654 4889999999999999999999999863 333444433331
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+.++ ..++..+++++++||.+||+.||.+|||+.++++||||.+.
T Consensus 239 --------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 239 --------KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp --------CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred --------CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 11111 11223589999999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=372.86 Aligned_cols=283 Identities=33% Similarity=0.594 Sum_probs=229.2
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----K 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----C
Confidence 456799999999999999999999999999999999854432 23479999999999999999999843 3
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
...|+||||++++++..+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFA 171 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCc
Confidence 44889999999876555432 45679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.........
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 7654332 233467899999999997766789999999999999999999999999999999999998888776654332
Q ss_pred --cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 --MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.+.....+..............+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 233344445555444444444445689999999999999999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=375.65 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=186.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|.+.+.||+|+||+||+|++ +|+.||||++...... ...|+..+..++|||||++++++.... .....+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 5799999999999999999987 6899999998654322 124555666789999999999886543 223458899
Q ss_pred eeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 115 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 115 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~--------~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
||||+ |+|.+.+.. ..+++..+..++.|++.||.|||+ + +|+||||||+|||++. ++.+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEeC
Confidence 99998 588887753 468999999999999999999998 6 9999999999999996 788999999
Q ss_pred cccccCccCCC-----cceeeccCCCCChhhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------
Q 016950 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENA--------- 246 (380)
Q Consensus 186 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~--------- 246 (380)
|+|+....... ....+||+.|||||++.+.. .++.++|||||||++|||+||.+||.....
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 99986544332 22357999999999996542 267799999999999999999887643321
Q ss_pred -----HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 247 -----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 247 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+.+...+...+. .+ .+|. .......++.+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~---------rp-----~~p~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKL---------RP-----NIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CSSCCHHHHHHHHTTSCC---------CC-----CCCG-------GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHhcccC---------CC-----CCCc-------cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1111111100000 00 0010 00001134578899999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=361.10 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=209.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ....+|+.+++.++||||+++++++. +...
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence 4578999999999999999999999999999999986543 23468999999999999999999883 3445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~ 187 (380)
.|+||||+++ +|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+||+++.. .+.+||+|||+
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 8899999985 8888887665567889999999999999999999999 799999999999999532 46799999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.............+|+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------- 244 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------- 244 (285)
T ss_dssp CCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred ceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-------
Confidence 98765555555678899999999984 358999999999999999999999999887666555443311000
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
+ .....+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 245 ----------~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 ----------A---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------C---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------c---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0 001236899999999999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=363.95 Aligned_cols=293 Identities=33% Similarity=0.569 Sum_probs=235.5
Q ss_pred CCCccccceeeeeeeecCCceEEEEEEEC-CCCcEEEEEEeeccc------cchHHHHHHHHhC---CCCceeeeceeee
Q 016950 32 GEPKQTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFF 101 (380)
Q Consensus 32 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~ 101 (380)
+.....++|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34456688999999999999999999995 678999999885321 2345788777766 8999999999886
Q ss_pred ecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 102 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
..........++||||++++|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEE
T ss_pred ecccCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEE
Confidence 4444456778999999999988888642 23458999999999999999999999 79999999999999996 77899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....+.+.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 161 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999866544444456789999999999654 489999999999999999999999999999999999999888887
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
...+...... ....+......+ ...+...+++.+.+||.+||+.||.+|||+.++++||||+++.+..
T Consensus 240 ~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 240 EEDWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp GGGSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cccCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 6654321110 011111111111 2234456899999999999999999999999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=372.93 Aligned_cols=317 Identities=34% Similarity=0.579 Sum_probs=241.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC-Cce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 109 (380)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++...... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999999999999999986432 2234799999999999999999988543321 112
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+||||+.++|.+.+ ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence 35899999998765544 2458999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..|.+..+.+..+.
T Consensus 175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 64322 3346789999999999765678999999999999999999999999999999999999999998877655433
Q ss_pred CCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
..... -..+......+.. ....+++++.+||.+||+.||++|||+.++++||||+.+..+........ .++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~----~~~~ 327 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ----PFDD 327 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS----CCCC
T ss_pred hHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC----CCcc
Confidence 21000 0111111112222 22357999999999999999999999999999999998876544322211 2222
Q ss_pred hhhhccCCHHHHhhhChHHHHh
Q 016950 347 KQELSGASPELVNKLIPDHVKR 368 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~ 368 (380)
..+....+.+..++.+.+++.+
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~ 349 (353)
T 3coi_A 328 SLEHEKLTVDEWKQHIYKEIVN 349 (353)
T ss_dssp TTTTCCCCHHHHHHHHHHHHHT
T ss_pred chhhccCCHHHHHHHHHHHHHh
Confidence 2333456666777666665543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=376.72 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=216.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
...++|++.+.||+|+||.||+|.++.+++.||+|++.... ....+|+.+++.++||||+++++++. +...
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCE
Confidence 34578999999999999999999999999999999986532 23458999999999999999999984 3445
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC-CCCcEEEEeeccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSA 188 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~ikl~Dfg~a 188 (380)
+|+||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||++
T Consensus 123 ~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccc
Confidence 8899999985 77666542 34579999999999999999999999 79999999999999974 2467999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~---------- 267 (387)
T 1kob_A 199 TKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW---------- 267 (387)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC----------
T ss_pred eecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 87765555556788999999999965 4589999999999999999999999999888777766655211
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.++ ......+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 268 -------~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 268 -------EFD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------CCC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------CCC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 111 111234799999999999999999999999999999998743
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=379.36 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=197.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++++.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence 4578999999999999999999999999999999996543 334589999999999999999999843 34488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC-CcEEEEeeccccc
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQ 190 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~-~~ikl~Dfg~a~~ 190 (380)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+. +.+||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999975 77777653 3569999999999999999999999 7999999999999998522 2599999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......++.....
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~----------- 236 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS----------- 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT-----------
T ss_pred ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc-----------
Confidence 544444556789999999999977654455599999999999999999999876543333333221110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.++. ...+++++++||.+||+.||.+|||+.|+++||||...
T Consensus 237 --~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 237 --VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp --TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred --CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0011111 12478999999999999999999999999999999653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=368.77 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=208.8
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+..++|++++.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~ 77 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EG 77 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence 345688999999999999999999999999999999985432 34568999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~ 151 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGL 151 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CeEEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeec
Confidence 458899999986 6555443 45679999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 188 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 188 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
+....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+...............
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---- 227 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---- 227 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT----
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc----
Confidence 97653322 22346789999999999776655889999999999999999999998765442222222110000
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+ ...+++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 228 -----------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 -----------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------------CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 000 123789999999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=367.43 Aligned_cols=259 Identities=26% Similarity=0.451 Sum_probs=206.0
Q ss_pred CCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------------------------cchHH
Q 016950 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNR 80 (380)
Q Consensus 31 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------------------------~~~~~ 80 (380)
++.....++|++.+.||+|+||.||+|.+..+++.||||++.... ....+
T Consensus 6 ~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp ----CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred CCCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 344456789999999999999999999999999999999986432 23457
Q ss_pred HHHHHHhCCCCceeeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 81 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 81 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
|+.+++.++||||+++++++... ....+|+||||+++ +|.+. .....+++..++.++.||+.||+|||+ +
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~ 156 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-Q 156 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred HHHHHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-C
Confidence 99999999999999999988542 23458899999986 44332 134579999999999999999999999 7
Q ss_pred CeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC-cceeeccCCCCChhhhhCCCC--CCchhhHHHHHHHHHHHHh
Q 016950 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLL 236 (380)
Q Consensus 160 ~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~ 236 (380)
||+||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+... ++.++|||||||++|+|++
T Consensus 157 ~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp TEECCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 9999999999999996 77899999999986544322 234578999999999865432 4788999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH
Q 016950 237 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316 (380)
Q Consensus 237 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 316 (380)
|..||.+.+.......+... ...++. ...+++++.+||.+||+.||++|||+.
T Consensus 236 g~~pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~ 288 (298)
T 2zv2_A 236 GQCPFMDERIMCLHSKIKSQ-----------------ALEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVP 288 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHC-----------------CCCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred CCCCCCCccHHHHHHHHhcc-----------------cCCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHH
Confidence 99999888766555444331 011111 124789999999999999999999999
Q ss_pred HHhcCCCccc
Q 016950 317 EACAHPFFDE 326 (380)
Q Consensus 317 e~l~hp~~~~ 326 (380)
|+++||||++
T Consensus 289 e~l~hp~~~~ 298 (298)
T 2zv2_A 289 EIKLHPWVTR 298 (298)
T ss_dssp HHTTCHHHHC
T ss_pred HHhcCccccC
Confidence 9999999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=368.94 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=207.9
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeec
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
...++|++.+.||+|+||.||+|++. .+++.||+|++.+.. ....+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34578999999999999999999985 689999999986432 2235799999999999999999988443
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 104 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
..+|+||||+. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 94 -----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl 162 (327)
T 3a62_A 94 -----GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHVKL 162 (327)
T ss_dssp -----SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCEEE
T ss_pred -----CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcEEE
Confidence 34889999998 477777653 3568999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 183 CDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 183 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---- 237 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---- 237 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 999999754332 223345789999999999654 58999999999999999999999999988877777766521
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||.+||+.||.+|| ++.++++||||+.+.|.
T Consensus 238 -------------~~------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 238 -------------LN------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp -------------CC------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred -------------CC------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 11 2234799999999999999999999 89999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=386.90 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=216.9
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.....++|.+.+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--- 87 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--- 87 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 3456788999999999999999999999999999999986432 234589999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
...+|+||||++ ++|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 88 --~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~D 159 (476)
T 2y94_A 88 --PSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIAD 159 (476)
T ss_dssp --SSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred --CCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEe
Confidence 345889999997 47766654 45679999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------- 232 (476)
T 2y94_A 160 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI------- 232 (476)
T ss_dssp CSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-------
T ss_pred ccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-------
Confidence 9999877655555567899999999999776545889999999999999999999999887776666554311
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+. .+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 233 ----------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ----------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 11 123478999999999999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=366.86 Aligned_cols=286 Identities=29% Similarity=0.507 Sum_probs=221.4
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceE
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 110 (380)
.-...++|++.+.||+|+||+||+|.+..+++.||+|++... .....+|+.+++.++ |+||+++++++.... ...
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~ 107 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRT 107 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCC
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCc
Confidence 334567899999999999999999999999999999998643 344568999999997 999999999885422 334
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||||+.+ +|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++.
T Consensus 108 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 7899999996 544443 248899999999999999999999 7999999999999999755589999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHh-h
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIR-C 267 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~-~ 267 (380)
............+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+....+.+.....- .
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 76655555567889999999999775678999999999999999999999984 556667777777666644332211 1
Q ss_pred cCCCCCCc---cCCCCCCCCccccc----CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 268 MNPNYTDF---RFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 268 ~~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
........ .........|...+ ...+++++.+||.+||++||.+|||++|+|+||||+++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 11000000 00011111222211 2237999999999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=358.56 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=216.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCC
Confidence 4578999999999999999999999999999999986543 22347999999999999999999883 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg 186 (380)
..++||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++.+ ...+||+|||
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 58899999985 67666653 3568999999999999999999999 799999999999999752 2349999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 228 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS---- 228 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence 99876655555567889999999999654 5899999999999999999999999998877777666552211110
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 333 (380)
.....+++++.+||.+||+.||++|||+.|+++||||++..+....
T Consensus 229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 0112478999999999999999999999999999999886554433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=371.02 Aligned_cols=279 Identities=25% Similarity=0.433 Sum_probs=221.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----CCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----HPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~ 107 (380)
..++|++++.||+|+||+||+|++..+++.||||++.... .....|+.+++.+. ||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~---- 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY---- 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET----
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC----
Confidence 4568999999999999999999999999999999986432 23356899999986 99999999988543
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC------------
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------------ 175 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~------------ 175 (380)
..+|+||||+.++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 109 -~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 -DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp -TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred -CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchhc
Confidence 348899999988998888742 23458999999999999999999999 79999999999999973
Q ss_pred ------------CCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 016950 176 ------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243 (380)
Q Consensus 176 ------------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~ 243 (380)
..+.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 257899999999975433 23356789999999999754 489999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCCCCC---------CccCCCCCCC--------CcccccCCCCChHHHHHHHhhcc
Q 016950 244 ENAVDQLVEIIKVLGTPTREEIRCMNPNYT---------DFRFPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQ 306 (380)
Q Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~ 306 (380)
.+..+.+..+....+.++...+........ ...+|..... .....+....++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 999999999988888877765543221100 0011110000 00000111235788899999999
Q ss_pred cCCCCCCCHHHHhcCCCcc
Q 016950 307 YSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 307 ~dp~~R~t~~e~l~hp~~~ 325 (380)
+||++|||+.|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=364.47 Aligned_cols=258 Identities=26% Similarity=0.380 Sum_probs=216.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 85 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE---- 85 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence 4578999999999999999999999999999999986432 22458999999999999999999884
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC---cEE
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVK 181 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~ik 181 (380)
....+|+||||++ ++|.+.+. ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++. .+|
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~k 159 (321)
T 2a2a_A 86 -NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK 159 (321)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred -cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEE
Confidence 3345889999997 47777775 35678999999999999999999999 79999999999999986332 799
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred EccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 999999987665555556678999999999865 4589999999999999999999999999887777766554221111
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
..+...+++.+.+||.+||+.||.+|||+.++++||||+.+.+
T Consensus 239 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 239 -------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred -------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 1122347899999999999999999999999999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=376.34 Aligned_cols=289 Identities=21% Similarity=0.301 Sum_probs=211.0
Q ss_pred CCccccceeeeeeeecC--CceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 33 EPKQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
.....++|++++.||+| +||+||+|+++.+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 98 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD- 98 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-
Confidence 34567889999999999 99999999999999999999996543 2334799999999999999999998543
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
..+|+||||+.+ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus 99 ----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~ 170 (389)
T 3gni_B 99 ----NELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLS 170 (389)
T ss_dssp ----TEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEEC
T ss_pred ----CEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEc
Confidence 348999999984 777777642 23569999999999999999999999 79999999999999996 7789999
Q ss_pred eecccccCccCC--------CcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 184 DFGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 184 Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
|||.+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999886442221 12234778999999999763 458999999999999999999999998877666554443
Q ss_pred HHhCCCC-------HHHHhhc------CCCCCC-----ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH
Q 016950 255 KVLGTPT-------REEIRCM------NPNYTD-----FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 316 (380)
Q Consensus 255 ~~~~~~~-------~~~~~~~------~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 316 (380)
....... .+.+... .....+ ...+. ........++..+++++.+||.+||++||++|||+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ 329 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329 (389)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence 2110000 0000000 000000 00000 000111123456899999999999999999999999
Q ss_pred HHhcCCCcccccCCC
Q 016950 317 EACAHPFFDELREPN 331 (380)
Q Consensus 317 e~l~hp~~~~~~~~~ 331 (380)
|+|+||||+.+.+..
T Consensus 330 ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 330 TLLNHSFFKQIKRRA 344 (389)
T ss_dssp HHTTSGGGGGC---C
T ss_pred HHhcCHHHHHHhhcc
Confidence 999999999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=387.34 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=215.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++++.||+|+||+||+|.++.+++.||||++.+. .....+|+.+++.++||||+++++++. ..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cC
Confidence 4568899999999999999999999999999999998532 233458999999999999999999983 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEee
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF 185 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Df 185 (380)
..+|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 458999999985 77776653 3579999999999999999999999 79999999999999964 2457999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 243 (486)
T 3mwu_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--- 243 (486)
T ss_dssp SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---
T ss_pred CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---
Confidence 99987665555556789999999999965 4899999999999999999999999999888877776653111110
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. .+..+|+++++||.+||+.||.+|||+.++|+||||+....
T Consensus 244 -----------------~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 -----------------P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -----------------G-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -----------------c-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 0 11237999999999999999999999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=384.89 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=209.4
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----- 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----- 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence 34578999999999999999999999999999999986431 223468889999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+|+||||+++ +|...+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCC
Confidence 3348899999986 67666653 3578999999999999999999996149999999999999996 7789999999
Q ss_pred ccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+|+..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 364 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------- 364 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------
Confidence 99864332 333456889999999999654 5899999999999999999999999998887777666541
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 331 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++.+||.+||++||.+|| |+.|+++||||+++.+..
T Consensus 365 --------~~~------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 365 --------EIR------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 111 2334799999999999999999999 999999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=386.28 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=215.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----------------cchHHHHHHHHhCCCCceeeec
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRVMDHPNVISLK 97 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------------~~~~~e~~~l~~l~h~niv~~~ 97 (380)
...++|++++.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34678999999999999999999999999999999986432 2235799999999999999999
Q ss_pred eeeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC
Q 016950 98 HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL 176 (380)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~ 176 (380)
+++ .+...+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus 113 ~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 113 DVF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESST
T ss_pred EEE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecC
Confidence 998 344558999999985 77777653 3569999999999999999999999 799999999999999863
Q ss_pred C--CcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 177 T--HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 177 ~--~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
+ ..+||+|||++.............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+.+..+.
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3 2699999999987766555566789999999999853 48999999999999999999999999998888877776
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.......... +..+|+++++||.+||++||.+|||+.|+|+||||+....
T Consensus 261 ~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 261 KGKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HCCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred cCCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 6322211111 1347999999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=386.57 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=214.7
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
+...++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----- 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE----- 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----
Confidence 345678999999999999999999999999999999986432 22357999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....+|+||||++| +|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeec
Confidence 34458999999985 7777776544445679999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~ 260 (380)
|++........ ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. .+....+...
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---- 408 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---- 408 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----
Confidence 99987654433 3345899999999999654 589999999999999999999999987632 3333333321
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
.. .++..+++++++||.+||+.||.+||+ ++++++||||+.+.|.
T Consensus 409 -------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 409 -------------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp -------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred -------------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 01 123458999999999999999999996 5899999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=359.37 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=200.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... ..++...++.++||||+++++++....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~----- 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG----- 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----
Confidence 457899999999999999999999999999999998643221 123445577889999999999885433
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..|+||||++++|.+.+.........+++..++.++.||+.||+|||+ + |++||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCCc
Confidence 388999999999988887766677889999999999999999999999 8 9999999999999996 778999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhh---hCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHH
Q 016950 189 KQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l---~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~ 264 (380)
.............+|+.|+|||++ .....++.++||||+||++|+|++|..||... .....+....... .+.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--- 233 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SPQ--- 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CCC---
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CCC---
Confidence 876555555556789999999997 34455899999999999999999999999864 3333343333310 000
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.....+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 234 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 234 -----------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp -----------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred -----------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 01124789999999999999999999999999999998743
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.91 Aligned_cols=259 Identities=31% Similarity=0.516 Sum_probs=218.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|.++.+++.||||++.... ....+|+.+++.++||||+++++++. .
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 97 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----D 97 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 45678999999999999999999999999999999985432 23458999999999999999999983 3
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEe
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD 184 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~D 184 (380)
...+|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 98 KGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp SSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 4458999999985 7766665 45679999999999999999999999 79999999999999952 357899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+.........
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 248 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL-- 248 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS--
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 999987665555566789999999999965 4899999999999999999999999999888887777652111110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
. .+..+++++++||.+||++||.+|||+.|+|+||||+.....
T Consensus 249 ------------------~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 249 ------------------P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp ------------------G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred ------------------c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 0 112379999999999999999999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=355.37 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=216.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++.+.||+|+||.||+|.+..+++.+|+|++... .....+|+.+++.++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeE
Confidence 457899999999999999999999999999999998643 233458999999999999999999884 34458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE---cCCCCcEEEEeecc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 187 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~ikl~Dfg~ 187 (380)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +|++||||||+||++ +. ++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~ 155 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFGL 155 (277)
T ss_dssp EEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEeccc
Confidence 899999985 77676653 3568999999999999999999999 799999999999999 53 67899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......+...+
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 231 (277)
T 3f3z_A 156 AARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-- 231 (277)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--
T ss_pred ceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--
Confidence 987665555566789999999999854 3899999999999999999999999998887777776653222222111
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus 232 -----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 232 -----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 23789999999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=363.97 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=197.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccch------HHHHHHH-HhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------NRELQLM-RVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~------~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
++|++.+.||+|+||+||+|.+..+++.||||++....... ..|+..+ +..+|+||+++++++.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 68999999999999999999999999999999885432221 2334333 34489999999998843 345
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+||||++++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeeee
Confidence 889999999998887764 34679999999999999999999999 79999999999999986 77899999999987
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~---------- 269 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYL---------- 269 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCC----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCC----------
Confidence 655555555678999999999865 589999999999999999999777655332221 111 000
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
...++..+++++.+||.+||++||++|||+.|+++||||++
T Consensus 270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 11123457999999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=387.42 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=213.6
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
+...++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----- 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE----- 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----
Confidence 345678999999999999999999999999999999985431 22357999999999999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+||||++| +|...+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DF 330 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDL 330 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEec
Confidence 34458999999974 777766532 23459999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGTPTR 262 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~ 262 (380)
|++............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. ..+...+...
T Consensus 331 Gla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----- 404 (576)
T 2acx_A 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----- 404 (576)
T ss_dssp TTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----
T ss_pred ccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----
Confidence 999876655555567899999999999654 4899999999999999999999999876432 2222222110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
...++..+++++++||.+||+.||.+|| +++|+++||||+++.|.
T Consensus 405 -----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 405 -----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp -----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred -----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 0112345899999999999999999999 79999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=362.82 Aligned_cols=286 Identities=30% Similarity=0.519 Sum_probs=221.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecC--------
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT-------- 104 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 104 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999999999999999886443 23357999999999999999998874321
Q ss_pred -CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 -SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 -~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.......|+||||++++|.+.+. ...+++..++.++.|++.||+|||+ +||+||||||+||+++..++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 12345688999999998887764 3578999999999999999999999 7999999999999998657789999
Q ss_pred eecccccCccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 184 DFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 184 Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998653321 1233456899999999877667899999999999999999999999999998888888887776
Q ss_pred CCHHHHhhcCCCCCCc---cCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 260 PTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
+..+...........+ ... ....++ ..+...+++++.+||.+||+.||.+|||+.++++||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CchhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 6655443321111000 000 000111 12334589999999999999999999999999999999987554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=367.21 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
....++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. ....
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeE
Confidence 345678999999999999999999999999999999986542 344579999999999999999999843 3458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEeeccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSA 188 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Dfg~a 188 (380)
++||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. .++.+||+|||++
T Consensus 124 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp EEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 899999985 7766664 35678999999999999999999999 79999999999999973 2578999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~ 267 (380)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .+..+.....
T Consensus 199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~--------- 268 (349)
T 2w4o_A 199 KIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY--------- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC---------
T ss_pred cccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC---------
Confidence 876554444566789999999999654 58999999999999999999999998766554 3333332100
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+ .......++.++.+||.+||+.||++|||+.|+++||||....
T Consensus 269 --------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 269 --------YF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp --------CC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred --------cc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00 0011234799999999999999999999999999999998743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=384.21 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=212.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++++.||+|+||+||+|.++.+++.||+|++.+.. ....+|+.+++.++||||+++++++. ...
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 109 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKR 109 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence 4568999999999999999999999999999999986432 23458999999999999999999983 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg 186 (380)
.+|+|||||.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.. .+.+||+|||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 58899999985 77776653 3568999999999999999999999 799999999999999752 3459999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++.............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+.+..+..........
T Consensus 185 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 259 (494)
T 3lij_A 185 LSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--- 259 (494)
T ss_dssp TCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG---
T ss_pred CCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence 9987766555566789999999999853 58999999999999999999999999998888777776532211111
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+..+++.+++||.+||+.||.+|||+.++|+||||+...
T Consensus 260 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 260 ----------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp ----------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred ----------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 1234799999999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=372.17 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=207.5
Q ss_pred ceee--eeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 39 SYMA--ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 39 ~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++.. ...+|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~ 162 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIV 162 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 3444 678999999999999999999999999986532 334589999999999999999998843 34588
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc-CCCCcEEEEeeccccc
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQ 190 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~-~~~~~ikl~Dfg~a~~ 190 (380)
+||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||++..
T Consensus 163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999985 77666653 33468999999999999999999999 7999999999999994 2357899999999987
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------- 309 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------- 309 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--------
T ss_pred cCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--------
Confidence 765555556679999999999854 45899999999999999999999999999888888777663211110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.....+++++++||.+||+.||.+|||+.|+|+||||++..
T Consensus 310 -----------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 310 -----------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp -----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred -----------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 01134799999999999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=373.12 Aligned_cols=304 Identities=27% Similarity=0.392 Sum_probs=225.1
Q ss_pred ccCCCCCcccceEEeecCCCCCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHh
Q 016950 11 VVDGSDHVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRV 87 (380)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~ 87 (380)
....+++..|+..+...+.. ..++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.
T Consensus 15 ~e~~~~~~~~~~~~~~~g~~-----~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~ 89 (397)
T 1wak_A 15 QEDPNDYCKGGYHLVKIGDL-----FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKS 89 (397)
T ss_dssp -------CC--CCSSCTTCE-----ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCCceEEehhhh-----cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHH
Confidence 33444455555544444333 2467999999999999999999999999999999997543 234579999998
Q ss_pred CC--------CCceeeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 016950 88 MD--------HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159 (380)
Q Consensus 88 l~--------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~ 159 (380)
++ |+||+++++++.... .....+|+||||+++++++.+... ....+++..++.++.||+.||+|||+ +
T Consensus 90 l~~~~~~~~~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~ 165 (397)
T 1wak_A 90 VRNSDPNDPNREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-K 165 (397)
T ss_dssp HHHSCTTCGGGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-T
T ss_pred HhhcCCCCCCcceeeeeecceeecC-CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-h
Confidence 85 788999999885332 245568999999999888877642 23569999999999999999999999 8
Q ss_pred -CeeecCCCCCCEEEcCCC------------------------------------------------CcEEEEeeccccc
Q 016950 160 -RVCHRDLKPQNLLVDPLT------------------------------------------------HQVKICDFGSAKQ 190 (380)
Q Consensus 160 -~iiH~Dlkp~Nill~~~~------------------------------------------------~~ikl~Dfg~a~~ 190 (380)
||+||||||+|||++.++ ..+||+|||++..
T Consensus 166 ~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~ 245 (397)
T 1wak_A 166 CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245 (397)
T ss_dssp TCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEE
T ss_pred CCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccc
Confidence 999999999999998632 2799999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHH
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~ 264 (380)
.... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..+.+..+.+..+.++...
T Consensus 246 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 322 (397)
T 1wak_A 246 VHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322 (397)
T ss_dssp TTBC--SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred cccc--CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence 5432 33457899999999997654 8999999999999999999999998655 5667788888888887765
Q ss_pred HhhcCCCCCCc-------cCCCCCCCCccc------ccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 265 IRCMNPNYTDF-------RFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 265 ~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
+.........+ ............ .++...++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 53221110000 000000000000 011224567899999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=367.98 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=211.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----- 98 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE----- 98 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----
Confidence 4578999999999999999999999999999999985431 23457999999999999999999983
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhc------------------------------------CCCCCHHHHHHHHHHHH
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSA------------------------------------NQRMPLIYVKLYTYQIF 149 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~ql~ 149 (380)
+....|+||||+++ +|.+.+..+... ...+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 34458899999974 776666321110 22346788899999999
Q ss_pred HHHHHhHcCCCeeecCCCCCCEEEcCCC-CcEEEEeecccccCccCC-----CcceeeccCCCCChhhhhCC-CCCCchh
Q 016950 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGE-----ANISYICSRFYRAPELIFGA-TEYTTSI 222 (380)
Q Consensus 150 ~al~~LH~~~~iiH~Dlkp~Nill~~~~-~~ikl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~-~~~~~~~ 222 (380)
.||+|||+ +||+||||||+|||++.++ ..+||+|||++....... ......+|+.|+|||++.+. ..++.++
T Consensus 179 ~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 179 SALHYLHN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 7999999999999998532 279999999997653322 12346789999999999642 5589999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHH
Q 016950 223 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 302 (380)
Q Consensus 223 DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 302 (380)
|||||||++|+|++|..||.+.+..+....+.......... ....+++++.+||.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~ 312 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLS 312 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHH
Confidence 99999999999999999999998888777766532111100 11236899999999
Q ss_pred hhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 303 RLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 303 ~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
+||+.||.+|||+.++++||||+++.+..
T Consensus 313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 313 NLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp HHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred HHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 99999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=395.28 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=216.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++++.||+|+||+||+|+++.+++.||||++.+.. .....|..++..+ +|++|+.++.++ ++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 4578999999999999999999999999999999986431 2234688888877 799999999988 44
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+|+||||++| +|...+.. ...+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DFG 487 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADFG 487 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCCT
T ss_pred CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeecc
Confidence 4568999999985 77777763 3579999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 187 SAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 187 ~a~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+|+.... .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------- 557 (674)
T 3pfq_A 488 MCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 557 (674)
T ss_dssp TCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS---------
T ss_pred eeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 9986432 333456789999999999965 45899999999999999999999999999888887777651
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH-----HHHhcCCCcccccCCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN 331 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~e~l~hp~~~~~~~~~ 331 (380)
... ++..+++++++||++||++||++|+++ +|+++||||+.+.|..
T Consensus 558 --------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 558 --------NVA------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 111 234589999999999999999999997 9999999999987754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=363.10 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=211.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 56999999999999999999999999999999986432 1235799999999999999999988543 34
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
.|+||||+.|++.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence 889999999998887753 34678999999999999999999999 79999999999999996 78999999999976
Q ss_pred CccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+.+..+..... +.
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~------- 272 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------- 272 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-------
Confidence 533 234678999999999853 34589999999999999999999999998887776665554210 00
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.....+++.+.+||.+||+.||++|||+.++++||||...
T Consensus 273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0112468999999999999999999999999999999763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=370.95 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=201.4
Q ss_pred ccccceeee-eeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceEEE
Q 016950 35 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 35 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...++|.+. +.||+|+||+||+|.++.+++.||||++... ....+|+.++ +..+||||+++++++.... .+..++|
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~ 135 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 135 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEE
Confidence 355778887 7999999999999999999999999998643 3456788876 5568999999999884322 3356789
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeecccc
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 189 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~a~ 189 (380)
+|||||.| +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999985 888877632 23469999999999999999999999 799999999999999853 5679999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHH
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEI 265 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 265 (380)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... ....+..
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~---------- 281 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---------- 281 (400)
T ss_dssp ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----------
T ss_pred ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----------
Confidence 7655544556788999999999854 558999999999999999999999998765322 1222221
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.++. ..+..+++++++||++||+.||.+|||+.++++||||...
T Consensus 282 -------~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 282 -------GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp -------TCCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------CcccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 0111111 0113479999999999999999999999999999999863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=354.25 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=211.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 468999999999999999999999999999999986432 234589999999999999999998843
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC---CcEEE
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKI 182 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~---~~ikl 182 (380)
....++||||++ ++|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++.++ ..+||
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred -CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEE
Confidence 345889999997 578777753 3578999999999999999999999 7999999999999998632 17999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+|||++.............+|+.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+........
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 231 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD- 231 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-
T ss_pred EecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-
Confidence 99999987655544455678999999999865 4589999999999999999999999999887776665543211111
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
......+++.+.+||.+||+.||++|||+.++++||||+.+++..
T Consensus 232 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 ------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp ------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred ------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 112234789999999999999999999999999999999876554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=362.79 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=189.1
Q ss_pred ccccceeee---eeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCce
Q 016950 35 KQTISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 35 ~~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 109 (380)
+..++|.+. +.||+|+||+||+|.++.+++.||||++.+.. ....+|+.+++.+. ||||+++++++. +..
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~ 79 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQL 79 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCC
Confidence 345678886 78999999999999999999999999997543 34568999999997 999999999983 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~ikl~Dfg 186 (380)
..|+||||+++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.++ ..+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEEEEECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEEEEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 58899999985 7777775 35679999999999999999999999 7999999999999998532 279999999
Q ss_pred ccccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhC
Q 016950 187 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLG 258 (380)
Q Consensus 187 ~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-------~~~~~i~~~~~ 258 (380)
++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+...
T Consensus 155 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-- 231 (325)
T 3kn6_A 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-- 231 (325)
T ss_dssp TCEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--
T ss_pred cceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--
Confidence 998654332 23456779999999998654 5899999999999999999999999875432 222222111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.+.+ ....+..+++++++||.+||+.||.+|||+.++++||||++.
T Consensus 232 ---------------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 232 ---------------DFSF--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp ---------------CCCC--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred ---------------CCCC--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 0000 011112479999999999999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=364.66 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=212.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhC-CCCceeeeceeeeecC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFSTT 104 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 104 (380)
++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 67999999999999999999999999999999986432 1234789999998 8999999999883
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
.....|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+|||++. ++.+||+
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~ 242 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS 242 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence 34458899999986 77777653 3578999999999999999999999 79999999999999996 7889999
Q ss_pred eecccccCccCCCcceeeccCCCCChhhhhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016950 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999877655555567899999999998632 3478899999999999999999999998887777666655322
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+.... +..+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 221111 1237899999999999999999999999999999973
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=363.30 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=207.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeec
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--- 98 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--- 98 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence 4578999999999999999999999999999999986542 2334799999999999999999988
Q ss_pred CCCCceEEEEEeeccc-c-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 104 TSKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
.....+++||||+. | +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 99 --~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~k 170 (335)
T 3dls_A 99 --ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTIK 170 (335)
T ss_dssp --ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEE
T ss_pred --eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcEE
Confidence 34445889999986 4 6766665 45679999999999999999999999 79999999999999996 78899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 171 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~------ 238 (335)
T 3dls_A 171 LIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE------ 238 (335)
T ss_dssp ECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT------
T ss_pred EeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh------
Confidence 999999987766665667789999999999977654588999999999999999999999653210 00
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.. ...+..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 239 -----------~~------------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 239 -----------AA------------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -----------TC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -----------hc------------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 01123479999999999999999999999999999999763
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=351.49 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=209.9
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++. +
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence 4568899999999999999999999999999999998542 223457999999999999999999884 3
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEecc
Confidence 3458899999985 77777753 3568999999999999999999999 79999999999999986 7789999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++...... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 223 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--------- 223 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred ccccCCcc-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence 98654332 2345678999999999865 458999999999999999999999999888777766655421
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.. ++..+++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus 224 --------~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 --------FT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred --------CC------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 11 22347899999999999999999999999999999988643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=366.73 Aligned_cols=284 Identities=32% Similarity=0.528 Sum_probs=219.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCC-CC-----ceeeeceeeeecCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-HP-----NVISLKHCFFSTTS 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~ 105 (380)
...++|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.++ |+ +|+++.+++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-- 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence 345789999999999999999999999999999999975432 2346888888775 44 488888887443
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-CCCeeecCCCCCCEEEcC-CCCcEEEE
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDP-LTHQVKIC 183 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~-~~~iiH~Dlkp~Nill~~-~~~~ikl~ 183 (380)
..+|+||||++++|.+.+... ....+++..++.++.|++.||.|||+ ..||+||||||+|||++. .++.+||+
T Consensus 129 ---~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 ---NHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ---TEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred ---CceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 358899999999999888743 23468999999999999999999994 169999999999999953 35679999
Q ss_pred eecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++..
T Consensus 204 DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 204 DFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999986532 23456789999999999765 48999999999999999999999999999999999999999988876
Q ss_pred HHhhcCCC---C-----CCccC----------CCCCCCCcccccCC-----------------CCChHHHHHHHhhcccC
Q 016950 264 EIRCMNPN---Y-----TDFRF----------PQIKAHPWHKVFHK-----------------RMPPEAIDLASRLLQYS 308 (380)
Q Consensus 264 ~~~~~~~~---~-----~~~~~----------~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~d 308 (380)
.+...... + ..+.. .......+...+.. ..++++++||.+||++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 65422100 0 00000 00000001110000 00147899999999999
Q ss_pred CCCCCCHHHHhcCCCccccc
Q 016950 309 PSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 309 p~~R~t~~e~l~hp~~~~~~ 328 (380)
|++|||+.|+|+||||+...
T Consensus 361 P~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 361 PKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTTSCCHHHHTTSGGGCC--
T ss_pred hhhCCCHHHHhcCcccccCC
Confidence 99999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=360.47 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=200.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC----
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS---- 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 105 (380)
...++|++++.||+|+||.||+|+++.+++.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 34678999999999999999999999999999999986432 234589999999999999999998865432
Q ss_pred ------------------------------------------------CCceEEEEEeecccc-hHHHHHHHhhhcCCCC
Q 016950 106 ------------------------------------------------KNELFLNLVMEYVPE-SMYRVLKHYSSANQRM 136 (380)
Q Consensus 106 ------------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l 136 (380)
....++++|||||++ +|.+.+.... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence 123358899999986 7777776422 22345
Q ss_pred CHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCC-------------Ccceeecc
Q 016950 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------ANISYICS 203 (380)
Q Consensus 137 ~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-------------~~~~~~~t 203 (380)
++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++....... ......||
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hhHHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 666789999999999999999 79999999999999996 7789999999998665432 12335689
Q ss_pred CCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCC
Q 016950 204 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH 283 (380)
Q Consensus 204 ~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (380)
+.|+|||++.+. .++.++|||||||++|+|++|..|+.. ....+...........
T Consensus 240 ~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~------------------- 294 (332)
T 3qd2_B 240 KLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLL------------------- 294 (332)
T ss_dssp GGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHH-------------------
T ss_pred cCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcc-------------------
Confidence 999999999764 589999999999999999998776521 1111111111110000
Q ss_pred CcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 284 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 284 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
....++++.+||.+||+.||.+|||+.|+++||||+++
T Consensus 295 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 295 ------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 01247788999999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=372.75 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=198.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.+.. ....+|+.+++.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 468999999999999999999999999999999986432 13458999999999999999999872
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEE
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVK 181 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ik 181 (380)
... .|+||||+.+ +|.+.+ .....+++..++.++.||+.||+|||+ +||+||||||+|||++.. +..+|
T Consensus 211 --~~~-~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SSE-EEEEEECCTTCBGGGGT----SSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cCc-eEEEEEcCCCCcHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence 222 6799999986 554444 345779999999999999999999999 799999999999999752 33599
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+......+...+.....
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999987665555556789999999999853 345789999999999999999999999876544333333221110
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. +....+..+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 363 ~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 363 N------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp C------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred C------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0 0111123479999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=351.27 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=214.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHhCC-CCceeeeceee
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCF 100 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~ 100 (380)
...++|++.+.||+|+||.||+|.++.+++.||||++.... ....+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999999999999999986432 22347899999995 99999999988
Q ss_pred eecCCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 101 FSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 101 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
. .....++||||++ ++|.+.+.. ...+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.
T Consensus 94 ~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~ 162 (298)
T 1phk_A 94 E-----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMN 162 (298)
T ss_dssp E-----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCC
T ss_pred c-----cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCc
Confidence 3 3445889999998 478777763 3578999999999999999999999 79999999999999996 778
Q ss_pred EEEEeecccccCccCCCcceeeccCCCCChhhhh-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~-----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
+||+|||++.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 9999999998766555555667899999999985 23457899999999999999999999999888777666655
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
........ . ....+++.+.+||.+||+.||.+|||+.++++||||++....
T Consensus 243 ~~~~~~~~--------------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 243 SGNYQFGS--------------------P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp HTCCCCCT--------------------T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cCCcccCc--------------------c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 52111100 0 112378999999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=353.73 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=209.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.....|...+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 42 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 116 (321)
T 2c30_A 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EE 116 (321)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred CchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CE
Confidence 33456899999999999999999999999999999986433 2245899999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||+++ +|.+.+. ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus 117 ~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeeee
Confidence 8899999986 6665553 3569999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..... +.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~------- 260 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PK------- 260 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-------
T ss_pred ecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC-------
Confidence 654432 2345678999999999965 4589999999999999999999999998887766655543210 00
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
. .....+++.+.+||.+||+.||++|||+.++++||||...
T Consensus 261 -----------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 -----------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -----------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -----------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 0 0012368999999999999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=358.01 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=211.8
Q ss_pred ccccceeee-eeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
...++|.+. +.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.+ .||||+++++++.
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~----- 99 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE----- 99 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----
Confidence 345678888 89999999999999999999999999986432 2345799999998 4699999999983
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEE
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKIC 183 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~ 183 (380)
....+|+||||+.+ +|.+.+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 34458899999986 65555431 234679999999999999999999999 79999999999999985 24689999
Q ss_pred eecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 184 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 184 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~- 254 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE- 254 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred eCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-
Confidence 99999876555555567889999999999654 5899999999999999999999999998888777766653222111
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 333 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~ 333 (380)
.....+++.+.+||.+||+.||.+|||++++|+||||+.+.+....
T Consensus 255 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 255 ------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp ------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred ------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 1123478999999999999999999999999999999998776543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=350.29 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=212.5
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
+...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----- 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----
Confidence 345678999999999999999999999999999999986542 22347999999999999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....++||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~df 159 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF 159 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCC
T ss_pred cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEec
Confidence 33458899999984 67666653 3578999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|++...... .......+|+.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+....+....+...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 230 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 230 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred cCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------
Confidence 999865432 22334678999999999865 45899999999999999999999999988766655544321
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+++.+.+||.+||+.||++|||+.++++||||.....+
T Consensus 231 ---------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 231 ---------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------cCC------------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 111 223478999999999999999999999999999999875443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=346.84 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=208.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
....|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+.+++.++||||+++++++.... .+..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCc
Confidence 3456999999999999999999999999999999986432 22357999999999999999999885443 3456
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
++|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +| ++||||||+||+++..++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred eEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 68899999975 78777753 3568999999999999999999999 78 99999999999998447889999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++..... .......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.+................
T Consensus 178 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 247 (290)
T 1t4h_A 178 LATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------- 247 (290)
T ss_dssp GGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-------
T ss_pred Ccccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-------
Confidence 9975432 33345678999999998853 4899999999999999999999999886655444333221100
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
...++...++++.+||.+||+.||.+|||+.++++||||++
T Consensus 248 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 -------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01123346889999999999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=351.36 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=212.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--- 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---
Confidence 3568999999999999999999999999999999985431 33458999999999999999999885422
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
....|+||||+.+++.+.+... ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~ 155 (305)
T 2wtk_C 80 KQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGV 155 (305)
T ss_dssp --CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred CCeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeecccc
Confidence 3348899999999887777643 34679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCC---CcceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+....... ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------- 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------- 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------
Confidence 97654322 123456899999999986533 2478999999999999999999999988776666555441
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~ 331 (380)
.+. ++..+++.+.+||.+||+.||.+|||+.++++||||++...+.
T Consensus 229 ----------~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 ----------SYA------------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ----------CCC------------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ----------CCC------------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 011 2234789999999999999999999999999999999865443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=350.78 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=186.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 4678999999999999999999999999999999986432 33458999999999999999999883 34
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...|+||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecc
Confidence 458899999975 77777653 34678999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
+....... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||...+..+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 226 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------- 226 (278)
T ss_dssp CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence 98654322 23346789999999998654 488999999999999999999999987654333221100
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+ .++..++.++.+||.+||+.||++|||+.++++||||...
T Consensus 227 ------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 011 1233478999999999999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.76 Aligned_cols=253 Identities=26% Similarity=0.464 Sum_probs=212.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH----- 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----
Confidence 34568899999999999999999999999999999998542 123458999999999999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Df 158 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIADF 158 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECCC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEecc
Confidence 33458899999985 88777763 3468999999999999999999999 79999999999999986 778999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|++...... ......+|+.|+|||++.+. .++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 159 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 227 (284)
T 2vgo_A 159 GWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--------- 227 (284)
T ss_dssp TTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT---------
T ss_pred cccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc---------
Confidence 998754332 23346789999999999654 4899999999999999999999999988776665554431
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
... ++..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 228 --------~~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 --------DLK------------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp --------CCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred --------ccC------------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 111 2234789999999999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=355.65 Aligned_cols=256 Identities=29% Similarity=0.452 Sum_probs=213.8
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
+....+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----- 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 345578999999999999999999999999999999986542 23357999999999999999999884
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+...+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Df 185 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDF 185 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCC
T ss_pred cCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeec
Confidence 33458899999985 77766653 3578999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 186 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 186 g~a~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|++...... .......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...
T Consensus 186 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------- 256 (335)
T 2owb_A 186 GLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 256 (335)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------
T ss_pred cCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--------
Confidence 999865433 223346789999999999654 4899999999999999999999999988776666554431
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.+. ++..+++.+.+||.+||+.||++|||+.|+++||||.....+
T Consensus 257 ---------~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 257 ---------EYS------------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ---------CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------CCC------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 111 123478999999999999999999999999999999875443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=348.33 Aligned_cols=253 Identities=29% Similarity=0.427 Sum_probs=203.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----- 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----
Confidence 45678999999999999999999999999999999985432 234589999999999999999998843
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg 156 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADFG 156 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECCCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEeecc
Confidence 3458899999975 88777753 3568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++.............+|+.|+|||++.+....+.++|+||||+++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------- 227 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence 99876555444556789999999999765545789999999999999999999998877666555544310
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.. ++..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 228 --------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 --------FY------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------cc------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00 123478999999999999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.99 Aligned_cols=255 Identities=20% Similarity=0.243 Sum_probs=205.8
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.....++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+..+..+ +||||+++++++...
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-- 83 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-- 83 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--
Confidence 3445688999999999999999999999999999999986532 2234688888888 999999999988443
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC---------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--------- 175 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--------- 175 (380)
...++||||+++ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 84 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 84 ---DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp ---TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC----------
T ss_pred ---CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccc
Confidence 358899999975 8988887665556789999999999999999999999 79999999999999974
Q ss_pred ---------CCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 016950 176 ---------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (380)
Q Consensus 176 ---------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~ 246 (380)
....+||+|||.+....... ...+|+.|+|||++.+...++.++|||||||++|+|++|.+|+...+.
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred ccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 23479999999998654332 346899999999997665677899999999999999999988755432
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
. ..+... .. ..++..+++++.+||.+||+.||++|||+.++++||||++
T Consensus 237 ~---~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 237 W---HEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp H---HHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred H---HHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 2 222110 00 1123457999999999999999999999999999999987
Q ss_pred c
Q 016950 327 L 327 (380)
Q Consensus 327 ~ 327 (380)
.
T Consensus 286 ~ 286 (289)
T 1x8b_A 286 A 286 (289)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=355.50 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=197.8
Q ss_pred cccceeee-eeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++. +.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.+ +||||+++++++.. ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence 45679995 78999999999999999999999999986542 2345799999884 79999999999844 33
Q ss_pred EEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC--cEEEEeec
Q 016950 110 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~ikl~Dfg 186 (380)
.+|+||||++ ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 5889999998 578777763 3568999999999999999999999 79999999999999986332 39999999
Q ss_pred ccccCccCC--------CcceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------
Q 016950 187 SAKQLIAGE--------ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV------- 247 (380)
Q Consensus 187 ~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~------- 247 (380)
++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987543221 12234689999999998641 33788999999999999999999999876421
Q ss_pred --------HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 248 --------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 248 --------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
.....+.... +.++ ......+++++++||.+||+.||.+|||+.|++
T Consensus 240 ~~~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGK-----------------YEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCC-----------------CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccC-----------------cccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 1222222210 0111 001124789999999999999999999999999
Q ss_pred cCCCcccccC
Q 016950 320 AHPFFDELRE 329 (380)
Q Consensus 320 ~hp~~~~~~~ 329 (380)
+||||++...
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=359.67 Aligned_cols=290 Identities=30% Similarity=0.491 Sum_probs=222.1
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCC-----------CCceeeece
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLKH 98 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~ 98 (380)
.+...++|++.+.||+|+||+||+|++..+++.||||++..+. ....+|+.+++.++ |+||+++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 4445678999999999999999999999999999999997543 23457888888876 899999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcC--
Q 016950 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDP-- 175 (380)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~-- 175 (380)
++.... .+...+++||||+.++|.+.+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEE
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccC
Confidence 885443 344578899999988998888753 23558999999999999999999999 8 9999999999999953
Q ss_pred ---CCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------h
Q 016950 176 ---LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------A 246 (380)
Q Consensus 176 ---~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~ 246 (380)
....+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+ .
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 2347999999999765432 2345789999999999765 48999999999999999999999998654 5
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCC------CCCc-cCCCCCCCCccc------ccCCCCChHHHHHHHhhcccCCCCCC
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPN------YTDF-RFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRC 313 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~ 313 (380)
.+.+..+...+|.++...+...... ...+ ........+... .++..+++++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 5677888888888876654321100 0000 000000000000 12233567899999999999999999
Q ss_pred CHHHHhcCCCcccccC
Q 016950 314 TALEACAHPFFDELRE 329 (380)
Q Consensus 314 t~~e~l~hp~~~~~~~ 329 (380)
|+.|+|+||||++...
T Consensus 327 t~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTLG 342 (373)
T ss_dssp CHHHHHTCGGGTTCTT
T ss_pred CHHHHhhChhhhcccC
Confidence 9999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=362.60 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=199.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCCCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 109 (380)
.+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+++.++ |+||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 469999999999999999999765 8999999986442 22357999999996 5999999998843 33
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|||+..++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++.
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecCccc
Confidence 4899999877888888763 4578999999999999999999999 7999999999999996 4679999999998
Q ss_pred cCccCCC---cceeeccCCCCChhhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHH
Q 016950 190 QLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIK 255 (380)
Q Consensus 190 ~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~~~~~~i~~ 255 (380)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 6643322 2346789999999998652 3589999999999999999999999987543 233332221
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. . .... ++...++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 283 ~---~------------~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 P---N------------HEIE------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp T---T------------SCCC------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred c---c------------ccCC------------CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0 0 0111 2233578999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=350.99 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=211.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 81 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHY 81 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEE
Confidence 4578999999999999999999999999999999986532 23458999999999999999999884 33458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE---cCCCCcEEEEeecc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS 187 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~ikl~Dfg~ 187 (380)
|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +|++||||||+||++ +. ++.+||+|||+
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg~ 155 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEE-NSKIMITDFGL 155 (304)
T ss_dssp EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSST-TCCEEBCSCST
T ss_pred EEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCC-CCCEEEccCCc
Confidence 899999975 77777753 3568999999999999999999999 799999999999999 43 67899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-------- 225 (304)
T 2jam_A 156 SKMEQN-GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-------- 225 (304)
T ss_dssp TCCCCC-BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC--------
T ss_pred ceecCC-CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 975432 22334568999999999865 45899999999999999999999999988877766666542111
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+ ...++..+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 226 ---------~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 226 ---------F--------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------C--------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------C--------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 0 111223579999999999999999999999999999999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=356.24 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=199.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCC--CceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~ 108 (380)
..+|++.+.||+|+||.||+|.+ .+++.||||++.... ....+|+.+++.++| +||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 45799999999999999999987 468999999986432 223579999999987 99999999884 34
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..+|+|||+.+++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeecccc
Confidence 45899999888898888863 4678999999999999999999999 7999999999999997 467999999999
Q ss_pred ccCccCCC---cceeeccCCCCChhhhhC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 016950 189 KQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEII 254 (380)
Q Consensus 189 ~~~~~~~~---~~~~~~t~~y~aPE~l~~----------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~ 254 (380)
........ .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 86644322 234678999999999854 245899999999999999999999999865432 2222222
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. .. . ...++...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 235 ~---~~------------~------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 235 D---PN------------H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp C---TT------------S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred c---CC------------c------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 1 00 0 1112334678999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=365.90 Aligned_cols=266 Identities=14% Similarity=0.124 Sum_probs=189.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhC--CCCceeeeceee-------
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM--DHPNVISLKHCF------- 100 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l--~h~niv~~~~~~------- 100 (380)
..+|++.+.||+|+||+||+|.+..+++.||||++..... ...+|+.+++.+ +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4459999999999999999999999999999999976432 223564444444 699988855333
Q ss_pred eecCC------------CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHhHcCCCee
Q 016950 101 FSTTS------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVC 162 (380)
Q Consensus 101 ~~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~ql~~al~~LH~~~~ii 162 (380)
..... .....+|+||||++++|.+.+..... .+.+... ..++.||+.||+|||+ +||+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS-KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence 21111 01145889999999999998875422 2344444 5677999999999999 7999
Q ss_pred ecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 016950 163 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF 241 (380)
Q Consensus 163 H~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf 241 (380)
||||||+|||++. ++.+||+|||+|+.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||
T Consensus 217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECT-TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECC-CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999996 77899999999985532 22245677999999999641 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+..... ...+............+.......+++.+.+||.+||+.||++|||+.++++|
T Consensus 294 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 8764220 00111111111111111122234689999999999999999999999999999
Q ss_pred CCcccccC
Q 016950 322 PFFDELRE 329 (380)
Q Consensus 322 p~~~~~~~ 329 (380)
|||+++.+
T Consensus 354 p~f~~~~~ 361 (371)
T 3q60_A 354 PEFLQLQN 361 (371)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=354.33 Aligned_cols=283 Identities=27% Similarity=0.478 Sum_probs=220.0
Q ss_pred cccceeeeeeeecCCceEEEEEEE-CCCCcEEEEEEeeccc---cchHHHHHHHHhCCCC------ceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++.... ....+|+.+++.++|+ +++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--- 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--- 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence 346899999999999999999998 5688999999986543 2345788888888665 48888888843
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC---------
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 176 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--------- 176 (380)
...+|+||||++++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 89 --~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 --HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp --TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred --CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCc
Confidence 3358899999988998888642 23468899999999999999999999 799999999999999853
Q ss_pred ---------CCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 016950 177 ---------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 247 (380)
Q Consensus 177 ---------~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~ 247 (380)
++.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 34699999999976432 23356789999999999654 5899999999999999999999999999998
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCC----CCccCCCCC---------CCCccc--ccCCCCChHHHHHHHhhcccCCCCC
Q 016950 248 DQLVEIIKVLGTPTREEIRCMNPNY----TDFRFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSPSLR 312 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R 312 (380)
+....+....+..+...+....... ....++... ..++.. ......++++.+||.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 8888888888887766554332110 000000000 000000 0011235789999999999999999
Q ss_pred CCHHHHhcCCCcccccC
Q 016950 313 CTALEACAHPFFDELRE 329 (380)
Q Consensus 313 ~t~~e~l~hp~~~~~~~ 329 (380)
||+.|+++||||+.++.
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 99999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=346.32 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=206.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GN 78 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CC
Confidence 45678999999999999999999999999999999986432 234579999999999999999998843 33
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..|+||||+++ +|.+.+. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~ 152 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLA 152 (276)
T ss_dssp EEEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCc
Confidence 48899999985 6655443 45679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 189 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 189 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
....... ......+|+.|+|||++.+...++.++|+|||||++|+|++|..||.+................
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------ 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------
Confidence 7653322 2234578999999999976554578999999999999999999999876543222111110000
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.. . ....+++.+.+||.+||+.||++|||+.|+++||||++..
T Consensus 227 ----------~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 227 ----------YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ----------TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ----------cc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 00 0 0123789999999999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.91 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=212.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CC
Confidence 3468999999999999999999999999999999985432 234589999999999999999998843 34
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeec
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG 186 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg 186 (380)
..|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++.+ +..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 58899999975 77776653 3468999999999999999999999 799999999999999753 2369999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
++.............+|+.|+|||++.+ .++.++|+||||+++|+|++|..||.+.+..+....+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 242 (287)
T 2wei_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD----- 242 (287)
T ss_dssp GGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred cceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-----
Confidence 9987655544455678999999999854 389999999999999999999999999887776665554211000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.+ ....+++++.+||.+||+.||++|||+.++++||||++..+
T Consensus 243 ----------~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 ----------LP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp ----------SG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred ----------ch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 00 11247899999999999999999999999999999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=353.79 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=204.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeec
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3478999999999999999999999999999999985432 234589999999999999999998732
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC--CcE
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQV 180 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~--~~i 180 (380)
.. .|+||||+.+ +|.+.+. ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++ ..+
T Consensus 87 ----~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 87 ----ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp ----SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCE
T ss_pred ----Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeE
Confidence 11 6899999985 7766654 45679999999999999999999999 7999999999999998632 249
Q ss_pred EEEeecccccCccCCCcceeeccCCCCChhhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016950 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
||+|||++.............+|+.|+|||++. +...++.++|||||||++|+|++|..||........+...+....
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (322)
T 2ycf_A 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236 (322)
T ss_dssp EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence 999999998664433333457899999999974 345589999999999999999999999987654332322222111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
.. +....+..+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 237 ~~------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 237 YN------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp CC------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cc------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 00 0011123478999999999999999999999999999999764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=358.51 Aligned_cols=277 Identities=20% Similarity=0.299 Sum_probs=207.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 467999999999999999999999999999999986432 23358999999999999999999885433 2347
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE----cCCCCcEEEEeec
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 186 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~ikl~Dfg 186 (380)
|+||||++ ++|.+.+.... ....+++..++.++.||+.||+|||+ +||+||||||+|||+ +. .+.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEEccCC
Confidence 89999998 57877776432 23448999999999999999999999 799999999999998 53 5679999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIK 255 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~----~~~~~~i~~ 255 (380)
++.............+|+.|+|||++.. ...++.++|||||||++|+|++|..||..... .+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9987766655556789999999999852 34589999999999999999999999975432 333444433
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
.........+...... .+.+.. .-+....+...+++.+.+||.+||++||++|||++|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENG--PIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTC--CEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCC--ccccCc--cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2111111111100000 000000 000011122235678999999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=353.27 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=209.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence 345789999999999999999999999999999999865421 2357888999999999999999885443 23
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....|+||||++ ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg 161 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFG 161 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCCS
T ss_pred CcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeecc
Confidence 345689999997 477777753 3578999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...........+..
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 240 (311)
T ss_dssp CC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc
Confidence 9976543321 2235689999999999765 5899999999999999999999999998877776665553222111
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus 241 -------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 -------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 112347999999999999999999999999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=342.96 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=214.0
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
|...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... .
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 78 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---T 78 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---G
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---C
Confidence 456789999999999999999999999999999999986432 2235799999999999999999987543 2
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----eeecCCCCCCEEEcCCCCcEE
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-----iiH~Dlkp~Nill~~~~~~ik 181 (380)
...+|+||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +| ++||||||+||+++. ++.+|
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~k 156 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVK 156 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEE
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEE
Confidence 3358899999985 8888887665556679999999999999999999999 79 999999999999996 77899
Q ss_pred EEeecccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 182 ICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-- 233 (279)
T 2w5a_A 157 LGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 233 (279)
T ss_dssp ECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred EecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc--
Confidence 999999976543322 2235679999999999764 489999999999999999999999998877666555544110
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..++..+++++.++|.+||+.||.+|||+.|+++|||+..-
T Consensus 234 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 --------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01223478999999999999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=372.61 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=193.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHH---HHHhCCCCceeeece-------e
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQ---LMRVMDHPNVISLKH-------C 99 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~---~l~~l~h~niv~~~~-------~ 99 (380)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ....+|+. +++.++||||+++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999999999999999986321 23357884 455558999999984 3
Q ss_pred eeecC---------CCCce---EEEEEeecccchHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 016950 100 FFSTT---------SKNEL---FLNLVMEYVPESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (380)
Q Consensus 100 ~~~~~---------~~~~~---~~~lv~e~~~~~l~~~l~~~~~~---~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~ 164 (380)
+.... ..+.. ..|+||||++|+|.+.+...... ...+++..+..++.||+.||+|||+ +||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 32211 11111 27899999999999888753221 1234458888899999999999999 799999
Q ss_pred CCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCC----------CCCCchhhHHHHHHHHHHH
Q 016950 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL 234 (380)
Q Consensus 165 Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~l 234 (380)
||||+|||++. ++.+||+|||+|+... .......| +.|+|||++.+. ..++.++|||||||++|+|
T Consensus 231 Dikp~NIll~~-~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQ-RGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcC-CCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999996 6789999999998532 23334566 999999999765 2589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC
Q 016950 235 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 314 (380)
Q Consensus 235 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 314 (380)
++|..||.+.+.......+. .....+++++.+||.+||+.||++|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 99999997654321111000 011347999999999999999999999
Q ss_pred HHHHhcCCCccccc
Q 016950 315 ALEACAHPFFDELR 328 (380)
Q Consensus 315 ~~e~l~hp~~~~~~ 328 (380)
+.++++||||+.++
T Consensus 354 ~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 354 PLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHTSHHHHHHH
T ss_pred HHHHhhChHHHHHH
Confidence 99999999998864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=354.01 Aligned_cols=283 Identities=25% Similarity=0.434 Sum_probs=219.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC-cEEEEEEeeccc---cchHHHHHHHHhCCCCc------eeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRVMDHPN------VISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||+||+|.+..++ +.||+|++.... ....+|+.+++.++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~---- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----
Confidence 468999999999999999999998877 689999986532 23457899999887665 7777777733
Q ss_pred CceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC-----------
Q 016950 107 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----------- 175 (380)
Q Consensus 107 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~----------- 175 (380)
...+|+||||+++++++.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred -CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccc
Confidence 3358899999999888877642 23568999999999999999999999 79999999999999932
Q ss_pred -------CCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 016950 176 -------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 248 (380)
Q Consensus 176 -------~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~ 248 (380)
..+.+||+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 267899999999975432 23346789999999999654 58999999999999999999999999999988
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCC----CccCCCCC---------CCCcccc--cCCCCChHHHHHHHhhcccCCCCCC
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYT----DFRFPQIK---------AHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRC 313 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~ 313 (380)
.+..+.+..+.++...+........ ...++... ..++... .....+.++.+||.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 8888888888877765543221100 00000000 0000000 0011245889999999999999999
Q ss_pred CHHHHhcCCCcccccCC
Q 016950 314 TALEACAHPFFDELREP 330 (380)
Q Consensus 314 t~~e~l~hp~~~~~~~~ 330 (380)
|+.|+++||||+++.+.
T Consensus 327 t~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPE 343 (355)
T ss_dssp CHHHHTTSGGGGGCCHH
T ss_pred CHHHHhcChhhcCCChh
Confidence 99999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=360.20 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=205.8
Q ss_pred CccccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeecc--------ccchHHHHHHHHhC-CCCceeeeceeee
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVM-DHPNVISLKHCFF 101 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~ 101 (380)
....++|++.+.||+|+||+||+|++. .+++.||||++.+. .....+|+.+++.+ +|+||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345689999999999999999999985 58999999988532 12334799999999 6999999999884
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcE
Q 016950 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~i 180 (380)
. ...+|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+
T Consensus 130 ~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~ 198 (355)
T 1vzo_A 130 T-----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHV 198 (355)
T ss_dssp E-----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCE
T ss_pred e-----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcE
Confidence 3 3348899999985 78777763 3568999999999999999999999 79999999999999996 7789
Q ss_pred EEEeecccccCccCC--CcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016950 181 KICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 257 (380)
||+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+....
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 999999997653322 22345789999999999753 347899999999999999999999997543222222221110
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
. . . ...++..+++.+.+||.+||+.||.+|| |+.++++||||+.+.+.
T Consensus 279 ~--------~-----~------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 279 L--------K-----S------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp H--------H-----C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred h--------c-----c------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 0 0 0 0012334789999999999999999999 99999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=343.76 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=206.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----Ce
Confidence 34578999999999999999999999999999999885432 2335799999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||||+++ +|...+.. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA 165 (302)
T ss_dssp EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence 8899999986 66665543 34669999999999999999999999 79999999999999996 7789999999875
Q ss_pred cCccC-CCcceeeccCCCCChhhhh----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~-~~~~~~~~t~~y~aPE~l~----~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
..... .......+|+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT---- 241 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence 32211 1223457899999999984 34458999999999999999999999999888776666554421100
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...+..++..+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus 242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 001234688999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=359.49 Aligned_cols=282 Identities=25% Similarity=0.407 Sum_probs=208.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 105 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 105 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CE
Confidence 3568999999999999999999999999999999986542 2345799999999999999999988543 34
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
+|+||||+++ +|.+.+.. ...+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|||++
T Consensus 106 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFGVS 179 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCCCC
T ss_pred EEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECCCC
Confidence 8899999985 88777763 3568999999999999999999998 6 9999999999999996 778999999998
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHhh
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 267 (380)
...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... +.+.......
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 654322 22346789999999999654 58999999999999999999999999877655433221111 1100000000
Q ss_pred c--CCCCCCccCCCC------------CCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 268 M--NPNYTDFRFPQI------------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~--~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
. ......+..... ............+++++.+||.+||++||++|||+.|+|+||||+...+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 0 000000000000 00000111123478899999999999999999999999999999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=349.12 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=192.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----EL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----CE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----Cc
Confidence 46799999999999999999999999999999988533 223357889999999999999999885433 38
Q ss_pred EEEeeccc-chHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 112 NLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
++||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEEEEecc
Confidence 89999997 478777764332 24568999999999999999999999 79999999999999996 7789999999
Q ss_pred ccccCccCC------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 187 SAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 187 ~a~~~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+......... +
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~ 244 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--P 244 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--C
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--C
Confidence 987553321 12345789999999998654458999999999999999999999998877665544333211 0
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
. ..............+++++.+||.+||+.||.+|||+.++++||||++....
T Consensus 245 ~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 245 P-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp C-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred C-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 0 0000000111234578999999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=344.85 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=207.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhC-CCCceeeeceeeeecCCC-Cc
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NE 108 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~ 108 (380)
....++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.+ +||||+++++++...... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34567899999999999999999999999999999998643 23446899999998 899999999998654321 13
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCcC
Confidence 458899999985 888877643 23568999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+....... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+.... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--- 251 (326)
T 2x7f_A 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-A--- 251 (326)
T ss_dssp TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C---
T ss_pred ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-c---
Confidence 87654322 2334578999999999852 3458899999999999999999999998887766655443310 0
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+ ......+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus 252 ---------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 ---------------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ---------------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ---------------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0 01123478999999999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=343.19 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=206.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++... ..+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEE
Confidence 3567999999999999999999999999999999987543 3346899999999999999999988543 34889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus 102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLT 176 (314)
T ss_dssp EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECB
T ss_pred EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhhh
Confidence 9999986 77777653 35679999999999999999999999 79999999999999996 7789999999997654
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 177 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----------- 243 (314)
T 3com_A 177 DTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P----------- 243 (314)
T ss_dssp TTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----------
T ss_pred hhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c-----------
Confidence 332 23345789999999998654 589999999999999999999999988776655544333100 0
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+ ..+..+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 244 --~~------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 --TF------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp --CC------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred --cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00 01223689999999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=350.70 Aligned_cols=267 Identities=22% Similarity=0.354 Sum_probs=187.2
Q ss_pred Cccccceeeee-eeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 34 PKQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 34 ~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
....++|.+.+ .||+|+||+||+|.++.+++.||||++........+....++.++|+||+++++++.... .+..+++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 102 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLL 102 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEE
Confidence 34567899965 699999999999999999999999999776555545555677889999999999885433 3356688
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeecccc
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 189 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~a~ 189 (380)
+||||+.+ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ .+.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 99999986 888877642 23579999999999999999999999 799999999999999752 3459999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 247 (336)
T 3fhr_A 180 ETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---------- 247 (336)
T ss_dssp EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred ecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----------
Confidence 65432 2334677999999999854 45899999999999999999999999776544332211111000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+.++ ......+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 248 ---~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 ---GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000011 01123479999999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=339.88 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=204.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeC
Confidence 3567999999999999999999999999999999885322 2235799999999999999999988 344
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~ 157 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGI 157 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCSS
T ss_pred CeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCCC
Confidence 458899999986 77777753 3578999999999999999999999 79999999999999996 77899999999
Q ss_pred cccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 188 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 188 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+............ .+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~----- 230 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP----- 230 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC-----
T ss_pred ccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC-----
Confidence 986543322 2345789999999999765 48999999999999999999999999888766554443311 01
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.....+...+++.+.++|.+||+.||.+||+..+.+.++|..-+.
T Consensus 231 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 ------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111123345799999999999999999999777777777765543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=341.30 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=209.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+.|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence 356999999999999999999999999999999986432 3346899999999999999999988543 348
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+. ...+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeeccccee
Confidence 899999986 6666653 3578999999999999999999999 79999999999999996 77899999999976
Q ss_pred CccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ......+|+.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+... .+
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 236 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP--------- 236 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC---------
T ss_pred cCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC---------
Confidence 54432 22345789999999999654 5899999999999999999999999888776655544331 00
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..++..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus 237 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01223478999999999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=338.72 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=200.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCC-------
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTS------- 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------- 105 (380)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4578999999999999999999999999999999986433 233579999999999999999998765321
Q ss_pred -CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEE
Q 016950 106 -KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC 183 (380)
Q Consensus 106 -~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~ 183 (380)
......|+||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEe
Confidence 345678999999985 88888763 34567889999999999999999999 79999999999999986 7789999
Q ss_pred eecccccCccC---------------CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-H
Q 016950 184 DFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-V 247 (380)
Q Consensus 184 Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~-~ 247 (380)
|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++ ||..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999765321 112345689999999999766668999999999999999998 5543222 2
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
+....+... ...+ ...+....++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 236 ~~~~~~~~~-----------------~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 236 NILKKLRSV-----------------SIEF--------PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHST-----------------TCCC--------CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHhcccc-----------------cccc--------CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 222222110 0011 111334568889999999999999999999999999999763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=346.86 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=205.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeeee
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFS 102 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~ 102 (380)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++ |+||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~- 118 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE- 118 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence 34568999999999999999999999999999999986432 23357999999996 599999999884
Q ss_pred cCCCCceEEEEEeeccc--chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcE
Q 016950 103 TTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV 180 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~i 180 (380)
.....++|+|++. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+
T Consensus 119 ----~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 119 ----RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp ----CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred ----cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence 3345889999997 678877763 3578999999999999999999999 7999999999999998557889
Q ss_pred EEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 181 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
||+|||++...... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||...+. +.. +
T Consensus 190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-- 258 (320)
T 3a99_A 190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-- 258 (320)
T ss_dssp EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C--
T ss_pred EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c--
Confidence 99999999865433 233467899999999997665557899999999999999999999965321 111 0
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
. ..++..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 259 -------------~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 259 -------------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------c------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 0 012235799999999999999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=338.26 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=201.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
++|.....||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ....++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 34445559999999999999999999999999986542 234579999999999999999998843 334889
Q ss_pred Eeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +|++||||||+||+++..++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999997 5777777642 223456788999999999999999999 7999999999999998657789999999997654
Q ss_pred cCC-CcceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 243 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV----------- 243 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-----------
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-----------
Confidence 322 22345789999999998653 23789999999999999999999999765433222111111110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
...++..+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 244 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 244 ---------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ---------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0112345799999999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=345.61 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=186.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-----hHHHHH-HHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ...|+. +++.++||||+++++++.. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CCc
Confidence 46899999999999999999999999999999998654221 123444 6777899999999998853 334
Q ss_pred EEEEeecccchHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.++||||+.++|.+.+..... ....+++..++.++.|++.||.|||+ + |++||||||+||+++. ++.+||+|||++
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~ 173 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCDFGIS 173 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECCCSSS
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEccCCCc
Confidence 889999999988877764322 35779999999999999999999999 8 9999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhh---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 189 KQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~---~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..... +....
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-------- 243 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LTQVV-------- 243 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCC--------
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--HHHHh--------
Confidence 8765544444557899999999983 2344889999999999999999999999865422110 00000
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
. .....+.......+++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus 244 --------~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 244 --------K-----GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp --------C-----SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred --------c-----CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 0 00001111122357999999999999999999999999999999987543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=342.20 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=190.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...++..+++.++||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----N 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----C
Confidence 456789999999999999999999999999999999865422 11234456788899999999998843 3
Q ss_pred eEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~-~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...|+||||+++.+..+... ....+++..++.++.||+.||.|||+ + |++||||||+||+++. ++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEECCC
Confidence 35889999997655544432 35678999999999999999999998 6 9999999999999996 77899999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~ 262 (380)
+.............+|+.|+|||++.+ ...++.++|||||||++|+|++|..||... ...+.+..+.... +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~- 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP- 248 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC-
Confidence 976655544455678999999999852 345789999999999999999999999874 3444444443310 00
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..+ ....+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus 249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 000 0124789999999999999999999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=347.87 Aligned_cols=275 Identities=20% Similarity=0.332 Sum_probs=207.2
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------------------cchHHHHHHHHhCCCCce
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRVMDHPNV 93 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------------------~~~~~e~~~l~~l~h~ni 93 (380)
...++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3457899999999999999999998 99999999985321 445689999999999999
Q ss_pred eeeceeeeecCCCCceEEEEEeecccc-hHHHHHHHh--hhc--CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 94 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 94 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
+++++++.. ...+|+||||+++ +|.+.+... ... ...+++..++.++.||+.||.|||+.+|++||||||
T Consensus 106 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 106 LTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred ceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 999999843 3458899999986 655541100 112 567999999999999999999999723999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh-
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA- 246 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~~DiwslGvil~~ll~g~~pf~~~~~- 246 (380)
+||+++. ++.+||+|||++...... ......+|+.|+|||++.+...++. ++|||||||++|+|++|..||.+.+.
T Consensus 181 ~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 181 SNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred HhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 9999996 778999999999865433 3334678999999999976545666 99999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+....+.......+. ....+..+ .. ..........+++++.+||.+||+.||.+|||+.++++||||++
T Consensus 259 ~~~~~~i~~~~~~~~~--------~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYPL--------DRNHFLYP-LT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCCC--------SSSSSTTT-TC-C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCcc--------chhhhhcc-cc-ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 4444433221000000 00000000 00 00011122458999999999999999999999999999999987
Q ss_pred cc
Q 016950 327 LR 328 (380)
Q Consensus 327 ~~ 328 (380)
..
T Consensus 329 ~~ 330 (348)
T 2pml_X 329 TN 330 (348)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=338.85 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=195.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++.+.||+|+||+||+|++ +++.||+|++..... ...+|+.+++.++||||+++++++.. ...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----PPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----TTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCc
Confidence 56899999999999999999987 688999999864432 23479999999999999999998843 333
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
+++||||+.+ +|.+.+.... ....+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECCCCC
Confidence 7899999985 7877776321 11238999999999999999999999 79 999999999999996 77899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------- 257 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------- 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred CccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-------
Confidence 97543332 23346789999999999654 4899999999999999999999999988877666554331111
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc--CCCccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 326 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~ 326 (380)
..++..+++++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 258 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 --------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1123458999999999999999999999999986 455543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=339.74 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=200.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||+||+|.+..+++.||||++... .....+|+.+++.+ +|+||+++++++.. ....|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccE
Confidence 446799999999999999999999999999999998643 33467899999999 99999999998844 33588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc-----EEEEeecc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGS 187 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~-----ikl~Dfg~ 187 (380)
+||||+.++|.+++... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++. +||+|||+
T Consensus 82 lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEECCCTT
T ss_pred EEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEEEccc
Confidence 99999987888888642 4679999999999999999999999 79999999999999986 454 99999999
Q ss_pred cccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Q 016950 188 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKV 256 (380)
Q Consensus 188 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~ 256 (380)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. .+.+..+...
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 986544322 235678999999999965 4589999999999999999999999987543 3333333322
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....+.+. ....++ ++.+||.+||+.||.+||+++++++
T Consensus 236 ~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 236 KRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111111 111234 9999999999999999999988775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=340.69 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=198.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhC----CCCceeeeceee
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVM----DHPNVISLKHCF 100 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l----~h~niv~~~~~~ 100 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34568999999999999999999999999999999985432 2234799999998 899999999988
Q ss_pred eecCCCCceEEEEEeec-cc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 101 FSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 101 ~~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
.. ....++|+|+ +. ++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+||+++..++
T Consensus 108 ~~-----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 108 ET-----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT
T ss_pred ec-----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC
Confidence 33 3347899998 55 588877763 3568999999999999999999999 79999999999999985478
Q ss_pred cEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 016950 179 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 179 ~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
.+||+|||++...... ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.... .+...
T Consensus 178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-- 248 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-- 248 (312)
T ss_dssp EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence 8999999999865433 23456789999999998765545669999999999999999999996532 11110
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
.. .++..+++.+.+||.+||+.||++|||+.|+++||||+....
T Consensus 249 ---------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 249 ---------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp ---------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ---------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 00 123357999999999999999999999999999999997644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=348.21 Aligned_cols=256 Identities=18% Similarity=0.215 Sum_probs=205.1
Q ss_pred cccceeeeeeeecCCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++++.||+|+||+||+|. +..+++.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 34789999999999999999999 45678899999985432 223479999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCc
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQ 179 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ 179 (380)
....|+||||+. ++|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+ +..
T Consensus 146 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 --SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCce
Confidence 333689999997 488888875432 23468999999999999999999999 799999999999999842 335
Q ss_pred EEEEeecccccCccC---CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 255 (380)
+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999754221 222345678899999999654 48999999999999999998 9999999887776665543
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.... ..+..+++.+.+||.+||+.||.+|||+.++++|.++-.
T Consensus 302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2110 012347899999999999999999999999999988754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.31 Aligned_cols=250 Identities=18% Similarity=0.217 Sum_probs=202.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.+ +|+|++++++++. .....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeE
Confidence 346799999999999999999999999999999988643 34567899999999 7999999998873 334588
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC-----cEEEEeecc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGS 187 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~-----~ikl~Dfg~ 187 (380)
+||||+.++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++ .+||+|||+
T Consensus 83 lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCCTT
T ss_pred EEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEECcc
Confidence 9999998888888864 34569999999999999999999999 79999999999999975 33 399999999
Q ss_pred cccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Q 016950 188 AKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKV 256 (380)
Q Consensus 188 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~---~~~~~~~i~~~ 256 (380)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ..+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 986544322 2345789999999998654 48999999999999999999999998743 33444443332
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...++... +...+++++.+||.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 21111111 12247999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=335.63 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=197.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCC--CCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~ 107 (380)
...+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++ |+||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-----
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-----
Confidence 4467999999999999999999975 58899999986432 22357999999997 5999999998843
Q ss_pred ceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 108 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 108 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
....|+|||+..++|.+.+.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++ ++.+||+|||+
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCSS
T ss_pred CCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeEEEeeccc
Confidence 345889999888898888863 4578999999999999999999999 7999999999999997 47899999999
Q ss_pred cccCccCCC---cceeeccCCCCChhhhhCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Q 016950 188 AKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEI 253 (380)
Q Consensus 188 a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----------~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i 253 (380)
+........ .....+|+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 986543322 2245689999999998641 35788999999999999999999999765432 222222
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
... . . ...++...++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 253 ~~~--------------~-~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 253 IDP--------------N-H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HCT--------------T-S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred Hhc--------------c-c------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 110 0 0 0112234688999999999999999999999999999998743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.12 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=201.5
Q ss_pred cccceeeeeeeecCCceEEEEEEEC-------CCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeee
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFS 102 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~ 102 (380)
..++|++.+.||+|+||.||+|++. .++..||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999975 3456799999865422 235799999999 89999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCC
Q 016950 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~ 169 (380)
...+|+||||+.+ +|.+.+..... ....+++..+..++.||+.||+|||+ +||+||||||+
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~ 232 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAAR 232 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchh
Confidence 3348899999985 88888875321 23458999999999999999999999 79999999999
Q ss_pred CEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016950 170 NLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 245 (380)
Q Consensus 170 Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~ 245 (380)
|||++. ++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 233 NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999996 78899999999986543322 2234567889999999764 48999999999999999999 999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+....+..... ...+..+++++.+||.+||+.||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6665544432100 01223478999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=335.64 Aligned_cols=255 Identities=24% Similarity=0.423 Sum_probs=202.2
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ...
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----Cee
Confidence 3578999999999999999999999999999999885432 2345899999999999999999998543 348
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++||||+.+ +|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGLARL 157 (310)
T ss_dssp EEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeeccccee
Confidence 899999985 78777764 35679999999999999999999999 79999999999999996 78899999999976
Q ss_pred CccCCCc---------------ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016950 191 LIAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 191 ~~~~~~~---------------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 255 (380)
....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---- 232 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---- 232 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence 5332221 14578999999999965 458999999999999999999999987543210000
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
............+..+++.+.+||.+||+.||++|||+.++++ |++.++.
T Consensus 233 ----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 233 ----------------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp ----------------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred ----------------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 0000000111123457899999999999999999999999986 7776643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=338.92 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=200.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
...++|++.+.||+|+||.||+|.+..+++ .||||++.... ....+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 345789999999999999999999986655 49999986532 2335799999999999999999988 3
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....|+||||+++ +|.+.+.. ....+++..+..++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Df 195 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVSDF 195 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEECCC
Confidence 34458899999975 77777753 34579999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 999866443221 123446789999999654 48999999999999999999 999999888777666554421111
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12347999999999999999999999999885
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=355.90 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=192.8
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
.+|.+.+.||+|+||+|+. ....+++.||||++... .....+|+.+++.+ +||||+++++++. +..+.|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEE
Confidence 4699999999999999763 44668999999998644 34457899999999 7999999998883 344589999
Q ss_pred ecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC----CCcEEEEeecccccC
Q 016950 116 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGSAKQL 191 (380)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~----~~~ikl~Dfg~a~~~ 191 (380)
|||+++|.+.+.. ....+.+..+..++.||+.||+|||+ +||+||||||+|||++.. ..++||+|||+|+..
T Consensus 98 E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999999888864 23345555677899999999999999 799999999999999531 236889999999866
Q ss_pred ccCC----CcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 192 IAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 192 ~~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
.... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||........ ..+. +...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~---~~~~--- 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILL---GACS--- 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHT---TCCC---
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHh---ccCC---
Confidence 4332 2334678999999999864 3447889999999999999999 9999965543322 1111 1110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.+... .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus 247 ------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 247 ------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp ------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000 0011356789999999999999999999999999998654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=329.37 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=210.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC----------
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT---------- 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------- 104 (380)
....+|++.+.||+|+||.||+|.+..+++.||+|++........+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3457899999999999999999999999999999999877777889999999999999999998874311
Q ss_pred -CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 105 -SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 105 -~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
......+++||||+++ +|.+.+... ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl 163 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKI 163 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEE
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEE
Confidence 1235568899999996 888888643 24578999999999999999999999 79999999999999996 788999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+|||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.... .....+..
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~------- 233 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD------- 233 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT-------
T ss_pred CcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc-------
Confidence 999999876655555566789999999999654 58999999999999999999998874211 11111110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..++..+++.+.+||.+||+.||.+|||+.++++|++.-.
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0012337899999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=338.11 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=185.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCC-CCceeeeceeeeecCC---CCce
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS---KNEL 109 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~~~ 109 (380)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999885432 22357899999995 9999999998854322 4556
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+++||||+.|+|.+.+.... ....+++..++.++.||+.||.|||+ +| |+||||||+|||++. ++.+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEecCcc
Confidence 688999999999988886533 34579999999999999999999999 79 999999999999996 77899999999
Q ss_pred cccCccCCCc-------------ceeeccCCCCChhhhh--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016950 188 AKQLIAGEAN-------------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (380)
Q Consensus 188 a~~~~~~~~~-------------~~~~~t~~y~aPE~l~--~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 252 (380)
+......... ....+|+.|+|||++. ....++.++|||||||++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9865433221 1346899999999983 234578999999999999999999999976543222110
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
. +.. ......++.+.+||.+||+.||.+|||+.++++|-+
T Consensus 265 ~---------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---------------------YSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---------------------ccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 000 011236788999999999999999999999998744
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=328.66 Aligned_cols=246 Identities=19% Similarity=0.308 Sum_probs=201.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence 3468999999999999999999986 57789999997543 334589999999999999999998843 33488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEeccccccccc
Confidence 99999985 67777653 34568999999999999999999999 79999999999999986 678999999999755
Q ss_pred ccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ......+|+.|+|||++.+. .++.++|+||+||++|+|++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 3321 12234557789999999654 48999999999999999999 9999999887776665543211
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..+++.+.++|.+||+.||++|||+.++++|
T Consensus 226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01123468999999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=351.80 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=190.2
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhC-CCCceeeeceeeeecCCCCceEEEEEe
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.|.+.+.||+|+||+||.+ ...+|+.||||++..+. ....+|+.+++.+ +||||+++++++ .....+|+||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence 45788899999999999875 45689999999986543 2346899999876 899999999887 3445589999
Q ss_pred ecccchHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC------------CCcE
Q 016950 116 EYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------------THQV 180 (380)
Q Consensus 116 e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~------------~~~i 180 (380)
|||+++|.+.+......... .++..++.++.||+.||+|||+ +||+||||||+|||++.. ...+
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99999998888643221111 1333457799999999999999 799999999999999742 3479
Q ss_pred EEEeecccccCccCCC-----cceeeccCCCCChhhhhC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016950 181 KICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (380)
Q Consensus 181 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~------~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 248 (380)
||+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+....+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999987644322 124578999999999965 2458999999999999999999 999997654432
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+.... +..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 --~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 --SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp --HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred --HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 2222211 0111100 0001124688999999999999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=337.33 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=189.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++.+.||+|+||.||+|.+..++. .||+|++.... ....+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999999887765 89999886432 2345899999999999999999988654332
Q ss_pred C-ceEEEEEeecccc-hHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 107 N-ELFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 107 ~-~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
+ ....++||||+.+ +|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~kl 178 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTVCV 178 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCEEE
Confidence 1 1234899999986 78777754332 22368999999999999999999999 79999999999999996 788999
Q ss_pred EeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999976543322 2234457789999999664 48999999999999999999 9999998887766665543210
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-------HHHHhcCCCccccc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDELR 328 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~e~l~hp~~~~~~ 328 (380)
. ..+..+++++.+||.+||+.||.+||| +++++.|||+....
T Consensus 258 ~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 258 L----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred C----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0 112347899999999999999999999 78899999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=340.97 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=201.9
Q ss_pred ccceeeeeeeecCCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|. +..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence 5789999999999999999999 55677999999996532 2245799999999 789999999988432
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhc----------------------------------------------------
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA---------------------------------------------------- 132 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~---------------------------------------------------- 132 (380)
...+++||||+.+ +|.+.+......
T Consensus 99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 2237799999985 888887653211
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC---cce
Q 016950 133 ----------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NIS 199 (380)
Q Consensus 133 ----------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~ 199 (380)
...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++........ ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccc
Confidence 1228999999999999999999999 79999999999999986 77899999999986543322 224
Q ss_pred eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCC
Q 016950 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278 (380)
Q Consensus 200 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (380)
..+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+...+.....+
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 315 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------ 315 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence 5678899999999754 58999999999999999998 999999877655555544421111
Q ss_pred CCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123478999999999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.92 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=196.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCCCceeeeceeeeec
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-- 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--
Confidence 34568999999999999999999999999999999985322 23457999999999999999999872
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCc-
Q 016950 104 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQ- 179 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~- 179 (380)
+.. ++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +| |+||||||+||+++. ++.
T Consensus 94 ---~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~~ 163 (287)
T 4f0f_A 94 ---NPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDEN 163 (287)
T ss_dssp ---TTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCTT
T ss_pred ---CCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCCC
Confidence 222 49999998 577776653 44579999999999999999999999 79 999999999999985 443
Q ss_pred ----EEEEeecccccCccCCCcceeeccCCCCChhhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Q 016950 180 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LVE 252 (380)
Q Consensus 180 ----ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~--~~~ 252 (380)
+||+|||++..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.... ...
T Consensus 164 ~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp CSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred CceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 99999999975432 3344678999999999843 23468899999999999999999999987654333 222
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+.. .+ +...++..+++++.+||.+||+.||.+|||+.++++
T Consensus 242 ~~~-~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 242 IRE-EG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHH-SC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hhc-cC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 221 11 111133457999999999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.14 Aligned_cols=246 Identities=19% Similarity=0.288 Sum_probs=201.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++||||+++++++ ......+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4578999999999999999999865 56789999986543 2345899999999999999999988 3334488
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+++ +|.+.+... ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccceec
Confidence 99999975 687777642 3468999999999999999999999 79999999999999996 778999999999765
Q ss_pred ccCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 224 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL--------- 224 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred chhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------
Confidence 433221 223456779999999654 48999999999999999999 99999988877666554431100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+...++.+.++|.+||+.||++|||+.++++|
T Consensus 225 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 -------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0122368899999999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.01 Aligned_cols=268 Identities=23% Similarity=0.263 Sum_probs=198.1
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||+||+|++. ++.||||++..... ...+|+.+++.++||||+++++++.... .....+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 3468999999999999999999874 78999999864432 2345888899999999999999986544 2244578
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC----------CeeecCCCCCCEEEcCCCCcEE
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------RVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~----------~iiH~Dlkp~Nill~~~~~~ik 181 (380)
+||||+++ +|.+.+.. ..+++..++.++.|++.||+|||+ . ||+||||||+|||++. ++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TCCEE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CCeEE
Confidence 99999985 88887753 458999999999999999999999 8 9999999999999996 78899
Q ss_pred EEeecccccCccCCC---cceeeccCCCCChhhhhCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 016950 182 ICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 254 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~----~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~ 254 (380)
|+|||++........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999976543322 2335789999999999653 235678899999999999999999998754322221122
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.....+....+...... ....+. +...+ ....++++.+||.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVH--KKKRPV-----LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHHHHHTT--SCCCCC-----CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhhhhhhc--ccCCCC-----ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222333222211000 000000 00000 0113456999999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=338.38 Aligned_cols=258 Identities=15% Similarity=0.132 Sum_probs=197.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-----CcEEEEEEeeccccchHHH---------------HHHHHhCCCCceeee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRE---------------LQLMRVMDHPNVISL 96 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~e---------------~~~l~~l~h~niv~~ 96 (380)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........+| +..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999998765 5889999987654433333 344556679999999
Q ss_pred ceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc--
Q 016950 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-- 174 (380)
Q Consensus 97 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~-- 174 (380)
++++.... .+..+.|+||||+.++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESS
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecC
Confidence 99886543 34567899999997788888764 34679999999999999999999999 7999999999999998
Q ss_pred CCCCcEEEEeecccccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 016950 175 PLTHQVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 246 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~ 246 (380)
. ++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...
T Consensus 189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 189 N-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp C-TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred C-CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 4 67899999999976543221 1234589999999999654 489999999999999999999999986433
Q ss_pred HHHHHHHHHH-hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 247 VDQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 247 ~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.......... ........+.... ....+++++.+|+.+||+.||.+||++.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCF-------------------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHS-------------------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhc-------------------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3332222221 1111111111100 01247899999999999999999999998875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=339.18 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=202.9
Q ss_pred cccceeeeeeeecCCceEEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeee
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS 102 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~ 102 (380)
..++|.+.+.||+|+||.||+|++..+ +..||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 347899999999999999999997543 3579999986542 2235799999999 99999999998843
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCC
Q 016950 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ 169 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~ 169 (380)
....|+||||+.+ +|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~ 220 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR 220 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence 3337899999985 88888875331 12469999999999999999999999 79999999999
Q ss_pred CEEEcCCCCcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 016950 170 NLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN 245 (380)
Q Consensus 170 Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~ 245 (380)
|||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 221 NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 221 NVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999996 7889999999998654332 22334568889999999764 58999999999999999999 999999887
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 246 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+....+..... ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665554433110 01123479999999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=326.40 Aligned_cols=253 Identities=24% Similarity=0.257 Sum_probs=200.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++|++++..+..+.. .....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence 44578999999999999999999999999999999886433 345689999999999887776655533 233478
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc--CCCCcEEEEeeccccc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQ 190 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~--~~~~~ikl~Dfg~a~~ 190 (380)
+||||+.++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||++..
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999998888888763 34579999999999999999999999 7999999999999994 2367899999999986
Q ss_pred CccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 016950 191 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT 259 (380)
Q Consensus 191 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~~~ 259 (380)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. .+.+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 544322 2345789999999999654 489999999999999999999999986432 2233333321111
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+.. .+...+++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 TPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CchH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1111 112347899999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=341.58 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQP 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCC
Confidence 4578999999999999999999999999999999986432 234579999999999999999998843 334
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+||||++ ++|.+.+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCCCce
Confidence 789999998 588887764 23468999999999999999999999 79999999999999996 7789999999997
Q ss_pred cCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 190 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 190 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
....... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 333 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------- 333 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-------
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 5432211 1122346789999999654 48999999999999999998 9999998877665544332100
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ..+..+++++.+||.+||+.||++|||+.++++
T Consensus 334 ---------~------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 ---------L------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------C------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 012347899999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=335.56 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=202.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEE--EEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
...++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----
Confidence 34478999999999999999999999898865 99988642 23346799999999 89999999999843
Q ss_pred CceEEEEEeecccc-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
...+|+||||+++ +|.+.+.... .....+++..++.++.||+.||.|||+ +||+||||||+||++
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV 175 (327)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred -CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence 3358899999975 8888876432 223579999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 252 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~ 252 (380)
+. ++.+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cC-CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 86 778999999999754433333445668899999999654 48999999999999999998 9999998877665544
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+.... ....+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32210 001123478999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=332.27 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=201.3
Q ss_pred cccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
...+|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3578999999999999999999983 456899999986532 233579999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~ 164 (380)
....|+||||+. ++|.+.+..... ....+++..++.++.||+.||+|||+ +||+||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~ 174 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVHR 174 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEECC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCccc
Confidence 334789999998 588888875432 12348999999999999999999999 799999
Q ss_pred CCCCCCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 016950 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 240 (380)
Q Consensus 165 Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~p 240 (380)
||||+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 175 dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999996 78899999999976543322 1234557889999999764 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
|.+.+.......+..... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998876655544332100 0122347999999999999999999999999986
Q ss_pred C
Q 016950 321 H 321 (380)
Q Consensus 321 h 321 (380)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=324.05 Aligned_cols=243 Identities=28% Similarity=0.435 Sum_probs=189.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 46899999999999999999997 48899999885431 23457999999999999999999883 33
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC---eeecCCCCCCEEEcCC-------C
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---VCHRDLKPQNLLVDPL-------T 177 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~---iiH~Dlkp~Nill~~~-------~ 177 (380)
...|+||||+++ +|.+.+. ...+++..++.++.|++.||.|||+ +| ++||||||+||+++.. +
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccC
Confidence 448899999985 6655552 4679999999999999999999999 79 9999999999999752 5
Q ss_pred CcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 016950 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~ 257 (380)
+.+||+|||++....... .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp CCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred cceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 679999999997654332 2345789999999999654 48999999999999999999999999887666554443210
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....++..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0111234578999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=351.68 Aligned_cols=273 Identities=22% Similarity=0.336 Sum_probs=201.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 467999999999999999999999999999999986432 23358999999999999999999885432 2347
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE----cCCCCcEEEEeec
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKICDFG 186 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill----~~~~~~ikl~Dfg 186 (380)
|+||||+.+ +|.+.+.... ....+++..++.++.||+.||+|||+ +||+||||||+|||+ +. .+.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEEecCC
Confidence 899999974 7777765422 23348999999999999999999999 799999999999998 53 5679999999
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIK 255 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~-------~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~ 255 (380)
++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99876555545566789999999998541 347889999999999999999999997432 2344444433
Q ss_pred HhCCCCHHHHhhcCC-CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 256 VLGTPTREEIRCMNP-NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
+.|. ..+..... ....+.+.. ..+....+...+++.+.+||++||++||++|+|+.++++
T Consensus 242 --~~p~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKPS-GAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCCT-TCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCCc-ccchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 2222 11110000 000000000 000011122235678899999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=337.31 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=201.5
Q ss_pred cccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV--- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence 3578999999999999999999987 455899999986542 234579999999999999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~ 164 (380)
....|+||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~ 198 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR 198 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence 3347899999985 888888653211 2678999999999999999999999 799999
Q ss_pred CCCCCCEEEcCCCCcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 016950 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPL 240 (380)
Q Consensus 165 Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~p 240 (380)
||||+|||++. ++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 199 Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999986 7789999999987543221 22345678899999998754 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 241 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 241 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
|.+.+..+....+..... ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 998887666655443100 0122357899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.81 Aligned_cols=252 Identities=23% Similarity=0.262 Sum_probs=197.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++|++++..+..+.. .....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCceE
Confidence 3457899999999999999999999999999999986433 3456789999999999888777666543 233478
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE---cCCCCcEEEEeecccc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK 189 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill---~~~~~~ikl~Dfg~a~ 189 (380)
+||||+.++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||+ +. ++.+||+|||++.
T Consensus 82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTCE
T ss_pred EEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCccce
Confidence 9999998888888763 34579999999999999999999999 799999999999999 54 6789999999998
Q ss_pred cCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 016950 190 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG 258 (380)
Q Consensus 190 ~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 258 (380)
....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence 6544322 2345789999999999654 4899999999999999999999999875432 22222222111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+. ......+++++.+||.+||+.||++|||+.++++
T Consensus 236 ~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 236 STPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCH------------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cchh------------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1111 1112347899999999999999999999999885
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=334.01 Aligned_cols=256 Identities=14% Similarity=0.151 Sum_probs=192.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECC---CCcEEEEEEeeccccc---------------hHHHHHHHHhCCCCceeeece
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRVMDHPNVISLKH 98 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~---------------~~~e~~~l~~l~h~niv~~~~ 98 (380)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...... ..+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 7889999998654322 225667788889999999999
Q ss_pred eeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC
Q 016950 99 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 178 (380)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~ 178 (380)
++.... .+....|+||||+.++|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~ 188 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-KN 188 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-SS
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-CC
Confidence 886533 33566899999997788777653 3379999999999999999999999 79999999999999986 44
Q ss_pred --cEEEEeecccccCccCC--------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--Ch
Q 016950 179 --QVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NA 246 (380)
Q Consensus 179 --~ikl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~--~~ 246 (380)
.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +.
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 89999999997653221 11345789999999999764 5899999999999999999999999653 22
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..............+...... .+ ...+++++.+||.+||+.||++|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKW-AP-------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHH-SC-------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhcccccHHHHhh-cc-------------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222222222111111111 00 0147899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.23 Aligned_cols=247 Identities=18% Similarity=0.262 Sum_probs=199.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...++|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+.+++.++|+||+++++++. .....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence 34578999999999999999999876 67789999997543 33458999999999999999999883 33448
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEcccccccc
Confidence 89999997 577777753 23568999999999999999999999 79999999999999996 77899999999975
Q ss_pred CccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 191 LIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 191 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
..... ......+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 240 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------- 240 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--------
T ss_pred ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC--------
Confidence 53321 11233457789999999755 48999999999999999998 99999988877766655442111
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 241 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 --------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123468999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=328.43 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=202.2
Q ss_pred ccceeeeeeeecCCceEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence 46899999999999999999985 4577899999986542 2345799999999 99999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
....++||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +|++||||||+|
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~N 175 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccce
Confidence 3337899999985 88888865321 12358999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
|+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 176 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99996 78899999999986654432 1234567889999998654 48999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.............+ ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 65555554421110 1123478999999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=333.48 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=200.9
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++... .....+|+.+++.+ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee---
Confidence 468999999999999999999973 45678999998643 22345899999999 89999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecC
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~D 165 (380)
....|+||||+++ +|.+.+...... ...+++..++.++.||+.||+|||+ +||+|||
T Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D 197 (344)
T 1rjb_A 121 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197 (344)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred --CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence 3347899999975 888888643211 1347999999999999999999999 7999999
Q ss_pred CCCCCEEEcCCCCcEEEEeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 016950 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF 241 (380)
Q Consensus 166 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf 241 (380)
|||+|||++. ++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||
T Consensus 198 ikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 198 LAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp CSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999996 788999999999865443322 234568889999998654 48999999999999999998 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+......+..++..... ...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp TTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 887766555554442100 01123478999999999999999999999999976
Q ss_pred C
Q 016950 322 P 322 (380)
Q Consensus 322 p 322 (380)
.
T Consensus 329 l 329 (344)
T 1rjb_A 329 L 329 (344)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.26 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=196.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcE----EEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++.+.||+|+||+||+|.+..+++. ||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 456899999999999999999999888876 677766322 133458999999999999999999772
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+ ...++||||+. ++|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PSQVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SSCEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CCeEEECCC
Confidence 1 12779999998 577777753 23578899999999999999999999 79999999999999986 778999999
Q ss_pred cccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 235 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--- 235 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---
T ss_pred CcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---
Confidence 99987644332 2334567899999999754 48999999999999999999 9999998776655544432100
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 236 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01122367889999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=324.78 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=204.7
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++..+.. ...+|+.+++.++||||+++++++. .....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence 346789999999999999999999999999999999875532 3458999999999999999999883 33348
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+. ++|.+.+... ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCcccee
Confidence 89999998 5888877642 34568999999999999999999999 79999999999999986 77899999999986
Q ss_pred CccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 191 LIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 191 ~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------- 230 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 230 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------
T ss_pred ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------
Confidence 644332 1234567889999999654 48999999999999999999 9999998876655544433110
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0122347899999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.13 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=198.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.... ......|
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 457999999999999999999999999999999885432 23458999999999999999999885432 3445688
Q ss_pred EEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+.+ +|.+.+.........+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcchhc
Confidence 99999986 8888887766567789999999999999999999999 79999999999999986 778999999998754
Q ss_pred ccCCCc----------ceeeccCCCCChhhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 016950 192 IAGEAN----------ISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLG 258 (380)
Q Consensus 192 ~~~~~~----------~~~~~t~~y~aPE~l~~~~--~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~ 258 (380)
...... ....||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 321111 1234689999999985433 2688999999999999999999999531100 001111110
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....+ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00011 113478999999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.86 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=202.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC-----Cc
Confidence 346899999999999999999984 468999999986432 2346899999999999999999988433 33
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---CeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---RVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~---~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
.++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ + ||+||||||+|||++. ++.+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccCc
Confidence 7799999985 8888887655555669999999999999999999999 8 9999999999999996 7789999999
Q ss_pred ccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 016950 187 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGTP 260 (380)
Q Consensus 187 ~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~ 260 (380)
++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9986543322 22345899999999996544 8999999999999999999999995211 0000111100
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
...................+....++.+.+++.+||+.||.+|||+.++++|-.-..
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 000111111111111222222334578999999999999999999999998765443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=326.90 Aligned_cols=243 Identities=16% Similarity=0.214 Sum_probs=194.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCC-------cEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG- 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence 4578999999999999999999998877 469999985433 2335799999999999999999988433
Q ss_pred CCCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc----
Q 016950 105 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ---- 179 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~---- 179 (380)
...++||||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.
T Consensus 85 ----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~~ 155 (289)
T 4fvq_A 85 ----DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDRKTG 155 (289)
T ss_dssp ----TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBGGGT
T ss_pred ----CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCccccc
Confidence 33689999998 588888764 23348999999999999999999999 79999999999999986 444
Q ss_pred ----EEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 016950 180 ----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEII 254 (380)
Q Consensus 180 ----ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~ 254 (380)
+||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+...... ..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~ 231 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FY 231 (289)
T ss_dssp BCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HH
T ss_pred ccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hh
Confidence 99999999865422 22356789999999997656689999999999999999995 55665555443332 22
Q ss_pred HHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 255 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
... ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 210 01122357889999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=327.20 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=194.8
Q ss_pred ccccceeeeeeeecCCceEEEEEEECC---CCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
...++|.+.+.||+|+||.||+|.+.. +++.||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345789999999999999999998765 45689999986432 223579999999999999999999866554
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
......++||||+.+ +|...+.... .....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEE
Confidence 444457899999985 7777775322 234679999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 183 CDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 99999976543321 2234567889999999654 58999999999999999999 9999998877666555443110
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 268 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01223578999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=327.48 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=194.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHh--CCCCceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...++|++.+.||+|+||+||+|++ +++.||||++..... ...+|.+++.. ++||||+++++++.... .....+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 3467899999999999999999987 789999999865432 23456677666 79999999998875533 345568
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH--------~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
|+||||+++ +|.+.++ ...+++..+..++.|++.||+||| + +||+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEE
Confidence 899999985 7777773 357999999999999999999999 9 79999999999999996 778999
Q ss_pred EeecccccCccCCCc-----ceeeccCCCCChhhhhCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 016950 183 CDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLFP 242 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g----------~~pf~ 242 (380)
+|||++......... ....||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999755433221 2347899999999996543 244799999999999999999 88886
Q ss_pred CCCh----HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 243 GENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 243 ~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
.... ...........+. .+.. ....+....++++.+||.+||+.||++|||+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQ-----------------RPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCC-----------------CCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCCCCcchhhhhHHHhccCC-----------------CCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 5322 2222222211000 0000 0011222356789999999999999999999999
Q ss_pred hc
Q 016950 319 CA 320 (380)
Q Consensus 319 l~ 320 (380)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=328.07 Aligned_cols=258 Identities=28% Similarity=0.399 Sum_probs=193.7
Q ss_pred cccceeeeeeeecCCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 35689999999999999999998 56789999999986543 23458999999999999999999875422
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~Dfg 159 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDFG 159 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEccCc
Confidence 2237899999975 888887642 3458999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||...... .. ...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~---~~~~~~~~ 233 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FM---RMIGNDKQ 233 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HH---HHHCTTCC
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--HH---hhhcCccc
Confidence 9986543322 1223457779999999765 4899999999999999999999998653211 11 11111110
Q ss_pred H------HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 E------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ........ .....+..+++++.+||.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 234 GQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp THHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhcc-------------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000000 001123457999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.83 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=193.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++.+.||+|+||+||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 4578999999999999999999998887654 77766432 22345799999999999999999988532
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
. .++|+||+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Df 161 (327)
T 3poz_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEEEccC
Confidence 1 568888887 577777763 35679999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence 999765433322 233457789999999764 48999999999999999999 99999887766554433321100
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+..++.++.+++.+||+.||.+|||+.++++|
T Consensus 239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 --------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp --------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0123478899999999999999999999999876
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=330.31 Aligned_cols=260 Identities=24% Similarity=0.292 Sum_probs=208.5
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~ 104 (380)
...++|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+|+.+++.++|+||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence 34578999999999999999999876 4678899999864322 23479999999999999999998843
Q ss_pred CCCceEEEEEeecccc-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 105 SKNELFLNLVMEYVPE-SMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
....++||||+.+ +|.+.+...... ...+++..+..++.||+.||.|||+ +||+||||||+||+++. +
T Consensus 100 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~-~ 174 (322)
T 1p4o_A 100 ---GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-D 174 (322)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-T
T ss_pred ---CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC-C
Confidence 3347899999985 888887653321 2457899999999999999999999 79999999999999996 7
Q ss_pred CcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 016950 178 HQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 253 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i 253 (380)
+.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 7899999999976533321 2234568889999998654 48999999999999999999 89999988776665554
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC------CCcccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFDEL 327 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h------p~~~~~ 327 (380)
..... ...+..+++.+.+||.+||+.||.+|||+.++++| |+|+.+
T Consensus 254 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 254 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 43100 00123478999999999999999999999999976 777766
Q ss_pred cCC
Q 016950 328 REP 330 (380)
Q Consensus 328 ~~~ 330 (380)
.+.
T Consensus 306 ~~~ 308 (322)
T 1p4o_A 306 SFY 308 (322)
T ss_dssp CST
T ss_pred ccc
Confidence 544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=323.70 Aligned_cols=247 Identities=27% Similarity=0.357 Sum_probs=190.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
...++|++.+.||+|+||.||+|.+..+ +..||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 4457899999999999999999998754 4579999885432 234579999999999999999998721
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
+ ..|+||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+|||++. ++.+||+||
T Consensus 88 ~--~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Df 160 (281)
T 1mp8_A 88 N--PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF 160 (281)
T ss_dssp S--SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC-
T ss_pred C--ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEECcc
Confidence 1 26799999985 78777753 34568999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 186 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 186 g~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---- 235 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 235 (281)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC----
Confidence 99986543322 1233457789999999654 48999999999999999997 9999998877666655443110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..++..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 236 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01233579999999999999999999999998853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=327.43 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=190.0
Q ss_pred CCCCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeec
Q 016950 31 NGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFST 103 (380)
Q Consensus 31 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~ 103 (380)
+..+...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~- 105 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI- 105 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-
Confidence 344556789999999999999999999999999999999986432 234579999999999999999998844
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
....|+||||+++ +|.+.+.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||
T Consensus 106 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~kl 175 (309)
T 2h34_A 106 ----DGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAYL 175 (309)
T ss_dssp ----TTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEE
T ss_pred ----CCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEEE
Confidence 3348899999985 88777763 3568999999999999999999999 79999999999999996 778999
Q ss_pred EeecccccCccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 183 CDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 183 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.. .+...+.... +
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~ 252 (309)
T 2h34_A 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-P 252 (309)
T ss_dssp CSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-C
T ss_pred ecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-C
Confidence 9999987654332 1234578999999999865 45899999999999999999999999876544 2222222100 0
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-CHHHHhc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACA 320 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-t~~e~l~ 320 (380)
....++..+++++.++|.+||+.||.+|| |++++++
T Consensus 253 ------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 ------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01112345899999999999999999999 7777663
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.18 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=193.9
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++...
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 104 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--- 104 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---
Confidence 345678999999999999999999999999999999986421 2234799999999999999999988543
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
...++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 105 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Df 180 (310)
T 2wqm_A 105 --NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDL 180 (310)
T ss_dssp --TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC
T ss_pred --CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEec
Confidence 348899999986 8888887766667789999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHH
Q 016950 186 GSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTRE 263 (380)
Q Consensus 186 g~a~~~~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~ 263 (380)
|++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+...+....
T Consensus 181 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 254 (310)
T 2wqm_A 181 GLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD----- 254 (310)
T ss_dssp ------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-----
T ss_pred cceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-----
Confidence 99876543322 234578999999999865 45899999999999999999999999765321 11211111101
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
++. .....+++++.+||.+||+.||.+|||+.++++ .++++
T Consensus 255 -------------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l 295 (310)
T 2wqm_A 255 -------------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM 295 (310)
T ss_dssp -------------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -------------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence 000 011347899999999999999999999999985 34444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=322.08 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=191.2
Q ss_pred CCccccceeee-eeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HhCCCCceeeeceeeeecCCCCceE
Q 016950 33 EPKQTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 33 ~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.....++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... .+...
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 34456789888 7899999999999999999999999998654 3456788877 6679999999999884422 33566
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~ 187 (380)
+|+||||+++ +|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+||+++.. ++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 8999999985 888887642 23469999999999999999999999 799999999999999853 56799999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.... ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 167 a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------ 212 (299)
T 3m2w_A 167 AKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------ 212 (299)
T ss_dssp CEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------------
T ss_pred ccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------------
Confidence 86431 13478899999999999999999999977654321110000
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
..... ...+.......+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 213 ------~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 213 ------RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ------SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ------HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000 00111111245799999999999999999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=337.31 Aligned_cols=268 Identities=22% Similarity=0.236 Sum_probs=199.7
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
....++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+|+.+++.++||||+++++++.. ..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 108 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RN 108 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TT
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CC
Confidence 34567899999999999999999995 478999999886443 234589999999999999999998843 33
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
..++||||+++ +|.+.+.........+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGIS 186 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeecccc
Confidence 47899999985 6666654322233468999999999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 189 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 189 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+......... ...
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----~~~ 260 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-----ESH 260 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-----HHH
T ss_pred cccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-----hcc
Confidence 7543221 22345689999999998665 48999999999999999999999997654322111100000 000
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 322 (380)
... .+...........+....++.+.+++.+||+.||++|||+.++++|.
T Consensus 261 --~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 261 --NNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp --TTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --ccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 01111111111222233567899999999999999999999999764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.70 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=201.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|.+..+++ .||+|.+.... ....+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence 4689999999999999999999977664 79999986542 2345899999999 89999999998843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
...+|+||||+++ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT 198 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence 3347899999985 88888865432 14568999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 016950 175 PLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL 250 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~ 250 (380)
. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+......+
T Consensus 199 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 N-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp G-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred C-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 6 77899999999986544332 1234567889999998754 48999999999999999998 99999887766555
Q ss_pred HHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 251 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 251 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+......+ ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 5554421110 012336899999999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.52 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=200.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeee
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF 101 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~ 101 (380)
...++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999976 467789999986542 2235799999999 8999999999884
Q ss_pred ecCCCCceEEEEEeecccc-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCC
Q 016950 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 168 (380)
Q Consensus 102 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp 168 (380)
. ...+|+||||+.+ +|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||
T Consensus 112 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp 185 (334)
T 2pvf_A 112 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA 185 (334)
T ss_dssp S-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSG
T ss_pred c-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCcc
Confidence 3 3347899999985 88888764321 12348999999999999999999999 7999999999
Q ss_pred CCEEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 016950 169 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE 244 (380)
Q Consensus 169 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~ 244 (380)
+||+++. ++.+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999996 78899999999976543322 2233557889999999654 48999999999999999999 99999988
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 245 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+..+....+..... ...+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666555443210 01123478999999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=346.34 Aligned_cols=254 Identities=20% Similarity=0.203 Sum_probs=192.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCC-Cceeeec---------ee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDH-PNVISLK---------HC 99 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h-~niv~~~---------~~ 99 (380)
...|...+.||+|+||+||+|.+..+|+.||||++.... ....+|+.+++.++| +|...+. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 346999999999999999999999999999999886322 233588999998877 2221111 11
Q ss_pred ------------eeecCCCCceEEEEEeecccchHHHHHHHh---hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 016950 100 ------------FFSTTSKNELFLNLVMEYVPESMYRVLKHY---SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 164 (380)
Q Consensus 100 ------------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~ 164 (380)
+..........++++|+++.++|.+++... ......+++..+..++.||+.||+|||+ +||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccC
Confidence 111000112236789999999888887543 2234557888899999999999999999 799999
Q ss_pred CCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhh---------CCCCCCchhhHHHHHHHHHHHH
Q 016950 165 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELL 235 (380)
Q Consensus 165 Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~---------~~~~~~~~~DiwslGvil~~ll 235 (380)
||||+|||++. ++.+||+|||+++..... .....| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999996 677999999998764332 334566 9999999983 3344788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCH
Q 016950 236 LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 315 (380)
Q Consensus 236 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 315 (380)
+|+.||.+.+..+....+ +. -...+++++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999776532211100 00 012478999999999999999999999
Q ss_pred HHHhcCCCccccc
Q 016950 316 LEACAHPFFDELR 328 (380)
Q Consensus 316 ~e~l~hp~~~~~~ 328 (380)
.++++||||+.+.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.92 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=200.3
Q ss_pred ccceeeeeeeecCCceEEEEEEE-----CCCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||+||+|.+ ..+++.||+|++..... ...+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 46899999999999999999985 45778999999865432 234799999999 789999999987432
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL 172 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~------------~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nil 172 (380)
...+++||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ +||+||||||+||+
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEE
Confidence 2237899999985 888887643211 1238999999999999999999999 79999999999999
Q ss_pred EcCCCCcEEEEeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 016950 173 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD 248 (380)
Q Consensus 173 l~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~ 248 (380)
++. ++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+
T Consensus 181 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 986 778999999999865443322 234668899999999654 48999999999999999998 999998876555
Q ss_pred HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+...+.....+ ..+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444443321110 0123478999999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=320.44 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=197.4
Q ss_pred CccccceeeeeeeecCCceEEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
....++|++.+.||+|+||+||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 3456789999999999999999998654 34569999986542 234579999999999999999998732
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
. ..|+||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|
T Consensus 85 --~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D 156 (281)
T 3cc6_A 85 --E-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGD 156 (281)
T ss_dssp --S-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECC
T ss_pred --C-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCc
Confidence 1 15799999984 78777754 34568999999999999999999999 79999999999999996 78899999
Q ss_pred ecccccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 185 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 185 fg~a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~- 234 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP- 234 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-
Confidence 999986543322 2234557889999999654 48999999999999999998 999998777666555444321110
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 235 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 235 ---------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 123478999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=317.47 Aligned_cols=245 Identities=19% Similarity=0.306 Sum_probs=200.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++.. ....|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence 468999999999999999999986 67789999997543 334589999999999999999998843 334789
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccccccc
Confidence 9999985 78777753 34568999999999999999999999 79999999999999986 7789999999997653
Q ss_pred cCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... ......+|+.|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 221 11234557789999999654 48999999999999999999 8999998887766655543110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123468999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=333.77 Aligned_cols=253 Identities=13% Similarity=0.134 Sum_probs=195.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCC--------CcEEEEEEeeccccchHHHHHHHHhCCCCceeeec------------
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLK------------ 97 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~------------ 97 (380)
++|++.+.||+|+||.||+|++..+ ++.||+|++... ....+|+.+++.++||||++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 5799999999999999999999874 889999998765 4567899999999999999843
Q ss_pred ---eeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 98 ---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 98 ---~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
+++.. .....|+||||+.++|.+.+... ....+++..++.++.||+.||+|||+ +||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEc
Confidence 33321 23458899999977998888742 23679999999999999999999999 7999999999999999
Q ss_pred CCCC--cEEEEeecccccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 016950 175 PLTH--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 244 (380)
Q Consensus 175 ~~~~--~ikl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~ 244 (380)
. ++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 194 ~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 194 P-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp T-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred C-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 6 55 899999999976543221 1234789999999999654 5899999999999999999999999876
Q ss_pred C-hHHHHHHHHHH-hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 245 N-AVDQLVEIIKV-LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 245 ~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ..+.+...... ...+. . + +. .......+++++.+||.+||+.||++|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~---------~---~--~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG---------P---F--VG------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC---------C---E--EC------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh---------h---h--hh------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 33333332221 11110 0 0 00 00001246899999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=321.44 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=194.8
Q ss_pred ccceeeeeeeecCCceEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3569999999999999999999 56789999999986432 33468999999999999999999885432
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
...+++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEECccc
Confidence 2347899999985 88877753 34569999999999999999999999 79999999999999986 7889999999
Q ss_pred ccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 187 SAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 187 ~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
++........ .....+|..|+|||++.+. .++.++|||||||++|+|++|..|+.... .. .....+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~~~~ 245 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPM--AL---FLKMIGPTHG 245 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HH---HHHHHCSCCG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchh--hH---HhhccCCccc
Confidence 9986654432 2234567789999999664 48899999999999999999998864321 11 1111111110
Q ss_pred H----HH-hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 E----EI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. .+ ...... .....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTLKEG-------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHHhcc-------------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 00 000000 001123457999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=315.80 Aligned_cols=246 Identities=17% Similarity=0.238 Sum_probs=199.0
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|++ +++.||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---A 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---S
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---C
Confidence 3467899999999999999999998 48899999986432 22457899999999999999999884432 2
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEee
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
...++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||+ +| ++||||||+||+++. ++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEec
Confidence 347899999985 88888763 122358999999999999999999999 79 999999999999996 778999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~--~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|++..... ....+|+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 158 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 229 (271)
T 3kmu_A 158 DVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR---- 229 (271)
T ss_dssp GSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----
T ss_pred cceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----
Confidence 98764322 23567999999999976432 334899999999999999999999988877766655442111
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..++..+++++.+||.+||+.||++|||+.++++
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123457999999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=328.82 Aligned_cols=256 Identities=18% Similarity=0.216 Sum_probs=200.1
Q ss_pred cccceeeeeeeecCCceEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC---
Confidence 45789999999999999999999 55678899999985432 233579999999999999999998843
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCc
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQ 179 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ 179 (380)
....|+||||++ ++|.+.+..... ....+++..++.++.||+.||.|||+ +||+||||||+|||++.+ +..
T Consensus 105 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 --SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCC
T ss_pred --CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcce
Confidence 333789999996 588888875322 12458999999999999999999999 799999999999999842 346
Q ss_pred EEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~ 255 (380)
+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence 9999999987543222 12234568899999998654 48999999999999999998 9999998877665554433
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
... ...+..+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 110 0012347899999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.40 Aligned_cols=265 Identities=25% Similarity=0.314 Sum_probs=200.0
Q ss_pred CccccceeeeeeeecCCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
-...++|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++|+||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG--- 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence 3445789999999999999999999 56789999999986543 224689999999999999999998754
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
.+...+|+||||++ ++|.+.+... ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl~D 170 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKIAD 170 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEEcc
Confidence 23445889999996 5787777642 3468999999999999999999999 79999999999999986 78899999
Q ss_pred ecccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 185 FGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 185 fg~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||......... ........+
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~ 248 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVP 248 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CC
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccc
Confidence 999986543332 2234568889999999654 4899999999999999999999999654322110 000000000
Q ss_pred CHHHH-hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 261 TREEI-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 261 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....+ ...... .....+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 249 ~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 249 ALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 000000 0011234579999999999999999999999999643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=334.42 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=189.0
Q ss_pred cccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...+|++.+.||+|+||.||+|++. .++..||||++.... ....+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 3468999999999999999999987 467789999986432 234579999999999999999998843
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....|+||||++ ++|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECcCc
Confidence 334789999997 588877763 34579999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~- 270 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 99865433211 122346789999999654 48999999999999999998 999999888766655543311110
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+++.+.+||.+||+.||.+||++.++++
T Consensus 271 ---------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 ---------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 12247899999999999999999999998875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=336.77 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=198.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|++.+.||+|+||.||++... ++.||||++..+. ....+|+.+++.++||||+++++++.... ..+|+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEE
Confidence 4578999999999999999999874 7799999997543 33458999999999999999999875432 23789
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+.+ +|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCccccc
Confidence 9999985 888888642 23347899999999999999999999 79999999999999996 7789999999998543
Q ss_pred cCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------- 404 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 404 (450)
T ss_dssp --------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred cc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 22 2233568889999999754 58999999999999999998 9999998776665554433110
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123458999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.30 Aligned_cols=247 Identities=26% Similarity=0.302 Sum_probs=198.8
Q ss_pred ccceeeee-eeecCCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~---- 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE---- 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence 46788877 9999999999999864 467889999986532 2235799999999999999999987 221
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..++||||+.+ +|.+.+.. ....+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL 156 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEECcccc
Confidence 27899999986 77766642 34569999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---- 231 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 231 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence 986543322 1223457889999999654 48999999999999999998 9999998877665554433100
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
..++..+++++.+||.+||+.||.+|||+.++++|.+
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0123357999999999999999999999999998744
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=318.18 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=195.4
Q ss_pred ccceeeee-eeecCCceEEEEEE--ECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 37 TISYMAER-VVGTGSFGIVFQAK--CLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~-~lg~G~~g~Vy~~~--~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..+|++.+ .||+|+||.||+|. ...+++.||+|++.... ....+|+.+++.++||||+++++++ ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 46799998 99999999999995 45678999999986432 2345799999999999999999987 222
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||+ +|++||||||+||+++. ++.+||+|||
T Consensus 91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg 162 (291)
T 1xbb_A 91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFG 162 (291)
T ss_dssp --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEEccCC
Confidence 2779999998 577777753 4569999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 187 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 187 ~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-- 238 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R-- 238 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C--
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--
Confidence 99865443321 123346789999999654 48899999999999999999 999999887766554443210 0
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..++..+++.+.++|.+||+.||.+|||+.++++
T Consensus 239 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122357999999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=341.24 Aligned_cols=264 Identities=22% Similarity=0.255 Sum_probs=205.5
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.+...++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|++.+..+..+.. ....
T Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~ 77 (483)
T 3sv0_A 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDY 77 (483)
T ss_dssp CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTE
T ss_pred CCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCE
Confidence 345667899999999999999999999999999999987543 3456789999999988655554444432 2334
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc--CCCCcEEEEeeccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSA 188 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~--~~~~~ikl~Dfg~a 188 (380)
.++||||+.++|.+++.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||++
T Consensus 78 ~~lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 789999998898888864 34679999999999999999999999 7999999999999993 13678999999999
Q ss_pred ccCccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHh
Q 016950 189 KQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVL 257 (380)
Q Consensus 189 ~~~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~---~~~~~~i~~~~ 257 (380)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 86644322 1256789999999999654 489999999999999999999999987543 23333333221
Q ss_pred CCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc----------CCCcccc
Q 016950 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA----------HPFFDEL 327 (380)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~----------hp~~~~~ 327 (380)
.....+ .+...+++++.+||.+||+.||.+||++.++++ ++|+..+
T Consensus 233 ~~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~ 288 (483)
T 3sv0_A 233 VATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVF 288 (483)
T ss_dssp HHSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred ccccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCc
Confidence 111111 112347899999999999999999999987663 6776555
Q ss_pred cC
Q 016950 328 RE 329 (380)
Q Consensus 328 ~~ 329 (380)
.|
T Consensus 289 dW 290 (483)
T 3sv0_A 289 DW 290 (483)
T ss_dssp HH
T ss_pred Cc
Confidence 44
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=360.60 Aligned_cols=284 Identities=26% Similarity=0.339 Sum_probs=205.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC-CCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 110 (380)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 467999999999999999999999999999999886432 223579999999999999999887633111 12344
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC--cEEEEeecc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGS 187 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~--~ikl~Dfg~ 187 (380)
.|+||||+++ +|.+.+.... ....+++..++.++.|++.||+|||+ +||+||||||+||+++.++. .+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 7899999974 7877776422 23368999999999999999999999 79999999999999986332 489999999
Q ss_pred cccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 188 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 188 a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+........... .......+..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCS
T ss_pred ccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhh
Confidence 987766655566788999999999854 458999999999999999999999998765432211100 0000000000
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.......+.++. ..+....+...+++.+.+||.+||++||++|||+.++++||||+.+.
T Consensus 247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 000011111111 11112223344678999999999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=327.52 Aligned_cols=245 Identities=25% Similarity=0.346 Sum_probs=191.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
..++|++++.||+|+||.||+|.+..+++.+ |+|.+... .....+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 3467999999999999999999999888765 56655322 22345799999999999999999988532
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
. .++|++|+. ++|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+||
T Consensus 90 --~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kL~Df 161 (327)
T 3lzb_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDF 161 (327)
T ss_dssp --S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCT
T ss_pred --C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEEEccC
Confidence 1 668888887 477777764 34679999999999999999999999 79999999999999986 788999999
Q ss_pred cccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-- 238 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 238 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 999865433222 233457789999999764 48999999999999999999 99999988766655444331110
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++++.+||.+||+.||.+|||+.++++
T Consensus 239 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 --------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp --------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012347899999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.50 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=202.7
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...+|++.+.||+|+||.||+|.++.++..||||++..+. ....+|+.+++.++||||+++++++.. ...+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence 3467999999999999999999999999999999997543 234589999999999999999998843 33478
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+. ++|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccceec
Confidence 9999998 5888888642 34568999999999999999999999 79999999999999986 778999999999865
Q ss_pred ccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------- 437 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---------- 437 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 43321 1123456789999999654 48999999999999999999 9999998876655544332100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 438 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 ------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0123357999999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=324.38 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=193.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
...+|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS----- 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----
Confidence 4468999999999999999999987553 459999986432 22347999999999999999999883
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEECCC
Confidence 33448899999986 77777753 34679999999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 99986543321 1123457789999999654 58999999999999999999 999998887766655543311100
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+..+++.+.+||.+||+.||.+||++.+++++
T Consensus 271 ----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 ----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 123478999999999999999999999998864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=317.57 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=186.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++.+.||+|+||.||+|++. ..+|+|++.... ....+|+.+++.++|+||++++++.. . ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~-----~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-----PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-C-----Cc
Confidence 457999999999999999999853 359999885432 22357999999999999999988541 1 12
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||||+.+ +|.+.+.. ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLAT 168 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCCC---
T ss_pred cEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEccceecc
Confidence 6799999985 77666642 34678999999999999999999999 79999999999999996 7889999999997
Q ss_pred cCccC---CCcceeeccCCCCChhhhhC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAG---EANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~---~~~~~~~~t~~y~aPE~l~~--~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
..... .......+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+.........+..
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 246 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-- 246 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC--
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc--
Confidence 54332 12234568999999999852 345788999999999999999999999987766666555543211110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 ---------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ---------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01122347899999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=316.96 Aligned_cols=246 Identities=21% Similarity=0.313 Sum_probs=193.3
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
....++|++.+.||+|+||.||+|.+ +++.||+|++..+. ....+|+.+++.++||||+++++++... ....
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 44567899999999999999999987 58899999986543 2345799999999999999999986432 2247
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|+||||+++ +|.+.+.... ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeecccccc
Confidence 899999986 8888876432 2237889999999999999999999 79999999999999996 77899999999875
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------ 231 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------ 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence 4332 2234568899999999654 48999999999999999998 999998877655544332210
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01123457999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=318.05 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=196.0
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
+....+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-- 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS--
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC--
Confidence 345668999999999999999999976443 458999886432 2235799999999999999999986432
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
....++||||+++ +|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|
T Consensus 99 --~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~D 171 (298)
T 3f66_A 99 --EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVAD 171 (298)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECS
T ss_pred --CCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECc
Confidence 2347799999986 88777753 34668999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCC-----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 185 FGSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 185 fg~a~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
||++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..+....+.....
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 99997653322 12334567889999999654 48999999999999999999 6788877766655544433111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++.+.++|.+||+.||.+|||+.++++
T Consensus 251 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 ----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112347899999999999999999999999885
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.24 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=199.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||+||+|.+. ++..||||++.... ....+|+.+++.++||||+++++++. . ..+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~-----~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-----EPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-----SSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C-----CccE
Confidence 3468999999999999999999975 46789999997543 23458999999999999999998873 1 1277
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+. |+|.+.+.... ...+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCceEc
Confidence 9999998 48888886422 2357888999999999999999999 79999999999999996 788999999999865
Q ss_pred ccCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
.... ......+|+.|+|||++... .++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------- 405 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------- 405 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 3221 11223457789999999654 48999999999999999999 999999988877776655421111
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+..+++++.+||.+||+.||.+|||+.++++
T Consensus 406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 12347899999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=314.78 Aligned_cols=249 Identities=23% Similarity=0.386 Sum_probs=195.9
Q ss_pred CccccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 34 PKQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 34 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
+.....|.+.+.||+|+||+||+|.+..+++ .||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 95 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE- 95 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-
Confidence 3445678899999999999999999766554 79999886432 22347999999999999999999885332
Q ss_pred CCceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
...++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|
T Consensus 96 ---~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~D 167 (298)
T 3pls_A 96 ---GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVAD 167 (298)
T ss_dssp ---SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECC
T ss_pred ---CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCc
Confidence 22479999996 577777753 35678999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccC-----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 016950 185 FGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG 258 (380)
Q Consensus 185 fg~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 258 (380)
||++...... .......+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 9999754332 12223456889999999965 458999999999999999999 5566666665554444333111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
. ..+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 L----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp C----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 012347899999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.51 Aligned_cols=245 Identities=25% Similarity=0.314 Sum_probs=197.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++.. . ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcE
Confidence 3578999999999999999999965 56789999986543 334589999999999999999988731 1 267
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||+. ++|.+.+... ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCcccccc
Confidence 9999997 5777776532 12368999999999999999999999 79999999999999996 778999999999865
Q ss_pred ccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 192 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 192 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 228 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------- 228 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC----------
Confidence 43321 1233457789999999654 48999999999999999999 9999998887666655433110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++++.+||.+||+.||++|||+.++++
T Consensus 229 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112347899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=323.24 Aligned_cols=277 Identities=23% Similarity=0.329 Sum_probs=193.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHH--HHhCCCCceeeeceeeeecCCCCceEE
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQL--MRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...++|++.+.||+|+||.||+|+. +++.||||++...... ...|..+ +..++|+||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4567899999999999999999976 7899999998654322 2234444 445899999999987655555666678
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---------CeeecCCCCCCEEEcCCCCcEE
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---------RVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~---------~iiH~Dlkp~Nill~~~~~~ik 181 (380)
|+||||+++ +|.+.+.. ...++..++.++.||+.||+|||+ + ||+||||||+|||++. ++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSCEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCcEE
Confidence 899999974 88887753 345888999999999999999999 8 9999999999999996 78899
Q ss_pred EEeecccccCccCC---------CcceeeccCCCCChhhhhCC------CCCCchhhHHHHHHHHHHHHhCCCCCC-CCC
Q 016950 182 ICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFP-GEN 245 (380)
Q Consensus 182 l~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~l~~~------~~~~~~~DiwslGvil~~ll~g~~pf~-~~~ 245 (380)
|+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||. +..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999997654321 12234689999999999653 235678999999999999999976653 322
Q ss_pred hHHHHHHHHH-HhCCCCHHHHhhc-CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh----
Q 016950 246 AVDQLVEIIK-VLGTPTREEIRCM-NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---- 319 (380)
Q Consensus 246 ~~~~~~~i~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l---- 319 (380)
..+....+.. ....+....+... ........++.. |.. ...+++++.+||.+||+.||++|||+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----CCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----ccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 1111111111 1112222211111 000000011110 000 011456899999999999999999999994
Q ss_pred --cCCCccc
Q 016950 320 --AHPFFDE 326 (380)
Q Consensus 320 --~hp~~~~ 326 (380)
.++|-++
T Consensus 315 ~ll~~~~~~ 323 (336)
T 3g2f_A 315 ELMMIWERN 323 (336)
T ss_dssp HHHHCCCC-
T ss_pred HHHHHHHhc
Confidence 5677665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=323.66 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=187.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHhC--CCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM--DHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|++. ++.||||++..... ...+|.+++..+ +||||+++++++.... .....+|+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence 468999999999999999999874 89999999865432 223455555554 8999999999886543 22245889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~--------~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
||||+.+ +|.+.++. ..+++..++.++.|++.||.|||+ + ||+||||||+|||++. ++.+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEEe
Confidence 9999985 88888753 468999999999999999999999 8 9999999999999996 77899999
Q ss_pred ecccccCccCCCc-----ceeeccCCCCChhhhhCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCC
Q 016950 185 FGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLG----------QPLFPG 243 (380)
Q Consensus 185 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~l~~~~~~~~------~~DiwslGvil~~ll~g----------~~pf~~ 243 (380)
||++......... ....||+.|+|||++.+.. +.. ++|||||||++|+|++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999765433221 2457899999999996543 333 49999999999999999 677754
Q ss_pred CCh----HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 244 ENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 244 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
... ............. .+ .++ .......+++++.+||.+||+.||.+|||+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~---------~~-----~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKL---------RP-----SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCC---------CC-----CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcCCCCchhhhHHHHhhhcc---------Cc-----ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 321 1222221111000 00 000 0001123567899999999999999999999998
Q ss_pred cC
Q 016950 320 AH 321 (380)
Q Consensus 320 ~h 321 (380)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=316.52 Aligned_cols=246 Identities=30% Similarity=0.408 Sum_probs=186.3
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|++.+.||+|+||+||+|++ .++.||+|++.... ....+|+.+++.++||||+++++++. +. .|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence 356899999999999999999987 47889999986543 23458999999999999999998773 22 579
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~--~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
||||+++ +|.+.+.... ....+++..+..++.|++.||+|||+. +||+||||||+||+++.++..+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999985 7877776321 122478889999999999999999983 38999999999999987444589999999975
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||................+..
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 222 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---------- 222 (307)
T ss_dssp -----------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------
T ss_pred cccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------
Confidence 4322 234568999999999965 458999999999999999999999997643322111111100100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+...+++.+.+||.+||+.||.+|||+.++++
T Consensus 223 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 223 ----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122347999999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=328.79 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=188.6
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.....|++.+.||+|+||+||+|....++ ..||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--- 162 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--- 162 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---
Confidence 34457999999999999999999976443 468999885432 2234799999999999999999986432
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....|+||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 163 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DF 236 (373)
T 3c1x_A 163 -EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADF 236 (373)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred -CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeec
Confidence 2236799999985 88877753 34568899999999999999999999 79999999999999996 778999999
Q ss_pred cccccCccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 016950 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 186 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~- 314 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR- 314 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-
Confidence 99986533221 1234567889999999654 58999999999999999999 7889987766555444332100
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 315 ---------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00123478999999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=335.25 Aligned_cols=244 Identities=26% Similarity=0.315 Sum_probs=195.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+.+++.++||||+++++++.. ...|+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~i 255 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 255 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceEE
Confidence 4689999999999999999999864 4679999987543 234689999999999999999988732 12679
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+.+ +|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 256 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 331 (452)
T ss_dssp EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccceecC
Confidence 9999985 888877532 23468999999999999999999999 89999999999999986 7789999999998654
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------- 400 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 400 (452)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 3221 1233457789999999654 58999999999999999999 99999998877766655432110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++.+.+||.+||+.||++|||++++++
T Consensus 401 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 401 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012347899999999999999999999999885
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.21 Aligned_cols=247 Identities=13% Similarity=0.183 Sum_probs=190.7
Q ss_pred ccceeeeeeeecCCceEEEEE-----EECCCCcEEEEEEeeccc-cchHHHHHHHHhCC---CCceeeeceeeeecCCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~ 107 (380)
.++|++.+.||+|+||+||+| .+..+++.||+|++.... ....+|+.+++.++ |+||+++++++....
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--- 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--- 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS---
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC---
Confidence 467999999999999999999 467789999999986543 33457888888886 899999999885433
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC---------
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--------- 176 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--------- 176 (380)
..|+||||++ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..
T Consensus 141 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 --GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp --CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC-----
T ss_pred --CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCcccccc
Confidence 3789999998 588888875443 35679999999999999999999999 799999999999999741
Q ss_pred -CCcEEEEeecccccCcc---CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 016950 177 -THQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 252 (380)
Q Consensus 177 -~~~ikl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~ 252 (380)
.+.+||+|||+|+.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 57899999999965432 22233467899999999997654 89999999999999999999999965432100
Q ss_pred HHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCC
Q 016950 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323 (380)
Q Consensus 253 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~ 323 (380)
..... ++. + ..++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus 294 --------------~~~~~-----~~~---------~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 294 --------------KPEGL-----FRR---------L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp --------------EECSC-----CTT---------C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred --------------eechh-----ccc---------c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 00000 000 0 13678899999999999999976655555443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.07 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=191.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-CCc--EEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||+||+|.+.. +++ .||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4689999999999999999998643 333 68999885431 2235799999999999999999988432
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
. .++||||+. ++|.+.+... ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+||
T Consensus 94 --~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Df 165 (291)
T 1u46_A 94 --P-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 165 (291)
T ss_dssp --S-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred --C-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCEEEccc
Confidence 1 679999998 5888777642 3568999999999999999999999 79999999999999986 778999999
Q ss_pred cccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 999866443321 233567789999999654 48999999999999999999 999999888776665554311000
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+..+++++.++|.+||+.||.+|||+.++++ +++++
T Consensus 245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~ 282 (291)
T 1u46_A 245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA 282 (291)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence 012347999999999999999999999999986 44443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=319.66 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=193.8
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.|...+.||+|+||.||+|.+ +++.||+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 104 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD 104 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence 466679999999999999986 68899999985421 234579999999999999999998843 334
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.++||||++ ++|.+.+... .....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR 181 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence 789999997 5787777643 234678999999999999999999999 79999999999999996 7789999999987
Q ss_pred cCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 190 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 190 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+.............
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 259 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence 6543222 223568999999999854 47899999999999999999999998765443333332221111000000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.... .. ...+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 260 ~~~~--------~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 260 YIDK--------KM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HSCS--------SC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hccc--------cc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 00 00111245789999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=315.58 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=196.1
Q ss_pred ccccceeeeeeeecCCceEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
....+|++++.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence 445689999999999999999998 46789999999986543 23458999999999999999999875432
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
...+++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 116 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kL~Df 189 (326)
T 2w1i_A 116 -RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred -CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CCcEEEecC
Confidence 2247899999985 88887764 34568999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|++........ .....++..|+|||++.+. .++.++|||||||++|+|++|..||..... .. .+..+...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~ 263 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDK 263 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTC
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhcccc
Confidence 99986644332 1223457789999999654 489999999999999999999999864311 11 11111111
Q ss_pred HHH-----H-hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 REE-----I-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
... + ..+... .. ...+..+++++.+||.+||+.||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNN-GR------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTHHHHHHHHHHHHTT-CC------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhhhHHHHHHHhhcC-CC------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 0 000000 00 0123357999999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=315.99 Aligned_cols=256 Identities=29% Similarity=0.367 Sum_probs=192.0
Q ss_pred ccce-eeeeeeecCCceEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISY-MAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++| ++++.||+|+||+||++.. ..+++.||||++.... ....+|+.+++.++||||+++++++....
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG-- 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--
Confidence 3455 9999999999999988753 4578999999997543 22458999999999999999999886532
Q ss_pred CceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
...+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+||
T Consensus 107 -~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~Df 178 (318)
T 3lxp_A 107 -AASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGDF 178 (318)
T ss_dssp -TTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCG
T ss_pred -CceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECCc
Confidence 3358899999985 7777664 2358999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 186 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 186 g~a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+...
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~ 252 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQ 252 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCC
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccc
Confidence 99987654332 2234568889999999754 488999999999999999999999965422100 0000000
Q ss_pred HH----HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 262 RE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 262 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.. .+...... ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 253 GQMTVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 00000000 0001123457999999999999999999999999984
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=333.32 Aligned_cols=247 Identities=19% Similarity=0.176 Sum_probs=183.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCC---------CCceee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMD---------HPNVIS 95 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~---------h~niv~ 95 (380)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ |+||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 78999999996542 33468999998886 666665
Q ss_pred eceeee-----------------ecC--------CCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 016950 96 LKHCFF-----------------STT--------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 149 (380)
Q Consensus 96 ~~~~~~-----------------~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~ 149 (380)
+.+++. ... ..+...+|+|||||.+ ++++.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 555432 200 0113458899999975 4444442 25689999999999999
Q ss_pred HHHHHhH-cCCCeeecCCCCCCEEEcCCCC--------------------cEEEEeecccccCccCCCcceeeccCCCCC
Q 016950 150 RGLAYIH-TVPRVCHRDLKPQNLLVDPLTH--------------------QVKICDFGSAKQLIAGEANISYICSRFYRA 208 (380)
Q Consensus 150 ~al~~LH-~~~~iiH~Dlkp~Nill~~~~~--------------------~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~a 208 (380)
.||+||| + +||+||||||+|||++. ++ .+||+|||+|+.... ...+||+.|+|
T Consensus 172 ~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~a 245 (336)
T 2vuw_A 172 ASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTC
T ss_pred HHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccC
Confidence 9999999 9 79999999999999986 43 899999999986543 24589999999
Q ss_pred hhhhhCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcc
Q 016950 209 PELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 286 (380)
Q Consensus 209 PE~l~~~~~~~~~~DiwslGvi-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (380)
||++.+.. +.++||||+|++ .++++.|..||.+..... ....+....... .. ..
T Consensus 246 PE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~----~~ 301 (336)
T 2vuw_A 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------TK----CN 301 (336)
T ss_dssp SGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------SC----CC
T ss_pred hhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------cc----cc
Confidence 99996543 889999998777 777888999995422111 122222110000 00 00
Q ss_pred cccCCCCChHHHHHHHhhcccCCCCCCCHHHHh-cCCCcc
Q 016950 287 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD 325 (380)
Q Consensus 287 ~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l-~hp~~~ 325 (380)
...+..+++++++||++||++| |+.|+| +||||+
T Consensus 302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0112236889999999999987 999999 999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.73 Aligned_cols=244 Identities=26% Similarity=0.322 Sum_probs=198.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ....+|+.+|+.++|+||+++++++.. ..+|+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence 4679999999999999999999864 4679999997543 234689999999999999999988732 22779
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
||||+.+ +|.+.+... ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccceecC
Confidence 9999985 888887532 23468899999999999999999999 89999999999999986 7789999999998653
Q ss_pred cCC--CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------- 483 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 483 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 221 11223456789999999654 58999999999999999999 99999998877766655431110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++.+.+||.+||+.||++|||+.++++
T Consensus 484 ------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 484 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012347899999999999999999999999885
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=317.24 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=192.7
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHh--CCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
++|++.+.||+|+||.||+|++ +++.||||++.... ....+|+++++. ++||||+++++++.... .....+|+|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 6899999999999999999987 58999999986543 233578888887 79999999999885443 222358899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH--------~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
|||+++ +|.+.+.. ..+++..++.++.|++.||.||| + +||+||||||+|||++. ++.+||+||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~Df 191 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIADL 191 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECCC
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEEC
Confidence 999986 88888753 46899999999999999999999 8 79999999999999996 778999999
Q ss_pred cccccCccCCC-----cceeeccCCCCChhhhhCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCCC
Q 016950 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGEN 245 (380)
Q Consensus 186 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~-----~~~~~DiwslGvil~~ll~g----------~~pf~~~~ 245 (380)
|++........ .....+|+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 99976544332 234578999999999965432 23689999999999999999 78886542
Q ss_pred h----HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 246 A----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 246 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
. .+.+......... ...++. ......+++.+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~--------------~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKL--------------RPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCC--------------CCCCCG-------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHh--------------CCCCcc-------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2 1222221110000 000000 00111245689999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=339.90 Aligned_cols=237 Identities=24% Similarity=0.303 Sum_probs=190.2
Q ss_pred eeeeecCCceEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 43 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+.||+|+||.||+|.+ ..+++.||||++.... ....+|+.+++.++||||+++++++.. . ..++|
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~-~~~lv 447 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-SWMLV 447 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-SEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C-CEEEE
Confidence 34899999999999954 4667899999986432 234589999999999999999998731 1 16799
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||+.+ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus 448 ~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 448 MEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRA 521 (635)
T ss_dssp EECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC
T ss_pred EEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEcCCcccccc
Confidence 999985 7777775 35679999999999999999999999 79999999999999996 77899999999986543
Q ss_pred CCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 194 GEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 194 ~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~--------- 591 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------- 591 (635)
T ss_dssp -------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred CccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 322 1223457889999999654 48999999999999999998 99999998887766555442110
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
..+..+++++.+||.+||+.||++|||+.++++
T Consensus 592 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 -------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 122347999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.12 Aligned_cols=248 Identities=26% Similarity=0.308 Sum_probs=194.4
Q ss_pred cceeeee-eeecCCceEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 38 ISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 38 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
+++.+.+ .||+|+||.||+|.++ .++..||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~----- 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----
Confidence 3455555 8999999999999876 356679999986532 234589999999999999999998742 1
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+||||+.+ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeeccCc
Confidence 27899999985 67766642 35669999999999999999999999 79999999999999996 788999999999
Q ss_pred ccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 189 KQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 189 ~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----- 557 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----- 557 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 865433221 122346789999999654 58999999999999999998 9999999887776655543110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh---cCCCcc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFFD 325 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l---~hp~~~ 325 (380)
..++..+++++.+||.+||+.||.+|||+.+++ ++.|+.
T Consensus 558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 012335899999999999999999999999874 444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=312.56 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=195.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...++|++.+.||+|+||.||+|.+.. .+|+|++... .....+|+.+++.++|+||+++++++....
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 102 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP---- 102 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS----
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC----
Confidence 345789999999999999999999753 4999988532 123457999999999999999999885433
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+++||||+. ++|.+.+.. ....+++..++.++.||+.||+|||+ +|++||||||+||+++ ++.+||+|||+
T Consensus 103 -~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 -HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDFGL 175 (319)
T ss_dssp -CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred -ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeecCC
Confidence 3889999998 477766642 34468999999999999999999999 7999999999999998 46799999999
Q ss_pred cccCccC------CCcceeeccCCCCChhhhhC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 016950 188 AKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 253 (380)
Q Consensus 188 a~~~~~~------~~~~~~~~t~~y~aPE~l~~--------~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i 253 (380)
+...... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.........+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 8654211 12233468999999999864 234789999999999999999999999988776665544
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
....... .....+++++.++|.+||+.||.+|||+.++++ .++.+.
T Consensus 256 ~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 256 GTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp HTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred ccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 3311000 011236889999999999999999999999985 455443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.32 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=197.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++.+.||+|+||.||+|.+..+ +..||+|++.... ....+|+.+++.++||||+++++++.. +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 357899999999999999999998654 4679999886432 234579999999999999999998721 1
Q ss_pred ceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
..|+||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DFG 536 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFG 536 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEecC
Confidence 2679999998 578777763 34568999999999999999999999 79999999999999996 7889999999
Q ss_pred ccccCccCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 187 SAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 187 ~a~~~~~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
++......... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---- 611 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 611 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC----
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 99866433221 223457889999999654 58999999999999999997 99999998887776666542110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 612 ------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122357899999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=338.37 Aligned_cols=242 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+|+.+++.++||||+++++++......+...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 78999999885432 22357999999999999999999987665545556
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||||++| +|.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++. +.+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~--~~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE--EQLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS--SCEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC--CcEEEEecccch
Confidence 7899999986 5544332 378999999999999999999999 79999999999999985 379999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +.+.
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~-------- 286 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE-------- 286 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT--------
T ss_pred hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc--------
Confidence 65433 346789999999998653 589999999999999999999998653110 0000
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
..+ ....++.+.+||.+||+.||.+||+..+.+.|+|+.-+
T Consensus 287 ------------~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 ------------DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------------TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------------ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 00146789999999999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=297.50 Aligned_cols=228 Identities=15% Similarity=0.047 Sum_probs=176.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 107 (380)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.++..++||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----- 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----- 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----
Confidence 34478999999999999999999999999999999996542 234579999999999999999999844
Q ss_pred ceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeec
Q 016950 108 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 186 (380)
Q Consensus 108 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg 186 (380)
....|+||||++| +|.+.++. + .....+..++.||+.||+|||+ +||+||||||+|||++. ++.+||++++
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~~~~ 174 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAYPA 174 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEECSCC
T ss_pred CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEEecc
Confidence 3348899999985 77776631 2 3556788899999999999999 79999999999999996 7788887433
Q ss_pred ccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 187 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 187 ~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
|++ .++.++|||||||++|+|++|+.||.+.+..+.+....
T Consensus 175 -------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~------------ 215 (286)
T 3uqc_A 175 -------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------------ 215 (286)
T ss_dssp -------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC------------
T ss_pred -------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH------------
Confidence 333 27899999999999999999999998765321110000
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
... .........+...+++++.+||.+||+.||.+| |+.++++ .+..+
T Consensus 216 ---------~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~ 263 (286)
T 3uqc_A 216 ---------RDT-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQA 263 (286)
T ss_dssp ---------BCT-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHH
T ss_pred ---------HHh-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHH
Confidence 000 000011122334689999999999999999999 9999986 34443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-33 Score=276.52 Aligned_cols=180 Identities=19% Similarity=0.082 Sum_probs=124.5
Q ss_pred eeecCCceEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHhC-CCCceeeeceeeeecCCCCce
Q 016950 45 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 45 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 109 (380)
..+.|+.|.+..++....|+.||+|.+.++. ....+|+++|+++ .|+||+++++++ +++.
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 4567888888888888889999999996542 2235799999999 799999999998 5555
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+||||||++| +|.+.+. ..+.+++. .|+.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeecccC
Confidence 69999999996 7777776 34566654 588999999999999 89999999999999996 788999999999
Q ss_pred ccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 016950 189 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL 240 (380)
Q Consensus 189 ~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p 240 (380)
+...... ...+.+||+.|+|||++.+ .+..++|+||+|++++.|.++..+
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 8664432 3445789999999999865 367889999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=234.05 Aligned_cols=179 Identities=17% Similarity=0.209 Sum_probs=133.2
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
...+.||+|+||+||+|. ..++.+++|+..... ....+|+.+++.++||||+++..+......
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 456799999999999994 467889999764321 113589999999999999955444433222
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.|+||||++ ++|.+.+.. +..++.|++.||+|||+ +||+||||||+|||++. .+||+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence 479999998 577776642 45789999999999999 89999999999999984 899999999
Q ss_pred cccCccCCC--------cceeeccCCCCChhhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 016950 188 AKQLIAGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP 242 (380)
Q Consensus 188 a~~~~~~~~--------~~~~~~t~~y~aPE~l~~~-~~~~~~~DiwslGvil~~ll~g~~pf~ 242 (380)
|+....... .....||+.|+|||++.+. ..|+..+|+||..+-..+.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 987644321 1356789999999998541 237888999999999888888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=189.89 Aligned_cols=137 Identities=18% Similarity=0.211 Sum_probs=108.0
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeece
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLKH 98 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~~ 98 (380)
.+.+.||+|+||.||+|.+ .+|+.||+|++.... ....+|+.+++.++ | +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3449999999999999999 889999999985321 12458999999998 5 66666
Q ss_pred eeeecCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 99 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 99 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
++.. ...|+||||++| +|.+ +. ......++.|++.||.|||+ +||+||||||+|||++ +
T Consensus 169 ~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~--~ 228 (282)
T 1zar_A 169 VYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS--E 228 (282)
T ss_dssp EEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE--T
T ss_pred EEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE--C
Confidence 5521 225799999986 5544 21 12345799999999999999 7999999999999999 6
Q ss_pred CcEEEEeecccccCccCCCcceeeccCCCCChhhhh
Q 016950 178 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~ 213 (380)
+.+||+|||+|.. +..++|||++.
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 7899999999863 34578999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.3e-21 Score=170.74 Aligned_cols=135 Identities=19% Similarity=0.235 Sum_probs=102.7
Q ss_pred ceeeeeeeecCCceEEEEEEECCCCcE--EEEEEeeccc----------------------------cchHHHHHHHHhC
Q 016950 39 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRVM 88 (380)
Q Consensus 39 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~~----------------------------~~~~~e~~~l~~l 88 (380)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998788999 9999864321 1345799999999
Q ss_pred CCCceeeeceeeeecCCCCceEEEEEeecccc------hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhH-cCCCe
Q 016950 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRV 161 (380)
Q Consensus 89 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH-~~~~i 161 (380)
.|+++... ..+.. ...++||||+++ .|.+... ..++..+..++.|++.||.||| + +||
T Consensus 128 ~~~~i~~p-~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~-~gi 192 (258)
T 1zth_A 128 KEAGVSVP-QPYTY------MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQE-AEL 192 (258)
T ss_dssp HHTTCCCC-CEEEE------ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred HhCCCCCC-eEEEc------CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence 88765222 11111 125699999953 3433321 1234567889999999999999 9 799
Q ss_pred eecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 162 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 162 iH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 99999999999984 7999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-17 Score=154.05 Aligned_cols=133 Identities=14% Similarity=0.151 Sum_probs=89.5
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----------c----------------hHHHHHHHHhCCCCce
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------Y----------------KNRELQLMRVMDHPNV 93 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----------~----------------~~~e~~~l~~l~h~ni 93 (380)
|.+.+.||.|++|.||+|.+. +|+.||||++..... . ..+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999974 699999998743210 0 0134444444433222
Q ss_pred eeeceeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 94 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
. ....+. .. . .+|||||++|..+..+ .....+..++.||+.+|.+||+ +|||||||||.|||+
T Consensus 176 ~-vp~p~~-~~-~----~~LVME~i~G~~L~~l---------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 176 P-VPEPIA-QS-R----HTIVMSLVDALPMRQV---------SSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNILI 238 (397)
T ss_dssp S-CCCEEE-EE-T----TEEEEECCSCEEGGGC---------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEE
T ss_pred C-CCeeee-cc-C----ceEEEEecCCccHhhh---------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEE
Confidence 1 111110 00 1 3599999997422111 1112346788999999999999 799999999999999
Q ss_pred cCCCC---------cEEEEeeccccc
Q 016950 174 DPLTH---------QVKICDFGSAKQ 190 (380)
Q Consensus 174 ~~~~~---------~ikl~Dfg~a~~ 190 (380)
+.++. .+.|+||+-+-.
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 75221 388999998753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.2e-11 Score=109.79 Aligned_cols=136 Identities=15% Similarity=0.082 Sum_probs=100.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+.|++...++.|+.+.||++.. .++.+++|.... ......+|+.+++.+. +..+.+++++... ....
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 45799999999999999999974 368999998863 3345678999999884 5566677766532 2347
Q ss_pred EEEeecccch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------------
Q 016950 112 NLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------- 158 (380)
Q Consensus 112 ~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-------------------------------- 158 (380)
|+|||+++|. +.+.+ .+......++.++..+|..||+.
T Consensus 86 ~lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 8999999984 43321 01112346778888999999971
Q ss_pred --------------------------CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 --------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 --------------------------~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..++|+|++|.||+++. +..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 24899999999999985 5556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=2.4e-10 Score=100.93 Aligned_cols=134 Identities=14% Similarity=0.062 Sum_probs=89.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv 114 (380)
..|.+....+.|..+.||++. ..+|..+++|..... .....+|+.+++.+.+.+ +.+++..... ....++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEE
Confidence 346665555567779999996 456778999987543 234568999999886544 4446555422 1237799
Q ss_pred eecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-----------------------------------
Q 016950 115 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------------------------------- 159 (380)
Q Consensus 115 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~----------------------------------- 159 (380)
|||++|..+. .. ... ...++.++...|..||+..
T Consensus 94 ~e~i~G~~l~-~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 94 LGEVPGQDLL-SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EECCSSEETT-TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEecCCcccC-cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999974222 10 011 1245566777777777621
Q ss_pred ----------------------CeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 160 ----------------------RVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 160 ----------------------~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+++|+|++|.||+++. +..+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 2999999999999985 4556699999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-09 Score=100.46 Aligned_cols=141 Identities=16% Similarity=0.163 Sum_probs=97.8
Q ss_pred eeeeeeecCCceEEEEEEECCCCcEEEEEEee--cc-----ccchHHHHHHHHhCCC--CceeeeceeeeecCCCCceEE
Q 016950 41 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 41 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~--~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~ 111 (380)
.-++.|+.|.++.||++... +..+++|+.. .. .....+|..+++.+.. ..+.+++....+.. .....
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCe
Confidence 34667899999999998753 4688899775 22 2355689999999874 44566665542221 11235
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------- 158 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~--------------------------------- 158 (380)
|+||||++|..... ..-..++......++.+++.+|..||+.
T Consensus 117 ~~vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 117 FYIMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 69999999842100 1123466777888899999999999962
Q ss_pred ------------------------CCeeecCCCCCCEEEcCCCC-cEEEEeeccccc
Q 016950 159 ------------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ 190 (380)
Q Consensus 159 ------------------------~~iiH~Dlkp~Nill~~~~~-~ikl~Dfg~a~~ 190 (380)
..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999986433 368999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.5e-10 Score=102.51 Aligned_cols=184 Identities=15% Similarity=0.190 Sum_probs=108.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCC-CCceeeeceeeeec-CCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFST-TSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~~~~~lv~e~~ 118 (380)
++.++.|....||++. ..+++|+.... .....+|..+++.+. +..+. +-.++... ........|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~-vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLP-IPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSC-CCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCC-CCceEeecCCCCCCCcceEEEccc
Confidence 3458999999999864 46899976543 234568999998874 33321 22222111 112222346899999
Q ss_pred cch-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------------
Q 016950 119 PES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------------- 158 (380)
Q Consensus 119 ~~~-l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~--------------------------------------- 158 (380)
+|. +..... ..++......++.|+...+..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 973 222111 1345555556666666666666641
Q ss_pred ------------------CCeeecCCCCCCEEEcCC-CCcEEEEeecccccCccCCCcceeeccCCC---CChhhhh---
Q 016950 159 ------------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFY---RAPELIF--- 213 (380)
Q Consensus 159 ------------------~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~l~--- 213 (380)
..++|+|++|.||+++.+ +..+.|+||+.+....... .......+ .+|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHH
Confidence 247999999999999864 3457899999986432110 00001111 2232210
Q ss_pred ---CCC-------CCCchhhHHHHHHHHHHHHhCCCCC
Q 016950 214 ---GAT-------EYTTSIDIWSAGCVLAELLLGQPLF 241 (380)
Q Consensus 214 ---~~~-------~~~~~~DiwslGvil~~ll~g~~pf 241 (380)
+.. ....-.+.|++|.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0123368999999999999999877
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.4e-06 Score=78.69 Aligned_cols=69 Identities=10% Similarity=-0.056 Sum_probs=44.7
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCc---eeeeceeeeecCCCCceEEEEEeec
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
++.++.|....||++ +..+++|+.... .....+|..+|+.+.+.. +.+++.+.. . .....++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence 445788988999988 567899975432 234468999999987532 333333221 1 12235699999
Q ss_pred ccc
Q 016950 118 VPE 120 (380)
Q Consensus 118 ~~~ 120 (380)
++|
T Consensus 95 i~G 97 (306)
T 3tdw_A 95 VQG 97 (306)
T ss_dssp CCS
T ss_pred cCC
Confidence 997
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.1e-05 Score=71.34 Aligned_cols=130 Identities=15% Similarity=0.144 Sum_probs=80.5
Q ss_pred eecCCce-EEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEEEeecccc-h
Q 016950 46 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-S 121 (380)
Q Consensus 46 lg~G~~g-~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~ 121 (380)
+..|..| .||+......+..+++|.-.... ....+|...|+.+.. -.+.+++.+..+ ....++|||+++| +
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence 4445444 69998877778889999875432 234579999888742 224444444422 2236799999987 3
Q ss_pred HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------------------------------------------
Q 016950 122 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------------------------------------------- 158 (380)
Q Consensus 122 l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~------------------------------------------- 158 (380)
+.+.... .......+..++...|.-||+.
T Consensus 107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 3332211 0011123334444444444431
Q ss_pred --------------CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 --------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 --------------~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..++|+|+.|.|||++. ++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 12789999999999985 5556799999885
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=9.4e-06 Score=74.19 Aligned_cols=30 Identities=27% Similarity=0.589 Sum_probs=26.3
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 58999999999999975 5679999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.3e-05 Score=72.35 Aligned_cols=72 Identities=19% Similarity=0.164 Sum_probs=44.4
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHhCCC--C-ceeeeceeeeecCCCC
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDH--P-NVISLKHCFFSTTSKN 107 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~ 107 (380)
-.+.||.|..+.||++....+++.+++|...... .....|..+++.+.. + .+.+++.+ +..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--- 108 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--- 108 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC---
Confidence 3567899999999999766667899999754221 123578888887742 2 23344322 221
Q ss_pred ceEEEEEeecccc
Q 016950 108 ELFLNLVMEYVPE 120 (380)
Q Consensus 108 ~~~~~lv~e~~~~ 120 (380)
. .++|||++++
T Consensus 109 ~--~~lvmE~l~g 119 (397)
T 2olc_A 109 M--AVTVMEDLSH 119 (397)
T ss_dssp T--TEEEECCCTT
T ss_pred c--cEEEEEeCCC
Confidence 1 3599999975
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=2.9e-05 Score=71.56 Aligned_cols=78 Identities=12% Similarity=0.079 Sum_probs=49.0
Q ss_pred eeeeee-ecCCceEEEEEEEC--C----CCcEEEEEEeeccc-------cchHHHHHHHHhCCC---Cceeeeceeeeec
Q 016950 41 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRVMDH---PNVISLKHCFFST 103 (380)
Q Consensus 41 ~~~~~l-g~G~~g~Vy~~~~~--~----~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~~~~~ 103 (380)
...+.| +.|....+|++... . ++..+++|...... ....+|+.+++.+.. -.+.+++....+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88888999988753 1 25689999775432 345789998888742 2345555443211
Q ss_pred CCCCceEEEEEeecccc
Q 016950 104 TSKNELFLNLVMEYVPE 120 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~ 120 (380)
. .....++|||+++|
T Consensus 103 ~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 D--VLGTPFFLMDYVEG 117 (357)
T ss_dssp T--TTSSCEEEEECCCC
T ss_pred C--ccCCceEEEEecCC
Confidence 1 01224689999986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00077 Score=56.58 Aligned_cols=97 Identities=18% Similarity=0.072 Sum_probs=63.5
Q ss_pred hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcce
Q 016950 121 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 199 (380)
Q Consensus 121 ~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~ 199 (380)
+|.++|.. .+.+++++++|.+++|.+.+|.-+ ++ +.-..+=+.|..|++.. +|.|.+.+ ..+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWR-DGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEET-TSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEec-CCceeccc-cccc----------
Confidence 68888875 467899999999999999998776 22 12223445678899987 67676543 1110
Q ss_pred eeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh
Q 016950 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL 236 (380)
Q Consensus 200 ~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~ 236 (380)
.....+.|||... ...+.+.-|+|||+++|..+-
T Consensus 98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 1122466888752 345788999999999999985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00045 Score=61.92 Aligned_cols=65 Identities=15% Similarity=0.110 Sum_probs=40.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCcee-eeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
++.|+.|....+|++ ..+++|+..... ....+|..+++.+....+. +++... .. . -++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~---~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA---T--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT---T--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC---C--CEEEEeec
Confidence 677889999999998 568899875432 2235788888877433332 333222 11 1 23889999
Q ss_pred -cc
Q 016950 119 -PE 120 (380)
Q Consensus 119 -~~ 120 (380)
+|
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 64
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0013 Score=62.01 Aligned_cols=79 Identities=13% Similarity=-0.043 Sum_probs=45.8
Q ss_pred HcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCCcceeec--cCCCCChhhhhCCC--CCCchhhHHHHHHHH
Q 016950 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGAT--EYTTSIDIWSAGCVL 231 (380)
Q Consensus 156 H~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~l~~~~--~~~~~~DiwslGvil 231 (380)
+. ..++|+|++|.|||++. ++ +.|+||+.+.............. ...|.+|+...... .-....++.++...+
T Consensus 230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45 68999999999999985 44 99999999864321111111111 12355555432111 112234555777777
Q ss_pred HHHHhC
Q 016950 232 AELLLG 237 (380)
Q Consensus 232 ~~ll~g 237 (380)
|..+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.001 Score=59.99 Aligned_cols=142 Identities=13% Similarity=0.057 Sum_probs=73.3
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeec--cccchHHHHHHHHhCCCCc--eeeeceeeeecCCC----CceEEEE
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMDHPN--VISLKHCFFSTTSK----NELFLNL 113 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~--~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~----~~~~~~l 113 (380)
-.+.|+.|....+|++... + ..+++|.... .......|..+++.+.... +.+++.. .... .....++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES-S-CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC-C-ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence 3456778888999998753 3 3688998865 3344567888887774322 2232211 0000 0123578
Q ss_pred EeecccchH------------HHHH---HHhhhc-CCC----CCHHHHHH---------------HHHHHHHHHHHhHc-
Q 016950 114 VMEYVPESM------------YRVL---KHYSSA-NQR----MPLIYVKL---------------YTYQIFRGLAYIHT- 157 (380)
Q Consensus 114 v~e~~~~~l------------~~~l---~~~~~~-~~~----l~~~~~~~---------------i~~ql~~al~~LH~- 157 (380)
++++++|.. -+.+ ...... ... ........ +...+...++.+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998621 1111 111000 000 01000000 00112333444441
Q ss_pred -----CCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 158 -----VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 158 -----~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
..+++|+|+.+.|||++. +..+.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 147999999999999985 4445799999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0059 Score=58.02 Aligned_cols=70 Identities=14% Similarity=0.230 Sum_probs=45.2
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCce-eeeceeeeecCCCCceEEEEEeec
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY 117 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 117 (380)
-++.|+.|....+|++.....+..+++|+...... ...+|..+++.|...++ .++++.+ .+ ..|+||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 34568888889999998754457899998743221 22589999999875554 3444443 22 158999
Q ss_pred ccc
Q 016950 118 VPE 120 (380)
Q Consensus 118 ~~~ 120 (380)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0039 Score=58.76 Aligned_cols=70 Identities=14% Similarity=0.238 Sum_probs=46.2
Q ss_pred eeeeeecCCceEEEEEEECC-------CCcEEEEEEeec-cc-cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEE
Q 016950 42 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~-~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~ 111 (380)
-++.|+.|....||++.... .++.+++|+... .. ....+|..+++.+...++ .++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence 35668888889999998653 357899998844 22 334478888888753333 4444433 22
Q ss_pred EEEeecccc
Q 016950 112 NLVMEYVPE 120 (380)
Q Consensus 112 ~lv~e~~~~ 120 (380)
.+|+||++|
T Consensus 148 g~v~e~l~G 156 (429)
T 1nw1_A 148 GRLEEYIPS 156 (429)
T ss_dssp EEEECCCCE
T ss_pred CEEEEEeCC
Confidence 278899875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0051 Score=54.49 Aligned_cols=74 Identities=15% Similarity=0.077 Sum_probs=48.1
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
..-++.+|.|..+.||++.. .+|+.|++|+..... .....|+..|+.|....-+.+-.++... . -++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv~ 89 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLAM 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEEE
Confidence 45567899999999999984 578899999865332 2346899999988432212222222111 1 24889
Q ss_pred ecccc
Q 016950 116 EYVPE 120 (380)
Q Consensus 116 e~~~~ 120 (380)
||+.+
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 99863
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0038 Score=56.12 Aligned_cols=71 Identities=14% Similarity=0.038 Sum_probs=49.3
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCC---CCceeeeceeeeecCCCCceEEEEEeecc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVMEYV 118 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 118 (380)
.+.|+.|....+|++.. ++..+++|+..... .....|...|+.|. ...+.+++..... ....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence 46689999999999874 46788999876442 33467888888773 2445555554321 23477999999
Q ss_pred cc
Q 016950 119 PE 120 (380)
Q Consensus 119 ~~ 120 (380)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 85
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.005 Score=56.94 Aligned_cols=138 Identities=14% Similarity=0.210 Sum_probs=75.1
Q ss_pred eeeeecCCceEEEEEEECC-------CCcEEEEEEeecc---ccchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEE
Q 016950 43 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~ 111 (380)
++.|..|....+|++.... +++.|++|+.... .....+|..+++.+...++ .+++..+ ++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~---- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE---- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence 3457778888999998642 3578999986332 2233478888887743233 3444433 22
Q ss_pred EEEeecccch-H--------------HHHHHHhhhc----CCCC--CHHHHHHHHHHHHH-------------------H
Q 016950 112 NLVMEYVPES-M--------------YRVLKHYSSA----NQRM--PLIYVKLYTYQIFR-------------------G 151 (380)
Q Consensus 112 ~lv~e~~~~~-l--------------~~~l~~~~~~----~~~l--~~~~~~~i~~ql~~-------------------a 151 (380)
.+||||++|. + .+.+...-.. .... -+..+..++.++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 1889999851 1 1111111111 1111 23445555544321 1
Q ss_pred HHH----hHc---CCCeeecCCCCCCEEEcCC---CCcEEEEeecccc
Q 016950 152 LAY----IHT---VPRVCHRDLKPQNLLVDPL---THQVKICDFGSAK 189 (380)
Q Consensus 152 l~~----LH~---~~~iiH~Dlkp~Nill~~~---~~~ikl~Dfg~a~ 189 (380)
+.. |.. ...++|+|+.+.||+++.+ .+.+.++||..|.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 222 1368999999999999863 2579999999885
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0061 Score=55.00 Aligned_cols=73 Identities=14% Similarity=0.031 Sum_probs=42.7
Q ss_pred eeeecCCceEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHhCCCCc--eeeeceeeeecCC--CCceEEEEEee
Q 016950 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVME 116 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~---~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e 116 (380)
..++ |....||++.. .+|+.+++|..... ......|..+++.+.... +.+++.. +... ......+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 3456 77889998763 35668999988632 233456888887774222 3333322 1100 01224568999
Q ss_pred cccc
Q 016950 117 YVPE 120 (380)
Q Consensus 117 ~~~~ 120 (380)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0043 Score=57.15 Aligned_cols=69 Identities=13% Similarity=0.136 Sum_probs=40.7
Q ss_pred eeeeecCCceEEEEEEECC--------CCcEEEEEEeecccc---chHHHHHHHHhCCCCce-eeeceeeeecCCCCceE
Q 016950 43 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF 110 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~--------~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 110 (380)
.+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~---- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N---- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence 4567788888999998643 136889998754322 23578888888753333 3444332 1
Q ss_pred EEEEeecccc
Q 016950 111 LNLVMEYVPE 120 (380)
Q Consensus 111 ~~lv~e~~~~ 120 (380)
-++||||++|
T Consensus 109 ~~~v~e~i~G 118 (369)
T 3c5i_A 109 GGRIEEWLYG 118 (369)
T ss_dssp TEEEEECCCS
T ss_pred CcEEEEEecC
Confidence 1478999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.013 Score=52.96 Aligned_cols=32 Identities=41% Similarity=0.476 Sum_probs=26.9
Q ss_pred CCeeecCCCCCCEEEcCC---CCcEEEEeeccccc
Q 016950 159 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ 190 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~---~~~ikl~Dfg~a~~ 190 (380)
..++|+|+.+.|||++.+ .+.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 589999999999999852 15789999999864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0092 Score=54.31 Aligned_cols=31 Identities=26% Similarity=0.473 Sum_probs=26.4
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
..++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence 47999999999999985 56799999988753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.54 E-value=0.14 Score=47.90 Aligned_cols=70 Identities=11% Similarity=0.150 Sum_probs=44.7
Q ss_pred eeeeeecCCceEEEEEEECCC-------CcEEEEEEeeccc---cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceE
Q 016950 42 AERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR---RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF 110 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~-------~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~ 110 (380)
-++.|..|....+|++..... ++.|++|+..... ....+|..+++.+...++ .++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~---- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P---- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence 345567788889999986521 5789999874422 223588988888853333 3333322 2
Q ss_pred EEEEeecccc
Q 016950 111 LNLVMEYVPE 120 (380)
Q Consensus 111 ~~lv~e~~~~ 120 (380)
-+.|+||++|
T Consensus 145 ~~~I~efI~G 154 (424)
T 3mes_A 145 EGRIEEFIDG 154 (424)
T ss_dssp TEEEEECCCS
T ss_pred CCEEEEEeCC
Confidence 1478999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.13 E-value=0.66 Score=42.96 Aligned_cols=29 Identities=24% Similarity=0.476 Sum_probs=24.3
Q ss_pred eeecCCCCCCEEEcC-----CCCcEEEEeecccc
Q 016950 161 VCHRDLKPQNLLVDP-----LTHQVKICDFGSAK 189 (380)
Q Consensus 161 iiH~Dlkp~Nill~~-----~~~~ikl~Dfg~a~ 189 (380)
++|+|+.+.|||+.+ .+..+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999942 35679999999885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 380 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-123 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-67 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-65 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-65 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-60 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-60 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 357 bits (917), Expect = e-123
Identities = 225/346 (65%), Positives = 281/346 (81%), Gaps = 3/346 (0%)
Query: 23 ISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL 82
+ T G P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQD+R+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 83 QLMRVMDHPNVISLKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 141
Q+MR +DH N++ L++ F+S+ K+E++LNLV++YVPE++YRV +HYS A Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
KLY YQ+FR LAYIH+ +CHRD+KPQNLL+DP T +K+CDFGSAKQL+ GE N+SYI
Sbjct: 125 KLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
CSR+YRAPELIFGAT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
RE+IR MNPNYT+F+FPQIKAHPW KVF R PPEAI L SRLL+Y+P+ R T LEACAH
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 322 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 367
FFDELR+PN +LPNGR P LFNF + ++P L LIP H +
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 2e-74
Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRVMDHPNVI 94
Y +G G++G+V A VAIKK+ + + Y RE++++ H N+I
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + T + + LV + +Y++LK Q + ++ + YQI RGL Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPE 210
IH+ V HRDLKP NLL++ T +KICDFG A+ + Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 268
++ + YT SIDIWS GC+LAE+L +P+FPG++ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 269 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
P PW+++F +A+DL ++L ++P R +A AHP+ ++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 328 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 368
+P+ F F EL E + +LI + R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-70
Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 31/305 (10%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ +G G+ G+VF+ +G +A K + + + RELQ++ + P ++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
F+S +++ ME++ L R+P + + + +GL Y
Sbjct: 68 GFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
+ ++ HRD+KP N+LV+ ++K+CDFG + QLI AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 273
T Y+ DIWS G L E+ +G+ P +A +L+ +V G R P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 274 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319
+ I P K+ E D ++ L +P+ R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 320 AHPFF 324
H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 5e-70
Identities = 96/304 (31%), Positives = 150/304 (49%), Gaps = 23/304 (7%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 94
+G G F V++A+ T + VAIKK+ R + RE++L++ + HPN+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L F ++ ++LV +++ + + + ++K Y +GL Y
Sbjct: 64 GLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 213
+H + HRDLKP NLL+D +K+ DFG AK + ++ +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
GA Y +D+W+ GC+LAELLL P PG++ +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 331
F P H +F + +DL L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 332 ARLP 335
+LP
Sbjct: 293 CQLP 296
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-67
Identities = 104/337 (30%), Positives = 164/337 (48%), Gaps = 23/337 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 93
Y VG+G++G V A +TG VA+KK+ + + REL+L++ M H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L F S E ++ ++ + + Q++ +V+ YQI RGL
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 213
YIH+ + HRDLKP NL V+ KI DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 214 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
Y ++DIWS GC++AELL G+ LFPG + +DQL I++++GTP E ++ ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 274 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
Q+ + VF P A+DL ++L R TA +A AH +F + +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 331 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 367
+ P+ ++ E + L D V
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 3e-66
Identities = 103/316 (32%), Positives = 167/316 (52%), Gaps = 21/316 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y + VG+G++G V A TG VAIKK+ + + + REL+L++ M H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 94 ISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I L F + ++ LVM ++ + +++KH +++ ++ YQ+ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
YIH + HRDLKP NL V+ ++KI DFG A+Q Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 273 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
P+++ + + P A++L ++L R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 330 PNARLPNGRPLPPLFN 345
P + F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-65
Identities = 101/307 (32%), Positives = 167/307 (54%), Gaps = 21/307 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
+ +G G++G+V++A+ TGE VA+KK+ D + RE+ L++ ++HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L E L LV E++ + + + + SA +PL +K Y +Q+ +GLA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 212
+ H+ RV HRDLKPQNLL++ +K+ DFG A+ + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 271
G Y+T++DIWS GC+ AE++ + LFPG++ +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
FP+ + KV + + L S++L Y P+ R +A A AHPFF ++ +P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 332 ARLPNGR 338
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 209 bits (532), Expect = 1e-65
Identities = 89/300 (29%), Positives = 148/300 (49%), Gaps = 21/300 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RVMDHPNVISLK 97
Y R +G G + VF+A + E V +K + ++ K RE++++ + PN+I+L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
S+ LV E+V + ++ L Q + ++ Y Y+I + L Y H+
Sbjct: 97 DIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 158 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 217
+ + HRD+KP N+++D ++++ D+G A+ G+ + SR+++ PEL+
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 218 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y S+D+WS GC+LA ++ + P F G + DQLV I KVLGT + D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 277 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328
F I W + H + PEA+D +LL+Y R TA EA HP+F +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-65
Identities = 81/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G+FG VF+A+ +TG+ VA+KKVL + + RE+++++++ H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 94 ISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
++L + S + + + LV ++ + S+ + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-----SYICSRF 205
GL YIH ++ HRD+K N+L+ +K+ DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
YR PEL+ G +Y ID+W AGC++AE+ P+ G QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 266 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322
++ + +K ++ P A+DL +LL P+ R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 323 FFDELREPN 331
FF P+
Sbjct: 307 FFWSDPMPS 315
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (528), Expect = 1e-64
Identities = 71/325 (21%), Positives = 127/325 (39%), Gaps = 41/325 (12%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 95
Y +GTG+FG+V + TG A K V+ D+ +E+Q M V+ HP +++
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F NE+ + + E++ + + + + +M Y Q+ +GL ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 156 HTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H H DLKP+N++ ++++K+ DFG L ++ + + APE+ G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
D+WS G + LL G F GEN + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 332
+ + D +LL P+ R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 333 RLPNGRPLPPLFNFKQELSGASPEL 357
++P+ R + K + L
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPL 318
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-64
Identities = 97/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)
Query: 40 YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRVM---D 89
Y +G G++G VF+A+ L+ G VA+K+V + RE+ ++R + +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
HPNV+ L + + E L LV E+V + + L +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
RGL ++H+ RV HRDLKPQN+LV + Q+K+ DFG A+ A S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E++ + Y T +D+WS GC+ AE+ +PLF G + VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328
F A P K + DL + L ++P+ R +A A +HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-63
Identities = 101/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G VF+AK ET E VA+K+V D + RE+ L++ + H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L ++ L LV E+ + K++ S N + VK + +Q+ +GL
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELI 212
+ H+ V HRDLKPQNLL++ ++K+ +FG A+ S + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
FGA Y+TSID+WSAGC+ AEL +PLFPG + DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
+P A ++ DL LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-62
Identities = 72/328 (21%), Positives = 133/328 (40%), Gaps = 32/328 (9%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 101
+V+G G G V Q T E A+ K+LQD RE++L R P+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 102 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ + + L +VME + ++ ++ +Q I + Y+H++
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131
Query: 161 VCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 218
+ HRD+KP+NLL +K+ DFG AK+ + + + + +Y APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278
S D+WS G ++ LL G P F + + + + IR + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242
Query: 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 337
++ E L LL+ P+ R T E HP+ + P L
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 338 RPLPPLFNFKQELSGASPELVNKLIPDH 365
R L +++ + + D+
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 198 bits (505), Expect = 5e-62
Identities = 96/295 (32%), Positives = 157/295 (53%), Gaps = 20/295 (6%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 93
Y +G G++G+V++A+ GET A+KK+ ++ + RE+ +++ + H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
+ L + L LV E++ + + ++L + + K + Q+ G+A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 212
Y H RV HRDLKPQNLL++ ++KI DFG A+ I I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 271
G+ +Y+T+IDIWS GC+ AE++ G PLFPG + DQL+ I ++LGTP +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
D F + PW K + IDL S++L+ P+ R TA +A H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-60
Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 44/301 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+ + +G G++G V A T E VA+K V R +E+ + ++++H NV+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L +EY + MP + + +Q+ G+ Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPEL 211
+H + HRD+KP+NLL+D +KI DFG A + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 212 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271
+ + +D+WS G VL +L G+ + + Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+PW K+ + L ++L +PS R T + ++++ +
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270
Query: 332 A 332
A
Sbjct: 271 A 271
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (498), Expect = 4e-60
Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 42/322 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
Y +G+G+FG+V + TG K + D+ E+ +M + HP +I+
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F K E+ L ++E++ + ++ + +M V Y Q GL ++
Sbjct: 91 LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 156 HTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H + H D+KP+N++ + VKI DFG A +L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
D+W+ G + LL G F GE+ ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 334
+ PEA D LLQ P R T +A HP+ + ++ L
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL---KGDHSNL 293
Query: 335 PNGRPLPPLFNFKQELSGASPE 356
+ P +Q++ +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-60
Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 96
+ +G GSF V++ ET VA ++ + K+ E ++++ + HPN++
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ + +T K + + LV E + LK Y + M + ++ + QI +GL ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 157 T-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 215
T P + HRDLK N+ + T VKI D G A A A + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE- 187
Query: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275
+Y S+D+++ G + E+ + + Q+ + P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233
Query: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
F K PE ++ ++ + R + + H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-60
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 45/296 (15%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 93
Y +GTGS+G + + G+ + K++ +++ E+ L+R + HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ T+ L +VMEY + V+ + Q + +V Q+ L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 153 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYR 207
H V HRDLKP N+ +D VK+ DFG A+ L + +++ + +Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
+PE + Y DIWS GC+L EL P F + + +I +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
+F +I E ++ +R+L R + E +P
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-60
Identities = 99/355 (27%), Positives = 176/355 (49%), Gaps = 34/355 (9%)
Query: 30 KNGEPKQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RE 81
+ G+ T+ Y + +G+G+ GIV A VAIKK+ + + + RE
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 82 LQLMRVMDHPNVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIY 140
L LM+ ++H N+ISL + F + E + LVME + ++ +V++ +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------ 120
Query: 141 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 200
+ YQ+ G+ ++H+ + HRDLKP N++V +KI DFG A+ Y
Sbjct: 121 MSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY 178
Query: 201 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
+ +R+YRAPE+I G Y ++DIWS GC++ E++ + LFPG + +DQ ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 261 TREEIRCMNPNYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQY 307
E ++ + P ++ P+ + K+F +K +A DL S++L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 308 SPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 362
P+ R + +A HP+ + +P P P +++ + + + E +LI
Sbjct: 298 DPAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 349
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-59
Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 44/294 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 95
+ +G G+FG V++A+ ET A K + ++ E+ ++ DHPN++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L F+ + L +++E+ + + +++ Q L Y+
Sbjct: 74 LLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFG 214
H ++ HRDLK N+L +K+ DFG + + S+I + ++ APE++
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 215 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
T Y D+WS G L E+ +P N + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
K+ P R D + L+ + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (493), Expect = 2e-59
Identities = 98/357 (27%), Positives = 160/357 (44%), Gaps = 49/357 (13%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM 88
GEP + Y+ R +G G F V+ AK + VA+K V D+ Y E++L++ +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 89 DHPNVISLKH----------CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 138
+ + F+ N + + +V E + E++ ++K Y ++ +PL
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 124
Query: 139 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIA 193
IYVK + Q+ GL Y+H + H D+KP+N+L++ + Q+KI D G+A
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD- 183
Query: 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------V 247
E + I +R YR+PE++ GA + DIWS C++ EL+ G LF +
Sbjct: 184 -EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 248 DQLVEIIKVLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMP 294
D + +II++LG +R T F ++K P V F K
Sbjct: 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301
Query: 295 PEAIDLASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 344
E D S +LQ P R A HP+ +E+R P+ L +G +P F
Sbjct: 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-59
Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 49/305 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ + HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
I + C+ E LVMEY S + + + + T+ +GL
Sbjct: 77 TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
AY+H+ + HRD+K N+L+ VK+ DFGSA + S++ + ++ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 213 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
E Y +D+WS G EL +P NA+ L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
+ + + LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 331 NARLP 335
+
Sbjct: 277 TVIMD 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-58
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 48/292 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
+ R +G G FG V+ A+ ++ +A+K + RE+++ + HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++ L F T + L++EY P + + Y ++ L
Sbjct: 68 ILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
+Y H+ RV HRD+KP+NLL+ ++KI DFG + + + + Y PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMI 176
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
G + +D+WS G + E L+G+P F + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324
+F FP + A DL SRLL+++PS R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-58
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISL 96
YM +G G FGIV + + +T K V D+ +E+ ++ + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
F S L ++ E++ ++ + ++ + + Y +Q+ L ++
Sbjct: 67 HESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118
Query: 156 HTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 214
H+ + H D++P+N++ +KI +FG A+QL G+ + Y APE+
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 215 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 274
+T+ D+WS G ++ LL G F E + I+ T E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227
Query: 275 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
K + EA+D RLL R TA EA HP+ + E
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-57
Identities = 74/325 (22%), Positives = 133/325 (40%), Gaps = 52/325 (16%)
Query: 32 GEPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRV 87
G+PK+ Y +G G+ G V+ A + TG+ VAI+++ + E+ +MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 88 MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
+PN+++ + +EL++ VMEY + M + +
Sbjct: 74 NKNPNIVNYLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRE 124
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 206
+ L ++H+ +V HRD+K N+L+ VK+ DFG Q+ ++ S + + ++
Sbjct: 125 CLQALEFLHSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 207 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266
APE++ Y +DIWS G + E++ G+P + EN + L I GTP
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP------ 234
Query: 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326
+ + P +++ D +R L R +A E H F
Sbjct: 235 -------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
Query: 327 LREPNARLPNGRPLPPLFNFKQELS 351
+ L PL +E +
Sbjct: 276 AKPL-------SSLTPLIAAAKEAT 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 185 bits (470), Expect = 8e-57
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 54/306 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 86
Y + ++G G +V + T + A+K + + R +E+ ++R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 87 -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 145
V HPN+I LK + + F LV + + + L Y + + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKIM 116
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 205
+ + +H + HRDLKP+N+L+D + +K+ DFG + QL GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 206 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320
M+ NY F P+ DL SR L P R TA EA A
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 321 HPFFDE 326
HPFF +
Sbjct: 270 HPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 1e-56
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 42/303 (13%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
Y V+GTG+F V A+ T + VAIK + + E+ ++ + HPN++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+L + S L+L +M+ V L +Q+ + Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
+H + HRDLKP+NLL L ++ I DFG +K G + + Y APE++
Sbjct: 123 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y+ ++D WS G + LL G P F EN +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 332
+ + A D L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 333 RLP 335
+
Sbjct: 276 NIH 278
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-56
Identities = 82/320 (25%), Positives = 127/320 (39%), Gaps = 59/320 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 92
+ +++G GSF V A+ L T AIK + Y RE +M +DHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+ L F +L+ + Y L Y + YT +I L
Sbjct: 70 FVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAP 209
Y+H + HRDLKP+N+L++ ++I DFG+AK L S++ + Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
EL+ S D+W+ GC++ +L+ G P F N +IIK+
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 323
++ FP+ + P+A DL +LL + R E AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 324 FDELREPNARLPNGRPLPPL 343
F+ + L P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 51/324 (15%)
Query: 35 KQTIS--YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------REL 82
++ + Y +G+G F +V + + TG A K + + R + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 83 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 142
+++ + HPNVI+L + +N+ + L++E V L + + + +
Sbjct: 65 SILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEAT 116
Query: 143 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANIS 199
+ QI G+ Y+H+ ++ H DLKP+N+++ ++KI DFG A ++ G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 200 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259
+ + APE++ D+WS G + LL G F G+ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319
E + A D RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 320 AHPFFDELREPNARLPNGRPLPPL 343
HP+ A L + P
Sbjct: 270 QHPWIKPKDTQQA-LSSAWSHPQF 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-52
Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHP 91
++ +++G GSFG VF A+ +T + AIK + +D + +++ L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+ + F + + L VMEY+ L ++ + + L Y +I G
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 210
L ++H+ + +RDLK N+L+D H KI DFG K+ + G+A + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 211 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
++ G +Y S+D WS G +L E+L+GQ F G++ + IR NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 329
Y + + EA DL +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
Query: 330 PNARLPNGRPLPP----------LFNFKQELSGASPEL 357
L PP NF +E P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 64/303 (21%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 89
Y ++G+G FG V+ + VAIK V +DR E+ L++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 90 --HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 147
VI L F S L++E L + + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQ 118
Query: 148 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 207
+ + + H V HRD+K +N+L+D ++K+ DFGS L+ + +R Y
Sbjct: 119 VLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
PE I + S +WS G +L +++ G F + + +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327
F +R+ E L L PS R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 328 REP 330
P
Sbjct: 262 LLP 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (434), Expect = 1e-50
Identities = 72/320 (22%), Positives = 121/320 (37%), Gaps = 55/320 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD 89
+ R++G G FG V+ + +TG+ A+K + + R + L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
P ++ + + F + L+ +++ + L ++ S + ++ Y +I
Sbjct: 66 CPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 209
GL ++H V +RDLKP N+L+D H V+I D G A + + S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
E++ Y +S D +S GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 324
PE L LLQ + R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 325 DELREPNARLPNGRPLPPLF 344
L + ++ + PP
Sbjct: 269 RSL---DWQMVFLQKYPPPL 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (429), Expect = 2e-50
Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 92
+ R +GTGSFG V + G A+K + L+ + N E ++ ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
+I + F ++ + ++M+Y+ L +QR P K Y ++ L
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 117
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 212
Y+H+ + +RDLKP+N+L+D H +KI DFG AK + + + + Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 213 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272
Y SID WS G ++ E+L G F N + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 327
+ RFP + DL SRL+ S R + HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-48
Identities = 62/299 (20%), Positives = 108/299 (36%), Gaps = 51/299 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISL 96
+ +G+GSFG V++ K VA+K + Q + E+ ++R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 97 KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L +V ++ S+Y L + +I + Q +G+ Y+
Sbjct: 70 MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 212
H + HRDLK N+ + VKI DFG A + + S + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 213 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
Y+ D+++ G VL EL+ GQ + N DQ++ ++
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ P + P L + L+ R + A + L
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS--IELLAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 5e-48
Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 92
Y ++G G V A+ L VA+K + D RE Q ++HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 152
++++ + T L +VMEYV L+ M + L
Sbjct: 69 IVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 153 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRA 208
+ H + HRD+KP N+++ T+ VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 209 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
PE G D++S GCVL E+L G+P F G++ V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
H+ + + + + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-47
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 53/311 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 96
+++G G+FG V + TG A+K + ++ E ++++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
K+ F + L VMEY L + S + + Y +I L Y+H
Sbjct: 71 KYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
+ V +RD+K +NL++D +KI DFG K+ I+ A + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
+Y ++D W G V+ E++ G+ F ++ I+ + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 331
FP + + PEA L + LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 332 ARLPNGRPLPP 342
+ + LPP
Sbjct: 270 QDVVQKKLLPP 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-45
Identities = 53/282 (18%), Positives = 100/282 (35%), Gaps = 45/282 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 101
+ +G G FG V G VA+K + D + E +M + H N++ L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 102 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
L +V EY+ + S+ L+ S + + ++ + + Y+
Sbjct: 71 EEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 220
HRDL +N+LV + K+ DFG K+ + + APE + +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179
Query: 221 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 279
D+WS G +L E+ G+ +P D + + K ++
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220
Query: 280 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
PP ++ ++R + L+
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 4e-44
Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 45/302 (14%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
Y R +G+GSFG ++ + GE VAIK ++ E ++ ++M I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ + +VME + S+ ++ +++ L V L Q+ + YIH+
Sbjct: 69 RWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 158 VPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--------SYICSRFYR 207
HRD+KP N L+ + V I DFG AK+ + + + Y
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 208 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267
+ G E + D+ S G VL LG + G A + + ++ I
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 324
+ Y P E + + + + F
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
Query: 325 DE 326
+
Sbjct: 279 RQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 1e-43
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 24/267 (8%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 97
Y R +G GSFG++F+ L + VAIK + E + +++ I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 157
+ F L LV++ + S+ +L ++ + V + Q+ + IH
Sbjct: 67 YYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 158 VPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI--------SYICSRF 205
+ +RD+KP N L+ + + + DFG K + +
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
Y + G E + D+ + G V L G + G A + ++ +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKR 292
R + + + F + + + F
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 2e-41
Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 57/313 (18%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 96
+ +GTGSFG V K E+G A+K + L+ + E ++++ ++ P ++ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
+ F + + + + + R + + Y QI Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 216
++ + +RDLKP+NLL+D +++ DFG AK++ + + APE+I
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS-K 213
Query: 217 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
Y ++D W+ G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDELREPN 331
F + DL LLQ +L+ + H +F +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301
Query: 332 ARLPNGRPLPPLF 344
R + F
Sbjct: 302 WIAIYQRKVEAPF 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-41
Identities = 73/332 (21%), Positives = 131/332 (39%), Gaps = 58/332 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRVM 88
+ +V+GTG++G VF + + +TG+ A+K + + + E Q++ +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 148
+ H F T +K L+L+++Y+ L + S +R V++Y +I
Sbjct: 86 RQSPFLVTLHYAFQTETK----LHLILDYI---NGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 149 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRF 205
L ++H + +RD+K +N+L+D V + DFG +K+ +A E +Y +
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ G + + ++D WS G ++ ELL G F + + EI +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 320
P + + M A DL RLL P R A E
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
Query: 321 HPFFDELREPNARLPNGRPLPPLFNFKQELSG 352
H FF ++ L + P FK +
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP---FKPVIRD 318
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 4e-41
Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVIS 95
+ + + +G G FG V++ K GE VA+K + ++ E+ ++ H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 96 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + L LV +Y S++ L Y + + + GLA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115
Query: 155 IHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 205
+H P + HRDLK +N+LV I D G A + + I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 206 ---YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 257
Y APE++ + E DI++ G V E+ + G + QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 258 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
P+ EE+R + +++ + ++ + + + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-40
Identities = 65/296 (21%), Positives = 103/296 (34%), Gaps = 47/296 (15%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
E +G G FG V+ T VAIK + +E Q+M+ + H ++ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
S+ +++ V EY+ + + + L + QI G+AY+
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 217
HRDL+ N+LV K+ DFG A+ + E A + APE
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 218 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 330
P DL + + P R T A +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-39
Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 47/293 (16%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 96
+G G FG V+ VA+K + Q + E LM+ + H ++ L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 97 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 156
++ +++ + EY+ S ++ + + QI G+A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126
Query: 157 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFG 214
HRDL+ N+LV KI DFG A+ + E + APE I
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 215 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 273
+T D+WS G +L E++ G+ +PG + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 274 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 324
+ V P E L + P R T + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 48/291 (16%), Positives = 98/291 (33%), Gaps = 45/291 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 100
+ +G+G FG+V + VAIK + + + E ++M + HP ++ L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
+ LV E++ + + + + + G+AY+
Sbjct: 70 LEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEY 218
V HRDL +N LV +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 219 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 278
++ D+WS G ++ E+ + + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 279 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329
+ + + + + P R E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 56/303 (18%)
Query: 43 ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 94
++ +G+G+FG V + + +TVA+K + + E +M+ +D+P ++
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
+ + + LVME L Y N+ + + +Q+ G+ Y
Sbjct: 72 RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPE 210
+ HRDL +N+L+ H KI DFG +K L A E A + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
I ++++ D+WS G ++ E GQ + G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 326
R P E DL + Y R + ++D
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 327 LRE 329
+ E
Sbjct: 272 VNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-39
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 51/288 (17%)
Query: 44 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------RELQLMRVMDHPNV 93
+G GSFG+V + + +VA+K + D + RE+ M +DH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 153
I L + + +V E P + +L L + Y Q+ G+
Sbjct: 74 IRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 154 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 210
Y+ + R HRDL +NLL+ VKI DFG + L + + + F
Sbjct: 126 YLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 211 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269
++ + D W G L E+ GQ + G N L +I K
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229
Query: 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
R P+ + P + ++ + + P R T +
Sbjct: 230 ---EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 3e-39
Identities = 55/294 (18%), Positives = 111/294 (37%), Gaps = 43/294 (14%)
Query: 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 99
+ +G G +G V++ + TVA+K + +D +E +M+ + HPN++ L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 100 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 159
++ E++ + Q + + + QI + Y+
Sbjct: 82 CTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 217
HRDL +N LV H VK+ DFG ++ + A+ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 218 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277
++ D+W+ G +L E+ + Q+ E+++ D+R
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 278 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 331
+ P + +L Q++PS R + E H F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 5e-39
Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 54/309 (17%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDH 90
E+V+G G FG V G+ VAIK + + RR E +M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 91 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 150
PNVI L+ +T + ++ E++ + + + +I + I
Sbjct: 87 PNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139
Query: 151 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------ 204
G+ Y+ HRDL +N+LV+ K+ DFG ++ L ++ +Y +
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 205 FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 263
+ APE I ++T++ D+WS G V+ E++ G+ + D + I +
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248
Query: 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 323
D+R P P L Q + R +
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 324 FDELREPNA 332
+R PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 5e-39
Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 53/304 (17%)
Query: 44 RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 94
+V+G+G+FG V++ + GE VAIK++ + K E +M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
L ++T + L+ + +P +L + + Y+ + QI +G+ Y
Sbjct: 75 RLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR---FYRAPEL 211
+ R+ HRDL +N+LV H VKI DFG AK L A E + + A E
Sbjct: 127 LED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
I YT D+WS G + EL+ G + G A ++ I++
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE--------------- 227
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330
R P + + + R E F R+P
Sbjct: 228 --KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 331 NARL 334
L
Sbjct: 275 QRYL 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-38
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 70/314 (22%)
Query: 43 ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RVMDHP 91
+V+G+G+FG V A +T VA+K + + EL++M ++ H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK-------------------HYSS 131
N+++L T ++ L+ EY + L+
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 132 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191
+ + + YQ+ +G+ ++ HRDL +N+LV VKICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214
Query: 192 IAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 247
++ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 248 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 307
++I+ F+ E + +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306
Query: 308 SPSLRCTALEACAH 321
R + +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-38
Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 45/284 (15%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 100
+ +GTG FG+V K VAIK + + ++ E ++M + H ++ L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 101 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 160
T + +F ++ EY+ +L + R + + + Y+ + +
Sbjct: 69 ---TKQRPIF--IITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120
Query: 161 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATEY 218
HRDL +N LV+ VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 219 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 277
++ DIW+ G ++ E+ LG+ + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222
Query: 278 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
P + + + R T ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 51/293 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 94
V+G G FG V+ L+ A+K + + + E +M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 154
SL ++E +V+ Y+ R + + + Q+ +G+ +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145
Query: 155 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 209
+ + + HRDL +N ++D VK+ DFG A+ + E + + + + A
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
E + ++TT D+WS G +L EL+ G P +P N D V +++ R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
P Y P ++ + +R + E +
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-37
Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 54/303 (17%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVIS 95
+ +G G+FG V Q + VAIK + Q + RE Q+M +D+P ++
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 96 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 155
L + L LVME + K + +P+ V +Q+ G+ Y+
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAPEL 211
HRDL +N+L+ H KI DFG +K L A ++ + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 212 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270
I ++++ D+WS G + E L GQ + + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 327
PPE L S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
Query: 328 REP 330
+
Sbjct: 275 SKV 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 3e-36
Identities = 61/300 (20%), Positives = 110/300 (36%), Gaps = 56/300 (18%)
Query: 43 ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 94
+ V+G G+FG V +A+ + G AIK++ D R EL+++ ++ HPN+I
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 95 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSSANQRMPLIYV 141
+L + +L L +EY P ++ L+ +S + +
Sbjct: 75 NLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 142 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 201
+ + RG+ Y+ + HRDL +N+LV + KI DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 202 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261
+ A E + + YTT+ D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
+R E DL + + P R + +
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-35
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 65/305 (21%)
Query: 43 ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 91
+ +G G+FG V +A + TVA+K + L +R EL+++ + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY--------------SSANQRM 136
N+++L T + + EY + L+ +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 137 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196
L + ++YQ+ +G+A++ + HRDL +N+L+ KICDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200
Query: 197 NISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 252
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 253 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 312
+IK + + + P E D+ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 313 CTALE 317
T +
Sbjct: 293 PTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-35
Identities = 68/293 (23%), Positives = 101/293 (34%), Gaps = 50/293 (17%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDHP 91
R +G G FG V Q + VAIK R +E MR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 92 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 151
+++ L E + ++ME R + L + LY YQ+
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 152 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAP 209
LAY+ + R HRD+ +N+LV VK+ DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 210 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268
E I +T++ D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321
PP L ++ Y PS R E A
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-35
Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)
Query: 40 YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRVM 88
+ +G G+FG V +A T TVA+K + + R + L+ +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 89 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSANQR 135
H NV++L L +++E+ ++ L+
Sbjct: 75 HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 136 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 195
+ L ++ Y++Q+ +G+ ++ + + HRDL +N+L+ + VKICDFG A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188
Query: 196 ANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 251
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 252 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 311
+K T R P PE PS
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 312 RCTALEACAHPFFDELREPNA 332
R T E H L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 55/292 (18%), Positives = 95/292 (32%), Gaps = 50/292 (17%)
Query: 39 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMD 89
++V+G G FG V++ + VAIK + K E +M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 90 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 149
H N+I L+ + ++ EY+ K + ++ + I
Sbjct: 68 HHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120
Query: 150 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRF 205
G+ Y+ HRDL +N+LV+ K+ DFG ++ L
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 206 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265
+ APE I + S D+WS G V+ E++ E + ++++ I
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 317
FR P P L + Q + R +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 1e-33
Identities = 67/321 (20%), Positives = 108/321 (33%), Gaps = 73/321 (22%)
Query: 44 RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 93
R +G G+FG VFQA+ E VA+K + ++ RE LM D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 94 ISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMYRVLKHYSSA 132
+ + L + EY+ + + S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 133 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192
+ Q+ G+AY+ + HRDL +N LV VKI DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191
Query: 193 AGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 248
+ + A+ + + PE IF YTT D+W+ G VL E+ G + G +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 249 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 308
+ + I A P + P E +L
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 309 PSLRCTALEACAHPFFDELRE 329
P+ R + H + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)
Query: 40 YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 86
+ + +G G+FG V A+ + + VA+K + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 87 VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSAN 133
+ H N+I+L + L +++EY + ++ L+ +
Sbjct: 75 IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 134 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193
+++ + YQ+ RG+ Y+ + + HRDL +N+LV + +KI DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187
Query: 194 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 249
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 309
L +++K R E + P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278
Query: 310 SLRCTALEA 318
S R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 9e-31
Identities = 62/312 (19%), Positives = 111/312 (35%), Gaps = 63/312 (20%)
Query: 43 ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 92
R +G GSFG+V++ E VAIK V +++R E +M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 93 VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI------YVKLYT 145
V+ L ++ME + + L+ A P++ +
Sbjct: 85 VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 146 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--- 202
+I G+AY++ + HRDL +N +V VKI DFG + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 203 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 261
+ +PE + +TT D+WS G VL E+ L + + G + L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 315
P +L QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 316 LEACAHPFFDEL 327
++ P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 3e-19
Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 24/200 (12%)
Query: 44 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 103
+++G G VF E +K + ++++ R + L
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 104 TSKNELFL---NLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVP 159
+ L + Y E +++ + + + I +A +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-R 122
Query: 160 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIF 213
+ H DL N+LV + I DF + ++ ++ I + F R
Sbjct: 123 GIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174
Query: 214 GATEYTTSIDIWSAGCVLAE 233
Y T DI SA + +
Sbjct: 175 ---TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.9 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-65 Score=474.03 Aligned_cols=326 Identities=67% Similarity=1.190 Sum_probs=290.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHhCCCCceeeeceeeeecC-CCCceEEEEEee
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFLNLVME 116 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e 116 (380)
.+|+.+++||+|+||+||+|+++.+|+.||||++.++.....+|+.+|+.++|+||++++++|.... ..+..++|+|||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 3799999999999999999999999999999999887777779999999999999999999986543 345667899999
Q ss_pred cccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccCCC
Q 016950 117 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 196 (380)
Q Consensus 117 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~ 196 (380)
||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||++........
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 99998888887777778889999999999999999999999 89999999999999997566899999999987766666
Q ss_pred cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCcc
Q 016950 197 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 276 (380)
Q Consensus 197 ~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 276 (380)
..+..||+.|+|||++.+...|+.++||||+||++|+|++|++||.+.+..+.+..+.+.+|.+..+.+....+.+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 66788999999999998777799999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCchhhhccCCHH
Q 016950 277 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 356 (380)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (380)
++.....++.......+++++.+||.+||++||++|||+.|+|+||||+++..+....+.....+...++..+..+..++
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 338 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCGG
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCcc
Confidence 99988888888888889999999999999999999999999999999999988888788777778888887665566776
Q ss_pred HHhhhChH
Q 016950 357 LVNKLIPD 364 (380)
Q Consensus 357 ~~~~~~~~ 364 (380)
....++|.
T Consensus 339 ~~~~~~p~ 346 (350)
T d1q5ka_ 339 LATILIPP 346 (350)
T ss_dssp GHHHHSCT
T ss_pred ccccCCCc
Confidence 66666654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-61 Score=434.99 Aligned_cols=276 Identities=34% Similarity=0.609 Sum_probs=229.1
Q ss_pred eeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEE
Q 016950 42 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 42 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
.+++||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++|||||++++++.. ...+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-----~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-----KSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-----TTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCcee
Confidence 5689999999999999999999999999985332 234589999999999999999999943 33488
Q ss_pred EEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 113 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 113 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
+||||+.+++...+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. .+.+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence 999999987655543 356779999999999999999999999 89999999999999996 7889999999998664
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+++..+.+.+|.|..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345688999999999977777899999999999999999999999999999999999999999987766544333
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.....+......++...+ ..+++++++||.+||++||++|||++|+|+||||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 233333333344444433 35899999999999999999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-61 Score=427.27 Aligned_cols=248 Identities=29% Similarity=0.500 Sum_probs=213.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++.+. .....+|+.+++.++||||+++++++. +..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence 57899999999999999999999999999999998532 123457999999999999999999994 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeeccccee
Confidence 58999999985 77777753 3579999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
...... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 865433 34456899999999999764 4899999999999999999999999998887777665441
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+. ++..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 220 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EFT------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 23348999999999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-61 Score=430.73 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=209.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+++.++||||+++++++.+ ...
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 5678999999999999999999999999999999985432 334689999999999999999999954 345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+|||||++ +|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhe
Confidence 8999999985 6665553 45689999999999999999999999 79999999999999996 6789999999998
Q ss_pred cCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 190 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 190 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
...... .....+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.................
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------ 225 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------ 225 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------
Confidence 764332 23456899999999999776656788999999999999999999998765443333332211100
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.. ....+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 226 ---------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ---------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 00 11237999999999999999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-61 Score=431.41 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=215.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+++.++||||+++++++. +..
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECC
Confidence 368999999999999999999999999999999986421 23458999999999999999999984 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+|||||+| +|.+.+. ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccccc
Confidence 58999999985 7777665 34679999999999999999999999 79999999999999996 778999999999
Q ss_pred ccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 189 KQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 189 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
+...... .....+||+.|+|||++.+. .|+.++||||+||++|+|++|..||.+.+..+.+.++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--------- 225 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 225 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT---------
T ss_pred eecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC---------
Confidence 8764332 23356799999999999765 4899999999999999999999999998888877776541
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHH------HhcCCCcccccCCCCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNAR 333 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------~l~hp~~~~~~~~~~~ 333 (380)
.+. ++..+++++++||++||+.||++|||++| +++||||+++.|....
T Consensus 226 --------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 226 --------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp --------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred --------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 111 23458999999999999999999999987 6899999999876543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-60 Score=429.94 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=212.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
++|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+++.++||||+++++++.+. ..+|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 47999999999999999999999999999999986432 2346899999999999999999999543 34899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||+| +|.+.+. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence 9999986 6665543 2469999999999999999999999 79999999999999996 7889999999998765
Q ss_pred cCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 193 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
... .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..+.+..+..... +.
T Consensus 168 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~---------- 235 (293)
T d1yhwa1 168 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE---------- 235 (293)
T ss_dssp STTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------
T ss_pred cccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------
Confidence 433 3445689999999999965 4589999999999999999999999999888877776655311 10
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
+ ..+..+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus 236 ---~------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ---L------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---C------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---C------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 112347999999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=423.09 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=205.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++++.||+|+||+||+|+++.+|+.||+|++..... ...+|+.+++.++|||||++++++.+.. ...
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence 5789999999999999999999999999999999864422 2357999999999999999999886432 234
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----eeecCCCCCCEEEcCCCCcEEEEe
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-----iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
+|+|||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +| |+||||||+|||++. ++.+||+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~D 157 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLGD 157 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEECC
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEee
Confidence 789999998 58888887766677889999999999999999999998 56 999999999999996 78899999
Q ss_pred ecccccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 185 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 185 fg~a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
||+|+...... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+....+.... .
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~--- 231 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--F--- 231 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C---
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C---
Confidence 99998765433 2345788999999999965 458999999999999999999999999988877776665420 0
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 324 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~ 324 (380)
..++..+|+++.+||.+||+.||.+|||++|+++|||+
T Consensus 232 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01233579999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-60 Score=429.25 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=201.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||+++++++. +...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 466999999999999999999999999999999986432 22347999999999999999999983 44458
Q ss_pred EEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEeeccc
Q 016950 112 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSA 188 (380)
Q Consensus 112 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Dfg~a 188 (380)
|+|||||+ |+|.+.+. ....+++..++.++.||+.||+|||+ +||+||||||+|||+.. .++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence 99999998 58888775 35679999999999999999999999 79999999999999953 3578999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+....+.+....+
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 228 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-------- 228 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------
Confidence 876666555677899999999999654 58999999999999999999999999988877777666521111
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
....+..+|+++++||.+||++||++|||++|+++||||++
T Consensus 229 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 229 -----------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -----------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11123458999999999999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-59 Score=424.07 Aligned_cols=288 Identities=34% Similarity=0.578 Sum_probs=236.3
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCC-CcEEEEEEeecc------ccchHHHHHHHHhC---CCCceeeeceeeeecC
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRVM---DHPNVISLKHCFFSTT 104 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~ 104 (380)
...++|++++.||+|+||+||+|++..+ ++.||||++... .....+|+.+++.+ +||||++++++|....
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 4467899999999999999999999766 677999998532 22345788887766 7999999999987666
Q ss_pred CCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 105 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
......+|++|||+.++++..... .....+++..++.++.|++.||+|||+ +||+||||||+|||++. .+.+||+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~d 159 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLAD 159 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECS
T ss_pred cccCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecc
Confidence 667778999999999876655443 345678999999999999999999999 89999999999999996 77899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||+++............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9999876655556678899999999999664 599999999999999999999999999999999999999999988766
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
+....... ...+......+ ...+...+++.+++||.+||++||++|||++|+|+||||+++.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 239 WPRDVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp SCTTCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 54322111 11111111222 22345568999999999999999999999999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=430.84 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=217.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||++++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 578999999999999999999999999999999986431 2345899999999999999999999 4445
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+|||||+| +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeecccc
Confidence 69999999995 6666665 34678999999999999999999999 79999999999999997 788999999999
Q ss_pred ccCcc-CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 189 KQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 189 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
+.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------- 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence 86544 3344567899999999999654 5899999999999999999999999999988777666551
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
.+. ++..+|+++++||++||++||.+|++ ++|+++||||+++.|.
T Consensus 221 ------~~~------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 221 ------EIR------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------CCC------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------CCC------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 112 23458999999999999999999994 9999999999987653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=426.32 Aligned_cols=283 Identities=35% Similarity=0.656 Sum_probs=232.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++++.||+|+||+||+|+++.+|+.||||++..+ .....+|+.+++.++||||+++++++.+. ..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 6899999999999999999999999999999998543 22345899999999999999999999543 348
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+||||+.+++...+.. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence 99999999887766643 245679999999999999999999999 89999999999999996 778999999999765
Q ss_pred ccC-CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... .......||+.|+|||++.....++.++|+||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 433 3344568899999999987777678999999999999999999999999999999999999888877655443211
Q ss_pred CC-CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 271 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 271 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.. ....++......+.... ..+|+++++||++||++||++|||++|+|+||||+++..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhhhc-cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 10 11122222233333322 3588999999999999999999999999999999988654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-59 Score=435.14 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=221.9
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++|||||++++++.+ ...+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence 46789999999999999999999999999999999865432 33579999999999999999999844 3458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC-CCcEEEEeecccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~ 189 (380)
|+|||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ ++.+||+|||+|+
T Consensus 99 ~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~ 174 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174 (350)
T ss_dssp EEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchhe
Confidence 999999985 77776642 34679999999999999999999999 799999999999999642 5689999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
............||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+......+..
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------- 246 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 246 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------
T ss_pred ecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------
Confidence 87666666678899999999999765 4899999999999999999999999999888888877663222111
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
.....+|+++++||.+||++||++|||++|+|+||||+...++
T Consensus 247 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 247 ------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1123479999999999999999999999999999999986554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=423.12 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=212.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
+.|++++.||+|+||+||+|+++.+|+.||+|++... .....+|+.+|+.++|||||++++++.+. ..+|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEE
Confidence 5699999999999999999999999999999998643 23446899999999999999999998543 34889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||++ +|...+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|....
T Consensus 87 vmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhccC
Confidence 9999985 66666543 34679999999999999999999999 79999999999999996 7789999999997553
Q ss_pred cCC-CcceeeccCCCCChhhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 193 AGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 193 ~~~-~~~~~~~t~~y~aPE~l~~----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
... ......||+.|+|||++.. ...|+.++||||+||++|+|++|+.||.+.+..+.+.++.+... +
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--~------ 233 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--P------ 233 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--C------
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--C------
Confidence 321 2235678999999999843 34478999999999999999999999999888888777765211 0
Q ss_pred cCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 268 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.. ..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 234 ------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------TL------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------CC------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------CC------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 012347999999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-59 Score=422.39 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=218.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++|||||++++++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~---- 83 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE---- 83 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 4567999999999999999999999999999999985431 22358999999999999999999994
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC---cEE
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVK 181 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---~ik 181 (380)
+...+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. .+|
T Consensus 84 -~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 84 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred -ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceE
Confidence 44558999999985 78777763 3579999999999999999999999 79999999999999986332 599
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 261 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 261 (380)
|+|||+|.............+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+........
T Consensus 158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred ecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999999988766666667789999999999965 4589999999999999999999999999988888777655322111
Q ss_pred HHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCC
Q 016950 262 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 330 (380)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~ 330 (380)
..++..+|+++++||.+||+.||++|||++|+|+||||+...+.
T Consensus 237 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 237 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp -------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred -------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 12234589999999999999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-59 Score=414.97 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=207.0
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
|++.+.||+|+||+||+|.++.+++.||+|++.... ....+|+++|+.++|||||++++++.... .+...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 478889999999999999999999999999986432 22358999999999999999999886543 34556889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
|||||++ +|.+.+.. ...+++..++.++.||+.||+|||+ ++ |+||||||+|||++..++.+||+|||+|+.
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999985 77777753 4579999999999999999999999 78 999999999999975467899999999975
Q ss_pred CccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 191 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.. .......+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+......+.+.+.. +.++
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~--------- 231 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP--------- 231 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC---------
T ss_pred cc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC---------
Confidence 43 333456789999999999854 4899999999999999999999999876655544433321 1110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
..++...++++++||.+||+.||++|||++|+|+||||+
T Consensus 232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112334789999999999999999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-59 Score=430.73 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=219.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..++|++++.||+|+||+||+|.++.+|+.||||++.... ....+|+.+|+.++|||||+++++|. +...+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 4578999999999999999999999999999999986543 23357999999999999999999984 44458
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC-CCCcEEEEeecccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAK 189 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~-~~~~ikl~Dfg~a~ 189 (380)
|+|||||+| +|.+.+. .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ..+.+||+|||+|.
T Consensus 102 ~ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 102 VLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccce
Confidence 999999995 6655443 245579999999999999999999999 89999999999999973 35789999999999
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
............+|+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+..+......++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------- 248 (352)
T d1koba_ 178 KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------- 248 (352)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred ecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 87766666678899999999999654 589999999999999999999999999998888877766322111
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
......+|+++++||.+||++||.+|||+.|+|+||||+..
T Consensus 249 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 -----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11223589999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-59 Score=422.48 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=210.9
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..|++++.||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++|||||++++++.+. ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 459999999999999999999999999999999865432 234799999999999999999998543 34
Q ss_pred EEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 111 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 111 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
+|+|||||.++++..+. .....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus 90 ~~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI 164 (309)
T ss_dssp EEEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred EEEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeecccccc
Confidence 89999999976554433 245679999999999999999999999 89999999999999996 78999999999986
Q ss_pred CccCCCcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 191 LIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 191 ~~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
... .....||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+.+..+.+..+......+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (309)
T d1u5ra_ 165 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------- 233 (309)
T ss_dssp SSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred cCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 533 3356899999999998643 358999999999999999999999999988887777666521100
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+..+|+++++||.+||+.||.+|||++|+|+||||.+
T Consensus 234 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 012347999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-58 Score=422.57 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=215.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHhCCCCceeeeceeeeecCCCCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++||||+++++++. +..
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCC
Confidence 46799999999999999999999999999999998643 123458999999999999999999994 344
Q ss_pred EEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccc
Q 016950 110 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA 188 (380)
Q Consensus 110 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a 188 (380)
.+|+|||||.| ++...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred eeeeEeeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccc
Confidence 58999999996 4444444 46778999999999999999999999 89999999999999996 788999999999
Q ss_pred ccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 016950 189 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 268 (380)
Q Consensus 189 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (380)
+.... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+...++...
T Consensus 152 ~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------ 216 (316)
T d1fota_ 152 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------ 216 (316)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------
T ss_pred eEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------------
Confidence 86543 33457899999999999654 5899999999999999999999999999888888777652
Q ss_pred CCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 269 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
... ++..+|++++++|.+||++||.+|+ |++++++||||+++.|.
T Consensus 217 -----~~~------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 217 -----ELR------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp -----CCC------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----CCC------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 111 2234799999999999999999996 89999999999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=429.55 Aligned_cols=282 Identities=26% Similarity=0.421 Sum_probs=207.8
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
..++|++++.||+|+||+||+|+++.+|+.||+|++..+. ....+|+.+|+.++|||||+++++|.+ ...
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3578999999999999999999999999999999986432 233579999999999999999999943 345
Q ss_pred EEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+|||||+| +|.+.+.. ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCcc
Confidence 8999999995 77777753 3579999999999999999999996139999999999999996 7889999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHhhc
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV-EIIKVLGTPTREEIRCM 268 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~ 268 (380)
..... ...+.+||++|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+... ......+.+........
T Consensus 154 ~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 154 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred ccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 65432 23457899999999999765 59999999999999999999999998776543221 12222222111100000
Q ss_pred CCC-----CCCccCCCC---------CCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 269 NPN-----YTDFRFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 269 ~~~-----~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
... +.....+.. ............+|++++|||.+||++||.+|||++|+|+||||++..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 000 000000000 0000001111236889999999999999999999999999999987543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-58 Score=410.90 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=217.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------------chHHHHHHHHhCC-CCceeeeceeeee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------YKNRELQLMRVMD-HPNVISLKHCFFS 102 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------------~~~~e~~~l~~l~-h~niv~~~~~~~~ 102 (380)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+++.++ ||||+++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence 4689999999999999999999999999999999865321 2347999999997 999999999993
Q ss_pred cCCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEE
Q 016950 103 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK 181 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ik 181 (380)
+...+|+|||||++ +|.+.+.. .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k 150 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK 150 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred ----cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence 44558999999985 88888863 4579999999999999999999999 79999999999999996 78899
Q ss_pred EEeecccccCccCCCcceeeccCCCCChhhhhC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 016950 182 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 256 (380)
Q Consensus 182 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~-----~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~ 256 (380)
|+|||+|+............||+.|+|||++.+ ...++.++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999988766656666789999999999853 344788999999999999999999999999888877777662
Q ss_pred hCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 257 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.-.+. .....++|+++++||.+||+.||++|||++|+|+||||++
T Consensus 231 ~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 231 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp CCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 11111 0112248999999999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=423.10 Aligned_cols=316 Identities=32% Similarity=0.547 Sum_probs=240.0
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ....+|+.+|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999999999999999986432 123479999999999999999999865432 2334
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|||||+.++...++ ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+|.
T Consensus 97 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-cccccccccccee
Confidence 578999999877776654 2579999999999999999999999 89999999999999996 7889999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++.+.+....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 6533 33457889999999999877778999999999999999999999999999999999999999999887665433
Q ss_pred CCCC---CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
.... ....+......+... ...++++++|||.+||++||++|||+.|+|+||||+.+.+..... . ......
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~-~----~~~~~~ 321 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP-Q----VQKYDD 321 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------C----CCCCCC
T ss_pred chhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc-c----CCCCCC
Confidence 2110 012233333344433 345899999999999999999999999999999999986543321 1 111122
Q ss_pred hhhhccCCHHHHhhhChHHHH
Q 016950 347 KQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~ 367 (380)
..+....+.+.+++++-+++.
T Consensus 322 ~~~~~~~~~~e~k~~~~~e~~ 342 (346)
T d1cm8a_ 322 SFDDVDRTLDEWKRVTYKEVL 342 (346)
T ss_dssp C-----CCHHHHHHHHHHHHH
T ss_pred chhhhhcCHHHHHHHHHHHhh
Confidence 222334566677776655543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-58 Score=423.70 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=217.6
Q ss_pred CCccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCC
Q 016950 33 EPKQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS 105 (380)
Q Consensus 33 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 105 (380)
.+...++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++||||+++++++.
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~---- 111 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK---- 111 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE----
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc----
Confidence 3445789999999999999999999999999999999986421 22358999999999999999999984
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEe
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD 184 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~D 184 (380)
....+|+||||+.+ ++...+.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|
T Consensus 112 -~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~D 184 (350)
T d1rdqe_ 112 -DNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTD 184 (350)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred -cccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeee
Confidence 34458899999985 66666653 3579999999999999999999999 79999999999999996 77899999
Q ss_pred ecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 185 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 185 fg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
||+|+.... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 185 FG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------- 254 (350)
T d1rdqe_ 185 FGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------- 254 (350)
T ss_dssp CTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred ceeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-------
Confidence 999987643 23457899999999999764 48999999999999999999999999998888777776521
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
.. ++..+++++.+||++||++||.+|+ |++++++||||+++.|.
T Consensus 255 ----------~~------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 255 ----------VR------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp ----------CC------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred ----------CC------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 11 2335899999999999999999995 89999999999988764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-57 Score=411.75 Aligned_cols=277 Identities=35% Similarity=0.646 Sum_probs=225.3
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++++.||+|+||+||+|+++ +|+.||||++.... ....+|+.+|+.++||||+++++++.... ..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 68999999999999999999985 78999999985432 23458999999999999999999995443 38
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|++|||+.++++..+.. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||.|...
T Consensus 76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence 89999999987766653 46789999999999999999999999 79999999999999997 788999999999765
Q ss_pred ccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 192 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 192 ~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
.... ......+++.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 4332 234457899999999998777789999999999999999999999999999999999999999888765543321
Q ss_pred CCC-CccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 271 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 271 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
... ...+......++ ..+...++++++|||++||++||++|||++|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 111 111222222222 2334558999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=420.93 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=218.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++++.||+|+||+||+|.++.+++.||||++..... ...+|+.+|+.++||||++++++|.+ ...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence 5789999999999999999999999999999999965432 34589999999999999999999943 345899
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC-CCcEEEEeecccccC
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQL 191 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~-~~~ikl~Dfg~a~~~ 191 (380)
|||||+| +|.+.+.. ....+++..++.|+.||+.||+|||+ +||+||||||+|||++.+ ..++||+|||++...
T Consensus 79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999995 77777642 34579999999999999999999999 799999999999999752 357999999999877
Q ss_pred ccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCC
Q 016950 192 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 271 (380)
Q Consensus 192 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 271 (380)
..........+|+.|+|||.+.+. .|+.++||||+||++|+|++|..||.+.+..+.+..+.+....++..
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 225 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------- 225 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChh--------
Confidence 665556667889999999998654 58999999999999999999999999999888888887743222222
Q ss_pred CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 272 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
.+..+|+++++||.+||++||.+|||++|+++||||++
T Consensus 226 -----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 226 -----------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -----------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -----------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 22347999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.7e-58 Score=426.08 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=209.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchH---HHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKN---RELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .... +++.+++.++|||||+++++|.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 468999999999999999999999999999999985432 1112 3466777788999999999984
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
....+|+|||||+ |+|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence 3445899999999 577777753 4678999999999999999999999 89999999999999996 788999999
Q ss_pred cccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 016950 186 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 265 (380)
Q Consensus 186 g~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 265 (380)
|+|+..... ......||+.|+|||++.+...|+.++|||||||++|+|++|+.||.+.+..+...........
T Consensus 152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 999865443 3345689999999999976666899999999999999999999999876543332211111110
Q ss_pred hhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCC-----HHHHhcCCCcccccCC
Q 016950 266 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP 330 (380)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e~l~hp~~~~~~~~ 330 (380)
...++..+|+++++||.+||++||++||| ++|+++||||+++.|.
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 01123458999999999999999999999 7999999999988654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-58 Score=418.12 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=212.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH-HhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
+++|++++.||+|+||+||+|+++.+|+.||||++.++. .....|..++ +.++||||+++++++. +.
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~ 75 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TK 75 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cC
Confidence 368999999999999999999999999999999996432 1223455554 4789999999999994 44
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+|||||++ +|...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. .+.+||+|||+
T Consensus 76 ~~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~ 149 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGM 149 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred CceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccch
Confidence 458999999985 7777765 34678999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCC-CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 016950 188 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 266 (380)
Q Consensus 188 a~~~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 266 (380)
|+...... ......||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.+..+... .
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~------- 219 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N------- 219 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-------
T ss_pred hhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C-------
Confidence 98654433 33456889999999999764 5899999999999999999999999999888777766541 1
Q ss_pred hcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH-HHhcCCCcccccCC
Q 016950 267 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP 330 (380)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-e~l~hp~~~~~~~~ 330 (380)
.. +++.+|+++++||++||++||++|||+. ++++||||+++++.
T Consensus 220 --------~~------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 220 --------PF------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp --------CC------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred --------CC------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 11 2345899999999999999999999995 89999999987653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=417.06 Aligned_cols=319 Identities=33% Similarity=0.611 Sum_probs=243.8
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
..+|++++.||+|+||+||+|.++.+|+.||||++.+... ...+|+.+|+.++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3579999999999999999999999999999999864322 23479999999999999999999866554455557
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
|+++++++++|.+.+.. ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|...
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceeec
Confidence 78888888899888863 469999999999999999999999 79999999999999996 788999999999765
Q ss_pred ccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 016950 192 IAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 267 (380)
Q Consensus 192 ~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (380)
.... .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.........+.+.......
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 4332 233467899999999986666689999999999999999999999999999999999888888887664432
Q ss_pred cCCC---CCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCC
Q 016950 268 MNPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF 344 (380)
Q Consensus 268 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 344 (380)
.... ......+.....+|...+ ..+++++++||.+||++||.+|||++|+|+||||+....+.... ......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~~ 314 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF 314 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCcc
Confidence 1100 001123333334444433 35899999999999999999999999999999999765543221 112334
Q ss_pred CchhhhccCCHHHHhhhChHHHH
Q 016950 345 NFKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
++..+......+.+++++.++.+
T Consensus 315 ~~~~~~~~~~~~~l~~l~~~e~~ 337 (345)
T d1pmea_ 315 KFDMELDDLPKEKLKELIFEETA 337 (345)
T ss_dssp --------CCHHHHHHHHHHHSG
T ss_pred CCChhhhhCCHHHHHHHHHHHHH
Confidence 55566667777888877666543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=408.96 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHhCC--CCceeeeceeeeecC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFSTT 104 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 104 (380)
.++|++.+.||+|+||+||+|+++.+|+.||||++.++. ....+|+.+++.++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--- 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--- 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence 457999999999999999999999999999999986432 22358999999986 899999999984
Q ss_pred CCCceEEEEEeecccc--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 105 SKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 105 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
+...+|+||||+.+ ++...+. ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred --eCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence 34458899999974 5555554 34679999999999999999999999 899999999999999975678999
Q ss_pred EeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 183 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 183 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
+|||+|..... .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+ .+.+.
T Consensus 153 ~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------ 219 (273)
T d1xwsa_ 153 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------ 219 (273)
T ss_dssp CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred Cccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence 99999976433 334467899999999999776656788999999999999999999997632 12220
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
.. .++..+|+++++||.+||++||++|||++|+|+||||+++.
T Consensus 220 -----------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 -----------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp -----------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -----------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 01 13345899999999999999999999999999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-56 Score=413.53 Aligned_cols=284 Identities=28% Similarity=0.486 Sum_probs=224.5
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+.+|+.++ ||||++++++|... ....+++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeE
Confidence 3578999999999999999999999999999999986543 34568999999995 99999999988543 2334889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||||.++.+.. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|.....
T Consensus 110 v~e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEeecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999753211 23579999999999999999999999 79999999999999987566799999999987766
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
........+|+.|+|||++.+...++.++||||+||++|+|++|..||... +..+....+...+|.+....+.......
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 666667789999999999987777899999999999999999999999754 4556677777777765544332211110
Q ss_pred CCc----cCCCCCCCCcccc----cCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccC
Q 016950 273 TDF----RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 329 (380)
Q Consensus 273 ~~~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~ 329 (380)
... ..+......+... ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 0111111112211 12347899999999999999999999999999999998765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=416.78 Aligned_cols=319 Identities=30% Similarity=0.515 Sum_probs=233.3
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++++.||+|+||+||+|.++.+|+.||||++.+.. ....+|+.+++.++||||++++++|..... +...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999999999999999996442 224589999999999999999999854432 3456
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+|+|||||.++++..+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhhh
Confidence 78999999999877655 3568999999999999999999999 79999999999999997 6779999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......+++...+.+..+.+....
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 77666666677899999999999764 58999999999999999999999999999999999999999988887665433
Q ss_pred CCCCCc--cCCCCCCCCcccc-----------cCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCC
Q 016950 270 PNYTDF--RFPQIKAHPWHKV-----------FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN 336 (380)
Q Consensus 270 ~~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~ 336 (380)
..+..+ ..+......+... .....+++++|||++||++||++||||+|+|+||||+...++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~-- 324 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-- 324 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT--
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc--
Confidence 221110 0011111111111 1112467899999999999999999999999999999864432211
Q ss_pred CCCCCCCCCchhhhccCCHHHHhhhChHHHH
Q 016950 337 GRPLPPLFNFKQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (380)
...|...+...+....+.+.+++++-.++.
T Consensus 325 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 325 -APPPQIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp -CCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 112233333333345666677777666553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=415.72 Aligned_cols=265 Identities=24% Similarity=0.358 Sum_probs=211.2
Q ss_pred ccccceeeee-eeecCCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHH-hCCCCceeeeceeeeecCCCCceEEE
Q 016950 35 KQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 35 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~ 112 (380)
...++|.+++ .||+|+||+||+|+++.+++.||||++.+. ....+|+.++. ..+|||||+++++|.+.. ....++|
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~ 85 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 85 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEE
Confidence 4567899875 699999999999999999999999998654 44568998865 558999999999885432 3356689
Q ss_pred EEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCC--CCcEEEEeecccc
Q 016950 113 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK 189 (380)
Q Consensus 113 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~--~~~ikl~Dfg~a~ 189 (380)
+|||||+ |+|.+.+.. .....+++..++.|+.||+.||+|||+ +||+||||||+|||++.. .+.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence 9999998 588888863 124579999999999999999999999 799999999999999852 3579999999998
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
............||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+......
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~---------- 231 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---------- 231 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS----------
T ss_pred eccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc----------
Confidence 7766666667889999999999855 45999999999999999999999999887655544433321110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+.+|. .....+|+++++||++||++||++|||+.|+++||||.+
T Consensus 232 ---~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 232 ---GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ---CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ---CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 1111111 111247999999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=411.84 Aligned_cols=316 Identities=34% Similarity=0.554 Sum_probs=245.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHhCCCCceeeeceeeeecCC-CCce
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL 109 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 109 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++||||+++++++..... ++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999865422 23479999999999999999998854432 2333
Q ss_pred EEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 110 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 110 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.+++++++++++|.+++. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence 455666666678877663 3579999999999999999999999 89999999999999996 7889999999997
Q ss_pred cCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 190 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 190 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... .......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.+..+.+..+......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 543 233456789999999998777778999999999999999999999999999999999999999988876554322
Q ss_pred CCCCC---ccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccccCCCCCCCCCCCCCCCCCc
Q 016950 270 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF 346 (380)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 346 (380)
..... ...+......+...+ ..++++++|||.+||++||++|||+.|+|+||||+++..+.. .+....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~-----~~~~~~~~~ 321 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD-----EPVADPYDQ 321 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS-----CCCCCCCCC
T ss_pred chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc-----CCCCCCCCC
Confidence 11000 012222333333332 358999999999999999999999999999999998765432 233444455
Q ss_pred hhhhccCCHHHHhhhChHHHH
Q 016950 347 KQELSGASPELVNKLIPDHVK 367 (380)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~ 367 (380)
..+......+.++.++.+++.
T Consensus 322 ~~~~~~~~~~~~k~~~~~e~~ 342 (348)
T d2gfsa1 322 SFESRDLLIDEWKSLTYDEVI 342 (348)
T ss_dssp GGGGCCCCHHHHHHHHHHHHH
T ss_pred cccchhcCHHHHHHHHHHHhh
Confidence 555566777777777666643
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=399.47 Aligned_cols=281 Identities=35% Similarity=0.576 Sum_probs=228.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
++|++++.||+|+||+||+|+++.+++.||||++..+. ....+|+.+++.++||||+++++++.. ....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-----~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-----ccce
Confidence 58999999999999999999999999999999986432 223589999999999999999999843 4448
Q ss_pred EEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccC
Q 016950 112 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 191 (380)
Q Consensus 112 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~ 191 (380)
++|++++.++.+..+. ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++. .+.+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence 8999999986555443 256788999999999999999999999 89999999999999996 778999999999876
Q ss_pred ccCCC-cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 192 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 192 ~~~~~-~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
..... .....+++.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 54433 33456688999999997776689999999999999999999887 56677788888888888887765544332
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 328 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~~ 328 (380)
........+..............+++.+++||++||++||.+|||++|+|+||||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 22222222222223333344456899999999999999999999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=404.73 Aligned_cols=287 Identities=28% Similarity=0.481 Sum_probs=224.1
Q ss_pred ccccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCC---
Q 016950 35 KQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS--- 105 (380)
Q Consensus 35 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 105 (380)
..+++|++++.||+|+||+||+|+++.+|+.||||++..+. ....+|+.+|+.++|+||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 45789999999999999999999999999999999985332 223589999999999999999998854321
Q ss_pred CCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 106 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.....+|+||||+.+++..... .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~df 161 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADF 161 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCC
T ss_pred ccCceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEeeec
Confidence 2234588999999987665543 356779999999999999999999999 79999999999999996 788999999
Q ss_pred cccccCccC-----CCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|++...... ......+||++|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999755422 223345789999999999877779999999999999999999999999999999999999998888
Q ss_pred CHHHHhhcCCCCC--CccCCCCCCCCccccc-CCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCccc
Q 016950 261 TREEIRCMNPNYT--DFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 326 (380)
Q Consensus 261 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~ 326 (380)
..+........-. .+.............+ ....+++++|||.+||++||++|||++|+|+||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 7665443321111 1111111111111111 0124788999999999999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-54 Score=386.45 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=203.6
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
..++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+|+.+++.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 35679999999999999999999999999999999864321 2357999999999999999999886544 334
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+|||||+| +|...+. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.++++|||.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~ 157 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTT
T ss_pred ceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhhh
Confidence 568899999996 6665554 34679999999999999999999999 89999999999999996 77899999999
Q ss_pred cccCccCC----CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
+....... .....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+.+++.....++
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 234 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-- 234 (277)
T ss_dssp CEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred hhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--
Confidence 87543322 23456789999999999654 589999999999999999999999999988888777665321111
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcc
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 325 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~ 325 (380)
......+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 235 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112345899999999999999999999544445577764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-53 Score=383.62 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=202.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||+||+|.++.+++.||||++..+.. ...+|+.+|+.++|||||++++++.+. ..+|+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEE
Confidence 3579999999999999999999999999999999865433 345899999999999999999998433 33789
Q ss_pred Eeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||+ |+|...+.. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccceeecC
Confidence 999998 577777753 245678999999999999999999999 89999999999999996 7889999999998765
Q ss_pred cCCCc--ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 193 AGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 193 ~~~~~--~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
..... ....+|+.|+|||++.+. .|+.++||||+||++|+|++|..||........+.+++..-.
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------ 233 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------ 233 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------
T ss_pred CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------
Confidence 44332 234578899999999765 489999999999999999996655544333333433333100
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCCCcccc
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 327 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp~~~~~ 327 (380)
...++..+++++.+||.+||+.||.+|||++|+++ +|+.+
T Consensus 234 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred ---------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 01123458999999999999999999999999965 55544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=388.37 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=202.0
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~aiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
++|++.+.||+|+||+||+|++..+++ .||+|.+.... ....+|+.++..+ +|||||++++++.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---- 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---- 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence 689999999999999999999876554 69999885332 2345799999888 89999999999843
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCC
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL 166 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dl 166 (380)
...+|+|||||+ |+|.+.+..... ....+++..++.|+.||+.||+|||+ +||+||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRDl 190 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDL 190 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETTC
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccC
Confidence 334889999998 588888864321 12458999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCCcEEEEeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 016950 167 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP 242 (380)
Q Consensus 167 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~ 242 (380)
||+|||++. ++.+||+|||+|+........ ....+|+.|+|||++.+. .++.++|||||||++|||++ |.+||.
T Consensus 191 Kp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 999999996 789999999999876554432 245679999999999754 58999999999999999997 899999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 243 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+.+..+.+.+++..-..+ .++..+|+++++||.+||+.||++|||++|+++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 887777666665521111 1234589999999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=375.77 Aligned_cols=244 Identities=19% Similarity=0.306 Sum_probs=192.5
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.+|++++.||+|+||+||+|.++ +++.||||++..+. ....+|+.+++.++|||||++++++.... .+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEE
Confidence 47999999999999999999976 56789999986543 23458999999999999999999984432 37899
Q ss_pred eecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchheeccC
Confidence 999984 67776653 44678899999999999999999999 89999999999999996 78899999999986644
Q ss_pred CCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... .....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||...+..+.+..+......
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------- 221 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------- 221 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------
Confidence 332 2235689999999999654 59999999999999999999 57778777776666665542110
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+..+++++.+||.+||+.||++|||++|+++|
T Consensus 222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1223478999999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=379.06 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=196.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF 110 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 110 (380)
.++|++.+.||+|+||+||+|+.. ..||||++.... ....+|+.+++.++|||||+++++... + .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~--~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----P--Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----c--E
Confidence 457999999999999999999753 469999985332 233579999999999999999886521 1 2
Q ss_pred EEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 111 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 111 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
+|+|||||+ |+|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEcccccee
Confidence 679999998 578777753 34679999999999999999999999 89999999999999996 7889999999997
Q ss_pred cCccCC---CcceeeccCCCCChhhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 190 QLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 190 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
...... ......||+.|+|||++.+. ..|+.++|||||||++|||+||+.||.+.+....+...+.....++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--- 229 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--- 229 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence 654322 22345789999999998643 3479999999999999999999999998877666655554311111
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....++..+++++.+||.+||+.||++|||+.|+++|
T Consensus 230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111234589999999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=378.98 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=202.1
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||+||+|.++ +++.||||++..+.. ...+|+.+++.++|||||++++++.. + .+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~--~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----E--PIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----S--SCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----C--CeEE
Confidence 368999999999999999999975 678899999965432 34589999999999999999997632 1 1579
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||++ +|.+.+... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccceEEcc
Confidence 9999985 666654322 23458999999999999999999999 89999999999999996 7889999999998765
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....+|+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------- 228 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------- 228 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 4332 2345678999999999754 489999999999999999995 666777666666555443110
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc--CCCccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE 326 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~ 326 (380)
...+..+++++.+||.+||+.||++|||++++++ |+||..
T Consensus 229 -----------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 -----------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1123458999999999999999999999999998 888864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=379.96 Aligned_cols=246 Identities=24% Similarity=0.318 Sum_probs=190.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|++.+.||+|+||+||+|+++.+++ .||||.+.... ....+|+.+|+.++|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS----- 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 4679999999999999999999987765 58899875432 2345899999999999999999998433
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+|||||++ +|.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCccc
Confidence 338899999995 66665552 34579999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCCCc------ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 188 AKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 188 a~~~~~~~~~------~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|+........ ....+|+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+......+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9866443221 124568899999999754 58999999999999999998 899999988877666554321111
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+..+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123479999999999999999999999998764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=387.83 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=209.0
Q ss_pred cccceeeeeeeecCCceEEEEEEEC---CCCcEEEEEEeecc--------ccchHHHHHHHHhCCC-Cceeeeceeeeec
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVMDH-PNVISLKHCFFST 103 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~aiK~~~~~--------~~~~~~e~~~l~~l~h-~niv~~~~~~~~~ 103 (380)
..++|++++.||+|+||+||+|++. .+|+.||||++.+. .....+|+.++++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 3588999999999999999999974 47899999988532 1234589999999977 799999998843
Q ss_pred CCCCceEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEE
Q 016950 104 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 182 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl 182 (380)
...++++|||+.+ +|...+.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus 101 ----~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL 170 (322)
T d1vzoa_ 101 ----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVL 170 (322)
T ss_dssp ----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEE
T ss_pred ----CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEE
Confidence 3458899999995 77777653 4567899999999999999999999 79999999999999997 688999
Q ss_pred EeecccccCccCC--CcceeeccCCCCChhhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 016950 183 CDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 259 (380)
Q Consensus 183 ~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~l~~~~-~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 259 (380)
+|||+|+...... ......|++.|+|||.+.+.. .++.++||||+||++|+|++|..||.+.+..+....+.+....
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 9999998654332 233567899999999996543 4688999999999999999999999887655555554432110
Q ss_pred CCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCC-----CHHHHhcCCCcccccCC
Q 016950 260 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 330 (380)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~hp~~~~~~~~ 330 (380)
. ...++..+|+++++||.+||++||.+|| |++|+++||||+.+++.
T Consensus 251 ~-------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 251 S-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp C-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred C-------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 0 0012345899999999999999999999 58999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=371.13 Aligned_cols=244 Identities=18% Similarity=0.259 Sum_probs=203.1
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
++|++++.||+|+||+||+|+++ +++.||||++.++. ....+|+.+++.++||||+++++++.+. ..+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence 57999999999999999999974 77899999987643 3345899999999999999999988432 338899
Q ss_pred eeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||++ |++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+....
T Consensus 78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheeccC
Confidence 99998 566666542 34568899999999999999999999 89999999999999996 78899999999986544
Q ss_pred CCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCC
Q 016950 194 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 270 (380)
Q Consensus 194 ~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 270 (380)
... .....+|+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+....
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~----------- 220 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------- 220 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred CCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 332 2235679999999999754 48999999999999999998 89999999887776665542111
Q ss_pred CCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 271 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..+..+++++.+||.+||+.||++|||++++++|
T Consensus 221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1223478999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=374.93 Aligned_cols=250 Identities=26% Similarity=0.314 Sum_probs=202.1
Q ss_pred ccceeeeee-eecCCceEEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERV-VGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|.+.+. ||+|+||+||+|.++. ++..||||++.... ....+|+.+|+.++|||||++++++.. .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~---- 81 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E---- 81 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S----
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C----
Confidence 357888885 9999999999998764 44579999986432 223579999999999999999998732 1
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
.+|+|||||++ +|.+.+. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 82 -~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGl 155 (285)
T d1u59a_ 82 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGL 155 (285)
T ss_dssp -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred -eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeeccchh
Confidence 17899999995 7766653 245679999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+...
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---- 230 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---- 230 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred hhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 987644322 2234578899999999655 48999999999999999998 9999998887766655543110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH---hcCCCccc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE 326 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~---l~hp~~~~ 326 (380)
..++..+|+++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 231 ------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 231 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 01234589999999999999999999999877 67888854
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=374.35 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=194.7
Q ss_pred eeeecCCceEEEEEEEC--CCCcEEEEEEeeccc------cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEEe
Q 016950 44 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 115 (380)
Q Consensus 44 ~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 115 (380)
+.||+|+||+||+|... .+++.||||++.... ....+|+.+|+.++|||||++++++.. . . .|+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~----~-~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E----S-WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S----S-EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C----C-EEEEE
Confidence 47999999999999864 456789999985432 234589999999999999999998732 1 1 67999
Q ss_pred ecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCccC
Q 016950 116 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 194 (380)
Q Consensus 116 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~ 194 (380)
|||++ +|.+.+. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccchhhhhhcccc
Confidence 99985 7777665 45679999999999999999999999 89999999999999996 788999999999866443
Q ss_pred CCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 195 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 195 ~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
... ....||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+. ..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~--------- 228 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER--------- 228 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC---------
T ss_pred ccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC---------
Confidence 322 234678999999999754 48999999999999999998 89999998877665554331 00
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHH---hcCCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~---l~hp~~~~~ 327 (380)
..++..+|+++.+||.+||+.||++|||++++ |+|+|++-+
T Consensus 229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence 01234589999999999999999999999988 567776543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=368.65 Aligned_cols=251 Identities=26% Similarity=0.330 Sum_probs=197.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++.+.||+|+||+||+|.++.+ +.||||++..+. ....+|+.+++.++|+|||++++++.. .. +++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~-~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EP-IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS-CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CC-eEE
Confidence 47899999999999999999998655 579999986543 234589999999999999999998732 11 679
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCc
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 192 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~ 192 (380)
|||||.+ ++...+.. .....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus 89 v~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchhhhcc
Confidence 9999995 56655543 234569999999999999999999999 79999999999999996 7889999999998654
Q ss_pred cCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 016950 193 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 269 (380)
Q Consensus 193 ~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 269 (380)
.... .....+|+.|+|||++.+. .++.++|||||||++|+|++| .+||.+....+.+..+.+....
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------- 233 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------- 233 (285)
T ss_dssp -----------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred CCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 3322 2335679999999999654 589999999999999999995 5556666666666554432111
Q ss_pred CCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc--CCCcccc
Q 016950 270 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL 327 (380)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--hp~~~~~ 327 (380)
.++..+++++++||.+||+.||++|||++++++ |+||...
T Consensus 234 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 123358999999999999999999999999987 8899764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=366.84 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=190.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.++|++.+.||+|+||+||+|.+..++ ..||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 368999999999999999999987654 468899885322 223579999999999999999998731
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
..+|+||||+++ ++...+. .....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEccchh
Confidence 127899999985 5655544 245678999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCCC--cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 016950 188 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 264 (380)
Q Consensus 188 a~~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 264 (380)
|+....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~------ 227 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------ 227 (273)
T ss_dssp ----------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred heeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------
Confidence 986543322 2345678999999999654 58999999999999999998 8999999888777766543110
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
..++..+|+++.+||.+||+.||++|||+.|+++|
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 ----------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234589999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=372.28 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=195.4
Q ss_pred cceeeeeeeecCCceEEEEEEECCCCc----EEEEEEeecc-----ccchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++++.||+|+||+||+|.+..+|+ .||+|++... .....+|+.+++.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 469999999999999999999988876 5788877432 22346899999999999999999988532
Q ss_pred eEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
. .++++||+. ++|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEeecccc
Confidence 1 456677776 577766653 46779999999999999999999999 89999999999999996 78899999999
Q ss_pred cccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 016950 188 AKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 263 (380)
Q Consensus 188 a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 263 (380)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+....
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---- 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC----
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9876443322 234679999999999765 58999999999999999998 89999988776655544431110
Q ss_pred HHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcCC
Q 016950 264 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 322 (380)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~hp 322 (380)
..+..+++++.+||.+||+.||.+|||+.|+++|.
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 01234789999999999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=361.59 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=187.6
Q ss_pred cceeeeeeeecCCceEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCc
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 108 (380)
.+|++.++||+|+||+||+|..+.++ ..||||++.... ....+|+.+++.++|||||++++++...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~----- 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----- 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence 46999999999999999999987654 469999985432 2235899999999999999999988433
Q ss_pred eEEEEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecc
Q 016950 109 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 187 (380)
Q Consensus 109 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~ 187 (380)
...++|||||.+ ++...+. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFGl 156 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGL 156 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC
T ss_pred CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcccch
Confidence 338899999986 4544443 245679999999999999999999999 79999999999999996 78899999999
Q ss_pred cccCccCCC----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCH
Q 016950 188 AKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTR 262 (380)
Q Consensus 188 a~~~~~~~~----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 262 (380)
|+....... .....||+.|+|||++.+. .++.++|||||||++|||++| .+||.+.+..+.+..+.....
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---- 231 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---- 231 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC----
Confidence 987544322 2234578999999999654 599999999999999999995 555555555554444332110
Q ss_pred HHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 263 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
...+..+++.+.+||.+||+.||++|||+.|+++
T Consensus 232 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1123347899999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=366.02 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=190.0
Q ss_pred cceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCCC
Q 016950 38 ISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 38 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 106 (380)
++|++++.||+|+||+||+|.+.. +++.||||++..... ...+|..++.++ .|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence 689999999999999999999754 457899999864322 223455666555 688999988876432
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEE
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 173 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill 173 (380)
...+++|||||+ |+|.+.+..... ....+++..+..++.||+.||+|||+ +||+||||||+|||+
T Consensus 90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILL 167 (299)
T ss_dssp -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccceeE
Confidence 223789999998 578888765332 13458999999999999999999999 799999999999999
Q ss_pred cCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 016950 174 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQ 249 (380)
Q Consensus 174 ~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~ 249 (380)
+. ++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||++|+|++| .+||.+.+..+.
T Consensus 168 ~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 78899999999986543322 2345789999999999764 589999999999999999986 578988776666
Q ss_pred HHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 250 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 250 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
+...+.....+ .++..+++++.+||.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65555421111 1233479999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-50 Score=363.88 Aligned_cols=258 Identities=23% Similarity=0.264 Sum_probs=200.0
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|+|++..+..+... ....++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence 345799999999999999999999999999999987543 34567899999999888766655544322 234789
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC--CCCcEEEEeecccccC
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL 191 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~--~~~~ikl~Dfg~a~~~ 191 (380)
||||+++++...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. .+..+||+|||+|+..
T Consensus 81 vme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 81 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999987766653 45679999999999999999999999 89999999999999864 2347999999999876
Q ss_pred ccCCC--------cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CC
Q 016950 192 IAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG---TP 260 (380)
Q Consensus 192 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~~~~---~~ 260 (380)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.+... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 44321 2345789999999999654 489999999999999999999999987765544433322110 00
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHH---HHhcCCCccc
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE 326 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---e~l~hp~~~~ 326 (380)
+. ..+...+|+++.+||.+||+.||++||+++ ++|+|+|.+.
T Consensus 236 ~~------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 236 PI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp CH------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred Ch------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 10 112235799999999999999999999986 5678887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=355.74 Aligned_cols=244 Identities=21% Similarity=0.321 Sum_probs=194.6
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV 114 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 114 (380)
.++|++++.||+|+||.||+|.+ .|+.||||++.++. ....+|+++++.++||||+++++++... ...+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEEE
Confidence 46899999999999999999998 47789999996553 3346899999999999999999987532 2237899
Q ss_pred eeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeecccccCcc
Q 016950 115 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 193 (380)
Q Consensus 115 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~~~~ 193 (380)
|||++ |+|.+.+... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS 155 (262)
T ss_dssp ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC------
T ss_pred EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccceecCC
Confidence 99998 5788877542 22358899999999999999999999 89999999999999996 78899999999986533
Q ss_pred CCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCCCC
Q 016950 194 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 272 (380)
Q Consensus 194 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (380)
. .....+|+.|+|||++.+. .++.++|||||||++|||++ |++||...+..+....+.+.
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---------------- 216 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------- 216 (262)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------------
T ss_pred C--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2 2345678899999999765 58999999999999999998 79999888777666554321
Q ss_pred CCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 273 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
....++..+++++.+||.+||+.||.+|||+.+++++
T Consensus 217 ------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 ------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0111334578999999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=366.06 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=203.4
Q ss_pred cccceeeeeeeecCCceEEEEEEECCCCcE--EEEEEeecc-----ccchHHHHHHHHhC-CCCceeeeceeeeecCCCC
Q 016950 36 QTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN 107 (380)
Q Consensus 36 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 107 (380)
..++|++.+.||+|+||+||+|.++.+|.. ||||++... .....+|+.+|+.+ +|||||++++++...
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~---- 83 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---- 83 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC----
Confidence 457899999999999999999999988864 677776432 23456899999998 799999999998543
Q ss_pred ceEEEEEeeccc-chHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEc
Q 016950 108 ELFLNLVMEYVP-ESMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD 174 (380)
Q Consensus 108 ~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~ 174 (380)
..+|+||||++ |+|.+.+... ......+++..+..++.||+.||.|||+ ++|+||||||+|||++
T Consensus 84 -~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVG 161 (309)
T ss_dssp -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC
T ss_pred -CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEc
Confidence 34899999999 5888877532 1245679999999999999999999999 7999999999999999
Q ss_pred CCCCcEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 016950 175 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEI 253 (380)
Q Consensus 175 ~~~~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~-~pf~~~~~~~~~~~i 253 (380)
. ++.+||+|||+|+............+|+.|+|||.+.+. .++.++|||||||++|+|++|. +||.+.+..+....+
T Consensus 162 ~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 E-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp G-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred C-CCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 6 778999999999876555555556789999999999765 4899999999999999999964 678888777666554
Q ss_pred HHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 254 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
.+.. ...++..+++++.+||.+||+.||++|||+.++++|
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3210 011234579999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=359.05 Aligned_cols=244 Identities=26% Similarity=0.336 Sum_probs=190.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCC-C--cEEEEEEeeccc-------cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~aiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||.||+|+...+ + ..||||++.++. ....+|+.+++.++||||+++++++.+.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 35799999999999999999986533 3 368999885421 2335899999999999999999988421
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
.+++||||++ +++.+.+.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus 84 ---~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~vkl~Df 155 (273)
T d1u46a_ 84 ---PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDF 155 (273)
T ss_dssp ---SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred ---chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccceeeccc
Confidence 2579999998 466665543 34569999999999999999999999 89999999999999997 788999999
Q ss_pred cccccCccCCCc----ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 016950 186 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 260 (380)
Q Consensus 186 g~a~~~~~~~~~----~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 260 (380)
|+++........ ....++..|+|||++.+. .++.++|||||||++|||++ |..||.+.+..+.+..+.+....+
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 999876444332 223567889999999764 58999999999999999998 899999999888877665421110
Q ss_pred CHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHh
Q 016950 261 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 319 (380)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 319 (380)
..+..+|+++.+||.+||+.||++|||+.+++
T Consensus 235 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 235 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12345899999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=358.98 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=194.5
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCC-------cEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeec
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFST 103 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~ 103 (380)
.++|++++.||+|+||.||+|++..++ ..||||++.++.. ...+|...+..+ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 478999999999999999999976554 4799999865432 223577777777 89999999999943
Q ss_pred CCCCceEEEEEeeccc-chHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 104 TSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 104 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
...+++|||||. |+|.+.+.... .....+++..+..++.||+.||+|||+ ++|+||||||+|
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN 165 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence 334889999998 57877776432 123568999999999999999999999 899999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
||++. ++.+||+|||+++....... .....+|+.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.+.+.
T Consensus 166 iLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99996 77899999999987654432 2345778999999999764 59999999999999999998 7999988877
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+....+... ..+ .++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 6655443321 100 123458999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-49 Score=360.42 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=199.8
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++++.||+|+||+||+|+.+ .+++.||||++..+. ....+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 467999999999999999999975 356789999986432 2346899999999999999999988443
Q ss_pred CceEEEEEeeccc-chHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecC
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 165 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~D 165 (380)
...+++|||+. |+|.+.+.... .....+++..+..|+.|++.||+|||+ ++++|||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrD 165 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRD 165 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeE
Confidence 33789999998 57887775321 123358899999999999999999999 7999999
Q ss_pred CCCCCEEEcCCCCcEEEEeecccccCccCC---CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 016950 166 LKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLF 241 (380)
Q Consensus 166 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~-~pf 241 (380)
|||+|||++. ++.+||+|||+|+...... ......+|+.|+|||.+.+. .|+.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999996 7889999999997553332 22345678999999999764 4999999999999999999985 789
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 242 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+.+..+.+..+.+... ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 88888877766543110 0123458999999999999999999999999954
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=357.61 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=205.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHhCCCCceeeeceeeeecCCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSK 106 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~aiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 106 (380)
.++|++.+.||+|+||+||+|.++. ++..||||++..... ...+|+.+++.++||||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC---
Confidence 3789999999999999999998753 357899999965322 235899999999999999999988432
Q ss_pred CceEEEEEeeccc-chHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCc
Q 016950 107 NELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ 179 (380)
Q Consensus 107 ~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ 179 (380)
...++||||+. |+|...+..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.
T Consensus 96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~-~~~ 171 (308)
T d1p4oa_ 96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFT 171 (308)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT-TCC
T ss_pred --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC-Cce
Confidence 23789999998 577776653221 12346889999999999999999999 89999999999999996 788
Q ss_pred EEEEeecccccCccCCC---cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 016950 180 VKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 180 ikl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g-~~pf~~~~~~~~~~~i~~ 255 (380)
+||+|||+|+....... .....+|+.|+|||.+.+. .++.++|||||||++|+|+|| .+||.+.+..+.+..+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999986544322 2334679999999999754 489999999999999999998 588988888777766654
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc------CCCcccc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDEL 327 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~------hp~~~~~ 327 (380)
... ...+..+++.+.+||.+||+.||++|||+.++++ +|+|+++
T Consensus 251 ~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 251 GGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 210 0022357899999999999999999999999997 7777654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=353.57 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=201.6
Q ss_pred ccceeeeeeeecCCceEEEEEEEC-----CCCcEEEEEEeecccc-----chHHHHHHHHhC-CCCceeeeceeeeecCC
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHCFFSTTS 105 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~-----~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 105 (380)
.++|++.+.||+|+||.||+|+.. .+++.||||++..... ...+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 478999999999999999999863 4668899999865432 234788999998 69999999999843
Q ss_pred CCceEEEEEeecccc-hHHHHHHHhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCC
Q 016950 106 KNELFLNLVMEYVPE-SMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN 170 (380)
Q Consensus 106 ~~~~~~~lv~e~~~~-~l~~~l~~~~--------------~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~N 170 (380)
...+|+|||||++ +|...+.... .....+++..+..++.||+.||+|||+ +|++||||||+|
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN 175 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence 3348899999984 7777775432 123468999999999999999999999 799999999999
Q ss_pred EEEcCCCCcEEEEeecccccCccCCCc---ceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCh
Q 016950 171 LLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA 246 (380)
Q Consensus 171 ill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~-g~~pf~~~~~ 246 (380)
|+++. ++.+|++|||.++........ ....+|+.|+|||++.+. .++.++|||||||++|+|+| |.+||.+.+.
T Consensus 176 Il~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99996 788999999999876543322 235779999999999654 58999999999999999998 7788888777
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 247 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.+.+.++++.-..+ ..+..+++++.+||.+||+.||.+|||++++++
T Consensus 254 ~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67776666531111 122347899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-48 Score=361.91 Aligned_cols=287 Identities=29% Similarity=0.465 Sum_probs=209.2
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHhCC-----------CCceeeeceeeee
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-----------HPNVISLKHCFFS 102 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 102 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.++.. ...+|+.+++.++ |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3569999999999999999999999999999999976532 3357888888775 5788888887744
Q ss_pred cCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCC----
Q 016950 103 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---- 178 (380)
Q Consensus 103 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~---- 178 (380)
.. ......++.++++.++...... ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.
T Consensus 92 ~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 22 2222333333434444333332 2356788999999999999999999996358999999999999975322
Q ss_pred -cEEEEeecccccCccCCCcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Q 016950 179 -QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLV 251 (380)
Q Consensus 179 -~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~------~~~~~~ 251 (380)
.++++|||.|..... ......+|+.|+|||++.+. .++.++|+||+||++++|++|+.||...+ ..+.+.
T Consensus 169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 499999999975433 33456889999999999764 48999999999999999999999997543 345677
Q ss_pred HHHHHhCCCCHHHHhhcCCC-------CCCccCCCCCCCCccc------ccCCCCChHHHHHHHhhcccCCCCCCCHHHH
Q 016950 252 EIIKVLGTPTREEIRCMNPN-------YTDFRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTALEA 318 (380)
Q Consensus 252 ~i~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 318 (380)
..+..+|.++...+...... ............++.. .+....+++++|||.+||++||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 77888898877665432110 0001111111111111 1122356789999999999999999999999
Q ss_pred hcCCCcccccC
Q 016950 319 CAHPFFDELRE 329 (380)
Q Consensus 319 l~hp~~~~~~~ 329 (380)
|+||||++...
T Consensus 326 L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 326 VNHPWLKDTLG 336 (362)
T ss_dssp HTCGGGTTCTT
T ss_pred hcCcccCCCCC
Confidence 99999997643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-48 Score=348.90 Aligned_cols=250 Identities=19% Similarity=0.220 Sum_probs=199.4
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHhCCC-CceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~l 113 (380)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++| +|++.+++++. .....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEE
Confidence 35799999999999999999999999999999988543 3445789999999976 89999888773 3344889
Q ss_pred EeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcC----CCCcEEEEeecccc
Q 016950 114 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAK 189 (380)
Q Consensus 114 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~----~~~~ikl~Dfg~a~ 189 (380)
||||++++|...+.. ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ..+.+||+|||+|+
T Consensus 79 vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 79 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999998887753 45679999999999999999999999 79999999999999964 24679999999998
Q ss_pred cCccCC--------CcceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 016950 190 QLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG 258 (380)
Q Consensus 190 ~~~~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 258 (380)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 654321 22345799999999999654 5999999999999999999999999865433 33333322111
Q ss_pred CCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 259 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
.++... +..++|+++.+++..|++.+|++||+.+.+.+
T Consensus 234 ~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111111 12347899999999999999999999876643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=347.05 Aligned_cols=244 Identities=21% Similarity=0.306 Sum_probs=188.5
Q ss_pred eeeeeeeecCCceEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHhCCCCceeeeceeeeecCCCCceEE
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 111 (380)
+...++||+|+||+||+|.+..++ ..||||++.... ....+|+++|++++||||+++++++.... ..+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence 444688999999999999987654 358999985321 23458999999999999999999875432 247
Q ss_pred EEEeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCCCcEEEEeeccccc
Q 016950 112 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 190 (380)
Q Consensus 112 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~~ 190 (380)
++|||||++ +|.+++. .....+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 105 ~lv~E~~~~g~l~~~~~---~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARD 179 (311)
T ss_dssp EEEEECCTTCBHHHHHH---CTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCC
T ss_pred EEEEEEeecCchhhhhc---cccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchhh
Confidence 899999995 5555554 245567888899999999999999999 79999999999999996 78899999999986
Q ss_pred CccCCC-----cceeeccCCCCChhhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Q 016950 191 LIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREE 264 (380)
Q Consensus 191 ~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~~DiwslGvil~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 264 (380)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...... +....+.. |..
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~~---- 252 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GRR---- 252 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TCC----
T ss_pred ccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CCC----
Confidence 543322 2235678999999998654 5899999999999999999977777654332 22322222 100
Q ss_pred HhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhcC
Q 016950 265 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 321 (380)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 321 (380)
...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 253 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 ----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01233578999999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=342.24 Aligned_cols=268 Identities=22% Similarity=0.224 Sum_probs=187.9
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHhCCCCceeeeceeeeecCCCCceEEEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 113 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~--~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 113 (380)
..+|.+.+.||+|+||+||+|+. +|+.||||++..+... . ..|+..+..++||||+++++++.... .....+|+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence 35799999999999999999986 6899999998654322 2 23444555789999999999987654 34456889
Q ss_pred Eeecccc-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCeeecCCCCCCEEEcCCCCcEEEEee
Q 016950 114 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDF 185 (380)
Q Consensus 114 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~-------~~iiH~Dlkp~Nill~~~~~~ikl~Df 185 (380)
|||||++ +|...++. ..+++.....++.|++.||.|||+. +||+||||||+|||++. ++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCC
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEec
Confidence 9999984 88888763 3688999999999999999999962 59999999999999996 789999999
Q ss_pred cccccCccCCC-----cceeeccCCCCChhhhhCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 016950 186 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 255 (380)
Q Consensus 186 g~a~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~-----~~~~~~DiwslGvil~~ll~g~~pf~~~~~~~~~~~i~~ 255 (380)
|+++....... .....||+.|+|||++.+.. .++.++|||||||++|||+||..||............ .
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-c
Confidence 99987644332 23467899999999986532 2567899999999999999999887532211000000 0
Q ss_pred HhCCCCHHHHhhcCCCCCCccCCCCCCCCcccccCCCCChHHHHHHHhhcccCCCCCCCHHHHhc
Q 016950 256 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 320 (380)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 320 (380)
....+..+.+..... .....|... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVC--EQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHT--TSCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHh--ccccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000011111100000 000000000 00001113356899999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.3e-25 Score=187.22 Aligned_cols=159 Identities=18% Similarity=0.120 Sum_probs=115.2
Q ss_pred eeeeeeeecCCceEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHhCCCCceeeec
Q 016950 40 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK 97 (380)
Q Consensus 40 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~ 97 (380)
|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999974 78999999864211 0112577888899999988876
Q ss_pred eeeeecCCCCceEEEEEeecccchHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecCCCCCCEEEcCCC
Q 016950 98 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 177 (380)
Q Consensus 98 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iiH~Dlkp~Nill~~~~ 177 (380)
+.. . .+++|||+++... ..++...+..++.|++.+|+|||+ +||+||||||+|||++.
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-- 138 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-- 138 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET--
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC--
Confidence 543 2 2599999997421 124445567899999999999999 79999999999999985
Q ss_pred CcEEEEeecccccCccCCCcceeeccCCCCC------hhhhhCCCCCCchhhHHHHHHH
Q 016950 178 HQVKICDFGSAKQLIAGEANISYICSRFYRA------PELIFGATEYTTSIDIWSAGCV 230 (380)
Q Consensus 178 ~~ikl~Dfg~a~~~~~~~~~~~~~~t~~y~a------PE~l~~~~~~~~~~DiwslGvi 230 (380)
..++|+|||.|.....+... . |.. .+.+ ...|+.++|+||+.--
T Consensus 139 ~~~~liDFG~a~~~~~~~~~-~------~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 139 EGIWIIDFPQSVEVGEEGWR-E------ILERDVRNIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TEEEECCCTTCEETTSTTHH-H------HHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred CCEEEEECCCcccCCCCCcH-H------HHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence 45999999999754322211 0 111 1112 1347889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=2.5e-06 Score=72.95 Aligned_cols=78 Identities=17% Similarity=0.108 Sum_probs=50.7
Q ss_pred ccceeeeeeeecCCceEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHhCC-CCceeeeceeeeecCCCCceEE
Q 016950 37 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL 111 (380)
Q Consensus 37 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 111 (380)
...|++.+..+.++.+.||++. .+++.+++|..... .....+|...++.+. +-.+.+++... .+....
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~ 85 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWS 85 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCce
Confidence 3468888876666778999886 36667888987533 223468888888774 22234444433 222346
Q ss_pred EEEeecccch
Q 016950 112 NLVMEYVPES 121 (380)
Q Consensus 112 ~lv~e~~~~~ 121 (380)
++||++++|.
T Consensus 86 ~lv~~~l~G~ 95 (263)
T d1j7la_ 86 NLLMSEADGV 95 (263)
T ss_dssp EEEEECCSSE
T ss_pred EEEEEecccc
Confidence 7999999873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=0.00011 Score=66.39 Aligned_cols=71 Identities=20% Similarity=0.130 Sum_probs=42.8
Q ss_pred eeeeecCCceEEEEEEECCCCcEEEEEEeecc-----------ccchHHHHHHHHhCC-C--CceeeeceeeeecCCCCc
Q 016950 43 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD-H--PNVISLKHCFFSTTSKNE 108 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----------~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 108 (380)
.+.||.|....||++.+..+++.+++|.-... ......|...|+.+. + ..+.+++. ++...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--- 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--- 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT---
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC---
Confidence 45689999999999998778889999964321 112346888887663 2 23444432 22221
Q ss_pred eEEEEEeecccc
Q 016950 109 LFLNLVMEYVPE 120 (380)
Q Consensus 109 ~~~~lv~e~~~~ 120 (380)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 3489999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=8.1e-05 Score=62.78 Aligned_cols=68 Identities=13% Similarity=0.073 Sum_probs=42.6
Q ss_pred ecCC-ceEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHhCCCCc--eeeeceeeeecCCCCceEEEEEeecccc
Q 016950 47 GTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPE 120 (380)
Q Consensus 47 g~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~-~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (380)
..|. .+.||++.. .++..+++|...... .....|...++.+.... +.+++....+ ....++||++++|
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEVPG 90 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECCSS
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEeeec
Confidence 3443 468898874 456678889775443 33567888888774333 3444443321 2236799999975
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.90 E-value=0.0034 Score=56.22 Aligned_cols=69 Identities=14% Similarity=0.231 Sum_probs=45.2
Q ss_pred eeeeecCCceEEEEEEECC-------CCcEEEEEEeeccc--cchHHHHHHHHhCCCCce-eeeceeeeecCCCCceEEE
Q 016950 43 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLN 112 (380)
Q Consensus 43 ~~~lg~G~~g~Vy~~~~~~-------~~~~~aiK~~~~~~--~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 112 (380)
++.|+.|..-.+|++.... .++.|.+++.-... ....+|..+++.+.-.++ .+++.++ ++ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence 4568889999999998653 34668888765322 223478888888753344 3555544 22 3
Q ss_pred EEeecccc
Q 016950 113 LVMEYVPE 120 (380)
Q Consensus 113 lv~e~~~~ 120 (380)
+|+||++|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78899875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.52 E-value=0.0072 Score=52.47 Aligned_cols=69 Identities=17% Similarity=0.015 Sum_probs=38.9
Q ss_pred ceEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHhCCCCce--eeeceeeeecCCCCceEEEEEeecccc
Q 016950 51 FGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVPE 120 (380)
Q Consensus 51 ~g~Vy~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~ 120 (380)
--.||++.. .+|+.|++|+..... .....|...+..|....+ +.....--........+.+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 358999974 678899999876432 334568888877743222 111110000000123346788888864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.012 Score=50.55 Aligned_cols=30 Identities=27% Similarity=0.203 Sum_probs=25.7
Q ss_pred CCeeecCCCCCCEEEcCCCCcEEEEeecccc
Q 016950 159 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 189 (380)
Q Consensus 159 ~~iiH~Dlkp~Nill~~~~~~ikl~Dfg~a~ 189 (380)
.|+||+|+.++||+++. +...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred cccccCCcchhhhhccc-ccceeEecccccc
Confidence 47999999999999995 5556799999884
|